Citrus Sinensis ID: 006090

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660--
Protein Sequence
MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHccccccccccccccccccccEEEEcccEEEEEEccccccccccEEEEEEcccccccccEEEEcccccccccccEEEEEEEcccEEEEcccccEEEEEEccccccccccEEEEcccccEEEEEcccccEEEEcccccccccccccEEccccccccEEEEEEcccccccccccEEEEEccccccEEEEEEcccEEEEEEccccccEEEEcccccccEEEcEEEEEEccccEEEEEEEEccccEEEEEcccccEEEEEEEcccccEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccHHHHHHHHcccccEEEEEEcccccEEEEEcccccccccccccEEEEEEEccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHcccccccccccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHHcccccEEEEEEccccccEEEEEEEcccccccccccccccccccccccHHHHHHHHHHHHHHccccccccEEEcccccccccccccccccccccccHHHccccccccccccEEcc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEccccEEEEEEEccccccccEEEEEEEEcccccccEEEEEEccccccccccEEEEEccccEEEEEEccccEEEEEcccccccccccEEEEEccccEEEEEcccccEEEEEccccccccccccEEcccccccccEEEEEcccccccccccEEEEEccccccEEEEEEcccEEEEEccccccEEEEcccccccccEEEEEEEEccccEEEEEEEEccccEEEEEEccccEEEEEEEEcccccEEEEEEccccccccHcccccccccccccccccccccccccccHHHHHcccccccEEEEccccEEEEcccccccccccccccHHHHHHHHHHcccEEEEEEccccEEEEEcccHHHHHHcccccccEEEEEccHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEHcccHccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccccccHHEEccccEEccc
Coil and Loop (DISEMBL)
MISVAIVVLLSScfysdfgtatatdtitssqfirdpesiissgskfklgffspdgnftnryIGIWynkggsanKTVVWVANrnkplidssgiftisedgnlvvlngkkqvhwSSNVSSLANNSNTRAQLLdsgnlvlhdnisqvsiwdsfqeptdtfysemkvstdlrtgkkvqltswrslsnpsigsfsagldsftipevfiwingtrpywrsgpwngryfigipdmnsvyldgfnlgedhqkgtRYLTfafadndvffaltpqgnleerawvdgkAHLKIYffyptndcdvygkcgafgscnsqkipicscllgfepknaedwnrgnwsggevegkqdgffkletmkvpyfaerssanedkckdqcsnncsckaYAYEIGVGCMIWthnlidirklpsggtnlYIRVAHeeldrkdmKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYanfstekvnparLQDLLVFNFEELANATNNFQLAnklgqggfgpvykgklqdgQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYeympnksldsflfdpqrqslldwpkrfNIIKGISRGLLYLHRDSRLRIIHRDLKasnilldddlnpkisdfglarifggnqdQAATKRLVGT
Flexible Loop (DISEMBL)
MISVAIVVLLSSCFYSDFGtatatdtitssqfirdpesiissgskfkLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEmkvstdlrtgkkvqltswrslsnpsiGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAErssanedkckdqcSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAheeldrkdmKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKasnilldddlNPKISDFGLArifggnqdqaATKRLVGT
Low Complexity Region (SEG)
MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIIssgskfklgffsPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWssnvsslannsnTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMKlviilsvivgiiaiaiCTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT
Disordered region (IsUnstruct)
**SVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNV**********AQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAE********CKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKE*SKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIA**************FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG*************
Disordered Region (DISOPRED)
*ISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVS******NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVA***********VIILSVIVGIIAIAICTFFAWRWFAKRKAM******************************LLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG*
Disordered Region (DISEMBL)
MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAER***********CSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT
Disordered Region (DISPRO)
MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMK**************************LQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL***
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQDGFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	662	2.2.26 [Sep-21-2011]
Q9SXB8	842	G-type lectin S-receptor-	yes	no	0.953	0.749	0.513	0.0
Q9SXB4	820	G-type lectin S-receptor-	no	no	0.975	0.787	0.496	0.0
Q9SXB5	820	G-type lectin S-receptor-	no	no	0.981	0.792	0.484	1e-177
Q9LPZ9	830	G-type lectin S-receptor-	no	no	0.953	0.760	0.472	1e-167
O81906	849	G-type lectin S-receptor-	no	no	0.960	0.749	0.445	1e-161
Q9SY89	842	Putative G-type lectin S-	no	no	0.962	0.756	0.444	1e-154
O64784	821	G-type lectin S-receptor-	no	no	0.969	0.781	0.429	1e-153
Q9SYA0	804	G-type lectin S-receptor-	no	no	0.968	0.797	0.441	1e-153
O64783	814	G-type lectin S-receptor-	no	no	0.975	0.793	0.425	1e-152
Q9SY95	802	G-type lectin S-receptor-	no	no	0.936	0.773	0.430	1e-148

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  665 bits (1715), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/666 (51%), Positives = 452/666 (67%), Gaps = 35/666 (5%)

Query: 25  DTITSSQFIRDPES--IISSGSKFKLGFFSPDGNFTN-RYIGIWYNKGGSANKTVVWVAN 81
           D IT S  I+D ES  ++     F+ GFF+P  + T  RY+GIWY K     +TVVWVAN
Sbjct: 31  DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEK--IPIQTVVWVAN 88

Query: 82  RNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNI 141
           ++ P+ D+SG+ +I +DGNL V +G+ ++ WS+NVS     + T  QL+DSGNL+L DN 
Sbjct: 89  KDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNR 148

Query: 142 SQVSI-WDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPE 200
           +   I W+SF+ P D+F   M + TD RTG  ++LTSW S  +PS G+++AG+  FT PE
Sbjct: 149 NNGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPE 208

Query: 201 VFIWINGTRPYWRSGPWNGRYFIGIPDMNSV-YLDGFNLGEDHQKGTRYLTFAFADNDVF 259
           + IW N   P WRSGPWNG+ FIG+P+M+S+ +LDGFNL  D+Q GT  +++A   ND F
Sbjct: 209 LLIWKNNV-PTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQ-GTISMSYA---NDSF 263

Query: 260 ---FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLG 316
              F L P+G + ++ W       +I   +P  DCD YG+CG FGSC++ + P C C+ G
Sbjct: 264 MYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKG 323

Query: 317 FEPKNAEDWNRGNWSGGEVE------------------GKQDGFFKLETMKVPYFAERSS 358
           F PKN  +WN GNWS G +                   GK DGF KL+ MKVP  AERS 
Sbjct: 324 FVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAERSE 383

Query: 359 ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKD 418
           A+E  C   C +NCSC AYAY+ G+GCM+W+ +L+D++     G +L+IRVAH EL    
Sbjct: 384 ASEQVCPKVCLDNCSCTAYAYDRGIGCMLWSGDLVDMQSFLGSGIDLFIRVAHSELKTHS 443

Query: 419 MKLVIILSVIVGIIAIA-ICTFFAWRWFAKRKA-MKENSKVQRLDLGEAYANFSTEKVNP 476
              V+I + ++G++ IA +C   A R + KR A  K+ S        EA  + +    N 
Sbjct: 444 NLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQ 503

Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE 536
            +L++L +F F+ LA +T++F L NKLGQGGFGPVYKGKL +GQEIAVKRLS+ SGQG E
Sbjct: 504 IKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLE 563

Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR 596
           E MNEV+VIS LQHRNLV+LLGCC+E EE ML+YEYMP KSLD++LFDP +Q +LDW  R
Sbjct: 564 ELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTR 623

Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           FNI++GI RGLLYLHRDSRL+IIHRDLKASNILLD++LNPKISDFGLARIF  N+D+A T
Sbjct: 624 FNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANT 683

Query: 657 KRLVGT 662
           +R+VGT
Sbjct: 684 RRVVGT 689

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1

 Score =  644 bits (1662), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/675 (49%), Positives = 456/675 (67%), Gaps = 29/675 (4%)

Query: 6   IVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIW 65
           + +L+ SCF+     + A +    S  + D E+I+SS   F+ GFFSP  N T+RY GIW
Sbjct: 11  VCILVLSCFF--LSVSLAQERAFFSGKLNDSETIVSSFRTFRFGFFSPV-NSTSRYAGIW 67

Query: 66  YNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNT 125
           YN    + +TV+WVAN++KP+ DSSG+ ++S+DGNLVV +G+++V WS+NVS+ A+ ++T
Sbjct: 68  YNS--VSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANST 125

Query: 126 RAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGK-KVQLTSWRSLSNP 184
            A+LLDSGNLVL +  S   +W+SF+ PTD++   M V T+ R G   V +TSW+S S+P
Sbjct: 126 VAELLDSGNLVLKEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDP 185

Query: 185 SIGSFSAGLDSFTIPEVFIWINGT--RPYWRSGPWNGRYFIGIPDMNS-VYLDGFNLGED 241
           S GS++A L     PE+FI  N       WRSGPWNG+ F G+PD+ + V+L  F + +D
Sbjct: 186 SPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDD 245

Query: 242 HQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
              G+  +++A      +F +  +G++  R W + + +  +    P  +CD Y +CG F 
Sbjct: 246 -TNGSVTMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFA 304

Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE------------GKQDGFFKLETMK 349
           +CN +K P+CSC+ GF P+N  +WN GNWSGG               G  DGF +L  MK
Sbjct: 305 TCNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSADGFLRLRRMK 364

Query: 350 VPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRV 409
           +P FA RS A+E +C   C   CSC A A+ +G GCMIW  +L+D ++L + G +LYIR+
Sbjct: 365 LPDFARRSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNGSLVDSQELSASGLDLYIRL 424

Query: 410 AHEELDRKDMKLVIILSVIVG-IIAIAICTFFAWRWFAKRKAMKENSKVQRL-DLGEAYA 467
           AH E+  KD + ++I +++ G I  +A C   A R   K++A K+    +++ +  EA A
Sbjct: 425 AHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALA 484

Query: 468 NFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL 527
                  N  +L++L +F F+ LA ATNNF L NKLGQGGFGPVYKGKLQ+GQEIAVKRL
Sbjct: 485 GG-----NKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRL 539

Query: 528 SKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR 587
           S+ASGQG EE +NEV+VIS LQHRNLV+LLGCC+  EE ML+YE+MP KSLD +LFD +R
Sbjct: 540 SRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRR 599

Query: 588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
             LLDW  RFNII GI RGLLYLHRDSRLRIIHRDLKASNILLD++L PKISDFGLARIF
Sbjct: 600 AKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIF 659

Query: 648 GGNQDQAATKRLVGT 662
            GN+D+A T+R+VGT
Sbjct: 660 PGNEDEANTRRVVGT 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1

 Score =  621 bits (1601), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 329/679 (48%), Positives = 447/679 (65%), Gaps = 29/679 (4%)

Query: 2   ISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRY 61
           +S  + VL  SCF+     + A +    S  + D E+I+SS   F+ GFFSP  N TNRY
Sbjct: 7   LSPIVHVLSLSCFF--LSVSLAHERALFSGTLNDSETIVSSFRTFRFGFFSPV-NSTNRY 63

Query: 62  IGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLAN 121
            GIWYN      +TV+WVAN++ P+ DSSG+ +ISEDGNLVV +G+++V WS+NVS+ A+
Sbjct: 64  AGIWYNS--IPVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRAS 121

Query: 122 NSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGK-KVQLTSWRS 180
            ++T A+LL+SGNLVL D  +   +W+SF+ PTD++   M V T+ RTG   + +TSW +
Sbjct: 122 ANSTVAELLESGNLVLKDANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTN 181

Query: 181 LSNPSIGSFSAGLDSFTIPEVFIWING--TRPYWRSGPWNGRYFIGIPDM-NSVYLDGFN 237
            S+PS GS++A L     PE+FI+ N       WRSGPWNG  F G+PD+   ++L  F 
Sbjct: 182 PSDPSPGSYTAALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFK 241

Query: 238 LGEDHQKGTRYLTFAFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKC 297
           + +D   G+  +++A         L  +G    R W + + +  +    P  +CD+Y +C
Sbjct: 242 VNDD-TNGSATMSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRC 300

Query: 298 GAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV------------EGKQDGFFKL 345
           G + +CN +K P CSC+ GF P+N  +WN GNWSGG +            +G  D F KL
Sbjct: 301 GQYTTCNPRKNPHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQNNKGSADRFLKL 360

Query: 346 ETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNL 405
           + MK+P FA RS A+E +C   C  +CSC A+A+ +G GCMIW  +L+D + L + G +L
Sbjct: 361 QRMKMPDFARRSEASEPECFMTCLQSCSCIAFAHGLGYGCMIWNRSLVDSQVLSASGMDL 420

Query: 406 YIRVAHEELDRKDMKLVII-LSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRL-DLG 463
            IR+AH E   +D + ++I  S+  GI  +A C   A R   K++A K+ +  +++    
Sbjct: 421 SIRLAHSEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKRAKKKGTDAEQIFKRV 480

Query: 464 EAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIA 523
           EA A  S EK     L++L +F F+ LA AT+NF L+NKLGQGGFGPVYKG L +GQEIA
Sbjct: 481 EALAGGSREK-----LKELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIA 535

Query: 524 VKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF 583
           VKRLS+ASGQG EE + EV+VIS LQHRNLV+L GCC+  EE ML+YE+MP KSLD ++F
Sbjct: 536 VKRLSQASGQGLEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIF 595

Query: 584 DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
           DP+   LLDW  RF II GI RGLLYLHRDSRLRIIHRDLKASNILLD++L PKISDFGL
Sbjct: 596 DPREAKLLDWNTRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGL 655

Query: 644 ARIFGGNQDQAATKRLVGT 662
           ARIF GN+D+A T+R+VGT
Sbjct: 656 ARIFPGNEDEANTRRVVGT 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2

 Score =  588 bits (1515), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 315/666 (47%), Positives = 430/666 (64%), Gaps = 35/666 (5%)

Query: 23  ATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANR 82
           ATD IT S   RD E+++S+ S F+ GFFSP  N T RY GIW+N      +TVVWVAN 
Sbjct: 21  ATDVITFSSEFRDSETVVSNHSTFRFGFFSPV-NSTGRYAGIWFNN--IPVQTVVWVANS 77

Query: 83  NKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVL--HDN 140
           N P+ DSSG+ +IS++GNLVV++G+ QVHWS+NV      +   A+LL++GNLVL    N
Sbjct: 78  NSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTN 137

Query: 141 ISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPE 200
                +W+SF+ P + +   M ++TD +TG+ ++L SW+S  +PS G +SAGL     PE
Sbjct: 138 TGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPE 197

Query: 201 VFIWINGTRPYWRSGPWNGRYFIGIPDMN-SVYLDGFNLGEDHQKGTRYLTFAFADNDVF 259
           + +W +     WRSGPWNG+YFIG+P+M+  + L    L  D+ +G+  +++A       
Sbjct: 198 LVVWKDDLL-MWRSGPWNGQYFIGLPNMDYRINLFELTLSSDN-RGSVSMSYAGNTLLYH 255

Query: 260 FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSC--NSQKIPICSCLLGF 317
           F L  +G++ +R W       K +   P+  CD Y  CG F SC  N    P C C+ GF
Sbjct: 256 FLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGF 315

Query: 318 EPKNAEDWNRGNWSGGEVEG---------------KQDGFFKLETMKVPYFAERSSANED 362
           +P++  +WN GNW+ G V                 K DGF +++ MKVP+  +RS ANE 
Sbjct: 316 KPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRSGANEQ 375

Query: 363 KCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELD-RKDMKL 421
            C + C  NCSC AY+++ G+GC++W+ NL+D+++    G   YIR+A  E   R +  +
Sbjct: 376 DCPESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRTNRSI 435

Query: 422 VIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKV-----NP 476
           VI ++++VG    A     A    AK +    N+++    L E     S+  V     N 
Sbjct: 436 VITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRL----LNERMEALSSNDVGAILVNQ 491

Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE 536
            +L++L +F F+ LA ATNNF + NKLGQGGFG VYKG+LQ+G +IAVKRLS+ SGQG E
Sbjct: 492 YKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVE 551

Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR 596
           EF+NEV+VIS LQHRNLVRLLG C+E EE ML+YE+MP   LD++LFDP +Q LLDW  R
Sbjct: 552 EFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTR 611

Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           FNII GI RGL+YLHRDSRL+IIHRDLKASNILLD++LNPKISDFGLARIF GN+D+ +T
Sbjct: 612 FNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVST 671

Query: 657 KRLVGT 662
            R+VGT
Sbjct: 672 VRVVGT 677

Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  567 bits (1462), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 305/684 (44%), Positives = 427/684 (62%), Gaps = 48/684 (7%)

Query: 18  FGTATATDTITSSQFIRD---PESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANK 74
           + ++ A +TI   + +RD    + ++S    F+LGFFSP G+ T+R++GIWY  G   +K
Sbjct: 20  YESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSP-GSSTHRFLGIWY--GNIEDK 76

Query: 75  TVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNV-SSLANNSNTRAQLLDSG 133
            VVWVANR  P+ D SG+  IS DGNLV+L+GK    WSSN+ SS  NN+N    + D+G
Sbjct: 77  AVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTG 136

Query: 134 NLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGL 193
           N VL +  +   IW+SF  PTDTF  +M+V  + +TG      SWRS ++PS G++S G+
Sbjct: 137 NFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGV 196

Query: 194 DSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSV--YLDGFNLGED-HQKGTRYLT 250
           D    PE+ +W       WRSG WN   F GIP+M+ +  YL GF L     + G+ Y T
Sbjct: 197 DPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFT 256

Query: 251 FAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQ-K 307
           +  +D  V   F +   G  EE  W +       +   P ++CD Y +CG FG C+ +  
Sbjct: 257 YVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGS 316

Query: 308 IPICSCLLGFEPKNAEDWNRG-----------NWSGGEVEGKQDGFFKLETMKVPYF--A 354
             ICSC+ G+E  +  +W+RG           N S GE     D F  L+++K+P F   
Sbjct: 317 NGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGE-----DEFLTLKSVKLPDFEIP 371

Query: 355 ERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEEL 414
           E +  + + C+++C  NCSC AY+   G+GCMIW  +L+D+++  +GG++L+IR+A  E+
Sbjct: 372 EHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEV 431

Query: 415 -DRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEK 473
            + +  K+ +I++V+VG+I I I     WR F ++K +      +  D     A+ +  K
Sbjct: 432 GENRKTKIAVIVAVLVGVILIGIFALLLWR-FKRKKDVSGAYCGKNTDTSVVVADLTKSK 490

Query: 474 VNPARLQ---------------DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD 518
              +                  +L VF+   +A ATN+F   N+LG+GGFGPVYKG L+D
Sbjct: 491 ETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLED 550

Query: 519 GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578
           G+EIAVKRLS  SGQG +EF NE+++I+ LQHRNLVRLLGCC E EE ML+YEYMPNKSL
Sbjct: 551 GREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSL 610

Query: 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
           D FLFD  +Q+L+DW  RF+II+GI+RGLLYLHRDSRLRIIHRDLK SN+LLD ++NPKI
Sbjct: 611 DFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKI 670

Query: 639 SDFGLARIFGGNQDQAATKRLVGT 662
           SDFG+ARIFGGNQ++A T R+VGT
Sbjct: 671 SDFGMARIFGGNQNEANTVRVVGT 694

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  545 bits (1405), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 299/672 (44%), Positives = 414/672 (61%), Gaps = 35/672 (5%)

Query: 20  TATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWV 79
           + + +++ T +  IR+ +S+IS    F+LGFF+P  N T RY+GIWY       +TVVWV
Sbjct: 25  SCSTSNSFTRNHTIREGDSLISEDESFELGFFTPK-NSTLRYVGIWYKN--IEPQTVVWV 81

Query: 80  ANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVL-H 138
           ANR KPL+D  G   I++DGNLV++NG+ +  WS+NV   +NN  T A L  +G+LVL  
Sbjct: 82  ANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNN--TVAVLFKTGDLVLCS 139

Query: 139 DNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTI 198
           D+  +   W+SF  PTDTF   M+V  +   G+      W+S S+PS G +S G+D    
Sbjct: 140 DSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGA 199

Query: 199 PEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSV--YLDGFNLGEDHQK-GTRYLTFAFAD 255
            E+ IW  G +  WRSGPWN   F GIPDM     Y+ GF L     + G+ Y T+  +D
Sbjct: 200 LEIVIW-EGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASD 258

Query: 256 NDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQK---IPI 310
           +  F  F + P G  E+  W     +  +  + P+ +C+ Y +CG +  C+  K      
Sbjct: 259 SSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGK 318

Query: 311 CSCLLGFEPKNAEDWNRGNWSGG------------EVEGKQDGFFKLETMKVPYFAERS- 357
           CSC+ GFEP + + WN  ++SGG             V G++DGF  L+ +KVP F     
Sbjct: 319 CSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVL 378

Query: 358 SANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELD-- 415
             N + CKD C+ +CSCKAYA  +G+GCMIWT +LID+     GG ++ IR+A  +L   
Sbjct: 379 HNNSETCKDVCARDCSCKAYALVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGG 438

Query: 416 RKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAM---KENSKVQRLDLGEAYANFSTE 472
           +++  L II+  ++G   + +C +  W++    KA    K++  V  +     Y++   +
Sbjct: 439 KENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIK 498

Query: 473 KV--NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA 530
            +  +     DL +F+F+ +A+AT +F   NKLGQGGFG VYKG   +G+EIAVKRLS  
Sbjct: 499 VLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGK 558

Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
           S QG EEF NE+++I+ LQHRNLVRLLGCC+E  E ML+YEYMPNKSLD FLFD  +Q  
Sbjct: 559 SKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGS 618

Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
           LDW KR+ +I GI+RGLLYLHRDSRL+IIHRDLKASNILLD ++NPKISDFG+ARIF   
Sbjct: 619 LDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYR 678

Query: 651 QDQAATKRLVGT 662
           QD A T R+VGT
Sbjct: 679 QDHANTIRVVGT 690

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64784|Y1136_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61360 OS=Arabidopsis thaliana GN=At1g61360 PE=2 SV=1

 Score =  542 bits (1397), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 293/682 (42%), Positives = 415/682 (60%), Gaps = 40/682 (5%)

Query: 2   ISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRY 61
           + +   +LL +  +S +G A     IT+S  +    ++ S G  ++LGFFS + N  N+Y
Sbjct: 1   MRIVACLLLITALFSSYGYAA----ITTSSPLSIGVTLSSPGGSYELGFFSSN-NSGNQY 55

Query: 62  IGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLAN 121
           +GIW+ K     + +VWVANR KP+  +    TIS +G+L++L+ KK + WSS     +N
Sbjct: 56  VGIWFKK--VTPRVIVWVANREKPVSSTMANLTISSNGSLILLDSKKDLVWSSGGDPTSN 113

Query: 122 NSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSL 181
               RA+LLD+GNLV+ DN++   +W SF+   DT      +  D+   KK  LTSW+S 
Sbjct: 114 K--CRAELLDTGNLVVVDNVTGNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKSE 171

Query: 182 SNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGED 241
           ++PS G F A +    +P   +   G+ PYWRSGPW G  F GIP+M++ Y++   + +D
Sbjct: 172 TDPSPGEFVAEITP-QVPSQGLIRKGSSPYWRSGPWAGTRFTGIPEMDASYVNPLGMVQD 230

Query: 242 HQKGTRYLTFAFADN--DVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGA 299
              GT    F    N    +  LTP+G+L  R   +       +F  P   CD+YG+CG 
Sbjct: 231 EVNGTGVFAFCVLRNFNLSYIKLTPEGSL--RITRNNGTDWIKHFEGPLTSCDLYGRCGP 288

Query: 300 FGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------------EVEGK-QDGFF 343
           FG C     P+C CL GFEPK+ E+W  GNWS G               E +GK +D F+
Sbjct: 289 FGLCVRSGTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQGKDRDVFY 348

Query: 344 KLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGG 402
            +  +K P   E +S +NE++C   C  NCSC A++Y  G+GC++W   L+D  K   GG
Sbjct: 349 HVSNIKPPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQELLDTVKFIGGG 408

Query: 403 TNLYIRVAHEELD-RKDMKLVIILSVIVGIIAIAICTFFA-WRWFAKRKAMKENSKVQRL 460
             L +R+AH EL  RK +K++ + ++ + +  I +      WR+  K+     +S V + 
Sbjct: 409 ETLSLRLAHSELTGRKRIKIITVATLSLSVCLILVLVACGCWRYRVKQNG---SSLVSKD 465

Query: 461 DLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQ 520
           ++  A+ +     +    +  L  F   +L  ATNNF + NKLGQGGFG VYKGKLQDG+
Sbjct: 466 NVEGAWKS----DLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGK 521

Query: 521 EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580
           EIAVKRL+ +S QG EEFMNE+ +IS LQHRNL+RLLGCC++ EE +L+YEYM NKSLD 
Sbjct: 522 EIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDI 581

Query: 581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
           F+FD +++  +DW  RFNII+GI+RGLLYLHRDS LR++HRDLK SNILLD+ +NPKISD
Sbjct: 582 FIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISD 641

Query: 641 FGLARIFGGNQDQAATKRLVGT 662
           FGLAR+F GNQ Q +T  +VGT
Sbjct: 642 FGLARLFHGNQHQDSTGSVVGT 663

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYA0|Y1150_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 OS=Arabidopsis thaliana GN=At1g61500 PE=2 SV=2

 Score =  541 bits (1395), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 299/677 (44%), Positives = 420/677 (62%), Gaps = 36/677 (5%)

Query: 1   MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNR 60
           M++    + L + F     + +++  IT+   +   +++ S+   ++LGFFSP+ N  ++
Sbjct: 1   MMTRFACLHLFTMFLFTLLSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPN-NTQDQ 59

Query: 61  YIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLA 120
           Y+GIW+    +  + VVWVANR KP+ DS+    IS  G+L++LNGK    WSS V+   
Sbjct: 60  YVGIWFKD--TIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVT--F 115

Query: 121 NNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRS 180
           ++S  RA+L DSGNL + DN+S+ ++W SF    DT      ++ +L T +K  LTSW+S
Sbjct: 116 SSSGCRAELSDSGNLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKS 175

Query: 181 LSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGE 240
            ++PS G F  G  +  +P     + G+ PYWRSGPW    F GIP M+  Y   F L +
Sbjct: 176 YTDPSPGDF-LGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQ 234

Query: 241 DHQKGTRYLTFAFADNDVF-FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGA 299
           D   G+ YLT+   D  +    LT +G++  + + D     ++Y+  P   CD YG CG 
Sbjct: 235 D-VNGSGYLTYFQRDYKLSRITLTSEGSI--KMFRDNGMGWELYYEAPKKLCDFYGACGP 291

Query: 300 FGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQ------------DGFFKLET 347
           FG C     P+C C  GF PK+ E+W RGNW+GG V   +            D F ++  
Sbjct: 292 FGLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIAN 351

Query: 348 MKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLY 406
           +K P F E  SS N ++C  +C +NCSC A+AY  G+GC++W  +L+D  +  + G  L 
Sbjct: 352 IKPPDFYEFASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQDLMDAVQFSATGELLS 411

Query: 407 IRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAW-RWFAKRKAMKENSKVQRLDLGEA 465
           IR+A  ELD    K  I+ S IV +    I  F A+  W  + + +   SK       +A
Sbjct: 412 IRLARSELDGNKRKKTIVAS-IVSLTLFMILGFTAFGVWRCRVEHIAHISK-------DA 463

Query: 466 YANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK 525
           + N     + P  +  L  F+   + NATNNF L+NKLGQGGFG VYKGKLQDG+EIAVK
Sbjct: 464 WKN----DLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVK 519

Query: 526 RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDP 585
           RLS +SGQG+EEFMNE+++IS LQHRNLVR+LGCC+E EE +LIYE+M NKSLD+FLFD 
Sbjct: 520 RLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDS 579

Query: 586 QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +++  +DWPKRF+II+GI+RGLLYLH DSRLR+IHRDLK SNILLD+ +NPKISDFGLAR
Sbjct: 580 RKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLAR 639

Query: 646 IFGGNQDQAATKRLVGT 662
           ++ G + Q  T+R+VGT
Sbjct: 640 MYQGTEYQDNTRRVVGT 656

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2

 Score =  538 bits (1386), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 290/682 (42%), Positives = 419/682 (61%), Gaps = 36/682 (5%)

Query: 1   MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNR 60
           M  + IV   S  F      + A   IT +  +   +++ S    ++LGFFSP+ N  N+
Sbjct: 1   MGKIGIVFFASLLFLLIIFPSCAFAAITRASPLSIGQTLSSPNGTYELGFFSPN-NSRNQ 59

Query: 61  YIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLA 120
           Y+GIW+       + VVWVANR+KP+ +++   TI+ +G+L+++  ++ V WS  +    
Sbjct: 60  YVGIWFKN--ITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWS--IGETF 115

Query: 121 NNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRS 180
           +++  RA+LL++GNLVL D +S+ ++W+SF+   DT   E  V  D+   KK  L+SW++
Sbjct: 116 SSNELRAELLENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKN 175

Query: 181 LSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGE 240
            ++PS G F A L +   P+ FI + G+RPYWR GPW    F GIP+M+  ++  F++ +
Sbjct: 176 PTDPSPGEFVAELTTQVPPQGFI-MRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQ 234

Query: 241 DHQKGTRYLTFAFA---DNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKC 297
           D   GT  LT++      N  +  LT  G+L+   W +G   +      P + CDVY  C
Sbjct: 235 DVAAGTGSLTYSLERRNSNLSYTTLTSAGSLK-IIWNNGSGWVT-DLEAPVSSCDVYNTC 292

Query: 298 GAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVEGKQ----------------DG 341
           G FG C     P C CL GF PK+ E+WN+ NW+GG +                    D 
Sbjct: 293 GPFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDI 352

Query: 342 FFKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPS 400
           F  +  +K P F E  S  NE+ C+ +C  NCSC A++Y   +GC++W   L+D+ +  +
Sbjct: 353 FDIVANVKPPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNRELVDVMQFVA 412

Query: 401 GGTNLYIRVAHEELDRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRL 460
           GG  L IR+A  EL   +   +I+ S++   I++ +   FA  W+ + KA + +S    L
Sbjct: 413 GGETLSIRLASSELAGSNRVKIIVASIVS--ISVFMILVFASYWYWRYKAKQNDSNPIPL 470

Query: 461 DLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQ 520
              E   +   E++ P   QD+  F+ + +   TNNF + NKLGQGGFGPVYKG LQDG+
Sbjct: 471 ---ETSQDAWREQLKP---QDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGK 524

Query: 521 EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580
           EIA+KRLS  SGQG EEFMNE+++IS LQHRNLVRLLGCC+E EE +LIYE+M NKSL++
Sbjct: 525 EIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNT 584

Query: 581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
           F+FD  ++  LDWPKRF II+GI+ GLLYLHRDS LR++HRD+K SNILLD+++NPKISD
Sbjct: 585 FIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISD 644

Query: 641 FGLARIFGGNQDQAATKRLVGT 662
           FGLAR+F G Q QA T+R+VGT
Sbjct: 645 FGLARMFQGTQHQANTRRVVGT 666

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY95|Y1155_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61550 OS=Arabidopsis thaliana GN=At1g61550 PE=2 SV=1

 Score =  526 bits (1354), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 285/662 (43%), Positives = 398/662 (60%), Gaps = 42/662 (6%)

Query: 18  FGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVV 77
           +   T T  ++  Q +  P  I      F+LGFFSP+ N  N Y+GIW+   G   +TVV
Sbjct: 18  YAAITPTSPLSIGQTLSSPNGI------FELGFFSPN-NSRNLYVGIWFK--GIIPRTVV 68

Query: 78  WVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVL 137
           WVANR   + D++    IS +G+L++ +GK    WS+  +  +N S+  A+L DSGNL++
Sbjct: 69  WVANRENSVTDATADLAISSNGSLLLFDGKHSTVWSTGETFASNGSS--AELSDSGNLLV 126

Query: 138 HDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFT 197
            D +S +++W SF+   DT      +  +  TG+K  L+SW+S ++P  G F   + +  
Sbjct: 127 IDKVSGITLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYITTQV 186

Query: 198 IPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADND 257
            P+ FI + G++PYWRSGPW    F G+P  +  Y   F++ +D      +         
Sbjct: 187 PPQGFI-MRGSKPYWRSGPWAKTRFTGVPLTDESYTHPFSVQQDANGSVYFSHLQRNFKR 245

Query: 258 VFFALTPQGNLE--ERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLL 315
               LT +G+L+       D   ++ +    P N CD YG CG FG C     P C C  
Sbjct: 246 SLLVLTSEGSLKVTHHNGTDWVLNIDV----PANTCDFYGVCGPFGLCVMSIPPKCKCFK 301

Query: 316 GFEPKNAEDWNRGNWSGGEV-------EGKQDG-----FFKLETMKVPYFAE-RSSANED 362
           GF P+ +E+W RGNW+GG V       +G   G     F  +  +K P F E  SS + +
Sbjct: 302 GFVPQFSEEWKRGNWTGGCVRRTELLCQGNSTGRHVNVFHPVANIKPPDFYEFVSSGSAE 361

Query: 363 KCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRKDMKLV 422
           +C   C +NCSC A+AY  G+GC+IW   L+D+ +   GG  L IR+A  E+     K  
Sbjct: 362 ECYQSCLHNCSCLAFAYINGIGCLIWNQELMDVMQFSVGGELLSIRLASSEMGGNQRKKT 421

Query: 423 IILSV--IVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQ 480
           II S+  I   + +A   F  WR+      +K N+ V ++ L  A+ N     +    + 
Sbjct: 422 IIASIVSISLFVTLASAAFGFWRY-----RLKHNAIVSKVSLQGAWRN----DLKSEDVS 472

Query: 481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMN 540
            L  F  + +  ATNNF L NKLGQGGFGPVYKGKLQDG+EIAVKRLS +SGQG+EEFMN
Sbjct: 473 GLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMN 532

Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           E+++IS LQH NLVR+LGCC+E EE +L+YE+M NKSLD+F+FD +++  +DWPKRF+II
Sbjct: 533 EILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRFSII 592

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
           +GI+RGLLYLHRDSRLRIIHRD+K SNILLDD +NPKISDFGLAR++ G + Q  T+R+V
Sbjct: 593 QGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIV 652

Query: 661 GT 662
           GT
Sbjct: 653 GT 654

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	662
224114125	832	predicted protein [Populus trichocarpa]	0.983	0.782	0.588	0.0
359496521	844	PREDICTED: G-type lectin S-receptor-like	0.977	0.766	0.567	0.0
224112032	824	predicted protein [Populus trichocarpa]	0.981	0.788	0.568	0.0
224114137	827	predicted protein [Populus trichocarpa]	0.980	0.784	0.576	0.0
224114141	824	predicted protein [Populus trichocarpa]	0.981	0.788	0.567	0.0
224078778	831	predicted protein [Populus trichocarpa]	0.983	0.783	0.562	0.0
296084622	817	unnamed protein product [Vitis vinifera]	0.965	0.782	0.576	0.0
359497280	920	PREDICTED: G-type lectin S-receptor-like	0.930	0.669	0.569	0.0
359496519	854	PREDICTED: G-type lectin S-receptor-like	0.980	0.759	0.546	0.0
359496538	887	PREDICTED: G-type lectin S-receptor-like	0.947	0.706	0.583	0.0

>gi|224114125|ref|XP_002316674.1| predicted protein [Populus trichocarpa] gi|222859739|gb|EEE97286.1| predicted protein [Populus trichocarpa]

 Score =  782 bits (2019), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/681 (58%), Positives = 499/681 (73%), Gaps = 30/681 (4%)

Query: 3   SVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYI 62
           S+  + L+  CF  +FG +   DTI+ SQFIRDPE+I+S+G KF+LGFFSP  N TNRY+
Sbjct: 8   SIIALHLILYCFCLEFGASI--DTISLSQFIRDPETIVSAGKKFELGFFSP-VNSTNRYV 64

Query: 63  GIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANN 122
            IWY+    +  T VWVANRNKPL DSSGI TISEDGNLVVLNG+K+  WSSNVS+  N+
Sbjct: 65  AIWYSN--ISITTPVWVANRNKPLNDSSGIMTISEDGNLVVLNGQKETLWSSNVSTGMND 122

Query: 123 SNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLS 182
           S  RAQL+D GNLVL  + +  S+W SFQEP+DT+  +M+++ + RTGKK  LTSW+S S
Sbjct: 123 S--RAQLMDDGNLVLGGSENGNSLWQSFQEPSDTYIPKMRLTANPRTGKKTPLTSWKSPS 180

Query: 183 NPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDH 242
           +PSIGSFS G+D  +IPEV +W N +RP WR+GPWNG+ FIG+P+MNSVYLDGFNL +D 
Sbjct: 181 DPSIGSFSLGIDPSSIPEVVLW-NDSRPIWRTGPWNGQVFIGVPEMNSVYLDGFNLADDG 239

Query: 243 QKGTRYLTFAFADNDVF--FALTPQGNLEERAWVD-GKAHLKIYFFYPTNDCDVYGKCGA 299
             G   L+  FAD      F L+ +G   +  W D  +   +  +    ++CDVYGKCG+
Sbjct: 240 NGGFT-LSVGFADESYITNFVLSSEGKFGQVFWDDMNEGSWRYQWESVQDECDVYGKCGS 298

Query: 300 FGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFK 344
           F SC+++  PICSCL GFEPKNA++WN  NW+ G V                GK+DGF K
Sbjct: 299 FASCDAKNTPICSCLKGFEPKNADEWNSRNWTHGCVRRKAMRCERIQNGGELGKEDGFSK 358

Query: 345 LETMKVPYFAERSSA-NEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGT 403
           LE +KVP FAE SS+  E KC+D C NNCSC AYAY  G+ CM+W  NL DI+K  SGG 
Sbjct: 359 LERVKVPGFAEWSSSITEQKCRDDCWNNCSCIAYAYYTGIYCMLWKGNLTDIKKFSSGGA 418

Query: 404 NLYIRVAHEELDRK--DMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLD 461
           +LYIR+A+ ELD K  +MK++I L+V+VG IAIAIC F++WRW  +++  K+    +R  
Sbjct: 419 DLYIRLAYTELDNKKINMKVIISLTVVVGAIAIAICVFYSWRWIERKRTSKKVLLPKRKH 478

Query: 462 LGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQE 521
                 N   + +N  +LQ+L +F+ + L  AT+NF  ANKLGQGGFGPVYKGK  DGQE
Sbjct: 479 PILLDENVIQDNLNHVKLQELPLFSLQMLIVATDNFNTANKLGQGGFGPVYKGKFPDGQE 538

Query: 522 IAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF 581
           IA+KRLS+ASGQGQEEFM EV+VIS LQH NLVRLLGCCVE EE ML+YEYMPN+SLD+F
Sbjct: 539 IALKRLSRASGQGQEEFMTEVVVISKLQHMNLVRLLGCCVEGEEKMLVYEYMPNRSLDAF 598

Query: 582 LFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641
           LFDP R+ LLDW KRFNI++GI RGLLYLHRDSRLRIIHRDLKASNILLD +LNPKISDF
Sbjct: 599 LFDPSRKQLLDWKKRFNIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDF 658

Query: 642 GLARIFGGNQDQAATKRLVGT 662
           G+ARIFG N+DQA T R+VGT
Sbjct: 659 GMARIFGRNEDQADTGRVVGT 679

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496521|ref|XP_002262970.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  775 bits (2000), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/694 (56%), Positives = 514/694 (74%), Gaps = 47/694 (6%)

Query: 4   VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
           +A+++LLS      FG  TA DT+TS++FI DPE+++S+GS FKLGFFS   + TNRY+G
Sbjct: 10  IALLLLLSVIC---FGFCTAIDTMTSTRFIEDPETLVSNGSAFKLGFFSL-ADSTNRYVG 65

Query: 64  IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
           IWY+    +  TV+WVANR+KPL DSSGI TISEDGNL+V+NG+K++ WSSNVS+ + NS
Sbjct: 66  IWYST--PSLSTVIWVANRDKPLNDSSGIVTISEDGNLLVMNGQKEIVWSSNVSNASANS 123

Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
           +  AQLLDSGNLVL DN   ++ W+S Q P+ +    MK+STD  TG+KV LTSW+S S+
Sbjct: 124 S--AQLLDSGNLVLQDNSGSIT-WESIQHPSHSLLPNMKISTDTNTGEKVVLTSWKSPSD 180

Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQ 243
           PSIGSFS G++   IP++FIW NG+ PYWRSGPW+ + FIGIPDM+SVY  GF + +D +
Sbjct: 181 PSIGSFSLGMNPLNIPQIFIW-NGSHPYWRSGPWSSQIFIGIPDMDSVYRSGFQVVDD-K 238

Query: 244 KGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
           +GT Y TF  A++ +F  + LT QG+L +     GK    + +    ++CDVYG CGAFG
Sbjct: 239 EGTVYATFTEANSSIFLYYVLTSQGSLVQTDREYGKEEWGVTWRSNKSECDVYGTCGAFG 298

Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV---------------EGKQDGFFKLE 346
            CNS   PICSCL G+EPK  E+W+RGNW+ G V               +GK DGFF+L 
Sbjct: 299 ICNSGTSPICSCLRGYEPKYTEEWSRGNWTSGCVRKTTLQCERTNSSGQQGKIDGFFRLT 358

Query: 347 TMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLY 406
           T+KVP +A+ S A+ED+C+++C  NCSC AY+Y  G+GCM+W+ +LID++K    G +LY
Sbjct: 359 TVKVPDYADWSLAHEDECREECLKNCSCIAYSYYSGIGCMLWSGSLIDLQKFTKRGADLY 418

Query: 407 IRVAHEEL--DRKDMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSK-VQRLDLG 463
           IR+AH EL  +++DMK++I +++++G IAIAICT+F WRW   R+A+KE SK +   D G
Sbjct: 419 IRLAHSELGKNKRDMKVIISVTIVIGTIAIAICTYFLWRWIG-RQAVKEKSKEILPSDRG 477

Query: 464 EAYANFST----EKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
            AY N+      + VN  +L++L + +FE+LA ATNNF  ANKLGQGGFGPVY+G L  G
Sbjct: 478 HAYQNYDMNMLGDNVNRVKLEELPLLDFEKLAAATNNFHEANKLGQGGFGPVYRGNLPGG 537

Query: 520 QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG-C----------CVEREENML 568
           Q+IAVKRLS+AS QGQEEFMNE++VIS +QHRNLVRLLG C          C+E +E +L
Sbjct: 538 QKIAVKRLSRASAQGQEEFMNEMIVISKIQHRNLVRLLGFCIEGDVRLLGFCIEGDEKLL 597

Query: 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628
           IYEYMPNKSLD+FLFDP ++  LDW +RF+II+GI RGLLYLHRDSRL+IIHRDLKASNI
Sbjct: 598 IYEYMPNKSLDAFLFDPLKRESLDWRRRFSIIEGIGRGLLYLHRDSRLKIIHRDLKASNI 657

Query: 629 LLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LLD+DLN KISDFG+ARIFG NQDQA T R+VGT
Sbjct: 658 LLDEDLNAKISDFGMARIFGSNQDQANTMRVVGT 691

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224112032|ref|XP_002332843.1| predicted protein [Populus trichocarpa] gi|222833304|gb|EEE71781.1| predicted protein [Populus trichocarpa]

 Score =  764 bits (1974), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/684 (56%), Positives = 492/684 (71%), Gaps = 34/684 (4%)

Query: 4   VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
           +A + LL  CF    G A   DTITSSQ+I+DPE+++S+G+KFKLGFFSP GN TNRY+G
Sbjct: 1   MAALRLLLCCFCWQLGAAV--DTITSSQYIKDPEAVVSAGNKFKLGFFSP-GNSTNRYVG 57

Query: 64  IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
           IWY+    +  T VW+ANRNKPL DSSGI TISEDGN+VVL+G+K++ WSSNVS+  +NS
Sbjct: 58  IWYSN--ISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS 115

Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
           +  AQL D GN++L       S+W SFQEP+DTF  +M+++ + RTGKK Q+TSW+S S+
Sbjct: 116 S--AQLTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSD 173

Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQ 243
           PS+GSFS+G++  +IPEVF+W N +RP+WRSGPWNG+ FIGIP+MNSVYL+G+NL +D  
Sbjct: 174 PSVGSFSSGIEPSSIPEVFVW-NDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGD 232

Query: 244 KGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
            GT  L+   A+      FAL+ +G   E  W       +    YP +DCD+YGKCG FG
Sbjct: 233 -GTFSLSVGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFG 291

Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFKLE 346
            CN+Q   IC CL GFEPKN+++WNR NW+ G V                 K+D F KL+
Sbjct: 292 FCNTQNSLICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLD 351

Query: 347 TMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNL 405
            +KVP F+E  SSA+E  CKD+C NNCSC AY+Y  G+GCM+W   L DIRK  SGG NL
Sbjct: 352 KVKVPDFSEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRGKLTDIRKFSSGGANL 411

Query: 406 YIRVAHEELDR-KDMKLVIILSVIVGIIAIAICTFFAWRWFAK-RKAMKENSKVQRLDLG 463
           Y+R+A  E  + +DMK VI ++V+ G I +A+  FF WR  AK R+  +E+ ++      
Sbjct: 412 YVRLADLEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRK 471

Query: 464 EAY-----ANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD 518
           + Y      N   E +N  + Q+L +F  + L  AT+ F  ANKLG+GGFGPVY+G L D
Sbjct: 472 KGYPIFFNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPD 531

Query: 519 GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578
           GQEIAVKRLS+ASGQGQEEFMNEV+VIS LQHRNLVRLLGCCVE +E ML+YEYMPNKSL
Sbjct: 532 GQEIAVKRLSRASGQGQEEFMNEVVVISELQHRNLVRLLGCCVEGDEKMLVYEYMPNKSL 591

Query: 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
           D+ LFDP R+ +LDW KRFNI+ GI RGLLYLHRDSRLRIIHRDLK SNILLD +LNPKI
Sbjct: 592 DASLFDPVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKI 651

Query: 639 SDFGLARIFGGNQDQAATKRLVGT 662
           SDFG+ARIFGGN+D   T+R+VGT
Sbjct: 652 SDFGMARIFGGNEDHVKTRRVVGT 675

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114137|ref|XP_002316677.1| predicted protein [Populus trichocarpa] gi|222859742|gb|EEE97289.1| predicted protein [Populus trichocarpa]

 Score =  764 bits (1974), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/685 (57%), Positives = 496/685 (72%), Gaps = 36/685 (5%)

Query: 3   SVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYI 62
           S    +L+  CF  +FG +   DTITSSQ+I+DPE I+S+G+KFKLGFFSP  N TNRY 
Sbjct: 8   STIAFLLILYCFCWEFGASV--DTITSSQYIKDPEDIVSAGNKFKLGFFSP-VNSTNRYA 64

Query: 63  GIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANN 122
            IWY+    +  T VWVANRN PL DSSGI TISEDGNLVVLNG+K++ WSSNVS+  N+
Sbjct: 65  AIWYSN--ISITTPVWVANRNMPLNDSSGIMTISEDGNLVVLNGQKEILWSSNVSTGMND 122

Query: 123 SNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLS 182
           S  RAQL+D GNLVL  + +  S+W SFQEP+DT+  +M+++ + RTGKK  L SW S+S
Sbjct: 123 S--RAQLMDDGNLVLGGSENGNSLWQSFQEPSDTYMPKMRLTANSRTGKKTLLKSWTSVS 180

Query: 183 NPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDH 242
           +PSIGS S G+D   IP+ +IW NG+RP WR+GPWNG+ FIGIP+M SVYLDGFN+  D 
Sbjct: 181 DPSIGSISGGIDPSRIPQFYIW-NGSRPIWRTGPWNGQVFIGIPEMVSVYLDGFNIA-DE 238

Query: 243 QKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAF 300
             GT  L+  FA+  +   + L+ +G   +  W D +   +  + +P ++CDVYGKCG+F
Sbjct: 239 GNGTFTLSVGFANESLISNYILSSEGKFGKVLWDDTEGSWRYEWKFPKDECDVYGKCGSF 298

Query: 301 GSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFKL 345
           GSCN +  PICSCL GFEPKNA++WN GNW+ G V                GK+DGF KL
Sbjct: 299 GSCNPKDSPICSCLKGFEPKNADEWNNGNWTNGCVRRRELQCERTQNGGQVGKEDGFLKL 358

Query: 346 ETMKVPYFAE-RSSANEDKCKDQCSN-NCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGT 403
           E MKVP F+E  SS +E  CK++C N NCSC AY+Y  G GCM+W  NL D++K P    
Sbjct: 359 ERMKVPDFSEWLSSTSEHTCKNECLNINCSCIAYSYYPGFGCMLWRGNLTDLKKFPIKAA 418

Query: 404 NLYIRVAHEELDRK--DMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKE----NSKV 457
           +LYIR+A  ELD K  ++K++I L+V+VG IAIAIC F++WR   +++  K+      KV
Sbjct: 419 DLYIRLADSELDNKKINLKVIISLTVVVGAIAIAICVFYSWRRIDRKRKSKKVFLSKRKV 478

Query: 458 QRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ 517
               L +   N   + +N  +LQ+L +F+ + L  AT+NF  ANKLGQGGFGPVYKG L 
Sbjct: 479 GYPILSDE--NMIQDNLNHVKLQELPLFSLQTLIAATDNFNTANKLGQGGFGPVYKGNLS 536

Query: 518 DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577
           DGQEIAVKRLS++SGQG EEFMNEV+VIS LQHRNLVR+LGCCVE EE MLIYEYMPNKS
Sbjct: 537 DGQEIAVKRLSRSSGQGLEEFMNEVVVISKLQHRNLVRILGCCVEGEEKMLIYEYMPNKS 596

Query: 578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637
           LD+FLFD  R+ LLDW  RF I++GI RGLLYLHRDSRLRIIHRDLKASNILLD +LNPK
Sbjct: 597 LDAFLFDSLRKQLLDWKNRFKIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPK 656

Query: 638 ISDFGLARIFGGNQDQAATKRLVGT 662
           ISDFG+ARIFG ++DQA T+R+VGT
Sbjct: 657 ISDFGMARIFGNHEDQANTRRVVGT 681

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114141|ref|XP_002316678.1| predicted protein [Populus trichocarpa] gi|222859743|gb|EEE97290.1| predicted protein [Populus trichocarpa]

 Score =  763 bits (1970), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/684 (56%), Positives = 492/684 (71%), Gaps = 34/684 (4%)

Query: 4   VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
           +A + LL  CF    G A   DTITSSQ+I+DPE+++S+G+KFKLGFFSP GN TNRY+G
Sbjct: 1   MAALRLLLCCFCWQLGAAV--DTITSSQYIKDPEAVVSAGNKFKLGFFSP-GNSTNRYVG 57

Query: 64  IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
           IWY+    +  T VW+ANRNKPL DSSGI TISEDGN+VVL+G+K++ WSSNVS+  +NS
Sbjct: 58  IWYSN--ISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS 115

Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
           +  AQL D GN++L       S+W SFQEP+DTF  +M+++ + RTGKK Q+TSW+S S+
Sbjct: 116 S--AQLTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSD 173

Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQ 243
           PS+GSFS+G++  +IPEVF+W N +RP+WRSGPWNG+ FIGIP+MNSVYL+G+NL +D  
Sbjct: 174 PSVGSFSSGIEPSSIPEVFVW-NDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGD 232

Query: 244 KGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFG 301
            GT  L+   A+      FAL+ +G   E  W       +    YP +DCD+YGKCG FG
Sbjct: 233 -GTFSLSVGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFG 291

Query: 302 SCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE---------------GKQDGFFKLE 346
            CN+Q   IC CL GFEPKN+++WNR NW+ G V                 K+D F KL+
Sbjct: 292 FCNTQNSLICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLD 351

Query: 347 TMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNL 405
            +KVP F+E  SSA+E  CKD+C NNCSC AY+Y  G+GCM+W   L DIRK  SGG NL
Sbjct: 352 KVKVPDFSEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRGKLTDIRKFSSGGANL 411

Query: 406 YIRVAHEELDR-KDMKLVIILSVIVGIIAIAICTFFAWRWFAK-RKAMKENSKVQRLDLG 463
           Y+R+A  E  + +DMK VI ++V+ G I +A+  FF WR  AK R+  +E+ ++      
Sbjct: 412 YVRLADLEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRK 471

Query: 464 EAY-----ANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD 518
           + Y      N   E +N  + Q+L +F  + L  AT+ F  ANKLG+GGFGPVY+G L D
Sbjct: 472 KGYPIFFNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPD 531

Query: 519 GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL 578
           GQEIAVKRLS+ASGQGQEEFMNEV+VIS LQH+NLVRLLGCCVE +E ML+YEYMPNKSL
Sbjct: 532 GQEIAVKRLSRASGQGQEEFMNEVVVISELQHKNLVRLLGCCVEGDEKMLVYEYMPNKSL 591

Query: 579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
           D+ LFDP R+ +LDW KRFNI+ GI RGLLYLHRDSRLRIIHRDLK SNILLD +LNPKI
Sbjct: 592 DASLFDPVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKI 651

Query: 639 SDFGLARIFGGNQDQAATKRLVGT 662
           SDFG+ARIFGGN+D   T+R+VGT
Sbjct: 652 SDFGMARIFGGNEDHVKTRRVVGT 675

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078778|ref|XP_002305625.1| predicted protein [Populus trichocarpa] gi|222848589|gb|EEE86136.1| predicted protein [Populus trichocarpa]

 Score =  752 bits (1942), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/681 (56%), Positives = 489/681 (71%), Gaps = 30/681 (4%)

Query: 2   ISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRY 61
           ISVA++ LL+S F  +    TA DTITS+QF++DPE+I+S+G+ + LGFFSP  N T+RY
Sbjct: 8   ISVALL-LLTSSFCVEI--ITAIDTITSTQFLKDPEAIVSNGNIYTLGFFSP-VNSTDRY 63

Query: 62  IGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLAN 121
           +GIW+N+      T +WVANRN PL DSSGI  IS+DG LVVLNG++++ WS+NVS+  +
Sbjct: 64  VGIWFNEVPVV--TAIWVANRNNPLNDSSGILAISKDGALVVLNGQQEILWSTNVSNFVS 121

Query: 122 NSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSL 181
           NS+  AQL D+GNLVL DN ++  +W+SFQ P+DTF+S MK+S + RTG K  +TSW+S 
Sbjct: 122 NSS--AQLSDTGNLVLRDNNNEEIMWESFQYPSDTFFSNMKLSANKRTGGKTLITSWKSA 179

Query: 182 SNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGED 241
           ++PSIGSFSAGL+   IPE+FIW +   PY+RSGPWN   FIG+P MNS  +DG NL +D
Sbjct: 180 TDPSIGSFSAGLNHLDIPEIFIWKD-NYPYFRSGPWNRLVFIGVPYMNSAAVDGLNLVDD 238

Query: 242 HQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGA 299
            + GT  LTF++A+  +   F LT QG LE+  W  G     + +  P  DC+ YG+CG 
Sbjct: 239 GE-GTIDLTFSYANQSIMSSFVLTSQGQLEQTRWEHGMEDRIVLWSVPMFDCEFYGRCGL 297

Query: 300 FGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG----------------EVEGKQDGFF 343
           FGSCN+Q  PICSCL GFEP N E+W  GNW+GG                E  GK D F 
Sbjct: 298 FGSCNAQASPICSCLRGFEPNNPEEWYVGNWTGGCIRRKSLQCERVKSESEAAGKNDVFL 357

Query: 344 KLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGT 403
           KL  MKVP  A+ S   E +CKD+C  NCSC AYAY+ G+GCM W  +LID+++ P+GG 
Sbjct: 358 KLGNMKVPDLAQWSRLTEIECKDKCLTNCSCIAYAYDSGIGCMSWIGDLIDVQEFPTGGA 417

Query: 404 NLYIRVAHEELD-RKDMKLVIILSVIVGIIAIA-ICTFFAWRWFAKRKAMKENSKVQRLD 461
           +LYIR+A+ ELD     K+++I+S ++G I  A IC    WR+ +K +  K +S      
Sbjct: 418 DLYIRMAYSELDGNHRKKVIVIVSAVIGTITSAMICALLTWRFMSKHRGEKLHSDTNEKH 477

Query: 462 LGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQE 521
                 + + + ++  +LQ+L +F+ E L  AT+ F L+NKLGQGGFGPVYKGKL DG+E
Sbjct: 478 PSFLDRDMAGDSMDHVKLQELPLFSLESLTAATDGFDLSNKLGQGGFGPVYKGKLSDGKE 537

Query: 522 IAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF 581
           IAVKRLS+ASGQG +EFMNEV VIS LQHRNLVRLLGCCVE EE +L+YEYMPNKSLD+F
Sbjct: 538 IAVKRLSRASGQGLKEFMNEVEVISKLQHRNLVRLLGCCVEGEEKLLVYEYMPNKSLDAF 597

Query: 582 LFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF 641
           L+DP R+ LLDW KRFNII+GI RGLLYLHRDSRLRIIHRDLKASNILLD +L PKISDF
Sbjct: 598 LYDPLRKQLLDWKKRFNIIEGICRGLLYLHRDSRLRIIHRDLKASNILLDPELKPKISDF 657

Query: 642 GLARIFGGNQDQAATKRLVGT 662
           G ARIFGG++DQA T R+VGT
Sbjct: 658 GAARIFGGDEDQANTIRVVGT 678

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296084622|emb|CBI25710.3| unnamed protein product [Vitis vinifera]

 Score =  746 bits (1926), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/677 (57%), Positives = 505/677 (74%), Gaps = 38/677 (5%)

Query: 7   VVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWY 66
           V LL +CF+  FG  +A DTITS+ FI+DPE+I+SSG  FKLGFFS DG+ +NRY+GIWY
Sbjct: 9   VSLLLTCFWFVFG-CSAIDTITSTHFIKDPETIVSSGRVFKLGFFSLDGS-SNRYVGIWY 66

Query: 67  NKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTR 126
           N   ++  T++WVAN+++PL DSSG+ TISEDGN+ VLNG+K++ WSSNVS+ A   N+ 
Sbjct: 67  NT--TSLLTIIWVANKDRPLNDSSGVLTISEDGNIQVLNGRKEILWSSNVSNPAA-VNSS 123

Query: 127 AQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSI 186
           AQL DSGNLVL D  + VS+W+S Q P+ +F  +MK+ST+ RT  +  LTSW+S S+PS+
Sbjct: 124 AQLQDSGNLVLRDK-NGVSVWESLQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSM 182

Query: 187 GSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGT 246
           GSF+AG++   IP+VFIW NG+RPYWRSGPW+G+   G+ D+  + LDG N+ +D ++GT
Sbjct: 183 GSFTAGVEPLNIPQVFIW-NGSRPYWRSGPWDGQILTGV-DVKWITLDGLNIVDD-KEGT 239

Query: 247 RYLTFAFADNDVFFA--LTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCN 304
            Y+TFA  ++  F+A  LTP+G L E +        +  +    N+C++YGKCG FG CN
Sbjct: 240 VYVTFAHPESGFFYAYVLTPEGILVETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCN 299

Query: 305 SQKIPICSCLLGFEPKNAEDWNRGNWSGGEV---------------EGKQDGFFKLETMK 349
           S+  PICSCL G+EPK+ ++WNRGNW+GG V               E K DGF KL  MK
Sbjct: 300 SRDSPICSCLKGYEPKHTQEWNRGNWTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMK 359

Query: 350 VPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRV 409
           VP FAE+S A ED C+ QC  NCSC AY+Y  G+GCM W+ +LIDI+KL S G NL+IRV
Sbjct: 360 VPDFAEQSYALEDDCRQQCLRNCSCIAYSYYTGIGCMWWSGDLIDIQKLSSTGANLFIRV 419

Query: 410 AHEEL--DRK-DMKLVIILSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGE-A 465
           AH EL  DRK D ++++I++VI+G IAIA+CT+F  RW A+++          L +G+ +
Sbjct: 420 AHSELKQDRKRDARVIVIVTVIIGTIAIALCTYFLRRWIARQRG--------NLLIGKFS 471

Query: 466 YANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK 525
             +   + VN  +L++L + +F +LA ATNNF  ANKLGQGGFGPVY+GKL +GQ+IAVK
Sbjct: 472 DPSVPGDGVNQVKLEELPLIDFNKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVK 531

Query: 526 RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDP 585
           RLS+AS QG EEFMNEV+VIS LQHRNLVRL+GCC+E +E MLIYE+MPNKSLD+ LFDP
Sbjct: 532 RLSRASTQGLEEFMNEVVVISKLQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDP 591

Query: 586 QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            ++ +LDW  RF II+GI RGLLYLHRDSRLRIIHRDLKASNILLD+DLNPKISDFG+AR
Sbjct: 592 VKRQILDWRTRFKIIEGIGRGLLYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMAR 651

Query: 646 IFGGNQDQAATKRLVGT 662
           IFG NQDQA TKR+VGT
Sbjct: 652 IFGSNQDQANTKRVVGT 668

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497280|ref|XP_003635472.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Vitis vinifera]

 Score =  743 bits (1919), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/646 (56%), Positives = 479/646 (74%), Gaps = 30/646 (4%)

Query: 39  IISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISED 98
           ++S+GS FKLGFF+P  + TNRY+GIWY+    +  TV+WVANR+KPL D SGI TISED
Sbjct: 229 LVSNGSAFKLGFFTP-ADSTNRYVGIWYST--PSLSTVIWVANRDKPLTDFSGIVTISED 285

Query: 99  GNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFY 158
           GNL+V+NG+K + WSSN+S+ A NS+  AQLLDSGNLVL DN  +++ W+S Q P+ +F 
Sbjct: 286 GNLLVMNGQKVIVWSSNLSNAAPNSS--AQLLDSGNLVLRDNSGRIT-WESIQHPSHSFL 342

Query: 159 SEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWN 218
            +MK+ST+  TG+KV LTSW+S S+PSIGSFSAG++   IP+VF+W NG+ PYWRSGPWN
Sbjct: 343 PKMKISTNTHTGEKVVLTSWKSPSDPSIGSFSAGINPLNIPQVFVW-NGSHPYWRSGPWN 401

Query: 219 GRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDG 276
           G+ FIG+P+MNSV+L+GF + +D ++GT Y TF  A++ +F  + LTP+G + +     G
Sbjct: 402 GQIFIGVPEMNSVFLNGFQVVDD-KEGTVYETFTLANSSIFLYYVLTPEGTVVKTYREFG 460

Query: 277 KAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV- 335
           K   ++ +    ++CDVYG CGA G C+S   PIC+CL G++PK  E+W+RGNW+ G V 
Sbjct: 461 KEKWQVAWKSNKSECDVYGTCGASGICSSGNSPICNCLKGYKPKYMEEWSRGNWTRGCVR 520

Query: 336 --------------EGKQDGFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEI 381
                         +GK DGFF+L ++KVP FA+ S A ED+C+ QC  NCSC AY+Y  
Sbjct: 521 KTPLQCERTNSSGQQGKIDGFFRLTSVKVPDFADWSLALEDECRKQCFKNCSCVAYSYYS 580

Query: 382 GVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEELDRK-DMKLVIILSVIVGIIAIAICTFF 440
            +GCM W+ N+ID +K   GG +LYIR+A+ ELD+K DMK +I +++++G IA  ICT+F
Sbjct: 581 SIGCMSWSGNMIDSQKFTQGGADLYIRLAYSELDKKRDMKAIISVTIVIGTIAFGICTYF 640

Query: 441 AWRWFAKRKAMKENSKVQRLDLGEAY----ANFSTEKVNPARLQDLLVFNFEELANATNN 496
           +WRW  K+    ++  +   D G+ Y     N   +  N  + ++L +   E+LA ATNN
Sbjct: 641 SWRWRGKQTVKDKSKGILLSDRGDVYQIYDKNMLGDHANQVKFEELPLLALEKLATATNN 700

Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           F  AN LGQGGFGPVY+GKL  GQEIAVKRLS+AS QG EEFMNEVMVIS +QHRNLVRL
Sbjct: 701 FHEANMLGQGGFGPVYRGKLPGGQEIAVKRLSRASAQGLEEFMNEVMVISKIQHRNLVRL 760

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           LGCC+E +E +LIYEYMPNKSLD+FLFDP ++  LDW KRF+II+GI RGLLYLHRDSRL
Sbjct: 761 LGCCIEGDEKLLIYEYMPNKSLDAFLFDPLKREFLDWRKRFSIIEGIGRGLLYLHRDSRL 820

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RIIHRDLKASNILLD+DLN KISDFG+ARIFG NQDQA T R+VGT
Sbjct: 821 RIIHRDLKASNILLDEDLNAKISDFGMARIFGSNQDQANTMRVVGT 866

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496519|ref|XP_002263029.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/706 (54%), Positives = 501/706 (70%), Gaps = 57/706 (8%)

Query: 4   VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIG 63
           +A+++LLS      FG  TA DT+TS++FI DPE+++S GS FKLGFFS   + TNRY+G
Sbjct: 10  IALLLLLSVIC---FGFCTAIDTMTSTRFIEDPETLVSDGSAFKLGFFSL-ADSTNRYVG 65

Query: 64  IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
           IWY+    +  T++WVANR+KPL DSSG+ TISEDGNL+V+NG+K++ WS+NVS+ A NS
Sbjct: 66  IWYST--PSLSTIIWVANRDKPLNDSSGLVTISEDGNLLVMNGQKEIFWSTNVSNAAANS 123

Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
           +  AQLLDSGNLVL DN  +++ W+S Q P+ +F  +MK+S D  +G+KV LTSW+S S+
Sbjct: 124 S--AQLLDSGNLVLRDNSGRIT-WESIQHPSHSFLPKMKISADTDSGEKVVLTSWKSPSD 180

Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYF-----IGIPDMNSVYLDGFNL 238
           PSIGSFS G++   IP+ F+W NG+ PYWRSGPWNG+ F     IG+P MNSV+L+GF  
Sbjct: 181 PSIGSFSLGMNPLNIPQAFVW-NGSHPYWRSGPWNGQIFIGQIYIGVPKMNSVFLNGFGF 239

Query: 239 G-EDHQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYG 295
              D + GT Y TF  A++ +F  + LTPQG + E    DGK   ++ +    ++CDVYG
Sbjct: 240 QVVDDKAGTVYETFTLANSSIFLYYVLTPQGTVVETYREDGKEEWEVTWRSNNSECDVYG 299

Query: 296 KCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEV---------------EGKQD 340
            CGAFG CNS   PICSCL G+EPK  E+W+RGNW+ G V               +GK D
Sbjct: 300 TCGAFGICNSGNSPICSCLRGYEPKYIEEWSRGNWTSGCVRKTPLQCERTNSSGQQGKLD 359

Query: 341 GFFKLETMKVPYFAERSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPS 400
           GFF+L T+KVP FA+ S A ED+C++QC  NCSC AY+Y  G+GCM W+ NLID+ K   
Sbjct: 360 GFFRLTTVKVPDFADWSLALEDECREQCLKNCSCMAYSYYSGIGCMSWSGNLIDLGKFTQ 419

Query: 401 GGTNLYIRVAHEELD-----------------RKDMKLVIILSVIVGIIAIAICTFFAWR 443
           GG +LYIR+A+ EL+                 ++DMK +I +++++G IAI I T+F+WR
Sbjct: 420 GGADLYIRLANSELEWNMRTPKLIKHLMATYKKRDMKAIISVTIVIGTIAIGIYTYFSWR 479

Query: 444 WFAKRKAMKENSKVQRLDLGEAYANFSTEKV----NPARLQDLLVFNFEELANATNNFQL 499
           W  K+    ++ ++   D G+AY  +   ++    N  +L++L +   E+L  ATNNF  
Sbjct: 480 WRRKQTVKDKSKEILLSDRGDAYQIYDMNRLGDNANQFKLEELPLLALEKLETATNNFHE 539

Query: 500 ANKLGQGGFGPVYK---GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           ANKLGQGGFGPVY+   GKL  GQEIAVKRLS+AS QG EEF NEV+VIS +QHRNLVRL
Sbjct: 540 ANKLGQGGFGPVYRVMLGKLPGGQEIAVKRLSRASAQGLEEFGNEVVVISKIQHRNLVRL 599

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           LG C+E +E +LIYEYMPNKSLDSFLFDP ++  LDW +RFNII+GI RGLLYLHRDSR 
Sbjct: 600 LGYCIEGDEKLLIYEYMPNKSLDSFLFDPLKRDFLDWRRRFNIIEGIGRGLLYLHRDSRF 659

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RIIHRDLKASNILLD+DL  KISDFG+ARI GGNQDQA T R+VGT
Sbjct: 660 RIIHRDLKASNILLDEDLTAKISDFGIARIVGGNQDQANTMRVVGT 705

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496538|ref|XP_002270222.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/663 (58%), Positives = 497/663 (74%), Gaps = 36/663 (5%)

Query: 25  DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
           DTITS+ FI+DPE+I+SSG  FKLGFFS DG+ +NRY+GIWYN   ++  T++WVAN+++
Sbjct: 87  DTITSTHFIKDPETIVSSGRVFKLGFFSLDGS-SNRYVGIWYNT--TSLLTIIWVANKDR 143

Query: 85  PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
           PL DSSG+ TISEDGN+ VLNG+K++ WSSNVS+ A   N+ AQL DSGNLVL D  + V
Sbjct: 144 PLNDSSGVLTISEDGNIQVLNGRKEILWSSNVSNPAA-VNSSAQLQDSGNLVLRDK-NGV 201

Query: 145 SIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIW 204
           S+W+S Q P+ +F  +MK+ST+ RT  +  LTSW+S S+PS+GSF+AG++   IP+VFIW
Sbjct: 202 SVWESLQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSMGSFTAGVEPLNIPQVFIW 261

Query: 205 INGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVFFA--L 262
            NG+RPYWRSGPW+G+   G+ D+  + LDG N+ +D ++GT Y+TFA  ++  F+A  L
Sbjct: 262 -NGSRPYWRSGPWDGQILTGV-DVKWITLDGLNIVDD-KEGTVYVTFAHPESGFFYAYVL 318

Query: 263 TPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKNA 322
           TP+G L E +        +  +    N+C++YGKCG FG CNS+  PICSCL G+EPK+ 
Sbjct: 319 TPEGILVETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCNSRDSPICSCLKGYEPKHT 378

Query: 323 EDWNRGNWSGGEV---------------EGKQDGFFKLETMKVPYFAERSSANEDKCKDQ 367
           ++WNRGNW+GG V               E K DGF KL  MKVP FAE+S A ED C+ Q
Sbjct: 379 QEWNRGNWTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMKVPDFAEQSYALEDDCRQQ 438

Query: 368 CSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAHEEL--DRK-DMKLVII 424
           C  NCSC AY+Y  G+GCM W+ +LIDI+KL S G NL+IRVAH EL  DRK D ++++I
Sbjct: 439 CLRNCSCIAYSYYTGIGCMWWSGDLIDIQKLSSTGANLFIRVAHSELKQDRKRDARVIVI 498

Query: 425 LSVIVGIIAIAICTFFAWRWFAKRKAMKENSKVQRLDLGEAYANFST-----EKVNPARL 479
           ++VI+G IAIA+CT+F  RW A+++A K   K++ L L      FS      + VN  +L
Sbjct: 499 VTVIIGTIAIALCTYFLRRWIARQRAKK--GKIEEL-LSFNRGKFSDPSVPGDGVNQVKL 555

Query: 480 QDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM 539
           ++L + +F +LA ATNNF  ANKLGQGGFGPVY+GKL +GQ+IAVKRLS+AS QG EEFM
Sbjct: 556 EELPLIDFNKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVKRLSRASTQGLEEFM 615

Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           NEV+VIS LQHRNLVRL+GCC+E +E MLIYE+MPNKSLD+ LFDP ++ +LDW  RF I
Sbjct: 616 NEVVVISKLQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDPVKRQILDWRTRFKI 675

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL 659
           I+GI RGLLYLHRDSRLRIIHRDLKASNILLD+DLNPKISDFG+ARIFG NQDQA TKR+
Sbjct: 676 IEGIGRGLLYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMARIFGSNQDQANTKRV 735

Query: 660 VGT 662
           VGT
Sbjct: 736 VGT 738

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	662
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.493	0.388	0.513	8.4e-136
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.886	0.730	0.450	2.3e-135
TAIR|locus:2197649	821	AT1G61360 [Arabidopsis thalian	0.960	0.774	0.424	5.4e-134
TAIR|locus:2197734	814	AT1G61370 [Arabidopsis thalian	0.894	0.727	0.432	1.6e-132
TAIR|locus:2197729	805	SD1-29 "S-domain-1 29" [Arabid	0.474	0.390	0.502	6.1e-131
TAIR|locus:2197664	804	AT1G61490 [Arabidopsis thalian	0.880	0.725	0.439	6.4e-131
TAIR|locus:2197704	831	AT1G61390 [Arabidopsis thalian	0.959	0.764	0.402	5.7e-130
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.611	0.517	0.341	6.9e-130
TAIR|locus:2197709	809	AT1G61480 [Arabidopsis thalian	0.894	0.731	0.434	1.2e-129
TAIR|locus:2200923	802	AT1G61550 [Arabidopsis thalian	0.947	0.781	0.412	1.9e-129

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 838 (300.0 bits), Expect = 8.4e-136, Sum P(2) = 8.4e-136
 Identities = 173/337 (51%), Positives = 223/337 (66%)

Query:   335 VEGKQDGFFKLETMKVPYFAERS-SANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLI 393
             V G++DGF  L+ +KVP F       N + CKD C+ +CSCKAYA  +G+GCMIWT +LI
Sbjct:   355 VAGQEDGFTVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIWTRDLI 414

Query:   394 DIRKLPSGGTNLYIRVAHEELD--RKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAM 451
             D+     GG ++ IR+A  +L   +++                  C +  W++    KA 
Sbjct:   415 DMEHFERGGNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAF 474

Query:   452 ---KENSKVQRLDLGEAYANFSTEKV---NPARLQDLLVFNFEELANATNNFQLANKLGQ 505
                K++  V  +     Y++ S  KV   +     DL +F+F+ +A+AT +F   NKLGQ
Sbjct:   475 LWKKKDITVSDIIENRDYSS-SPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQ 533

Query:   506 GGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE 565
             GGFG VYKG   +G+EIAVKRLS  S QG EEF NE+++I+ LQHRNLVRLLGCC+E  E
Sbjct:   534 GGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNE 593

Query:   566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
              ML+YEYMPNKSLD FLFD  +Q  LDW KR+ +I GI+RGLLYLHRDSRL+IIHRDLKA
Sbjct:   594 KMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKA 653

Query:   626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             SNILLD ++NPKISDFG+ARIF   QD A T R+VGT
Sbjct:   654 SNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1326 (471.8 bits), Expect = 2.3e-135, P = 2.3e-135
 Identities = 280/622 (45%), Positives = 380/622 (61%)

Query:    56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
             N  ++Y+GIW+    +  + VVWVANR KP+ DS+    IS  G+L++LNGK    W   
Sbjct:    55 NTQDQYVGIWFKD--TIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSG 112

Query:   116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
                       RA+L DSGNL + DN+S+ ++W SF    DT      ++ +L T +K  L
Sbjct:   113 VTFSSSG--CRAELSDSGNLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVL 170

Query:   176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
             TSW+S ++PS G F  G  +  +P     + G+ PYWRSGPW    F GIP M+  Y   
Sbjct:   171 TSWKSYTDPSPGDF-LGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGP 229

Query:   236 FNLGEDHQKGTRYLTFAFADNDVF-FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVY 294
             F L +D   G+ YLT+   D  +    LT +G++  + + D     ++Y+  P   CD Y
Sbjct:   230 FTLHQD-VNGSGYLTYFQRDYKLSRITLTSEGSI--KMFRDNGMGWELYYEAPKKLCDFY 286

Query:   295 GKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG-----EVE------GKQ-DGF 342
             G CG FG C     P+C C  GF PK+ E+W RGNW+GG     E++      G+  D F
Sbjct:   287 GACGPFGLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDF 346

Query:   343 FKLETMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSG 401
              ++  +K P F E  SS N ++C  +C +NCSC A+AY  G+GC++W  +L+D  +  + 
Sbjct:   347 HQIANIKPPDFYEFASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQDLMDAVQFSAT 406

Query:   402 GTNLYIRVAHEELD-RKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENSKVQRL 460
             G  L IR+A  ELD  K  K                 T F   W  + + +   SK    
Sbjct:   407 GELLSIRLARSELDGNKRKKTIVASIVSLTLFMILGFTAFGV-WRCRVEHIAHISK---- 461

Query:   461 DLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQ 520
                +A+ N     + P  +  L  F+   + NATNNF L+NKLGQGGFG VYKGKLQDG+
Sbjct:   462 ---DAWKN----DLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGK 514

Query:   521 EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580
             EIAVKRLS +SGQG+EEFMNE+++IS LQHRNLVR+LGCC+E EE +LIYE+M NKSLD+
Sbjct:   515 EIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDT 574

Query:   581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
             FLFD +++  +DWPKRF+II+GI+RGLLYLH DSRLR+IHRDLK SNILLD+ +NPKISD
Sbjct:   575 FLFDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISD 634

Query:   641 FGLARIFGGNQDQAATKRLVGT 662
             FGLAR++ G + Q  T+R+VGT
Sbjct:   635 FGLARMYQGTEYQDNTRRVVGT 656

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)]

 Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
 Identities = 290/683 (42%), Positives = 397/683 (58%)

Query:     4 VAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESI---IXXXXXXXXXXXXPDGNFTNR 60
             VA ++L+++ F S +G A  T   TSS     P SI   +               N  N+
Sbjct:     4 VACLLLITALF-SSYGYAAIT---TSS-----PLSIGVTLSSPGGSYELGFFSSNNSGNQ 54

Query:    61 YIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXXXXXXX 120
             Y+GIW+ K     + +VWVANR KP+  +    TIS +G+L++L+ KK + W        
Sbjct:    55 YVGIWFKK--VTPRVIVWVANREKPVSSTMANLTISSNGSLILLDSKKDLVWSSGGDPTS 112

Query:   121 XXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRS 180
                  RA+LLD+GNLV+ DN++   +W SF+   DT      +  D+   KK  LTSW+S
Sbjct:   113 NK--CRAELLDTGNLVVVDNVTGNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKS 170

Query:   181 LSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGE 240
              ++PS G F A +    +P   +   G+ PYWRSGPW G  F GIP+M++ Y++   + +
Sbjct:   171 ETDPSPGEFVAEITP-QVPSQGLIRKGSSPYWRSGPWAGTRFTGIPEMDASYVNPLGMVQ 229

Query:   241 DHQKGTRYLTFAFADND--VFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCG 298
             D   GT    F    N    +  LTP+G+L      +G   +K +F  P   CD+YG+CG
Sbjct:   230 DEVNGTGVFAFCVLRNFNLSYIKLTPEGSLRITR-NNGTDWIK-HFEGPLTSCDLYGRCG 287

Query:   299 AFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------------EVEGK-QDGF 342
              FG C     P+C CL GFEPK+ E+W  GNWS G               E +GK +D F
Sbjct:   288 PFGLCVRSGTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQGKDRDVF 347

Query:   343 FKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSG 401
             + +  +K P   E +S +NE++C   C  NCSC A++Y  G+GC++W   L+D  K   G
Sbjct:   348 YHVSNIKPPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQELLDTVKFIGG 407

Query:   402 GTNLYIRVAHEELD-RKDMKXXXXXXXXXXXXXXXXCTFFA-WRWFAKRKAMKENSKVQR 459
             G  L +R+AH EL  RK +K                      WR+  K+      SK   
Sbjct:   408 GETLSLRLAHSELTGRKRIKIITVATLSLSVCLILVLVACGCWRYRVKQNGSSLVSK-DN 466

Query:   460 LDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
             ++ G   ++  ++ V+      L  F   +L  ATNNF + NKLGQGGFG VYKGKLQDG
Sbjct:   467 VE-GAWKSDLQSQDVS-----GLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDG 520

Query:   520 QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD 579
             +EIAVKRL+ +S QG EEFMNE+ +IS LQHRNL+RLLGCC++ EE +L+YEYM NKSLD
Sbjct:   521 KEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLD 580

Query:   580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639
              F+FD +++  +DW  RFNII+GI+RGLLYLHRDS LR++HRDLK SNILLD+ +NPKIS
Sbjct:   581 IFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKIS 640

Query:   640 DFGLARIFGGNQDQAATKRLVGT 662
             DFGLAR+F GNQ Q +T  +VGT
Sbjct:   641 DFGLARLFHGNQHQDSTGSVVGT 663

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)]

 Score = 1299 (462.3 bits), Expect = 1.6e-132, P = 1.6e-132
 Identities = 271/627 (43%), Positives = 381/627 (60%)

Query:    56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
             N  N+Y+GIW+       + VVWVANR+KP+ +++   TI+ +G+L+++  ++ V W   
Sbjct:    55 NSRNQYVGIWFKN--ITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIG 112

Query:   116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
                       RA+LL++GNLVL D +S+ ++W+SF+   DT   E  V  D+   KK  L
Sbjct:   113 ETFSSNEL--RAELLENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVL 170

Query:   176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
             +SW++ ++PS G F A L +   P+ FI + G+RPYWR GPW    F GIP+M+  ++  
Sbjct:   171 SSWKNPTDPSPGEFVAELTTQVPPQGFI-MRGSRPYWRGGPWARVRFTGIPEMDGSHVSK 229

Query:   236 FNLGEDHQKGTRYLTFAFA---DNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCD 292
             F++ +D   GT  LT++      N  +  LT  G+L+   W +G   +      P + CD
Sbjct:   230 FDISQDVAAGTGSLTYSLERRNSNLSYTTLTSAGSLKI-IWNNGSGWVTD-LEAPVSSCD 287

Query:   293 VYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------EVEGKQ---- 339
             VY  CG FG C     P C CL GF PK+ E+WN+ NW+GG         +V        
Sbjct:   288 VYNTCGPFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQA 347

Query:   340 ---DGFFKLETMKVPYFAERSSA-NEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDI 395
                D F  +  +K P F E  S  NE+ C+ +C  NCSC A++Y   +GC++W   L+D+
Sbjct:   348 NNGDIFDIVANVKPPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNRELVDV 407

Query:   396 RKLPSGGTNLYIRVAHEELDRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENS 455
              +  +GG  L IR+A  EL   +                     FA  W+ + KA + +S
Sbjct:   408 MQFVAGGETLSIRLASSELAGSNR--VKIIVASIVSISVFMILVFASYWYWRYKAKQNDS 465

Query:   456 KVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK 515
                 L+  +   +   E++ P   QD+  F+ + +   TNNF + NKLGQGGFGPVYKG 
Sbjct:   466 NPIPLETSQ---DAWREQLKP---QDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGN 519

Query:   516 LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575
             LQDG+EIA+KRLS  SGQG EEFMNE+++IS LQHRNLVRLLGCC+E EE +LIYE+M N
Sbjct:   520 LQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMAN 579

Query:   576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN 635
             KSL++F+FD  ++  LDWPKRF II+GI+ GLLYLHRDS LR++HRD+K SNILLD+++N
Sbjct:   580 KSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMN 639

Query:   636 PKISDFGLARIFGGNQDQAATKRLVGT 662
             PKISDFGLAR+F G Q QA T+R+VGT
Sbjct:   640 PKISDFGLARMFQGTQHQANTRRVVGT 666

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 791 (283.5 bits), Expect = 6.1e-131, Sum P(2) = 6.1e-131
 Identities = 169/336 (50%), Positives = 212/336 (63%)

Query:   331 SGGEVEGKQ-DGFFKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIW 388
             S  + +GK  D F+++  +K P   + +S  N ++C   C  NCSC A+AY  G+GC++W
Sbjct:   336 SSMKTQGKDTDIFYRMTDVKTPDLHQFASFLNAEQCYQGCLGNCSCTAFAYISGIGCLVW 395

Query:   389 THNLIDIRKLPSGGTNLYIRVAHEELDRKDMKXXXXXXXXXXXXXXXX--CTFFAWRWFA 446
                L D  +  S G  L+IR+A  EL     +                       WR+ A
Sbjct:   396 NGELADTVQFLSSGEFLFIRLASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRA 455

Query:   447 KRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQG 506
             K+    +N   +R D+     NF               F    +  ATNNF  +NKLGQG
Sbjct:   456 KQNDAWKNG-FERQDVSGV--NF---------------FEMHTIRTATNNFSPSNKLGQG 497

Query:   507 GFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN 566
             GFGPVYKGKL DG+EI VKRL+ +SGQG EEFMNE+ +IS LQHRNLVRLLG C++ EE 
Sbjct:   498 GFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEK 557

Query:   567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKAS 626
             +LIYE+M NKSLD F+FDP  +  LDWPKRFNII+GI+RGLLYLHRDSRLR+IHRDLK S
Sbjct:   558 LLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVS 617

Query:   627 NILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             NILLDD +NPKISDFGLAR+F G Q Q  T+R+VGT
Sbjct:   618 NILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGT 653

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)]

 Score = 1284 (457.0 bits), Expect = 6.4e-131, P = 6.4e-131
 Identities = 275/626 (43%), Positives = 384/626 (61%)

Query:    56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
             N  N Y+GIW+   G   + VVWVANR  P  D+S    IS +G+L++ NGK  V W   
Sbjct:    54 NSQNLYVGIWFK--GIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNGKHGVVWSIG 111

Query:   116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
                      +RA+L D+GNLV+ DN S  ++W+SF+   DT      +  +L TG+K  L
Sbjct:   112 ENFASNG--SRAELTDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVL 169

Query:   176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
             TSW++ ++PS G F  G  +  +P   + + G+  Y+R+GPW    F GIP M+  Y   
Sbjct:   170 TSWKTDTDPSPGVF-VGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASP 228

Query:   236 FNLGEDHQKGTRYLTF---AFADNDVFFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCD 292
             F+L +D   G+ + T+   +F  + +   ++ +G+++ R   +G    ++ +  P N CD
Sbjct:   229 FSLQQD-ANGSGFFTYFDRSFKLSRII--ISSEGSMK-RFRHNG-TDWELSYMAPANSCD 283

Query:   293 VYGKCGAFGSCNSQKIPI-CSCLLGFEPKNAEDWNRGNWSGG-----EV--EGKQDG--- 341
             +YG CG FG C    +P+ C CL GF P + E+W RGNW+GG     E+  +G   G   
Sbjct:   284 IYGVCGPFGLC-IVSVPLKCKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQGNSTGKDV 342

Query:   342 --FFKLETMKVPYFAE-RSSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKL 398
               F  +  +K+P F E  SS + ++C   C +NCSC A+AY  G+GC+IW  NL+D  + 
Sbjct:   343 NIFHPVTNVKLPDFYEYESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQNLMDAVQF 402

Query:   399 PSGGTNLYIRVAHEEL--DRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENSK 456
              +GG  L IR+AH EL  ++++                    F  WR+  K KA      
Sbjct:   403 SAGGEILSIRLAHSELGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYT---- 458

Query:   457 VQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKL 516
                  L +A+ N    K  P     L  F    +  ATNNF L+NKLGQGGFG VYKGKL
Sbjct:   459 -----LKDAWRNDLKSKEVPG----LEFFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKL 509

Query:   517 QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK 576
             QDG+EIAVK+LS +SGQG+EEFMNE+++IS LQHRNLVR+LGCC+E EE +LIYE+M NK
Sbjct:   510 QDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNK 569

Query:   577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636
             SLD+F+FD +++  +DWPKRF+I++GI+RGLLYLHRDSRL++IHRDLK SNILLD+ +NP
Sbjct:   570 SLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNP 629

Query:   637 KISDFGLARIFGGNQDQAATKRLVGT 662
             KISDFGLAR++ G Q Q  T+R+VGT
Sbjct:   630 KISDFGLARMYEGTQCQDKTRRVVGT 655

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
 Identities = 272/676 (40%), Positives = 396/676 (58%)

Query:     6 IVVLLSSCFYSDFGTATATDTITSSQFIRDPESIIXXXXXXXXXXXXPDGNFTNRYIGIW 65
             ++++  +  Y+D  T++    ++  Q +  P+ +             P+ N   +Y+GIW
Sbjct:    32 LLIIFPTFGYADINTSSP---LSIGQTLSSPDGVYELGFFS------PN-NSRKQYVGIW 81

Query:    66 YNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXXXXXXXXXXXT 125
             +     A + VVWVANR+KP+  ++   TIS +G+L++L+G + V W             
Sbjct:    82 FKN--IAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFTSNK--C 137

Query:   126 RAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPS 185
              A+LLD+GNLV+ D++S  ++W SF+   +T   +  V  D+  GK   LTSWRS S+PS
Sbjct:   138 HAELLDTGNLVVIDDVSGKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPS 197

Query:   186 IGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKG 245
              G F+        P+  I   G+ PYWRSGPW    F GIP +++ Y+  F + +D  KG
Sbjct:   198 PGEFTLEFTPQVPPQGLIR-RGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKG 256

Query:   246 TRYLTFAFADNDV--FFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSC 303
             T   +++   N    +  LT +G ++   W DGK+  K++F  PT+ CD+Y  CG FG C
Sbjct:   257 TASFSYSMLRNYKLSYVTLTSEGKMKI-LWNDGKSW-KLHFEAPTSSCDLYRACGPFGLC 314

Query:   304 NSQKIPICSCLLGFEPKNAEDWNRGNWSGG---------------EVEGKQ-DGFFKLET 347
                + P C CL GF PK+ ++W +GNW+ G               + +GK+ D F+ +  
Sbjct:   315 VRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMTR 374

Query:   348 MKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLY 406
             +K P   + +   N ++C   C  NCSC A+AY  G+GC++W   L+D  +  S G +L 
Sbjct:   375 VKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYISGIGCLVWNRELVDTVQFLSDGESLS 434

Query:   407 IRVAHEELDRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKENSKVQRLDLGEAY 466
             +R+A  EL   + +                  F A++ +  R    E + +      +A+
Sbjct:   435 LRLASSELAGSN-RTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQDAW 493

Query:   467 ANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR 526
             A    + + P  +  + +F+   +  ATNNF  +NKLGQGGFGPVYKGKL DG+EIAVKR
Sbjct:   494 A----KDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKR 549

Query:   527 LSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ 586
             LS +SGQG +EFMNE+ +IS LQH+NLVRLLGCC++ EE +LIYEY+ NKSLD FLFD  
Sbjct:   550 LSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDST 609

Query:   587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
              +  +DW KRFNII+G++RGLLYLHRDSRLR+IHRDLK SNILLD+ + PKISDFGLAR+
Sbjct:   610 LKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARM 669

Query:   647 FGGNQDQAATKRLVGT 662
               G Q Q  T+R+VGT
Sbjct:   670 SQGTQYQDNTRRVVGT 685

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 653 (234.9 bits), Expect = 6.9e-130, Sum P(2) = 6.9e-130
 Identities = 150/439 (34%), Positives = 226/439 (51%)

Query:     1 MISVAIVVLLSSCFYSDFGTATATDTITSSQFIRDPESIIXXXXXXXXXXXXPDGNFTNR 60
             M +  ++ LL    +S    A ATD + ++Q ++D ++I+            P G+  NR
Sbjct:     1 MEATNVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGS-RNR 59

Query:    61 YIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXXXXXXX 120
             Y+GIWY K   + +TVVWVANR+ PL D SG   +SE+G+L + N +  + W        
Sbjct:    60 YLGIWYKK--ISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSS 117

Query:   121 XXXXTR---AQLLDSGNLVLHDN-ISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLT 176
                  R    Q+LD+GNLV+ ++   Q  IW S   P D F   MK   +  TG    LT
Sbjct:   118 QKASLRNPIVQILDTGNLVVRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLT 177

Query:   177 SWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDM--NSVYLD 234
             SWR++ +PS G+++  +D   +P+ F+  N    + R+GPWNG  F G+P++  N +Y  
Sbjct:   178 SWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVF-RTGPWNGLRFTGMPNLKPNPIYRY 236

Query:   235 GFNLGEDHQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTNDCD 292
              +   E+      Y T+   +  V     L P G L+   WVD       Y     + CD
Sbjct:   237 EYVFTEEEV----YYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCD 292

Query:   293 VYGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE------GK-QDGFFKL 345
              Y  CG++GSCN  + P C CL GF  K  + W  G+WS G V       GK +DGF K+
Sbjct:   293 QYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKI 352

Query:   346 ETMKVP-----YFAERSSANEDKCKDQCSNNCSCKAYA-YEI---GVGCMIWTHNLIDIR 396
               +K+P     ++ +    NE  CK  C  NC+C AY+ ++I   G GC++W  +LIDIR
Sbjct:   353 SKLKLPDTRTSWYDKNMDLNE--CKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIR 410

Query:   397 KLPSGGTNLYIRVAHEELD 415
             +    G +LY+R+A  E++
Sbjct:   411 EYNENGQDLYVRLASSEIE 429

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)]

 Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
 Identities = 271/623 (43%), Positives = 375/623 (60%)

Query:    56 NFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXX 115
             N  N+Y+GIW+   G   + VVWVANR KP+ DS+   TIS +G+L++ N    V W   
Sbjct:    54 NSQNQYVGIWFK--GIIPRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIG 111

Query:   116 XXXXXXXXXTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQL 175
                      +RA+L D+GNLV+ DN S  ++W+SF+   DT      +  +L TG+K  L
Sbjct:   112 ETFASNG--SRAELTDNGNLVVIDNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVL 169

Query:   176 TSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
             TSW+S ++PS G F+  +    +P     + G++ YWRSGPW    F GIP M+  Y   
Sbjct:   170 TSWKSHTDPSPGDFTVQITP-QVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSP 228

Query:   236 FNLGEDHQKGTRYLTFAFADNDV--FFALTPQGNLEERAWVDGKAHLKIYFFYPTNDCDV 293
             F+L +D   G+   T+ F  N    +  +T +G+L  + +       ++ F  P N CD+
Sbjct:   229 FSLQQD-TNGSGSFTY-FERNFKLSYIMITSEGSL--KIFQHNGMDWELNFEAPENSCDI 284

Query:   294 YGKCGAFGSCNSQKIPICSCLLGFEPKNAEDWNRGNWSGGEVE-----------GKQ-DG 341
             YG CG FG C     P C C  GF PK+ E+W RGNW+ G V            GK  +G
Sbjct:   285 YGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKRGNWTDGCVRHTELHCQGNTNGKTVNG 344

Query:   342 FFKLETMKVPYFAERSS-ANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPS 400
             F+ +  +K P F E +S  + + C   C +NCSC A+AY  G+GC++W  +L+D  +  +
Sbjct:   345 FYHVANIKPPDFYEFASFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQFSA 404

Query:   401 GGTNLYIRVAHEELDRKDMKXXXXXXXXXXXXXXXXCTFFAWRWFAKRKAMKE-NSKVQR 459
             GG  L IR+A  EL     K                   FA   F + K     ++K+ +
Sbjct:   405 GGEILSIRLASSELGGN--KRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISK 462

Query:   460 LDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
             +   EA+ N     + P  +  L  F    +  AT+NF L+NKLGQGGFG VYKGKLQDG
Sbjct:   463 IASKEAWNN----DLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDG 518

Query:   520 QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD 579
             +EIAVKRLS +SGQG+EEFMNE+++IS LQH+NLVR+LGCC+E EE +L+YE++ NKSLD
Sbjct:   519 KEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLD 578

Query:   580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639
             +FLFD +++  +DWPKRFNII+GI+RGL YLHRDS LR+IHRDLK SNILLD+ +NPKIS
Sbjct:   579 TFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKIS 638

Query:   640 DFGLARIFGGNQDQAATKRLVGT 662
             DFGLAR++ G + Q  T+R+ GT
Sbjct:   639 DFGLARMYQGTEYQDNTRRVAGT 661

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)]

 Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
 Identities = 278/674 (41%), Positives = 386/674 (57%)

Query:     9 LLSSCFYS-DFGTATATDTITSSQFIRDPESIIXXXXXXXXXXXXPDGNFTNRYIGIWYN 67
             L S+   S  +   T T  ++  Q +  P  I             P+ N  N Y+GIW+ 
Sbjct:     8 LFSTLLLSFSYAAITPTSPLSIGQTLSSPNGIFELGFFS------PN-NSRNLYVGIWFK 60

Query:    68 KGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWXXXXXXXXXXXXTRA 127
               G   +TVVWVANR   + D++    IS +G+L++ +GK    W              A
Sbjct:    61 --GIIPRTVVWVANRENSVTDATADLAISSNGSLLLFDGKHSTVWSTGETFASNGSS--A 116

Query:   128 QLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIG 187
             +L DSGNL++ D +S +++W SF+   DT      +  +  TG+K  L+SW+S ++P  G
Sbjct:   117 ELSDSGNLLVIDKVSGITLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPG 176

Query:   188 SFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTR 247
              F   + +   P+ FI + G++PYWRSGPW    F G+P  +  Y   F++ +D   G+ 
Sbjct:   177 EFVGYITTQVPPQGFI-MRGSKPYWRSGPWAKTRFTGVPLTDESYTHPFSVQQD-ANGSV 234

Query:   248 YLTFAFAD-NDVFFALTPQGNLE--ERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCN 304
             Y +    +       LT +G+L+       D   ++ +    P N CD YG CG FG C 
Sbjct:   235 YFSHLQRNFKRSLLVLTSEGSLKVTHHNGTDWVLNIDV----PANTCDFYGVCGPFGLCV 290

Query:   305 SQKIPICSCLLGFEPKNAEDWNRGNWSGGEV-------EGKQDG-----FFKLETMKVPY 352
                 P C C  GF P+ +E+W RGNW+GG V       +G   G     F  +  +K P 
Sbjct:   291 MSIPPKCKCFKGFVPQFSEEWKRGNWTGGCVRRTELLCQGNSTGRHVNVFHPVANIKPPD 350

Query:   353 FAER-SSANEDKCKDQCSNNCSCKAYAYEIGVGCMIWTHNLIDIRKLPSGGTNLYIRVAH 411
             F E  SS + ++C   C +NCSC A+AY  G+GC+IW   L+D+ +   GG  L IR+A 
Sbjct:   351 FYEFVSSGSAEECYQSCLHNCSCLAFAYINGIGCLIWNQELMDVMQFSVGGELLSIRLAS 410

Query:   412 EELDRKDMKXXXXXXXXXXXX--XXXXCTFFAWRWFAKRKAMKENSKVQRLDLGEAYAN- 468
              E+     K                    F  WR+      +K N+ V ++ L  A+ N 
Sbjct:   411 SEMGGNQRKKTIIASIVSISLFVTLASAAFGFWRY-----RLKHNAIVSKVSLQGAWRND 465

Query:   469 FSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLS 528
               +E V+      L  F  + +  ATNNF L NKLGQGGFGPVYKGKLQDG+EIAVKRLS
Sbjct:   466 LKSEDVS-----GLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLS 520

Query:   529 KASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ 588
              +SGQG+EEFMNE+++IS LQH NLVR+LGCC+E EE +L+YE+M NKSLD+F+FD +++
Sbjct:   521 SSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKR 580

Query:   589 SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               +DWPKRF+II+GI+RGLLYLHRDSRLRIIHRD+K SNILLDD +NPKISDFGLAR++ 
Sbjct:   581 VEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYE 640

Query:   649 GNQDQAATKRLVGT 662
             G + Q  T+R+VGT
Sbjct:   641 GTKYQDNTRRIVGT 654

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SXB8	Y1133_ARATH	2, ., 7, ., 1, 1, ., 1	0.5135	0.9531	0.7494	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_XI000360 hypothetical protein (832 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	662
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-44
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-36
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	5e-35
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	2e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-30
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	7e-30
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	1e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-22
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	3e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-20
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-18
pfam08276	66	pfam08276, PAN_2, PAN-like domain	8e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-11
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-11
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.004
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.004
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.004

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  160 bits (407), Expect = 7e-45
 Identities = 63/156 (40%), Positives = 86/156 (55%), Gaps = 14/156 (8%)

Query: 501 NKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVR 555
            KLG+G FG VYKGKL+       E+AVK L + AS + +++F+ E  V+  L H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGLLY 609
           LLG C E E   L+ EYM    L  +L      F    +S L      +    I++G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L      + +HRDL A N L+ +DL  KISDFGL+R
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  160 bits (406), Expect = 1e-44
 Identities = 64/154 (41%), Positives = 85/154 (55%), Gaps = 11/154 (7%)

Query: 498 QLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHR 551
            L  KLG+G FG VYKGKL+        E+AVK L + AS Q  EEF+ E  ++  L H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LLG C E E   ++ EYM    L S+L   + +  L      +    I+RG+ YL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  IHRDL A N L+ ++L  KISDFGL+R
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  160 bits (406), Expect = 1e-44
 Identities = 64/153 (41%), Positives = 85/153 (55%), Gaps = 10/153 (6%)

Query: 499 LANKLGQGGFGPVYKGKLQDG-----QEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
           L  KLG+G FG VYKG L+        E+AVK L + AS Q  EEF+ E  ++  L H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+LLG C E E  M++ EYMP   L  +L   + +  L      +    I+RG+ YL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE- 120

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 IHRDL A N L+ ++L  KISDFGL+R
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (401), Expect = 6e-44
 Identities = 59/150 (39%), Positives = 81/150 (54%), Gaps = 11/150 (7%)

Query: 502 KLGQGGFGPVYKGKL-----QDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVR 555
           KLG+G FG VYKG L         ++AVK L   AS + +EEF+ E  ++  L H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           LLG C + E   ++ EYMP   L  FL   +    L       +   I++G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              +HRDL A N L+ ++L  KISDFGL+R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  143 bits (364), Expect = 2e-39
 Identities = 58/163 (35%), Positives = 88/163 (53%), Gaps = 10/163 (6%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           LG+GGFG VY  +  + G+++A+K + K  S    EE + E+ ++  L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
            +     L+ EY    SL   L + + +  L   +   I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 621 RDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RDLK  NILLD D+   K++DFGL+++   ++     K +VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  140 bits (356), Expect = 9e-38
 Identities = 62/169 (36%), Positives = 85/169 (50%), Gaps = 11/169 (6%)

Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNL 553
           ++L  KLG G FG VYK K +  G+ +AVK L K     +  +    E+ ++  L H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           VRL+    +++   L+ EY     L  +L    R   L   +   I   I RGL YLH  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS- 116

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
               IIHRDLK  NILLD++   KI+DFGLA+    +     T   VGT
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  136 bits (346), Expect = 2e-36
 Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 11/168 (6%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNLV 554
           +++  KLG+G FG VY  +  + G+ +A+K + K   +   E  + E+ ++  L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL     + ++  L+ EY     L   L   +R  L +   RF  ++ I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
              I+HRDLK  NILLD+D + K++DFGLAR     +        VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGT 159

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 5e-36
 Identities = 63/181 (34%), Positives = 91/181 (50%), Gaps = 29/181 (16%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
            +     LG+G FG VY    +D G+ +AVK   LS  S +  E    E+ ++S+LQH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 553 LVRLLGCCVEREENML-IY-EYMPNKSLDSFLFDPQRQSLLDWPKRF-----NIIKGISR 605
           +VR  G   + E+N L I+ EY+   SL S L            K+F      +I+  +R
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108

Query: 606 ----GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
               GL YLH      I+HRD+K +NIL+D D   K++DFG A+  G  +    T  + G
Sbjct: 109 QILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165

Query: 662 T 662
           T
Sbjct: 166 T 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  127 bits (322), Expect = 5e-35
 Identities = 54/113 (47%), Positives = 67/113 (59%), Gaps = 4/113 (3%)

Query: 73  NKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDS 132
           N+TVVWVANR  PL DSS    +  DGNLV+ +G  +V WSSN S     S   A L D 
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSG--KGSGCVAVLQDD 58

Query: 133 GNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPS 185
           GNLVL+DN S   +W SF  PTDT     K   ++  G   +LTSW+S ++PS
Sbjct: 59  GNLVLYDN-SGKVLWQSFDHPTDTLLPGQKD-GNVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  115 bits (289), Expect = 2e-30
 Identities = 51/124 (41%), Positives = 67/124 (54%), Gaps = 8/124 (6%)

Query: 30  SQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDS 89
           S  +   ++++SSGS F+LGFF         Y  I Y      ++TVVWVANR+ P   S
Sbjct: 1   SNPLSSGQTLVSSGSLFELGFFKLIMQS-RDYNLILYKGS---SRTVVWVANRDNPS-GS 55

Query: 90  SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149
           S   T+  DGNLV+ +G   V WSSN +    N N    LLD GNLVL+D+     +W S
Sbjct: 56  SCTLTLQSDGNLVIYDGSGTVVWSSNTTR--VNGNYVLVLLDDGNLVLYDSDGNF-LWQS 112

Query: 150 FQEP 153
           F  P
Sbjct: 113 FDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 6e-30
 Identities = 60/173 (34%), Positives = 97/173 (56%), Gaps = 17/173 (9%)

Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQHRN 552
           N+QL + +G+G FG VYKG  L+ G  +A+K++S  K   +  +  M E+ ++ NL+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 553 LVRLLGCCVEREENMLIY-EYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLY 609
           +V+ +G  +E  +++ I  EY  N SL   +  F P  +SL+     +  +  + +GL Y
Sbjct: 61  IVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---AVY--VYQVLQGLAY 114

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH      +IHRD+KA+NIL   D   K++DFG+A          A+  +VGT
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (298), Expect = 6e-30
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 4/150 (2%)

Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           F L  KLG G FG V++G  ++   +A+K L       Q++F  EV  +  L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
              C   E   +I E M   SL +FL  P+ Q  L      ++   ++ G+ YL      
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARI 646
             IHRDL A NIL+ +DL  K++DFGLAR+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  113 bits (285), Expect = 7e-30
 Identities = 47/121 (38%), Positives = 67/121 (55%), Gaps = 9/121 (7%)

Query: 30  SQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDS 89
           S  +   ++++S  S F+LGFF+      N Y  I Y      ++TVVWVANR+ P+   
Sbjct: 1   SNTLSSGQTLVSGNSLFELGFFTL--IMQNDYNLILYKSS---SRTVVWVANRDNPV-SD 54

Query: 90  SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149
           S   T+  DGNLV+ +G  +V WSSN +    N N    LLD GNLV++D+     +W S
Sbjct: 55  SCTLTLQSDGNLVLYDGDGRVVWSSNTTG--ANGNYVLVLLDDGNLVIYDS-DGNFLWQS 111

Query: 150 F 150
           F
Sbjct: 112 F 112

Length = 114

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  112 bits (283), Expect = 1e-29
 Identities = 42/114 (36%), Positives = 61/114 (53%), Gaps = 8/114 (7%)

Query: 212 WRSGPWNGRYFIGIPDM--NSVYLDGFNLGEDHQKGTRYLTFAFADNDVF--FALTPQGN 267
           WRSGPWNG  F GIP+M   S Y+  F           Y T+   +N ++    L+ +G+
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNFTE----NNEEVYYTYRMTNNSIYSRLTLSSEGS 56

Query: 268 LEERAWVDGKAHLKIYFFYPTNDCDVYGKCGAFGSCNSQKIPICSCLLGFEPKN 321
           LE   W+       +++  P + CDVYG+CG +G C+    P C+C+ GF PKN
Sbjct: 57  LERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 55/173 (31%), Positives = 92/173 (53%), Gaps = 21/173 (12%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           F++  K+G+GGFG VYK +  + G+E+A+K +   S + +E+ +NE+ ++   +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLY 609
             G  ++++E  ++ E+    SL        +  L    +         + K + +GL Y
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH      IIHRD+KA+NILL  D   K+ DFGL+       D  A   +VGT
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 3e-28
 Identities = 56/153 (36%), Positives = 80/153 (52%), Gaps = 5/153 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLG G FG V+ G      ++AVK L K      E F+ E  ++  L+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L   C E E   ++ EYM   SL  FL   + + L   P+  ++   I+ G+ YL    
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLES-- 121

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
               IHRDL A NIL+ ++L  KI+DFGLAR+ 
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  114 bits (287), Expect = 3e-28
 Identities = 59/170 (34%), Positives = 87/170 (51%), Gaps = 23/170 (13%)

Query: 496 NFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNL 548
             +   +LG+G FG VYKG+L           +A+K L + A  + Q+EF  E  ++S+L
Sbjct: 6   AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF-------------DPQRQSLLDWPK 595
           QH N+V LLG C + +   +++EY+ +  L  FL              D   +S LD   
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +I   I+ G+ YL   S    +HRDL A N L+ + L  KISDFGL+R
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 2e-27
 Identities = 51/177 (28%), Positives = 91/177 (51%), Gaps = 27/177 (15%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQHR 551
           ++   ++G+G +G VYK +  + G+ +A+K++       +E F    + E+ ++  L+H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHP 58

Query: 552 NLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI--IKGISR-- 605
           N+VRL      + +    +++EYM +  L   L  P+         +F    IK   +  
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--------VKFTESQIKCYMKQL 109

Query: 606 --GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
             GL YLH +    I+HRD+K SNIL+++D   K++DFGLAR +        T R++
Sbjct: 110 LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (273), Expect = 2e-26
 Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 13/159 (8%)

Query: 496 NFQLANKLGQGGFGPVYKGK---LQDGQ--EIAVKRLSKASG-QGQEEFMNEVMVISNLQ 549
           + +   +LG+G FG V   +   L D    ++AVK L+ +   Q + +F  E+ ++  L 
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           H N+V+  G C +       LI EY+P+ SL  +L   + +  ++  +       I +G+
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGM 122

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
            YL      R IHRDL A NIL++ +   KISDFGLA++
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 51/161 (31%), Positives = 91/161 (56%), Gaps = 20/161 (12%)

Query: 503 LGQGGFGPVYKGK-LQDGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG VYKG  + +G+     +A+K L + +  +  +E ++E  V++++ H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
           LG C+   +  LI + MP   L  ++ + +     Q LL+W  +      I++G+ YL  
Sbjct: 75  LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
               R++HRDL A N+L+    + KI+DFGLA++   ++ +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 56/163 (34%), Positives = 81/163 (49%), Gaps = 14/163 (8%)

Query: 501 NKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVR 555
            +LG G FG V KG      G+E+  AVK L +     G++EF+ E  V++ L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           L+G C   E  ML+ E  P   L  +L   +   + D      +   ++ G+ YL     
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESK-- 114

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--QAAT 656
              +HRDL A N+LL +    KISDFG++R  G   D  +A T
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  104 bits (262), Expect = 4e-25
 Identities = 60/160 (37%), Positives = 86/160 (53%), Gaps = 6/160 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  KLG G FG V+ G      ++A+K L + S    E F+ E  ++  LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P+    L   K  ++   I+ G+ ++ R +
Sbjct: 65  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ + L  KI+DFGLAR+   N+  A
Sbjct: 123 ---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  103 bits (260), Expect = 8e-25
 Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 10/160 (6%)

Query: 503 LGQGGFGPVYKGKLQ--DGQEI--AVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           +G G FG V +G+L+    +EI  A+K L + +S + + +F+ E  ++    H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           G   +    M+I EYM N SLD FL   +        +   +++GI+ G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            +HRDL A NIL++ +L  K+SDFGL+R    ++    TK
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 21/165 (12%)

Query: 499 LANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHR 551
           L  +LG+G FG V+ G+        D + +AVK L + AS   +++F  E  +++N QH 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR---------FNII 600
           N+V+  G C E +  ++++EYM +  L+ FL    P    L                 I 
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             I+ G++YL   +    +HRDL   N L+  DL  KI DFG++R
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (259), Expect = 2e-24
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 28/199 (14%)

Query: 472 EKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA 530
           E+   A L+D++        +    ++   K+G+G  G VYK      G+E+A+K++ + 
Sbjct: 1   EEELKAALKDIV-----SEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RL 54

Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
             Q +E  +NE++++ + +H N+V      +  +E  ++ EYM   SL           +
Sbjct: 55  RKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDI 105

Query: 591 LDW-PKRFN------IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
           +     R N      + + + +GL YLH      +IHRD+K+ NILL  D + K++DFG 
Sbjct: 106 ITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGF 162

Query: 644 ARIFGGNQDQAATKRLVGT 662
           A      + +  +  +VGT
Sbjct: 163 AAQLTKEKSKRNS--VVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  104 bits (259), Expect = 4e-24
 Identities = 55/172 (31%), Positives = 87/172 (50%), Gaps = 10/172 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQH-R 551
           ++++  KLG+G FG VY  +  D + +A+K L+K      +  E F+ E+ ++++L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+L     +     L+ EY+   SL+  L    R+  L   +   I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 612 RDSRLRIIHRDLKASNILLDDDLN-PKISDFGLARIFGGNQDQAATKRLVGT 662
                 IIHRD+K  NILLD D    K+ DFGLA++       ++   L  T
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (253), Expect = 8e-24
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 17/174 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRN 552
           ++ +    LGQG  G VYK + +  G+  A+K++      + +++ + E+  + + +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR----GLL 608
           +V+  G   +  E  ++ EYM   SL   L     + +   P+   ++  I+R    GL 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPE--PVLAYIARQILKGLD 113

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           YLH      IIHRD+K SN+L++     KI+DFG++++     DQ  T   VGT
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGT 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 56/159 (35%), Positives = 82/159 (51%), Gaps = 8/159 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L   +G+G FG V  G  + GQ++AVK L   S   Q  F+ E  V++ L+H NLV
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLV 63

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRD 613
           +LLG  ++     ++ EYM   SL  +L    R  + L     F +   +  G+ YL   
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK 121

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
                +HRDL A N+L+ +DL  K+SDFGLA+     QD
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 53/156 (33%), Positives = 81/156 (51%), Gaps = 21/156 (13%)

Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQHRNLVRL 556
           KLG+G +G VYK +  + G+ +A+K++       +E      + E+ ++  L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS----RGLLYLHR 612
           L       +  L++EY  +  L  +L               N+IK I     RGL Y H 
Sbjct: 64  LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSP------NLIKSIMYQLLRGLAYCHS 116

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               RI+HRDLK  NIL++ D   K++DFGLAR FG
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.1 bits (248), Expect = 3e-23
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 13/173 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
            +++  ++G+G FG VY  +   DG+   +K   LS  S + +E+ +NEV ++  L H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK---GISRGLLY 609
           +++      E+ +  ++ EY     L   +   +++          I+     +   L Y
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH  SR +I+HRD+K  NI L  +   K+ DFG++++     D A T  +VGT
Sbjct: 119 LH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 50/145 (34%), Positives = 80/145 (55%), Gaps = 6/145 (4%)

Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G FG VYKG L+   E+AVK            +F+ E  ++    H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           V+++   ++ E +P  SL +FL   + +  L   K   +    + G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 621 RDLKASNILLDDDLNPKISDFGLAR 645
           RDL A N L+ ++   KISDFG++R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 57/160 (35%), Positives = 83/160 (51%), Gaps = 5/160 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLG G FG V+ G   +  ++AVK L K      + F+ E  ++  LQH  LV
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL     + E   +I EYM   SL  FL        +  PK  +    I+ G+ Y+ R +
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+N+L+ + L  KI+DFGLAR+   N+  A
Sbjct: 124 ---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 60/160 (37%), Positives = 84/160 (52%), Gaps = 20/160 (12%)

Query: 503 LGQGGFGPVYKGKLQD-------GQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLV 554
           LG G FG VY+G   D          +AVK L K A+ Q ++EF+ E  ++SN  H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS----LLDWPKRFNIIKGISRGLLYL 610
           +LLG C+  E   +I E M    L S+L D + +     LL   +  +I   +++G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 611 HRDSRLRIIHRDLKASNILL-----DDDLNPKISDFGLAR 645
               ++  IHRDL A N L+     D D   KI DFGLAR
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 91.0 bits (226), Expect = 3e-22
 Identities = 33/77 (42%), Positives = 49/77 (63%), Gaps = 2/77 (2%)

Query: 336 EGKQDGFFKLETMKVPYFAERSSA-NEDKCKDQCSNNCSCKAYAY-EIGVGCMIWTHNLI 393
           +G  DGF KL  +K+P  A   +A + ++C++ C +NCSC AYAY     GC++W   L 
Sbjct: 8   DGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLN 67

Query: 394 DIRKLPSGGTNLYIRVA 410
           ++R L SGG  LY+R+A
Sbjct: 68  NLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 5/160 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + QL  KLG G FG V++G   +   +AVK L K      ++F+ E  ++  L+H  L+
Sbjct: 6   TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L   C   E   ++ E M   SL  +L        L  P+  ++   ++ G+ YL   +
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN 123

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL A N+L+ ++   K++DFGLAR+   +  +A
Sbjct: 124 ---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 95.7 bits (238), Expect = 5e-22
 Identities = 54/170 (31%), Positives = 92/170 (54%), Gaps = 9/170 (5%)

Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
           +F++ NK+G+G FG V+K  +  D +  A+K+  LSK + + +EE ++E  V++ L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           ++R     +++ +  ++ EY  N  L   L   QR   L   + +     I  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
               +I+HRD+K+ N+ LD   N KI D G+A++   N + A T  +VGT
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 95.8 bits (238), Expect = 5e-22
 Identities = 58/162 (35%), Positives = 86/162 (53%), Gaps = 6/162 (3%)

Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
              + QL  KLG G FG V+ G      ++AVK L K      E F+ E  ++  L+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           LV+L    V  E   ++ EYM   SL  FL D + ++L   P   ++   ++ G+ Y+ R
Sbjct: 63  LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIER 120

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
              +  IHRDL+++NIL+ D L  KI+DFGLAR+   N+  A
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 52/163 (31%), Positives = 92/163 (56%), Gaps = 16/163 (9%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEFM-NEVMVISNLQ---H 550
           ++   ++G+G +G VYK + L  G+ +A+K++    S +G       E+ ++  L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 551 RNLVRLLGCC----VEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
            N+VRLL  C     +RE  + L++E++ ++ L ++L     +  L      ++++ + R
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           G+ +LH     RI+HRDLK  NIL+  D   KI+DFGLARI+ 
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 53/164 (32%), Positives = 78/164 (47%), Gaps = 17/164 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQ----DGQEIAVK---RLSKASGQGQEEFMNEVMVISNL 548
           +  L   LG G FG VY+G  +    D  E+ V         S Q + +F+ E +++S  
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGIS 604
            H+N+VRL+G   ER    ++ E M    L SFL +    P+R S L         + ++
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLAR 645
           +G  YL  +     IHRD+ A N LL         KI+DFG+AR
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 48/143 (33%), Positives = 78/143 (54%), Gaps = 6/143 (4%)

Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE 562
           LG G FG V+ GK +   ++A+K + + +   +++F+ E  V+  L H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRD 622
           +    ++ EYM N  L ++L   +R+  L      ++   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 623 LKASNILLDDDLNPKISDFGLAR 645
           L A N L+ +D   K+SDFGLAR
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 18/174 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
            +++  ++G+G  G V+K K  + G+ +A+K+  L +  G    + + E+  +   QH  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL---- 608
           +V+LL         +L+ EYMP+  L   L D +R      P     +K   R LL    
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEER------PLPEAQVKSYMRMLLKGVA 113

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           Y+H      I+HRDLK +N+L+  D   KI+DFGLAR+F   + +  + + V T
Sbjct: 114 YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VAT 163

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.6 bits (232), Expect = 3e-21
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 6/159 (3%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV+
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R   
Sbjct: 66  LYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER--- 120

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 6/153 (3%)

Query: 499 LANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V+  ++H NLV+LL
Sbjct: 10  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           G C       +I E+M   +L  +L +  RQ  ++      +   IS  + YL + +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN--- 124

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
            IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 58/150 (38%), Positives = 82/150 (54%), Gaps = 14/150 (9%)

Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKAS--GQGQE---EFMNEVMVISNLQHRNLVRL 556
           LG G FG VY+G  L DG   AVK +S A     GQE   +   E+ ++S LQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 557 LGCCVEREENMLIY-EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           LG   E E+N+ I+ E +P  SL   L   ++      P      + I  GL YLH   R
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLH--DR 121

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              +HRD+K +NIL+D +   K++DFG+A+
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)

Query: 495 NNFQLANKLGQGGFGPVYKGK---LQDGQE---IAVKRLSK-ASGQGQEEFMNEVMVISN 547
           NN +    +GQG FG V++ +   L   +    +AVK L + AS   Q +F  E  +++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-------------------PQRQ 588
             H N+V+LLG C   +   L++EYM    L+ FL                         
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 589 SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             L   ++  I K ++ G+ YL   S  + +HRDL   N L+ +++  KI+DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 93.0 bits (231), Expect = 7e-21
 Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 27/174 (15%)

Query: 497 FQLANKLGQGGFGPVYKGKL--QDG--QEIAVKRLSKASGQGQ---EEFMNEVMVISNLQ 549
            +L   LG+G FG V +G+L   DG   ++AVK + K         EEF++E   + +  
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59

Query: 550 HRNLVRLLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK-- 601
           H N+++L+G C E          M+I  +M +  L SFL       L   P++  +    
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLL 116

Query: 602 ----GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN 650
                I+ G+ YL   S    IHRDL A N +L +D+   ++DFGL++ I+ G+
Sbjct: 117 KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.9 bits (231), Expect = 7e-21
 Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 12/157 (7%)

Query: 503 LGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 558 GCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           G C    R    L+ EY+P  SL  +L   + +  LD  K       I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            R +HRDL   NIL++ +   KI DFGL ++   +++
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 52/148 (35%), Positives = 79/148 (53%), Gaps = 14/148 (9%)

Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
           +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+  L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 562 EREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           ++    ++ EYM N  L ++L +     Q   LL+      + K +  G+ YL      +
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE------MCKDVCEGMAYLESK---Q 120

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645
            IHRDL A N L+DD    K+SDFGL+R
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 58/164 (35%), Positives = 84/164 (51%), Gaps = 23/164 (14%)

Query: 502 KLGQGGFGPVYKGKL------QDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRNLV 554
           +LG+  FG VYKG L      +  Q +A+K L  KA G  +EEF +E M+ S LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLF-------------DPQRQSLLDWPKRFNIIK 601
            LLG   + +   +I+ Y  +  L  FL              D   +S L+     +I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            I+ G+ +L   S   ++H+DL   N+L+ D LN KISD GL R
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 51/150 (34%), Positives = 88/150 (58%), Gaps = 10/150 (6%)

Query: 503 LGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G G FG V++G L+  G++   +A+K L     + Q ++F++E  ++    H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           G   + +  M+I EYM N +LD +L D   +      +   +++GI+ G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIF 647
            +HRDL A NIL++ +L  K+SDFGL+R+ 
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 10/167 (5%)

Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           F +  KLG+G +G VYK    + GQ +A+K +     +  +E + E+ ++       +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
             G   +  +  ++ EY    S+   +        L   +   I+    +GL YLH    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---S 117

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            + IHRD+KA NILL+++   K++DFG++        +  T  ++GT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 51/171 (29%), Positives = 92/171 (53%), Gaps = 21/171 (12%)

Query: 493 ATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEF----MNEVMVISN 547
              ++++  KLG+G FG VYK  +++ G+ +A+K++   + +  + F    + E+ ++  
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63

Query: 548 LQHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           L+H N+V L+   VER +          ++  YM +  L   L +P  +  L   +    
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVK--LTESQIKCY 120

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
           +  +  G+ YLH +    I+HRD+KA+NIL+D+    KI+DFGLAR + G 
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 90.9 bits (225), Expect = 5e-20
 Identities = 55/161 (34%), Positives = 96/161 (59%), Gaps = 20/161 (12%)

Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG VYKG  + +G+ +    A+K L++ +G +   EFM+E ++++++ H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
           LG C+      L+ + MP+  L  ++ + +     Q LL+W  +      I++G++YL  
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
               R++HRDL A N+L+    + KI+DFGLAR+  G++ +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.0 bits (223), Expect = 6e-20
 Identities = 56/161 (34%), Positives = 89/161 (55%), Gaps = 10/161 (6%)

Query: 503 LGQGGFGPVYKG--KLQDGQEI--AVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
           +G G FG V  G  KL   +EI  A+K L     + Q  +F++E  ++    H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           G   + +  M++ EYM N SLD+FL     Q  +   +   +++GI+ G+ YL   S + 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMG 126

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            +HRDL A NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 7e-20
 Identities = 56/166 (33%), Positives = 79/166 (47%), Gaps = 16/166 (9%)

Query: 503 LGQGGFGPVYK-GKLQDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+G FG V    K   G+  A+K L K      +  E  + E  ++S + H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 559 CCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRL 616
              + EE + L+ EY P   L S L    ++      + RF     I   L YLH    L
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF-YAAEIVLALEYLHS---L 112

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            II+RDLK  NILLD D + K++DFGLA+      + + T    GT
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 54/154 (35%), Positives = 85/154 (55%), Gaps = 22/154 (14%)

Query: 503 LGQGGFGPVYKGKL-QDGQE---IAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G G FG V +G+L   G+    +A+K L     + Q  +F++E  ++    H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII------KGISRGLLYLH 611
           G   +    M+I E+M N +LDSFL    RQ+      +F +I      +GI+ G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL----RQN----DGQFTVIQLVGMLRGIAAGMKYL- 122

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             S +  +HRDL A NIL++ +L  K+SDFGL+R
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 6/158 (3%)

Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           L  ++G G FG V+ G   + +++A+K + + +   +E+F+ E  V+  L H  LV+L G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
            C ER    L++E+M +  L  +L    ++          +   +  G+ YL   +   +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           IHRDL A N L+ ++   K+SDFG+ R    +Q  ++T
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 19/167 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
           +N  L  +LG+G FG V+  +       QD   +AVK L  AS   +++F  E  +++NL
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL----------FDPQRQSLLDWPKRFN 598
           QH ++V+  G CVE +  ++++EYM +  L+ FL           +  R + L   +  +
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           I + I+ G++YL   +    +HRDL   N L+ ++L  KI DFG++R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 20/179 (11%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM--NEVMVISNLQHRNL 553
           +++   +G+G FG V K +   DG+ +  K +   +   +E+    +EV ++  L+H N+
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 554 VRLLGCCVEREENMLIY---EYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLL 608
           VR     ++R  N  +Y   EY     L   +     +R+ +    + F I + +++ LL
Sbjct: 62  VRYYDRIIDRS-NQTLYIVMEYCEGGDLAQLIQKCKKERKYI---EEEF-IWRILTQLLL 116

Query: 609 YLHR-----DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            L+      D    ++HRDLK +NI LD + N K+ DFGLA+I G +   A T   VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 56/161 (34%), Positives = 74/161 (45%), Gaps = 20/161 (12%)

Query: 502 KLGQGGFGPVYKGK-LQDGQE---IAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRL 556
           KLG G FG V +G+    G +   +AVK L         ++F+ E  ++ +L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS-----LLDWPKRFNIIKGISRGLLYLH 611
            G  V     M++ E  P  SL   L            L D+  +      I+ G+ YL 
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
                R IHRDL A NILL  D   KI DFGL R    N+D
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 9/159 (5%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQHRNL 553
           +Q   K+G+G +G VYK +    G+ +A+K++               E+ ++  L H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           ++LL     + +  L++E+M +  L   + D  RQ  L      + +  + +GL + H  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
               I+HRDLK  N+L++ +   K++DFGLAR FG    
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 28/162 (17%)

Query: 501 NKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVISNLQHRNLV 554
            KLG+G +  VYK +  + G+ +A+K++     +  ++ +N     E+ ++  L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 555 RLLGCCVEREENMLIYEYMP--------NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
            LL     +    L++E+M         +KS+   L     +S          +    RG
Sbjct: 66  GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKS---------YMLMTLRG 114

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           L YLH +    I+HRDLK +N+L+  D   K++DFGLAR FG
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-Q 549
           ++F+    +G+G F  V   K +   +E A+K L K      +  +    E  V++ L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 550 HRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           H  +++L     + EEN+  + EY PN  L  ++   ++   LD          I   L 
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YLH      IIHRDLK  NILLD D++ KI+DFG A++   N    + K
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 87.4 bits (216), Expect = 5e-19
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 21/162 (12%)

Query: 502 KLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +LG+G FG V+  +       QD   +AVK L +AS   +++F  E  +++ LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSL----------LDWPKRFNIIKGI 603
             G C E    ++++EYM +  L+ FL    P  + L          L   +   I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + G++YL   + L  +HRDL   N L+   L  KI DFG++R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 15/172 (8%)

Query: 498 QLANKLGQGGFGPVYKG-KLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           Q  NK+G G FG VY    L  G+ +AVK  R+     +  +E  +E+ V+  L+H NLV
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWP--KRFNIIKGISRGLLYLHR 612
           +  G  V RE+  +  EY    +L+  L   +   +LD    + +     +  GL YLH 
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVY--TLQLLEGLAYLHS 117

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT--KRLVGT 662
                I+HRD+K +NI LD +   K+ DFG A     N        + L GT
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 49/144 (34%), Positives = 81/144 (56%), Gaps = 6/144 (4%)

Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
           +LG G FG V+ GK +   ++A+K +++ +   +E+F+ E  V+  L H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR 621
           +++   ++ E+M N  L ++L   QRQ  L      ++ + +  G+ YL R+S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 622 DLKASNILLDDDLNPKISDFGLAR 645
           DL A N L+      K+SDFG+ R
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 17/165 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISN 547
               L  +LGQG FG VY+G      K +    +A+K +++ +   +  EF+NE  V+  
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF----DPQRQSLLDWPKRFNIIK-- 601
               ++VRLLG     +  +++ E M    L S+L     + +    L  P     I+  
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 602 -GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             I+ G+ YL      + +HRDL A N ++ +DL  KI DFG+ R
Sbjct: 126 AEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 86.3 bits (213), Expect = 9e-19
 Identities = 57/159 (35%), Positives = 86/159 (54%), Gaps = 6/159 (3%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           + +L  KLGQG FG V+ G      ++A+K L K      E F+ E  ++  L+H  LV 
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           L    V  E   ++ E+M   SL  FL +   + L   P+  ++   I+ G+ Y+ R   
Sbjct: 66  LYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIER--- 120

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           +  IHRDL+A+NIL+ D+L  KI+DFGLAR+   N+  A
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 53/148 (35%), Positives = 82/148 (55%), Gaps = 8/148 (5%)

Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           L   +G+G FG V +G+   GQ++AVK + K     Q  F+ E  V++ L H+NLVRLLG
Sbjct: 10  LGEIIGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQA-FLEETAVMTKLHHKNLVRLLG 66

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
             +      ++ E M   +L +FL    R +L+   +       ++ G+ YL      ++
Sbjct: 67  VILHNGLY-IVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           +HRDL A NIL+ +D   K+SDFGLAR+
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV 149

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 9/173 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKR--LSKASGQGQEEFMNEVMVISNLQHR 551
           ++++L   +G G    VY        E +A+KR  L K      +E   EV  +S   H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHP 59

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+     V  +E  L+  Y+   SL   +     +  LD      ++K + +GL YLH
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQA-ATKRLVGT 662
            + +   IHRD+KA NILL +D + KI+DFG+ A +  G        K  VGT
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 52/157 (33%), Positives = 78/157 (49%), Gaps = 12/157 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKR-----LSKASGQGQEEFMNEVMVISNL 548
            N++    LGQG FG VY     D G+E+AVK+      S  + +       E+ ++ NL
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           QH  +V+  GC  + E   +  EYMP  S+   L      +L +   R    + I  G+ 
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVE 118

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           YLH +    I+HRD+K +NIL D   N K+ DFG ++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 38/170 (22%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEE-----FMNEVMVISNL 548
           +Q   K+G+G +G VYK +    G+ +A+K  RL     + ++E      + E+ ++  L
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKEL 55

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMP---NKSLDS---FLFDPQRQSLLDWPKRFNIIKG 602
            H N+VRLL       +  L++E++     K +DS      DP             +IK 
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP------------LIKS 103

Query: 603 ----ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               + +G+ Y H  S  R++HRDLK  N+L+D +   K++DFGLAR FG
Sbjct: 104 YLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 53/156 (33%), Positives = 85/156 (54%), Gaps = 19/156 (12%)

Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-----FMNEVMVISNLQHRNLVR 555
           K+G+G +G VYKG+  + GQ +A+K++   S   +EE      + E+ ++  LQH N+V 
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVC 63

Query: 556 LLGCCVEREENMLIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           L    ++     LI+E++     K LDS        + L     + I++GI    L+ H 
Sbjct: 64  LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFCHS 119

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               R++HRDLK  N+L+D+    K++DFGLAR FG
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 10/153 (6%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQ-HRN 552
           +++  +LG G FG VY  +  + G+ +A+K++ K      EE MN  EV  +  L  H N
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L     E +E   ++EYM   +L   + D ++          +II  I +GL ++H+
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  HRDLK  N+L+      KI+DFGLAR
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 15/170 (8%)

Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLV 554
           F L   +G+G FG VYK    +  Q +A+K +     + + E +  E+  +S  +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +  G  ++  +  +I EY    S    L    +   LD      I++ +  GL YLH + 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGT 662
               IHRD+KA+NILL ++ + K++DFG++    G      +KR   VGT
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGT 161

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 10/161 (6%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLV 554
             +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V++ L+H NLV
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLV 62

Query: 555 RLLGCCVEREENMLIY-EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +LLG  VE +  + I  EYM   SL  +L    R S+L           +   + YL  +
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           +    +HRDL A N+L+ +D   K+SDFGL +     QD  
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 56/158 (35%), Positives = 83/158 (52%), Gaps = 10/158 (6%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           + +L  KLG G FG V+        ++AVK + K      E F+ E  V+  LQH  LV+
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHRD 613
           L    V +E   +I E+M   SL  FL   +  +Q L   PK  +    I+ G+ ++ + 
Sbjct: 66  L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQR 121

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
           +    IHRDL+A+NIL+   L  KI+DFGLAR+   N+
Sbjct: 122 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 56/151 (37%), Positives = 78/151 (51%), Gaps = 15/151 (9%)

Query: 503 LGQGGFGPV----YKGKLQD-GQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNLVRL 556
           LG+G FG V    Y       G+ +AVK L +  GQ     +  E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 557 LGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            GCC E+      LI EY+P  SL  +L  P+ +  L+  +     + I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               IHRDL A N+LLD+D   KI DFGLA+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 32/178 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE---------------IAVKRL-SKASGQGQEEF 538
              +L  KLG+G FG V+  + +   E               +AVK L +  +   + +F
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 539 MNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
           + E+ ++S L++ N++RLLG CV  +   +I EYM N  L+ FL   QR+    +    N
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANN 122

Query: 599 I-----------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           I              I+ G+ YL   + L  +HRDL   N L+ +    KI+DFG++R
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           N  + +++  +LG G FG VYK +  + G   A K +   S +  E+FM E+ ++S  +H
Sbjct: 2   NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V L        +  ++ E+    +LDS + + +R   L  P+   + + +   L +L
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H     ++IHRDLKA NILL  D + K++DFG++
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 77.7 bits (192), Expect = 8e-18
 Identities = 27/65 (41%), Positives = 36/65 (55%), Gaps = 6/65 (9%)

Query: 337 GKQDGFFKLETMKVPYFAERS---SANEDKCKDQCSNNCSCKAYAY---EIGVGCMIWTH 390
           G  DGF +L  MK+P         S    +C+ +C +NCSC AYAY     G GC+IWT 
Sbjct: 2   GGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTG 61

Query: 391 NLIDI 395
            L+D+
Sbjct: 62  ELVDM 66

Length = 66

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 49/149 (32%), Positives = 85/149 (57%), Gaps = 11/149 (7%)

Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DGQ+I  AVK L++ +   + E+F+ E +++ +  H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 558 GCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           G C+  E + +++  YM +  L +F+        +     F +   +++G+ YL   +  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYL---ASK 117

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + +HRDL A N +LD+    K++DFGLAR
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 61/168 (36%), Positives = 85/168 (50%), Gaps = 31/168 (18%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
            F+  N++G+G +G VY+ +     EI A+K  R+           + E+ ++ NL+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDS-FL-FDPQRQ---SLLD-WPKRFNI--IKGIS 604
           +V L              E +  K LDS FL  +   Q   SLLD  P  F+   +K + 
Sbjct: 68  IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114

Query: 605 ----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               RGL YLH +    IIHRDLK SN+LL D    KI+DFGLAR +G
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 49/156 (31%), Positives = 85/156 (54%), Gaps = 8/156 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
           NFQ   K+G+G +G VYK +    G+ +A+K  RL   +       + E+ ++  L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+LL       +  L++E++ ++ L  F+ D    S +  P   + +  + +GL + H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 20/155 (12%)

Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEE---------FMNEVMVISNLQHRN 552
           +G G FG VY G     G+ +AVK++   S     +            E+ ++  LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           +V+ LG  ++ +   +  EY+P  S+ + L  +    ++L+      N ++ I +GL YL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           H  +R  IIHRD+K +NIL+D+    KISDFG+++
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 31/178 (17%)

Query: 496 NFQLANKLGQGGFGPVYKGK------LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNL 548
           N  L   LG+G FG V K              +AVK L + +   +  + ++E  ++  +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPK 595
            H ++++L G C +    +LI EY    SL SFL + ++              S LD P 
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 596 RFNIIKG--------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              +  G        ISRG+ YL   + ++++HRDL A N+L+ +    KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 47/144 (32%), Positives = 78/144 (54%), Gaps = 6/144 (4%)

Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCV 561
           LG+G FG V+KG L+D   +AVK   +   Q  + +F++E  ++    H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR 621
           +R+   ++ E +P     SFL   + +       +F +    + G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKN---CIHR 117

Query: 622 DLKASNILLDDDLNPKISDFGLAR 645
           DL A N L+ ++   KISDFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.9 bits (203), Expect = 9e-17
 Identities = 57/159 (35%), Positives = 90/159 (56%), Gaps = 22/159 (13%)

Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHR 551
           +++  KLG+G +G V+K    +  + +A+K++  A   +   Q  F  E+M +  L  H 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHP 67

Query: 552 NLVRLLGCCVEREENM----LIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRG 606
           N+V+LL   V + EN     L++EYM     ++ L    R ++L D  KR+ I+  + + 
Sbjct: 68  NIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKA 119

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L Y+H  S   +IHRDLK SNILL+ D   K++DFGLAR
Sbjct: 120 LKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 53/167 (31%), Positives = 94/167 (56%), Gaps = 20/167 (11%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNLQH 550
           F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR----QSLLDWPKRFNIIKGISRG 606
            ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I++G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           + YL      R++HRDL A N+L+    + KI+DFGLA++ G ++ +
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 21/169 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL-QDG--QEIAVKRLSK-ASGQGQEEFMNEVMVISNL-Q 549
           N+ +  + +G+G FG V K ++ +DG   + A+KR+ + AS     +F  E+ V+  L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDP------QRQSLLDWPKR 596
           H N++ LLG C  R    L  EY P+ +L  FL        DP         S L   + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    ++RG+ YL   S+ + IHRDL A NIL+ ++   KI+DFGL+R
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 37/178 (20%)

Query: 502 KLGQGGFGPVYKGKLQDGQE-----------------IAVKRL-SKASGQGQEEFMNEVM 543
           KLG+G FG V+  ++ + Q+                 +AVK L   A+   + +F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------------FDPQRQS 589
           ++S L+  N++RLLG CV+ +   +I EYM N  L+ FL                P    
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 590 LL--DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L    +    ++   I+ G+ YL   S L  +HRDL   N L+ ++L  KI+DFG++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 51/163 (31%), Positives = 76/163 (46%), Gaps = 16/163 (9%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRLSKASGQG-QEEFMNEVMVISNL 548
           N Q    LG+G FG V+  K +  +E      + VK L K   +  Q EF  E+ +   L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKG 602
            H+N+VRLLG C E E + +I EY     L  FL       +  +   L   ++  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           I+ G+ +L   S  R +HRDL A N L+      K+S   L++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 22/166 (13%)

Query: 499 LANKLGQGGFGPVYKGK------LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
           L  +LG+G FG V+  +       +D   +AVK L   +   +++F  E  +++NLQH +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR-----------FNI 599
           +V+  G C + +  ++++EYM +  L+ FL    P    L+D   R            +I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              I+ G++YL   +    +HRDL   N L+  +L  KI DFG++R
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 48/149 (32%), Positives = 84/149 (56%), Gaps = 6/149 (4%)

Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +++  +LG G FG VYK K ++ G   A K +   S +  E++M E+ +++   H  +V+
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           LLG      +  ++ E+ P  ++D+ + +  R   L  P+   I + +   L YLH    
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS--- 128

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLA 644
           ++IIHRDLKA N+LL  D + K++DFG++
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 50/155 (32%), Positives = 85/155 (54%), Gaps = 6/155 (3%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNL 553
           NF+   KLG+G +  VYKG+ +   EI A+K +   + +G     + E+ ++  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           VRL        + ML++EYM +K L  ++     +  LD     +    + +G+ + H +
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
              R++HRDLK  N+L++     K++DFGLAR FG
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 54/178 (30%), Positives = 92/178 (51%), Gaps = 25/178 (14%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
           +F++  KLG+G +G VYK K L D Q  A+K   L   S + +E+ +NE+ +++++ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 553 LVR-----LLGC--CVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGIS 604
           ++      L G   C+       + EY P   L   +   +++  L+   + + I   + 
Sbjct: 61  IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RGL  LH     +I+HRDLK++NILL  +   KI D G++++   N      K  +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 54/170 (31%), Positives = 91/170 (53%), Gaps = 24/170 (14%)

Query: 499 LANKLGQGGFGPVYKGKL-QDGQ--EIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           L   LG+G FG V +G+L QD    ++AVK +  A  +    E+F++E + +    H N+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 554 VRLLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF------NIIK 601
           +RL+G C++  E+      ++I  +M +  L SFL       L D P+          + 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMT 119

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIFGGN 650
            I+ G+ YL   S    IHRDL A N +L++++N  ++DFGL+ +I+ G+
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 50/176 (28%), Positives = 93/176 (52%), Gaps = 21/176 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQ 549
           + ++   K+GQG FG V+K +  +  Q +A+K++       +E F    + E+ ++  L+
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLK 69

Query: 550 HRNLVRLLGCCVE--------REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
           H N+V L+  C          +    L++E+  +  L   L +   +  L   K+  ++K
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMK 126

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            +  GL Y+HR+   +I+HRD+KA+NIL+  D   K++DFGLAR F  +++    +
Sbjct: 127 MLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 21/156 (13%)

Query: 501 NKLGQGGFGPVYKGKLQDGQEIA---VKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           +++G G FG V  G+   G   A   VK L + A+   Q  F+ EV     L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLLDWPKRFNIIKGISRGLL 608
           LG C+E    +L+ E+ P   L ++L           Q+  L        +   ++ GLL
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLL 114

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           +LH   +   IH DL   N  L  DL+ KI D+GLA
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.1 bits (196), Expect = 6e-16
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 49/182 (26%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVMVIS 546
           ++L   +G G +G V      + G+++A+K++S         F +         E+ ++ 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLR 54

Query: 547 NLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDP-------QRQSLL 591
           +L+H N++ LL             + +   S + F        L +          Q L 
Sbjct: 55  HLRHENIIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT 101

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
           D   ++  +  I RGL YLH  +   +IHRDLK SNIL++ + + KI DFGLAR    ++
Sbjct: 102 DDHIQY-FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Query: 652 DQ 653
           D+
Sbjct: 158 DE 159

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 78.3 bits (193), Expect = 7e-16
 Identities = 55/155 (35%), Positives = 81/155 (52%), Gaps = 17/155 (10%)

Query: 502 KLGQGGFGPVYKGKLQDGQE-IAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           K+G+G +G VYK + +   E IA+K  RL +         + E+ ++  +QH N+VRL  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG----ISRGLLYLHRDS 614
                +   L++EY+    LD         S  D+ K   +IK     I RG+ Y H  S
Sbjct: 69  VVHSEKRLYLVFEYL---DLD---LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--S 120

Query: 615 RLRIIHRDLKASNILLDDDLNP-KISDFGLARIFG 648
             R++HRDLK  N+L+D   N  K++DFGLAR FG
Sbjct: 121 H-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154

Length = 294

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 12/159 (7%)

Query: 495 NNFQLANKLGQGGFGPVYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           NN      LG G FG V +       K     ++AVK L   A    +E  M+E+ ++S+
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           L  H N+V LLG C      ++I EY     L +FL   +R+S L      +    +++G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + +L   +    IHRDL A N+LL      KI DFGLAR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 31/161 (19%)

Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKR--LSKASGQGQEEFM--------NEVMVISNLQHR 551
           +G+G +G VY    +  G+ +AVK+  L        +           +E+  + +L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 552 NLVRLLGCCVEREENML-IY-EYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIKGIS 604
           N+V+ LG   E  E  L I+ EY+P  S+ S L     F+ Q              + + 
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--------TEQVL 118

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            GL YLH      I+HRDLKA N+L+D D   KISDFG+++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 22/161 (13%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS----KASGQGQ--EEFMNEVMVISNL 548
            +    +LG G F   Y+ + ++ G  +AVK+++     +S Q +  E    E+ +++ L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRG 606
            H +++R+LG   E     L  E+M   S+   L  +   +++++      N  + + RG
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLA 644
           L YLH +   +IIHRD+K +N+L+D     L  +I+DFG A
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 30/161 (18%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           ++L  ++G G +G VYK + +  G+ +A+K +    G   E    E+ ++   +H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSF-------LFDPQ-----RQSLLDWPKRFNIIKGI 603
             G  + R++  ++ EY    SL          L + Q     R++L             
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL------------- 111

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            +GL YLH       IHRD+K +NILL +D + K++DFG++
Sbjct: 112 -KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 21/169 (12%)

Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL- 548
           L + T  F+L   +G+G +G VYK + +   ++   ++       +EE   E  ++    
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60

Query: 549 QHRNLVRLLGC------CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN---- 598
            H N+    G           ++  L+ E     S+   +     + L    KR      
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWI 115

Query: 599 --IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             I++   RGL YLH +   ++IHRD+K  NILL  +   K+ DFG++ 
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 17/155 (10%)

Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
           LG+G +G VY  +    Q  IA+K + +   +  +    E+ + S L+HRN+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 562 EREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           E     +  E +P  SL + L           Q+++ + K+      I  GL YLH    
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEGLKYLH---D 126

Query: 616 LRIIHRDLKASNILLDDDLNP-KISDFGLARIFGG 649
            +I+HRD+K  N+L++      KISDFG ++   G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 29/170 (17%)

Query: 502 KLGQGGFGPVYKGKLQDGQE-----------------IAVKRL-SKASGQGQEEFMNEVM 543
           KLG+G FG V+  + +  ++                 +AVK L   A+   + +F+ E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSL------LDWPK 595
           ++S L+  N++RLL  C+  +   +I EYM N  L+ FL   +PQ  +       + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              +   I+ G+ YL   S L  +HRDL   N L+  +   KI+DFG++R
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 12/155 (7%)

Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLS------KASGQGQEEFMNEVMVISNLQH 550
           +     LG+G +G VY G    GQ IAVK++        A+ +  E+   EV ++ +L+H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V+ LG C++     +  E++P  S+ S L    R   L  P      K I  G+ YL
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           H +    ++HRD+K +N++L  +   K+ DFG AR
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 23/164 (14%)

Query: 502 KLGQGGFGPVYKGKL-----QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVR 555
           +LG+  FG +YKG L        Q +A+K L    + Q   EF  E  +++ L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLF--------------DPQRQSLLDWPKRFNIIK 601
           LLG   + +   +++EY+    L  FL               D   +S LD     +I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            I+ G+ YL   S    +H+DL A NIL+ + L+ KISD GL+R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 17/162 (10%)

Query: 497 FQLANKLGQGGFGPVYKGKLQDG-----QEIAVKRLSKASGQGQ-EEFMNEVMVISNLQH 550
             L++ L +G FG ++ G L D      +E+ VK +   + + Q    + E  ++  L H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 551 RNLVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK------GI 603
           +N++ +L  C+E  E   ++Y YM   +L  FL    R    + P+  +  +       I
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC-RLGEANNPQALSTQQLVHMAIQI 126

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + G+ YLH+     +IH+D+ A N ++D++L  KI+D  L+R
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 17/167 (10%)

Query: 493 ATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSK-ASGQGQEEFMNEVMVI 545
           A     ++ +LGQG FG VY    KG ++D  E  +A+K +++ AS + + EF+NE  V+
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF----DPQRQSLLDWP---KRFN 598
                 ++VRLLG   + +  ++I E M    L S+L     + +   +   P   K   
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 22/167 (13%)

Query: 497 FQLANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMN---EVMVISNLQH 550
           +++   +G+G +G VYK K +   DG+E A+K+      Q      +   E+ ++  L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 551 RNLVRLLGCCVEREENM--LIYEYMPNKSLD--SFLFDPQRQSLLDWPKRF--NIIKGIS 604
            N+V L+   +E  +    L+++Y  +       F    +R S+   P     +++  I 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSMVKSLLWQIL 118

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLARIF 647
            G+ YLH +    ++HRDLK +NIL+  +       KI D GLAR+F
Sbjct: 119 NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.7 bits (186), Expect = 5e-15
 Identities = 51/163 (31%), Positives = 85/163 (52%), Gaps = 13/163 (7%)

Query: 503 LGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRL 556
           LG+G FG V   +        G+++AVK L   SG     +   E+ ++ NL H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 557 LGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            G C E   N   LI E++P+ SL  +L  P+ ++ ++  ++      I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           R + +HRDL A N+L++ +   KI DFGL +    +++    K
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 499 LANKLGQGGFGPVYKG--KLQDGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQHRNL 553
           L   +G+G FG VY+G     + ++I  AVK      S   +E+F+ E  ++    H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V+L+G   E     ++ E  P   L S+L     +  LD          +S  L YL   
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              R +HRD+ A N+L+      K+ DFGL+R
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 11/150 (7%)

Query: 502 KLGQGGFGPVYKGKLQDG---QEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           ++G G FG V  G++  G    ++ VK L   AS Q Q +F+ E     +LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK---GISRGLLYLHRDS 614
           G C E    +L+ E+ P   L  +L    R++ L  P    + +    I+ GLL+LH+++
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLA 644
               IH DL   N LL  DL  KI D+GL+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 21/156 (13%)

Query: 502 KLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEF-MNEVMVISNLQHRNLVRLLG 558
           K+G+G +G V+K K ++  EI A+KR+      +G     + E+ ++  L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 559 CCVEREENMLIYEYMPN---KSLDSFLFDPQR---QSLLDWPKRFNIIKGISRGLLYLHR 612
                ++  L++EY      K  DS   D      +S +     F ++KG++    + H 
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----FQLLKGLA----FCHS 117

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                ++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 10/174 (5%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS---KASGQGQEEFMNEVMVISNLQ 549
             NF++  K+G+G F  VYK   L DG+ +A+K++        + +++ + E+ ++  L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLL 608
           H N+++ L   +E  E  ++ E      L   +   ++Q  L+     +     +   L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           ++H  S+ RI+HRD+K +N+ +      K+ D GL R F  +    A   LVGT
Sbjct: 121 HMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 58/177 (32%), Positives = 89/177 (50%), Gaps = 33/177 (18%)

Query: 497 FQLANKLGQGGFGPVYKG--KLQDG--QEIAVKRLSKA---SGQGQEEFMNEVMVISNLQ 549
           F L   LG+G FG V +   K +DG  Q++AVK L KA   S    EEF+ E   +    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 550 HRNLVRLLGCCVEREEN------MLIYEYMPNKSLDSFL---------FDPQRQSLLDWP 594
           H N+++L+G  +           M+I  +M +  L +FL         F    Q+L+   
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV--- 116

Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGN 650
            RF I   I+ G+ YL   S    IHRDL A N +L++++   ++DFGL++ I+ G+
Sbjct: 117 -RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 45/164 (27%), Positives = 84/164 (51%), Gaps = 12/164 (7%)

Query: 501 NKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
            K+G+G  G V        G+++AVK++     Q +E   NEV+++ + QH N+V +   
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
            +  +E  ++ E++   +L     D    + ++  +   +   + + L +LH      +I
Sbjct: 85  YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137

Query: 620 HRDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           HRD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 8e-15
 Identities = 49/162 (30%), Positives = 87/162 (53%), Gaps = 10/162 (6%)

Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+K+++      +E  +NE++V+   +H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RD+K+ NILL  D + K++DFG        Q + +T  +VGT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 52/170 (30%), Positives = 74/170 (43%), Gaps = 29/170 (17%)

Query: 502 KLGQGGFGPVYKGKLQDGQEI-----------------AVKRLSK-ASGQGQEEFMNEVM 543
           KLG+G FG V+  +    Q+                  AVK L   AS   +E+F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLLDWPK 595
           ++S L   N+ RLLG C       +I EYM N  L+ FL                L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              +   I+ G+ YL     L  +HRDL   N L+  +   KI+DFG++R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 11/164 (6%)

Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQHRNLVRLLGC 559
           +G+G FG V+  + +  Q++ + +        ++E     NE  V+  L H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
            +E +  M++ EY P  +L  ++   +  SLLD      I+    + LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLD---EDTILHFFVQILLALHHVHTKLIL 123

Query: 620 HRDLKASNILLDDDLNP-KISDFGLARIFGGNQDQAATKRLVGT 662
           HRDLK  NILLD      KI DFG+++I   ++ +A T  +VGT
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 19/170 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN----EVMVISNLQ 549
           N +++   +G+G +G V K + +  G+ +A+K+  K S +  E+       EV V+  L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKR--FNIIKGISRG 606
           H N+V L      +    L++EY+    L+  L +     L  D  +   + +++ I+  
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIA-- 114

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
             Y H      IIHRD+K  NIL+ +    K+ DFG AR          T
Sbjct: 115 --YCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 12/159 (7%)

Query: 489 ELANATNNFQLANKLGQGGFGPVYKG--KLQDGQE--IAVKRL-SKASGQGQEEFMNEVM 543
           EL N +   ++   LG G FG + +G  KL   +E  +A+  L +  S + +  F+ E +
Sbjct: 1   ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
            +    H N+VRL G        M++ EYM N +LDSFL   + Q  L   +   ++ G+
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGL 116

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           + G+ YL   S +  +H+ L A  +L++ DL  KIS F 
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 16/180 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG-QEEFMNEVMVISNLQHRN 552
                 ++LG+G  G V K +L++   I A+K ++       Q++ + E+ +  + +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 553 LVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRF-NIIKGISRGLLY 609
           +V+  G  ++   + +    EY    SLDS     +++      K    I + + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVG 661
           LH  SR +IIHRD+K SNILL      K+ DFG        LA  F G     A +R+ G
Sbjct: 121 LH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQG 177

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 10/154 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
            +FQ+  ++GQGG+G V+  K +D  EI A+KR+ K+      E    + E  +++  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+LL    + E   L  EY+P     + L +     L +   RF + +     +  L
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFE-AVDAL 117

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H    L  IHRDLK  N L+D   + K++DFGL+
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 50/181 (27%), Positives = 95/181 (52%), Gaps = 27/181 (14%)

Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEF----MNEVMVISNLQHR 551
           F +  ++G+G +G VYK + +D G+ +A+K++   + +  E F    + E+ ++  L HR
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66

Query: 552 NLVRLLGCCVEREENM----------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN--I 599
           N+V L     ++++ +          L++EYM     D  L       L+ + +      
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL 659
           +K +  GL Y H+ + L   HRD+K SNILL++    K++DFGLAR++   + +  T ++
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 660 V 660
           +
Sbjct: 179 I 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 54/154 (35%), Positives = 80/154 (51%), Gaps = 24/154 (15%)

Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG V+KG  + +G  I    A+K +   SG Q  +E  + ++ + +L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           LG C       L+ +  P  SL   +       DPQR  LL+W  +      I++G+ YL
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQR--LLNWCVQ------IAKGMYYL 125

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
                 R++HR+L A NILL  D   +I+DFG+A
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 17/161 (10%)

Query: 499 LANKLGQGGFGPVYKGKLQD---GQ---EIAVKRLSK-ASGQGQEEFMNEVMVISNLQHR 551
           L  +LGQG FG VY+G  +D   G+    +AVK +++ AS + + EF+NE  V+      
Sbjct: 10  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLF-------DPQRQSLLDWPKRFNIIKGIS 604
           ++VRLLG   + +  +++ E M +  L S+L        +   +      +   +   I+
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            G+ YL+     + +HRDL A N ++  D   KI DFG+ R
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 46/154 (29%), Positives = 83/154 (53%), Gaps = 6/154 (3%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAV-KRLSKASGQGQEEFMNEVMVISNLQH 550
           N    +++  +LG G FG VYK + ++   +A  K +   S +  E++M E+ ++++  H
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V+LL          ++ E+    ++D+ + + +R   L  P+   + K     L YL
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYL 119

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H +   +IIHRDLKA NIL   D + K++DFG++
Sbjct: 120 HEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 51/155 (32%), Positives = 84/155 (54%), Gaps = 20/155 (12%)

Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG VYKG  + DG+ +    A+K L +  S +  +E ++E  V++ +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
           LG C+      L+ + MP   L  ++ + +     Q LL+W  +      I++G+ YL  
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
              +R++HRDL A N+L+    + KI+DFGLAR+ 
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.3 bits (178), Expect = 7e-14
 Identities = 49/173 (28%), Positives = 88/173 (50%), Gaps = 37/173 (21%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL---SKASGQGQEEF----MNEVMVISN 547
            ++  N++ +G +G VY+ +  + G+ +A+K+L    +  G     F    + E+ ++  
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILLK 60

Query: 548 LQHRNLVRLLGCCVERE----ENM----LIYEYMPN--KSLDSFLFDPQRQSLLDWPKRF 597
           LQH N+V +      +E     N+    ++ EY+ +  KSL   +  P  QS     +  
Sbjct: 61  LQHPNIVTV------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQS-----EVK 109

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
            ++  +  G+ +LH +    I+HRDLK SN+LL++    KI DFGLAR +G  
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 24/168 (14%)

Query: 499 LANKLGQGGFGPVYKGKLQD------GQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QH 550
           L   LG+G FG V K +            +AVK L   A+ +   + ++E+ ++  + +H
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQ---SLLDWPKRFNIIK---- 601
           +N++ LLG C +     ++ EY  + +L  FL    P  +        P    + +    
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 602 ----GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                ++RG+ +L   S+ + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 136 SFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 11/156 (7%)

Query: 492 NATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           N  ++++L  ++G G +G VYK   L  G+  AVK +    G        E+ ++   +H
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSF--LFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V   G  + RE+  +  EY    SL     +  P  +  + +  R  +     +GL 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLA 120

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           YLH   ++   HRD+K +NILL D+ + K++DFG+A
Sbjct: 121 YLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 18/174 (10%)

Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLG 558
            +LG G  G V K   +  G+ +AVK +        Q++ + E+ ++       +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYLHRDSRL 616
                 +  +  EYM   SLD  L    ++     P+R    I   + +GL YLH     
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120

Query: 617 RIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
           +IIHRD+K SNIL++     K+ DFG        LA+ F G     A +R+ G 
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN 174

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 16/156 (10%)

Query: 502 KLGQGGFGPVYKG--KLQDGQ-EIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLL 557
           +LG G FG V KG  K++  Q ++A+K L   + +  ++E M E  ++  L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK---GISRGLLYLHRDS 614
           G C E E  ML+ E      L+ FL   + +  +      N+++    +S G+ YL   +
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN 115

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
               +HRDL A N+LL +    KISDFGL++  G +
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 10/154 (6%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
           F    ++G G FG VY  + ++  + +A+K++S +  Q  E++   + EV  +  L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
            +   GC +      L+ EY    + D  + +  ++ L +  +   I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHS 133

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
             R   IHRD+KA NILL +    K++DFG A +
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 52/158 (32%), Positives = 79/158 (50%), Gaps = 14/158 (8%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRL-----SKASGQGQEEFMNEVMVISNLQ 549
           N++L   LGQG FG VY     D G+E+AVK++     S  + +       E+ ++ NL 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 550 HRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           H  +V+  GC  +  E  L    E+MP  S+   L      +L +   R    + I  G+
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGV 119

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            YLH +    I+HRD+K +NIL D   N K+ DFG ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 43/156 (27%), Positives = 82/156 (52%), Gaps = 11/156 (7%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           N   +F+L  ++G G +G VYK + +  G+  A+K +    G+       E++++ + +H
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSF--LFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V   G  + R++  +  E+    SL     +  P  +S + +  R  +     +GL 
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLY 120

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           YLH   +   +HRD+K +NILL D+ + K++DFG++
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.3 bits (174), Expect = 2e-13
 Identities = 47/162 (29%), Positives = 88/162 (54%), Gaps = 10/162 (6%)

Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G V+    +  GQE+A+K+++      +E  +NE++V+  L++ N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 86  LVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RD+K+ N+LL  D + K++DFG        Q + +T  +VGT
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 12/163 (7%)

Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V   + +  G+++AVK +     Q +E   NEV+++ + QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  EE  ++ E++   +L   +     Q+ L+  +   + + + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A+I   ++D    K LVGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGT 180

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 48/162 (29%), Positives = 87/162 (53%), Gaps = 10/162 (6%)

Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+K+++      +E  +NE++V+   ++ N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RD+K+ NILL  D + K++DFG        Q + +T  +VGT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 28/176 (15%)

Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVRLLG 558
           + +G +G V+   K   G   A+K + KA        ++ + E  ++S  Q   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 559 CCVEREENM-LIYEYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
              + ++N+ L+ EY+P   L S L      D       D  +    I  I   L YLH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLA------RIFGGNQDQAATKRLVGT 662
                IIHRDLK  NIL+D + + K++DFGL+      R    N D+   KR+VGT
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 9/161 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHR 551
             ++    +G+G +G V K K ++ GQ +A+K+   S+     ++  M E+ ++  L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           NLV L+     ++   L++E++ +  LD     P     LD  +    +  I RG+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +   IIHRD+K  NIL+      K+ DFG AR      +
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 14/158 (8%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRL-----SKASGQGQEEFMNEVMVISNLQ 549
           N++L   LG+G FG VY     D G+E+AVK++     S+ + +       E+ ++ NL+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 550 HRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           H  +V+  GC  + EE  L    EYMP  S+   L      +L +   R    + I +G+
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR-RYTRQILQGV 119

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            YLH +    I+HRD+K +NIL D   N K+ DFG ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 30/163 (18%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQ-HRN 552
           +++  K+G+G F  V K +  + G+  A+K + K   +  E+  N  E+  +  L  H N
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPN 59

Query: 553 LVRLLGCCVEREEN----------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
           ++RL+    +R+            M +YE +             R+  L   +  + +  
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG-----------RKRPLPEKRVKSYMYQ 108

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + + L ++HR+    I HRD+K  NIL+ DD+  K++DFG  R
Sbjct: 109 LLKSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 19/181 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDG-------QEIAVKRLS-----KASGQGQEEFMNEVM 543
            + +   LG G FG VYK + ++        +EI V   +     +   +   + ++EV 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 544 VI-SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL-DSFLFDPQRQSLLDWPKRFNIIK 601
           +I   L+H N+VR     +E +   ++ + +    L + F    +++      + +NI  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
            +   L YLH++ R  I+HRDL  +NI+L +D    I+DFGLA+     Q ++    +VG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175

Query: 662 T 662
           T
Sbjct: 176 T 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 53/161 (32%), Positives = 80/161 (49%), Gaps = 21/161 (13%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNL-QHRNLVRLL 557
           +G+G FG V +  ++ DG ++  A+K L + AS     +F  E+ V+  L  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 558 GCCVEREENMLIYEYMPNKSLDSFL-------FDPQ------RQSLLDWPKRFNIIKGIS 604
           G C  R    +  EY P  +L  FL        DP         S L   +       ++
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            G+ YL   S  + IHRDL A N+L+ ++L  KI+DFGL+R
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 50/148 (33%), Positives = 81/148 (54%), Gaps = 10/148 (6%)

Query: 501 NKLGQGGFGPVYKG--KLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
           +KLG+G +  VYKG  KL D   +A+K +     +G     + EV ++ +L+H N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
                 +   L++EY+ +K L  +L D      +   K F  +  + RGL Y HR    +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---K 124

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++HRDLK  N+L+++    K++DFGLAR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 52/158 (32%), Positives = 79/158 (50%), Gaps = 14/158 (8%)

Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRL-----SKASGQGQEEFMNEVMVISNLQ 549
           N++    LGQG FG VY    +  G+E+A K++     S  + +       E+ ++ NLQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 550 HRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           H  +V+  GC  +R E  L    EYMP  S+   L      +L +   R    + I  G+
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGM 119

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            YLH +    I+HRD+K +NIL D   N K+ DFG ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.8 bits (170), Expect = 6e-13
 Identities = 48/163 (29%), Positives = 89/163 (54%), Gaps = 12/163 (7%)

Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ NILL  D + K++DFG  A+I     +Q+    +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 48/157 (30%), Positives = 84/157 (53%), Gaps = 16/157 (10%)

Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF--MNEVMVISNLQ---HRNLVR 555
           ++G G +G VYK +    G  +A+K +   + +       + EV ++  L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 556 LLGCC----VEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           L+  C     +RE  + L++E++ ++ L ++L D      L      ++++   RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           H +    I+HRDLK  NIL+      K++DFGLARI+
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 46/149 (30%), Positives = 80/149 (53%), Gaps = 10/149 (6%)

Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLL 557
           ++G G FG VY  + +++ + +A+K++S +  Q  E++   + EV  +  L+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           GC +      L+ EY    + D  L +  ++ L +  +   +  G  +GL YLH  +   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEV-EIAAVTHGALQGLAYLHSHN--- 135

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARI 646
           +IHRD+KA NILL +    K+ DFG A I
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 26/174 (14%)

Query: 495 NNFQLANKLGQGGFGPVYK----GKLQDGQE----IAVKRLS-KASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V +    G  +   +    +AVK L   A+ +   + ++E+ ++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  FL           FD  +  +  L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL  +SR R IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 11/151 (7%)

Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
           F    ++G+G FG VYKG     +E+ A+K +     + + E+   E+ V+S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           R  G  ++  +  +I EY+   S LD     P  ++ +       I++ I +GL YLH +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
              R IHRD+KA+N+LL +  + K++DFG+A
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 13/164 (7%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG GGFG V   K++   +  A+K + K        QE   +E  ++    H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
              +++   ++ EY     L + L D  R    ++  RF  I  +     YLH      I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHN---RGI 114

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           I+RDLK  N+LLD +   K+ DFG A+     Q    T    GT
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 57/181 (31%), Positives = 98/181 (54%), Gaps = 26/181 (14%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQE-IAVKRLSKASGQGQEEFM-----NEVMVISNLQ 549
           ++   ++G+G +G V+K + L++G   +A+KR+     Q  EE M      EV V+ +L+
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLE 59

Query: 550 ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
              H N+VRL   C     +RE  + L++E++ ++ L ++L D   +  +      +++ 
Sbjct: 60  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMF 117

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
            + RGL +LH     R++HRDLK  NIL+      K++DFGLARI+     Q A   +V 
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 171

Query: 662 T 662
           T
Sbjct: 172 T 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 68.3 bits (168), Expect = 2e-12
 Identities = 60/180 (33%), Positives = 84/180 (46%), Gaps = 31/180 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEE-FMNEVMVISNLQH 550
           ++F+    LG G FG V   + +   +  A+K LSKA      Q E  +NE  ++ +++H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR----- 605
             LV L G   +     L+ EY+P   L S L    R+S      RF     ++R     
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----RKS-----GRFPE--PVARFYAAQ 109

Query: 606 ---GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
               L YLH    L I++RDLK  N+LLD D   KI+DFG A+   G      T  L GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGT 161

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
           F    ++G G FG VY  + ++  + +A+K++S +  Q  E++   + EV  +  ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
            +   GC +      L+ EY    + D  L +  ++ L +  +   I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHS 143

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
            +   +IHRD+KA NILL +    K++DFG A I
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 11/164 (6%)

Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGFG V   +++  G+  A K+L K      +G++  +NE  ++  +  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               +++  L+   M    L   +++   +      +       I  GL +LH   + RI
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           ++RDLK  N+LLDD  N +ISD GLA      +     K   GT
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGT 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 11/164 (6%)

Query: 503 LGQGGFGP--VYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+G FG   +Y+ + +D   +  K   L++ S + + + +NE++++S LQH N++    
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
             ++    ++  EY    +L   +   Q+  L +       +  I   + Y+H+     I
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG---I 122

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +HRD+K  NI L      K+ DFG+++I G     A T  +VGT
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 10/150 (6%)

Query: 501 NKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRL 556
           +++G G FG VY        E+ AVK++S +  Q  E++   + EV  +  L+H N +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
            GC ++     L+ EY    + D  L +  ++ L +  +   I  G  +GL YLH  +  
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHSHN-- 141

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARI 646
            +IHRD+KA NILL +    K++DFG A  
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
            + +   L  G  G V+    + GQ   V  + K  GQ     + E M++ N+ H +++R
Sbjct: 67  GYTVIKTLTPGSEGRVFVAT-KPGQPDPV--VLKI-GQKGTTLI-EAMLLQNVNHPSVIR 121

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           +    V      ++   +P+ S D + +  +R   L   +   I K I  GL YLH    
Sbjct: 122 MKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA--- 175

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            RIIHRD+K  NI ++D     I D G A+
Sbjct: 176 QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 46/171 (26%), Positives = 86/171 (50%), Gaps = 14/171 (8%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQH---R 551
           +Q    +G+G +G VY+GK +  G+ +A+K ++  +      +   EV ++S L+     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+ +  G  ++     +I EY    S+ + +    +   +       II+ +   L Y+H
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +     +IHRD+KA+NIL+ +  N K+ DFG+A +   N  + +T   VGT
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 30/172 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-----FMNEVMVISNL 548
           + ++   K+G+G +G VYK +    G+ +A+K   K   +  EE      + E+ ++  L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQML 57

Query: 549 QHRN-LVRLLGCCVEREEN-------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
                +VRLL   VE  E         L++EY+ +  L  F+    R      P     I
Sbjct: 58  SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPA--KTI 112

Query: 601 KG----ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIF 647
           K     + +G+ + H+     ++HRDLK  N+L+D      KI+D GL R F
Sbjct: 113 KSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 55/161 (34%), Positives = 84/161 (52%), Gaps = 21/161 (13%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNL-QHRNLVRLL 557
           +G+G FG V K +++ DG  +  A+KR+ + AS     +F  E+ V+  L  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI-----SRGLLYLHR 612
           G C  R    L  EY P+ +L  FL   ++  +L+    F I         S+ LL+   
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 613 D--------SRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           D        S+ + IHRDL A NIL+ ++   KI+DFGL+R
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 12/156 (7%)

Query: 502 KLGQGGFGPVYKG--KLQDGQE-IAVKRLSKASGQG--QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  K++  ++ +AVK L   +     ++E + E  V+  L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ FL   Q+   +       ++  +S G+ YL   +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++  G +++
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 32/171 (18%)

Query: 498 QLANKLGQGGFGPVYKGK-LQDGQEIAVKR--LSKASGQGQEEFMN------------EV 542
           Q    LG+G +G V K      G+ +A+K+  + + S    ++               E+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPN---KSLDS--FLFDPQRQSLLDWPKRF 597
            +++ ++H N++ L+   VE +   L+ + M +   K +D    L + Q +         
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC-------- 123

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            I+  I  GL  LH+      +HRDL  +NI ++     KI+DFGLAR +G
Sbjct: 124 -ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170

Length = 335

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 13/171 (7%)

Query: 499 LANKLGQGGFGPVY---KGKLQDGQEIAV-KRLSKASGQGQEEFMN--EVMVISNLQHRN 552
           L  +LG+G FG VY     K    + + V K +        E      E  ++S L H  
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLYLH 611
           +V+     +ER+   +I EY   + LD  L +       L   +       +  G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +    RI+HRDLKA NI L ++L  KI DFG++R+  G+ D A T    GT
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGT 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.9 bits (164), Expect = 7e-12
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 47/167 (28%)

Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN---------EVMVISNLQHRN 552
           +G G +G V        G+++A+K+LS         F +         E+ ++ ++ H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSF----LFDP----------QRQSLLDWPKRFN 598
           ++ LL              + P  SL+ F    L             + Q L D   +F 
Sbjct: 76  VIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF- 122

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++  I RGL Y+H      IIHRDLK SNI +++D   KI DFGLAR
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 7/146 (4%)

Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           ++G+G FG V+ G+L+ D   +AVK   +      + +F+ E  ++    H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
           C +++   ++ E +      +FL        L   +   +++  + G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 620 HRDLKASNILLDDDLNPKISDFGLAR 645
           HRDL A N L+ +    KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 43/156 (27%), Positives = 81/156 (51%), Gaps = 13/156 (8%)

Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEV-MVISNLQHRNLVR 555
           F+L   +G G +G VYKG+     ++A  ++   +G  +EE   E+ M+     HRN+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 556 LLGCCVER------EENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLL 608
             G  +++      ++  L+ E+    S+   + + +  +L  +W     I + I RGL 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           +LH+    ++IHRD+K  N+LL ++   K+ DFG++
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 10/148 (6%)

Query: 501 NKLGQGGFGPVYKG--KLQDGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
            KLG+G +  V+KG  KL +   +A+K +     +G     + EV ++ +L+H N+V L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
                 +   L++EY+ +K L  ++ D      +   K F  +  I RGL Y HR    +
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR---K 124

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++HRDLK  N+L+++    K++DFGLAR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 10/171 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
            +++  K+G+G FG +Y  K + D +   +K   L+K   + +E    EV++++ ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V       E     ++ EY     L   + + QR  L    +  +    IS GL ++H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 613 DSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIFGGNQDQAATKRLVGT 662
               +I+HRD+K+ NI L  + +  K+ DFG+AR    + + A T   VGT
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 11/151 (7%)

Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
           F    K+G+G FG V+KG     Q++ A+K +     + + E+   E+ V+S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +  G  ++  +  +I EY+   S LD  L +P     LD  +   I++ I +GL YLH +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            +   IHRD+KA+N+LL +    K++DFG+A
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 18/160 (11%)

Query: 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQH 550
           TN +     +G G FG V   + Q  GQ +A+K++ K  ++    +    E+ ++ +L+H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 551 RNLVRLLGCCVE-REENMLIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
            N++ L    +   E+   + E +    ++ L S   + Q      + + F  +  I RG
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQ------FIQYF--LYQILRG 120

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
           L Y+H      ++HRDLK SNIL++++ + KI DFGLARI
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 34/174 (19%)

Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMN----EVMVISNLQHRNLVR 555
           N++G G  G VYK   +  G+  A+K +    G  ++        E+ ++ ++ H N+V+
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 556 LLGCCVEREENMLIYEYMPNKSLDS-------FLFDPQRQSLLDWPKRFNIIKGISRGLL 608
                    E  ++ E+M   SL+        FL D  RQ L               G+ 
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--------------SGIA 182

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           YLHR     I+HRD+K SN+L++   N KI+DFG++RI    Q        VGT
Sbjct: 183 YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGT 231

Length = 353

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 32/158 (20%)

Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEE-----FMNEVMVISNLQHRNL 553
           KLG+G +  VYKG+ +  GQ +A+K  RL        EE      + E  ++ +L+H N+
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLE------HEEGAPFTAIREASLLKDLKHANI 65

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRGL 607
           V L      ++   L++EY+ +  L  ++             L      F ++    RGL
Sbjct: 66  VTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLF----LFQLL----RGL 116

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            Y H+    R++HRDLK  N+L+ +    K++DFGLAR
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 14/167 (8%)

Query: 503 LGQGGFGPVY------KGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           LG+GGFG V        GKL   +++  KRL K   +G E  M E  +++ +  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSR 615
                 + +  L+   M    L   +++   ++     P+       I  GL +LH+   
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            RII+RDLK  N+LLD+D N +ISD GLA      Q +  TK   GT
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 12/163 (7%)

Query: 502 KLGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    +   G+++AVK++     Q +E   NEV+++ +  H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L     D    + ++  +   +   + R L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGT 181

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)

Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
           F    ++G+G FG V+KG     Q++ A+K +     + + E+   E+ V+S      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +  G  ++  +  +I EY+   S      D  R    D  +   ++K I +GL YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +   IHRD+KA+N+LL +  + K++DFG+A      Q +  T   VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 9/158 (5%)

Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE-EFMNEVMVISN 547
              AT+   L  KLG+G +  VYKG  + +GQ +A+K +S  + +G     + E  ++  
Sbjct: 1   FGAATSYLNL-EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKG 59

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L+H N+V L      +E    ++EYM        +  P    L  +  R  + + + RGL
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGL 116

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            Y+H      I+HRDLK  N+L+      K++DFGLAR
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 27/162 (16%)

Query: 503 LGQGGFGPVYKGKLQD---------GQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQH 550
           LGQG F  +YKG L+          GQE++V    K  G        F     ++S L H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL--KVLGSDHRDSLAFFETASLMSQLSH 60

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           ++LV+L G CV R+EN+++ EY+    LD FL   +    L W  + ++ K ++  L YL
Sbjct: 61  KHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117

Query: 611 HRDSRLRIIHRDLKASNILL---DDDLNP----KISDFGLAR 645
                 +++H ++   NIL+     +       K+SD G+  
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 20/159 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRN 552
           ++++   KLG+G +  VYKGK + +G+ +A+K +     +G     + E  ++  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKGISRG 606
           +V L      +E   L++EY+ +  L  ++        P+   L      F +++G+S  
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF----LFQLLRGLS-- 117

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             Y+H+     I+HRDLK  N+L+ D    K++DFGLAR
Sbjct: 118 --YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 39/170 (22%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           ++ ++  +LG+G +G V K + +  G  +AVKR+ +A+   QE            Q R L
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQE------------QKRLL 47

Query: 554 VRL-----LGCCVE---------REENMLIYEYMPNKSLDSF---LFDPQRQSLLDWPKR 596
           + L        C           RE ++ I   + + SLD F   ++D         P+ 
Sbjct: 48  MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTI----PED 103

Query: 597 F--NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
               I   I + L YLH  S+L +IHRD+K SN+L++ +   K+ DFG++
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           K+G+G +G V+K + ++ GQ +A+K+   S+     ++  + E+ ++  L+H NLV L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  L++EY  +  L+    +P+    +       II    + + + H+      
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHK---HNC 121

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           IHRD+K  NIL+      K+ DFG ARI  G  D
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 16/175 (9%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS---KASGQGQEEFMNEVMVISNLQHR 551
           NFQ+  K+G+G F  VY+   L D + +A+K++        + +++ + E+ ++  L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR--FNIIKGISRGL 607
           N+++ L   +E  E  ++ E      L   +  F  Q++ +   P+R  +     +   +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI---PERTVWKYFVQLCSAV 119

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            ++H  SR R++HRD+K +N+ +      K+ D GL R F  +    A   LVGT
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 24/167 (14%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
           +F+L   +G+G FG V   + +D +++ A+K ++K            +NE  ++  L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGIS 604
            LV L     + EENM L+ + +    L   L    ++       +F+       I  I 
Sbjct: 61  FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL---SQK------VKFSEEQVKFWICEIV 110

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
             L YLH      IIHRD+K  NILLD+  +  I+DF +A     + 
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 51/167 (30%), Positives = 79/167 (47%), Gaps = 17/167 (10%)

Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRL-SKASGQGQEEFMNEVMVISNLQH-RNLVRLLGC 559
           +G+G FG V K   +  G  +AVKR+ S    + Q+  + ++ V+        +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 560 CVEREENMLIYEYMPNKSLDSF---LFDPQRQSLLDWPKRF--NIIKGISRGLLYLHRDS 614
                +  +  E M + SLD F   +++  +  +   P+     I     + L YL  + 
Sbjct: 72  LFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLKEE- 126

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
            L+IIHRD+K SNILLD + N K+ DFG   I G   D  A  R  G
Sbjct: 127 -LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAG 169

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 26/170 (15%)

Query: 499 LANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL- 548
           L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++  + 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLLDWPK 595
           +H+N++ LLG C +     +I EY    +L  +L           ++P +  +  L +  
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 15/157 (9%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEV-MVISNLQHRNLV 554
           F+L   +G G +G VYKG+ ++ GQ  A+K +     + +EE   E+ M+     HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76

Query: 555 RLLGCCVER------EENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGL 607
              G  +++      ++  L+ E+    S+   + + +  +L  DW     I + I RGL
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            +LH     ++IHRD+K  N+LL ++   K+ DFG++
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 45/147 (30%), Positives = 78/147 (53%), Gaps = 8/147 (5%)

Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLG 558
           +KLG+G +  V+KG+ +     +A+K +     +G     + EV ++ NL+H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                    L++EY+ +  L  +L +      +   K F  +  + RGL Y H+    +I
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIF--MFQLLRGLSYCHKR---KI 124

Query: 619 IHRDLKASNILLDDDLNPKISDFGLAR 645
           +HRDLK  N+L+++    K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 9e-11
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 29/165 (17%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQH 550
            +Q  + +G+G +G V        G ++A+K++S    Q    F    + E+ ++   +H
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKH 62

Query: 551 RNLVRLLGC-CVEREENM----LIYEYMPN---KSLDSFLFDPQRQSLL-DWPKRFNIIK 601
            N++ +L        E+     ++ E M     K + +       Q L  D  + F  + 
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-------QHLSNDHIQYF--LY 113

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
            I RGL Y+H  +   ++HRDLK SN+LL+ + + KI DFGLARI
Sbjct: 114 QILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 58.0 bits (140), Expect = 1e-10
 Identities = 28/76 (36%), Positives = 45/76 (59%), Gaps = 5/76 (6%)

Query: 339 QDGFFKLETMKVPYFAE--RSSANEDKCKDQCSN-NCSCKAYAY-EIGVGCMIWTHN-LI 393
            D F +L   K+P F+    S A+ ++C  +C N NCSC+++ Y     GC++W+ + L 
Sbjct: 3   DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLG 62

Query: 394 DIRKLPSGGTNLYIRV 409
           D R  PSGG +LY ++
Sbjct: 63  DARLFPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 21/158 (13%)

Query: 503 LGQGGFGPVYKGKLQD----GQ----EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           LGQG F  ++KG  ++    G+    E+ +K L K+     E F     ++S L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
              G CV  +E++++ EY+   SLD++L   + ++L++   +  + K ++  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 615 RLRIIHRDLKASNILL-----DDDLNP---KISDFGLA 644
              + H ++ A N+LL         NP   K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 21/165 (12%)

Query: 502 KLGQGGFG-PVYKGKLQDGQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           K+G+G FG  +     +DG++  +K +  SK S + +EE   EV V+SN++H N+V+   
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 559 CCVEREENMLIYEYMPNKSL-------DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
              E     ++ +Y     L          LF P+ Q +LDW         I   L ++H
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLF-PEDQ-ILDW------FVQICLALKHVH 118

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
                +I+HRD+K+ NI L  D   K+ DFG+AR+     + A T
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 28/162 (17%)

Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL----- 556
           LG G  G V+     D  + +AVK++     Q  +  + E+ +I  L H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 557 ---------LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL--DWPKRFNIIKGISR 605
                    +G   E     ++ EYM     ++ L +   Q  L  +  + F  +  + R
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF--MYQLLR 125

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARI 646
           GL Y+H  +   ++HRDLK +N+ ++ +DL  KI DFGLARI
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 12/163 (7%)

Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    ++  G+ +AVK++     Q +E   NEV+++ + QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L     D    + ++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 30/172 (17%)

Query: 499 LANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVISNL- 548
           L   LG+G FG V         K K      +AVK L   A+ +   + ++E+ ++  + 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FD----PQRQSLLDW 593
           +H+N++ LLG C +     ++ EY    +L  +L           FD    P+ Q  L +
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ--LTF 133

Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 12/154 (7%)

Query: 497 FQLANKLGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           F+    LG+GGFG V        GK+   +++  KR+ K  G+     +NE  ++  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           R +V L      ++   L+   M    L   ++    ++  +  +       I  GL  L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H++   RI++RDLK  NILLDD  + +ISD GLA
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)

Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLS-KASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDW 593
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R    D 
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP--DE 132

Query: 594 PKRFNIIKG----ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              F  +      ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 133 QMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 16/175 (9%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS---KASGQGQEEFMNEVMVISNLQHR 551
           NF++  K+G+G F  VY+   L DG  +A+K++        + + + + E+ ++  L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR--FNIIKGISRGL 607
           N+++     +E  E  ++ E      L   +  F  Q++ +   P++  +     +   L
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI---PEKTVWKYFVQLCSAL 119

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            ++H  SR R++HRD+K +N+ +      K+ D GL R F  +    A   LVGT
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 43/153 (28%)

Query: 519 GQEIAVKRLSKASGQGQEEFMN---------EVMVISNLQHRNLVRLLGCCVEREENMLI 569
           GQ +A+K+LS+        F N         E++++  + H+N++ LL            
Sbjct: 41  GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83

Query: 570 YEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
             + P KSL+ F        L D       Q  LD  +   ++  +  G+ +LH      
Sbjct: 84  --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
           IIHRDLK SNI++  D   KI DFGLAR  G +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 18/172 (10%)

Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEV 542
           +   E L + T+ +++   +G+G +G VYK    +DG   AVK L   S    EE   E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEY 69

Query: 543 MVISNL-QHRNLVRLLGCCVEREENM-----LIYEYMPNKS----LDSFLFDPQRQSLLD 592
            ++ +L  H N+V+  G   + ++ +     L+ E     S    +   L   QR   LD
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR---LD 126

Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
                 I+ G   GL +LH +   RIIHRD+K +NILL  +   K+ DFG++
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 12/149 (8%)

Query: 502 KLGQGGFGPVYKGKLQDGQEIA---VKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           ++G G FG V   ++     +A   VK L + AS + Q EF+ +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQ---RQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           G CVE    +L++EY     L S+L   Q   R S L   +R      I+ G+ ++H   
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC--EIAAGVTHMH--- 116

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGL 643
           +   +H DL   N  L  DL  K+ D+G+
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 28/163 (17%)

Query: 495 NNFQLANKLGQGGFGPVY--KGKLQDGQEIAVKRLSKAS--GQGQEE-FMNE--VMVISN 547
           ++F++   +G+G FG V+  + K   GQ  A+K L K+    + Q      E  ++  ++
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59

Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIK 601
                +V+L     + EE++ L+ EYMP   L + L     F        +  + +    
Sbjct: 60  --SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY---- 106

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            I+  +L L    +L  IHRD+K  NIL+D D + K++DFGL 
Sbjct: 107 -IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 26/162 (16%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS--KASGQGQEEFM-NEVMVISNLQHR 551
           + +    +G G FG V+  + +  +   A+K ++  +     QE+ + NE  V+  + H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 552 NLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG------I 603
            ++RL     E ++  L  + EY+P   L S+L    R S      RF+   G      I
Sbjct: 62  FIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL----RNS-----GRFSNSTGLFYASEI 110

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              L YLH      I++RDLK  NILLD + + K++DFG A+
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 16/169 (9%)

Query: 496 NFQLANKLGQGGFGPVY----KGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISN 547
           NF+L   LG G +G V+     G    G+  A+K L KA+     +  E    E  V+  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           ++    +  L    + +  + LI +Y+    L + L+  QR+   +   R   I  I   
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRV-YIAEIVLA 117

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF-GGNQDQA 654
           L +LH+   L II+RD+K  NILLD + +  ++DFGL++ F    +++A
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)

Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 554 VRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 134

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 135 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 51/149 (34%), Positives = 74/149 (49%), Gaps = 13/149 (8%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNEVMV-ISNLQHRNLVRLL 557
           +G+G FG V   K   DG+  AVK L K +   ++E    M E  V + N++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRL 616
                 ++   + +Y+    L    F  QR+     P+ RF   + I+  L YLH    L
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLAR 645
            II+RDLK  NILLD   +  ++DFGL +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.5 bits (144), Expect = 4e-09
 Identities = 39/139 (28%), Positives = 67/139 (48%), Gaps = 11/139 (7%)

Query: 501 NKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           N + +G  G  YKGK +++G +  VK ++  +     E  +    +  LQH N+V+L+G 
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGL 751

Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
           C   +   LI+EY+  K+L   L        L W +R  I  GI++ L +LH      ++
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVV 805

Query: 620 HRDLKASNILLDDDLNPKI 638
             +L    I++D    P +
Sbjct: 806 VGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 19/159 (11%)

Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G +G V   Y  +L+  Q++AVK+LS+   S         E+ ++ +++H 
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 552 NLVRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           N++ LL        +E    + +   +    L++ +   + Q L D   +F +I  + RG
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQF-LIYQLLRG 130

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L Y+H      IIHRDLK SN+ +++D   +I DFGLAR
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 33/160 (20%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVMVISNLQHRN 552
           +G+G +G V   K  +  +++A+K+++ A       F N         E+ ++ +L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65

Query: 553 LVRLLGCC--VERE---ENMLIYEYMPNKSLDSFLFDPQR--QSLLDWPKRFNIIKGISR 605
           ++ +        RE   +  ++YE M     D+ L    R  Q+L D   ++ + + + R
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLR 119

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           GL Y+H  +   ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 35/168 (20%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVMVIS 546
            +    +G G FG V+     +DG+ +A+K++          F N         E+ ++ 
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKMLC 54

Query: 547 NLQHRNLVRLL--------GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
             +H N++  L              EE  ++ E M    L   +  PQ  S  D  K F 
Sbjct: 55  FFKHDNVLSALDILQPPHIDPF---EEIYVVTELM-QSDLHKIIVSPQPLSS-DHVKVF- 108

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
            +  I RGL YLH      I+HRD+K  N+L++ +   KI DFGLAR+
Sbjct: 109 -LYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 56/169 (33%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNL-QHRNLVRLL 557
           LG+G FG V   +L+   E+ AVK L K      ++    M E  V++   +H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 558 GCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSR 615
             C + ++ +  + EY+    L   +F  QR    D P+ RF   + I  GL +LH    
Sbjct: 63  -SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGT 662
             II+RDLK  N+LLD + + KI+DFG+ +  I GG      T    GT
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGT 159

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 53/165 (32%), Positives = 76/165 (46%), Gaps = 13/165 (7%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVI-SNLQHRNLVRLL 557
           +G+G FG V   K + DG   AVK L K +    + Q   M E  V+  NL+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
                 E+   + +Y+    L    F  QR+     P+       ++  + YLH    L 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           II+RDLK  NILLD   +  ++DFGL +   G + +  T    GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 13/154 (8%)

Query: 503 LGQGGFGPVYKGKL-QDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+G FG V   +L + G+  AVK L K         E  M E  ++S  ++   +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           CC +  + +  + E++    L   +F  Q+    D  +       I+  L++LH      
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG--- 116

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR--IFGG 649
           II+RDLK  N+LLD + + K++DFG+ +  IF G
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 41/156 (26%), Positives = 82/156 (52%), Gaps = 13/156 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRL--SKASGQGQEEFMNEVMVISNLQHR 551
           N F++   +G+G +G V K + ++ +EI A+K+   S+ + + +E  + E+ ++  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR--FNIIKGISRGLLY 609
           N+V L      R +  L++EY+  K++   L +       +  +   + +IK I     +
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH----W 115

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            H++    I+HRD+K  N+L+  +   K+ DFG AR
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 21/174 (12%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+G FG V+  +L+   Q  A+K L K         E  M E  V+S       +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           C  + +EN+  + EY+    L   +F  Q     D P+       I  GL +LH      
Sbjct: 63  CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--- 116

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR----------IFGGNQDQAATKRLVG 661
           I++RDLK  NILLD D + KI+DFG+ +           F G  D  A + L+G
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 11/148 (7%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
           LG+G FG V   +L+   E+ A+K L K      ++    M E  +++       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           CC + ++ +  + EY+    L   +F  QR    D P+       ++  L++LHR     
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645
           +I+RDLK  NILLD + + K++DFG+ +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 26/161 (16%)

Query: 497 FQLANKLGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           F+    LG+GGFG V        GK+   +++  KR+ K  G+     +NE  ++  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIKGI 603
           R +V L      ++   L+   M    L   +       FD +R               I
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY--------AAEI 111

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           + GL  LHR+   RI++RDLK  NILLDD  + +ISD GLA
Sbjct: 112 TCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 8/152 (5%)

Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRN 552
           F+    LG+GGFG V   +++  G+  A KRL K      +G+   +NE  ++  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V L      ++   L+   M    L   +++       +    F   + I  GL  LHR
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHR 120

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           ++    ++RDLK  NILLDD  + +ISD GLA
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 27/162 (16%)

Query: 503 LGQGGFGPVYKGKLQD---------GQEIAVKRLSKASGQGQEE----FMNEVMVISNLQ 549
           LG+G    +Y G L             E  +K + K       +    F     ++  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS-LLDWPKRFNIIKGISRGLL 608
           H+++V L G CV   EN+++ E++    LD F+    R+S +L  P +F + K ++  L 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM---HRKSDVLTTPWKFKVAKQLASALS 119

Query: 609 YLHRDSRLRIIHRDLKASNILL-----DDDLNP--KISDFGL 643
           YL  D  L  +H ++   NILL     D +  P  K+SD G+
Sbjct: 120 YL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 15/167 (8%)

Query: 496 NFQLANKLGQGGFGPVYKGK---LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ- 549
            ++L  +LGQG +G V   +     + + +A+K+++    +    +  + E+ ++ + + 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 550 HRNLVRLLGCCVEREEN---MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           H+N+  L    +    N   + +YE +    L   +   Q   L D   +  I + I  G
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP--LTDAHFQSFIYQ-ILCG 117

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           L Y+H  +   ++HRDLK  N+L++ D   KI DFGLAR F  N  +
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 30/158 (18%)

Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFM-----NEVMVISNLQHRNLVRL 556
           +G G +G V      + G+++A+K+LS+     Q E        E+ ++ ++QH N++ L
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 557 LGCCV------EREENMLIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L          E ++  L+  YM     K +   L + + Q L+     + ++     GL
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV-----YQMLC----GL 130

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            Y+H      IIHRDLK  N+ +++D   KI DFGLAR
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.8 bits (129), Expect = 9e-08
 Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 26/155 (16%)

Query: 503 LGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           LG+GGFG V        GK+   +++  KR+ K  G+     +NE  ++  +  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIKGISRGLLY 609
                 ++   L+   M    L   +       FD QR               +  GL  
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY--------AAELCCGLED 117

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           L R+   RI++RDLK  NILLDD  + +ISD GLA
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 21/43 (48%), Positives = 31/43 (72%), Gaps = 3/43 (6%)

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + RGL Y+H  +   +IHRDLK SN+L+++D   +I DFG+AR
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 11/148 (7%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVI-SNLQHRNLVRLL 557
           +G+G FG V   K + DG+  AVK L K    + + Q+  M E  V+  N++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
                 E+   + +++    L    F  QR+     P+       I+  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645
           I++RDLK  NILLD   +  ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 14/134 (10%)

Query: 495 NNFQLANKLGQGGFGPVYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           +N Q    LG G FG V +      GK  +   +AVK L + A    +E  M+E+ ++S+
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNII 600
           L QH+N+V LLG C      ++I EY     L +FL      F     +L +  +  +  
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157

Query: 601 KGISRGLLYLHRDS 614
           K I+    Y+  DS
Sbjct: 158 KNITLEKKYIRSDS 171

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 31/142 (21%)

Query: 519 GQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN 575
           G  +AVK+LS+   Q Q   +    E++++  + H+N++ LL              + P 
Sbjct: 46  GINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQ 92

Query: 576 KSLDSF--------LFDPQRQSL----LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL 623
           KSL+ F        L D     +    LD  +   ++  +  G+ +LH      IIHRDL
Sbjct: 93  KSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149

Query: 624 KASNILLDDDLNPKISDFGLAR 645
           K SNI++  D   KI DFGLAR
Sbjct: 150 KPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 22/160 (13%)

Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           F +   + +G FG VY G K  + +  AVK + KA      + +N+ MV      R+ + 
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA------DMINKNMVHQVQAERDALA 59

Query: 556 L--------LGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           L        L   ++   N+ L+ EY+    + S L         D       I  ++  
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL---HIYGYFDEEMAVKYISEVALA 116

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
           L YLHR     IIHRDLK  N+L+ ++ + K++DFGL+++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 12/148 (8%)

Query: 503 LGQGGFGPV------YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           LG+GGFG V        GK+   +++  KRL K SG+       E++   N     +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF--IVNL 58

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
                 +    L+   M    L   +++   + L +  +  +    I+ G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLA 644
            I++RD+K  N+LLDD  N ++SD GLA
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 15/148 (10%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRL---SKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG G  G V K K +  G  +A K +   +K+S + Q   + E+ ++   +   +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ--ILRELQIMHECRSPYIVSFYG 70

Query: 559 CCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
             +      +  E+M   SLD       P    +L       I   +  GL YL+  +  
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVH 123

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLA 644
           RI+HRD+K SNIL++     K+ DFG++
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 53.3 bits (128), Expect = 4e-07
 Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 19/151 (12%)

Query: 517 QDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQHRNLVRLL--GCCVEREENML--I 569
             G E+A+K L   + + + +   F  E  + + L H N+V LL  G        +L  +
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAV 57

Query: 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL 629
           +EY+P ++L   L        L   +   ++  +   L   H      I+HRDLK  NI+
Sbjct: 58  FEYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111

Query: 630 L---DDDLNPKISDFGLARIFGGNQDQAATK 657
           +       + K+ DFG+  +  G +D     
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 54/186 (29%), Positives = 84/186 (45%), Gaps = 40/186 (21%)

Query: 485 FNFEELANAT----NNFQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKASGQGQ-- 535
           F   E+ ++T      +Q    +G G  G V   Y   L+  + +A+K+LS+   Q Q  
Sbjct: 10  FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPF-QNQTH 66

Query: 536 -EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQ 586
            +    E++++  + H+N++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114

Query: 587 R----QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
                Q  LD  +   ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171

Query: 643 LARIFG 648
           LAR  G
Sbjct: 172 LARTAG 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 36/177 (20%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           +G+G +G V   +   DG++  +K+L+   AS + ++    E  ++S L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV----- 62

Query: 560 CVERE----ENMLIY----------EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
              RE    E+ L+Y           Y   K     L  P+ Q +++W         I+ 
Sbjct: 63  -AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLL-PENQ-VVEW------FVQIAM 113

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            L YLH      I+HRDLK  N+ L      K+ D G+AR+     D A+T  L+GT
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 31/177 (17%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           +   +++L N +G G FG VY+    D  E +A+K++     Q  +    E++++ NL H
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNH 118

Query: 551 RNLVRL-----LGCCVEREENM---LIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNI 599
            N++ L       C  + E+N+   ++ E++P   +K +  +  +     L        +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-------L 171

Query: 600 IKGIS----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGGNQ 651
           +K  S    R L Y+H  S+  I HRDLK  N+L+D + +  K+ DFG A+     Q
Sbjct: 172 VKLYSYQLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225

Length = 440

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 25/172 (14%)

Query: 505 QGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR----NLVRLLGC 559
           +G FG VY   K   G   A+K L K+    + +  N     + +  +     + +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSL----LDWPKRFNIIKGISRGLLYLHRDSR 615
              ++   L+ EY+      S +     ++L     DW K++  I  +  G+  LH+   
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARI------FGGNQDQAATKRLVG 661
             IIHRD+K  N+L+D   + K++DFGL+R       F G  D  A + ++G
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILG 167

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G +G VYK K +DG++     L +  G G       E+ ++  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 561 VEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY-----LHRD 613
           +   +    L+++Y  +       F   R S  +  K   + +G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKF--HRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 614 SRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIF 647
               ++HRDLK +NIL+  +  P     KI+D G AR+F
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 32/145 (22%), Positives = 55/145 (37%), Gaps = 15/145 (10%)

Query: 503 LGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
                   + K K      +AVK+  L   S +  +    E++    LQH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 561 VEREENMLIYEYMPNKS----LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +   E  ++   M   S    L +   +   +  +       I+K +   L Y+H     
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIH---SK 120

Query: 617 RIIHRDLKASNILLDDDLNPKISDF 641
             IHR +KAS+ILL  D    +S  
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 32/163 (19%)

Query: 497 FQLANKLGQGGFGPV----YKGKLQDGQEIAVKRLSKASGQGQEE---FMNE--VMVISN 547
           F+    LG+G FG V    YK     G+  A+K L K     ++E    M E  +   +N
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 548 -LQHRNLVRLLGCCVEREENMLIYEYMPNKSL------DSFLFDPQRQSLLDWPKRFNII 600
             +H  LV L  C    +    + EY     L      D F    + ++       F   
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRA------VF-YA 107

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
             +  GL YLH +   +I++RDLK  N+LLD +   KI+DFGL
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 17/102 (16%)

Query: 571 EYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628
           E+M   SLD  L    R      P+     I   + RGL YL R+ + +I+HRD+K SNI
Sbjct: 79  EHMDGGSLDQVLKKAGR-----IPENILGKISIAVLRGLTYL-RE-KHKIMHRDVKPSNI 131

Query: 629 LLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
           L++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 132 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 173

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 18/158 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE----FMN-EVMVISNL 548
           N+ +   ++G G  G VYK +  + G  +AVK++ +   +  EE     M+ +V++ S+ 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSH- 71

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRG 606
               +V+  G  +   +  +  E M +  LD  L    ++     P+     +   I + 
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELM-STCLDKLL----KRIQGPIPEDILGKMTVAIVKA 126

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           L YL    +  +IHRD+K SNILLD   N K+ DFG++
Sbjct: 127 LHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 18/158 (11%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHR 551
           +F++   LG G FG V   K +  G+  A+K L K      +  +    E  ++  L H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL--- 608
            +V ++    +      + E++    L + L    R     +P   ++ K     L+   
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----FPN--DVAKFYHAELVLAF 131

Query: 609 -YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            YLH      II+RDLK  N+LLD+  + K++DFG A+
Sbjct: 132 EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 17/174 (9%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSK---ASGQGQEEFMNEVMVISNLQHR 551
           +F     LG+G FG V   + +   E+ A+K L K         E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +  L  C +  + +  + EY+    L   ++  Q+      P        I+ GL +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQAATKRLVGT 662
           H      II+RDLK  N++LD + + KI+DFG+ +  IFGG      T+   GT
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGT 164

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 14/165 (8%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
           LG+G FG V   + +   +  A+K L K     ++E    + E  V+ N +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLR 617
                +    + EY     L    F   R+ +    + RF   + +S  L YLH      
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSCD--- 115

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +++RDLK  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 15/161 (9%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSKAS----GQGQEEFMNEVMVISN 547
           NF+L   LG G +G V+  +   G +     A+K L KA+     +  E    E  V+ +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           ++    +  L    + E  + LI +Y+    + + L+  QR +  +   RF     I   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRF-YSGEIILA 117

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           L +LH+   L I++RD+K  NILLD + +  ++DFGL++ F
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 36/170 (21%)

Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQH 550
           +Q    +G G  G V   Y   L   + +A+K+LS+   Q Q   +    E++++  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNH 75

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFN 598
           +N++ LL              + P KSL+ F        L D       Q  LD  +   
Sbjct: 76  KNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 124 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 12/164 (7%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
           LG+G FG V   + +  G+  A+K L K     ++E    + E  V+ N +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               ++    + EY+    L    F   R+ +    +       I   L YLH     +I
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           ++RDLK  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G +G VYK K +DG++     L +  G G       E+ ++  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 561 VEREENM--LIYEYMPNKSLDSFLF---DPQRQSLLDWPKRF--NIIKGISRGLLYLHRD 613
           +   +    L+++Y  +       F       +  +  P+    +++  I  G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 614 SRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIF 647
               ++HRDLK +NIL+  +  P     KI+D G AR+F
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 17/170 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSKAS----GQGQEEFMNEVMVISN 547
           NF+L   LG G +G V+  +   G +     A+K L KA+     +  E    E  V+ +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG-ISR 605
           ++    +  L    + +  + LI +Y+    L + L   +R       +   I  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
            L +LH+   L II+RD+K  NILLD + +  ++DFGL++ F  ++ + A
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 31/159 (19%)

Query: 503 LGQGGFGPV-YKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           +G G +G V      + G ++A+K+L +   S    +    E+ ++ +++H N++ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 560 CVEREENMLIYEYMPNKSLDSF----LFDP---------QRQSLLDWPKRFNIIKGISRG 606
                       + P+ SLD F    L  P          +   L   +   ++  + +G
Sbjct: 83  ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L Y+H      IIHRDLK  N+ +++D   KI DFGLAR
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 11/156 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQ--EIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           +F     LG G FG V     ++     +A+KR  K+    Q++     +E  +++ + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V L G   +     L+ E++      +FL   +R     +P            L++ 
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIFE 145

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
           +  S L I++RDLK  N+LLD D   K++DFG A++
Sbjct: 146 YLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180

Length = 340

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 19/180 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V K + +    I  ++L     +   + + + E+ V+       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR--QSLLDWPKRFNIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L + +R  + +L       +   + RGL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 11/155 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSK---ASGQGQEEFMNEVMVISNLQHR 551
           +F     LG+G FG V   + +   E+ A+K L K         E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +  L  C +  + +  + EY+    L   ++  Q+      P+       IS GL +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           HR     II+RDLK  N++LD + + KI+DFG+ +
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 11/164 (6%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
           LG+G FG V   K +  G+  A+K L K     ++E    + E  V+ N +H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                +    + EY     L    F   R+ +    +       I   L YLH  S   +
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           ++RDLK  N++LD D + KI+DFGL +   G +D A  K   GT
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 51/154 (33%), Positives = 73/154 (47%), Gaps = 23/154 (14%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSK---ASGQGQEEFMNEVMVIS-NLQHRNLVRLL 557
           LG+G FG V   +L+   E  A+K L K         E  M E  V++   +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 558 GCCVEREENML-IYEYMPNKSL-----DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
            C  + +E++  + EY+    L      S  FD  R        RF   + I  GL +LH
Sbjct: 63  -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAEIIC-GLQFLH 113

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +     II+RDLK  N+LLD D + KI+DFG+ +
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 13/156 (8%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+G FG V   +L+  G+  AVK L K         E  M E  V++       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 559 CCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           C  + +E++  + E++    L   +F  Q +   D  +       I  GL +LH      
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--- 116

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQ 651
           II+RDLK  N++LD D + KI+DFG+ +  +FG N+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 12/152 (7%)

Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRNL 553
           + Q    LG G  G VYK   L   + +AVK +    + + Q++ M+E+ ++       +
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +   G         +  E+M   SLD +   P+            I   + +GL YL   
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLDVYRKIPE-------HVLGRIAVAVVKGLTYLWS- 113

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             L+I+HRD+K SN+L++     K+ DFG++ 
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 12/149 (8%)

Query: 503 LGQGGFGPVY---KGKLQD-GQEIAVKRLSKASGQGQEEF--MNEVMVISNLQHRNLVRL 556
           LGQG FG V+   K    D GQ  A+K L KA+ + ++      E  +++ + H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
                   +  LI +++  +  D F    +     +   +F + + ++  L +LH    L
Sbjct: 64  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 117

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLAR 645
            II+RDLK  NILLD++ + K++DFGL++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 14/165 (8%)

Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
           LG+G FG V   + +  G+  A+K L K     ++E    + E  V+ N +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLR 617
                +    + EY     L    F   R+ +    + RF   + +S  L YLH      
Sbjct: 63  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVS-ALEYLHSRD--- 115

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 10/169 (5%)

Query: 495 NNFQLANKLGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMN---EVMVISNLQH 550
            +F     +G+G FG V    K   G+  A+K L K+    +++  +   E  V++    
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +V L     + +   LI E++P   L + L   +  +  +   RF + + +    L +
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMAECV----LAI 114

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRL 659
               +L  IHRD+K  NIL+D   + K+SDFGL+  F    D A  ++L
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKAS---GQGQEEFMNEVMVI-SNLQHRNLVRLL 557
           +G+G FG V   + +  ++  AVK L K +    + ++  M+E  V+  N++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
                 ++   + +Y+    L    +  QR+     P+       I+  L YLH    L 
Sbjct: 63  FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHS---LN 116

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645
           I++RDLK  NILLD   +  ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 21/42 (50%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
           R L Y+H  +   + HRDLK  NIL + D   KI DFGLAR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 16/157 (10%)

Query: 503 LGQGGFGPVYKGKLQDGQE----IAVKRLSKAS-GQGQEEFMN---EVMVISNLQHRNLV 554
           LG+GG+G V++ +   G +     A+K L KA+  + Q++  +   E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            L+       +  LI EY+    L   L   +R+ +         +  IS  L +LH+  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGG 649
              II+RDLK  NILLD   + K++DFGL +  I  G
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 11/106 (10%)

Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD--SFLFDPQRQSLLDWPKRFN 598
           E  ++  + H ++++L G     +   LI   +P    D   +L   +  ++ D      
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           I + + R + YLH +   RIIHRD+KA NI ++   +  + DFG A
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 18/169 (10%)

Query: 487 FEELANATNNFQLANKLGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVI 545
           F+   + ++ +++   +G+G +G V+K    ++G + AVK L        EE   E  ++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNIL 68

Query: 546 SNLQ-HRNLVRLLGCCVEREEN-----MLIYEYMPNKSL----DSFLFDPQRQSLLDWPK 595
             L  H N+V+  G   +++        L+ E     S+      FL   +R   ++ P 
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPI 125

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
              I+     GL +LH +   + IHRD+K +NILL  +   K+ DFG++
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 10/153 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN---EVMVISNLQH 550
           ++F+    +G+G FG V   + +D G   A+K L KA    +E+  +   E  ++     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +V++     ++    LI E++P   + + L   ++ +L +   +F I    +  +L +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAI 114

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
               +L  IHRD+K  N+LLD   + K+SDFGL
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 34/177 (19%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEE-FMNEVM------VIS 546
           +F L  KLG+G FG VYK  L + Q     +  L KA+  G  E +MNE +        +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCA 192

Query: 547 NLQHRNLVRLLGCCVEREENMLIYEY---------MPNK----SLDSFLFDPQRQSLLDW 593
           +  +  L  +     + +E  L++ Y         M +K    +++ +L   + Q L   
Sbjct: 193 DFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLG-KVQDLPKG 249

Query: 594 PKRFN-IIKGISRGLLY----LHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLA 644
            +R N II+ I R +L+    LH      I+HRD+K  NI+  +     KI D G A
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 16/156 (10%)

Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
           F+    LG+G  G V+  +L+  G+  A+K L K     + +    + E  +++ L H  
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 553 LVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQS---LLDWPKRFNIIKGISRGLL 608
           L  L     + E  + L+ +Y P   L   L   QRQ    L +   RF   + +   L 
Sbjct: 63  LPTLY-ASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAAE-VLLALE 117

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           YLH    L I++RDLK  NILL +  +  +SDF L+
Sbjct: 118 YLHL---LGIVYRDLKPENILLHESGHIMLSDFDLS 150

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 14/151 (9%)

Query: 501 NKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR----NL 553
           ++LG+G +G VYK   +  G  +A+K  RL        E   N++++  ++ H+     +
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-----DESKFNQIIMELDILHKAVSPYI 61

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V   G         +  EYM   SLD           +       I   + +GL +L  +
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
               IIHRD+K +N+L++ +   K+ DFG++
Sbjct: 122 --HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 12/164 (7%)

Query: 503 LGQGGFGP--VYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +G+G FG   + +    D Q+ A+K  RL K+S    E+   E ++++ ++H N+V    
Sbjct: 8   VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                    ++ EY     L   +   QR  L            +  G+ ++H     R+
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RV 121

Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +HRD+K+ NI L  +   K+ DFG AR+       A T   VGT
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGT 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 10/153 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEEFMNEVMVISNLQHR 551
           ++F+    +G+G FG V   + +D   I A+K+L K+    + Q   +     I      
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             V  L    + E  + LI EY+P   + + L   ++ +  +   RF I    +  +L +
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYI----AETILAI 114

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
               +L  IHRD+K  N+LLD   + K+SDFGL
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 10/152 (6%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN---EVMVISNLQHR 551
           +F+    +G+G FG V   + +D G   A+K L KA    +E+  +   E  ++      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
            +V++     ++    LI E++P   + + L   ++ +L +   +F I + +    L + 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETV----LAID 115

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
              +L  IHRD+K  N+LLD   + K+SDFGL
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 7/104 (6%)

Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           E+ ++  + HR ++ L+     R ++  +   MP    D F +   R   L   +   I 
Sbjct: 136 EIDILKTISHRAIINLIH--AYRWKS-TVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           + +   L YLH      IIHRD+K  NI LD+  N  + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.5 bits (107), Expect = 8e-05
 Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 22/134 (16%)

Query: 524 VKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE---YMPNKSLD- 579
           + +  KA  +   +  NE++ +  L H N++++        E +L  E   YM  +  D 
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247

Query: 580 ---SFLFDPQRQ---SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD 633
              SF++D         L    R  I+K +   + Y+H     ++IHRD+K  NI L+ D
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303

Query: 634 LNPKISDFGLARIF 647
               + DFG A  F
Sbjct: 304 GKIVLGDFGTAMPF 317

Length = 501

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    I  ++L     +   + + + E+ V+       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 119

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 29/173 (16%)

Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +G+GGFG VY  +  D G+  A+K L K      QG+   +NE +++S      LV    
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55

Query: 559 C----CVER-----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           C    C+       ++   I + M    L   L   Q     +   RF   + I  GL +
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEH 112

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+    VGT
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 29/173 (16%)

Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +G+GGFG VY  +  D G+  A+K L K      QG+   +NE +++S      LV    
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55

Query: 559 C----CVER-----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           C    C+       ++   I + M    L   L   Q     +   RF   + I  GL +
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAE-IILGLEH 112

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+    VGT
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 32/147 (21%), Positives = 53/147 (36%), Gaps = 15/147 (10%)

Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV--RLLGC 559
            L  G    VY    +D  +  +K           E   EV ++  L  + L   ++L  
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61

Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
                 + L+ E++  ++LD         S  +       +  +   L  LH+   L + 
Sbjct: 62  GESDGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLAEL---LAKLHQLPLLVLC 111

Query: 620 HRDLKASNILLDDDLNPKISDFGLARI 646
           H DL   NIL+DD     I D+  A  
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 495 NNFQLANKLGQGGFGPVY--KGKLQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQ 549
            +F + + +G+G FG V   + K   G   A+K + K+    QE    F  E  ++S   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---FDPQRQSLLDWPKRFNIIKGISRG 606
              + +L     +++   L+ EY P   L S L    D   + +     +F + + +   
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAELV--- 112

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            L +H   ++  +HRD+K  N+L+D   + K++DFG A
Sbjct: 113 -LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 23/43 (53%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++RG+ +L   SR + IHRDL A NILL ++   KI DFGLAR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 13/172 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN--- 552
           +F     LG+G FG V   + +   E+   ++ K     Q++ +   MV   +   +   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 553 --LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L +L  C    +    + EY+    L   ++  Q+      P        I+ GL +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      II+RDLK  N++LD + + KI+DFG+ +      D   TK   GT
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 17/167 (10%)

Query: 483 LVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEEFM 539
           +V    +L     ++ +   +G+G FG V   + +  Q++ A+K LSK     +    F 
Sbjct: 31  IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90

Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD---PQRQSLLDWPK 595
            E   I    +   V  L C  + ++ + ++ EYMP   L + + +   P++     W K
Sbjct: 91  WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAK 145

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
            +      +  +L L     + +IHRD+K  N+LLD   + K++DFG
Sbjct: 146 FYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 25/173 (14%)

Query: 497 FQLANKLGQGGFGPVYKGKLQD---GQEIAVKRLSKASGQG---QEEFMNEVMVISNLQH 550
           + +   +G+GG G VY     D    + +A+K++ +   +    ++ F+ E  + ++L H
Sbjct: 4   YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61

Query: 551 RNLVRLLGCCVEREENMLIYEYMP---NKSLDSFLFDPQRQSLLDWP-------KRF-NI 599
             +V +   C + +    +Y  MP     +L S L    ++  L            F +I
Sbjct: 62  PGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
              I   + Y+H  S+  ++HRDLK  NILL       I D+G A      ++
Sbjct: 119 FHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168

Length = 932

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 13/149 (8%)

Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----QHRNLVRLL 557
           +G+G +  V   +L+  + I   ++ K      +E ++ V    ++      H  LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLLYLHRDSRL 616
            C         + EY+    L   +F  QRQ  L +   RF   + IS  L YLH     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG-- 116

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLAR 645
            II+RDLK  N+LLD + + K++D+G+ +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 17/151 (11%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVI---SNLQHRNLVR 555
           +G+G +  V   +L+  + I A+K + K      E+      E  V    SN  H  LV 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLVG 60

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLLYLHRDS 614
           L  C         + E++    L   +F  QRQ  L +   RF   + IS  L +LH   
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG 116

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              II+RDLK  N+LLD + + K++D+G+ +
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 37/174 (21%)

Query: 503 LGQGGFGPVYKGKL--------QDGQEIAVKRLSKASGQGQE-----------------E 537
           LGQG    +Y G+L        ++ +      L + +  G+E                  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 538 FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           F     ++S + H +L  + G CV   EN+++ E++ +  LD  L   + +  + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNIL-----LDDDLNP--KISDFGLA 644
            + + ++  L YL   +   ++H ++ A NIL     L +  +P  K+SD G++
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 6e-04
 Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 29/182 (15%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQHR 551
           N +++  K+G G FG V+  K +  QE    +     G  + E    + EV V+  L+H+
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL--- 608
           N+VR +   + +  N  +Y  M          + Q+   +      + I  I+R LL   
Sbjct: 73  NIVRYIDRFLNK-ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 609 -YLHR----DSRLRIIHRDLKASNILLD-------------DDLN----PKISDFGLARI 646
            Y H      +  R++HRDLK  NI L              ++LN     KI DFGL++ 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 647 FG 648
            G
Sbjct: 192 IG 193

Length = 1021

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 6e-04
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)

Query: 595 KRFNIIKGISRGLLY-LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           +  N+IKG+ R +L  L +  R+ I+HRD+K  N+L+  D   KI DFG A
Sbjct: 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 23/43 (53%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++RG+ +L   SR + IHRDL A NILL ++   KI DFGLAR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.9 bits (98), Expect = 8e-04
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 13/160 (8%)

Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN-----LVRLL 557
           +G+G +  V   +L+   +I   ++ K      +E ++ V    ++  +      LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLLYLHRDSRL 616
            C        L+ EY+    L   +F  QRQ  L +   RF   + I   L +LH     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG-- 116

Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            II+RDLK  N+LLD D + K++D+G+ +   G  D  +T
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.6 bits (97), Expect = 9e-04
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +++G+ +L   SR + IHRDL A NILL ++   KI DFGLAR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 18/153 (11%)

Query: 503 LGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMN---EVMVISNLQHRNLVRLLG 558
           LG G FG V    K+      A+K L K     + +  +   E  +++   +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
              +++    + +Y+P   + S L      P+  +      RF I + ++  +  +H+  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA------RFYIAE-LTLAIESVHK-- 119

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            +  IHRD+K  NIL+D D + K++DFGL   F
Sbjct: 120 -MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 21/156 (13%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQHR 551
           +F +   +G+G FG V   + +  +++ A+K LSK     + +   F  E  ++++    
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103

Query: 552 NLVRLLGCCVEREENML--IYEYMPNKSLDSFLFD---PQRQSLLDWPKRFNIIKGISRG 606
            +V+L      +++  L  + EYMP   L + + +   P+      W  RF   + +   
Sbjct: 104 WIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-----KW-ARFYTAE-VVLA 154

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           L  +H    +  IHRD+K  N+LLD   + K++DFG
Sbjct: 155 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 32/96 (33%), Positives = 42/96 (43%), Gaps = 8/96 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           N       LG G FG V +       K      +AVK L   A    +E  M+E+ V+S 
Sbjct: 35  NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL 582
           L  H N+V LLG C      ++I EY     L +FL
Sbjct: 95  LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 12/159 (7%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQHRNLVRLLG 558
           +G+G FG V + + +D Q I A+K + KA    + E    + E  V++ +    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLR 617
                E+  L+  ++    L   L   QR+   D  + RF      +  L  L    +  
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYT----AELLCALENLHKFN 113

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           +I+RDLK  NILLD   +  + DFGL ++   + D+  T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 8/86 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           +N  L   LG G FG V +         Q   ++AVK L S A    ++  M+E+ ++S+
Sbjct: 37  DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSH 96

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEY 572
           L  H N+V LLG C +     +I EY
Sbjct: 97  LGPHLNIVNLLGACTKGGPIYIITEY 122

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 23/155 (14%)

Query: 503 LGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEFMN-----EVMVISNLQHRNLVRL 556
           +G+G FG VY+ + +D + I A+K LSK     ++E  +      ++V + L     +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 557 LGCCVEREENM-LIYEYMPNKSLDSFL-----FDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           L    + + ++ L+ +YM    L   L     F   R        +F I + +   L +L
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR-------AKFYIAELV-LALEHL 112

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           H+     I++RDLK  NILLD   +  + DFGL++
Sbjct: 113 HKYD---IVYRDLKPENILLDATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 9/152 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
           ++F++   +G+G FG V   K++  + I A+K L+K     + E   F  E  V+ N   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           + +  L     +     L+ +Y     L + L   + +   D  + +     I+  +L +
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAI 115

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           H   +L  +HRD+K  N+LLD + + +++DFG
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 17/27 (62%), Positives = 19/27 (70%)

Query: 619 IHRDLKASNILLDDDLNPKISDFGLAR 645
           IHRD+ A N+LL D    KI DFGLAR
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR 260

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 27/113 (23%), Positives = 42/113 (37%), Gaps = 26/113 (23%)

Query: 540 NEVMVISNLQHRNLVRLLGCCVER-----EENMLIY-EYMPNKSLDSFLFDPQRQSLLDW 593
            E  +++        R  G  V        +N LI  EY+  + L   L           
Sbjct: 48  REARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----------E 91

Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
             R ++++ + R +  LH+     I+H DL  SNI+L         DFGL   
Sbjct: 92  EARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 15/29 (51%), Positives = 22/29 (75%)

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGL 643
           ++  IHRD+K  NIL+D D + K++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	662
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.96
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.94
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.94
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.94
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.93
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.93
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.93
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.93
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.93
KOG0198	313	consensus MEKK and related serine/threonine protei	99.93
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.93
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.93
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.93
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.93
KOG0605	550	consensus NDR and related serine/threonine kinases	99.93
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.92
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.92
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.92
KOG0578	550	consensus p21-activated serine/threonine protein k	99.92
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.92
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.91
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.91
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.91
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.91
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
PTZ00267	478	NIMA-related protein kinase; Provisional	99.91
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.91
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.91
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.9
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.9
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.9
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.9
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.9
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.9
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.9
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.9
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.9
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.9
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.9
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.9
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.9
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.9
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.9
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.9
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.9
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.9
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.9
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.9
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.9
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.9
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.9
PHA02988	283	hypothetical protein; Provisional	99.9
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.89
KOG0589	426	consensus Serine/threonine protein kinase [General	99.89
PHA03212	391	serine/threonine kinase US3; Provisional	99.89
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.89
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.89
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.89
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.89
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.89
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.89
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.89
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.89
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.89
KOG0586	596	consensus Serine/threonine protein kinase [General	99.89
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.89
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.89
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.89
PTZ00283	496	serine/threonine protein kinase; Provisional	99.89
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.89
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.89
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.89
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.89
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.89
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.89
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.89
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.89
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.89
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.89
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.89
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.89
KOG0610	459	consensus Putative serine/threonine protein kinase	99.89
PHA03211	461	serine/threonine kinase US3; Provisional	99.89
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.89
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.89
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.88
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.88
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.88
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.88
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.88
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.88
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.88
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.88
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.88
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.88
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.88
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.88
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.88
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.88
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.88
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.88
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.88
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.88
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.88
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.88
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.88
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.88
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.88
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.88
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.88
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.88
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.88
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.88
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.88
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.88
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.88
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.88
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.88
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.88
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.88
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.88
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.88
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.88
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.88
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.88
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.88
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.88
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.87
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.87
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.87
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.87
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.87
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.87
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.87
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.87
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.87
PHA03207	392	serine/threonine kinase US3; Provisional	99.87
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.87
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.87
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.87
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.87
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.87
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.87
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.87
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.87
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.87
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.87
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.87
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.87
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.87
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.87
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.87
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.87
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.87
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.87
PHA03209	357	serine/threonine kinase US3; Provisional	99.87
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.87
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.87
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.87
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.87
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.87
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.87
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.87
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.87
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.87
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.87
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.87
KOG0584	632	consensus Serine/threonine protein kinase [General	99.87
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.87
PTZ00036	440	glycogen synthase kinase; Provisional	99.87
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.87
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.87
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.87
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.87
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.87
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.86
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.86
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.86
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.86
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.86
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.86
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.86
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.86
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.86
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.86
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.86
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.86
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.86
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.86
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.86
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.86
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.86
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.86
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.86
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.86
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.86
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.86
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.86
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.86
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.86
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.86
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.86
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.86
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.86
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.86
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.86
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.86
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.86
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.86
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.86
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.86
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.86
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.86
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.86
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.86
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.85
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.85
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.85
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.85
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.85
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.85
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.85
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.85
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.85
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.85
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.85
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.85
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.85
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.85
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.85
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.85
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.85
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.85
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.85
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.85
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.85
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.85
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.85
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.85
PHA03210	501	serine/threonine kinase US3; Provisional	99.85
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.84
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.84
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.84
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.84
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.84
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.84
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.84
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.84
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.84
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.84
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.84
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.84
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.84
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.84
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.84
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.84
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.84
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.84
PLN00009	294	cyclin-dependent kinase A; Provisional	99.84
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.84
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.84
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.84
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.83
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.83
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.83
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.83
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.83
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.83
PTZ00284	467	protein kinase; Provisional	99.83
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.83
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.83
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.83
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.83
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.83
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.83
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.83
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.83
KOG1152	772	consensus Signal transduction serine/threonine kin	99.83
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.83
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.83
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.83
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.82
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.82
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.82
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.82
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.82
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.82
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.82
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.82
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.82
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.82
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.81
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.81
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.81
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.81
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.81
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.81
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.81
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.81
PHA02882	294	putative serine/threonine kinase; Provisional	99.81
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.81
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.81
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.81
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.81
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.8
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.8
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.8
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.8
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.8
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.8
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.8
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.78
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.78
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.78
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.77
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.77
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.77
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.77
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.77
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.76
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.75
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.75
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.75
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.74
smart00090	237	RIO RIO-like kinase.	99.73
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.73
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.71
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.68
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.68
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.67
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.66
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.59
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.48
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.31
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.24
PLN00181	793	protein SPA1-RELATED; Provisional	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.06
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.03
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.85
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.84
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.65
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
KOG1243	690	consensus Protein kinase [General function predict	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.56
PRK09902	216	hypothetical protein; Provisional	98.55
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.39
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.33
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.29
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	98.27
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.22
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.2
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.2
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.19
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
PF01636	239	APH: Phosphotransferase enzyme family This family	98.14
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.05
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.0
PLN02876	822	acyl-CoA dehydrogenase	97.99
PRK10593	297	hypothetical protein; Provisional	97.87
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.77
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.7
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.66
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.56
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.56
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.23
PRK05231	319	homoserine kinase; Provisional	97.02
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.9
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.87
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.84
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.8
PLN02236	344	choline kinase	96.8
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.65
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.63
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.6
PLN02756	418	S-methyl-5-thioribose kinase	96.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.18
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.17
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.05
KOG2270	520	consensus Serine/threonine protein kinase involved	96.04
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.79
COG2334	331	Putative homoserine kinase type II (protein kinase	95.6
PRK12396	409	5-methylribose kinase; Reviewed	95.47
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.27
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.11
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.84

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-37  Score=325.14  Aligned_cols=168  Identities=54%  Similarity=0.917  Sum_probs=154.2

Q ss_pred             cccccCHHHHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEE
Q 006090          481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC  560 (662)
Q Consensus       481 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~  560 (662)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+++++.||||++.....+..++|.+|++++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999998764433156799999999999999999999999


Q ss_pred             EeCC-eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          561 VERE-ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       561 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                      .+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875544 78999999999999999999999998899999999999999999999999


Q ss_pred             eeCccccccC
Q 006090          640 DFGLARIFGG  649 (662)
Q Consensus       640 DFGla~~~~~  649 (662)
                      |||||+....
T Consensus       220 DFGLa~~~~~  229 (361)
T KOG1187|consen  220 DFGLAKLGPE  229 (361)
T ss_pred             CccCcccCCc
Confidence            9999976644

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-32  Score=273.54  Aligned_cols=159  Identities=32%  Similarity=0.597  Sum_probs=139.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+|.+.++||.|+|++||+|++. ++.+||||.+.+.  ....++....|+.+|+.++|||||+|++++.+++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            57888889999999999999976 5789999998764  44456678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC------CceEEEeeCccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD------LNPKISDFGLAR  645 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~------~~~ki~DFGla~  645 (662)
                      ||.+|+|..||++   +..+++.+...++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+||
T Consensus        90 yC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999954   446999999999999999999999998   9999999999999875      358999999999


Q ss_pred             cccCCcccccccccccC
Q 006090          646 IFGGNQDQAATKRLVGT  662 (662)
Q Consensus       646 ~~~~~~~~~~~~~~~Gt  662 (662)
                      .+.++.   ...+++|+
T Consensus       164 ~L~~~~---~a~tlcGS  177 (429)
T KOG0595|consen  164 FLQPGS---MAETLCGS  177 (429)
T ss_pred             hCCchh---HHHHhhCC
Confidence            997553   23335664

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.3e-30  Score=258.25  Aligned_cols=159  Identities=30%  Similarity=0.489  Sum_probs=137.2

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEccccccc-------cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQ-------GQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~-------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      +.|.+.+.||+|+||.|-+|.- .+++.||||.+.+.-..       ......+|+++|++|+|||||++++++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            5677889999999999999985 47999999999753111       223457999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEeeCc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGL  643 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~ki~DFGl  643 (662)
                      |||||||+||+|.+++..   ...+.+..-..+++|++.|+.|||+++   |+||||||+||||..+   ..+||+||||
T Consensus       252 YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999843   445777788889999999999999998   9999999999999766   7899999999


Q ss_pred             cccccCCcccccccccccC
Q 006090          644 ARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       644 a~~~~~~~~~~~~~~~~Gt  662 (662)
                      ||..+...   .+.++|||
T Consensus       326 AK~~g~~s---fm~TlCGT  341 (475)
T KOG0615|consen  326 AKVSGEGS---FMKTLCGT  341 (475)
T ss_pred             hhccccce---ehhhhcCC
Confidence            99997543   46678998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=266.99  Aligned_cols=150  Identities=39%  Similarity=0.611  Sum_probs=132.9

Q ss_pred             ccccccCccCceeEEEEEEcCCcEEEEEEccccccc--cHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-eeEEEEEccC
Q 006090          498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--GQEEFMNEVMVISNLQHRNLVRLLGCCVERE-ENMLIYEYMP  574 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~  574 (662)
                      ...+.||+|+||+||+|.++....||||++......  ..++|.+|+.+|.+++|||||+|+|+|.+.. ...+|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            345679999999999999985555999999764322  2569999999999999999999999999988 7899999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccccCC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGN  650 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~~~~  650 (662)
                      +|+|..+|++. ....+++..++++|.|||+||.|||++.+  ||||||||+||||+.++ ++||+|||+++.....
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999764 45679999999999999999999999873  99999999999999998 9999999999987654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.1e-29  Score=267.62  Aligned_cols=160  Identities=33%  Similarity=0.539  Sum_probs=144.9

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .+|...+.||+|+|+.||+++. ..|+.||+|++.+.   .....+...+||++.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5788899999999999999997 78999999998653   2234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+|++++|..++.   ++.++++.++..+..||+.||.|||+.+   |||||||..|++|++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999994   4567999999999999999999999988   999999999999999999999999999999877


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      .++..|  ++||
T Consensus       172 ~Erk~T--lCGT  181 (592)
T KOG0575|consen  172 GERKKT--LCGT  181 (592)
T ss_pred             ccccce--ecCC
Confidence            655444  7998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=266.41  Aligned_cols=151  Identities=39%  Similarity=0.726  Sum_probs=136.8

Q ss_pred             ccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      .+.+.+.||+|-||.|+.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+|+|+|..++..+||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34557899999999999999998889999999864 45567899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      |+|.+||.. .....+...+.+.++.|||+||+||++++   +|||||+++||||+++..+||+||||||...+++
T Consensus       286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            999999965 34556888999999999999999999998   9999999999999999999999999999665543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.5e-29  Score=260.72  Aligned_cols=161  Identities=30%  Similarity=0.537  Sum_probs=140.4

Q ss_pred             ccccccccccCccCceeEEEEE-EcCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  568 (662)
                      .+.|+..++||+|.||.||||+ ..+|+.||+|++....  +....-..+||.+|++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3568888999999999999998 4579999999987543  34456778999999999999999999999887  67899


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+|||++ +|.-++..  ..-.+++.++..++.|++.||.|||.++   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999975 77777743  3345899999999999999999999998   9999999999999999999999999999998


Q ss_pred             CCcccccccccc
Q 006090          649 GNQDQAATKRLV  660 (662)
Q Consensus       649 ~~~~~~~~~~~~  660 (662)
                      .......|++++
T Consensus       270 ~~~~~~~T~rVv  281 (560)
T KOG0600|consen  270 PSGSAPYTSRVV  281 (560)
T ss_pred             CCCCcccccceE
Confidence            887776777664

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=252.29  Aligned_cols=157  Identities=31%  Similarity=0.466  Sum_probs=136.8

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-eeEEEEEcc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-ENMLIYEYM  573 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~  573 (662)
                      ++..+.||+|..|+|||+.++ +++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344689999999999999987 6788999998543 3445678999999999999999999999999998 599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ  653 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~  653 (662)
                      ++|||++++...   ..+++...-+|+.+|++||.|||+..  .||||||||+||||++.|++||||||.++.+.+.   
T Consensus       161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            999999999433   55899999999999999999999732  3999999999999999999999999999999776   


Q ss_pred             ccccccccC
Q 006090          654 AATKRLVGT  662 (662)
Q Consensus       654 ~~~~~~~Gt  662 (662)
                       ..++++||
T Consensus       233 -~a~tfvGT  240 (364)
T KOG0581|consen  233 -IANTFVGT  240 (364)
T ss_pred             -hccccccc
Confidence             33446776

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=8e-29  Score=272.73  Aligned_cols=151  Identities=34%  Similarity=0.598  Sum_probs=134.4

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      +.+....++||+|+||+||+|+..      +.+.||||.|+..... .+.+|++|+++++.++|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            455666899999999999999853      3457999999876555 788999999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQR-----------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN  635 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~  635 (662)
                      +||+|||..|||.+||+...+           ..+|+..+.+.||.|||.||.||-++.   ++||||+.||+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            999999999999999963211           234889999999999999999999887   999999999999999999


Q ss_pred             eEEEeeCccccc
Q 006090          636 PKISDFGLARIF  647 (662)
Q Consensus       636 ~ki~DFGla~~~  647 (662)
                      +||+||||+|..
T Consensus       642 VKIsDfGLsRdi  653 (774)
T KOG1026|consen  642 VKISDFGLSRDI  653 (774)
T ss_pred             EEecccccchhh
Confidence            999999999854

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.95  E-value=1.3e-29  Score=223.39  Aligned_cols=111  Identities=47%  Similarity=0.699  Sum_probs=80.8

Q ss_pred             CCcEEEEccCCCCCCCC--CceEEEecCccEEEEcCCCCEEEee-ccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090           73 NKTVVWVANRNKPLIDS--SGIFTISEDGNLVVLNGKKQVHWSS-NVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus        73 ~~~~vW~anr~~p~~~~--~~~l~~~~~G~l~l~~~~~~~~w~~-~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      ++||||+|||+.|+...  ..+|.|+.||+|+|+|..++++|++ ++.+ ....+..|+|+|+|||||+|. .+.+||||
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~-~~~~~~~~~L~~~GNlvl~d~-~~~~lW~S   78 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSG-RGNSGCYLVLQDDGNLVLYDS-SGNVLWQS   78 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TT-SS-SSEEEEEETTSEEEEEET-TSEEEEES
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCC-ccccCeEEEEeCCCCEEEEee-cceEEEee
Confidence            46999999999999543  3789999999999999999999999 5553 111478999999999999985 67899999


Q ss_pred             ccCCccccccCCcccccccCCceeEEEEeccCCCCC
Q 006090          150 FQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPS  185 (662)
Q Consensus       150 Fd~PtDTlLpg~~l~~~~~tg~~~~L~S~~s~~d~s  185 (662)
                      |||||||+||+|+|+.+..+|.+..|+||++.+|||
T Consensus        79 f~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   79 FDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             cCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            999999999999999887777777799999999996

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2e-28  Score=252.09  Aligned_cols=160  Identities=34%  Similarity=0.576  Sum_probs=139.1

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhc--CCCCCcceeeEEEEeCC----eeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISN--LQHRNLVRLLGCCVERE----ENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~l  568 (662)
                      ...++.++||+|+||.||||.+. ++.||||++.   .+..+.|++|-++.+.  ++|+||+++++.-..+.    +.+|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34456789999999999999997 5999999984   4667789999988775  58999999999987666    7899


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD------SRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      |+||.++|+|.+||    +...++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+|||
T Consensus       286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999    456799999999999999999999986      35779999999999999999999999999


Q ss_pred             ccccccCCcccccccccccC
Q 006090          643 LARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       643 la~~~~~~~~~~~~~~~~Gt  662 (662)
                      ||.++..+..+..+-.-+||
T Consensus       362 LAl~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             eeEEecCCCCCcchhhhhhh
Confidence            99999877665544445665

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=8.4e-29  Score=267.22  Aligned_cols=155  Identities=33%  Similarity=0.598  Sum_probs=138.4

Q ss_pred             cccccccccCccCceeEEEEEEcC----CcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ....+.++||.|.||+|++|+++-    ...||||.|+.... ...++|+.|+.||+.++||||++|.|+.......++|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            456778999999999999999762    35799999987644 4467899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +|||+||+|+.||+...  ..+++.+...+.++||.||.||.+.+   .|||||.++|||++.+..+||+||||+|.+++
T Consensus       709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999996543  44899999999999999999999988   99999999999999999999999999999977


Q ss_pred             Ccccc
Q 006090          650 NQDQA  654 (662)
Q Consensus       650 ~~~~~  654 (662)
                      +.+..
T Consensus       784 d~~~~  788 (996)
T KOG0196|consen  784 DPEAA  788 (996)
T ss_pred             CCCcc
Confidence            76443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=245.07  Aligned_cols=161  Identities=30%  Similarity=0.443  Sum_probs=142.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++..   ..+.+...+|..+|.+++||.||+|+-.+++.+..|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999865 58899999997642   23467789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +||+.||.|..+|.   +...+++..+.-++.+|+.||.|||+.+   ||||||||+|||||++|+++|+||||++.-..
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999993   4456889999999999999999999998   99999999999999999999999999997755


Q ss_pred             CcccccccccccC
Q 006090          650 NQDQAATKRLVGT  662 (662)
Q Consensus       650 ~~~~~~~~~~~Gt  662 (662)
                      ..+  .+.+++||
T Consensus       178 ~~~--~t~tfcGT  188 (357)
T KOG0598|consen  178 DGD--ATRTFCGT  188 (357)
T ss_pred             CCC--ccccccCC
Confidence            443  45668998

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-28  Score=253.36  Aligned_cols=153  Identities=31%  Similarity=0.569  Sum_probs=134.4

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +....+.++||+|-||+|.+++...+..||||+++..... ..++|.+|+++|.+++|||||+|+|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3456678999999999999999988899999999875544 458999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |++|+|.+||...... .++-....+|+.|||.||+||.+-+   ++||||.++|+|+|.++++||+||||+|-+-.+
T Consensus       617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999543222 2455566789999999999999877   999999999999999999999999999965433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.94  E-value=8.3e-28  Score=234.69  Aligned_cols=149  Identities=24%  Similarity=0.435  Sum_probs=130.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +.|+.+.++|+|+||.|||++.+ +|+.||||++....  +.-.+-.++|+++|+.++|+|+|.|+.+|..+...+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777889999999999999976 59999999986532  2234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+..-|+++-+.   ...++...+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||||||+||.+..
T Consensus        82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9988777665422   234788899999999999999999998   99999999999999999999999999999974

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.94  E-value=3.6e-27  Score=226.74  Aligned_cols=150  Identities=31%  Similarity=0.594  Sum_probs=133.2

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEccccccc--cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQ--GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+|...++||+|.||.||+|+. .+|+.||||+++.....  -.....+|++.|+.++|+||+.|++++-+.+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3577789999999999999985 47999999999753221  24578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+ .+|+..|++  +...++..+...++.++++||+|||++.   |+||||||.|+|++++|.+||+||||||.++..
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            996 689999965  3456899999999999999999999988   999999999999999999999999999999753

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-27  Score=247.61  Aligned_cols=154  Identities=32%  Similarity=0.464  Sum_probs=137.4

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  567 (662)
                      ..++|...+.||+|+|++|++|+.. .++++|||++.+..   +...+....|-++|.+| .||.|++|+-.|.|....|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            4478889999999999999999854 68999999997632   23445677899999999 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|+||+++|+|.++|.+   ...+++.....++.||+.||.|||..+   ||||||||+|||||+||++||+|||-|+++
T Consensus       151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999999999954   456899999999999999999999998   999999999999999999999999999999


Q ss_pred             cCCcc
Q 006090          648 GGNQD  652 (662)
Q Consensus       648 ~~~~~  652 (662)
                      .+.+.
T Consensus       225 ~~~~~  229 (604)
T KOG0592|consen  225 SPSQK  229 (604)
T ss_pred             Chhhc
Confidence            76543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=252.63  Aligned_cols=150  Identities=39%  Similarity=0.569  Sum_probs=132.6

Q ss_pred             ccccccccccCccCceeEEEEEEcC--C--cE-EEEEEccc---cccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD--G--QE-IAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~--~--~~-vAvK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      .++..+.++||+|+||.||+|++..  +  .. ||||..+.   .......+|.+|+++|+.++|||||+|+|++.++.+
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3455667999999999999999763  2  23 89999874   335567899999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++|||+|+||+|+++|.+..  ..++..+++.++.+.|+||+|||+++   +|||||.+||+|++.++.+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            999999999999999995432  25899999999999999999999998   9999999999999999999999999988


Q ss_pred             ccc
Q 006090          646 IFG  648 (662)
Q Consensus       646 ~~~  648 (662)
                      .-.
T Consensus       311 ~~~  313 (474)
T KOG0194|consen  311 AGS  313 (474)
T ss_pred             CCc
Confidence            653

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.3e-27  Score=240.53  Aligned_cols=159  Identities=25%  Similarity=0.524  Sum_probs=141.4

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ..+|++.+.||+|.||+|-++.. ..|+.||||.+++.   +++..-.+++|+++|..|+||||+.++.+|+..+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35788899999999999999985 57999999988753   455666789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||..+|.|.+|+..   ...|++.+..++++||.+|+.|+|.+.   ++|||||.+|||||.|+++||+||||+.++..
T Consensus       132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999954   445899999999999999999999987   99999999999999999999999999999865


Q ss_pred             Cccccccccccc
Q 006090          650 NQDQAATKRLVG  661 (662)
Q Consensus       650 ~~~~~~~~~~~G  661 (662)
                      +.   ..++++|
T Consensus       206 ~k---fLqTFCG  214 (668)
T KOG0611|consen  206 KK---FLQTFCG  214 (668)
T ss_pred             cc---HHHHhcC
Confidence            43   3444665

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=1e-26  Score=226.76  Aligned_cols=157  Identities=34%  Similarity=0.460  Sum_probs=139.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccc---cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ---GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .+|+....||.|+||.|.+++.+ ++.-+|+|++++....   ..+...+|..+|+.+.||.+++|++.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46777899999999999999976 5778999999764332   2345778999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||++||.|.++|++.   ..+++..+..+|.||+.||.|||+.+   |++|||||+|||||.+|.+||+|||+|+.+.+.
T Consensus       124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999543   34889999999999999999999988   999999999999999999999999999988653


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                           +-+++||
T Consensus       198 -----T~TlCGT  204 (355)
T KOG0616|consen  198 -----TWTLCGT  204 (355)
T ss_pred             -----EEEecCC
Confidence                 5557887

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.1e-28  Score=234.58  Aligned_cols=165  Identities=27%  Similarity=0.507  Sum_probs=139.8

Q ss_pred             cccccccccCccCceeEEEEE-EcCCcEEEEEEccc--cccccHHHHHHHHHHHhcCCCCCcceeeE-EEEeCCe-eEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLG-CCVEREE-NMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g-~~~~~~~-~~lV  569 (662)
                      .+|++.++||+|.||+|||+. +.++..||.|.+.-  .+....+....|+.+|+.|+|||||+.++ -+.++.+ .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            467889999999999999998 56899999998863  24455677899999999999999999999 4556666 7899


Q ss_pred             EEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          570 YEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR--IIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      |||+..|+|...|..- +.+..+++.++++++.|+++||.++|..- ++  |+||||||.||+|+.+|.+||.||||+|.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999998542 33557999999999999999999999843 34  99999999999999999999999999999


Q ss_pred             ccCCcccccccccccC
Q 006090          647 FGGNQDQAATKRLVGT  662 (662)
Q Consensus       647 ~~~~~~~~~~~~~~Gt  662 (662)
                      +.....-  ....+||
T Consensus       178 l~s~~tf--A~S~VGT  191 (375)
T KOG0591|consen  178 LSSKTTF--AHSLVGT  191 (375)
T ss_pred             hcchhHH--HHhhcCC
Confidence            9776543  3336777

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-27  Score=241.45  Aligned_cols=151  Identities=30%  Similarity=0.485  Sum_probs=133.1

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEcccccccc-HHHHHHHHHHHhcCC-CCCcceeeEEEEeCC-eeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQ-HRNLVRLLGCCVERE-ENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~lV  569 (662)
                      .++|...++||.|.||.||+|+- .++..||||++++....- +-.=++|+..|++|. |||||+|..++.+.+ ..++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            36788899999999999999985 468899999998643332 223478999999998 999999999999988 89999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||||+ -+|.+++.++  ..++++..+..|+.||++||+|+|.+|   ++||||||+|||+..+..+||+||||||.+..
T Consensus        89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            99995 6899988654  567999999999999999999999998   99999999999999999999999999998865


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       163 k  163 (538)
T KOG0661|consen  163 K  163 (538)
T ss_pred             C
Confidence            4

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.93  E-value=1.6e-26  Score=241.58  Aligned_cols=159  Identities=30%  Similarity=0.494  Sum_probs=140.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.  ...+.+..++|++++++++|||||.++..++...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46788899999999999999876 5788999998653  33456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      |+.+ +|..+|.+   ...++++.+..|+.+++.||.|||+..   |+|||+||+||||+.++.+|+||||+||-+..+ 
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9976 99999944   455899999999999999999999987   999999999999999999999999999988764 


Q ss_pred             ccccccccccC
Q 006090          652 DQAATKRLVGT  662 (662)
Q Consensus       652 ~~~~~~~~~Gt  662 (662)
                       ..+.+++.||
T Consensus       154 -t~vltsikGt  163 (808)
T KOG0597|consen  154 -TSVLTSIKGT  163 (808)
T ss_pred             -ceeeeeccCc
Confidence             3456667776

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-25  Score=239.53  Aligned_cols=162  Identities=29%  Similarity=0.520  Sum_probs=139.2

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc----cc-ccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA----SG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREE  565 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~  565 (662)
                      ..++|.+.+.||+|+||+|++|... +++.||+|.+.+.    .. ...+.+.+|+.++++++ ||||++++.+......
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3468899999999999999999864 6899999977653    11 23456678999999998 9999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCcc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLA  644 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGla  644 (662)
                      .++||||+.+|+|.+++.+   ...+.+.....++.|++.|++|||+.+   |+||||||+||||+.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   456888999999999999999999998   9999999999999999 99999999999


Q ss_pred             ccccCCcccccccccccC
Q 006090          645 RIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       645 ~~~~~~~~~~~~~~~~Gt  662 (662)
                      .....  ......+.+||
T Consensus       169 ~~~~~--~~~~l~t~cGs  184 (370)
T KOG0583|consen  169 AISPG--EDGLLKTFCGS  184 (370)
T ss_pred             cccCC--CCCcccCCCCC
Confidence            99851  12234456775

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.93  E-value=4.3e-26  Score=225.53  Aligned_cols=151  Identities=29%  Similarity=0.444  Sum_probs=130.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV  569 (662)
                      +.|+..+.|++|.||.||+|+.. +++.||+|+++...+  ......++|+.+|.+++|||||.+..+....  +..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            56888999999999999999975 678999999975321  1234568999999999999999998887653  568999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||||++ +|.+++....  .++...++..++.|+++|++|||.+.   |+|||||++|+|+++.|.+||+||||||.++.
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999974 8888886544  45788999999999999999999987   99999999999999999999999999999987


Q ss_pred             Cc
Q 006090          650 NQ  651 (662)
Q Consensus       650 ~~  651 (662)
                      ..
T Consensus       230 p~  231 (419)
T KOG0663|consen  230 PL  231 (419)
T ss_pred             Cc
Confidence            63

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.7e-26  Score=233.76  Aligned_cols=160  Identities=28%  Similarity=0.485  Sum_probs=137.1

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhc--CCCCCcceeeEEEEeCC----eeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISN--LQHRNLVRLLGCCVERE----ENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~l  568 (662)
                      ....+.+.||+|.||+||+|.++ |+.||||++..   .+++.+.+|.++...  |+|+||..+++.-..++    +.+|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            46778899999999999999998 89999999953   455678889998875  59999999999876543    4689


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      |+||.++|||.+||    ....++....++++..+|.||+|||.+     ++|.|.|||||+.|||+.+++.+-|+|+||
T Consensus       287 vTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             eeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            99999999999999    346789999999999999999999964     788999999999999999999999999999


Q ss_pred             cccccCCccc--ccccccccC
Q 006090          644 ARIFGGNQDQ--AATKRLVGT  662 (662)
Q Consensus       644 a~~~~~~~~~--~~~~~~~Gt  662 (662)
                      |-....+.++  ...+..+||
T Consensus       363 Av~h~~~t~~idi~~N~rVGT  383 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGT  383 (513)
T ss_pred             eEEecccCCcccCCCCCccce
Confidence            9888665433  344445776

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-25  Score=228.38  Aligned_cols=150  Identities=34%  Similarity=0.544  Sum_probs=131.6

Q ss_pred             cccccccccCccCceeEEEEEEcC-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC--eeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE--ENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E  571 (662)
                      .++...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+.+|......  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456678999999999999999764 8999999887643333667899999999999999999999855544  5889999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~  649 (662)
                      |+++|+|.+++.+...  .+++..+..+.+||++||+|||+++   ||||||||+||||+. ++.+||+|||+|+....
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            9999999999954332  5999999999999999999999988   999999999999999 79999999999998874

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.93  E-value=2.1e-25  Score=224.78  Aligned_cols=150  Identities=29%  Similarity=0.524  Sum_probs=129.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCC-cceeeEEEEeCC------
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRN-LVRLLGCCVERE------  564 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~------  564 (662)
                      ..|...++||+|+||+||+|+.. +|+.||+|++.-...  .-.....+|+.++++++|+| ||+|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44666788999999999999965 689999999865333  23456789999999999999 999999999887      


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ..+||+||+ .-+|.+++....+. ..++...+..++.||++||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            678999999 46999999653322 35777889999999999999999998   99999999999999999999999999


Q ss_pred             ccccc
Q 006090          644 ARIFG  648 (662)
Q Consensus       644 a~~~~  648 (662)
                      |+.+.
T Consensus       167 Ara~~  171 (323)
T KOG0594|consen  167 ARAFS  171 (323)
T ss_pred             HHHhc
Confidence            99776

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-25  Score=230.30  Aligned_cols=148  Identities=31%  Similarity=0.500  Sum_probs=127.6

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--------------ccHHHHHHHHHHHhcCCCCCcceee
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--------------QGQEEFMNEVMVISNLQHRNLVRLL  557 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--------------~~~~~f~~E~~~l~~l~H~nIv~l~  557 (662)
                      .-+.|.+...||+|.||.|-+|... +++.||||++.+...              ...+..++|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3478999999999999999999854 688999999864211              1135789999999999999999999


Q ss_pred             EEEEeC--CeeEEEEEccCCCCHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006090          558 GCCVER--EENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL  634 (662)
Q Consensus       558 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~  634 (662)
                      .+.-+.  +..|||+|||..|.+...    ....+ +++.++.++.+++..||.|||.++   ||||||||+|+||+++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            998764  567999999999987532    23334 899999999999999999999998   99999999999999999


Q ss_pred             ceEEEeeCccccc
Q 006090          635 NPKISDFGLARIF  647 (662)
Q Consensus       635 ~~ki~DFGla~~~  647 (662)
                      ++||+|||.+...
T Consensus       248 ~VKIsDFGVs~~~  260 (576)
T KOG0585|consen  248 TVKISDFGVSNEF  260 (576)
T ss_pred             cEEeeccceeeec
Confidence            9999999999877

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=4.9e-25  Score=196.01  Aligned_cols=115  Identities=43%  Similarity=0.676  Sum_probs=100.4

Q ss_pred             CcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEEcCCCCE
Q 006090           31 QFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQV  110 (662)
Q Consensus        31 ~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~  110 (662)
                      +.|.+|+.|+|+++.|++|||.+. .....+.+|||...  + .++||.|||+.| ....++|.|+.||+|+|+|.+|.+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~-~q~~dgnlv~~~~~--~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~   76 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLI-MQSRDYNLILYKGS--S-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTV   76 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCC-CCCCeEEEEEEeCC--C-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcE
Confidence            568899999999999999999987 32248999999875  4 789999999998 446689999999999999999999


Q ss_pred             EEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCC
Q 006090          111 HWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEP  153 (662)
Q Consensus       111 ~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~P  153 (662)
                      +|++++..  ..+..+|+|+|+|||||++.+ +.+||||||||
T Consensus        77 vW~S~~~~--~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~~P  116 (116)
T cd00028          77 VWSSNTTR--VNGNYVLVLLDDGNLVLYDSD-GNFLWQSFDYP  116 (116)
T ss_pred             EEEecccC--CCCceEEEEeCCCCEEEECCC-CCEEEcCCCCC
Confidence            99999874  246789999999999999863 67899999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.93  E-value=1.5e-25  Score=197.08  Aligned_cols=108  Identities=42%  Similarity=0.945  Sum_probs=100.8

Q ss_pred             eccCCCCCcceecccCCcceeeeeeEeeecCCCCeEEEEEEEeCCcEE--EEEccCCcEEEEEeeCCCCceEEEEEeeCC
Q 006090          212 WRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFADNDVF--FALTPQGNLEERAWVDGKAHLKIYFFYPTN  289 (662)
Q Consensus       212 w~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~G~l~~~~~~~~~~~w~~~~~~~~~  289 (662)
                      ||+|+|||..|.++|+|.....+.+.|+.+  +++.+++|...+.+.+  ++||++|++++|.|.+..+.|...|.+|.+
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~--~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d   78 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSN--NEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKD   78 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEEC--CCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEeccc
Confidence            899999999999999999878888889988  8999999998777665  999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCccccCCCCCcccccCCCccCC
Q 006090          290 DCDVYGKCGAFGSCNSQKIPICSCLLGFEPKN  321 (662)
Q Consensus       290 ~C~~~~~CG~~g~C~~~~~~~C~C~~gF~~~~  321 (662)
                      +|++|+.||+||+|+.+..+.|+||+||+|++
T Consensus        79 ~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   79 QCDVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            99999999999999988888999999999974

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.93  E-value=5.2e-26  Score=240.63  Aligned_cols=152  Identities=35%  Similarity=0.626  Sum_probs=135.1

Q ss_pred             HHHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          488 EELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       488 ~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      +++....+.+.+.+.||+|.||+||+|++.  -.||||+|....  .+..+.|++|+..+++-+|.||+-++|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            445555566777899999999999999997  479999997543  3467899999999999999999999999998877


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                       .+|+.+|+|-+|..+|+..+  ..++..+.+.||+|||+||.|||.++   |||||||..||+|.+++.+||.||||+.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999998644  45889999999999999999999998   9999999999999999999999999986


Q ss_pred             cc
Q 006090          646 IF  647 (662)
Q Consensus       646 ~~  647 (662)
                      .-
T Consensus       537 vk  538 (678)
T KOG0193|consen  537 VK  538 (678)
T ss_pred             ee
Confidence            44

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.6e-26  Score=258.97  Aligned_cols=151  Identities=37%  Similarity=0.655  Sum_probs=134.6

Q ss_pred             ccccccccccCccCceeEEEEEEcC--Cc----EEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD--GQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~--~~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      ..+.++.+.||+|+||.||+|++.+  +.    .||||.+++. +.++..+|++|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3456678899999999999999753  33    4899999875 456678999999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          567 MLIYEYMPNKSLDSFLFDPQR----QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      ++++|||++|+|.+||++.+.    ...|+..+.+.|+.|||+|+.|||+++   .|||||++||+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999976422    356899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccc
Q 006090          643 LARIF  647 (662)
Q Consensus       643 la~~~  647 (662)
                      |||.+
T Consensus       848 lArDi  852 (1025)
T KOG1095|consen  848 LARDI  852 (1025)
T ss_pred             hhHhh
Confidence            99944

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.93  E-value=2.2e-25  Score=233.53  Aligned_cols=151  Identities=27%  Similarity=0.400  Sum_probs=136.2

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ..++|+++.+||+|+||.||+++-+ +|..+|+|+|++..   ..+.+..+.|-.+|...++|.||+|+..|++.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4478999999999999999999855 68999999998743   2345678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+|||++..+|.   +...|++..+..++.+++-|+.-||+.+   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   4567999999999999999999999998   9999999999999999999999999997654


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       293 ~  293 (550)
T KOG0605|consen  293 K  293 (550)
T ss_pred             h
Confidence            3

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=6.5e-26  Score=215.18  Aligned_cols=152  Identities=33%  Similarity=0.496  Sum_probs=134.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.   ..+-.+++++|+++-..|+||||.+++|++.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            57888999999999999999976 5778999998653   2234578999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||.++|+|...|.. ++...+++.....++.|+|.||.|+|..+   ||||||||+|+|++..+..||+|||-+-.-..+
T Consensus       102 Eya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  102 EYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            99999999999953 23445788889999999999999999887   999999999999999999999999998766533

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.92  E-value=5.1e-25  Score=234.24  Aligned_cols=154  Identities=32%  Similarity=0.499  Sum_probs=130.4

Q ss_pred             hccccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~  564 (662)
                      ..++|.+.++||+|+||.||+|...      +++.||||++..... ...+.+.+|+.++.++ +||||++++|+|.+.+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3467888999999999999999742      346799999875332 3356789999999999 8999999999987654


Q ss_pred             -eeEEEEEccCCCCHHHHhcCCCC--------------------------------------------------------
Q 006090          565 -ENMLIYEYMPNKSLDSFLFDPQR--------------------------------------------------------  587 (662)
Q Consensus       565 -~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------  587 (662)
                       ..++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999999864211                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          588 ---QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       588 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                         ...+++.++..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~  226 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  226 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence               134788899999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.92  E-value=1e-24  Score=228.31  Aligned_cols=152  Identities=32%  Similarity=0.570  Sum_probs=131.2

Q ss_pred             cccccccccCccCceeEEEEEEcC-----------------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCccee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-----------------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRL  556 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-----------------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l  556 (662)
                      ++|.+.++||+|+||.||++..++                 +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999997532                 3369999987542 2345679999999999999999999


Q ss_pred             eEEEEeCCeeEEEEEccCCCCHHHHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 006090          557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH  620 (662)
Q Consensus       557 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  620 (662)
                      ++++.+.+..++||||+++|+|.+++....                ....+++..+++++.||++||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999985321                1134788999999999999999999987   999


Q ss_pred             cCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          621 RDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       621 rDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||||+|||+++++.+||+|||+++.+..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceeccc
Confidence            99999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-25  Score=232.98  Aligned_cols=159  Identities=33%  Similarity=0.550  Sum_probs=142.2

Q ss_pred             cccccccccCccCceeEEEEE-EcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ..|..-++||+|+.|.||.+. ..+++.||||++........+-..+|+.+|+..+|+|||.++..+..+++.++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457777899999999999997 4568899999997755555667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ  653 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~  653 (662)
                      ++|+|.+.+    ....+++.++..|++++++||+|||.++   |||||||.+||||+.++.+||+|||++..+...+.+
T Consensus       353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            999999998    3445899999999999999999999998   999999999999999999999999999999887764


Q ss_pred             ccccccccC
Q 006090          654 AATKRLVGT  662 (662)
Q Consensus       654 ~~~~~~~Gt  662 (662)
                      ..  +++||
T Consensus       426 R~--TmVGT  432 (550)
T KOG0578|consen  426 RS--TMVGT  432 (550)
T ss_pred             cc--cccCC
Confidence            33  37887

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.92  E-value=2.4e-24  Score=231.81  Aligned_cols=152  Identities=22%  Similarity=0.297  Sum_probs=133.9

Q ss_pred             HhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      ....++|++.+.||+|+||.||+++.. +++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++++.++...
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            334578999999999999999999976 5788999998642   122345688999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence            999999999999999843    24788899999999999999999987   99999999999999999999999999998


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      +..
T Consensus       192 ~~~  194 (370)
T cd05621         192 MDE  194 (370)
T ss_pred             ccc
Confidence            754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.6e-24  Score=227.26  Aligned_cols=149  Identities=28%  Similarity=0.434  Sum_probs=133.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 58899999987532   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999943   345889999999999999999999988   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.91  E-value=3e-24  Score=230.73  Aligned_cols=148  Identities=25%  Similarity=0.363  Sum_probs=132.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||++... +++.+|+|++.+..   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888999999999999999865 58899999986532   223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999953   345899999999999999999999988   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-25  Score=233.31  Aligned_cols=159  Identities=32%  Similarity=0.549  Sum_probs=141.6

Q ss_pred             HHHHhhccccccccccCccCceeEEEEEEcC-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          488 EELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       488 ~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      ++++....++...++||-|-||.||.|.++. .-.||||.|+. +.-..++|+.|..+|+.|+|||+|+|+|+|......
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444445566778999999999999999874 56899999986 456789999999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      |||+|||..|+|.+||+++.+ ..++.-..+.+|.||+.||.||..++   +|||||.++|+|+.++..+||+||||+|+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999977644 44677788899999999999999988   99999999999999999999999999999


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +.++.
T Consensus       415 MtgDT  419 (1157)
T KOG4278|consen  415 MTGDT  419 (1157)
T ss_pred             hcCCc
Confidence            97753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.5e-24  Score=219.49  Aligned_cols=165  Identities=27%  Similarity=0.419  Sum_probs=140.8

Q ss_pred             ccccccccccCccCceeEEEEE-EcCCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+.|++.++||.|..++||+|. .+.++.||||++.-. .......+++|+..|+.++||||++.+..|..++..++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4679999999999999999998 456899999998643 33346889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ||.+||+.++++..-+ ..+++..+..|.+++++||.|||+++   .||||||+.||||+++|.+||+|||.+.-+....
T Consensus       105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999864333 34899999999999999999999998   9999999999999999999999999877665433


Q ss_pred             ccccc--cccccC
Q 006090          652 DQAAT--KRLVGT  662 (662)
Q Consensus       652 ~~~~~--~~~~Gt  662 (662)
                      .+...  ++++||
T Consensus       181 ~R~~~rf~tfvgt  193 (516)
T KOG0582|consen  181 DRQVTRFNTFVGT  193 (516)
T ss_pred             ceeeEeeccccCc
Confidence            33221  445665

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=5e-25  Score=238.86  Aligned_cols=150  Identities=32%  Similarity=0.578  Sum_probs=131.8

Q ss_pred             cccccCccCceeEEEEEE-cCCc----EEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          499 LANKLGQGGFGPVYKGKL-QDGQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~-~~~~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..++||+|+||+||||.+ +.++    +||+|++... ..+...++++|+-.|.+++||||+||+|+|.... ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            367999999999999985 4443    6899988653 3445789999999999999999999999998776 7899999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      |+.|.|.+|++.  .+..+.-...+.+..|||+||.|||++.   ++||||.+||||+.+...+||.|||+|+++..+..
T Consensus       779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999965  3456888899999999999999999886   99999999999999999999999999999988766


Q ss_pred             cc
Q 006090          653 QA  654 (662)
Q Consensus       653 ~~  654 (662)
                      +.
T Consensus       854 ey  855 (1177)
T KOG1025|consen  854 EY  855 (1177)
T ss_pred             cc
Confidence            53

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.7e-24  Score=231.23  Aligned_cols=147  Identities=26%  Similarity=0.346  Sum_probs=130.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.++||+|+||.||++... +++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888899999999999999865 68899999886422   233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999853   345888999999999999999999988   999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.1e-24  Score=230.61  Aligned_cols=149  Identities=25%  Similarity=0.366  Sum_probs=133.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+++.. +++.||||++....   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999975 58899999986532   233456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999853   345899999999999999999999988   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.91  E-value=4.4e-24  Score=226.23  Aligned_cols=149  Identities=26%  Similarity=0.386  Sum_probs=133.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999976 57899999986432   234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++.+..
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999953   345788999999999999999999988   99999999999999999999999999997754

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=4.8e-24  Score=230.67  Aligned_cols=146  Identities=25%  Similarity=0.348  Sum_probs=130.4

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .|...+.||+|+||+||+|+.. +++.+|+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999865 57899999986532   2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+++|+|.+++.+   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            9999999999853   345888999999999999999999987   999999999999999999999999998765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=6.4e-24  Score=224.41  Aligned_cols=141  Identities=28%  Similarity=0.328  Sum_probs=126.1

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +.||+|+||.||+++.. +++.+|+|+++...   ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68899999987532   233456889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99999853   345899999999999999999999988   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.2e-24  Score=223.22  Aligned_cols=149  Identities=26%  Similarity=0.390  Sum_probs=132.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36788899999999999999976 68899999986422   233456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999943   345889999999999999999999988   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-24  Score=233.75  Aligned_cols=161  Identities=32%  Similarity=0.531  Sum_probs=138.4

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------eeE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------ENM  567 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~  567 (662)
                      .|...+.||+|+||.||+|+.+ +|+.||||...+.. ....+...+|+++|++++|+|||++++.-.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3555789999999999999954 79999999987643 234556789999999999999999999866544      468


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCC--ceEEEeeCc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL--DDDL--NPKISDFGL  643 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~ki~DFGl  643 (662)
                      +|||||++|||...|.++.+...|++.+.+.+..+++.||.|||+++   |+||||||.||++  .++|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999888889999999999999999999999988   9999999999998  3344  479999999


Q ss_pred             cccccCCcccccccccccC
Q 006090          644 ARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       644 a~~~~~~~~~~~~~~~~Gt  662 (662)
                      ||-+.++.   ..+.++||
T Consensus       171 Arel~d~s---~~~S~vGT  186 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGT  186 (732)
T ss_pred             cccCCCCC---eeeeecCc
Confidence            99997765   34557887

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=6.1e-24  Score=226.11  Aligned_cols=149  Identities=26%  Similarity=0.383  Sum_probs=131.9

Q ss_pred             cccccccccCccCceeEEEEEEcC--CcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD--GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~--~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.+.||+|+||.||+|....  +..||+|++....   ......+.+|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568889999999999999998653  3689999886422   23356788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++|+|.+++.+   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999953   345889999999999999999999988   99999999999999999999999999987754

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.91  E-value=4.7e-24  Score=230.11  Aligned_cols=154  Identities=34%  Similarity=0.509  Sum_probs=132.6

Q ss_pred             ccccccccccCccCceeEEEEEE------cCCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~------~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~  565 (662)
                      .++|++.+.||+|+||.||+++.      .++..||||+++... ....+.+.+|+.++..+ +||||++++|+|.+++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999974      235689999987432 23456788999999999 89999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCC----------------------------------------------------------
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQR----------------------------------------------------------  587 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  587 (662)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          588 --------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       588 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                                    ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                          124789999999999999999999987   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=8.9e-24  Score=187.39  Aligned_cols=113  Identities=42%  Similarity=0.710  Sum_probs=99.2

Q ss_pred             CcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEEcCCCCE
Q 006090           31 QFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQV  110 (662)
Q Consensus        31 ~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~  110 (662)
                      +.|..|+.|+|+++.|++|||.+.  ....+.+|||+..  + .++||+|||+.|+.+ .+.|.|+.||+|+|+|.+|.+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~--~q~dgnlV~~~~~--~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~   75 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLI--MQNDYNLILYKSS--S-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRV   75 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccC--CCCCEEEEEEECC--C-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCE
Confidence            568889999999999999999987  3478999999885  5 789999999999765 388999999999999999999


Q ss_pred             EEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccC
Q 006090          111 HWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE  152 (662)
Q Consensus       111 ~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~  152 (662)
                      +|++++..  +.+...|+|+|+|||||++. .+.++||||||
T Consensus        76 vW~S~t~~--~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~  114 (114)
T smart00108       76 VWSSNTTG--ANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY  114 (114)
T ss_pred             EEEecccC--CCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence            99999862  34677899999999999986 35689999997

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=9.2e-24  Score=234.92  Aligned_cols=152  Identities=18%  Similarity=0.235  Sum_probs=133.5

Q ss_pred             ccccccccCccCceeEEEEEEc-C-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-D-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .|.+.+.||+|+||.||++... + ++.||+|.+..........+++|+.++++++||||+++++++.+++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999854 3 5778888776544445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          574 PNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       574 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++|+|.++|.+. .....+++.++..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            999999988542 23446889999999999999999999987   999999999999999999999999999987654

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=6.3e-25  Score=221.02  Aligned_cols=150  Identities=31%  Similarity=0.491  Sum_probs=122.7

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe---e--EEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE---N--MLI  569 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~---~--~lV  569 (662)
                      .|...+++|.|+||.||+|.+. ++++||||+.-....    .-.+|+++|++++|||||+|+-++....+   .  .+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666799999999999999976 468999998754322    22379999999999999999998876433   2  489


Q ss_pred             EEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCccccc
Q 006090          570 YEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIF  647 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGla~~~  647 (662)
                      |||||. +|..+++.. ..+..++...+.-+..||.+||+|||+.+   |+||||||+|+|+|.+ |.+||||||-|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999974 788888531 12344666777889999999999999987   9999999999999986 89999999999999


Q ss_pred             cCCccc
Q 006090          648 GGNQDQ  653 (662)
Q Consensus       648 ~~~~~~  653 (662)
                      ..++.+
T Consensus       177 ~~~epn  182 (364)
T KOG0658|consen  177 VKGEPN  182 (364)
T ss_pred             ccCCCc
Confidence            876654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=1.1e-23  Score=218.57  Aligned_cols=149  Identities=30%  Similarity=0.424  Sum_probs=130.9

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      |+..+.||+|+||+||++... +++.||+|.+....   ......+.+|++++.+++|+||+++.+++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667889999999999999864 68999999886432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|+|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            9999999888542 2335899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=1e-23  Score=223.41  Aligned_cols=142  Identities=29%  Similarity=0.343  Sum_probs=126.7

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +.||+|+||.||++... +++.||+|.+...   .......+.+|+++++.++||||+++.+++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999865 6889999998753   2234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +|..++..   ...+++.++..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            99998843   345899999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.91  E-value=6.1e-24  Score=228.81  Aligned_cols=150  Identities=24%  Similarity=0.314  Sum_probs=132.5

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ..++|++.++||+|+||.||+++.. +++.+|+|.+...   .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467899999999999999999875 5789999998642   12334567899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++.+    ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999843    24788888999999999999999987   9999999999999999999999999998775


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       194 ~  194 (370)
T cd05596         194 A  194 (370)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=6.7e-24  Score=229.64  Aligned_cols=146  Identities=25%  Similarity=0.377  Sum_probs=130.1

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +|...++||+|+||+||+|+.. +++.+|+|.+....   ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999865 57899999986532   2335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+++|+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            9999999999854   245788899999999999999999988   999999999999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=8.1e-24  Score=228.45  Aligned_cols=146  Identities=25%  Similarity=0.382  Sum_probs=130.2

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +|++.++||+|+||.||+++.. +++.||||.+....   ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999865 58899999986432   2234668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+++|+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|..+
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            9999999999954   345788899999999999999999988   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.1e-23  Score=221.61  Aligned_cols=141  Identities=26%  Similarity=0.315  Sum_probs=125.8

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ||+|+||.||+++.. +++.||+|.+...   .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999975 5789999998643   233456788999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      .+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            999953   345899999999999999999999988   99999999999999999999999999987543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-24  Score=197.32  Aligned_cols=148  Identities=28%  Similarity=0.507  Sum_probs=129.3

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccc--cccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|...++||+|.||+||||+.. +++.||+|++.-  .++.-....++|+.+++.++|.|||+|++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566799999999999999854 578899998754  2333456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |. .+|.+|...  -...++......++.|+++||.|+|+++   +.||||||+|.||+.+|+.|++||||||-++-
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            94 688888743  3445899999999999999999999998   99999999999999999999999999998763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.3e-24  Score=229.73  Aligned_cols=160  Identities=32%  Similarity=0.494  Sum_probs=138.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  568 (662)
                      -++|.+..+||+|.||+|++++++ +++.+|||.+++...   .+.+..+.|.+++... +||.|+.|+++++..++.++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            468999999999999999999987 477899999987533   3456778888888777 59999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+.||++..++    ....+++..+.-+|..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||+|...
T Consensus       447 vmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999954333    3345899999999999999999999998   9999999999999999999999999999776


Q ss_pred             CCcccccccccccC
Q 006090          649 GNQDQAATKRLVGT  662 (662)
Q Consensus       649 ~~~~~~~~~~~~Gt  662 (662)
                      ...+  .|.+++||
T Consensus       520 ~~g~--~TsTfCGT  531 (694)
T KOG0694|consen  520 GQGD--RTSTFCGT  531 (694)
T ss_pred             CCCC--ccccccCC
Confidence            4443  46679998

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=1.1e-23  Score=226.72  Aligned_cols=154  Identities=23%  Similarity=0.298  Sum_probs=134.8

Q ss_pred             HHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC
Q 006090          489 ELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE  564 (662)
Q Consensus       489 ~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~  564 (662)
                      ++....++|++.+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++.+.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445578999999999999999999976 5788999998642   1223456789999999999999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999999843    24788889999999999999999988   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +.+..
T Consensus       190 ~~~~~  194 (371)
T cd05622         190 MKMNK  194 (371)
T ss_pred             eEcCc
Confidence            98754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=1e-23  Score=222.80  Aligned_cols=141  Identities=28%  Similarity=0.332  Sum_probs=125.7

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +.||+|+||.||+++.. +++.||+|.++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999865 68899999986532   234456788999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|..++.+   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            99988843   335899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.5e-23  Score=222.39  Aligned_cols=150  Identities=24%  Similarity=0.314  Sum_probs=132.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+++.. +++.||+|.+.+.   .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999975 5889999998642   2233456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999999532  345889999999999999999999988   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=1.6e-23  Score=222.12  Aligned_cols=151  Identities=23%  Similarity=0.286  Sum_probs=132.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+++.. +++.+|+|.+.+.   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999975 5788999998642   1223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.+++.+.  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  235889999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.90  E-value=1.3e-23  Score=222.67  Aligned_cols=151  Identities=24%  Similarity=0.328  Sum_probs=133.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+++.. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999865 68899999987532   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.+++.+.  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999543  245899999999999999999999988   999999999999999999999999999887543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.90  E-value=2.8e-23  Score=219.66  Aligned_cols=142  Identities=29%  Similarity=0.322  Sum_probs=125.2

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +.||+|+||.||++... +++.||+|.++...   ......+..|++++..++||||+++.+++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68899999987532   233457788999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +|.+++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            99998843   3458999999999999999999997 56   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=4.1e-24  Score=228.11  Aligned_cols=150  Identities=31%  Similarity=0.470  Sum_probs=134.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +-|++++.||+|+-|.|-.|++. +|+.+|||++.+.   .......+.+|+.+|+.|.||||++|+++++++.+.|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788999999999999999964 7999999998654   2233456789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|.|.++|.   .+..+++.++.+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||||.+-.++
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999994   4566899999999999999999999987   999999999999999999999999999876554

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-24  Score=226.44  Aligned_cols=149  Identities=32%  Similarity=0.516  Sum_probs=130.4

Q ss_pred             cccccCHHHHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEE
Q 006090          481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC  560 (662)
Q Consensus       481 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~  560 (662)
                      ++....|++|.       .++-||.|+-|.||+|+++ ++.||||+++...+       .+|+-|++|+||||+.|.|+|
T Consensus       117 e~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  117 ELWEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hhccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeee
Confidence            34445555553       3688999999999999997 78999998864322       578889999999999999999


Q ss_pred             EeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEe
Q 006090          561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD  640 (662)
Q Consensus       561 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~D  640 (662)
                      ....-++||||||+.|.|.+.|+   ...+++......+..+||.||.|||.+.   |||||||.-||||..+..+||+|
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecc
Confidence            99999999999999999999994   3455788888999999999999999987   99999999999999999999999


Q ss_pred             eCccccccCC
Q 006090          641 FGLARIFGGN  650 (662)
Q Consensus       641 FGla~~~~~~  650 (662)
                      ||-++.+.+.
T Consensus       256 FGTS~e~~~~  265 (904)
T KOG4721|consen  256 FGTSKELSDK  265 (904)
T ss_pred             ccchHhhhhh
Confidence            9999988665

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.90  E-value=1.9e-23  Score=226.64  Aligned_cols=154  Identities=31%  Similarity=0.472  Sum_probs=132.1

Q ss_pred             hccccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVERE  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~  564 (662)
                      ..++|.+.++||+|+||.||+|+..      ....||||++..... ...+.|.+|+++++++. ||||++++|+|.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567888999999999999999853      134699999975332 33567999999999996 999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCC---------------------------------------------------------
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQR---------------------------------------------------------  587 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  587 (662)
                      ..+|||||+++|+|.++|.+...                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998854210                                                         


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          588 ------------------------------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       588 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                                                          ...+++.++..++.||++||.|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124788889999999999999999987   99999999999999


Q ss_pred             CCCceEEEeeCccccccC
Q 006090          632 DDLNPKISDFGLARIFGG  649 (662)
Q Consensus       632 ~~~~~ki~DFGla~~~~~  649 (662)
                      +++.+||+|||+++.+..
T Consensus       272 ~~~~~kL~DfGla~~~~~  289 (400)
T cd05105         272 QGKIVKICDFGLARDIMH  289 (400)
T ss_pred             CCCEEEEEeCCcceeccc
Confidence            999999999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.90  E-value=9.1e-24  Score=219.00  Aligned_cols=155  Identities=33%  Similarity=0.508  Sum_probs=131.1

Q ss_pred             ccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          500 ANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      .+.||.|-||+||-|+.+ +|+.||||++.+.  .......+++|+.+|.+++||.||.|...|+..+..++|||-+.|-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            488999999999999965 7999999999763  2345578999999999999999999999999999999999999554


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEeeCccccccCCccc
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISDFGLARIFGGNQDQ  653 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~DFGla~~~~~~~~~  653 (662)
                      -|+-.|..  ....|+++....+..||+.||.|||.++   |+|+||||+||||.+..   ++||||||+||++++..-+
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            45555533  3445888888899999999999999998   99999999999997643   7999999999999886533


Q ss_pred             ccccccccC
Q 006090          654 AATKRLVGT  662 (662)
Q Consensus       654 ~~~~~~~Gt  662 (662)
                         ..++||
T Consensus       724 ---rsVVGT  729 (888)
T KOG4236|consen  724 ---RSVVGT  729 (888)
T ss_pred             ---hhhcCC
Confidence               235666

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.90  E-value=1.2e-23  Score=226.92  Aligned_cols=154  Identities=34%  Similarity=0.528  Sum_probs=131.6

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~  565 (662)
                      .++|++.+.||+|+||.||++...      ++..||||+++... ......+.+|+++++.+ +|+||++++++|.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357888999999999999998742      23579999997533 23355788999999999 89999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCC-----------------------------------------------------------
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQ-----------------------------------------------------------  586 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  586 (662)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985321                                                           


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          587 --------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       587 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                              ....+++.++.+|+.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~  265 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND  265 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence                    1124788999999999999999999987   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.90  E-value=2.5e-23  Score=223.35  Aligned_cols=148  Identities=25%  Similarity=0.369  Sum_probs=131.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35788899999999999999875 58899999986432   233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||+++|+|.+++.+   ...+++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            99999999999843   345889999999999999999999988   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=2.5e-23  Score=220.66  Aligned_cols=149  Identities=29%  Similarity=0.371  Sum_probs=129.9

Q ss_pred             ccccccccCccCceeEEEEEEc----CCcEEEEEEccccc----cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCee
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS----GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  566 (662)
                      +|++.+.||+|+||.||+++..    +++.||+|++.+..    ....+.+..|+.++.++ +||||+++++++.+++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998752    57899999986421    22345688899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999843   345889999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCC
Q 006090          647 FGGN  650 (662)
Q Consensus       647 ~~~~  650 (662)
                      +...
T Consensus       155 ~~~~  158 (332)
T cd05614         155 FLSE  158 (332)
T ss_pred             cccc
Confidence            6443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.5e-23  Score=223.84  Aligned_cols=151  Identities=27%  Similarity=0.422  Sum_probs=134.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||+||+++.. +++.||||++....   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999976 68899999986532   234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++.+.   ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999543   46899999999999999999999987   999999999999999999999999999987654


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      .
T Consensus       155 ~  155 (350)
T cd05573         155 K  155 (350)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.90  E-value=2.4e-23  Score=213.64  Aligned_cols=148  Identities=28%  Similarity=0.502  Sum_probs=131.1

Q ss_pred             cccccccccCccCceeEEEEEEc----CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++.... ...+.|.+|+.++.+++||||++++|++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888999999999999999864    356899999876432 3356799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   ++||||||+|||++.++.+|++|||++...
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999542  245899999999999999999999987   999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.90  E-value=2.9e-23  Score=215.70  Aligned_cols=148  Identities=29%  Similarity=0.492  Sum_probs=129.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|.+.++||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999875 57899999886432 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++ ++|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          85 LD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            97 4899988532  235788999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=3e-23  Score=219.34  Aligned_cols=142  Identities=30%  Similarity=0.397  Sum_probs=124.8

Q ss_pred             cccCccCceeEEEEEEc----CCcEEEEEEccccc----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.||+|+||.||+++..    .++.||+|.++...    ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999853    57889999986521    22345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++++|.+++.+   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            999999999843   345788889999999999999999988   9999999999999999999999999998543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=3.9e-23  Score=219.32  Aligned_cols=150  Identities=23%  Similarity=0.282  Sum_probs=131.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.++||+|+||.||+++.+ +++.+|+|.+.+.   .......|.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999976 4678999998642   1223445889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999542  235889999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=8e-24  Score=234.49  Aligned_cols=151  Identities=28%  Similarity=0.421  Sum_probs=132.6

Q ss_pred             ccccccccccCccCceeEEEEEEcCC-cEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEE-Ee------CC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDG-QEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCC-VE------RE  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~-~~------~~  564 (662)
                      ..++.+.+.|.+|||+.||.+....+ .++|+|++-..++...+...+||++|++|+ |+|||.+++.. ..      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45677889999999999999998765 999999987778888999999999999997 99999999932 21      13


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      +.+|.||||++|+|-+++..+... .|++.++++|+.|+++|+++||... ++|||||||.+||||+.+++.||||||-|
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            578999999999999999654333 3999999999999999999999875 88999999999999999999999999987


Q ss_pred             cc
Q 006090          645 RI  646 (662)
Q Consensus       645 ~~  646 (662)
                      .-
T Consensus       194 tt  195 (738)
T KOG1989|consen  194 TT  195 (738)
T ss_pred             cc
Confidence            53

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.90  E-value=3.1e-23  Score=218.40  Aligned_cols=150  Identities=32%  Similarity=0.606  Sum_probs=129.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCc----EEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .+|++.+.||+|+||.||+|++. +++    .||+|.++... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999864 333    38999986533 33456899999999999999999999999864 5679


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999999543  235889999999999999999999987   9999999999999999999999999999876


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       161 ~~  162 (316)
T cd05108         161 AD  162 (316)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.90  E-value=5.1e-23  Score=218.29  Aligned_cols=151  Identities=26%  Similarity=0.344  Sum_probs=133.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367888999999999999999976 57889999886532 2335679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+|||+++++.+||+|||+++.+..
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999999953   335889999999999999999999853  399999999999999999999999999987644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=3.8e-23  Score=217.98  Aligned_cols=144  Identities=28%  Similarity=0.348  Sum_probs=126.8

Q ss_pred             cccCccCceeEEEEEE----cCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          501 NKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~----~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      +.||+|+||.||+++.    .+++.+|+|++....  ......+..|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    357899999987532  2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +|+|.+++.+   ...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            9999999843   345899999999999999999999988   999999999999999999999999999876443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=8.9e-24  Score=212.38  Aligned_cols=150  Identities=31%  Similarity=0.522  Sum_probs=129.8

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccc--cccccHHHHHHHHHHHhcCCCCCcceeeEEEEe-----CCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-----REE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-----~~~  565 (662)
                      ...|...+.||+|+||.|..+... +++.||||++..  ......++..+|+++|++++|+||+.+......     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345655789999999999999865 689999999974  234456788899999999999999999999865     345


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .|+|+|+| ..+|...|+.   ...|+......+.+|+++||.|+|+.+   |+||||||+|+|++.+...||+||||||
T Consensus       101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            79999999 6789999943   334888999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       174 ~~~~~  178 (359)
T KOG0660|consen  174 YLDKF  178 (359)
T ss_pred             ecccc
Confidence            99653

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.90  E-value=4.6e-24  Score=205.48  Aligned_cols=159  Identities=30%  Similarity=0.471  Sum_probs=136.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc----cc----HHHHHHHHHHHhcC-CCCCcceeeEEEEeCC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG----QG----QEEFMNEVMVISNL-QHRNLVRLLGCCVERE  564 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~----~~----~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~  564 (662)
                      +.|.-.+.||.|..+.|-+...+ ++++.|+|++.....    ..    .++-+.|+.+|+++ .||+|++|.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            55677789999999999888765 688999998854211    11    24567899999998 6999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++|+|.|+.|.|.++|.   ..-.+++++..+|++|+.+|+.|||..+   |+||||||+|||+|++.++||+|||+|
T Consensus        97 F~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             hhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence            9999999999999999993   3456899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCcccccccccccC
Q 006090          645 RIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       645 ~~~~~~~~~~~~~~~~Gt  662 (662)
                      ..+.+++.   ...++||
T Consensus       171 ~~l~~Gek---LrelCGT  185 (411)
T KOG0599|consen  171 CQLEPGEK---LRELCGT  185 (411)
T ss_pred             eccCCchh---HHHhcCC
Confidence            99988753   4446776

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.90  E-value=4e-23  Score=218.43  Aligned_cols=145  Identities=30%  Similarity=0.467  Sum_probs=125.3

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHH---hcCCCCCcceeeEEEEeCCeeEEE
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVI---SNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      |.+.+.||+|+||.||++... +++.||||.++...   ....+.+.+|++++   ++++||||+++++++.+++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566889999999999999865 58899999987532   22345566676654   567899999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |||+++++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999988842    35899999999999999999999987   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.90  E-value=5.3e-23  Score=212.87  Aligned_cols=152  Identities=34%  Similarity=0.564  Sum_probs=131.6

Q ss_pred             cccccccccCccCceeEEEEEE-----cCCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-----~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .+|++.++||+|+||.||+|..     ..+..||+|.+.... .+....|.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577789999999999999984     245789999987533 3344678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006090          569 IYEYMPNKSLDSFLFDPQ--------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL  634 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~  634 (662)
                      ||||+++++|.+++....              ....+++.+.+.++.|++.||.|||+++   |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999985321              1235889999999999999999999987   99999999999999999


Q ss_pred             ceEEEeeCccccccC
Q 006090          635 NPKISDFGLARIFGG  649 (662)
Q Consensus       635 ~~ki~DFGla~~~~~  649 (662)
                      .+||+|||+++.+..
T Consensus       162 ~~kl~dfg~~~~~~~  176 (283)
T cd05090         162 HVKISDLGLSREIYS  176 (283)
T ss_pred             cEEeccccccccccC
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.90  E-value=3.1e-23  Score=222.00  Aligned_cols=145  Identities=29%  Similarity=0.485  Sum_probs=126.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|+..++||+|+||.||+++.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566789999999999999865 68999999986432 23356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+..       ..++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999986532       3567788899999999999999988   99999999999999999999999999987754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.90  E-value=5.4e-23  Score=209.46  Aligned_cols=149  Identities=32%  Similarity=0.551  Sum_probs=133.2

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|++.+.||+|+||.||++...++..+|+|.+... ......|.+|++++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457778999999999999999888889999988643 3345689999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +|+|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999985432  35889999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=5.9e-23  Score=217.66  Aligned_cols=141  Identities=27%  Similarity=0.348  Sum_probs=124.3

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+++.. +++.+|+|.+++.   .......+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 5789999998753   223345678899888776 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999988843   345899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.90  E-value=3.7e-23  Score=211.50  Aligned_cols=146  Identities=41%  Similarity=0.717  Sum_probs=126.8

Q ss_pred             cccccCccCceeEEEEEEc-----CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          499 LANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~-----~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.+.||+|.||.||+|++.     .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4688999999999999987     25689999996532 33478999999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++|+|.++|... ....+++..+..|+.||++||.|||+.+   ++|+||+++||++++++.+||+|||+++...
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999654 2346899999999999999999999987   9999999999999999999999999999873

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.90  E-value=4.6e-23  Score=213.71  Aligned_cols=149  Identities=24%  Similarity=0.440  Sum_probs=130.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.+.||+|+||.||+++.. +++.+|+|+++...  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999976 57889999986532  2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |++++.+..+..   ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            999887765542   2345889999999999999999999987   99999999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.90  E-value=5.6e-23  Score=217.31  Aligned_cols=146  Identities=28%  Similarity=0.399  Sum_probs=127.5

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCC-CCcceeeEEEEeCCeeEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +|++.+.||+|+||.||+|+.. +++.||||.+...   .....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4777899999999999999876 4678999998753   22345678889999999976 56888999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999999999843   345889999999999999999999987   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.90  E-value=6.2e-23  Score=214.75  Aligned_cols=149  Identities=30%  Similarity=0.486  Sum_probs=130.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999976 688999999865332 234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |++ ++|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            995 6888877432  345788999999999999999999988   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA02988 hypothetical protein; Provisional

Probab=99.90  E-value=6.2e-23  Score=212.71  Aligned_cols=143  Identities=18%  Similarity=0.329  Sum_probs=125.3

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEcccccccc---HHHHHHHHHHHhcCCCCCcceeeEEEEe----CCeeEEEEEc
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVRLLGCCVE----REENMLIYEY  572 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~---~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey  572 (662)
                      ...|++|+++.||+|++ +++.||||+++......   .+.|.+|+.+|.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 58999999997643322   4678899999999999999999999987    3467899999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|+|.+++.+   ...+++.....++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.+..
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            999999999954   34588999999999999999999984 5   78999999999999999999999999997644

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.89  E-value=6.3e-23  Score=216.65  Aligned_cols=142  Identities=28%  Similarity=0.417  Sum_probs=124.6

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+|+.. +++.||+|.++...   ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 47899999987532   23445678899998876 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++|..++.+   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence            999998843   345889999999999999999999988   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=7.7e-24  Score=222.44  Aligned_cols=162  Identities=25%  Similarity=0.459  Sum_probs=140.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccc--cccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe-eEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-NMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lV~  570 (662)
                      ++|...+++|+|+||.++..+.+ ++..+++|.+.-  ......+....|+.++++++|||||.+.+.+++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46778899999999999998866 467889987753  344456688999999999999999999999999998 89999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +|++||+|.+.|.+.+ ...+++++++.++.|++.|+.|||++.   |+|||||+.||++..++.+||.|||+||.++.+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996543 567899999999999999999999776   999999999999999999999999999999887


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      .+.  ..+++||
T Consensus       160 ~~~--a~tvvGT  169 (426)
T KOG0589|consen  160 DSL--ASTVVGT  169 (426)
T ss_pred             hhh--hheecCC
Confidence            633  3336776

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=7e-23  Score=221.90  Aligned_cols=142  Identities=21%  Similarity=0.328  Sum_probs=126.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|++.++||+|+||.||++... +++.||+|....      ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999864 678999997532      3567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +. ++|.+++..   ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            95 788888843   235889999999999999999999987   9999999999999999999999999998654

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.89  E-value=5.4e-23  Score=223.07  Aligned_cols=155  Identities=30%  Similarity=0.485  Sum_probs=132.3

Q ss_pred             hhccccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCC-CCCcceeeEEEEeC
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER  563 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~  563 (662)
                      ...++|.+.++||+|+||.||+|++.      .++.||+|+++.... ...+.+.+|++++.++. ||||++++|+|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34456788899999999999999864      246799999975432 23457899999999997 99999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCC---------------------------------------------------------
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQ---------------------------------------------------------  586 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------  586 (662)
                      +..++|+||+++|+|.++|++..                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999996421                                                         


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 006090          587 --------------------------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI  628 (662)
Q Consensus       587 --------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI  628 (662)
                                                            ....+++..++.|+.||++||+|||+.+   |+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence                                                  1124788889999999999999999887   99999999999


Q ss_pred             EEcCCCceEEEeeCccccccC
Q 006090          629 LLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       629 Ll~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++.+||+|||+++.+..
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~  291 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMR  291 (401)
T ss_pred             EEeCCCEEEEEecCcceeccc
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.89  E-value=7.6e-23  Score=216.40  Aligned_cols=142  Identities=31%  Similarity=0.385  Sum_probs=122.6

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHH-HHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVM-VISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||+||+++.. +++.+|+|++....   ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 68899999986431   233445666665 46778999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~  147 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence            999988843   345899999999999999999999988   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.89  E-value=6.4e-23  Score=217.36  Aligned_cols=141  Identities=26%  Similarity=0.328  Sum_probs=125.0

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+++.. +++.||+|.+++..   ......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999975 57899999987532   23345688999999988 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            999988843   345899999999999999999999988   999999999999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.89  E-value=7.7e-23  Score=217.10  Aligned_cols=151  Identities=25%  Similarity=0.351  Sum_probs=132.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367889999999999999999976 57889999876532 2334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++|.+++..   ...+++.....++.|+++||.|||+..  +|+||||||+|||+++++.+||+|||+++.+..
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999953   345888999999999999999999752  399999999999999999999999999987643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=7.2e-23  Score=209.21  Aligned_cols=151  Identities=31%  Similarity=0.552  Sum_probs=135.8

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|++.+.||+|++|.||+|...+++.||+|.++.. ....++|.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            4568889999999999999999877889999998753 344678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999995432 345899999999999999999999987   99999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.89  E-value=8.1e-23  Score=215.99  Aligned_cols=142  Identities=32%  Similarity=0.395  Sum_probs=122.3

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHH-HHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVM-VISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||+||+++.. +++.||+|.+....   .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68899999986432   223345555655 46789999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+|.+++.+   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~  147 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence            999999843   345889999999999999999999988   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.89  E-value=5.7e-23  Score=218.68  Aligned_cols=160  Identities=29%  Similarity=0.473  Sum_probs=139.3

Q ss_pred             hccccccccccCccCceeEEEEEEcC-CcEEEEEEccccccc---cHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ---GQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENM  567 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~  567 (662)
                      ....|++.+.||+|.||.||+++.+. |+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678889999999999999999774 999999999764333   3468999999999998 999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CceEEEeeCc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD----LNPKISDFGL  643 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~ki~DFGl  643 (662)
                      +|||++.+|.|.+.|...    .+++..+..++.||+.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999554    2899999999999999999999987   9999999999999653    4799999999


Q ss_pred             cccccCCcccccccccccC
Q 006090          644 ARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       644 a~~~~~~~~~~~~~~~~Gt  662 (662)
                      |+.+.++.   ....++||
T Consensus       186 a~~~~~~~---~~~~~~Gt  201 (382)
T KOG0032|consen  186 AKFIKPGE---RLHTIVGT  201 (382)
T ss_pred             ceEccCCc---eEeeecCC
Confidence            99998722   34446776

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.89  E-value=7e-23  Score=215.83  Aligned_cols=142  Identities=31%  Similarity=0.408  Sum_probs=122.6

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+|+.. +++.||+|.++...   ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57889999987532   23345566777777654 899999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            999999843   335889999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.89  E-value=8.2e-23  Score=208.38  Aligned_cols=149  Identities=32%  Similarity=0.571  Sum_probs=133.2

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|.+.+.||+|+||+||++...++..+|+|.++.. .....+|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            457778999999999999999877778999988753 3345779999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|.+++....  ..+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            999999985432  25899999999999999999999987   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=3.6e-23  Score=220.48  Aligned_cols=152  Identities=28%  Similarity=0.485  Sum_probs=135.6

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ....|.+...||+|.|++|..++.. ++.+||||.+.+...  ...+.+.+|+++|+.++|||||+|+.+.+.....|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467889999999999999999965 689999999976432  3345689999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+.+|.+.+||.+   ...+.+..+..++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++-.+..
T Consensus       134 ~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999953   344566888899999999999999998   99999999999999999999999999999875


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      +
T Consensus       208 ~  208 (596)
T KOG0586|consen  208 G  208 (596)
T ss_pred             c
Confidence            4

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.89  E-value=6.7e-23  Score=209.33  Aligned_cols=151  Identities=36%  Similarity=0.598  Sum_probs=135.5

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+.+++..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            3578889999999999999999888889999998653 334678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++.+. ....+++.++..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999998543 2345888999999999999999999987   99999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.89  E-value=4.9e-23  Score=210.21  Aligned_cols=153  Identities=35%  Similarity=0.582  Sum_probs=138.7

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +..+|++.++||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578889999999999999999888899999999876555677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++.+.. ...+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999996532 345899999999999999999999987   99999999999999999999999999987743

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.89  E-value=8.5e-23  Score=215.82  Aligned_cols=147  Identities=28%  Similarity=0.384  Sum_probs=127.5

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +|.+.+.||+|+||.||+++.. +++.||+|.+.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677899999999999999876 57799999987532   22345577788888877 5899999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||+++|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999999843   345889999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6.3e-23  Score=228.66  Aligned_cols=158  Identities=21%  Similarity=0.304  Sum_probs=134.1

Q ss_pred             HhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC---
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE---  564 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~---  564 (662)
                      ....++|.+.+.||+|+||+||+++.. +++.||||.+...  .......+.+|+.++..++|+||+++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344578999999999999999999854 6899999998643  2344567889999999999999999988775433   


Q ss_pred             -----eeEEEEEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          565 -----ENMLIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       565 -----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                           ..++||||+++|+|.++|.... ....+++..+..++.|++.||.|||+.+   |+||||||+||||++++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 2579999999999999986422 2356899999999999999999999987   999999999999999999999


Q ss_pred             EeeCccccccCCc
Q 006090          639 SDFGLARIFGGNQ  651 (662)
Q Consensus       639 ~DFGla~~~~~~~  651 (662)
                      +|||+++.+....
T Consensus       185 ~DFGls~~~~~~~  197 (496)
T PTZ00283        185 GDFGFSKMYAATV  197 (496)
T ss_pred             EecccCeeccccc
Confidence            9999999876543

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=9.6e-23  Score=210.97  Aligned_cols=150  Identities=31%  Similarity=0.589  Sum_probs=131.9

Q ss_pred             cccccccccCccCceeEEEEEEc-----CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-----~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  567 (662)
                      .+|++.+.||+|+||.||++..+     +++.||+|.+........+.|.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788899999999999999753     4788999998765555667899999999999999999999987643  4578


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|+||+++++|.+++.+.  ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  235899999999999999999999987   999999999999999999999999999977


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ..
T Consensus       159 ~~  160 (284)
T cd05081         159 PQ  160 (284)
T ss_pred             cC
Confidence            54

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.89  E-value=1.1e-22  Score=210.55  Aligned_cols=145  Identities=32%  Similarity=0.445  Sum_probs=126.6

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ||+|+||+||++... +++.+|+|.+.....   ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999865 688999999864322   2345678899999999999999999999999999999999999999


Q ss_pred             HHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          579 DSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       579 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ..++.... ....+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            98875322 3346899999999999999999999987   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.89  E-value=8.8e-23  Score=215.75  Aligned_cols=146  Identities=29%  Similarity=0.408  Sum_probs=127.2

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEE
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      |...+.||+|+||+||+++.. +++.||+|.+....   ....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            666899999999999999865 58899999986532   233456788999988885 5788899999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+++|+|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            9999999999843   345899999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.89  E-value=9.2e-23  Score=215.31  Aligned_cols=141  Identities=30%  Similarity=0.434  Sum_probs=124.4

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+++.. +++.||||.+.+.   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 5789999998653   223456778898888876 699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+|.+++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            999998843   335889999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1e-22  Score=211.29  Aligned_cols=150  Identities=31%  Similarity=0.432  Sum_probs=131.4

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +|+..++||+|+||+||++... +++.||+|.+....   ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677899999999999999864 68899999986432   2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999988543 2345899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.89  E-value=9.2e-23  Score=216.60  Aligned_cols=146  Identities=25%  Similarity=0.456  Sum_probs=126.2

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----eeE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENM  567 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  567 (662)
                      +|++.++||+|+||.||+|... +++.||||++...  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999965 6899999998642  2234457889999999999999999999986533     479


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||++ ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 689988843   335899999999999999999999988   999999999999999999999999999866


Q ss_pred             c
Q 006090          648 G  648 (662)
Q Consensus       648 ~  648 (662)
                      .
T Consensus       154 ~  154 (338)
T cd07859         154 F  154 (338)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.89  E-value=1.1e-22  Score=214.84  Aligned_cols=141  Identities=32%  Similarity=0.401  Sum_probs=121.2

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHH-HHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVM-VISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      ++||+|+||.||+++.. +++.+|+|.+.+..   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57899999986432   123345556654 57889999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++|..++.+   ...+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999988843   345788889999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.89  E-value=1.1e-22  Score=209.83  Aligned_cols=153  Identities=31%  Similarity=0.551  Sum_probs=131.9

Q ss_pred             hccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      ..++|++.+.||+|+||.||+|...      .+..||||++.... .....+|.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999753      24679999886432 2345678999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQR-------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      .++||||+++++|.+++.+...       ...+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       234688899999999999999999987   999999999999999999999


Q ss_pred             EeeCcccccc
Q 006090          639 SDFGLARIFG  648 (662)
Q Consensus       639 ~DFGla~~~~  648 (662)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (277)
T cd05062         161 GDFGMTRDIY  170 (277)
T ss_pred             CCCCCccccC
Confidence            9999998654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.89  E-value=1.4e-22  Score=207.99  Aligned_cols=144  Identities=31%  Similarity=0.493  Sum_probs=123.4

Q ss_pred             cccCccCceeEEEEEEcC---CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      ++||+|+||.||+|+...   ...+++|.+.... ......|.+|++.++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   3468888776432 234567899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          577 SLDSFLFDPQR--QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       577 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence            99999965332  233567888999999999999999987   999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.89  E-value=1.6e-22  Score=207.15  Aligned_cols=149  Identities=34%  Similarity=0.606  Sum_probs=132.5

Q ss_pred             cccccccccCccCceeEEEEEEcC----CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.+.||+|+||.||+|.+..    ...||||.++... .....+|.+|+.++++++||||+++++.+.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998752    3579999887543 33456799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||+++.+.
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999998543  236899999999999999999999987   9999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.89  E-value=1e-22  Score=211.36  Aligned_cols=153  Identities=29%  Similarity=0.530  Sum_probs=131.2

Q ss_pred             hccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      ..++|++.++||+|+||.||+|...      .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4568899999999999999999753      24579999886432 2234568899999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQ-------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      .++||||+++|+|.+++.+..       ....+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996422       1234677888999999999999999987   999999999999999999999


Q ss_pred             EeeCcccccc
Q 006090          639 SDFGLARIFG  648 (662)
Q Consensus       639 ~DFGla~~~~  648 (662)
                      +|||+++.+.
T Consensus       161 ~Dfg~~~~~~  170 (288)
T cd05061         161 GDFGMTRDIY  170 (288)
T ss_pred             CcCCcccccc
Confidence            9999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.3e-22  Score=206.84  Aligned_cols=148  Identities=32%  Similarity=0.556  Sum_probs=132.2

Q ss_pred             ccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +|++.+.||+|+||.||++..+++..+|+|.+... ......|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            46778999999999999999877778999988643 23456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999985422  35899999999999999999999988   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.89  E-value=1.5e-22  Score=232.58  Aligned_cols=150  Identities=23%  Similarity=0.373  Sum_probs=131.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.++||+|+||.||+|... +++.||+|++.....   ...++|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888999999999999999865 588999999865322   23467999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          571 EYMPNKSLDSFLFDPQ--------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      ||+++++|.+++....        ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999985311        1234677888999999999999999987   9999999999999999999999999


Q ss_pred             ccccc
Q 006090          643 LARIF  647 (662)
Q Consensus       643 la~~~  647 (662)
                      +|+..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99987

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=1.5e-22  Score=214.37  Aligned_cols=141  Identities=27%  Similarity=0.336  Sum_probs=124.8

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||+||+++.. +++.+|+|+++...   ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999997532   23345688999999888 699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+|..++..   ...+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999988843   345899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=2e-22  Score=206.50  Aligned_cols=148  Identities=29%  Similarity=0.495  Sum_probs=133.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++.+..++..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            56888999999999999999964 67899999987544445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++++|.+++.+   ...+++.++..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            99999999853   345889999999999999999999987   9999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.89  E-value=2e-22  Score=209.24  Aligned_cols=152  Identities=34%  Similarity=0.620  Sum_probs=133.4

Q ss_pred             cccccccccCccCceeEEEEEEc------CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .+|.+.+.||+|+||+||++...      ++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56788899999999999999742      245689999876555556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          569 IYEYMPNKSLDSFLFDPQ----------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      ||||+++++|.+++....          ....+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999985321          2235899999999999999999999987   999999999999999999999


Q ss_pred             EeeCccccccC
Q 006090          639 SDFGLARIFGG  649 (662)
Q Consensus       639 ~DFGla~~~~~  649 (662)
                      +|||+++.+..
T Consensus       162 ~dfg~~~~~~~  172 (288)
T cd05093         162 GDFGMSRDVYS  172 (288)
T ss_pred             ccCCccccccC
Confidence            99999986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.89  E-value=1.3e-22  Score=216.34  Aligned_cols=153  Identities=30%  Similarity=0.500  Sum_probs=129.0

Q ss_pred             ccccccccccCccCceeEEEEEE------cCCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC-C
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER-E  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~------~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~-~  564 (662)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788899999999999999973      346789999997533 23356788999999999 689999999988754 4


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCC---------------------------------------------------------
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQR---------------------------------------------------------  587 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  587 (662)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999999853210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          588 -------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       588 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                             ...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~  231 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  231 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEeccccccccc
Confidence                   124788899999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.89  E-value=1.9e-22  Score=212.47  Aligned_cols=141  Identities=33%  Similarity=0.447  Sum_probs=123.3

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+|... +++.||||.++...   ....+.+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 47889999987532   23345667788888764 899999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+|.+++.+   ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999999843   345889999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=1.1e-22  Score=207.01  Aligned_cols=149  Identities=29%  Similarity=0.342  Sum_probs=134.3

Q ss_pred             cccccccccCccCceeEEEEEEcC-CcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +.|++.+.||.|.-|+||++++.+ +..+|+|++.+..   .....+...|-+||+.++||-++.|++.++.++..+|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457778999999999999999875 5789999997643   344567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |||+||+|..++. .++...+++..+..+|.+|+-||+|||-.|   ||.|||||+||||-++|++-|+||.|+...
T Consensus       157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999998774 456677999999999999999999999988   999999999999999999999999999876

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=1.9e-22  Score=221.77  Aligned_cols=145  Identities=23%  Similarity=0.311  Sum_probs=127.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ...|.+.+.||+|+||.||++... .++.||||....      ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357888999999999999999976 478899996422      2457899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +. ++|.+++...  ...+++.+++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            95 7888888432  235899999999999999999999988   999999999999999999999999999987544

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.89  E-value=1.7e-22  Score=212.82  Aligned_cols=141  Identities=31%  Similarity=0.423  Sum_probs=123.2

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+++.. +++.||+|.++...   ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 57899999987532   23445677788887755 899999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999999843   345889999999999999999999988   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=2.4e-22  Score=207.77  Aligned_cols=150  Identities=32%  Similarity=0.522  Sum_probs=126.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCc----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|++.+.||+|+||+||+|... +++    .+++|.+..... ....++..|+.++++++||||++++|++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            45677899999999999999864 344    477887754322 23467888888999999999999999875 455789


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999542  345899999999999999999999987   9999999999999999999999999998775


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       161 ~~  162 (279)
T cd05111         161 PD  162 (279)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=1.4e-22  Score=208.93  Aligned_cols=142  Identities=25%  Similarity=0.375  Sum_probs=121.6

Q ss_pred             ccCccCceeEEEEEEcC-------------------------CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCccee
Q 006090          502 KLGQGGFGPVYKGKLQD-------------------------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL  556 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~~-------------------------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l  556 (662)
                      +||+|+||.||+|.+..                         ...|++|.+.........+|.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13488998876444445678999999999999999999


Q ss_pred             eEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC--
Q 006090          557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL--  634 (662)
Q Consensus       557 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~--  634 (662)
                      +|+|.++...++||||+++|+|..++.+.  ...+++..+..++.||++||+|||+.+   |+||||||+|||+++.+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999998542  345889999999999999999999987   99999999999998654  


Q ss_pred             -----ceEEEeeCcccccc
Q 006090          635 -----NPKISDFGLARIFG  648 (662)
Q Consensus       635 -----~~ki~DFGla~~~~  648 (662)
                           .+|++|||+++...
T Consensus       157 ~~~~~~~kl~d~g~~~~~~  175 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTAL  175 (274)
T ss_pred             cCccceeeecCCccccccc
Confidence                 38999999987553

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=2.3e-22  Score=206.52  Aligned_cols=145  Identities=33%  Similarity=0.488  Sum_probs=124.8

Q ss_pred             cccCccCceeEEEEEEcC---CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +.||+|+||.||+|+..+   +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   3578999886543 234457899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          577 SLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       577 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +|.+++....  .....++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999996432  2234677888899999999999999987   9999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.89  E-value=2.1e-22  Score=212.95  Aligned_cols=142  Identities=28%  Similarity=0.369  Sum_probs=120.6

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHH-HHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVM-VISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+++.. +++.+|+|.+....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 56789999986432   122344555544 56788999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++|.+++..   ...+.+.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            999999853   334778888899999999999999988   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.89  E-value=2.3e-22  Score=210.98  Aligned_cols=149  Identities=28%  Similarity=0.495  Sum_probs=129.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|.+.++||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999875 578899999864332 2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            975 888887543  335788999999999999999999987   99999999999999999999999999986543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.8e-22  Score=210.44  Aligned_cols=151  Identities=31%  Similarity=0.533  Sum_probs=130.0

Q ss_pred             cccccccccCccCceeEEEEEEcC---------------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD---------------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLG  558 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~---------------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g  558 (662)
                      ++|++.++||+|+||.||++....               ...||+|.+.... ......|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987542               1248999987532 233557999999999999999999999


Q ss_pred             EEEeCCeeEEEEEccCCCCHHHHhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006090          559 CCVEREENMLIYEYMPNKSLDSFLFDPQR---------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL  629 (662)
Q Consensus       559 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL  629 (662)
                      ++..++..++||||+++++|.+++.....         ...+++..++.++.|+++||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999999854211         124788999999999999999999987   999999999999


Q ss_pred             EcCCCceEEEeeCcccccc
Q 006090          630 LDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~  648 (662)
                      +++++.+||+|||+++.+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             EcCCCcEEecccccccccc
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.88  E-value=2.1e-22  Score=207.72  Aligned_cols=151  Identities=32%  Similarity=0.600  Sum_probs=133.0

Q ss_pred             cccccccccCccCceeEEEEEEcC------CcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      .+|.+.+.||+|+||.||+|...+      ++.||||.++..... ..+.|.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457788999999999999998643      478999998764443 4578999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          568 LIYEYMPNKSLDSFLFDPQ-----------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      +||||+++++|.++|....           ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999996421           2345889999999999999999999987   9999999999999999999


Q ss_pred             EEEeeCcccccc
Q 006090          637 KISDFGLARIFG  648 (662)
Q Consensus       637 ki~DFGla~~~~  648 (662)
                      ||+|||+++.+.
T Consensus       162 kl~d~g~~~~~~  173 (280)
T cd05049         162 KIGDFGMSRDVY  173 (280)
T ss_pred             EECCcccceecc
Confidence            999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.88  E-value=2.1e-22  Score=217.19  Aligned_cols=148  Identities=27%  Similarity=0.443  Sum_probs=128.6

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----eeE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENM  567 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  567 (662)
                      +|++.++||+|+||.||++... +++.||||++...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3677899999999999999964 6899999998643  2234567889999999999999999999998876     789


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|+||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+|+..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 678887743   345899999999999999999999988   999999999999999999999999999876


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       154 ~~~  156 (372)
T cd07853         154 EPD  156 (372)
T ss_pred             ccC
Confidence            543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=2.5e-22  Score=207.45  Aligned_cols=154  Identities=28%  Similarity=0.480  Sum_probs=133.7

Q ss_pred             ccccccccccCccCceeEEEEEEcC-----CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~-----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~  566 (662)
                      .++|++.+.||+|+||.||+|....     +..|++|++.... ......+.+|+.++++++||||+++++++.+ +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999765     6789999887532 2345678999999999999999999999877 4678


Q ss_pred             EEEEEccCCCCHHHHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQ-----SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      ++++||+++++|.+++......     ..+++.++..++.||+.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998543222     46899999999999999999999987   999999999999999999999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |+++.+...
T Consensus       162 g~~~~~~~~  170 (280)
T cd05043         162 ALSRDLFPM  170 (280)
T ss_pred             CCcccccCC
Confidence            999977543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.88  E-value=3.2e-22  Score=206.88  Aligned_cols=151  Identities=37%  Similarity=0.649  Sum_probs=131.0

Q ss_pred             cccccccccCccCceeEEEEEEcC------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... .....+|.+|++++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467788999999999999998643      2579999886533 233567899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006090          568 LIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL  634 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~  634 (662)
                      ++|||+++++|.+++.....             ...+++.+++.++.||+.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999854321             145889999999999999999999987   99999999999999999


Q ss_pred             ceEEEeeCcccccc
Q 006090          635 NPKISDFGLARIFG  648 (662)
Q Consensus       635 ~~ki~DFGla~~~~  648 (662)
                      .+||+|||+++...
T Consensus       162 ~~~L~dfg~~~~~~  175 (283)
T cd05048         162 TVKISDFGLSRDIY  175 (283)
T ss_pred             cEEECCCcceeecc
Confidence            99999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.88  E-value=3e-22  Score=208.74  Aligned_cols=153  Identities=29%  Similarity=0.528  Sum_probs=131.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-----------------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcce
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-----------------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVR  555 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-----------------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~  555 (662)
                      .++|++.++||+|+||.||++...                 +...+|+|.+.... ......|.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356888999999999999998532                 23468999987532 334568999999999999999999


Q ss_pred             eeEEEEeCCeeEEEEEccCCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006090          556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASN  627 (662)
Q Consensus       556 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N  627 (662)
                      +++++.+++..++||||+++++|.+++.+..        ....+++.++..++.||+.||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999986422        1234788899999999999999999988   9999999999


Q ss_pred             EEEcCCCceEEEeeCccccccC
Q 006090          628 ILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       628 ILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++.+||+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             EEEcCCCCEEeccCcccccccC
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.88  E-value=3.2e-22  Score=208.06  Aligned_cols=152  Identities=30%  Similarity=0.568  Sum_probs=133.1

Q ss_pred             cccccccccCccCceeEEEEEEc------CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .+|.+.+.||+|+||.||+++..      +...+++|.++.......+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999743      345689999876555556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006090          569 IYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN  635 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~  635 (662)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985421             1234899999999999999999999988   999999999999999999


Q ss_pred             eEEEeeCccccccC
Q 006090          636 PKISDFGLARIFGG  649 (662)
Q Consensus       636 ~ki~DFGla~~~~~  649 (662)
                      +||+|||+++....
T Consensus       162 ~~l~dfg~a~~~~~  175 (291)
T cd05094         162 VKIGDFGMSRDVYS  175 (291)
T ss_pred             EEECCCCcccccCC
Confidence            99999999986644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.88  E-value=2.4e-22  Score=209.00  Aligned_cols=155  Identities=29%  Similarity=0.505  Sum_probs=133.9

Q ss_pred             hhccccccccccCccCceeEEEEEEcC------CcEEEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER  563 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~  563 (662)
                      ...++|++.+.||+|+||.||++....      ...+|+|.+... ......++.+|++++.++ +|+||+++++++.++
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345678889999999999999998642      357899988753 223446788999999999 799999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006090          564 EENMLIYEYMPNKSLDSFLFDP-------------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL  630 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl  630 (662)
                      +..+++|||+++|+|.+++...             .....+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            9999999999999999998532             22346899999999999999999999987   9999999999999


Q ss_pred             cCCCceEEEeeCccccccC
Q 006090          631 DDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       631 ~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++.+||+|||+++.+..
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         166 TEDHVMKIADFGLARDIHH  184 (293)
T ss_pred             cCCCeEEeCcccccccccc
Confidence            9999999999999997754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.88  E-value=3.6e-22  Score=207.37  Aligned_cols=150  Identities=29%  Similarity=0.519  Sum_probs=124.0

Q ss_pred             ccccccccCccCceeEEEEEEc--CCcEEEEEEccccc--cccHHHHHHHHHHHhcC---CCCCcceeeEEEEe-----C
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNL---QHRNLVRLLGCCVE-----R  563 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~--~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~-----~  563 (662)
                      +|.+.+.||+|+||.||+++..  +++.||+|+++...  ......+.+|+.+++++   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6788899999999999999863  46789999886432  22234566787777665   69999999999863     3


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ...++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            45789999996 6899988543 2345899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ++.+...
T Consensus       157 ~~~~~~~  163 (290)
T cd07862         157 ARIYSFQ  163 (290)
T ss_pred             eEeccCC
Confidence            9877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.88  E-value=3.1e-22  Score=205.33  Aligned_cols=151  Identities=31%  Similarity=0.597  Sum_probs=132.0

Q ss_pred             cccccccccCccCceeEEEEEEc-C---CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-D---GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.++... ....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999864 2   3379999886533 23356889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999542  235899999999999999999999987   99999999999999999999999999998754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       159 ~  159 (267)
T cd05066         159 D  159 (267)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=3.4e-22  Score=204.53  Aligned_cols=150  Identities=35%  Similarity=0.593  Sum_probs=131.4

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|.+.++||+|+||.||+|+..+...||+|.++.. ....+.|.+|++++++++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            3568889999999999999999877778999998752 334567999999999999999999999874 45679999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++.+. ....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            999999999542 2345799999999999999999999987   99999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.88  E-value=2e-22  Score=214.19  Aligned_cols=154  Identities=31%  Similarity=0.502  Sum_probs=129.5

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC-C
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVER-E  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~-~  564 (662)
                      .++|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357888999999999999999642      247899999874322 2345688899999999 799999999988754 5


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCC---------------------------------------------------------
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQR---------------------------------------------------------  587 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  587 (662)
                      ..++++||+++++|.++|.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            57899999999999999853211                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          588 -QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       588 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                       ...++|..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~  226 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD  226 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence             136899999999999999999999987   999999999999999999999999999987443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=3e-23  Score=221.64  Aligned_cols=155  Identities=33%  Similarity=0.545  Sum_probs=137.0

Q ss_pred             cccccccccCccCceeEEEEEEc--CCc--EEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ--DGQ--EIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~--~~~--~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +...+.++||+|.||.|++|.+.  +|+  .||||.++..... ....|++|+.+|.+|+|||+++|+|+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            34455789999999999999975  344  5899999865443 67899999999999999999999999887 677899


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +|.++.|||.+.|++ .....+-......++.|||.||.||..+.   +|||||.++|+||-....+||+||||.|-++.
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 45566788899999999999999999987   99999999999999999999999999999988


Q ss_pred             Ccccc
Q 006090          650 NQDQA  654 (662)
Q Consensus       650 ~~~~~  654 (662)
                      +++..
T Consensus       265 ned~Y  269 (1039)
T KOG0199|consen  265 NEDMY  269 (1039)
T ss_pred             CCcce
Confidence            87654

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.88  E-value=3.4e-22  Score=204.51  Aligned_cols=150  Identities=33%  Similarity=0.568  Sum_probs=133.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .+|.+.++||+|+||.||+|... .++.||+|.+.. ......++.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45777899999999999999975 478899999875 3345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            999999998543 2345899999999999999999999987   99999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.88  E-value=3.7e-22  Score=205.01  Aligned_cols=149  Identities=32%  Similarity=0.610  Sum_probs=125.5

Q ss_pred             ccccccCccCceeEEEEEEcCC-c--EEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------Cee
Q 006090          498 QLANKLGQGGFGPVYKGKLQDG-Q--EIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------EEN  566 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~~~~-~--~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~~  566 (662)
                      .+.++||+|+||.||+|..... .  .+|+|.++..  .....+.|..|++++++++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4578999999999999997643 2  5899988653  234467889999999999999999999988643      245


Q ss_pred             EEEEEccCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          567 MLIYEYMPNKSLDSFLFDP---QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ++++||+++|+|.+++...   .....+++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987422   12345899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      ++.+..
T Consensus       159 ~~~~~~  164 (272)
T cd05075         159 SKKIYN  164 (272)
T ss_pred             ccccCc
Confidence            997753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.88  E-value=4e-22  Score=207.14  Aligned_cols=151  Identities=32%  Similarity=0.518  Sum_probs=129.6

Q ss_pred             ccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.+.+++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3677899999999999999853      235688998865432 345679999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006090          569 IYEYMPNKSLDSFLFDPQ---------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASN  627 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N  627 (662)
                      ++||+++++|.+++....                     ....+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999985321                     1235889999999999999999999987   9999999999


Q ss_pred             EEEcCCCceEEEeeCccccccC
Q 006090          628 ILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       628 ILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++.+||+|||+++.+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~  179 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYE  179 (290)
T ss_pred             EEEcCCCcEEeccccccccccC
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.88  E-value=3.3e-22  Score=209.33  Aligned_cols=153  Identities=28%  Similarity=0.517  Sum_probs=132.3

Q ss_pred             ccccccccccCccCceeEEEEEEc--------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER  563 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~--------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~  563 (662)
                      ..+|.+.+.||+|+||.||+++..        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888899999999999999741        23479999886532 34457899999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL  630 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl  630 (662)
                      ...++||||+++++|.+++.+...             ...+++.++..++.||++||.|||+++   |+||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999965321             235788999999999999999999987   9999999999999


Q ss_pred             cCCCceEEEeeCccccccC
Q 006090          631 DDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       631 ~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++.+||+|||+++.+..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         171 TENNVMKIADFGLARDVNN  189 (304)
T ss_pred             cCCCcEEECCCccceeccc
Confidence            9999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.88  E-value=4e-22  Score=204.68  Aligned_cols=150  Identities=31%  Similarity=0.573  Sum_probs=128.4

Q ss_pred             cccccccCccCceeEEEEEEcC----CcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe-----
Q 006090          497 FQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-----  565 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-----  565 (662)
                      |.+.+.||+|+||.||+|+...    +..||+|+++...  ......+.+|+++++.++||||+++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4568899999999999998642    3679999987432  2345689999999999999999999999877654     


Q ss_pred             -eEEEEEccCCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          566 -NMLIYEYMPNKSLDSFLFDPQ---RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       566 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                       .++++||+++++|.+++....   ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             689999999999999985432   2346899999999999999999999987   999999999999999999999999


Q ss_pred             CccccccC
Q 006090          642 GLARIFGG  649 (662)
Q Consensus       642 Gla~~~~~  649 (662)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.88  E-value=3.8e-22  Score=229.96  Aligned_cols=150  Identities=27%  Similarity=0.422  Sum_probs=133.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.++||+|+||.||+|... +++.||||+++...   ......+..|+.+++.++||||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 68899999986532   223467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++..   ...+++..++.|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~  157 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR  157 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence            99999999999843   235788999999999999999999987   999999999999999999999999999977543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.88  E-value=3.1e-22  Score=207.01  Aligned_cols=151  Identities=35%  Similarity=0.551  Sum_probs=130.2

Q ss_pred             ccccccccCccCceeEEEEEEcC------CcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      +|.+.++||+|+||.||+|...+      ++.||+|+++..... ..+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46678999999999999998642      478999999754332 24568899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006090          569 IYEYMPNKSLDSFLFDP-------------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN  635 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~  635 (662)
                      ++||+++++|.+++...             .....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999998421             11235888999999999999999999987   999999999999999999


Q ss_pred             eEEEeeCccccccC
Q 006090          636 PKISDFGLARIFGG  649 (662)
Q Consensus       636 ~ki~DFGla~~~~~  649 (662)
                      +||+|||+++.+..
T Consensus       163 ~kl~Dfg~~~~~~~  176 (283)
T cd05091         163 VKISDLGLFREVYA  176 (283)
T ss_pred             eEeccccccccccc
Confidence            99999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.88  E-value=4.4e-22  Score=208.86  Aligned_cols=149  Identities=27%  Similarity=0.338  Sum_probs=130.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999865 57788999876432 23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++++|.+++.+.   ..+++..+..++.||++||.|||+..  +++||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999999542   45889999999999999999999742  39999999999999999999999999998664

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.88  E-value=3.3e-22  Score=210.88  Aligned_cols=141  Identities=32%  Similarity=0.444  Sum_probs=124.5

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||+||+++.. +++.+|||.+++..   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 47899999987532   23455678899998888 699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++|..++.+   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999998843   335899999999999999999999987   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.88  E-value=3.8e-22  Score=204.71  Aligned_cols=155  Identities=28%  Similarity=0.383  Sum_probs=133.2

Q ss_pred             HhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344556666789999999999999865 5778999998765556677899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeCcccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFG  648 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~  648 (662)
                      +||+++++|.+++.........++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||++..+.
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999964322212278888999999999999999987   999999999999986 6799999999998764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.88  E-value=3.9e-22  Score=204.69  Aligned_cols=151  Identities=32%  Similarity=0.604  Sum_probs=132.3

Q ss_pred             cccccccccCccCceeEEEEEEcC-C---cEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-G---QEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~---~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .+|++.+.||+|+||.||+|.... +   ..||||.++.. ......+|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            356778999999999999998753 3   36999998754 233457899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998543  345899999999999999999999987   99999999999999999999999999987754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       159 ~  159 (269)
T cd05065         159 D  159 (269)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.88  E-value=3.7e-22  Score=202.70  Aligned_cols=143  Identities=29%  Similarity=0.551  Sum_probs=127.3

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ++||+|+||.||+|... +++.+|+|.+.... ......|.+|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999975 68899999876432 33456799999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      .+++...  ...+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            9998532  335889999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.6e-22  Score=211.66  Aligned_cols=140  Identities=26%  Similarity=0.314  Sum_probs=120.3

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC---CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL---QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      ||+|+||+||+++.. +++.||||++....   ......+..|..++.+.   +||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999865 58899999986432   12234455677776655   699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+|.+++.+   ...+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            999998843   345889999999999999999999988   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.88  E-value=8e-23  Score=215.89  Aligned_cols=153  Identities=30%  Similarity=0.531  Sum_probs=132.8

Q ss_pred             hhccccccccccCccCceeEEEEEEcC---C--cEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQD---G--QEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~~---~--~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      ..++...+.+.||+|-||.||+|.+.+   |  -.||||..+.. .....+.|+.|..+|++++|||||+|+|+|.+ .+
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            344556667899999999999998642   2  25899999874 34557889999999999999999999999975 56


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++|||.++-|.|..||...  ...|+......++.||+.||+|||+..   .+||||.++|||+.+...+||+||||+|
T Consensus       465 ~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence            79999999999999999543  345888999999999999999999987   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+.++
T Consensus       540 ~~ed~  544 (974)
T KOG4257|consen  540 YLEDD  544 (974)
T ss_pred             hcccc
Confidence            98764

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.88  E-value=3.9e-22  Score=204.35  Aligned_cols=149  Identities=27%  Similarity=0.504  Sum_probs=133.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|.+.++||+|+||.||+++.. +++.+|+|.++.........+.+|+.+++.++||||+++++.+.+++..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57888899999999999999865 58899999987654455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++..   ...+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..+..
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999843   345899999999999999999999987   99999999999999999999999999986643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=3.8e-22  Score=203.13  Aligned_cols=149  Identities=34%  Similarity=0.615  Sum_probs=134.1

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|++.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46778899999999999999876 78999999976433 56789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccc
Confidence            999999985432 235899999999999999999999988   99999999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.88  E-value=5e-22  Score=206.82  Aligned_cols=153  Identities=31%  Similarity=0.528  Sum_probs=132.6

Q ss_pred             ccccccccccCccCceeEEEEEEcC-----------------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcce
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD-----------------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVR  555 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~-----------------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~  555 (662)
                      .++|++.++||+|+||.||+++...                 +..||+|.+.... ......|.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999998642                 2458999987543 234568899999999999999999


Q ss_pred             eeEEEEeCCeeEEEEEccCCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006090          556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASN  627 (662)
Q Consensus       556 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N  627 (662)
                      +++++..++..++|+||+++++|.+++.+..        ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986432        1235899999999999999999999987   9999999999


Q ss_pred             EEEcCCCceEEEeeCccccccC
Q 006090          628 ILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       628 ILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++.++.+||+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             eeecCCCceEEccccceeeccc
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.88  E-value=6.7e-22  Score=204.52  Aligned_cols=147  Identities=31%  Similarity=0.508  Sum_probs=132.0

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      |++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566789999999999999976 4678899988765555677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++|..++.+.  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999987542  345899999999999999999999987   9999999999999999999999999997664

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=4e-22  Score=205.37  Aligned_cols=153  Identities=30%  Similarity=0.520  Sum_probs=132.7

Q ss_pred             ccccccccccCccCceeEEEEEEcC------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......|.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578889999999999999998642      3679999986543 23356789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          567 MLIYEYMPNKSLDSFLFDPQ-------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                      ++||||+++++|.+++....       ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999985422       1234789999999999999999999987   9999999999999999999999


Q ss_pred             eeCccccccC
Q 006090          640 DFGLARIFGG  649 (662)
Q Consensus       640 DFGla~~~~~  649 (662)
                      |||+++.+..
T Consensus       162 dfg~~~~~~~  171 (277)
T cd05032         162 DFGMTRDIYE  171 (277)
T ss_pred             Ccccchhhcc
Confidence            9999987644

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.88  E-value=3.6e-22  Score=205.13  Aligned_cols=153  Identities=29%  Similarity=0.532  Sum_probs=132.6

Q ss_pred             hhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC------
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER------  563 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~------  563 (662)
                      .+++.|++.+.||+|+||.||+|... +++.||+|.+... ......+..|+.++.++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999875 5788999988653 34556788999999998 699999999998763      


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998542 2346899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      ++.+..
T Consensus       158 ~~~~~~  163 (272)
T cd06637         158 SAQLDR  163 (272)
T ss_pred             ceeccc
Confidence            987643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.6e-22  Score=206.21  Aligned_cols=151  Identities=30%  Similarity=0.485  Sum_probs=135.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|++.+.||+|+||.||++... +++.+|+|.+........+.|.+|++++++++||||+++++.+.++...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457888999999999999999975 5789999998765555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++.+.  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            9999999998542  235899999999999999999999988   99999999999999999999999999876643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.88  E-value=3.9e-22  Score=204.83  Aligned_cols=143  Identities=28%  Similarity=0.462  Sum_probs=121.7

Q ss_pred             cccCccCceeEEEEEEcCCc---EEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          501 NKLGQGGFGPVYKGKLQDGQ---EIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~---~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      ++||+|+||.||+++..++.   .+++|.++... ....+.|.+|+.+++.++||||+++++.|.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999865433   45667665432 345678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          577 SLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       577 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      +|.+++.+... ....++.....++.||++||+|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            99999965322 234677788899999999999999987   99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=5.1e-22  Score=202.72  Aligned_cols=151  Identities=36%  Similarity=0.618  Sum_probs=135.9

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|.+.++||+|+||.||++..++++.+|||.+... .....++.+|+.++++++|+||+++++++.++...++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4678889999999999999999888889999998753 345678999999999999999999999999989999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++.+. ....+++.++..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999999999553 2245899999999999999999999987   99999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=4.8e-22  Score=203.56  Aligned_cols=144  Identities=26%  Similarity=0.449  Sum_probs=124.1

Q ss_pred             cccCccCceeEEEEEEcC-------------CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          501 NKLGQGGFGPVYKGKLQD-------------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~-------------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      +.||+|+||.||+|+...             ...|++|.+..........|.+|+.+++.++||||+++++++.++...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998542             2258899887654455668899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-------eEEEe
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN-------PKISD  640 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~ki~D  640 (662)
                      +||||+++++|..++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999988532  345899999999999999999999987   999999999999987664       89999


Q ss_pred             eCccccccC
Q 006090          641 FGLARIFGG  649 (662)
Q Consensus       641 FGla~~~~~  649 (662)
                      ||++..+..
T Consensus       156 ~g~~~~~~~  164 (262)
T cd05077         156 PGIPITVLS  164 (262)
T ss_pred             CCCCccccC
Confidence            999986643

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=4.1e-22  Score=206.47  Aligned_cols=151  Identities=23%  Similarity=0.390  Sum_probs=132.8

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +|++.+.||+|+||.||++... +++.+|+|.++.. .......+.+|++++++++||||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778899999999999999976 6889999988643 2333567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++++|.+++........+++..+..++.|++.||.|||++.  +|+||||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999999865433446899999999999999999999742  39999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.88  E-value=3.9e-22  Score=203.04  Aligned_cols=142  Identities=29%  Similarity=0.500  Sum_probs=123.3

Q ss_pred             cccCccCceeEEEEEEcCCc-----------EEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          501 NKLGQGGFGPVYKGKLQDGQ-----------EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~-----------~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.++++++||||++++|++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999986432           4778877653332 6789999999999999999999999988 778999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-------ceEEEeeC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-------NPKISDFG  642 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~ki~DFG  642 (662)
                      |||+++|+|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999995432  25899999999999999999999987   99999999999999888       79999999


Q ss_pred             ccccccC
Q 006090          643 LARIFGG  649 (662)
Q Consensus       643 la~~~~~  649 (662)
                      +++.+..
T Consensus       154 ~a~~~~~  160 (259)
T cd05037         154 IPITVLS  160 (259)
T ss_pred             ccccccc
Confidence            9987654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.88  E-value=4.9e-22  Score=205.45  Aligned_cols=151  Identities=32%  Similarity=0.566  Sum_probs=132.8

Q ss_pred             cccccccccCccCceeEEEEEEc------CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .+|...++||+|+||.||++...      ++..+|+|.+..........|.+|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45677899999999999999742      355789999876666667789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          569 IYEYMPNKSLDSFLFDPQR------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      ++||+++++|.+++.....            ...+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            135899999999999999999999987   9999999999999999999


Q ss_pred             EEEeeCcccccc
Q 006090          637 KISDFGLARIFG  648 (662)
Q Consensus       637 ki~DFGla~~~~  648 (662)
                      ||+|||+++.+.
T Consensus       162 kL~dfg~~~~~~  173 (280)
T cd05092         162 KIGDFGMSRDIY  173 (280)
T ss_pred             EECCCCceeEcC
Confidence            999999998664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=8e-22  Score=204.05  Aligned_cols=145  Identities=37%  Similarity=0.605  Sum_probs=126.6

Q ss_pred             ccccccCccCceeEEEEEE-----cCCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEEE
Q 006090          498 QLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLI  569 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~-----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV  569 (662)
                      +..+.||+|+||+||++..     .+++.||+|.+..... .....|.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7789999999999988653     3577899999875432 3456789999999999999999999998764  357899


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++.+    ..+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            999999999999843    34899999999999999999999987   99999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.88  E-value=5.8e-22  Score=207.39  Aligned_cols=152  Identities=34%  Similarity=0.522  Sum_probs=132.3

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~  565 (662)
                      .++|.+.+.||+|+||.||++...      .+..||||.++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            367888999999999999999742      24579999887543 23346789999999999 79999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||||+++|+|.+++.+.. ...+++.++..++.||+.||+|||+++   |+|+||||+|||++.++.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999995422 234899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccC
Q 006090          646 IFGG  649 (662)
Q Consensus       646 ~~~~  649 (662)
                      .+..
T Consensus       190 ~~~~  193 (302)
T cd05055         190 DIMN  193 (302)
T ss_pred             cccC
Confidence            7654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.88  E-value=8.7e-22  Score=199.65  Aligned_cols=144  Identities=33%  Similarity=0.551  Sum_probs=128.1

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHH
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD  579 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  579 (662)
                      ++||+|+||.||+|...+++.+|+|.+...... ....|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            469999999999999888899999998754332 3457899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       580 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++...  ...+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||+++....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccc
Confidence            998542  235789999999999999999999987   99999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=1e-21  Score=202.86  Aligned_cols=143  Identities=28%  Similarity=0.430  Sum_probs=124.7

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ||+|+||.||+++.. +++.+|+|.+....   ......+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999865 58999999986422   12344566799999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      .+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||++..+..
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            9888543 2335889999999999999999999987   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.88  E-value=4.6e-22  Score=208.27  Aligned_cols=150  Identities=35%  Similarity=0.636  Sum_probs=129.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCc--EEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ--EIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~--~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.+.||+|+||.||+|..+ ++.  .+|+|.++... ......|.+|++++.++ +||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56788899999999999999875 343  46888776432 33456789999999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          570 YEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      +||+++++|.+++.+..             ....+++.+++.++.||+.||+|||+.+   |+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999996432             1235889999999999999999999987   9999999999999999999


Q ss_pred             EEEeeCccccc
Q 006090          637 KISDFGLARIF  647 (662)
Q Consensus       637 ki~DFGla~~~  647 (662)
                      ||+|||+++..
T Consensus       164 kl~dfg~~~~~  174 (303)
T cd05088         164 KIADFGLSRGQ  174 (303)
T ss_pred             EeCccccCccc
Confidence            99999999743

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.88  E-value=7.8e-22  Score=205.78  Aligned_cols=149  Identities=28%  Similarity=0.476  Sum_probs=134.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..+|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++.+.++...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357888899999999999999854 6889999998765555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++.+    ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            999999999842    34789999999999999999999987   99999999999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.88  E-value=7.9e-22  Score=204.56  Aligned_cols=148  Identities=30%  Similarity=0.422  Sum_probs=129.7

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      |...+.||+|+||+||++... +++.+|+|.+....   ......+.+|++++++++|+||+++.+++.+++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556789999999999999875 68899999986432   12345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999998885432 335899999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.88  E-value=8.4e-22  Score=204.77  Aligned_cols=150  Identities=34%  Similarity=0.480  Sum_probs=133.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||.||++... +++.+|+|.+....   ......+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788999999999999999975 58899999886432   233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+|+||+|+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999844   245889999999999999999999987   999999999999999999999999999887544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.88  E-value=8.3e-22  Score=203.48  Aligned_cols=149  Identities=31%  Similarity=0.558  Sum_probs=128.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCc----EEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|++.++||+|+||+||+|+.. +++    .||+|.++... ....+++.+|+.++..++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56788899999999999999854 444    48999886532 3345678999999999999999999999975 45689


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999998542  335899999999999999999999987   9999999999999999999999999999875


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       161 ~  161 (279)
T cd05109         161 I  161 (279)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.87  E-value=5e-22  Score=208.29  Aligned_cols=152  Identities=30%  Similarity=0.514  Sum_probs=131.8

Q ss_pred             ccccccccccCccCceeEEEEEEc--------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER  563 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~--------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~  563 (662)
                      .++|.+.+.||+|+||.||+++..        ....+|+|.++... .....++..|++++.++ +||||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367889999999999999999753        23469999987532 33456788999999999 799999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL  630 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl  630 (662)
                      +..++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999964321             235899999999999999999999987   9999999999999


Q ss_pred             cCCCceEEEeeCcccccc
Q 006090          631 DDDLNPKISDFGLARIFG  648 (662)
Q Consensus       631 ~~~~~~ki~DFGla~~~~  648 (662)
                      +.++.+||+|||+++.+.
T Consensus       174 ~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         174 TEDNVMKIADFGLARDIH  191 (307)
T ss_pred             cCCCcEEECCCccccccc
Confidence            999999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.87  E-value=7e-22  Score=204.65  Aligned_cols=150  Identities=31%  Similarity=0.558  Sum_probs=130.3

Q ss_pred             cccccccccCccCceeEEEEEEc-----CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--Cee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-----~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  566 (662)
                      ..|++.++||+|+||.||+++..     ++..||+|.++... ......+.+|++++++++||||+++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34677899999999999999842     47789999987543 33456799999999999999999999999875  567


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++++|.+++.+.  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998432  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      +..
T Consensus       159 ~~~  161 (284)
T cd05079         159 IET  161 (284)
T ss_pred             ccc
Confidence            754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.87  E-value=8.8e-22  Score=203.68  Aligned_cols=149  Identities=32%  Similarity=0.565  Sum_probs=131.1

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+....  ......+.+|+.++.+++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677899999999999999975 68899999886432  22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++ ++|.+++........+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            97 689888855444456899999999999999999999987   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.87  E-value=7.4e-22  Score=206.08  Aligned_cols=149  Identities=28%  Similarity=0.478  Sum_probs=134.6

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            6788899999999999999986 468999999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++++|.+++.+    ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999842    34789999999999999999999987   999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.87  E-value=6.2e-22  Score=202.15  Aligned_cols=149  Identities=38%  Similarity=0.620  Sum_probs=132.6

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|++.++||+|+||.||+|..++++.+|+|.+... ......|.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence            4678889999999999999999888899999998753 34457899999999999999999999986 456789999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++.+.
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            999999998543 2346899999999999999999999887   9999999999999999999999999998776

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.87  E-value=7.7e-22  Score=207.61  Aligned_cols=153  Identities=30%  Similarity=0.524  Sum_probs=131.7

Q ss_pred             ccccccccccCccCceeEEEEEEc--------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER  563 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~--------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~  563 (662)
                      .++|.+.++||+|+||.||+++..        ....+|+|.++... ......+..|+++++++ +||||+++++++.++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888999999999999999742        24568999887532 23456789999999999 699999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL  630 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl  630 (662)
                      +..++||||+++|+|.+++....             ....+++.++..++.||+.||.|||+++   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999995422             1245899999999999999999999987   9999999999999


Q ss_pred             cCCCceEEEeeCccccccC
Q 006090          631 DDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       631 ~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++.+||+|||+++.+..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~  186 (314)
T cd05099         168 TEDNVMKIADFGLARGVHD  186 (314)
T ss_pred             cCCCcEEEccccccccccc
Confidence            9999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.87  E-value=7.3e-22  Score=203.29  Aligned_cols=150  Identities=32%  Similarity=0.482  Sum_probs=131.6

Q ss_pred             cccccccccCccCceeEEEEEEc------CCcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|++...||+|+||.||+|+.+      +.+.|++|.+...... ...+|.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999864      2457999988654333 4568999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQ------SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999643321      25899999999999999999999988   999999999999999999999999


Q ss_pred             Cccccc
Q 006090          642 GLARIF  647 (662)
Q Consensus       642 Gla~~~  647 (662)
                      |+++..
T Consensus       162 ~~~~~~  167 (275)
T cd05046         162 SLSKDV  167 (275)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.87  E-value=1.1e-21  Score=200.47  Aligned_cols=149  Identities=36%  Similarity=0.591  Sum_probs=130.6

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|.+.++||+|++|.||++....+..+|+|.+... ....+.|.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            568888999999999999999887778999988653 334567899999999999999999999875 456789999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|.+++.+. ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            99999999543 2345789999999999999999999987   99999999999999999999999999987744

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.87  E-value=7.4e-22  Score=202.20  Aligned_cols=152  Identities=22%  Similarity=0.460  Sum_probs=132.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.++||+|+||.||+|+.. +++.||||.+...   .......|.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888999999999999999965 6889999987532   2233457899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++.... ....+++..+..++.||++||+|||+++   ++|+||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999885322 2345788999999999999999999987   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=6e-22  Score=215.04  Aligned_cols=146  Identities=23%  Similarity=0.381  Sum_probs=127.8

Q ss_pred             ccccccccccCccCceeEEEEEEc---CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     +.+.+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999754   3567999987642     23568999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |++. ++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 68888883   3356899999999999999999999987   999999999999999999999999999877654


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      .
T Consensus       239 ~  239 (392)
T PHA03207        239 P  239 (392)
T ss_pred             c
Confidence            3

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.87  E-value=1.1e-21  Score=200.18  Aligned_cols=143  Identities=32%  Similarity=0.584  Sum_probs=123.6

Q ss_pred             ccCccCceeEEEEEEc---CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCC
Q 006090          502 KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS  577 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  577 (662)
                      .||+|+||.||+|.+.   .+..||+|.+..... ...++|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   345799999875432 33467999999999999999999999885 457799999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       578 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |.+++...  ...+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.+...
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            99998532  345899999999999999999999987   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.87  E-value=8.3e-22  Score=201.23  Aligned_cols=149  Identities=36%  Similarity=0.623  Sum_probs=131.6

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|++.++||+|+||.||++..+++..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4678889999999999999998888899999987533 34567999999999999999999999875 456799999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|.+++.+. ....+++.++..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            99999998543 2345799999999999999999999987   99999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.87  E-value=1.4e-21  Score=202.01  Aligned_cols=144  Identities=26%  Similarity=0.370  Sum_probs=127.8

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +|++.++||+|+||.||++... +++.+|+|.+... .....++|.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5677899999999999999864 6889999988643 2334567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999997653       3678888999999999999999987   99999999999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=1.2e-21  Score=203.72  Aligned_cols=149  Identities=32%  Similarity=0.508  Sum_probs=134.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|++++++++||||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999976 47899999987666666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++++|..++.+.  ...+++..+..++.|++.+|+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999887432  245899999999999999999999987   9999999999999999999999999987653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.87  E-value=5.5e-22  Score=201.94  Aligned_cols=145  Identities=37%  Similarity=0.622  Sum_probs=128.5

Q ss_pred             cccccccCccCceeEEEEEEcC-CcEEEEEEccccccccH--HHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQ--EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~--~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      |++.+.||+|+||+||+++... ++.+|+|.+........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999764 56899999976433322  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++++|.++|.   ....+++..+..++.||++||.|||+.+   |+|+||||+||++++++.++|+|||++..+
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999995   3456899999999999999999999987   999999999999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.1e-23  Score=216.82  Aligned_cols=150  Identities=31%  Similarity=0.499  Sum_probs=130.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +.|+.++.||.|+||.||-+... +.+.||||++.-.   +......++.|+..|.+++|||++..-||+......+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            45777899999999999999854 6788999998643   2334567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||| -||-.++|.  ....++.+-++.-|..+.+.||+|||+.+   .||||||+.||||++.|.+||+|||-|.+..+.
T Consensus       106 EYC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  106 EYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            999 466666662  23456888899999999999999999998   999999999999999999999999999988664

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.1e-21  Score=200.41  Aligned_cols=149  Identities=33%  Similarity=0.509  Sum_probs=131.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|.+.+.||+|++|.||++... +++.+|+|.+....     ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999864 58899999875421     1234578899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999999843   345788999999999999999999987   9999999999999999999999999998764


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       156 ~  156 (263)
T cd06625         156 T  156 (263)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-22  Score=199.01  Aligned_cols=151  Identities=30%  Similarity=0.463  Sum_probs=133.9

Q ss_pred             CHHHHHhhccccccccccCccCceeEEEEE-EcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeC
Q 006090          486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER  563 (662)
Q Consensus       486 ~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~  563 (662)
                      .++++.+.+     .+.||+|+|+.|-.++ +.++.++|||++.+..........+|++++...+ |+||++|+.+++++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            456666665     4789999999999887 6789999999999877777888999999999985 99999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEe
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISD  640 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~D  640 (662)
                      ...|||||-|.||+|...|.+   +.-+++.++.++..+||.||.|||.++   |.||||||+|||-.+..   -+||+|
T Consensus       149 ~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence            999999999999999999943   445889999999999999999999998   99999999999997654   489999


Q ss_pred             eCccccc
Q 006090          641 FGLARIF  647 (662)
Q Consensus       641 FGla~~~  647 (662)
                      |.|+.-+
T Consensus       223 fDLgSg~  229 (463)
T KOG0607|consen  223 FDLGSGI  229 (463)
T ss_pred             ccccccc
Confidence            9998654

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.87  E-value=1.3e-21  Score=202.38  Aligned_cols=150  Identities=27%  Similarity=0.457  Sum_probs=132.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|+..+.||+|+||.||+++.. +++.||+|++....  ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36788899999999999999976 58899999886432  2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |++++.|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999999887743   235899999999999999999999987   999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.87  E-value=1.1e-21  Score=203.42  Aligned_cols=149  Identities=30%  Similarity=0.424  Sum_probs=129.9

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      |+..+.||+|+||.||++... +++.+|+|.+....   ......+..|+.++++++|+||+++++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566789999999999999865 58899999886432   22235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.....
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            9999999988542 2235889999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.87  E-value=1.2e-21  Score=199.03  Aligned_cols=151  Identities=30%  Similarity=0.494  Sum_probs=133.7

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.+.||+|++|.||++... +++.+++|.+...  ......++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3677899999999999999975 5889999987642  234567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999643 2346899999999999999999999987   999999999999999999999999999977543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.87  E-value=1.6e-21  Score=199.44  Aligned_cols=152  Identities=24%  Similarity=0.484  Sum_probs=134.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 7899999987532   2233568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++.+.. ....+++.++..++.|+++||+|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999985422 2345899999999999999999999987   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.87  E-value=1.1e-21  Score=199.40  Aligned_cols=149  Identities=34%  Similarity=0.502  Sum_probs=131.8

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +|+..+.||+|+||+||+|... +++.|++|.+....     .+..+.+.+|++++++++|+||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3666789999999999999976 68899999886432     22456799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +||+++++|.+++.+   ...+++..+..++.||++||+|||+.+   |+|+||+|+||++++++.+||+|||+++....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999943   235889999999999999999999987   99999999999999999999999999987654


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       155 ~  155 (258)
T cd06632         155 F  155 (258)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.87  E-value=8.6e-22  Score=205.48  Aligned_cols=150  Identities=32%  Similarity=0.589  Sum_probs=128.9

Q ss_pred             cccccccccCccCceeEEEEEEcC-C--cEEEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-G--QEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~--~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467888999999999999998753 3  24788888642 233456789999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          570 YEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999995422             1135889999999999999999999987   9999999999999999999


Q ss_pred             EEEeeCccccc
Q 006090          637 KISDFGLARIF  647 (662)
Q Consensus       637 ki~DFGla~~~  647 (662)
                      ||+|||+++..
T Consensus       159 kl~dfg~~~~~  169 (297)
T cd05089         159 KIADFGLSRGE  169 (297)
T ss_pred             EECCcCCCccc
Confidence            99999998743

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.87  E-value=1.1e-21  Score=201.04  Aligned_cols=150  Identities=33%  Similarity=0.625  Sum_probs=131.8

Q ss_pred             cccccccccCccCceeEEEEEEcC-C---cEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-G---QEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|+..+.||+|+||.||+|+... +   ..+|+|.++... ....+.+..|++++++++||||+++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467778999999999999999752 3   368999887542 33456799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999998542  345899999999999999999999987   99999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.87  E-value=1.3e-21  Score=199.50  Aligned_cols=142  Identities=33%  Similarity=0.562  Sum_probs=123.8

Q ss_pred             ccCccCceeEEEEEEc---CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          502 KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +||+|+||.||+|.++   ++..+|+|+++...  ....+++.+|+.++++++||||++++|++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   56889999986432  234568999999999999999999999985 45678999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            99999943   235889999999999999999999987   999999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.87  E-value=1.1e-21  Score=203.43  Aligned_cols=152  Identities=32%  Similarity=0.574  Sum_probs=132.5

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .++|+..+.||+|+||.||++...      ++..+|+|.+.... .....+|.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888999999999999999864      36789999987532 33456799999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQ-------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASN  627 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N  627 (662)
                      ++|+||+++++|.+++....                   ....+++.+++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999995321                   1234788999999999999999999987   9999999999


Q ss_pred             EEEcCCCceEEEeeCcccccc
Q 006090          628 ILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       628 ILl~~~~~~ki~DFGla~~~~  648 (662)
                      |++++++.+||+|||+++.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             eEecCCCceEECccccceecc
Confidence            999999999999999998654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.4e-21  Score=201.85  Aligned_cols=150  Identities=31%  Similarity=0.586  Sum_probs=130.2

Q ss_pred             cccccccccCccCceeEEEEEEcC-Cc----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .+|++.+.||+|+||.||+|.... +.    .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467778999999999999998652 32    589998865433 345678999999999999999999999987 78899


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+||+++|+|.+++.+.  ...+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999999543  234899999999999999999999987   9999999999999999999999999998875


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       161 ~~  162 (279)
T cd05057         161 VD  162 (279)
T ss_pred             Cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.87  E-value=1.8e-21  Score=197.94  Aligned_cols=147  Identities=41%  Similarity=0.676  Sum_probs=131.0

Q ss_pred             cccCccCceeEEEEEEcC----CcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+++...    +..+++|.+...... ..+.+.+|++++..++|+||+++++++.++...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999764    778999998764333 367899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          576 KSLDSFLFDPQR------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       576 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++|.+++.....      ...+++..+..++.|+++||.|||+++   ++||||||+||++++++.+||+|||+++.+..
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      356899999999999999999999987   99999999999999999999999999998865


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       158 ~  158 (262)
T cd00192         158 D  158 (262)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.87  E-value=1.5e-21  Score=201.33  Aligned_cols=152  Identities=34%  Similarity=0.574  Sum_probs=131.4

Q ss_pred             ccccccccccCccCceeEEEEEEcC------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......|..|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678889999999999999998753      4678999886433 33456799999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEE
Q 006090          567 MLIYEYMPNKSLDSFLFDPQR----QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKIS  639 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~  639 (662)
                      ++||||+++++|.+++.....    ...+++..++.++.||++||+|||+.+   ++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999864321    235899999999999999999999987   99999999999998765   69999


Q ss_pred             eeCcccccc
Q 006090          640 DFGLARIFG  648 (662)
Q Consensus       640 DFGla~~~~  648 (662)
                      |||+++.+.
T Consensus       162 dfg~~~~~~  170 (277)
T cd05036         162 DFGMARDIY  170 (277)
T ss_pred             cCccccccC
Confidence            999998774

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=1.8e-21  Score=208.66  Aligned_cols=144  Identities=26%  Similarity=0.377  Sum_probs=126.0

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ...+|.+.+.||+|+||.||+|+.. +++.||+|.....      ....|+.++++++||||+++++++.++...++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999976 4678999975432      23569999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+. ++|.+++..  ....+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            995 688888854  2345899999999999999999999987   9999999999999999999999999998643

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.87  E-value=1e-21  Score=208.60  Aligned_cols=152  Identities=29%  Similarity=0.511  Sum_probs=131.1

Q ss_pred             cccccccccCccCceeEEEEEEc--------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE  564 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~--------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~  564 (662)
                      .+|.+.+.||+|+||.||++...        ....||+|.++... ....+++.+|+++++++ +||||+++++++.+++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999887432 33457899999999999 7999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                      ..++++||+++|+|.++|....             ....+++.+++.++.||++||+|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986422             2235889999999999999999999987   99999999999999


Q ss_pred             CCCceEEEeeCccccccC
Q 006090          632 DDLNPKISDFGLARIFGG  649 (662)
Q Consensus       632 ~~~~~ki~DFGla~~~~~  649 (662)
                      +++.+||+|||+++.+..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         169 EDNVMKIADFGLARDVHN  186 (334)
T ss_pred             CCCcEEECCcccceeccc
Confidence            999999999999987644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.87  E-value=2.3e-21  Score=234.35  Aligned_cols=142  Identities=28%  Similarity=0.537  Sum_probs=122.6

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ..+...+.||+|+||.||+|+. .+++.||||++......    ...|++.+++++|||||+++|+|.+.+..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            3466678999999999999997 47899999998653222    234688899999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++|+|.++++      .++|.++.+|+.|||+||+|||..+..+|+||||||+||+++.++.+++. ||++...
T Consensus       766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            9999999993      28999999999999999999997766679999999999999999988876 7766544

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.9e-21  Score=198.28  Aligned_cols=151  Identities=28%  Similarity=0.510  Sum_probs=135.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++.+++..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367888999999999999999875 5788999998765555678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++...  ...+++.++..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++..+..
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            9999999998542  245889999999999999999999987   99999999999999999999999999987654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.87  E-value=1.3e-21  Score=203.92  Aligned_cols=149  Identities=31%  Similarity=0.532  Sum_probs=131.1

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccccc-----cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-----GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +|++.+.||+|+||.||+|... +++.||||.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677889999999999999975 5889999998754322     234677899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+ +++|.+++.+..  ..+++..+..++.||++||+|||+++   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999995432  36899999999999999999999988   99999999999999999999999999987754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       155 ~  155 (298)
T cd07841         155 P  155 (298)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.87  E-value=9.3e-22  Score=201.46  Aligned_cols=152  Identities=22%  Similarity=0.469  Sum_probs=133.1

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||.||++.. .+++.+|||.+...   ......+|.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3577889999999999999995 47899999987542   2233467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++... .....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998532 22356899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.87  E-value=1.3e-21  Score=199.23  Aligned_cols=144  Identities=35%  Similarity=0.506  Sum_probs=128.0

Q ss_pred             cccCccCceeEEEEEEcC--C--cEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQD--G--QEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~--~--~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      ++||+|++|.||+|.+..  +  ..||+|.+..... ...+.|.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  2  3689999976554 556789999999999999999999999988 888999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++|.+++.+... ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999965432 46899999999999999999999987   99999999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=1.8e-21  Score=199.43  Aligned_cols=148  Identities=32%  Similarity=0.564  Sum_probs=130.1

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccccc---------cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ---------GQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~---------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      +|.+...||+|++|.||+|... +++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999864 5789999988643221         12568899999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++|+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999943   345788999999999999999999987   9999999999999999999999999998


Q ss_pred             cccC
Q 006090          646 IFGG  649 (662)
Q Consensus       646 ~~~~  649 (662)
                      .+..
T Consensus       155 ~~~~  158 (267)
T cd06628         155 KLEA  158 (267)
T ss_pred             cccc
Confidence            8763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.87  E-value=2.7e-23  Score=202.39  Aligned_cols=159  Identities=27%  Similarity=0.501  Sum_probs=140.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +-|.+.++||+|+||.|||+.++ .|+.+|||.+-.  ....+++..|+.+|...+.|+||+.+|.+......++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            45778899999999999999876 689999998853  456789999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ  653 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~  653 (662)
                      .-|++.+.++-  ++.+|++.++..+.+..++||+|||...   -||||||+.||||+-+|.+||+|||.|..+.+.-.+
T Consensus       111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            99999999853  4567999999999999999999999865   899999999999999999999999999998764333


Q ss_pred             ccccccccC
Q 006090          654 AATKRLVGT  662 (662)
Q Consensus       654 ~~~~~~~Gt  662 (662)
                      .  ++++||
T Consensus       186 R--NTVIGT  192 (502)
T KOG0574|consen  186 R--NTVIGT  192 (502)
T ss_pred             h--CccccC
Confidence            2  336776

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.87  E-value=1.2e-21  Score=200.50  Aligned_cols=147  Identities=33%  Similarity=0.552  Sum_probs=130.0

Q ss_pred             ccccccccCccCceeEEEEEEcCCcEEEEEEccccc------cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +|...+.||+|+||+||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            366788999999999999998888999999886422      12235688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +||+++++|.+++.+   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||+++.+.
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999999943   235789999999999999999999987   9999999999999999999999999998653

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.87  E-value=2.2e-21  Score=197.45  Aligned_cols=151  Identities=24%  Similarity=0.415  Sum_probs=133.2

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778899999999999999854 5888999987543  234456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++.+.. ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999996432 345899999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.87  E-value=9.4e-22  Score=203.67  Aligned_cols=159  Identities=26%  Similarity=0.441  Sum_probs=134.5

Q ss_pred             HHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEE---
Q 006090          487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCV---  561 (662)
Q Consensus       487 ~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~---  561 (662)
                      ++.+..+.++|++.+.||+|+||.||+++.. +++.+|+|.++.. .....++.+|+.++.++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3455567789999999999999999999875 5789999987642 22346788999999999 6999999999985   


Q ss_pred             --eCCeeEEEEEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          562 --EREENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       562 --~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                        .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345679999999999999987532 22346889999999999999999999987   999999999999999999999


Q ss_pred             EeeCccccccC
Q 006090          639 SDFGLARIFGG  649 (662)
Q Consensus       639 ~DFGla~~~~~  649 (662)
                      +|||+++.+..
T Consensus       166 ~dfg~~~~~~~  176 (286)
T cd06638         166 VDFGVSAQLTS  176 (286)
T ss_pred             ccCCceeeccc
Confidence            99999987643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=1.9e-21  Score=199.84  Aligned_cols=148  Identities=30%  Similarity=0.449  Sum_probs=129.1

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--c--------cHHHHHHHHHHHhcCCCCCcceeeEEEEeCC
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--Q--------GQEEFMNEVMVISNLQHRNLVRLLGCCVERE  564 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~--------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~  564 (662)
                      +|...+.||+|+||.||+|... +++.+|+|.++....  .        ..+.+.+|+.++++++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3667889999999999999864 588999998753211  0        1246788999999999999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||+++++|.+++.+.   ..+++..+..++.||+.||.|||+++   ++|+||+|+||++++++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999999543   46899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       156 ~~~~~  160 (272)
T cd06629         156 KKSDD  160 (272)
T ss_pred             ccccc
Confidence            87643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.87  E-value=1.7e-22  Score=215.45  Aligned_cols=156  Identities=29%  Similarity=0.490  Sum_probs=130.7

Q ss_pred             cccccCccCceeEEEEEEc-CCcEEEEEEc--cc--cccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe--eEEEEE
Q 006090          499 LANKLGQGGFGPVYKGKLQ-DGQEIAVKRL--SK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE--NMLIYE  571 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l--~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lV~E  571 (662)
                      ..++||+|+|-+||||... +|.+||---+  .+  ..+...+.|..|+.+|+.|+||||++++..+.+...  .-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3689999999999999875 4677763222  11  244556899999999999999999999999998766  679999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~~  650 (662)
                      .|..|+|..|+.   +...++.+....+++||++||.|||++. |||||||||..||+|+- -|.+||+|.|||.++...
T Consensus       124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999994   4455888899999999999999999986 78999999999999975 579999999999999766


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      ...    .++||
T Consensus       200 ~ak----svIGT  207 (632)
T KOG0584|consen  200 HAK----SVIGT  207 (632)
T ss_pred             ccc----eeccC
Confidence            532    26776

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=1.9e-21  Score=200.76  Aligned_cols=150  Identities=32%  Similarity=0.585  Sum_probs=131.6

Q ss_pred             cccccccccCccCceeEEEEEEc-----CCcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVE--REEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-----~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~  566 (662)
                      ..|++.+.||+|+||.||++++.     .+..+|||.+...... ..+.|.+|++++++++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35667799999999999999864     3678999998764332 46789999999999999999999999987  5578


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999995432  25899999999999999999999987   99999999999999999999999999998


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      +..
T Consensus       159 ~~~  161 (284)
T cd05038         159 LPE  161 (284)
T ss_pred             ccc
Confidence            863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.87  E-value=1.3e-21  Score=215.28  Aligned_cols=150  Identities=25%  Similarity=0.430  Sum_probs=123.1

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--------
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--------  563 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--------  563 (662)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999875 57899999885422    2345799999999999999999986532        


Q ss_pred             CeeEEEEEccCCCCHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEee
Q 006090          564 EENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDF  641 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DF  641 (662)
                      ...++||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            235689999975 67666632 123456899999999999999999999988   99999999999999765 7999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |+|+.+...
T Consensus       216 Gla~~~~~~  224 (440)
T PTZ00036        216 GSAKNLLAG  224 (440)
T ss_pred             ccchhccCC
Confidence            999977543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.87  E-value=2e-21  Score=203.10  Aligned_cols=148  Identities=30%  Similarity=0.506  Sum_probs=129.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|.+.++||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999875 57899999886432 23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++ ++|.+++.+.  ...+++..+..++.||++||.|||+.+   |+|+||||+|||+++++.+||+|||+++...
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            97 6898888543  335789999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.87  E-value=1.9e-21  Score=198.72  Aligned_cols=150  Identities=35%  Similarity=0.562  Sum_probs=132.8

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|++.++||+|+||.||++...++..+|+|.+... ....+.|.+|++++++++|+||+++.+.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4678889999999999999999877788999988753 3345679999999999999999999999887 7789999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++... ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999999543 2345789999999999999999999987   99999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.87  E-value=9e-22  Score=211.90  Aligned_cols=149  Identities=29%  Similarity=0.421  Sum_probs=130.8

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-C-----CCcceeeEEEEeCCeeEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-H-----RNLVRLLGCCVEREENML  568 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~l  568 (662)
                      +|.+.+.||+|.||+|.|+... +++.||||+++. .....++...|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999854 689999999986 3455667788999999996 5     389999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC--ceEEEeeCcccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL--NPKISDFGLARI  646 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~--~~ki~DFGla~~  646 (662)
                      |+|.+ .-+|.++|... +...++...+..|+.||+.||.+||+.+   |||+||||+||||.+..  .+||+|||.|..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 57999999654 4456899999999999999999999887   99999999999997644  799999999987


Q ss_pred             ccCC
Q 006090          647 FGGN  650 (662)
Q Consensus       647 ~~~~  650 (662)
                      ....
T Consensus       341 ~~q~  344 (586)
T KOG0667|consen  341 ESQR  344 (586)
T ss_pred             cCCc
Confidence            7654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.87  E-value=2.4e-21  Score=197.39  Aligned_cols=148  Identities=32%  Similarity=0.564  Sum_probs=129.3

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~  573 (662)
                      ++|.+.+.||+|+||.||++... +..+|+|.++..  ...+.|.+|+.++++++|+|++++++++.. ++..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46788899999999999999875 788999988643  335679999999999999999999998654 45689999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++.+. ....+++..++.++.||+.||+|||+++   |+||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999998543 2345889999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.87  E-value=2.1e-21  Score=202.57  Aligned_cols=149  Identities=28%  Similarity=0.502  Sum_probs=134.5

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .+|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            5688899999999999999985 468999999887655555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++++|.+++.+    ..+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999999842    34899999999999999999999987   999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.86  E-value=1.9e-21  Score=208.67  Aligned_cols=147  Identities=30%  Similarity=0.437  Sum_probs=125.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------  564 (662)
                      .++|++.+.||+|+||.||++... +++.||||.+...  .......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999865 5889999998643  2234567889999999999999999999986543      


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence            46999999975 5666652     23788899999999999999999988   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       171 ~~~~~  175 (359)
T cd07876         171 RTACT  175 (359)
T ss_pred             ccccc
Confidence            86543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.86  E-value=1.8e-21  Score=199.28  Aligned_cols=148  Identities=32%  Similarity=0.492  Sum_probs=128.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--Cee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  566 (662)
                      ++|.+.+.||+|+||.||++... +++.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999875 58899999875321     12345788999999999999999999998764  457


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      +++|||+++++|.+++.+   ...+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999999843   234788899999999999999999987   99999999999999999999999999986


Q ss_pred             cc
Q 006090          647 FG  648 (662)
Q Consensus       647 ~~  648 (662)
                      +.
T Consensus       156 ~~  157 (265)
T cd06652         156 LQ  157 (265)
T ss_pred             cc
Confidence            64

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.86  E-value=2.2e-21  Score=203.29  Aligned_cols=146  Identities=23%  Similarity=0.375  Sum_probs=130.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||.||++... .++.|++|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36788899999999999999975 47899999886532   233457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            99999999999943   245899999999999999999999987   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.86  E-value=4.1e-21  Score=195.40  Aligned_cols=150  Identities=22%  Similarity=0.370  Sum_probs=132.0

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +|++.++||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999865 5889999987532 2334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++... ....+++.....++.||++||.|||+.+   |+|+||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999999988532 2345788999999999999999999987   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.86  E-value=2.9e-22  Score=191.28  Aligned_cols=154  Identities=29%  Similarity=0.371  Sum_probs=136.7

Q ss_pred             hccccccccccCccCceeEEEEE-EcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-----Cee
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-----EEN  566 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  566 (662)
                      ..++|.+.++||+|||.-||.++ +.++..+|+|++.....++.+..++|++..++++||||+++++++..+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34789999999999999999998 567889999999876667788999999999999999999999987654     348


Q ss_pred             EEEEEccCCCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      ||+++|...|+|.+.+...+. ...+++.+.+.|+.+|++||.+||+.. ++..||||||.|||+.+.+.++|.|||-+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999865443 447999999999999999999999986 689999999999999999999999999876


Q ss_pred             cc
Q 006090          646 IF  647 (662)
Q Consensus       646 ~~  647 (662)
                      ..
T Consensus       178 ~a  179 (302)
T KOG2345|consen  178 QA  179 (302)
T ss_pred             cc
Confidence            44

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.86  E-value=3e-21  Score=198.35  Aligned_cols=143  Identities=36%  Similarity=0.642  Sum_probs=123.6

Q ss_pred             cccCccCceeEEEEEEcC-Cc--EEEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQD-GQ--EIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~-~~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999753 33  4688888643 234456889999999999 799999999999999999999999999


Q ss_pred             CCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          576 KSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       576 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      ++|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986422             1235789999999999999999999987   9999999999999999999999999


Q ss_pred             cccc
Q 006090          643 LARI  646 (662)
Q Consensus       643 la~~  646 (662)
                      +++.
T Consensus       158 l~~~  161 (270)
T cd05047         158 LSRG  161 (270)
T ss_pred             Cccc
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.86  E-value=2.2e-21  Score=199.26  Aligned_cols=149  Identities=28%  Similarity=0.489  Sum_probs=129.0

Q ss_pred             cccccccccCccCceeEEEEEEcC----CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|.+.++||+|+||.||+|...+    ...||||...... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998643    2468999886543 3455689999999999999999999999875 557899


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999543  235899999999999999999999987   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.86  E-value=1.4e-21  Score=202.26  Aligned_cols=149  Identities=29%  Similarity=0.481  Sum_probs=131.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.++||+|+||.||++..+ +++.+|+|++.....  ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999986 588999998865322  235678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++|.++...   ...+++.++..++.||++||+|||+.+   |+|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999887743   234899999999999999999999987   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.6e-21  Score=207.82  Aligned_cols=149  Identities=30%  Similarity=0.434  Sum_probs=127.8

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------  563 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------  563 (662)
                      ..++|.+.+.||+|+||.||++... +++.||||++....  ....+.+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3468999999999999999999864 67899999986532  22345678999999999999999999987643      


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ...++++|++ +++|.+++.    ...+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999988 789988873    235899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      ++.+..
T Consensus       165 ~~~~~~  170 (343)
T cd07878         165 ARQADD  170 (343)
T ss_pred             ceecCC
Confidence            987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.86  E-value=1.4e-21  Score=203.58  Aligned_cols=146  Identities=27%  Similarity=0.468  Sum_probs=129.7

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            333578999999999999865 5789999998765555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++|.+++..    ..+++.++..++.||+.||+|||+++   |+||||||+||++++++.+||+|||++..+..
T Consensus       104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            999998832    34789999999999999999999987   99999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.86  E-value=4.1e-21  Score=194.78  Aligned_cols=143  Identities=34%  Similarity=0.582  Sum_probs=128.6

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHH
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD  579 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  579 (662)
                      ++||+|+||.||++...+++.||+|.+...... ....|.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877899999988754333 4568999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       580 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++.+.  ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            998542  235789999999999999999999987   9999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.86  E-value=3.3e-21  Score=196.13  Aligned_cols=149  Identities=30%  Similarity=0.589  Sum_probs=132.4

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      .+|++.+.||+|+||.||++...+++.+|+|.+... .....+|.+|++++++++||||+++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            357778999999999999999877889999988653 3345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            99999998542  235789999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.86  E-value=4.7e-21  Score=195.86  Aligned_cols=153  Identities=29%  Similarity=0.473  Sum_probs=135.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.+.||+|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+.+++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999864 57889999986432 23567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++........+++.....++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999965433356899999999999999999999987   999999999999999999999999999877654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-22  Score=207.92  Aligned_cols=160  Identities=29%  Similarity=0.455  Sum_probs=140.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..|...+.||+|.||.||||... .++.||+|++.-. .....++.+.|+.++..++|+||.+.+|.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45666799999999999999865 6889999998643 344567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      |.+|++.+.|.   ....+++....-|.++++.||.|||.++   .+|||||+.|||+.++|.+|++|||.+..+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999983   3444578888889999999999999998   99999999999999999999999999999987765


Q ss_pred             cccccccccC
Q 006090          653 QAATKRLVGT  662 (662)
Q Consensus       653 ~~~~~~~~Gt  662 (662)
                      +.  .+++||
T Consensus       167 rr--~tfvGT  174 (467)
T KOG0201|consen  167 RR--KTFVGT  174 (467)
T ss_pred             cc--cccccc
Confidence            54  458887

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.86  E-value=2.6e-21  Score=202.53  Aligned_cols=150  Identities=34%  Similarity=0.676  Sum_probs=127.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCc----EEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|+..+.||+|+||.||+|... +++    .||+|.+..... ....++.+|+.++++++||||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677899999999999999864 343    478888865332 2345789999999999999999999998754 4679


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998542  335889999999999999999999987   9999999999999999999999999999775


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       161 ~~  162 (303)
T cd05110         161 GD  162 (303)
T ss_pred             Cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.86  E-value=2.6e-21  Score=199.88  Aligned_cols=151  Identities=26%  Similarity=0.427  Sum_probs=127.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHH-HhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMV-ISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.+.||+|+||.||++... +++.||+|+++... .....++..|+.. ++.++||||+++++++.+++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788899999999999999976 58999999986532 2334566667765 566789999999999999999999999


Q ss_pred             ccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |++ ++|.+++... .....+++..+..++.||+.||+|||++ +   ++||||||+||++++++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 7888887532 2335689999999999999999999986 5   99999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.86  E-value=1.8e-21  Score=200.70  Aligned_cols=148  Identities=30%  Similarity=0.480  Sum_probs=131.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34667789999999999999865 57889999886432 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++.    ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999999883    245889999999999999999999987   99999999999999999999999999987754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.4e-21  Score=204.47  Aligned_cols=140  Identities=24%  Similarity=0.308  Sum_probs=114.1

Q ss_pred             hccccccccccCccCceeEEEEEEc--CCcEEEEEEcccc-----ccccHHHHHHHHHHHhcCCCCCcce-eeEEEEeCC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKA-----SGQGQEEFMNEVMVISNLQHRNLVR-LLGCCVERE  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~--~~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~-l~g~~~~~~  564 (662)
                      ..++|.+.+.||+|+||+||+|...  +++.+|||++...     .....+.|.+|+++|++++|+|++. ++.    .+
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence            4477999999999999999999865  4677899987532     1123557999999999999999985 443    24


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCceEEEeeCc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL-KASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~ki~DFGl  643 (662)
                      ..+|||||+++++|.. + .  ..   .   ...++.|++++|.|||+++   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~-~-~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-A-R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHH-h-C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            6799999999999963 2 1  11   1   1467889999999999987   999999 99999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      |+.+..
T Consensus       159 A~~~~~  164 (365)
T PRK09188        159 ASVFRR  164 (365)
T ss_pred             ceeccc
Confidence            998754

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.86  E-value=3.6e-21  Score=195.63  Aligned_cols=150  Identities=27%  Similarity=0.496  Sum_probs=134.9

Q ss_pred             ccccccccccCccCceeEEEEEEcC-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|+..+.||+|+||.||++.... ++.+++|.+.....  .+++.+|++++++++||||+++++.+.++...++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678889999999999999999764 78999999865322  67899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++..  ....+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++..+...
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            999999999843  2346899999999999999999999987   999999999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.86  E-value=3.2e-21  Score=196.88  Aligned_cols=148  Identities=34%  Similarity=0.504  Sum_probs=132.9

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccccc--cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ--GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|+..+.||+|+||.||++... +++.+++|.+......  ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777899999999999999865 6889999998754432  567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++..+..
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            999999999853   334788999999999999999999988   99999999999999999999999999988754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.86  E-value=3.6e-21  Score=199.91  Aligned_cols=148  Identities=30%  Similarity=0.369  Sum_probs=129.6

Q ss_pred             ccccccccCccCceeEEEEEE----cCCcEEEEEEcccccc----ccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCee
Q 006090          496 NFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKASG----QGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~----~~~~~vAvK~l~~~~~----~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  566 (662)
                      +|++.+.||+|+||.||+++.    .+++.||+|++.....    ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367789999999999999986    3678999999865322    2346788999999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++|+||+++++|.+++..   ...+++.....++.||++||.|||+.+   ++||||||+|||+++++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345788999999999999999999987   99999999999999999999999999987


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      +..
T Consensus       155 ~~~  157 (290)
T cd05613         155 FHE  157 (290)
T ss_pred             ccc
Confidence            754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.86  E-value=4.5e-21  Score=198.39  Aligned_cols=149  Identities=30%  Similarity=0.542  Sum_probs=132.8

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999975 68899999986543  23356899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      + +++|.+++....  ..+++.++..++.||++||+|||+.+   ++|+||||+||++++++.++|+|||+++.+...
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 999999985432  45899999999999999999999987   999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.86  E-value=4.7e-21  Score=198.09  Aligned_cols=150  Identities=31%  Similarity=0.558  Sum_probs=131.6

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +|+..++||+|++|.||+|+.. +++.||||.++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999975 588999999875433 23567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++ +|.+++........+++..+..++.||++||.|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            85 88888854443456899999999999999999999987   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.86  E-value=3.9e-21  Score=202.38  Aligned_cols=145  Identities=28%  Similarity=0.471  Sum_probs=119.9

Q ss_pred             ccccCccCceeEEEEEEc---CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCeeEEEEEccC
Q 006090          500 ANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENMLIYEYMP  574 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~  574 (662)
                      ..+||+|+||.||+|+..   +++.+|+|.+...  .....+.+|++++++++||||+++++++..  +...++|+||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   4578999998643  223567899999999999999999999865  455789999996


Q ss_pred             CCCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEeeCcc
Q 006090          575 NKSLDSFLFDP------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLA  644 (662)
Q Consensus       575 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~ki~DFGla  644 (662)
                       ++|.+++...      .....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5788776421      12235889999999999999999999988   9999999999999    45678999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07868         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            887543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.86  E-value=2.9e-21  Score=200.60  Aligned_cols=147  Identities=29%  Similarity=0.510  Sum_probs=129.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 578999999865322 2335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++ ++|.+++.+..  ..+++.....++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        85 ~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            98 49999885432  35889999999999999999999987   999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.86  E-value=3.9e-21  Score=199.77  Aligned_cols=161  Identities=30%  Similarity=0.450  Sum_probs=136.5

Q ss_pred             cCHHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEe
Q 006090          485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE  562 (662)
Q Consensus       485 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~  562 (662)
                      +...++..++++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++.++ +||||+++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344556667889999999999999999999974 6889999988643 22345678899999999 79999999999876


Q ss_pred             CC-----eeEEEEEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          563 RE-----ENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       563 ~~-----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      .+     ..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            43     579999999999999988532 22346899999999999999999999987   9999999999999999999


Q ss_pred             EEEeeCccccccC
Q 006090          637 KISDFGLARIFGG  649 (662)
Q Consensus       637 ki~DFGla~~~~~  649 (662)
                      ||+|||+++.+..
T Consensus       168 kl~dfg~~~~~~~  180 (291)
T cd06639         168 KLVDFGVSAQLTS  180 (291)
T ss_pred             EEeecccchhccc
Confidence            9999999987643

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.86  E-value=3e-21  Score=199.91  Aligned_cols=149  Identities=25%  Similarity=0.358  Sum_probs=131.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46778899999999999999865 58889999876432 33457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++++|.+++..   ...+++.....++.|++.||.|||+..  +++||||||+||++++++.++|+|||+++.+.
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999999998843   345899999999999999999999742  39999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.86  E-value=2.4e-21  Score=207.52  Aligned_cols=148  Identities=29%  Similarity=0.431  Sum_probs=125.9

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----  564 (662)
                      ..++|.+.+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468999999999999999999864 58899999987532  233467889999999999999999999986543     


Q ss_pred             -eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          565 -ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       565 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                       ..++||||+++ +|.+.+.     ..+++..+..++.|+++||.|||+++   |+||||||+||||++++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             46999999965 6666662     23788999999999999999999988   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      ++....
T Consensus       166 ~~~~~~  171 (355)
T cd07874         166 ARTAGT  171 (355)
T ss_pred             cccCCC
Confidence            987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.86  E-value=2.9e-21  Score=201.67  Aligned_cols=144  Identities=28%  Similarity=0.466  Sum_probs=128.7

Q ss_pred             cccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCC
Q 006090          499 LANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS  577 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  577 (662)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3468999999999999865 688999999865444556778899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       578 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus       105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            9998732    35889999999999999999999987   99999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.86  E-value=3.9e-23  Score=196.42  Aligned_cols=150  Identities=28%  Similarity=0.442  Sum_probs=129.7

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEccc--cccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++.|++.+.||+|.|+.|++... ++|+.+|+|.+..  -.....+++.+|+++-+.|+|||||+|.....+....|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46788889999999999999875 4688888887642  23346778899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~ki~DFGla~~~  647 (662)
                      |+|.|++|..-|-.   +...++..+.++++||+++|.|+|.++   |||||+||.|+||.+.   --+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999876632   355788889999999999999999998   9999999999999643   36999999999999


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ++
T Consensus       164 ~~  165 (355)
T KOG0033|consen  164 ND  165 (355)
T ss_pred             CC
Confidence            83

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.86  E-value=4.5e-21  Score=199.27  Aligned_cols=150  Identities=31%  Similarity=0.463  Sum_probs=129.3

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++++|.+.+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+++++.++|+||+++.+++.+++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 588999999865332 23456789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||++ ++|.+++...  ...+++..+..++.||++||.|||+.+   |+|+||||+|||++.++.+||+|||+++...
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            9996 6777776432  234788888999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.86  E-value=3.7e-21  Score=195.73  Aligned_cols=146  Identities=34%  Similarity=0.601  Sum_probs=127.9

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|.+.+.||+|+||.||++.. .++.+|+|.++..  .....+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4678889999999999999985 5788999998643  2346789999999999999999999998764 4799999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            999999996432 335889999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1e-22  Score=214.99  Aligned_cols=161  Identities=25%  Similarity=0.450  Sum_probs=139.4

Q ss_pred             cccccccccCccCceeEEEEEEcC-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +.|.+...||.|+||+|||+..++ +-..|.|++...+....+.|+.|+++|+..+||+||+|++.+...+..+++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            456778899999999999998764 3345778888878888999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ  653 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~  653 (662)
                      .||-++..+..  -...|++.++.-+++|++.||.|||++.   |||||||+.|||+.-+|.++|+|||.+........+
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            99999988743  3456999999999999999999999998   999999999999999999999999998877554332


Q ss_pred             ccccccccC
Q 006090          654 AATKRLVGT  662 (662)
Q Consensus       654 ~~~~~~~Gt  662 (662)
                      ..  .++||
T Consensus       187 RD--sFIGT  193 (1187)
T KOG0579|consen  187 RD--SFIGT  193 (1187)
T ss_pred             hc--cccCC
Confidence            22  25665

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.86  E-value=4.5e-21  Score=199.75  Aligned_cols=149  Identities=29%  Similarity=0.488  Sum_probs=133.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999854 67899999986544455678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++++|.+++.+    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+...
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            99999999843    34788999999999999999999987   999999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=1.4e-21  Score=199.37  Aligned_cols=144  Identities=28%  Similarity=0.490  Sum_probs=124.0

Q ss_pred             cccCccCceeEEEEEEcC--------CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~--------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.||+|+||.||+|....        ...+|+|.+........++|.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998642        234888887654445567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--------eEEEeeCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN--------PKISDFGLA  644 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~ki~DFGla  644 (662)
                      +++|+|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999996432  35899999999999999999999987   999999999999988765        699999998


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      .....
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=7.1e-21  Score=200.30  Aligned_cols=151  Identities=26%  Similarity=0.327  Sum_probs=133.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.....   ...+.+..|++++++++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999976 488999999865332   24567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++.+. ....+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999998532 3346899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.86  E-value=4.3e-21  Score=206.28  Aligned_cols=147  Identities=29%  Similarity=0.436  Sum_probs=125.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------C
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------E  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~  564 (662)
                      .++|.+.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999865 5789999998653  223456788999999999999999999987643      3


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||+++ +|.+++.     ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            46999999964 6777762     23788999999999999999999987   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       174 ~~~~~  178 (364)
T cd07875         174 RTAGT  178 (364)
T ss_pred             cccCC
Confidence            87654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.86  E-value=3e-21  Score=197.66  Aligned_cols=148  Identities=29%  Similarity=0.511  Sum_probs=129.9

Q ss_pred             ccccccccCccCceeEEEEEE-cCCcEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASG------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467789999999999999985 4688999998864221      134678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIF  647 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~  647 (662)
                      |+||+++++|.+++.+   ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++ .+||+|||+++.+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   345889999999999999999999987   99999999999998776 6999999999877


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ..
T Consensus       155 ~~  156 (268)
T cd06630         155 AA  156 (268)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.86  E-value=4.9e-21  Score=195.57  Aligned_cols=143  Identities=31%  Similarity=0.554  Sum_probs=121.7

Q ss_pred             cccCccCceeEEEEEEcC----CcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCeeEEEEEccC
Q 006090          501 NKLGQGGFGPVYKGKLQD----GQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REENMLIYEYMP  574 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~  574 (662)
                      +.||+|+||.||+|...+    ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998642    357999988543 23345688899999999999999999998764 455789999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++|.+++.+.  ...+++..++.++.||++||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999543  234678888999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.86  E-value=5.7e-21  Score=202.24  Aligned_cols=145  Identities=20%  Similarity=0.284  Sum_probs=125.5

Q ss_pred             cccccCcc--CceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          499 LANKLGQG--GFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       499 ~~~~lG~G--~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +.++||+|  +|++||++... +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999865 68999999986532  223456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+..+
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            9999999985322 234899999999999999999999987   999999999999999999999999875544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=5.7e-21  Score=195.80  Aligned_cols=148  Identities=32%  Similarity=0.514  Sum_probs=128.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--Cee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  566 (662)
                      .+|+..+.||+|+||.||++... ++..+|+|.+....     ......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888899999999999999865 58899999875421     12345688999999999999999999998763  567


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++++||+++++|.+++.+   ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   234789999999999999999999887   99999999999999999999999999986


Q ss_pred             cc
Q 006090          647 FG  648 (662)
Q Consensus       647 ~~  648 (662)
                      +.
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            64

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=6.8e-21  Score=194.12  Aligned_cols=143  Identities=36%  Similarity=0.591  Sum_probs=124.4

Q ss_pred             cccCccCceeEEEEEEcC----CcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      ++||+|+||.||+|+...    +..+|+|.+..... ...+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998542    26899999875433 24568999999999999999999999876 5567999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++|.+++.+.   ..+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++.+...
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            9999999543   25899999999999999999999987   999999999999999999999999999977543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.86  E-value=8.1e-21  Score=195.17  Aligned_cols=150  Identities=31%  Similarity=0.553  Sum_probs=126.1

Q ss_pred             cccccccCccCceeEEEEEEc----CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------  564 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------  564 (662)
                      |.+.+.||+|+||.||+|.+.    .++.||||.+...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999999864    3678999988653  2334667899999999999999999999987543      


Q ss_pred             eeEEEEEccCCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQ---RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      ..++++||+++|+|.+++....   ....+++.....++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2378999999999998874321   2235789999999999999999999987   999999999999999999999999


Q ss_pred             CccccccC
Q 006090          642 GLARIFGG  649 (662)
Q Consensus       642 Gla~~~~~  649 (662)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99997743

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.86  E-value=5.5e-21  Score=194.23  Aligned_cols=149  Identities=40%  Similarity=0.670  Sum_probs=131.1

Q ss_pred             ccccccCccCceeEEEEEEcC-----CcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          498 QLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~~~-----~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+.+.||+|+||.||+++...     +..||+|.+...... ..+.+..|++++.+++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            457899999999999999763     378999999764433 56789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++++|.+++..... ..+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999854222 12899999999999999999999987   999999999999999999999999999877543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=7e-21  Score=196.17  Aligned_cols=148  Identities=28%  Similarity=0.492  Sum_probs=131.4

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCC---CCCcceeeEEEEeCCeeEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .|+..+.||+|+||.||+|... +++.+|+|.+... ......++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4677889999999999999964 6889999988653 2344567889999999986   999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++..    ..+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999999843    26899999999999999999999987   999999999999999999999999999887544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.85  E-value=3.3e-21  Score=222.52  Aligned_cols=157  Identities=25%  Similarity=0.414  Sum_probs=130.3

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENM  567 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  567 (662)
                      ..++|.+.++||+|+||+||+++.. .++.+|+|.+...  .......|..|+.++++|+|||||++++++.+.  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999975 4678899987642  233456789999999999999999999988653  5679


Q ss_pred             EEEEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCcEEEcCC---------
Q 006090          568 LIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSR----LRIIHRDLKASNILLDDD---------  633 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiHrDlkp~NILl~~~---------  633 (662)
                      |||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999985422 23468999999999999999999998541    349999999999999642         


Q ss_pred             --------CceEEEeeCccccccC
Q 006090          634 --------LNPKISDFGLARIFGG  649 (662)
Q Consensus       634 --------~~~ki~DFGla~~~~~  649 (662)
                              ..+||+|||+++.+..
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~  194 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGI  194 (1021)
T ss_pred             cccccCCCCceEEccCCccccccc
Confidence                    3489999999987753

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.85  E-value=4e-22  Score=195.55  Aligned_cols=152  Identities=28%  Similarity=0.477  Sum_probs=126.1

Q ss_pred             cccccccccCccCceeEEEEEEc---C--CcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ---D--GQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~---~--~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~  566 (662)
                      ..|+....||+|.||.|||+.-.   +  ..++|+|+++....  .-.....+|+.+++.++||||+.|..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            35777889999999999999643   2  23789999875311  123467899999999999999999999887 7778


Q ss_pred             EEEEEccCCCCHHHHhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CceEEEe
Q 006090          567 MLIYEYMPNKSLDSFLF--DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD----LNPKISD  640 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~ki~D  640 (662)
                      +|++||.+. +|...|+  +......++...+..|..||+.|+.|||++-   |+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999975 6777764  3333457899999999999999999999987   9999999999999877    8999999


Q ss_pred             eCccccccCC
Q 006090          641 FGLARIFGGN  650 (662)
Q Consensus       641 FGla~~~~~~  650 (662)
                      +||||++...
T Consensus       180 lGlaR~~~~p  189 (438)
T KOG0666|consen  180 LGLARLFNNP  189 (438)
T ss_pred             ccHHHHhhcc
Confidence            9999998653

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.85  E-value=6.2e-21  Score=197.72  Aligned_cols=149  Identities=30%  Similarity=0.536  Sum_probs=123.5

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcC---CCCCcceeeEEEEeC-----C
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNL---QHRNLVRLLGCCVER-----E  564 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~-----~  564 (662)
                      +|++.+.||+|+||+||+++.. +++.||+|.++....  .....+.+|+++++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777899999999999999865 688999998864322  2234566777777665   699999999998653     4


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            4789999997 5888888543 2345899999999999999999999988   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +.+..
T Consensus       156 ~~~~~  160 (288)
T cd07863         156 RIYSC  160 (288)
T ss_pred             ccccC
Confidence            88754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.85  E-value=2.9e-21  Score=196.84  Aligned_cols=149  Identities=28%  Similarity=0.382  Sum_probs=133.3

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +|++.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999976 58899999886532   2346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++++|.+++...   ..+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999432   46889999999999999999999987   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.85  E-value=7.5e-21  Score=196.20  Aligned_cols=148  Identities=29%  Similarity=0.468  Sum_probs=131.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..|+..++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677889999999999999875 57899999886432 34466789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++..    ..+++.+...++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            999999999842    34788999999999999999999987   99999999999999999999999999987754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.85  E-value=8.4e-21  Score=195.84  Aligned_cols=147  Identities=30%  Similarity=0.478  Sum_probs=130.3

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      -|+..++||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667889999999999999864 57899999876432 234567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+..
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999999842    35889999999999999999999987   99999999999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=7.2e-21  Score=195.85  Aligned_cols=149  Identities=29%  Similarity=0.446  Sum_probs=133.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35778899999999999999975 58899999886533 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999843    26899999999999999999999987   999999999999999999999999999887643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.85  E-value=8.5e-21  Score=193.07  Aligned_cols=150  Identities=29%  Similarity=0.457  Sum_probs=132.2

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.++||+|+||.||++... +++.+|+|.+...  .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999865 6889999988642  233456899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++... ....+++.+++.++.|++.||+|||+.+   ++|+||+|+|||++.++.++|+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999999998542 2235789999999999999999999987   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.85  E-value=9e-21  Score=199.44  Aligned_cols=145  Identities=28%  Similarity=0.474  Sum_probs=119.8

Q ss_pred             ccccCccCceeEEEEEEc---CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCeeEEEEEccC
Q 006090          500 ANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENMLIYEYMP  574 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~  574 (662)
                      ..+||+|+||.||+|+..   ++..+|+|.+...  .....+.+|++++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999865   3468999988653  223567899999999999999999999864  456789999996


Q ss_pred             CCCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEeeCcc
Q 006090          575 NKSLDSFLFDP------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLA  644 (662)
Q Consensus       575 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~ki~DFGla  644 (662)
                       ++|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    ++++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             4777776321      12235889999999999999999999987   9999999999999    56779999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07867         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            987543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=5.4e-22  Score=222.72  Aligned_cols=169  Identities=25%  Similarity=0.288  Sum_probs=144.4

Q ss_pred             HHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe
Q 006090          487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE  562 (662)
Q Consensus       487 ~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~  562 (662)
                      ..++....++|.+.++||+|+||.|..++++ +++.+|+|++.+.   -.....-|+.|-++|..-+.+-|+.|.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455556688999999999999999999986 5778899999762   23345678999999999899999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      ..+.|||||||+||+|-.++.+   ...+++..+..++..|+-||.-||+.|   .|||||||.|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            9999999999999999999943   336889999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCcccccccccccC
Q 006090          643 LARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       643 la~~~~~~~~~~~~~~~~Gt  662 (662)
                      -+-.+..+. .......+||
T Consensus       221 sClkm~~dG-~V~s~~aVGT  239 (1317)
T KOG0612|consen  221 SCLKMDADG-TVRSSVAVGT  239 (1317)
T ss_pred             hHHhcCCCC-cEEeccccCC
Confidence            998887543 2334446777

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=8.2e-21  Score=194.41  Aligned_cols=148  Identities=32%  Similarity=0.521  Sum_probs=128.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-----ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--Cee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-----SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  566 (662)
                      .+|.+.+.||+|+||.||++... +++.+|+|.+...     ..+....+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999865 5889999987421     223456789999999999999999999998764  457


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++++||+++++|.+++..   ...+++.....++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999843   234788999999999999999999987   99999999999999999999999999987


Q ss_pred             cc
Q 006090          647 FG  648 (662)
Q Consensus       647 ~~  648 (662)
                      +.
T Consensus       156 ~~  157 (264)
T cd06653         156 IQ  157 (264)
T ss_pred             cc
Confidence            64

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.85  E-value=8.7e-21  Score=193.56  Aligned_cols=150  Identities=29%  Similarity=0.484  Sum_probs=135.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.+.||+|++|.||+++.. +++.|++|++..... .....+.+|++.+.+++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            35778899999999999999977 489999999876433 4467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++...   ..+++..+..++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999542   568999999999999999999999 87   999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.85  E-value=6.9e-21  Score=196.99  Aligned_cols=149  Identities=30%  Similarity=0.559  Sum_probs=130.2

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|+..+.||+|++|.||+|+.. +++.||||.+....  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4777899999999999999875 58899999886432  22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++ ++|.+++... ....+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            96 6899888543 2346899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=8.6e-22  Score=200.67  Aligned_cols=154  Identities=30%  Similarity=0.400  Sum_probs=129.3

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEcccc-cc------ccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCe
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA-SG------QGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REE  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~-~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~  565 (662)
                      ++|-++++||+|+|+.|||+.. ...+-||||+-... +.      ...+...+|-++.+.|+||.||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            5788899999999999999984 45678899865321 11      123456789999999999999999999865 556


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeC
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFG  642 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFG  642 (662)
                      .+-|+|||+|.+|+-||.   ....+++.++..|+.||+.||.||.+.. +||||-||||.||||-.   -|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence            789999999999999994   4567899999999999999999999875 88999999999999955   4689999999


Q ss_pred             ccccccCCcc
Q 006090          643 LARIFGGNQD  652 (662)
Q Consensus       643 la~~~~~~~~  652 (662)
                      |++++.++..
T Consensus       619 LSKIMdddSy  628 (775)
T KOG1151|consen  619 LSKIMDDDSY  628 (775)
T ss_pred             hhhhccCCcc
Confidence            9999976543

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.85  E-value=9.8e-21  Score=198.87  Aligned_cols=150  Identities=29%  Similarity=0.504  Sum_probs=127.6

Q ss_pred             ccccccccCccCceeEEEEEEc---CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENM  567 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  567 (662)
                      +|++.++||+|+||.||+|...   +++.+|+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677899999999999999975   37899999987632   33346778899999999999999999999988  7889


Q ss_pred             EEEEccCCCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC----CCceEEEee
Q 006090          568 LIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD----DLNPKISDF  641 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~----~~~~ki~DF  641 (662)
                      +||||+++ +|.+++....  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6766663221  2236889999999999999999999987   999999999999999    999999999


Q ss_pred             CccccccC
Q 006090          642 GLARIFGG  649 (662)
Q Consensus       642 Gla~~~~~  649 (662)
                      |+++.+..
T Consensus       157 g~~~~~~~  164 (316)
T cd07842         157 GLARLFNA  164 (316)
T ss_pred             ccccccCC
Confidence            99997754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.85  E-value=9.5e-21  Score=197.07  Aligned_cols=150  Identities=27%  Similarity=0.455  Sum_probs=127.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCe-----
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREE-----  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~-----  565 (662)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999975 58899999876432  223467889999999995 6999999999987766     


Q ss_pred             eEEEEEccCCCCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeC
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQR--QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFG  642 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFG  642 (662)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 88888754322  346899999999999999999999987   999999999999999 8899999999


Q ss_pred             cccccc
Q 006090          643 LARIFG  648 (662)
Q Consensus       643 la~~~~  648 (662)
                      +++.+.
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            998664

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.85  E-value=9.4e-21  Score=197.08  Aligned_cols=150  Identities=28%  Similarity=0.464  Sum_probs=129.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV  569 (662)
                      ++|+..+.||+|+||.||+|+.+ +++.+|+|.++...  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46788899999999999999976 57899999886432  22234678899999999999999999999887  889999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||++ ++|.+++...  ...+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 5999888542  235899999999999999999999987   99999999999999999999999999997755


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       159 ~  159 (293)
T cd07843         159 P  159 (293)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.85  E-value=8.7e-21  Score=196.44  Aligned_cols=150  Identities=27%  Similarity=0.456  Sum_probs=131.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..  .......+.+|++++++++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999976 5789999988643  23345688999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |++++.+..++.+   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998777766632   234899999999999999999999987   999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.85  E-value=8.9e-21  Score=196.04  Aligned_cols=158  Identities=28%  Similarity=0.500  Sum_probs=134.1

Q ss_pred             CHHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEe-
Q 006090          486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE-  562 (662)
Q Consensus       486 ~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~-  562 (662)
                      +..++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+... .....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34455556788999999999999999999974 5788999987543 33456788999999998 69999999999863 


Q ss_pred             -----CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceE
Q 006090          563 -----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK  637 (662)
Q Consensus       563 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  637 (662)
                           .+..+++|||+++|+|.+++... ....+++..+..++.||++||+|||+.+   |+|+||||+||++++++.+|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45679999999999999998542 2345788889999999999999999987   99999999999999999999


Q ss_pred             EEeeCcccccc
Q 006090          638 ISDFGLARIFG  648 (662)
Q Consensus       638 i~DFGla~~~~  648 (662)
                      |+|||+++...
T Consensus       162 l~dfg~~~~~~  172 (282)
T cd06636         162 LVDFGVSAQLD  172 (282)
T ss_pred             EeeCcchhhhh
Confidence            99999988654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.85  E-value=1.5e-20  Score=191.23  Aligned_cols=150  Identities=24%  Similarity=0.390  Sum_probs=129.6

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E  571 (662)
                      +|++.+.||+|++|.||++... +++.+|+|.+....  ....+.+.+|++++++++|+|++++.+.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999865 57889999986432  2345678899999999999999999998764 445789999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++|.+++... ....+++.++..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999998542 2345899999999999999999999988   99999999999999999999999999987743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.85  E-value=1.2e-20  Score=197.85  Aligned_cols=150  Identities=30%  Similarity=0.477  Sum_probs=129.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .+.|...+.||+|+||.||+|+.. +++.||+|.+.....   ...+++.+|++++++++||||+++.+++.+++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999875 588999998864322   2345788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +||++ |+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++....
T Consensus        94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 6777776432  235899999999999999999999987   99999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=7.9e-21  Score=194.95  Aligned_cols=154  Identities=28%  Similarity=0.501  Sum_probs=133.6

Q ss_pred             hhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCC-----
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE-----  564 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~-----  564 (662)
                      .++++|++.+.||+|+||.||+|... +++.+++|.+... ......|.+|+.+++++ +|+||+++++++.+..     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999975 5788999988653 33457899999999999 6999999999997654     


Q ss_pred             -eeEEEEEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          565 -ENMLIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       565 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                       ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999999985422 2356899999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccC
Q 006090          643 LARIFGG  649 (662)
Q Consensus       643 la~~~~~  649 (662)
                      ++.....
T Consensus       159 ~~~~~~~  165 (275)
T cd06608         159 VSAQLDS  165 (275)
T ss_pred             cceeccc
Confidence            9876643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.3e-21  Score=187.08  Aligned_cols=143  Identities=16%  Similarity=0.177  Sum_probs=110.7

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccc--c-------HHHH-----------------HHHHHHHhcCCCCCc
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--G-------QEEF-----------------MNEVMVISNLQHRNL  553 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~nI  553 (662)
                      ...||+|+||.||+|..++|+.||||+++.....  .       ...|                 ..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999998653211  1       1122                 349999999988776


Q ss_pred             ceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCcEEEcC
Q 006090          554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL-HRDSRLRIIHRDLKASNILLDD  632 (662)
Q Consensus       554 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlkp~NILl~~  632 (662)
                      .....+..  ...+|||||++++++...+.   ....+++.+...++.|++.+|.|+ |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            54433322  23489999999887765432   224588899999999999999999 6777   99999999999998 


Q ss_pred             CCceEEEeeCccccccCCc
Q 006090          633 DLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       633 ~~~~ki~DFGla~~~~~~~  651 (662)
                      ++.++|+|||+|.......
T Consensus       153 ~~~v~LiDFG~a~~~~~~~  171 (190)
T cd05147         153 DGKLYIIDVSQSVEHDHPH  171 (190)
T ss_pred             CCcEEEEEccccccCCCcC
Confidence            4789999999998765443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.85  E-value=5.4e-21  Score=197.74  Aligned_cols=148  Identities=28%  Similarity=0.516  Sum_probs=128.8

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.+.||+|+||.||+++.. +++.+|+|++....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777899999999999999975 68899999886432  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++ ++|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            97 5788877432  345899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.85  E-value=6.7e-21  Score=195.35  Aligned_cols=145  Identities=40%  Similarity=0.634  Sum_probs=125.3

Q ss_pred             cccCccCceeEEEEEEcC-------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQD-------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~-------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... .....+|.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998642       2578999886533 24466899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-----ceEEEeeCc
Q 006090          573 MPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-----NPKISDFGL  643 (662)
Q Consensus       573 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~ki~DFGl  643 (662)
                      +++++|.+++.+..    ....+++.+++.++.||+.||.|||+.+   ++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996422    2235789999999999999999999887   99999999999999887     899999999


Q ss_pred             ccccc
Q 006090          644 ARIFG  648 (662)
Q Consensus       644 a~~~~  648 (662)
                      ++.+.
T Consensus       158 ~~~~~  162 (269)
T cd05044         158 ARDIY  162 (269)
T ss_pred             ccccc
Confidence            98664

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.85  E-value=4.6e-21  Score=214.23  Aligned_cols=152  Identities=24%  Similarity=0.407  Sum_probs=120.2

Q ss_pred             ccccccccccCccCceeEEEEEEcC--CcEEEEE------------------EccccccccHHHHHHHHHHHhcCCCCCc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD--GQEIAVK------------------RLSKASGQGQEEFMNEVMVISNLQHRNL  553 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~--~~~vAvK------------------~l~~~~~~~~~~f~~E~~~l~~l~H~nI  553 (662)
                      .++|.+.++||+|+||+||++..+.  +...++|                  .+. ........+.+|+++|++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            4689999999999999999987542  2222222                  111 112234568899999999999999


Q ss_pred             ceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR--QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       554 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                      +++++++.+.+..++|+|++. ++|.+++.....  .......+...|+.||+.||.|||+.+   ||||||||+||||+
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999995 577777643211  122335667789999999999999987   99999999999999


Q ss_pred             CCCceEEEeeCccccccCC
Q 006090          632 DDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       632 ~~~~~ki~DFGla~~~~~~  650 (662)
                      .++.+||+|||+++.+...
T Consensus       302 ~~~~vkL~DFGla~~~~~~  320 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKE  320 (501)
T ss_pred             CCCCEEEEeCCCceecCcc
Confidence            9999999999999987654

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.3e-20  Score=189.11  Aligned_cols=149  Identities=33%  Similarity=0.521  Sum_probs=133.5

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.+.||+|++|.||+++.. +++.+++|.+.....  .....+.+|++++.+++|||++++++++.+++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999865 578999999876443  3556899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999998432   46899999999999999999999987   999999999999999999999999999987553

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.84  E-value=1.1e-20  Score=193.28  Aligned_cols=148  Identities=28%  Similarity=0.400  Sum_probs=132.1

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +|+..+.||+|+||.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+..+...++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677899999999999999976 58899999887543 344567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++++|.+++....  ..+++..+..++.|+++||+|||+ .+   ++|+||||+||++++++.+||+|||++..+.
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999995432  568899999999999999999999 66   9999999999999999999999999998664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.84  E-value=1.6e-20  Score=194.81  Aligned_cols=151  Identities=28%  Similarity=0.404  Sum_probs=129.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  570 (662)
                      ++|...++||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35778899999999999999975 57889999886432 23467799999999999999999999998654  3679999


Q ss_pred             EccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||+++++|.+++... .....+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999987432 22345888999999999999999999987   9999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.84  E-value=9.2e-21  Score=193.21  Aligned_cols=141  Identities=32%  Similarity=0.461  Sum_probs=126.2

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ||+|+||.||+++.. +++.+++|.+.....   ...+.+.+|++++.+++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 489999999865332   3456789999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      .+++.+.   ..+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            9999542   35899999999999999999999987   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.84  E-value=2.1e-20  Score=193.71  Aligned_cols=151  Identities=29%  Similarity=0.528  Sum_probs=135.5

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++.|+..+.||+|++|.||++..+ +++.+++|.+..... ..+.+.+|++++++++|+||+++++.+...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999987 688999999875433 56788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.+||+|||++..+..
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999995432  36899999999999999999999987   99999999999999999999999999876654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.84  E-value=3.6e-20  Score=187.00  Aligned_cols=149  Identities=34%  Similarity=0.632  Sum_probs=134.8

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      |...+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+||+++++++..+...++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            667889999999999999976 6889999999765545678899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++|.+++....  ..+++..+..++.|+++||.|||..+   ++|+||+|+||++++++.+||+|||++......
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999985422  46899999999999999999999977   999999999999999999999999999888654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.84  E-value=1.7e-20  Score=192.45  Aligned_cols=153  Identities=27%  Similarity=0.507  Sum_probs=128.5

Q ss_pred             ccccccccCccCceeEEEEEEcC--CcEEEEEEcccc----------ccccHHHHHHHHHHHhc-CCCCCcceeeEEEEe
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQD--GQEIAVKRLSKA----------SGQGQEEFMNEVMVISN-LQHRNLVRLLGCCVE  562 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~--~~~vAvK~l~~~----------~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~  562 (662)
                      +|++.+.||+|+||.||++....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36778999999999999999764  678999987532          12234567788888865 799999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          563 REENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      ++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+..  +++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999987431 23346899999999999999999999632  3999999999999999999999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |++......
T Consensus       159 g~~~~~~~~  167 (269)
T cd08528         159 GLAKQKQPE  167 (269)
T ss_pred             cceeecccc
Confidence            999877554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.84  E-value=1.8e-20  Score=193.40  Aligned_cols=143  Identities=31%  Similarity=0.462  Sum_probs=125.5

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 58899999886422   22345678899999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      .+++.+... ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            999864332 35899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.1e-20  Score=207.86  Aligned_cols=154  Identities=27%  Similarity=0.449  Sum_probs=121.6

Q ss_pred             hccccccccccCccCceeEEEEEE-----------------cCCcEEEEEEccccccccHHHH--------------HHH
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKL-----------------QDGQEIAVKRLSKASGQGQEEF--------------MNE  541 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~-----------------~~~~~vAvK~l~~~~~~~~~~f--------------~~E  541 (662)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 2346799999865332223333              346


Q ss_pred             HHHHhcCCCCCc-----ceeeEEEEe--------CCeeEEEEEccCCCCHHHHhcCCC---------------------C
Q 006090          542 VMVISNLQHRNL-----VRLLGCCVE--------REENMLIYEYMPNKSLDSFLFDPQ---------------------R  587 (662)
Q Consensus       542 ~~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~  587 (662)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++++|.++|+...                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     778888764        356799999999999999986421                     1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       588 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ...++|..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~  361 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT  361 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence            123577889999999999999999987   99999999999999999999999999976643

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.84  E-value=1.6e-20  Score=196.06  Aligned_cols=151  Identities=29%  Similarity=0.547  Sum_probs=129.7

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----  564 (662)
                      ..++|++.+.||+|+||.||+|... +++.||+|.++...  ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567889999999999999999976 57899999986432  223456788999999999999999999987755     


Q ss_pred             -----eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          565 -----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       565 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                           ..++|+||+++ +|.+++...  ...+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                 78999999986 777776432  345899999999999999999999987   9999999999999999999999


Q ss_pred             eeCccccccC
Q 006090          640 DFGLARIFGG  649 (662)
Q Consensus       640 DFGla~~~~~  649 (662)
                      |||+++.+..
T Consensus       159 dfg~~~~~~~  168 (302)
T cd07864         159 DFGLARLYNS  168 (302)
T ss_pred             cccccccccC
Confidence            9999987754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.84  E-value=2.3e-20  Score=194.30  Aligned_cols=143  Identities=27%  Similarity=0.455  Sum_probs=128.3

Q ss_pred             ccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          500 ANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ..+||+|+||.||++... +++.||||.+..........+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            368999999999999875 6889999988654445567799999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      .+++..    ..+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            998732    34789999999999999999999987   99999999999999999999999999876643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.84  E-value=2.5e-20  Score=189.46  Aligned_cols=151  Identities=28%  Similarity=0.470  Sum_probs=131.3

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|+..+.||+|+||.||++... +++.+|+|.+...  .....+.+.+|++++++++||||+++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777899999999999999864 6789999988643  233467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++.+. ....+++..+..++.|++++|.|||+++   ++|+||||+||+++++ +.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999999542 2345899999999999999999999987   9999999999999865 46899999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=5.4e-21  Score=198.12  Aligned_cols=159  Identities=25%  Similarity=0.375  Sum_probs=136.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .-|.+.+.||+|-|..|-++++- +|..||||++.+.  +......+..|++.|+.++|||||+|+.+...+...|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            44677789999999999999854 7999999999753  23344568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-cCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL-DDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~ki~DFGla~~~~~~  650 (662)
                      .=.+|+|.+||.+  ....+.+....+++.||+.|+.|+|+-.   ++||||||+||.+ .+-|.+||.|||++..+.++
T Consensus        98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999954  3445889999999999999999999877   9999999999876 56789999999999999877


Q ss_pred             ccccccccccc
Q 006090          651 QDQAATKRLVG  661 (662)
Q Consensus       651 ~~~~~~~~~~G  661 (662)
                      +.   .++.+|
T Consensus       173 ~k---L~TsCG  180 (864)
T KOG4717|consen  173 KK---LTTSCG  180 (864)
T ss_pred             ch---hhcccc
Confidence            53   333555

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=3e-21  Score=218.39  Aligned_cols=149  Identities=35%  Similarity=0.533  Sum_probs=122.3

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe--------
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--------  562 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--------  562 (662)
                      -.++|+..+.||+||||.|||++.+ +|+.+|||++... +........+|++.+++|+|||||+++..+.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3467888999999999999999966 7999999998643 23344578899999999999999988732110        


Q ss_pred             ----------------------------------------------------------------------C---------
Q 006090          563 ----------------------------------------------------------------------R---------  563 (662)
Q Consensus       563 ----------------------------------------------------------------------~---------  563 (662)
                                                                                            +         
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                  0         


Q ss_pred             --------------------------------CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 006090          564 --------------------------------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH  611 (662)
Q Consensus       564 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH  611 (662)
                                                      ...||=||||+.-.|.+++++.....  .....++++++|++||+|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                            12378899999888888885433221  45678899999999999999


Q ss_pred             hCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       612 ~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      +++   ||||||||.||+||++..+||.|||+|..
T Consensus       715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             hCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            998   99999999999999999999999999998

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.84  E-value=2.1e-20  Score=205.58  Aligned_cols=170  Identities=26%  Similarity=0.500  Sum_probs=145.6

Q ss_pred             CHHHHHhhccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEe-
Q 006090          486 NFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE-  562 (662)
Q Consensus       486 ~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~-  562 (662)
                      .++.+...++.|++.+.||.|.+|.||+++. ++++.+|+|++.. .....++...|.++++.. +|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3445556778899999999999999999984 4688999998865 445566777888998888 69999999999874 


Q ss_pred             ----CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          563 ----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       563 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                          +++.+||||||.+||..+++.+.. ...+.|.....|++.++.||.+||...   +||||||-.||||+.++.+|+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                467899999999999999997655 667999999999999999999999987   999999999999999999999


Q ss_pred             EeeCccccccCCcccccccccccC
Q 006090          639 SDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       639 ~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      .|||++..+.....+.+|  .+||
T Consensus       165 vDFGvSaQldsT~grRnT--~iGt  186 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGRRNT--FIGT  186 (953)
T ss_pred             eeeeeeeeeecccccccC--cCCC
Confidence            999999999776554433  5665

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.84  E-value=3e-20  Score=192.12  Aligned_cols=142  Identities=30%  Similarity=0.383  Sum_probs=119.1

Q ss_pred             ccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHh---cCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVIS---NLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~---~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..++.   ..+||||+.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58899999886432   122334455554443   3479999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            9999999843   345899999999999999999999988   99999999999999999999999999976643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.84  E-value=2.1e-20  Score=198.77  Aligned_cols=148  Identities=32%  Similarity=0.586  Sum_probs=127.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC--CeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER--EENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~~  567 (662)
                      .++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888999999999999999975 5789999988542  223445678899999999 999999999998754  3579


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||++ ++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 599988843    26889999999999999999999987   999999999999999999999999999877


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ..
T Consensus       158 ~~  159 (337)
T cd07852         158 SE  159 (337)
T ss_pred             cc
Confidence            44

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.84  E-value=3.9e-20  Score=187.57  Aligned_cols=150  Identities=34%  Similarity=0.527  Sum_probs=134.1

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIY  570 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  570 (662)
                      +|+..+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|++++++++||||+++++.+.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667899999999999999976 688999999865432  4567899999999999999999999999988  8899999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++.+.   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998542   26899999999999999999999987   999999999999999999999999999988655


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      .
T Consensus       155 ~  155 (260)
T cd06606         155 E  155 (260)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.84  E-value=4.5e-20  Score=192.06  Aligned_cols=150  Identities=29%  Similarity=0.498  Sum_probs=127.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.+.||+|++|.||+|+.. +++.||+|.+....  ......+.+|++++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999975 68899999886432  2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~  649 (662)
                      |++ ++|.+++... ....+++.....++.||+.||+|||+++   ++||||+|+||++++ ++.+||+|||+++.+..
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 5788877432 2233678888899999999999999987   999999999999985 56799999999987643

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.84  E-value=4.2e-20  Score=191.64  Aligned_cols=146  Identities=26%  Similarity=0.459  Sum_probs=129.7

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      |...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            334579999999999999864 6789999988654445566789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++|.+++.+    ..+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||++.....
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            999999844    34889999999999999999999987   99999999999999999999999999886643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.84  E-value=3.1e-20  Score=189.67  Aligned_cols=142  Identities=30%  Similarity=0.421  Sum_probs=126.6

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ||+|+||.||+++.. +++.+|+|.+....   ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 48899999986432   23456799999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      .+++.+   ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            999954   234889999999999999999999987   999999999999999999999999999987553

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=3e-20  Score=192.02  Aligned_cols=148  Identities=30%  Similarity=0.554  Sum_probs=129.9

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEEEEE
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIYE  571 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E  571 (662)
                      |++.++||+|+||.||+|+.. +++.+|+|++....  ......+.+|++++++++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456789999999999999976 47899999997642  23346788999999999999999999999988  88999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9974 898888543  246899999999999999999999987   999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.84  E-value=3.1e-20  Score=198.03  Aligned_cols=149  Identities=26%  Similarity=0.452  Sum_probs=128.6

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----  564 (662)
                      ..++|++.+.||+|+||.||++... +++.||||++....  ......+.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4578999999999999999999854 68899999885422  223456889999999999999999999987654     


Q ss_pred             -eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          565 -ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       565 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                       ..++||||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             358999999 7799988732    35899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      ++....
T Consensus       165 ~~~~~~  170 (343)
T cd07880         165 ARQTDS  170 (343)
T ss_pred             cccccc
Confidence            987654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.84  E-value=2.2e-20  Score=189.88  Aligned_cols=151  Identities=26%  Similarity=0.488  Sum_probs=131.6

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.+.||+|+||.||++... ++..+|+|.+...  .....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777899999999999999976 5788999988643  123456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++.+. ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++ .+||+|||++..+...
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998542 2335799999999999999999999987   99999999999999885 5799999999887543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=3.4e-20  Score=180.38  Aligned_cols=142  Identities=19%  Similarity=0.218  Sum_probs=112.9

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccc--c------------------------HHHHHHHHHHHhcCCCCCc
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--G------------------------QEEFMNEVMVISNLQHRNL  553 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~--~------------------------~~~f~~E~~~l~~l~H~nI  553 (662)
                      ...||+|+||+||+|...+|+.||||++......  .                        ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998753211  0                        1124678999999999988


Q ss_pred             ceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcC
Q 006090          554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDD  632 (662)
Q Consensus       554 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~  632 (662)
                      .....+...  ..+|||||++++++.....   ....++......++.|++.+|.++|+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            655544333  3489999999886543321   12346788899999999999999999 77   99999999999999 


Q ss_pred             CCceEEEeeCccccccCC
Q 006090          633 DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       633 ~~~~ki~DFGla~~~~~~  650 (662)
                      ++.++|+|||+|+.+...
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            889999999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.84  E-value=2.8e-20  Score=189.70  Aligned_cols=156  Identities=26%  Similarity=0.507  Sum_probs=130.3

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCeeEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENMLIY  570 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  570 (662)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .....+.+..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677899999999999999864 6788999988642  23345678899999999999999999998764  34578999


Q ss_pred             EccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDS--RLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ||+++++|.+++... .....+++..++.++.||+.||+|||..+  ..+++|+||||+||++++++.+||+|||+++.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542 22456899999999999999999999332  234999999999999999999999999999988


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       161 ~~~~  164 (265)
T cd08217         161 GHDS  164 (265)
T ss_pred             cCCc
Confidence            6543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.83  E-value=1.3e-20  Score=193.95  Aligned_cols=150  Identities=33%  Similarity=0.485  Sum_probs=133.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|.+.+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|++++.+++ ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999975 6899999988652   2234567889999999998 99999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++.+   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999953   336899999999999999999999987   99999999999999999999999999987754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       155 ~  155 (280)
T cd05581         155 N  155 (280)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=3.2e-21  Score=189.98  Aligned_cols=160  Identities=30%  Similarity=0.356  Sum_probs=137.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|..+++||+|.||+|-+++-+ +++.+|+|++++...   .+...-+.|-++|+..+||.+..|--.++..+..++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            67888999999999999999865 688999999987433   33345677889999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||..||.|.-+|.+   ...+++.....+...|+.||.|||+++   ||.||||.+|.|||++|++||+||||++.-...
T Consensus       248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999888843   445788888889999999999999988   999999999999999999999999999965544


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      ..  .+.+++||
T Consensus       322 g~--t~kTFCGT  331 (516)
T KOG0690|consen  322 GD--TTKTFCGT  331 (516)
T ss_pred             cc--eeccccCC
Confidence            33  35568887

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.83  E-value=3.9e-20  Score=191.20  Aligned_cols=147  Identities=31%  Similarity=0.572  Sum_probs=128.6

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      |++.+.||+|++|.||+|... ++..||+|++....  ......+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456789999999999999865 68999999886432  223457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      + ++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||+++.+.
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            5 68999885422 235899999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.83  E-value=4.2e-20  Score=193.43  Aligned_cols=149  Identities=31%  Similarity=0.548  Sum_probs=126.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe------
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE------  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~------  565 (662)
                      ++|++.++||+|+||.||+++.. +++.||||.+....  ......+.+|++++++++||||+++++++...+.      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57888999999999999999975 58899999885432  2223456789999999999999999999876543      


Q ss_pred             --eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          566 --NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       566 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                        .++||||++ ++|.+++...  ...+++.++..++.||++||.|||+++   ++|+||||+||++++++.+||+|||+
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence              499999996 5888877432  235899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      +..+..
T Consensus       166 ~~~~~~  171 (310)
T cd07865         166 ARAFSL  171 (310)
T ss_pred             cccccC
Confidence            987743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.83  E-value=3.9e-20  Score=191.96  Aligned_cols=149  Identities=30%  Similarity=0.383  Sum_probs=128.9

Q ss_pred             ccccccccCccCceeEEEEEEc----CCcEEEEEEccccc----cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCee
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS----GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  566 (662)
                      +|++.+.||+|++|.||+++..    +++.+|||.++...    ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677899999999999999743    46789999886422    22345688999999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999843   245889999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCC
Q 006090          647 FGGN  650 (662)
Q Consensus       647 ~~~~  650 (662)
                      +...
T Consensus       155 ~~~~  158 (288)
T cd05583         155 FLAE  158 (288)
T ss_pred             cccc
Confidence            6443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.83  E-value=4.2e-20  Score=193.83  Aligned_cols=150  Identities=34%  Similarity=0.547  Sum_probs=128.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  568 (662)
                      .++|++.+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357888999999999999999975 588999998864322  2234567899999999999999999998765  45799


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||++ ++|.+++...  ...+++.++..++.||++||+|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            999996 5888888542  245899999999999999999999988   9999999999999999999999999998875


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       160 ~  160 (309)
T cd07845         160 L  160 (309)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PTZ00284 protein kinase; Provisional

Probab=99.83  E-value=2.7e-20  Score=206.81  Aligned_cols=151  Identities=19%  Similarity=0.283  Sum_probs=122.0

Q ss_pred             HHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCC------CCcceeeEEEE
Q 006090          489 ELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH------RNLVRLLGCCV  561 (662)
Q Consensus       489 ~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H------~nIv~l~g~~~  561 (662)
                      ++....++|++.++||+|+||+||++... .++.||||+++.. ....+++..|++++.+++|      ++++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999865 5788999998642 2334456677777776654      45889999887


Q ss_pred             eC-CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC-----
Q 006090          562 ER-EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDL-----  634 (662)
Q Consensus       562 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~-----  634 (662)
                      .. ...++|||++ +++|.+++.+   ...+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            65 4678999988 7788888843   34589999999999999999999974 6   99999999999998765     


Q ss_pred             -----------ceEEEeeCccccc
Q 006090          635 -----------NPKISDFGLARIF  647 (662)
Q Consensus       635 -----------~~ki~DFGla~~~  647 (662)
                                 .+||+|||++...
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~  298 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDE  298 (467)
T ss_pred             ccccccCCCCceEEECCCCccccC
Confidence                       4999999988654

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.83  E-value=6.3e-20  Score=189.60  Aligned_cols=141  Identities=30%  Similarity=0.379  Sum_probs=118.7

Q ss_pred             ccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHH---HhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMV---ISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~---l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      .||+|+||.||++... +++.||+|.+.+...   .....+..|..+   ++...||||+++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 578999998865321   222334455443   444579999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            9999998843   346899999999999999999999987   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.83  E-value=3.3e-20  Score=197.15  Aligned_cols=148  Identities=28%  Similarity=0.466  Sum_probs=127.4

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----ee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----EN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~  566 (662)
                      .++|++.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467999999999999999999864 68899999986432 234566889999999999999999999876543     47


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++|+||++ ++|.+++.    ...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            99999996 58887773    235899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      ...
T Consensus       156 ~~~  158 (336)
T cd07849         156 ADP  158 (336)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.83  E-value=5.9e-20  Score=196.01  Aligned_cols=155  Identities=29%  Similarity=0.426  Sum_probs=131.4

Q ss_pred             HHHHHhhccccccccccCccCceeEEEEEE-cCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC
Q 006090          487 FEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER  563 (662)
Q Consensus       487 ~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~  563 (662)
                      ..++...+++|.+.+.||+|+||.||++.. .+++.||+|+++...  ....+.+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            455666778999999999999999999985 468899999986532  22346788999999999999999999988643


Q ss_pred             ------CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceE
Q 006090          564 ------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK  637 (662)
Q Consensus       564 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  637 (662)
                            ...++++|++ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  2357888877 7899888732    34899999999999999999999987   99999999999999999999


Q ss_pred             EEeeCccccccC
Q 006090          638 ISDFGLARIFGG  649 (662)
Q Consensus       638 i~DFGla~~~~~  649 (662)
                      |+|||+++....
T Consensus       161 l~dfg~~~~~~~  172 (345)
T cd07877         161 ILDFGLARHTDD  172 (345)
T ss_pred             Eecccccccccc
Confidence            999999987643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.4e-20  Score=200.83  Aligned_cols=155  Identities=32%  Similarity=0.492  Sum_probs=131.8

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHH
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLD  579 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  579 (662)
                      -+||+|.||+||-|+.. +...+|||-+.....+..+-...|+.+.++++|.|||+.+|.|.+++..-+.||-+|||||.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            47999999999999965 45679999987767777778899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEeeCccccccCCcccccc
Q 006090          580 SFLFDPQRQSLL--DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAAT  656 (662)
Q Consensus       580 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~ki~DFGla~~~~~~~~~~~~  656 (662)
                      ++|+.  +=.++  .+.+.-.+-+||++||.|||++.   |+|||||-.|||++ -.|.+||+|||-+|.+.+-  ...|
T Consensus       661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~T  733 (1226)
T KOG4279|consen  661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCT  733 (1226)
T ss_pred             HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Cccc
Confidence            99953  22334  66777788999999999999988   99999999999996 4789999999999988542  1234


Q ss_pred             cccccC
Q 006090          657 KRLVGT  662 (662)
Q Consensus       657 ~~~~Gt  662 (662)
                      .++.||
T Consensus       734 ETFTGT  739 (1226)
T KOG4279|consen  734 ETFTGT  739 (1226)
T ss_pred             cccccc
Confidence            445555

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=6.9e-20  Score=186.92  Aligned_cols=142  Identities=26%  Similarity=0.346  Sum_probs=120.7

Q ss_pred             cccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHH-hcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVI-SNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.||+|+||.||+|... +++.||+|.+.....   .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 588999999865321   2233455565554 445899999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||+++...
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            999999843   245889999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.83  E-value=7.6e-20  Score=188.77  Aligned_cols=146  Identities=27%  Similarity=0.430  Sum_probs=124.3

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCC-CCCcceeeEEEEeC--CeeEEEEE
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER--EENMLIYE  571 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E  571 (662)
                      |++.++||+|+||.||+++.. +++.+|+|+++... .........|+.++.++. |+||+++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456789999999999999865 58899999987532 222334567889999885 99999999999987  88999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |++ ++|.+++...  ...+++.++..++.||+.||.|||+.+   |+||||||+||+++. +.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            997 5888887432  246899999999999999999999987   999999999999999 9999999999987754

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=2.2e-20  Score=212.29  Aligned_cols=158  Identities=32%  Similarity=0.486  Sum_probs=134.7

Q ss_pred             HHhhccccccccccCccCceeEEEEEEc----C----CcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEE
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQ----D----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGC  559 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~----~----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~  559 (662)
                      ++...++..+.+.||+|.||+|++|.+.    .    ...||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3344455566779999999999999854    1    4579999998643 34577899999999999 69999999999


Q ss_pred             EEeCCeeEEEEEccCCCCHHHHhcCCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 006090          560 CVEREENMLIYEYMPNKSLDSFLFDPQ-----------RQ--SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKAS  626 (662)
Q Consensus       560 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~  626 (662)
                      |.+++..++|.||++.|+|.+||+..+           ..  ..++..+.+.++.|||.||+||++..   +|||||.+|
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999997544           00  23888999999999999999999987   999999999


Q ss_pred             cEEEcCCCceEEEeeCccccccCC
Q 006090          627 NILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       627 NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||||.++..+||+||||||.....
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~  471 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNK  471 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCC
Confidence            999999999999999999966443

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.83  E-value=9.7e-20  Score=184.75  Aligned_cols=152  Identities=24%  Similarity=0.478  Sum_probs=134.6

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|.+.+.||+|+||.||++... +++.+++|++.....  ....++.+|++++++++|||++++.+.+.+++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677899999999999999975 588999999875432  4566789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++.+.. ....+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999986432 1356899999999999999999999987   999999999999999999999999999877554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.83  E-value=1.4e-20  Score=197.89  Aligned_cols=150  Identities=25%  Similarity=0.379  Sum_probs=129.6

Q ss_pred             ccccccccCccCceeEEEEEEcC-CcEEEEEEcccccc--------ccHHHHHHHHHHHhcCC---CCCcceeeEEEEeC
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASG--------QGQEEFMNEVMVISNLQ---HRNLVRLLGCCVER  563 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~  563 (662)
                      +|...+++|+|+||.|+.+.++. ..+|+||.+.+...        ...-..-.|+.+|..++   |+||++++.+++++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            58889999999999999999874 56899998865321        11223567999999996   99999999999999


Q ss_pred             CeeEEEEEcc-CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          564 EENMLIYEYM-PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       564 ~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      +..||+||-. ++-+|.++|.   .+..+++.++.-|++||+-|+++||+++   |||||||-+||+++.+|-+||+|||
T Consensus       642 d~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence            9999999975 4568999993   3456899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCc
Q 006090          643 LARIFGGNQ  651 (662)
Q Consensus       643 la~~~~~~~  651 (662)
                      -|.+...+.
T Consensus       716 saa~~ksgp  724 (772)
T KOG1152|consen  716 SAAYTKSGP  724 (772)
T ss_pred             chhhhcCCC
Confidence            999887665

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.83  E-value=6.9e-20  Score=196.11  Aligned_cols=148  Identities=30%  Similarity=0.453  Sum_probs=126.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------C
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------E  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~  564 (662)
                      .++|+..+.||+|+||.||++... +++.||+|.+...  .......+.+|+.++++++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            467999999999999999999865 6889999998642  223345678899999999999999999998644      3


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||++ ++|.+.+..     .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            4699999996 588887732     2788999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.....
T Consensus       166 ~~~~~~  171 (353)
T cd07850         166 RTAGTS  171 (353)
T ss_pred             eeCCCC
Confidence            977543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.83  E-value=1.2e-19  Score=191.20  Aligned_cols=148  Identities=30%  Similarity=0.491  Sum_probs=127.9

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .|...+.||+|+||.||+++.. ++..+|+|.+.....   .....+.+|++++++++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667889999999999999965 578999998864322   234578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |++ |+|.+++...  ...+++.++..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            997 5777776432  345899999999999999999999987   99999999999999999999999999886654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.83  E-value=3.6e-20  Score=196.68  Aligned_cols=148  Identities=24%  Similarity=0.464  Sum_probs=128.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEe----CCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----REENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~  567 (662)
                      .+|++.+.||+|+||.||++... +++.||+|++....  ......+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888999999999999999865 58899999987532  2345677889999999999999999998763    34679


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|+||+. ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999995 689998843   334899999999999999999999987   999999999999999999999999999876


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ..
T Consensus       158 ~~  159 (334)
T cd07855         158 SS  159 (334)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.82  E-value=9.6e-21  Score=176.15  Aligned_cols=156  Identities=28%  Similarity=0.410  Sum_probs=130.7

Q ss_pred             hhccccccccccCccCceeEEEEEE-cCCcEEEEEEcccc-ccccHHHHHHHHHHHhc-CCCCCcceeeEEEEeCCeeEE
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA-SGQGQEEFMNEVMVISN-LQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ...+...-.+.||+|++|.|-+-++ .+|+.+|+|++... ..+.+++.++|+++..+ ...|.+|+++|...+....++
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            3344555578999999999988885 47999999998643 45667888999998655 479999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          569 IYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      .||.|. .||+.+-.+. .....+++...=+||..|.+||.|||++  +.+||||+||+||||+.+|++||||||++.++
T Consensus       123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999994 6888775321 2345688888999999999999999996  46999999999999999999999999999988


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      .+.
T Consensus       200 ~dS  202 (282)
T KOG0984|consen  200 VDS  202 (282)
T ss_pred             hhh
Confidence            654

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.82  E-value=8.1e-20  Score=194.27  Aligned_cols=149  Identities=26%  Similarity=0.487  Sum_probs=128.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----e
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----E  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~  565 (662)
                      .++|.+.+.||+|+||.||++... +++.||||.+...  .......+.+|+.++++++|+||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357888999999999999999864 6889999988653  2233456788999999999999999999886543     4


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++|+||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 789888843   345899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccC
Q 006090          646 IFGG  649 (662)
Q Consensus       646 ~~~~  649 (662)
                      ....
T Consensus       157 ~~~~  160 (337)
T cd07858         157 TTSE  160 (337)
T ss_pred             ccCC
Confidence            7754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.82  E-value=6.5e-20  Score=186.20  Aligned_cols=152  Identities=30%  Similarity=0.526  Sum_probs=133.0

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|++.++||+|+||.||+++.. +++.+++|.+....  .....++.+|++++++++|+||+++++++.++...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777899999999999999865 67899999886532  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++.+.. ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999985422 2356899999999999999999999987   999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.82  E-value=2.2e-19  Score=184.41  Aligned_cols=149  Identities=26%  Similarity=0.349  Sum_probs=121.7

Q ss_pred             Hhhcccccccccc--CccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCee
Q 006090          491 ANATNNFQLANKL--GQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       491 ~~~~~~f~~~~~l--G~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  566 (662)
                      ....++|++.+.+  |+|+||.||++..+ +++.+|+|.+.......     .|+.....+ +||||+++++.+...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3344566666666  99999999999865 57889999876432111     122222222 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLAR  645 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~  645 (662)
                      ++||||+++++|.+++...   ..+++.++..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||+++
T Consensus        85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            9999999999999999542   36899999999999999999999987   99999999999999998 99999999998


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       159 ~~~~~  163 (267)
T PHA03390        159 IIGTP  163 (267)
T ss_pred             ecCCC
Confidence            76543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.82  E-value=9.5e-20  Score=193.00  Aligned_cols=151  Identities=31%  Similarity=0.489  Sum_probs=129.5

Q ss_pred             HhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCee
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REEN  566 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~  566 (662)
                      ...+++|++.+.||+|+||.||++... +++.||+|++...  .....+.+..|++++.+++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346688999999999999999999855 6889999987542  22335678899999999999999999999876 5578


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++|+||+ +++|.+++.    ...+++.....++.|+++||+|||+.+   |+||||+|+|||+++++.+||+|||+++.
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999999 568988883    234788888899999999999999987   99999999999999999999999999986


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      ...
T Consensus       158 ~~~  160 (328)
T cd07856         158 QDP  160 (328)
T ss_pred             cCC
Confidence            543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.82  E-value=9.5e-20  Score=193.48  Aligned_cols=147  Identities=27%  Similarity=0.411  Sum_probs=126.7

Q ss_pred             cccc-cccccCccCceeEEEEEEc-CCcEEEEEEcccccccc--------------HHHHHHHHHHHhcCCCCCcceeeE
Q 006090          495 NNFQ-LANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQG--------------QEEFMNEVMVISNLQHRNLVRLLG  558 (662)
Q Consensus       495 ~~f~-~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~nIv~l~g  558 (662)
                      ++|. +.+.||+|+||.||++... +++.||||.++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3577999999999999865 68899999886432211              125789999999999999999999


Q ss_pred             EEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       559 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      ++..++..++||||++ ++|.+++..   ...+++.....++.||++||.|||+.+   |+|+||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 689998843   345889999999999999999999987   999999999999999999999


Q ss_pred             EeeCcccccc
Q 006090          639 SDFGLARIFG  648 (662)
Q Consensus       639 ~DFGla~~~~  648 (662)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (335)
T PTZ00024        161 ADFGLARRYG  170 (335)
T ss_pred             CCccceeecc
Confidence            9999998776

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.82  E-value=8e-20  Score=188.80  Aligned_cols=148  Identities=31%  Similarity=0.490  Sum_probs=128.3

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEcc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      |++.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999976 478899999865322 22334567999999998 999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                       +++|.+++.... ...+++.++..++.|++++|.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence             889998885432 246899999999999999999999987   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.82  E-value=1.2e-19  Score=189.23  Aligned_cols=149  Identities=27%  Similarity=0.441  Sum_probs=126.2

Q ss_pred             cccccccccCccCceeEEEEEEcC-CcEEEEEEccccc-cccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.+.||+|+||.||+|+.+. ++.||||.++... .....++..|+.++.+.. ||||+++++++.++...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567788999999999999999874 8899999986532 233456777888777775 9999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |++ ++|.+++...  ...+++..+..++.||++||+|||+. +   |+||||+|+||++++++.+||+|||+++.+..
T Consensus        95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            985 5777766432  23689999999999999999999974 5   99999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.82  E-value=1.7e-19  Score=191.36  Aligned_cols=147  Identities=29%  Similarity=0.448  Sum_probs=123.8

Q ss_pred             ccccccccCccCceeEEEEEEc-C--CcEEEEEEccccc--cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC----Ce
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-D--GQEIAVKRLSKAS--GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER----EE  565 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~--~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~----~~  565 (662)
                      +|.+.+.||+|+||.||++... .  +..+|+|++....  ....+.+.+|++++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677899999999999999965 3  6789999886432  22356788999999999 599999999986543    34


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++++||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688899886 689988843   345899999999999999999999988   9999999999999999999999999998


Q ss_pred             cccC
Q 006090          646 IFGG  649 (662)
Q Consensus       646 ~~~~  649 (662)
                      .+..
T Consensus       154 ~~~~  157 (332)
T cd07857         154 GFSE  157 (332)
T ss_pred             eccc
Confidence            7653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.82  E-value=1.2e-19  Score=190.70  Aligned_cols=145  Identities=22%  Similarity=0.224  Sum_probs=123.7

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +.+.+|.|+++.|++++. +++.||||++...  .....+.+.+|+++++.++|+||+++++++.+++..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            345556666666666655 5899999998653  3345678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +|.+++.+.. ...+++.....++.|+++||+|||+++   |+||||||+||+++.++.+||+|||.+..+.
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            9999996432 235788999999999999999999987   9999999999999999999999999987664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=3.9e-20  Score=195.87  Aligned_cols=154  Identities=25%  Similarity=0.396  Sum_probs=131.9

Q ss_pred             CHHHHHhhc---cccccccccCccCceeEEEEE-EcCCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeE
Q 006090          486 NFEELANAT---NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLG  558 (662)
Q Consensus       486 ~~~~l~~~~---~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g  558 (662)
                      +|..|+.+.   .-|-.++.||-|+||+|.++. .++...+|+|.|++.+.   ......+.|-+||+..+.+-||+|+-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            455555543   457778999999999999997 44556789999976543   33456788999999999999999999


Q ss_pred             EEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       559 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      .|.+++.+|+||||++||++-++|.+   ...+++..+..++.++..|+.+.|..+   +|||||||.|||||.+|++||
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceee
Confidence            99999999999999999999999843   455788888888899999999999987   999999999999999999999


Q ss_pred             EeeCccc
Q 006090          639 SDFGLAR  645 (662)
Q Consensus       639 ~DFGla~  645 (662)
                      .||||+.
T Consensus       771 TDFGLCT  777 (1034)
T KOG0608|consen  771 TDFGLCT  777 (1034)
T ss_pred             eeccccc
Confidence            9999975

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.81  E-value=7.4e-20  Score=193.76  Aligned_cols=148  Identities=30%  Similarity=0.494  Sum_probs=130.6

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----eeE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENM  567 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  567 (662)
                      +|.+.+.||+|+||.||+++.. +++.+|+|++....  ....+.+.+|+++++.++||||+++.+++.+..     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999975 48899999987543  344578999999999999999999999998875     789


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||++ ++|.+++.+   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 589888843   236899999999999999999999988   999999999999999999999999999987


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       154 ~~~  156 (330)
T cd07834         154 DPD  156 (330)
T ss_pred             ccc
Confidence            654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.81  E-value=1.4e-19  Score=191.57  Aligned_cols=144  Identities=24%  Similarity=0.304  Sum_probs=123.7

Q ss_pred             ccccCcc--CceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          500 ANKLGQG--GFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       500 ~~~lG~G--~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      .+.||+|  +||+||+++.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567777  89999999874 68999999986432  2234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +++|.+++.+.. ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++||+.+...
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            999999985432 234889999999999999999999987   999999999999999999999999865443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.81  E-value=2.3e-21  Score=186.56  Aligned_cols=151  Identities=30%  Similarity=0.410  Sum_probs=126.3

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.+.+..||.|+||+|+|-.++ .|+.+|||+++... ..++++++.|++...+- +.||||+++|.+..++..++.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3444678999999999999876 68999999997543 46778999999976555 799999999999999999999999


Q ss_pred             cCCCCHHHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |. .||+.+...  ..+...+++...-+|....++||.||.++  +.|||||+||+|||||..|.+||||||++..+.+
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            94 677766421  12345588888888999999999999875  4699999999999999999999999999987754

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.81  E-value=2.7e-19  Score=185.02  Aligned_cols=149  Identities=31%  Similarity=0.536  Sum_probs=125.4

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcC---CCCCcceeeEEEEeCCe-----
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNL---QHRNLVRLLGCCVEREE-----  565 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~-----  565 (662)
                      |++.+.||+|+||.||+|+.+ +++.+|+|+++....  .....+.+|+.++.++   +||||+++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456789999999999999986 488999999864322  2234567788777665   69999999999998776     


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .+++|||++ ++|.+++.... ...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||+++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999997 58988885432 235899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       156 ~~~~~  160 (287)
T cd07838         156 IYSFE  160 (287)
T ss_pred             eccCC
Confidence            87543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.81  E-value=2.1e-19  Score=191.43  Aligned_cols=147  Identities=29%  Similarity=0.480  Sum_probs=125.4

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------  564 (662)
                      .++|...+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368888999999999999999864 68999999986432  223456889999999999999999999987643      


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++|+||+. .+|..++     ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            4589999996 4777765     124789999999999999999999987   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       165 ~~~~~  169 (342)
T cd07879         165 RHADA  169 (342)
T ss_pred             cCCCC
Confidence            87643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.81  E-value=1.7e-19  Score=186.96  Aligned_cols=150  Identities=29%  Similarity=0.409  Sum_probs=124.9

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +|...++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++.+++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555789999999999999865 57899999886432 234567899999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++ ++|.++...  ......+++..+..++.|++.||+|||+. +   |+||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            86 455544311  11234689999999999999999999975 5   99999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.81  E-value=1.5e-19  Score=186.63  Aligned_cols=148  Identities=30%  Similarity=0.526  Sum_probs=129.4

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      |+..+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++++++|+||+++++++.+++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            455788999999999999875 688999998865332  24567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++ +|.+++...  ...+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||.+..+...
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            75 888887542  246899999999999999999999988   999999999999999999999999999887654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.81  E-value=3.6e-19  Score=185.51  Aligned_cols=149  Identities=21%  Similarity=0.317  Sum_probs=111.4

Q ss_pred             ccccccccccCccCceeEEEEEEcCC----cEEEEEEccccccccH-----------HHHHHHHHHHhcCCCCCcceeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSKASGQGQ-----------EEFMNEVMVISNLQHRNLVRLLG  558 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~----~~vAvK~l~~~~~~~~-----------~~f~~E~~~l~~l~H~nIv~l~g  558 (662)
                      .++|.+.++||+|+||.||+|...+.    ..+|+|..........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36799999999999999999997643    4556665332211110           11223334456678999999999


Q ss_pred             EEEeCC----eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006090          559 CCVERE----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL  634 (662)
Q Consensus       559 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~  634 (662)
                      ++....    ..++++|++. .++.+.+..   ....++..+..|+.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            876554    3468888774 466666532   223567888999999999999999987   99999999999999999


Q ss_pred             ceEEEeeCccccccC
Q 006090          635 NPKISDFGLARIFGG  649 (662)
Q Consensus       635 ~~ki~DFGla~~~~~  649 (662)
                      .+||+|||+|+.+..
T Consensus       164 ~~~l~DFGla~~~~~  178 (294)
T PHA02882        164 RGYIIDYGIASHFII  178 (294)
T ss_pred             cEEEEEcCCceeecc
Confidence            999999999998753

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.81  E-value=2.8e-19  Score=187.58  Aligned_cols=149  Identities=31%  Similarity=0.505  Sum_probs=127.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +.|+..+.||+|+||.||+|... +++.+|+|.+...   .....+++.+|++++++++|+|++++++++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44677789999999999999965 5788999987532   2233457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+. |+|.+++...  ...+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..+..
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 6887776432  235789999999999999999999987   99999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=1.7e-19  Score=185.99  Aligned_cols=147  Identities=33%  Similarity=0.544  Sum_probs=129.7

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      |+..+.||+|.+|.||+|+.. +++.+|+|.+....  ......+..|++++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455788999999999999976 48999999987643  333567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      + ++|.+++.+..  ..+++..+..++.|+++||+|||+.+   |+||||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            8 58999995422  35899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.81  E-value=6.2e-19  Score=185.48  Aligned_cols=145  Identities=32%  Similarity=0.505  Sum_probs=125.3

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      |...++||+|+||.||+|+.. +++.|++|.+.....   ...+.+.+|++++++++|||++++++++.+++..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555688999999999999864 578999998864322   2335688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +. ++|.+++..  ....+++.++..++.||+.||.|||+.+   |+|+||+|+||++++++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            96 577777743  2345899999999999999999999987   999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.81  E-value=5.6e-20  Score=188.68  Aligned_cols=154  Identities=30%  Similarity=0.421  Sum_probs=136.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +.|..-++||+|+||.|+-+..+ +|+-+|.|++.+.   -.++....++|-.+|.+++.+.||.|--.++.++..+||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            55777789999999999998865 6888999888643   2345677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ..|.||+|.-+|.+... ..+++..+..+|.+|+.||.+||.+.   ||.|||||+|||||+.|+++|+|.|||..+.++
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999988865433 46899999999999999999999987   999999999999999999999999999998776


Q ss_pred             cc
Q 006090          651 QD  652 (662)
Q Consensus       651 ~~  652 (662)
                      +.
T Consensus       341 ~~  342 (591)
T KOG0986|consen  341 KP  342 (591)
T ss_pred             Cc
Confidence            54

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.80  E-value=1.9e-19  Score=188.57  Aligned_cols=150  Identities=33%  Similarity=0.571  Sum_probs=126.8

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------  564 (662)
                      .++|++.++||+|+||.||+|+.. +++.+|+|++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            368999999999999999999965 578999998864322  22346789999999999999999999876543      


Q ss_pred             --eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          565 --ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       565 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                        ..++|+||+.+ +|...+...  ...+++..+..++.||++||+|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999964 677776432  345899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccC
Q 006090          643 LARIFGG  649 (662)
Q Consensus       643 la~~~~~  649 (662)
                      +++.+..
T Consensus       161 ~~~~~~~  167 (311)
T cd07866         161 LARPYDG  167 (311)
T ss_pred             cchhccC
Confidence            9987654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.80  E-value=3.4e-19  Score=180.36  Aligned_cols=142  Identities=34%  Similarity=0.424  Sum_probs=126.4

Q ss_pred             cCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       503 lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 488999998865332   2456789999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      .+++...   ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999432   35899999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.80  E-value=2.9e-20  Score=175.32  Aligned_cols=147  Identities=24%  Similarity=0.501  Sum_probs=127.8

Q ss_pred             ccccccccccCccCceeEEEEE-EcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCe--eEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREE--NMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~--~~lV  569 (662)
                      .++|++.+++|+|.+++||.|. ..+.+.++||.+++   ...+...+|+.+|..+. ||||++|++...+...  ..||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            3679999999999999999998 45678899999975   45578889999999997 9999999999987654  5799


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCcccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIFG  648 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGla~~~~  648 (662)
                      +||+.+.+...+.      ..++-..+..++.++++||.|+|+.|   |+|||+||.|++||.. ...+|+|+|||.++.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999999887665      23666778889999999999999998   9999999999999975 479999999999998


Q ss_pred             CCcc
Q 006090          649 GNQD  652 (662)
Q Consensus       649 ~~~~  652 (662)
                      ++++
T Consensus       185 p~~e  188 (338)
T KOG0668|consen  185 PGKE  188 (338)
T ss_pred             CCce
Confidence            8764

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.80  E-value=1.5e-19  Score=184.49  Aligned_cols=151  Identities=30%  Similarity=0.466  Sum_probs=125.4

Q ss_pred             ccccccccCccCceeEEEEEEcC-CcEEEEEEcccc-----ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKA-----SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +|.+.++||+|+||.||+++... +..+++|.++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998653 444555555431     122345677899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          570 YEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++|+||||+||++++ +.+||+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988532 23356899999999999999999999987   999999999999975 569999999998775


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       157 ~~  158 (260)
T cd08222         157 GS  158 (260)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=3.2e-21  Score=184.09  Aligned_cols=150  Identities=30%  Similarity=0.598  Sum_probs=123.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--------
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--------  563 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--------  563 (662)
                      +.|....+||+|.||+||+++.. +++.||+|++--.  .+.......+|+++|..++|+|++.|+..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666789999999999999865 5778898865321  122245678999999999999999999888643        


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ...|||+++|+. +|.-+|.+..  ..++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            346999999964 7888885432  34788899999999999999999887   99999999999999999999999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ||.+.-.
T Consensus       171 ar~fs~~  177 (376)
T KOG0669|consen  171 ARAFSTS  177 (376)
T ss_pred             ccceecc
Confidence            9887543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.80  E-value=2.1e-19  Score=191.53  Aligned_cols=146  Identities=29%  Similarity=0.468  Sum_probs=126.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC----------
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER----------  563 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~----------  563 (662)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999865 5889999998765555667889999999999999999999876544          


Q ss_pred             ----CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEE
Q 006090          564 ----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKI  638 (662)
Q Consensus       564 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki  638 (662)
                          ...++|+||++ ++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+||+++. +..+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 589888732    35889999999999999999999987   999999999999985 567999


Q ss_pred             EeeCcccccc
Q 006090          639 SDFGLARIFG  648 (662)
Q Consensus       639 ~DFGla~~~~  648 (662)
                      +|||+++.+.
T Consensus       157 ~dfg~~~~~~  166 (342)
T cd07854         157 GDFGLARIVD  166 (342)
T ss_pred             CCcccceecC
Confidence            9999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.80  E-value=2.1e-20  Score=212.55  Aligned_cols=152  Identities=36%  Similarity=0.474  Sum_probs=131.8

Q ss_pred             hccccccccccCccCceeEEEEE-EcCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .+-+++....||.|.||.||.+. .++|...|+|-++...  ........+|+.++..|+|||+|+.+|+-.+++..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34567778999999999999998 4568889999775432  23345678999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||||++|+|.+.+.   .....++.....+-.|++.|++|||+++   ||||||||.||+|+.+|.+|+.|||-|+.+.+
T Consensus      1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999983   3334666667778899999999999998   99999999999999999999999999999876


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      +
T Consensus      1387 ~ 1387 (1509)
T KOG4645|consen 1387 N 1387 (1509)
T ss_pred             c
Confidence            5

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.79  E-value=2.6e-19  Score=190.89  Aligned_cols=149  Identities=30%  Similarity=0.469  Sum_probs=129.0

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe----
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE----  565 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~----  565 (662)
                      ..++|.+...||+|++|.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567999999999999999999976 5789999988642  22234567889999999999999999998876655    


Q ss_pred             --eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          566 --NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       566 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                        .++|+||+ +++|.+++..    ..+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              79999999 6799998843    45899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      +..+..
T Consensus       165 ~~~~~~  170 (343)
T cd07851         165 ARHTDD  170 (343)
T ss_pred             cccccc
Confidence            987754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.5e-18  Score=170.12  Aligned_cols=138  Identities=20%  Similarity=0.267  Sum_probs=107.2

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcC-----CCCCcceeeEEEEeCC---eeE-EE
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----QHRNLVRLLGCCVERE---ENM-LI  569 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~~~-lV  569 (662)
                      ..+.||+|+||.||.  .+.....+||++........+.+.+|+++++.+     +||||++++|++.++.   ..+ +|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357899999999996  443333468887654444567899999999999     5799999999998874   333 78


Q ss_pred             EEc--cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCcEEEcCC----CceEEEeeC
Q 006090          570 YEY--MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL-LYLHRDSRLRIIHRDLKASNILLDDD----LNPKISDFG  642 (662)
Q Consensus       570 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiHrDlkp~NILl~~~----~~~ki~DFG  642 (662)
                      +||  +++++|.+++.+.    .+++.  ..++.|++.++ .|||+++   |+||||||+|||++.+    .+++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  6689999999432    25554  35677888777 8999998   9999999999999743    389999955


Q ss_pred             ccccc
Q 006090          643 LARIF  647 (662)
Q Consensus       643 la~~~  647 (662)
                      -++.+
T Consensus       155 G~~~~  159 (210)
T PRK10345        155 GESTF  159 (210)
T ss_pred             CCcce
Confidence            55444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.6e-20  Score=181.06  Aligned_cols=151  Identities=28%  Similarity=0.479  Sum_probs=125.9

Q ss_pred             ccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----eeEEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----ENMLIYE  571 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E  571 (662)
                      .+.||-|+||.||..+.+ +|+.||.|++...  .-...+.+.+|+++|.-++|.|+...++...-..     +.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            478999999999999865 7999999988542  2223467889999999999999999998876443     4588999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      .| ..+|.+.|-.+   ..++.+.+.-+.+||++||.|||+.+   |.||||||.|.|+++|-..|||||||||.-+.++
T Consensus       138 Lm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  138 LM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence            99 56898888543   45777888889999999999999988   9999999999999999999999999999887766


Q ss_pred             cccccc
Q 006090          652 DQAATK  657 (662)
Q Consensus       652 ~~~~~~  657 (662)
                      ..-++.
T Consensus       211 ~~hMTq  216 (449)
T KOG0664|consen  211 RLNMTH  216 (449)
T ss_pred             hhhhHH
Confidence            554443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.78  E-value=1e-18  Score=176.05  Aligned_cols=133  Identities=24%  Similarity=0.186  Sum_probs=115.2

Q ss_pred             cCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcC
Q 006090          506 GGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD  584 (662)
Q Consensus       506 G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  584 (662)
                      |.+|.||++... +++.+|+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999865 68899999986532     234455555566799999999999999999999999999999999843


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          585 PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       585 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                         ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++++|||+++.+..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~  137 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED  137 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence               234899999999999999999999987   99999999999999999999999998876654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.78  E-value=3e-18  Score=169.99  Aligned_cols=149  Identities=37%  Similarity=0.571  Sum_probs=132.6

Q ss_pred             cccccccCccCceeEEEEEEcC-CcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      |.+.+.||+|++|+||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999875 789999999765444 57789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++|.+++.....  .+++..+..++.++++++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999854221  1789999999999999999999987   999999999999999999999999999988654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.1e-18  Score=183.42  Aligned_cols=161  Identities=25%  Similarity=0.380  Sum_probs=136.6

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEcc--ccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~--~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ..|++.++||.||.+.||++...+.+.+|+|++.  ..+.+....|++|+..|.+|+ |.+||+|++|-..++..|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            4588899999999999999998888889988764  345566788999999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      |= .-+|.++|.+. .....+| .+..+..|++.|+.++|+++   |||.||||.|+|+-+ |.+||+|||+|.-+..+.
T Consensus       441 ~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  441 CG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             cc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            76 57899999543 2333445 67789999999999999998   999999999999965 589999999999998876


Q ss_pred             ccccccccccC
Q 006090          652 DQAATKRLVGT  662 (662)
Q Consensus       652 ~~~~~~~~~Gt  662 (662)
                      .....-..+||
T Consensus       514 TsI~kdsQvGT  524 (677)
T KOG0596|consen  514 TSIVKDSQVGT  524 (677)
T ss_pred             cceeeccccCc
Confidence            66555555776

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.77  E-value=3.8e-19  Score=171.92  Aligned_cols=150  Identities=25%  Similarity=0.411  Sum_probs=124.3

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .+....||.|..|+|++.+++ .|..+|||.+.+. ..++.++++..++++.+- +.|.||+.+|++..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344678999999999999976 4789999998754 334566778888876665 4899999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      . .-++++|.+.  ..++++...-++...+.+||.||.++.  .|||||+||+|||+|+.|++|+||||++..+.+..
T Consensus       174 s-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  174 S-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             H-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            4 3455555432  345888888899999999999998864  69999999999999999999999999999886654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.77  E-value=6.1e-19  Score=193.32  Aligned_cols=149  Identities=31%  Similarity=0.468  Sum_probs=120.6

Q ss_pred             cccccccCccCcee-EEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          497 FQLANKLGQGGFGP-VYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       497 f~~~~~lG~G~fG~-Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      |...+.+|.|+.|+ ||+|.++ +++||||++..   ....-..+|+..|+.- +||||||++|.-.++...|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            45567889999876 8999996 89999999854   3344567899999887 5999999999999999999999999 


Q ss_pred             CCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---C--CceEEEeeCcccccc
Q 006090          575 NKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---D--LNPKISDFGLARIFG  648 (662)
Q Consensus       575 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~ki~DFGla~~~~  648 (662)
                      .-+|++++..... .....-.....+..|+++||++||+-+   ||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5799999965311 111111334677899999999999976   999999999999976   3  479999999999998


Q ss_pred             CCccc
Q 006090          649 GNQDQ  653 (662)
Q Consensus       649 ~~~~~  653 (662)
                      .++..
T Consensus       663 ~~~sS  667 (903)
T KOG1027|consen  663 GGKSS  667 (903)
T ss_pred             CCcch
Confidence            87654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.7e-19  Score=182.75  Aligned_cols=160  Identities=29%  Similarity=0.379  Sum_probs=131.8

Q ss_pred             cccccccccCccCceeEEEEEEcC-CcEEEEEEcccccc---ccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASG---QGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .+|..+.+||+|+||+|.+++.+. .+.+|||+|++...   ...+--+.|-++|+.. +-|.+++|..+++.-+..|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467779999999999999998774 56789999986422   1223345677777766 467899999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+.+|+|--.|.   +-..+.+..+..+|.+||-||-|||+++   ||.||||..|||||.+|++||+||||++.-.-
T Consensus       429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999987773   3445777888999999999999999998   99999999999999999999999999986543


Q ss_pred             CcccccccccccC
Q 006090          650 NQDQAATKRLVGT  662 (662)
Q Consensus       650 ~~~~~~~~~~~Gt  662 (662)
                      +.  ..+.+++||
T Consensus       503 ~~--~TTkTFCGT  513 (683)
T KOG0696|consen  503 DG--VTTKTFCGT  513 (683)
T ss_pred             CC--cceeeecCC
Confidence            32  346668887

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.77  E-value=1.7e-18  Score=195.05  Aligned_cols=150  Identities=25%  Similarity=0.352  Sum_probs=107.0

Q ss_pred             hccccccccccCccCceeEEEEEEc-C----CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEE------EE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-D----GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC------CV  561 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~----~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~------~~  561 (662)
                      ..++|++.++||+|+||.||+|++. +    +..||||++.....  .+.+..|  .+.+..+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3578999999999999999999975 4    68999998764221  1111111  1122222232222211      34


Q ss_pred             eCCeeEEEEEccCCCCHHHHhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006090          562 EREENMLIYEYMPNKSLDSFLFDPQRQ-----------------SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK  624 (662)
Q Consensus       562 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk  624 (662)
                      ++...++||||+++++|.+++......                 .......+..++.||++||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            567789999999999999998542110                 01123345679999999999999987   9999999


Q ss_pred             CCcEEEcC-CCceEEEeeCccccccC
Q 006090          625 ASNILLDD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       625 p~NILl~~-~~~~ki~DFGla~~~~~  649 (662)
                      |+|||+++ ++.+||+|||+|+.+..
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~  308 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRV  308 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccc
Confidence            99999986 57999999999987643

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.76  E-value=5e-19  Score=173.22  Aligned_cols=147  Identities=26%  Similarity=0.345  Sum_probs=122.3

Q ss_pred             ccccccc-cccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEe----CCee
Q 006090          494 TNNFQLA-NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE----REEN  566 (662)
Q Consensus       494 ~~~f~~~-~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~  566 (662)
                      +++|++. ++||-|-.|+|..+..+ +++.+|+|+|..     ....++|+++.-.. .|||||+++++++.    ....
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4556543 68999999999998865 688899998854     23567899986555 69999999999764    3446


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeCc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGL  643 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFGl  643 (662)
                      ++|||.|+||.|.+.|.+ +....++++++..|+.||+.|+.|||+.+   |.||||||+|+|...   |-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence            799999999999999854 34457999999999999999999999988   999999999999965   45799999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      ||.-.+
T Consensus       211 AK~t~~  216 (400)
T KOG0604|consen  211 AKETQE  216 (400)
T ss_pred             ccccCC
Confidence            997764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.75  E-value=3.2e-18  Score=172.81  Aligned_cols=162  Identities=27%  Similarity=0.428  Sum_probs=137.8

Q ss_pred             CHHHHHhhccccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeE
Q 006090          486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLG  558 (662)
Q Consensus       486 ~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g  558 (662)
                      ...++.....++....++.+|.||.||+|.+.      +.+.|-||.++.... -....|+.|..++..+.|||+..+.|
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            34555556678888999999999999999654      345688898876433 34567899999999999999999999


Q ss_pred             EEEeC-CeeEEEEEccCCCCHHHHhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 006090          559 CCVER-EENMLIYEYMPNKSLDSFLF-----DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD  632 (662)
Q Consensus       559 ~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~  632 (662)
                      ++.++ ...+++|.++.-|+|..||.     +.+....++-.+...+|.|++.||+|||.++   |||.||.++|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            99875 45789999999999999997     4445556788889999999999999999988   999999999999999


Q ss_pred             CCceEEEeeCccccccCC
Q 006090          633 DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       633 ~~~~ki~DFGla~~~~~~  650 (662)
                      ..++||+|-.|+|.+.+.
T Consensus       432 ~LqVkltDsaLSRDLFP~  449 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPG  449 (563)
T ss_pred             heeEEeccchhccccCcc
Confidence            999999999999987553

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.75  E-value=2.3e-17  Score=160.84  Aligned_cols=143  Identities=36%  Similarity=0.643  Sum_probs=127.2

Q ss_pred             cCccCceeEEEEEEcC-CcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHHH
Q 006090          503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS  580 (662)
Q Consensus       503 lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  580 (662)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|++.+++++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 889999998754332 35789999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeCccccccCC
Q 006090          581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       581 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~~  650 (662)
                      ++....  ..+++..+..++.+++++|.|||+.+   ++|+||+|.||+++. ++.++|+|||++......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            985422  35889999999999999999999987   999999999999999 899999999999877553

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.2e-19  Score=186.28  Aligned_cols=158  Identities=29%  Similarity=0.383  Sum_probs=137.2

Q ss_pred             ccccccccCccCceeEEEEEEcCCc-EEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDGQ-EIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~~-~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +++....||-|+||.|-+++.+... .+|+|.+++.   ....++....|-.+|...+.|.||+|+-.+.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4455678999999999999987443 3788887653   33445668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      -|-||.|-..|++   +..++..+...++..+.+|+.|||.++   ||.|||||+|.|||.+|-+||.|||+|+.++.++
T Consensus       501 aClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  501 ACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            9999999999954   445788888889999999999999998   9999999999999999999999999999998876


Q ss_pred             ccccccccccC
Q 006090          652 DQAATKRLVGT  662 (662)
Q Consensus       652 ~~~~~~~~~Gt  662 (662)
                         .|.+++||
T Consensus       575 ---KTwTFcGT  582 (732)
T KOG0614|consen  575 ---KTWTFCGT  582 (732)
T ss_pred             ---ceeeecCC
Confidence               47779998

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.1e-18  Score=170.58  Aligned_cols=160  Identities=28%  Similarity=0.379  Sum_probs=136.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|.++.+||+|+|.+|..+++. +.+.+|+|++++.   ..+...-.+.|-.+.... +||.+|.|..++......++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            67889999999999999999976 5678899988753   334455677777777666 699999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      .||+++|+|--++   ++...|+++.+..+...|.-||.|||+.+   ||.||||..|||||.+|++||.|+|+++.-..
T Consensus       330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999985444   45556899999999999999999999998   99999999999999999999999999996654


Q ss_pred             CcccccccccccC
Q 006090          650 NQDQAATKRLVGT  662 (662)
Q Consensus       650 ~~~~~~~~~~~Gt  662 (662)
                      ..+  .+++++||
T Consensus       404 ~gd--~tstfcgt  414 (593)
T KOG0695|consen  404 PGD--TTSTFCGT  414 (593)
T ss_pred             CCc--ccccccCC
Confidence            433  46668887

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.6e-17  Score=164.36  Aligned_cols=136  Identities=22%  Similarity=0.316  Sum_probs=115.4

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccc--------cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--------GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~--------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.||+|++|.||+|.. .+..+++|+.......        ....+.+|++++..++|++|+....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 5778999976532211        124678899999999999998888888888889999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +++++|.+++...      .+ .+..++.+++.+|.++|+.+   ++|+|++|+|||++ ++.++|+|||+++...
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            9999999998421      22 78899999999999999988   99999999999999 7899999999998754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.74  E-value=1.5e-17  Score=166.43  Aligned_cols=138  Identities=34%  Similarity=0.521  Sum_probs=124.1

Q ss_pred             CceeEEEEEEc-CCcEEEEEEcccccccc-HHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcC
Q 006090          507 GFGPVYKGKLQ-DGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD  584 (662)
Q Consensus       507 ~fG~Vykg~~~-~~~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  584 (662)
                      +||.||+++.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48899999997654444 68999999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          585 PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       585 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ..   .+++..+..++.+++++|.|||+.+   ++|+||+|+||++++++.++|+|||++..+...
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            22   2889999999999999999999987   999999999999999999999999999988653

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00090 RIO RIO-like kinase

Probab=99.73  E-value=2.1e-17  Score=165.98  Aligned_cols=147  Identities=18%  Similarity=0.184  Sum_probs=114.2

Q ss_pred             cccccccccCccCceeEEEEE--EcCCcEEEEEEccccccc------------------------cHHHHHHHHHHHhcC
Q 006090          495 NNFQLANKLGQGGFGPVYKGK--LQDGQEIAVKRLSKASGQ------------------------GQEEFMNEVMVISNL  548 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~--~~~~~~vAvK~l~~~~~~------------------------~~~~f~~E~~~l~~l  548 (662)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||+|.+......                        ....+..|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  567999999988643210                        012356899999999


Q ss_pred             CCC--CcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 006090          549 QHR--NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKAS  626 (662)
Q Consensus       549 ~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~  626 (662)
                      .|.  .+.++++.    ...++||||+++.+|...+..   ...++..+...++.||+.+|.+||+.+  +|+||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            753  34455543    235899999999888765422   223555667899999999999999875  4999999999


Q ss_pred             cEEEcCCCceEEEeeCccccccCCc
Q 006090          627 NILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       627 NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ||+++ ++.++|+|||+|...+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccCCcc
Confidence            99999 8899999999999876544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.73  E-value=1.9e-17  Score=163.04  Aligned_cols=140  Identities=13%  Similarity=0.145  Sum_probs=115.7

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHH---------HHHHHHHHhcCCCCCcceeeEEEEeC-
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE---------FMNEVMVISNLQHRNLVRLLGCCVER-  563 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~---------f~~E~~~l~~l~H~nIv~l~g~~~~~-  563 (662)
                      .++|...+++|.|+||.||.... ++..+|+|.+.+......+.         |.+|+..+.++.||+|..+..+.... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            57899999999999999999766 57789999997543322222         67899999999999999999886643 


Q ss_pred             -------CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          564 -------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       564 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                             ...+|||||++|.+|.++..       ++.    ....+|+.+|..+|..+   ++|||+||+||+++.++ +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence                   34789999999999988741       222    24569999999999998   99999999999999988 9


Q ss_pred             EEEeeCccccccC
Q 006090          637 KISDFGLARIFGG  649 (662)
Q Consensus       637 ki~DFGla~~~~~  649 (662)
                      +|+|||..+....
T Consensus       174 ~liDfg~~~~~~e  186 (232)
T PRK10359        174 RIIDLSGKRCTAQ  186 (232)
T ss_pred             EEEECCCcccccc
Confidence            9999999987743

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.73  E-value=6.2e-18  Score=163.48  Aligned_cols=147  Identities=23%  Similarity=0.436  Sum_probs=120.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEE-EEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGC-CVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~E  571 (662)
                      +.|.+.+.||+|.||.+-+++++ ..+.+++|.+.. ....+++|.+|..---.| .|.||+.-+.. ++..+...+++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            56788899999999999999987 467888898754 334578999998765555 58999887665 555667779999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-cC-CCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL-DD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~-~~~~ki~DFGla~~~~~  649 (662)
                      |+|.|+|.+-+.    ...+-+....+++.|+++||.|+|+++   ++|||||.+|||| +. ..++||||||+.+..+.
T Consensus       103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999998873    244777788899999999999999998   9999999999999 33 34899999999987653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=1.7e-17  Score=157.91  Aligned_cols=151  Identities=25%  Similarity=0.417  Sum_probs=127.4

Q ss_pred             ccccccccccCccCceeEEEEE-EcCCcEEEEEEccccccccHHHHHHHHHHHhcCCC-CCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+.|.+.++||.|+||.+|.|. +.+|.+||||.-+..  ...-...-|.++.+.++| ..|.++..+..++....||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3679999999999999999998 567999999986543  233456778899999975 788999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~ki~DFGla~~~~  648 (662)
                      .+ |-||++++.-+.+  .++..+++.+|.|++.-++|+|.++   .|||||||+|+|+.-+   ..+.++|||||+.+-
T Consensus        92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 7899998754333  3788999999999999999999998   9999999999999654   468899999999986


Q ss_pred             CCcc
Q 006090          649 GNQD  652 (662)
Q Consensus       649 ~~~~  652 (662)
                      +...
T Consensus       166 d~~t  169 (341)
T KOG1163|consen  166 DIRT  169 (341)
T ss_pred             cccc
Confidence            5443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=3.3e-17  Score=160.57  Aligned_cols=147  Identities=20%  Similarity=0.215  Sum_probs=113.9

Q ss_pred             HHhhccccccccccCccCceeEEEEEEcCCcEEEEEEcccccc----------------------ccHHHHHHHHHHHhc
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG----------------------QGQEEFMNEVMVISN  547 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~----------------------~~~~~f~~E~~~l~~  547 (662)
                      +......|.+.+.||+|+||.||++..++++.||||++.....                      .....+..|..++.+
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            3333344777899999999999999988899999998653210                      011236778888988


Q ss_pred             CCCC--CcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 006090          548 LQHR--NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA  625 (662)
Q Consensus       548 l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp  625 (662)
                      +.|+  .++..++    ....++||||+++++|.+....         .....++.++++++.++|+.+   |+||||||
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            8877  4455544    2455899999999999765410         234578899999999999987   99999999


Q ss_pred             CcEEEcCCCceEEEeeCccccccCCcc
Q 006090          626 SNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       626 ~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      +||++++++.++|+|||++..+..+..
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~~~~  180 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDHPNA  180 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCCccH
Confidence            999999999999999999987766443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=2.3e-17  Score=185.84  Aligned_cols=141  Identities=21%  Similarity=0.295  Sum_probs=114.7

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccc-------cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS-------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~-------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ..|...++||+|+||.||+|.+.+...++.+++.+..       ....+.+.+|++++.+++|++++....++.+....+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            3445678999999999999988644433322222211       112356889999999999999999888888888889


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++++|.+++.           ....++.|++++|.|||+.+   ++||||||+|||+ +++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999999883           45679999999999999988   9999999999999 6789999999999986


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       478 ~~~  480 (535)
T PRK09605        478 DLI  480 (535)
T ss_pred             Cch
Confidence            543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.73  E-value=8.8e-19  Score=187.40  Aligned_cols=152  Identities=28%  Similarity=0.488  Sum_probs=136.5

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ..++|++...+|.|.+|.|||++.. .++..|||.++-.......-.+.|+-+++..+|||||.++|-+...+..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            4467888999999999999999954 688999999987666667777889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||.+|+|++.-+-   -.++++.+....++..++||+|||+.+   -+|||||-.|||+++.+.+|++|||.+..++.-
T Consensus        93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999997743   346888899999999999999999998   799999999999999999999999999988654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=4e-17  Score=159.91  Aligned_cols=133  Identities=23%  Similarity=0.347  Sum_probs=109.5

Q ss_pred             ccCccCceeEEEEEEcCCcEEEEEEcccccc--------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASG--------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .||+|+||.||+|.+ ++..|++|.......        ....++.+|++++..++|+++.....++.+.+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 478899998643211        11356788999999999887766666666777789999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++....          ..++.+++++|.+||+.+   ++|+|++|+||+++ ++.+++.|||+++....
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE  141 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence            9999999873211          078999999999999987   99999999999999 88999999999987654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=9.6e-17  Score=154.74  Aligned_cols=133  Identities=23%  Similarity=0.235  Sum_probs=107.1

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEccccccc----cHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEcc
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ----GQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~----~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ....|++|+||+||.+.- .+..++.+.+.....-    ....|.+|+++|++++ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            357899999999997766 5788887877653221    1225889999999995 5889999886    4569999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL-KASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +|.+|.+.+.    .      ....++.|++++|.++|+++   |+|||| ||.|||+++++.++|+|||+|....+
T Consensus        81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            9999875431    1      12357789999999999998   999999 79999999999999999999996554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.68  E-value=1.7e-16  Score=157.63  Aligned_cols=150  Identities=22%  Similarity=0.361  Sum_probs=125.8

Q ss_pred             cccccccccCccCceeEEEEE-EcCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      -+|.+.++||+|.||.++.|+ +-+++.||||.-..  ..+.-+++.|.+..+.| ..++|...+-+-.++.+..||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            468889999999999999998 55789999996432  22334567788887777 468999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-----ceEEEeeCccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-----NPKISDFGLARIF  647 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~ki~DFGla~~~  647 (662)
                      + |-||++++.-+.+  .++.+++..+|.|++.-++|+|++.   +|.|||||+|+||...+     .+.|+|||||+.+
T Consensus       106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            9 7899998754433  4888999999999999999999998   99999999999997644     5899999999999


Q ss_pred             cCCcc
Q 006090          648 GGNQD  652 (662)
Q Consensus       648 ~~~~~  652 (662)
                      .+...
T Consensus       180 rDp~T  184 (449)
T KOG1165|consen  180 RDPKT  184 (449)
T ss_pred             cCccc
Confidence            76543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.68  E-value=6.9e-17  Score=173.63  Aligned_cols=146  Identities=24%  Similarity=0.338  Sum_probs=122.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +..|.+...+|.|+|+.|.++... +++..+||++.+..    .+-.+|+.++.+. +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            466788888999999999999854 67889999997642    2334677666655 79999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-cCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL-DDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++.++-|.+.+....    ..-..+..|+.+|+.|+.|||+++   +|||||||+|||+ ++.++++|+|||.++.+.+.
T Consensus       397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999998877774322    222677789999999999999988   9999999999999 58999999999999988765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.67  E-value=5.1e-16  Score=163.89  Aligned_cols=145  Identities=26%  Similarity=0.396  Sum_probs=120.9

Q ss_pred             ccccccccCccCceeEEEEEEcCC--cEEEEEEccccccccHHHHHHHHHHHhcCCC----CCcceeeEEE-EeCCeeEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDG--QEIAVKRLSKASGQGQEEFMNEVMVISNLQH----RNLVRLLGCC-VEREENML  568 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~--~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l  568 (662)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    +++.++++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997643  4788887654333333378889999888863    5889999988 47778899


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-----CceEEEeeCc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-----LNPKISDFGL  643 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~ki~DFGl  643 (662)
                      ||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.+   ++||||||.|+++...     ..++|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889999774333 456899999999999999999999998   9999999999999865     4699999999


Q ss_pred             cc
Q 006090          644 AR  645 (662)
Q Consensus       644 a~  645 (662)
                      |+
T Consensus       174 ar  175 (322)
T KOG1164|consen  174 AR  175 (322)
T ss_pred             Cc
Confidence            99

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.66  E-value=3.3e-16  Score=158.65  Aligned_cols=157  Identities=22%  Similarity=0.300  Sum_probs=130.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-C-CC----cceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-H-RN----LVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H-~n----Iv~l~g~~~~~~~~  566 (662)
                      +++|.+...+|+|.||.|-+...+ .+..||||+++. .....+..+-|++++.+|. + |+    +|++.+++.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999999865 468899999875 3344566788999999994 2 33    78888889999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--------------
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--------------  632 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--------------  632 (662)
                      ++|+|.+ |-|+.++|.. ....+++...+..|+.|++++++|||+..   ++|-||||+|||+-+              
T Consensus       167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999999 6699999954 34456889999999999999999999987   999999999999832              


Q ss_pred             ------CCceEEEeeCccccccCCcccccc
Q 006090          633 ------DLNPKISDFGLARIFGGNQDQAAT  656 (662)
Q Consensus       633 ------~~~~ki~DFGla~~~~~~~~~~~~  656 (662)
                            +..+||+|||-|..-.+.+...+.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVs  271 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVS  271 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCcceeee
Confidence                  235899999999988777655443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.66  E-value=1.4e-16  Score=163.31  Aligned_cols=149  Identities=25%  Similarity=0.512  Sum_probs=128.8

Q ss_pred             HHhhccccccccccCccCceeEEEEEEc----CCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCC
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVERE  564 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~  564 (662)
                      +....+.|...++||+|.|++||++++.    ..+.||+|.+...  +......+|+++|..+. |.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344577888999999999999999854    3578999998653  44567889999999995 999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGL  643 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGl  643 (662)
                      ...+|+||+++-...+++..      ++..++..++..+..||+++|.++   ||||||||+|+|.+.. +.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999998833      667888999999999999999998   9999999999999864 5788999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      |-....
T Consensus       180 A~~~d~  185 (418)
T KOG1167|consen  180 AQRYDG  185 (418)
T ss_pred             HHHHHh
Confidence            986543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.3e-15  Score=141.03  Aligned_cols=138  Identities=22%  Similarity=0.214  Sum_probs=117.5

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCC--CCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH--RNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+.++..++|  +++++++++...++..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35789999999999999864 7899998865332  5678999999999976  58999999988888899999999988


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      .+..+          +......++.+++++|+++|.....+++|+|++|+|||+++.+.+++.|||+++....
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~  141 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP  141 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence            76543          5567778899999999999987555699999999999999999999999999987544

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.63  E-value=2.4e-16  Score=156.22  Aligned_cols=146  Identities=30%  Similarity=0.435  Sum_probs=120.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------e
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------E  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------~  565 (662)
                      .+|.....+|.|.- .|.-+... .+++||+|++...  ..+..+...+|..++..+.|+||++++.++.-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56766788888887 55555432 5789999988642  2344567889999999999999999999986543      4


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .|+||||| ..+|...+.     ..++..+...|..|++.|+.|||+.+   |+||||||+||++..+...||.|||+|+
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            69999999 578888873     34788889999999999999999988   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .-+.+
T Consensus       167 ~e~~~  171 (369)
T KOG0665|consen  167 TEDTD  171 (369)
T ss_pred             ccCcc
Confidence            66544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.5e-15  Score=147.17  Aligned_cols=139  Identities=22%  Similarity=0.252  Sum_probs=100.6

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccc--cHHH----------------------HHHHHHHHhcCCCC--Cc
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ--GQEE----------------------FMNEVMVISNLQHR--NL  553 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~--~~~~----------------------f~~E~~~l~~l~H~--nI  553 (662)
                      .+.||+|+||+||+|...+++.||||++......  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999888999999987643211  1111                      13455666666433  34


Q ss_pred             ceeeEEEEeCCeeEEEEEccCCCCHHHH-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEc
Q 006090          554 VRLLGCCVEREENMLIYEYMPNKSLDSF-LFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       554 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~  631 (662)
                      .+.+++    ...++||||++++.+... +... .   .. .....++.+++.++.++|. .+   |+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-h---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            555543    346899999999543221 1110 0   11 5677899999999999998 76   99999999999999


Q ss_pred             CCCceEEEeeCccccccCCc
Q 006090          632 DDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       632 ~~~~~ki~DFGla~~~~~~~  651 (662)
                       ++.++|+|||.|..+....
T Consensus       150 -~~~~~liDfg~a~~~~~~~  168 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDHPN  168 (187)
T ss_pred             -CCcEEEEECcccccccCcc
Confidence             8999999999998776543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.9e-15  Score=157.12  Aligned_cols=134  Identities=25%  Similarity=0.379  Sum_probs=112.8

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCC-----CC---CcceeeEEEEeC--
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-----HR---NLVRLLGCCVER--  563 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----H~---nIv~l~g~~~~~--  563 (662)
                      .+|.+.++||-|-|++||++.. ++.+-||+|+.+. .....+..+.||++|++++     |+   .||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6899999999999999999984 4678899999875 3445667889999999883     33   599999999864  


Q ss_pred             --CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 006090          564 --EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD  633 (662)
Q Consensus       564 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~  633 (662)
                        .+.+||+|++ |-+|..+|.... ...++...+.+|++||+.||.|||.++  +|||-||||+||||..+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence              4679999999 678888885533 345889999999999999999999987  79999999999999665

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=8.4e-15  Score=147.38  Aligned_cols=137  Identities=22%  Similarity=0.300  Sum_probs=107.5

Q ss_pred             ccccC-ccCceeEEEEEEcCCcEEEEEEccccc-------------cccHHHHHHHHHHHhcCCCCCc--ceeeEEEEeC
Q 006090          500 ANKLG-QGGFGPVYKGKLQDGQEIAVKRLSKAS-------------GQGQEEFMNEVMVISNLQHRNL--VRLLGCCVER  563 (662)
Q Consensus       500 ~~~lG-~G~fG~Vykg~~~~~~~vAvK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~nI--v~l~g~~~~~  563 (662)
                      ...|| .|+.|+||++... +..++||++....             ......+.+|++++.+++|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 7889999999886 6788888775311             1223568889999999998774  7788875543


Q ss_pred             Ce----eEEEEEccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          564 EE----NMLIYEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       564 ~~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      ..    .++|+||+++ .+|.+++.+    ..++..    .+.+|+.+|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    2599999997 689988843    234443    3578999999999998   999999999999999999999


Q ss_pred             EeeCcccccc
Q 006090          639 SDFGLARIFG  648 (662)
Q Consensus       639 ~DFGla~~~~  648 (662)
                      +|||.++...
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999998865

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.59  E-value=3e-14  Score=148.14  Aligned_cols=150  Identities=35%  Similarity=0.563  Sum_probs=128.5

Q ss_pred             cccccccCccCceeEEEEEEcCCcEEEEEEccccccc---cHHHHHHHHHHHhcCCCC-CcceeeEEEEeCCeeEEEEEc
Q 006090          497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ---GQEEFMNEVMVISNLQHR-NLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++...+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556788999999999999987  88899988764333   367899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccccCCc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQ  651 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~~~~~  651 (662)
                      +.++++.+++........++......++.|++.++.|+|+.+   ++|||+||+||+++... .+|++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977743221125888999999999999999999988   99999999999999998 79999999999776543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.58  E-value=3.1e-15  Score=156.16  Aligned_cols=160  Identities=23%  Similarity=0.334  Sum_probs=133.7

Q ss_pred             cCHHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCC------CCcceee
Q 006090          485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH------RNLVRLL  557 (662)
Q Consensus       485 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H------~nIv~l~  557 (662)
                      +.+.|+.  -++|.+..-.|+|-|++|.+|... .++.||||++... +.-.+.=+.|+++|++|+.      -|.++|+
T Consensus       424 v~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  424 VRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             Eehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3444443  367888888999999999999865 4789999999763 3334555789999999952      4899999


Q ss_pred             EEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ce
Q 006090          558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NP  636 (662)
Q Consensus       558 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~  636 (662)
                      -.|...++++||+|-+ .-+|.+.|.+....-.|....+..++.|+.-||..|-..+   |+|.||||.|||+++.. .+
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence            9999999999999988 5689999976666667888899999999999999999877   99999999999999854 68


Q ss_pred             EEEeeCccccccCCc
Q 006090          637 KISDFGLARIFGGNQ  651 (662)
Q Consensus       637 ki~DFGla~~~~~~~  651 (662)
                      ||||||-|...++++
T Consensus       577 KLCDfGSA~~~~ene  591 (752)
T KOG0670|consen  577 KLCDFGSASFASENE  591 (752)
T ss_pred             eeccCcccccccccc
Confidence            999999999887765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=7.4e-14  Score=152.52  Aligned_cols=143  Identities=23%  Similarity=0.274  Sum_probs=101.8

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccH----------------------------------------HHHH
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ----------------------------------------EEFM  539 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~----------------------------------------~~f~  539 (662)
                      .+.||.|++|+||+|++++|+.||||+.++......                                        -.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999999865321100                                        1245


Q ss_pred             HHHHHHhcC----CCCCcceeeEEE-EeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 006090          540 NEVMVISNL----QHRNLVRLLGCC-VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR-GLLYLHRD  613 (662)
Q Consensus       540 ~E~~~l~~l----~H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~  613 (662)
                      +|...+.++    +|.+-+.+-..+ ......+|||||++|++|.+++.....  ..   .+..++.++++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            565555544    232222222222 224567999999999999887632111  12   23457777766 46788988


Q ss_pred             CCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       614 ~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +   ++|+|+||.||+++++++++++|||+++.+.+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            7   999999999999999999999999999988654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=6.7e-14  Score=160.85  Aligned_cols=146  Identities=23%  Similarity=0.344  Sum_probs=115.1

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC---CCCcceeeEEEEeCCeeEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ..+.|.+...||+|+||+||+|+..+++.||+|+-++...=   +|.-=.+++.||+   -+-|..+.....-.+..+||
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            34678999999999999999999888999999987654321   2222233444444   23344555555557778999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------CCceEEEeeC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-------DLNPKISDFG  642 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~ki~DFG  642 (662)
                      +||.+.|+|.+++.   ..+.++|...+.++.|+++-+.+||..+   |||+||||+|+||..       ...++|+|||
T Consensus       773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence            99999999999994   5567999999999999999999999988   999999999999943       3468999999


Q ss_pred             ccccc
Q 006090          643 LARIF  647 (662)
Q Consensus       643 la~~~  647 (662)
                      -|--+
T Consensus       847 ~siDm  851 (974)
T KOG1166|consen  847 RSIDM  851 (974)
T ss_pred             cceee
Confidence            88655

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.39  E-value=3.6e-13  Score=106.39  Aligned_cols=58  Identities=47%  Similarity=1.019  Sum_probs=50.9

Q ss_pred             CCCcEEEEEeecCCCcccc---cccchhHHHHhhccCCCeeeEeec---CCceeEEeecccccc
Q 006090          338 KQDGFFKLETMKVPYFAER---SSANEDKCKDQCSNNCSCKAYAYE---IGVGCMIWTHNLIDI  395 (662)
Q Consensus       338 ~~~~f~~~~~~~~p~~~~~---~~~~~~~C~~~Cl~nCsC~a~~y~---~~~~C~~~~~~l~~~  395 (662)
                      .+++|.++++|++|++...   .+.++++|++.|++||||+||+|.   ++++|++|.++|+|+
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL   66 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence            4689999999999998543   468999999999999999999998   467899999999874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=5.2e-12  Score=120.12  Aligned_cols=133  Identities=20%  Similarity=0.158  Sum_probs=99.8

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc-ceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      .+.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.++ .+++++.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367899999999999976 77899998754321 23456789999988865554 4555543  3446899999999887


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS--RLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      .+..        .   ....++.+++++|+.||...  +..++|+|++|.||+++ ++.++++|||.+..-.
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~  138 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND  138 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence            5420        0   11245678999999999876  23469999999999999 6789999999998644

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.31  E-value=2.3e-12  Score=142.58  Aligned_cols=145  Identities=20%  Similarity=0.283  Sum_probs=94.1

Q ss_pred             cccccccccCccCceeEEEEEEcC-CcEEEEEEcccccccc----------------------------------HH---
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQG----------------------------------QE---  536 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~----------------------------------~~---  536 (662)
                      ..|+. +.||.|++|+||+|++++ |+.||||++++.....                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 789999999999999987 9999999987532110                                  11   


Q ss_pred             ---HHHHHHHHHhcC----CCCCcceeeEEEEe-CCeeEEEEEccCCCCHHHHhcCCCCC---CCCCHHHHHHHHHHHHH
Q 006090          537 ---EFMNEVMVISNL----QHRNLVRLLGCCVE-REENMLIYEYMPNKSLDSFLFDPQRQ---SLLDWPKRFNIIKGISR  605 (662)
Q Consensus       537 ---~f~~E~~~l~~l----~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~  605 (662)
                         +|.+|+.-+.++    .+.+.+.+-.++.+ ....+|||||++|+.|.++-.-....   ..+.......++.||  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               234444444333    23333333333333 45678999999999998742111111   012222222233333  


Q ss_pred             HHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEeeCccccccCC
Q 006090          606 GLLYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFGLARIFGGN  650 (662)
Q Consensus       606 ~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~ki~DFGla~~~~~~  650 (662)
                           +..+   ++|+|+||.||+++.++    ++++.|||++..+.+.
T Consensus       277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 3455   99999999999999988    9999999999988654

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.24  E-value=1.2e-11  Score=100.89  Aligned_cols=68  Identities=24%  Similarity=0.438  Sum_probs=59.8

Q ss_pred             CCCcEEEEEeecCCCcccccccchhHHHHhhcc---CCCeeeEeecC-CceeEEeeccc-ccccccCCCCcceeEE
Q 006090          338 KQDGFFKLETMKVPYFAERSSANEDKCKDQCSN---NCSCKAYAYEI-GVGCMIWTHNL-IDIRKLPSGGTNLYIR  408 (662)
Q Consensus       338 ~~~~f~~~~~~~~p~~~~~~~~~~~~C~~~Cl~---nCsC~a~~y~~-~~~C~~~~~~l-~~~~~~~~~~~~lylr  408 (662)
                      ....|.++.++++|++..   .++++|++.|++   ||||+||+|.+ +.+|.+|.+++ .+++..++.+.++|+|
T Consensus         7 ~~g~fl~~~~~klpd~~~---~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129           7 SAGTTLIKIALKIKTTKA---NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             cCCeEEEeecccCCcccc---cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence            456799999999998764   689999999999   99999999974 56899999999 9998888778899987

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.22  E-value=1e-11  Score=146.97  Aligned_cols=90  Identities=18%  Similarity=0.258  Sum_probs=69.7

Q ss_pred             cCCC-CCcceeeEEE-------EeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 006090          547 NLQH-RNLVRLLGCC-------VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI  618 (662)
Q Consensus       547 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  618 (662)
                      .++| +||+++++++       .+....++++||+ +++|.++|...  ...+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4556 5888888887       3334567888988 56999999542  345899999999999999999999988   9


Q ss_pred             EecCCCCCcEEEcCCCceEEEeeC
Q 006090          619 IHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       619 iHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      +||||||+||||+..+.+|++|||
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~  125 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESA  125 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeecc
Confidence            999999999999654444333333

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=1.9e-10  Score=114.12  Aligned_cols=145  Identities=18%  Similarity=0.262  Sum_probs=114.2

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCC--CCcceeeEEEEeCC---eeEEEEEccC
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQH--RNLVRLLGCCVERE---ENMLIYEYMP  574 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~Ey~~  574 (662)
                      +.|+.|..+.||+++..+|+.+++|....... .....+..|+++++.+.+  .++.+++.+..+..   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999987668899998764322 135678899999999965  45678888876643   5689999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS----------------------------------------  614 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------  614 (662)
                      +.++.+.+..    ..++..++..++.+++++|++||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765521    34677888889999999999998531                                        


Q ss_pred             -------------CCceEecCCCCCcEEEcC--CCceEEEeeCccccccC
Q 006090          615 -------------RLRIIHRDLKASNILLDD--DLNPKISDFGLARIFGG  649 (662)
Q Consensus       615 -------------~~~iiHrDlkp~NILl~~--~~~~ki~DFGla~~~~~  649 (662)
                                   +..++|+|++|.|||++.  ++.+.|+||+.+..-..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~~  209 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGDP  209 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCCh
Confidence                         245899999999999998  66789999999886543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.18  E-value=5.7e-12  Score=122.29  Aligned_cols=138  Identities=27%  Similarity=0.483  Sum_probs=114.8

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      +..+|.+...|+.|+|+++ |..+++|++...  .....+.|..|.-.|+.+.||||..++|.|.......++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3567888999999999998 455566766532  3344578999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                      +|...|+.. ..-..+..++.++|.+||+||+|||+-. +-|.---|.++.|+||++.+++|+
T Consensus       273 slynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence            999999764 3446788899999999999999999976 224445689999999999988875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=3.8e-10  Score=108.95  Aligned_cols=137  Identities=14%  Similarity=0.103  Sum_probs=100.4

Q ss_pred             cccCccCceeEEEEEEcC-------CcEEEEEEcccc-------------cc---------ccHHHHH----HHHHHHhc
Q 006090          501 NKLGQGGFGPVYKGKLQD-------GQEIAVKRLSKA-------------SG---------QGQEEFM----NEVMVISN  547 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~-------~~~vAvK~l~~~-------------~~---------~~~~~f~----~E~~~l~~  547 (662)
                      ..||.|.-+.||.|.-.+       +..+|||..+..             ..         ...+.+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998553       478999976421             00         0012333    79999998


Q ss_pred             CC--CCCcceeeEEEEeCCeeEEEEEccCCCCHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCC
Q 006090          548 LQ--HRNLVRLLGCCVEREENMLIYEYMPNKSLDS-FLFDPQRQSLLDWPKRFNIIKGISRGLLYL-HRDSRLRIIHRDL  623 (662)
Q Consensus       548 l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDl  623 (662)
                      +.  ..++.+++++    ...+|||||+.+..+.. .|.    ...++..+...+..+++.+|..| |..+   |+|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            85  3677788765    56789999997654321 221    12344556677889999999999 7776   999999


Q ss_pred             CCCcEEEcCCCceEEEeeCccccccC
Q 006090          624 KASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       624 kp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++|||++ ++.+.|+|||.|-....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 46899999999987754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=1.5e-11  Score=138.76  Aligned_cols=145  Identities=29%  Similarity=0.376  Sum_probs=111.2

Q ss_pred             cccccCccCceeEEEEEEc-CCcEEEEEEcc----cc-cc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          499 LANKLGQGGFGPVYKGKLQ-DGQEIAVKRLS----KA-SG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~----~~-~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ....+|.|++|.|+..... .....+.|...    .. .. .....+..|..+-..++|||++..+....+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            3578999999977777643 23333333221    11 11 111225667777788999999888888777777776799


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++ +|..++...   ..+...++..++.|+..|+.|+|+.+   |.|||||++|+++..++.+||+|||.+..+.-.
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 999998432   35777888999999999999999998   999999999999999999999999999877543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=3e-10  Score=105.98  Aligned_cols=138  Identities=23%  Similarity=0.363  Sum_probs=106.0

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEE-Ecccccc-------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVK-RLSKASG-------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK-~l~~~~~-------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..+++|+-+.+|.+.+. |.++.+| ++.+...       -......+|+.+|.+++--.|....=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999875 4445555 3333211       1134578899999998766666666667788888999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      +++..|.++|...          +..++..|-+-+.-||..+   |+|+||.++||++..+. +.++||||++.-...++
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~Ed  146 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVED  146 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHHh
Confidence            9999999998432          3567788888899999998   99999999999998775 99999999997655444


Q ss_pred             c
Q 006090          653 Q  653 (662)
Q Consensus       653 ~  653 (662)
                      .
T Consensus       147 ~  147 (204)
T COG3642         147 K  147 (204)
T ss_pred             h
Confidence            3

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.16  E-value=5.8e-11  Score=99.01  Aligned_cols=72  Identities=43%  Similarity=0.928  Sum_probs=60.0

Q ss_pred             CCcEEEEEeecCCCcccc-cccchhHHHHhhccCCCeeeEeecC-CceeEEeecccccccccCCCCcceeEEee
Q 006090          339 QDGFFKLETMKVPYFAER-SSANEDKCKDQCSNNCSCKAYAYEI-GVGCMIWTHNLIDIRKLPSGGTNLYIRVA  410 (662)
Q Consensus       339 ~~~f~~~~~~~~p~~~~~-~~~~~~~C~~~Cl~nCsC~a~~y~~-~~~C~~~~~~l~~~~~~~~~~~~lylrv~  410 (662)
                      .++|.++.++++|+.... ...++++|++.|++||+|+||+|.+ +.+|.+|..++.+.+.....+.++|+||+
T Consensus        11 ~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~   84 (84)
T cd01098          11 TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA   84 (84)
T ss_pred             CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence            367999999999977654 5678999999999999999999985 45699999999988765545678999974

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.06  E-value=1.4e-09  Score=100.92  Aligned_cols=150  Identities=21%  Similarity=0.305  Sum_probs=109.9

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEE-Eccccc-------cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVK-RLSKAS-------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK-~l~~~~-------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ....|-+|+-+.|+++.+. |+...|| +..+..       ....+..++|++++.+++--.|.-..=++.+.....|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            3678899999999999987 5665555 333211       112356788999999987656655555677788888999


Q ss_pred             EccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEeeCcccc
Q 006090          571 EYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISDFGLARI  646 (662)
Q Consensus       571 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~DFGla~~  646 (662)
                      ||+++ .++.+++...-... .+......++..|-+.+.-||.+.   |||+||..+||+|..++   .+.+.||||+..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46888874322222 222333688999999999999998   99999999999997665   358999999987


Q ss_pred             ccCCccc
Q 006090          647 FGGNQDQ  653 (662)
Q Consensus       647 ~~~~~~~  653 (662)
                      -...+++
T Consensus       166 s~~~EDK  172 (229)
T KOG3087|consen  166 SRLPEDK  172 (229)
T ss_pred             ccCcccc
Confidence            6554444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.03  E-value=4.1e-11  Score=129.55  Aligned_cols=144  Identities=25%  Similarity=0.304  Sum_probs=117.0

Q ss_pred             ccCccCceeEEEEE----EcCCcEEEEEEccccccc--cHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEccC
Q 006090          502 KLGQGGFGPVYKGK----LQDGQEIAVKRLSKASGQ--GQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       502 ~lG~G~fG~Vykg~----~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      .+|+|.||.|+...    .+.+...|+|.+++....  .......|..++..++ ||.+|++.-.++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999764    234666788877653221  1125567888888887 9999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      +|.|...+.   .....++.....+...+|-++.++|+.+   |+|||+|++||+++.+|++|+.|||+++..-...
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            999988873   3344666666777788999999999988   9999999999999999999999999999876543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.94  E-value=4.1e-09  Score=107.34  Aligned_cols=150  Identities=23%  Similarity=0.312  Sum_probs=98.7

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccc---cccccHHHHHHHHHHHhcCCC----------CCcceeeEEEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH----------RNLVRLLGCCV  561 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~---~~~~~~~~f~~E~~~l~~l~H----------~nIv~l~g~~~  561 (662)
                      .+...+.||.|+++.||.++.. +++++|||....   ......+++++|.-.+..+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455789999999999999987 489999997642   233456778777766665433          11222222221


Q ss_pred             ---------eCC--------eeEEEEEccCCCCHHHHhc---CCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 006090          562 ---------ERE--------ENMLIYEYMPNKSLDSFLF---DPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH  620 (662)
Q Consensus       562 ---------~~~--------~~~lV~Ey~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  620 (662)
                               ...        ..+++|+-+ .++|.+++.   ... ....+....++.+-.|+++.+++||..+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                     111        236677777 578887753   111 1223444556777899999999999998   999


Q ss_pred             cCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          621 RDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       621 rDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +||||+|++++++|.++|+||+-....+.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~  197 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT  197 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc
Confidence            99999999999999999999998876654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=2.1e-08  Score=102.24  Aligned_cols=141  Identities=18%  Similarity=0.112  Sum_probs=102.7

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEcccccc-----------ccHHHHHHHHHHHhcCC--CCCcceeeEEEEeC----
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG-----------QGQEEFMNEVMVISNLQ--HRNLVRLLGCCVER----  563 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~-----------~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~----  563 (662)
                      +.+-+.....|++.++. |+.+.||+......           .....+.+|...+.++.  .-..++++++.+..    
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            34444444457777774 78899997643221           11124789999998884  34455667776542    


Q ss_pred             -CeeEEEEEccCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------CC
Q 006090          564 -EENMLIYEYMPNK-SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-------DL  634 (662)
Q Consensus       564 -~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~  634 (662)
                       ...+||+|++++- +|.+++.+.. ....+...+..++.+++..++-||..+   |+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence             3468999999986 8999884211 223456677899999999999999998   999999999999985       46


Q ss_pred             ceEEEeeCcccc
Q 006090          635 NPKISDFGLARI  646 (662)
Q Consensus       635 ~~ki~DFGla~~  646 (662)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999999864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.88  E-value=2.4e-09  Score=115.96  Aligned_cols=100  Identities=35%  Similarity=0.559  Sum_probs=90.2

Q ss_pred             HhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006090          545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK  624 (662)
Q Consensus       545 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk  624 (662)
                      |+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+..  ....++|.-...+.++|++||+|||.-.  -..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568899999999999999999999999999999999965  2345899999999999999999999854  23999999


Q ss_pred             CCcEEEcCCCceEEEeeCcccccc
Q 006090          625 ASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       625 p~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++|+++|....+||+|||+..+..
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             cccceeeeeEEEEechhhhccccc
Confidence            999999999999999999999885

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.86  E-value=4.1e-10  Score=127.90  Aligned_cols=143  Identities=20%  Similarity=0.241  Sum_probs=115.7

Q ss_pred             ccccccccCccCceeEEEEEEcCCcEEEEEEccccc-cccHHHHHHHHHHHh--cCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS-GQGQEEFMNEVMVIS--NLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~--~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++...+.||.+.|=+|.+++.++|. |+||++-+.. .-..+.|.++++-++  .++|||.+.+.-+-..+.-.|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4566789999999999999998777 8889875543 445666766655444  45899999887766666667889899


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      +. -+|.+.|   ..+..+...+..-||.|++.||.-+|..+   |.|+|||.+||||+.=.=+.|+||.--|.
T Consensus       103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence            84 5788877   34556788888999999999999999988   99999999999999988999999986553

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=3.8e-09  Score=108.10  Aligned_cols=88  Identities=28%  Similarity=0.505  Sum_probs=68.5

Q ss_pred             CCCCcceeeEEEEeC---------------------------CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHH
Q 006090          549 QHRNLVRLLGCCVER---------------------------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK  601 (662)
Q Consensus       549 ~H~nIv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  601 (662)
                      +|||||++.+++.+.                           ...|+||.-.+ -+|.+||..    ...+...+.-|..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence            589999888876532                           23588888774 589998843    2245566777889


Q ss_pred             HHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCC--ceEEEeeCcc
Q 006090          602 GISRGLLYLHRDSRLRIIHRDLKASNILL--DDDL--NPKISDFGLA  644 (662)
Q Consensus       602 ~ia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~ki~DFGla  644 (662)
                      |+++|+.|||+++   |.|||||+.||||  |+|.  ...|+|||.+
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccccee
Confidence            9999999999998   9999999999998  4444  4679999965

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=1.6e-08  Score=97.28  Aligned_cols=128  Identities=25%  Similarity=0.308  Sum_probs=84.8

Q ss_pred             eEEEEEEcCCcEEEEEEcccccc-------------c-------------cHHHHHHHHHHHhcCCCC--CcceeeEEEE
Q 006090          510 PVYKGKLQDGQEIAVKRLSKASG-------------Q-------------GQEEFMNEVMVISNLQHR--NLVRLLGCCV  561 (662)
Q Consensus       510 ~Vykg~~~~~~~vAvK~l~~~~~-------------~-------------~~~~f~~E~~~l~~l~H~--nIv~l~g~~~  561 (662)
                      .||.|...++..+|||..+....             .             ......+|.+.|.++...  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38999988899999997643100             0             023467899999999754  67777755  


Q ss_pred             eCCeeEEEEEccC--CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          562 EREENMLIYEYMP--NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL-HRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       562 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                        ....|||||++  +..+..+....     ++......++.+++..+..+ |..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              24589999998  55554433111     11234456777888866664 6766   9999999999999988 9999


Q ss_pred             EeeCccccccCC
Q 006090          639 SDFGLARIFGGN  650 (662)
Q Consensus       639 ~DFGla~~~~~~  650 (662)
                      +|||.|......
T Consensus       148 IDf~qav~~~~p  159 (188)
T PF01163_consen  148 IDFGQAVDSSHP  159 (188)
T ss_dssp             --GTTEEETTST
T ss_pred             EecCcceecCCc
Confidence            999999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.69  E-value=1.3e-07  Score=100.61  Aligned_cols=140  Identities=20%  Similarity=0.318  Sum_probs=112.5

Q ss_pred             eeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEE----eCCeeEEEEEccCC-CCHHHHh
Q 006090          509 GPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV----EREENMLIYEYMPN-KSLDSFL  582 (662)
Q Consensus       509 G~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~l  582 (662)
                      .+.||+... +|..+++|+++....+....-..-+++++++.|+|||+|..++.    .+...++||+|.|+ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            467888855 79999999995433333333345678899999999999999887    34567899999986 5677766


Q ss_pred             cCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          583 FDPQ------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       583 ~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +...            ....+++...+.++.|+..||.++|+.|   +..+-|.|++||++.+.+++|+..|+..++..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            5322            2234788899999999999999999998   888999999999999999999999999988766


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            5

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.65  E-value=3.6e-09  Score=119.59  Aligned_cols=151  Identities=26%  Similarity=0.388  Sum_probs=118.9

Q ss_pred             cccccccccCccCceeEEEEEEc--CCcEEEEEEccccc--cccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~--~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ..|.+.+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45666788999999999888753  34456777665432  222334445777666675 99999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH-RDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIF  647 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~  647 (662)
                      .||..++++.+-+... .....+......+..|+..++.|+| ..+   +.|||+||+|.+++..+ ..|++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999998877311 1113455667788999999999999 776   99999999999999999 9999999999988


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ..
T Consensus       176 ~~  177 (601)
T KOG0590|consen  176 RN  177 (601)
T ss_pred             cc
Confidence            76

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.61  E-value=2.5e-07  Score=91.72  Aligned_cols=138  Identities=20%  Similarity=0.232  Sum_probs=96.6

Q ss_pred             cccccccCccCceeEEEEEEcCCcEEEEEEcccccc----------------------ccHHHHHHHHHHHhcCCCC--C
Q 006090          497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG----------------------QGQEEFMNEVMVISNLQHR--N  552 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~----------------------~~~~~f~~E~~~l~~l~H~--n  552 (662)
                      ..+.++||.|.-+.||.|..+.|.++|||.-+....                      .......+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            455789999999999999999999999995322100                      0123467899999999643  7


Q ss_pred             cceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 006090          553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD  632 (662)
Q Consensus       553 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~  632 (662)
                      |.+.+++    +...+||||+++-.|...--     ..-....   |+..|++-+.-+-..+   |||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC-----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            7777665    56689999999866643210     1122233   3333444333333445   999999999999999


Q ss_pred             CCceEEEeeCccccccC
Q 006090          633 DLNPKISDFGLARIFGG  649 (662)
Q Consensus       633 ~~~~ki~DFGla~~~~~  649 (662)
                      +|.+.++||--+-....
T Consensus       238 dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         238 DGDIVVIDWPQAVPISH  254 (304)
T ss_pred             CCCEEEEeCcccccCCC
Confidence            99999999987765543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=4.5e-07  Score=89.26  Aligned_cols=109  Identities=25%  Similarity=0.278  Sum_probs=88.3

Q ss_pred             cHHHHHHHHHHHhcCC--CCCcceeeEEEEeCC----eeEEEEEccCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 006090          534 GQEEFMNEVMVISNLQ--HRNLVRLLGCCVERE----ENMLIYEYMPNK-SLDSFLFDPQRQSLLDWPKRFNIIKGISRG  606 (662)
Q Consensus       534 ~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  606 (662)
                      ....+.+|...+.++.  .-.+++.+++.+...    ..+||+|++++. +|.+++.+..   .++......++.++++.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARL  130 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHH
Confidence            3456788988888874  455777888877643    348999999984 7999984311   15566788999999999


Q ss_pred             HHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEeeCcccccc
Q 006090          607 LLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISDFGLARIFG  648 (662)
Q Consensus       607 L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~DFGla~~~~  648 (662)
                      ++-||+.+   |+|+|++++|||++.+.   .+.++||+-++...
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999998   99999999999999887   89999999988765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.57  E-value=2.5e-07  Score=101.53  Aligned_cols=121  Identities=19%  Similarity=0.272  Sum_probs=100.2

Q ss_pred             cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHH
Q 006090          517 QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR  596 (662)
Q Consensus       517 ~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~  596 (662)
                      .++.+|.|...+...........+-++.|+.++||||++++.........|||+|-+  ..|..++.+      +.....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHHH
Confidence            368899998887655533445677888999999999999999999999999999987  467777732      234555


Q ss_pred             HHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       597 ~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      .-.+.||+.||.|||..+  .++|++|.-..|.+++.|.-||.+|-++...
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            667899999999999776  5999999999999999999999999988654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=2.4e-07  Score=102.29  Aligned_cols=143  Identities=17%  Similarity=0.229  Sum_probs=94.2

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccccH------------------------------H----------HHHH
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ------------------------------E----------EFMN  540 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~------------------------------~----------~f~~  540 (662)
                      +.|+.++-|+||+|++++|+.||||+..+.-.+..                              +          .|.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68899999999999999999999998865322110                              0          1334


Q ss_pred             HHHHHhcC----C-CCCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 006090          541 EVMVISNL----Q-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL-LYLHRDS  614 (662)
Q Consensus       541 E~~~l~~l----~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~  614 (662)
                      |..-+.++    + .++|.-..=++.-.....|+|||++|-.+.+...-..  ..++.+   .|+..++++. ..+-..+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence            44444333    2 2333222223333567899999999999888742111  224422   3333333321 1222234


Q ss_pred             CCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       615 ~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                         ++|.|..|.||+++.++++-+.|||+...+.+..
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~  319 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF  319 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence               9999999999999999999999999999887653

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.56  E-value=3.5e-07  Score=80.96  Aligned_cols=89  Identities=22%  Similarity=0.328  Sum_probs=63.8

Q ss_pred             eEEEecCccEEEEcCC-CCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           92 IFTISEDGNLVVLNGK-KQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        92 ~l~~~~~G~l~l~~~~-~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      ++.++.||+||+++.. +.++|++++... ......+.|+++|||||++.+ +.++|+|     +|              
T Consensus        23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~-g~~vW~S-----~t--------------   81 (114)
T smart00108       23 TLIMQNDYNLILYKSSSRTVVWVANRDNP-VSDSCTLTLQSDGNLVLYDGD-GRVVWSS-----NT--------------   81 (114)
T ss_pred             ccCCCCCEEEEEEECCCCcEEEECCCCCC-CCCCEEEEEeCCCCEEEEeCC-CCEEEEe-----cc--------------
Confidence            4566789999999875 589999998642 223368999999999999863 5679997     11              


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccC
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSG  215 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g  215 (662)
                                  ....|.|.+.|+++|...++-  ...++.|.+.
T Consensus        82 ------------~~~~~~~~~~L~ddGnlvl~~--~~~~~~W~Sf  112 (114)
T smart00108       82 ------------TGANGNYVLVLLDDGNLVIYD--SDGNFLWQSF  112 (114)
T ss_pred             ------------cCCCCceEEEEeCCCCEEEEC--CCCCEEeCCC
Confidence                        012356788899999866542  3346788754

>PRK09902 hypothetical protein; Provisional

Probab=98.55  E-value=1.9e-06  Score=83.59  Aligned_cols=141  Identities=17%  Similarity=0.173  Sum_probs=105.8

Q ss_pred             ccCccCceeEEEEEEcCCcEEEEEEcccc------ccccHHHHHHHHHHHhcCC--CCCcceeeEEEEeCC----eeEEE
Q 006090          502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKA------SGQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVERE----ENMLI  569 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~~~~~vAvK~l~~~------~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~----~~~lV  569 (662)
                      --|+||-+.|++-.+. |+.+-+|+-...      .+.+...|.+|...|.++.  ...+.+++.+.....    ..+||
T Consensus        25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            3456888889998876 457888876521      1446789999999999885  334666663322222    35899


Q ss_pred             EEccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--eEEEeeCcccc
Q 006090          570 YEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN--PKISDFGLARI  646 (662)
Q Consensus       570 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~ki~DFGla~~  646 (662)
                      +|-+++ -+|.+++.+. .....+...+..+..+|++.++-||..+   +.|+|+-+.|||++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998764 5899888432 2234677788899999999999999998   999999999999987666  99999987765


Q ss_pred             c
Q 006090          647 F  647 (662)
Q Consensus       647 ~  647 (662)
                      .
T Consensus       180 ~  180 (216)
T PRK09902        180 R  180 (216)
T ss_pred             h
Confidence            4

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.46  E-value=9e-07  Score=78.59  Aligned_cols=89  Identities=24%  Similarity=0.345  Sum_probs=63.7

Q ss_pred             EEEec-CccEEEEcCC-CCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           93 FTISE-DGNLVVLNGK-KQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        93 l~~~~-~G~l~l~~~~-~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      +.++. ||+||+++.. +.++|++++... ......+.|+++|||||++.+ +.++|||=     |              
T Consensus        24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~-g~~vW~S~-----~--------------   82 (116)
T cd00028          24 LIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGS-GTVVWSSN-----T--------------   82 (116)
T ss_pred             CCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCC-CcEEEEec-----c--------------
Confidence            45665 9999999765 589999998642 235668999999999999853 56799861     1              


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                  ....+.+.+.|+++|...++-  ....+.|.+..
T Consensus        83 ------------~~~~~~~~~~L~ddGnlvl~~--~~~~~~W~Sf~  114 (116)
T cd00028          83 ------------TRVNGNYVLVLLDDGNLVLYD--SDGNFLWQSFD  114 (116)
T ss_pred             ------------cCCCCceEEEEeCCCCEEEEC--CCCCEEEcCCC
Confidence                        002456888899999866542  23567888654

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.39  E-value=1.6e-07  Score=101.92  Aligned_cols=149  Identities=23%  Similarity=0.270  Sum_probs=119.6

Q ss_pred             hhccccccccccCccCceeEEEEEEc--CCcEEEEEEccccccccH--HHHHHHHHHHhcC-CCCCcceeeEEEEeCCee
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKASGQGQ--EEFMNEVMVISNL-QHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~--~~~~vAvK~l~~~~~~~~--~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  566 (662)
                      ....+|.+...||.|.|+.|++...+  ++..+++|.+.+......  ..-..|+.+...+ .|.++++....+....+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888999999999999998754  567888888765433222  2224566666666 588999988888888888


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLAR  645 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGla~  645 (662)
                      |+=-||++++++...+   .-...+++..++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.+.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            8999999999987665   33456888899999999999999999876   9999999999999886 788999999986


Q ss_pred             c
Q 006090          646 I  646 (662)
Q Consensus       646 ~  646 (662)
                      .
T Consensus       416 ~  416 (524)
T KOG0601|consen  416 R  416 (524)
T ss_pred             c
Confidence            4

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=7.9e-06  Score=81.55  Aligned_cols=135  Identities=15%  Similarity=0.134  Sum_probs=87.4

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCC--CcceeeEEEEeCCeeEEEEEccCCCC-
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR--NLVRLLGCCVEREENMLIYEYMPNKS-  577 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gs-  577 (662)
                      .+||+|..+.||+.   .+...++|......  ......+|.+++..+..-  -+.+.+++..+.+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            68999999999984   24566778765422  344568899999888543  35778888888888889999999863 


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHh-CCCCc
Q 006090          578 LDSFLFDPQRQSLLDWPKRFNIIKGISRG---------------------------------------LLYLHR-DSRLR  617 (662)
Q Consensus       578 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------L~yLH~-~~~~~  617 (662)
                      +...+.       .+......++.++++.                                       ..+|.. .....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            221110       0001111111111111                                       122221 12345


Q ss_pred             eEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          618 IIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       618 iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++|+|+.|.||++++++ +.|+||+.+..-.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~Gd  184 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGYGN  184 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCcCC
Confidence            78999999999999988 9999999987543

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.33  E-value=3.3e-07  Score=99.58  Aligned_cols=150  Identities=25%  Similarity=0.366  Sum_probs=119.7

Q ss_pred             ccccccccCc--cCceeEEEEEE---cCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeE
Q 006090          496 NFQLANKLGQ--GGFGPVYKGKL---QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENM  567 (662)
Q Consensus       496 ~f~~~~~lG~--G~fG~Vykg~~---~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~  567 (662)
                      .|.+.+.+|.  |.+|.||.+..   .++..+|+|+-+..  .++....=.+|+....+++ |+|.++....+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4555788999  99999999986   35778999874432  2233334456777777784 999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeC
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR----GLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFG  642 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFG  642 (662)
                      +-+|++. .+|.++.+..-  ..++....+.+..+..+    ||.++|...   |+|-|+||.||.+..+ ..+++.|||
T Consensus       195 iqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999984 78888875432  23566677777777878    999999988   9999999999999999 899999999


Q ss_pred             ccccccCCc
Q 006090          643 LARIFGGNQ  651 (662)
Q Consensus       643 la~~~~~~~  651 (662)
                      +...++...
T Consensus       269 ~v~~i~~~~  277 (524)
T KOG0601|consen  269 LVSKISDGN  277 (524)
T ss_pred             eeEEccCCc
Confidence            999887654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.29  E-value=1.3e-06  Score=83.30  Aligned_cols=62  Identities=27%  Similarity=0.165  Sum_probs=54.0

Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+|.+++.+.  ...+++.++..|+.||++||.|||+++         ||+|||++.++.+|+  ||+++.....
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence            7899999532  345999999999999999999999875         999999999999999  9999987553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=3.3e-06  Score=92.96  Aligned_cols=142  Identities=15%  Similarity=0.196  Sum_probs=90.3

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccH-------------------------------------HHHHHHH
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ-------------------------------------EEFMNEV  542 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~-------------------------------------~~f~~E~  542 (662)
                      .+.|+.-+.|+||+|++++|+.||||+-++.-....                                     -.|..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            478999999999999999999999998765322110                                     1244454


Q ss_pred             HHHhc----CCCCC------cceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 006090          543 MVISN----LQHRN------LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR  612 (662)
Q Consensus       543 ~~l~~----l~H~n------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~  612 (662)
                      +-..+    +.|-+      |.+++-  .-...+.|+||||+|..+.+.-.=  ....++......-+.+...-+-+-  
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~--  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFK--  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHh--
Confidence            43322    34544      223222  224578999999999887765321  112244443333322222222222  


Q ss_pred             CCCCceEecCCCCCcEEEcC----CCceEEEeeCccccccCC
Q 006090          613 DSRLRIIHRDLKASNILLDD----DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       613 ~~~~~iiHrDlkp~NILl~~----~~~~ki~DFGla~~~~~~  650 (662)
                      .   +++|+|-.|.||++..    ++.+.+.||||.+.+...
T Consensus       320 ~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             c---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            2   3999999999999984    668999999999877543

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=98.27  E-value=1.3e-05  Score=70.84  Aligned_cols=99  Identities=25%  Similarity=0.443  Sum_probs=69.2

Q ss_pred             CeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEc-cCCCCCCCCCceEEEecCccEEEEcCCCCEEEeec
Q 006090           37 ESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVA-NRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSN  115 (662)
Q Consensus        37 ~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~a-nr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~w~~~  115 (662)
                      +++.+.+|.+.|-|..+| +     |.|. +    ...+++|.. +...+.. ..+.+.|+.||||||+|..+.++|++.
T Consensus        12 ~p~~~~s~~~~L~l~~dG-n-----Lvl~-~----~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf   79 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDG-N-----LVLY-D----SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSF   79 (114)
T ss_dssp             EEEEECETTEEEEEETTS-E-----EEEE-E----TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST
T ss_pred             cccccccccccceECCCC-e-----EEEE-c----CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeec
Confidence            456565589999999988 3     4343 3    234779999 5444432 458899999999999999999999994


Q ss_pred             cccCcCCccceEEEcc--CCCEEEEeCCCCceeeeeccCC
Q 006090          116 VSSLANNSNTRAQLLD--SGNLVLHDNISQVSIWDSFQEP  153 (662)
Q Consensus       116 ~~~~~~~~~~~~~l~d--~GNlvl~~~~~~~~~WQSFd~P  153 (662)
                      .    ....+.+..++  .||++ +.. ...+.|.|=+.|
T Consensus        80 ~----~ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dp  113 (114)
T PF01453_consen   80 D----YPTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDP  113 (114)
T ss_dssp             T----SSS-EEEEEET--TSEEE-EES-TSSEEEESS---
T ss_pred             C----CCccEEEeccCcccCCCc-ccc-ceEEeECCCCCC
Confidence            3    23567888888  99999 653 356789987666

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.22  E-value=8.6e-07  Score=101.43  Aligned_cols=113  Identities=25%  Similarity=0.356  Sum_probs=77.5

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ...+|...+.|-.|++|.||..+++ ..+.+|+|.-++...     .++   ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-----lRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-----LRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccchh-----hhc---cccccCCccee-----------------
Confidence            3467888999999999999999876 367788854332110     000   22222333333                 


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                          |+=...+..   ...++.        +++.+++|||+.+   |+|||+||.|.||..-|++|+.||||+++..
T Consensus       136 ----gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ----GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ----chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence                444444422   122221        2378999999988   9999999999999999999999999998653

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.21  E-value=3.5e-06  Score=68.68  Aligned_cols=69  Identities=41%  Similarity=0.913  Sum_probs=52.5

Q ss_pred             CcEEEEEeecCCCcccc--cccchhHHHHhhcc-CCCeeeEeecC-CceeEEee-cccccccccCCCCcceeEE
Q 006090          340 DGFFKLETMKVPYFAER--SSANEDKCKDQCSN-NCSCKAYAYEI-GVGCMIWT-HNLIDIRKLPSGGTNLYIR  408 (662)
Q Consensus       340 ~~f~~~~~~~~p~~~~~--~~~~~~~C~~~Cl~-nCsC~a~~y~~-~~~C~~~~-~~l~~~~~~~~~~~~lylr  408 (662)
                      ..|.++.++.++.....  ...++++|++.|++ +|+|.||.|.. +.+|.+|. .++.+....+..+.++|.+
T Consensus         4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeEEe
Confidence            45788888888744332  45689999999999 99999999975 55799999 7777776555555566654

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.20  E-value=6.6e-06  Score=79.51  Aligned_cols=106  Identities=22%  Similarity=0.221  Sum_probs=84.0

Q ss_pred             HHHHHHHhcCCC-CCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006090          539 MNEVMVISNLQH-RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR  617 (662)
Q Consensus       539 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  617 (662)
                      ..|.-++..+++ +++++++|+|    ..++|.||.+.+++...-..-......+|..|.+||.++++.+.+|++...-.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888888976 6999999999    45889999987765421000011123689999999999999999999865445


Q ss_pred             eEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          618 IIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       618 iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +.-+|++|+|+-+++++++|+.|...+-...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999999876553

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.20  E-value=1.9e-05  Score=76.94  Aligned_cols=138  Identities=15%  Similarity=0.233  Sum_probs=92.2

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHH---------HHHHHHHhcCC---CCCcceeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEF---------MNEVMVISNLQ---HRNLVRLLGCCV  561 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f---------~~E~~~l~~l~---H~nIv~l~g~~~  561 (662)
                      .++|...+.+-......|.+...+ ++...+|.........++.|         .+++..+.+++   -...+.++.+..
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            467777777777777777777775 67888887654333222222         23344344442   223333333333


Q ss_pred             eC-----CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          562 ER-----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       562 ~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      ..     ...+|+|||++|..|.++..       ++.    .++..|+++|.-||+.+   +.|+|..|+|++++.+ .+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence            22     34468999999988876541       222    35567888899999998   9999999999999965 49


Q ss_pred             EEEeeCccccc
Q 006090          637 KISDFGLARIF  647 (662)
Q Consensus       637 ki~DFGla~~~  647 (662)
                      ++.||+..+..
T Consensus       174 ~iID~~~k~~~  184 (229)
T PF06176_consen  174 RIIDTQGKRMS  184 (229)
T ss_pred             EEEECcccccc
Confidence            99999988754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.19  E-value=8.7e-07  Score=89.19  Aligned_cols=94  Identities=29%  Similarity=0.366  Sum_probs=78.8

Q ss_pred             HhcCCCCCcceeeEEEEeCC-----eeEEEEEccCCCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 006090          545 ISNLQHRNLVRLLGCCVERE-----ENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRI  618 (662)
Q Consensus       545 l~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  618 (662)
                      |-.+.|.|||++..|+.+..     +..+++|||+.|+|..+|++.++ ...+....-.+++.||..||.|||+-. ++|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence            44457999999999987543     46899999999999999976443 345666667789999999999999975 889


Q ss_pred             EecCCCCCcEEEcCCCceEEE
Q 006090          619 IHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       619 iHrDlkp~NILl~~~~~~ki~  639 (662)
                      +|+++..+-|.+..++.+||.
T Consensus       200 ihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             ccCCcchhheeecCCceEEec
Confidence            999999999999999999985

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=2e-05  Score=79.63  Aligned_cols=144  Identities=14%  Similarity=0.156  Sum_probs=88.6

Q ss_pred             cccCccCc-eeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          501 NKLGQGGF-GPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       501 ~~lG~G~f-G~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      +.|-.|.. ..||+.... +..+.||+.....   .....+|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus         4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555555 778999765 4678888775432   345667888888873 45567888888777778999999999887


Q ss_pred             HHHh-------------------cCCCC-CCCCC--HHHHHHHH-H-------------------HHHHHHHHHHh----
Q 006090          579 DSFL-------------------FDPQR-QSLLD--WPKRFNII-K-------------------GISRGLLYLHR----  612 (662)
Q Consensus       579 ~~~l-------------------~~~~~-~~~l~--~~~~~~i~-~-------------------~ia~~L~yLH~----  612 (662)
                      ....                   +.... .....  ......-. .                   .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6432                   11100 00111  00000000 0                   01111222211    


Q ss_pred             CCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       613 ~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ...+.++|+|+.|.|||++++..+.|+||+.|.+-.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd  195 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD  195 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence            123459999999999999998888999999987543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.14  E-value=2.8e-05  Score=77.42  Aligned_cols=145  Identities=24%  Similarity=0.222  Sum_probs=87.2

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCC--CCcceeeEEEEeC---CeeEEEEEccC
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH--RNLVRLLGCCVER---EENMLIYEYMP  574 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~---~~~~lV~Ey~~  574 (662)
                      .+.|+.|..+.||+....+ ..+++|.....  .....+..|..++..+..  ..+.+++.+....   ...+++||+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3678899999999999886 68999987543  445677888888888742  3466777765443   34689999999


Q ss_pred             CCCHHH----------------Hh---cCC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 006090          575 NKSLDS----------------FL---FDP-QRQSLLDWPKR---------FNI------------IKGISR-GLLYLHR  612 (662)
Q Consensus       575 ~gsL~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~ia~-~L~yLH~  612 (662)
                      +..+..                .+   +.. .......+...         ...            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111 11111111110         000            111222 2333332


Q ss_pred             ----CCCCceEecCCCCCcEEEc-CCCceEEEeeCccccc
Q 006090          613 ----DSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIF  647 (662)
Q Consensus       613 ----~~~~~iiHrDlkp~NILl~-~~~~~ki~DFGla~~~  647 (662)
                          .....++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence                2345699999999999999 6666789999988754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.05  E-value=9.2e-07  Score=94.57  Aligned_cols=81  Identities=28%  Similarity=0.413  Sum_probs=72.1

Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++.|++|...+|.++|.+.......++...+.++.|++.|+.|   ++   .+|||+||.||....+.++||.||||.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999776666778899999999999999999   55   899999999999999999999999998


Q ss_pred             ccccCCc
Q 006090          645 RIFGGNQ  651 (662)
Q Consensus       645 ~~~~~~~  651 (662)
                      .......
T Consensus       404 ts~~~~~  410 (516)
T KOG1033|consen  404 TSQDKDE  410 (516)
T ss_pred             eecccCC
Confidence            8775443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.00  E-value=6.8e-05  Score=73.96  Aligned_cols=154  Identities=18%  Similarity=0.225  Sum_probs=100.5

Q ss_pred             CHHHHHhhcccccccc---ccCccCceeEEEEEEcCCcEEEEEEccccccccH------------------------HHH
Q 006090          486 NFEELANATNNFQLAN---KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ------------------------EEF  538 (662)
Q Consensus       486 ~~~~l~~~~~~f~~~~---~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~------------------------~~f  538 (662)
                      +.+.+.....+..+.+   .|.+|.-+.||+|...++..+|||+.+.......                        .-.
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            3444444444444444   4556778889999987899999998764221110                        113


Q ss_pred             HHHHHHHhcCC--CCCcceeeEEEEeCCeeEEEEEccCCCC-HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006090          539 MNEVMVISNLQ--HRNLVRLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR  615 (662)
Q Consensus       539 ~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  615 (662)
                      ..|..-|.++.  +-.+.+.+++.    ...|||||+.... -.-.|    +...++..+...+..++++.|.-|-... 
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            45666666663  45556666553    4579999996541 11111    1112333366777888888888777633 


Q ss_pred             CceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       616 ~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                       ++||+||..-|||+. ++.+.|+|||=|-.....
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence             399999999999999 889999999988776543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=8e-05  Score=88.53  Aligned_cols=79  Identities=16%  Similarity=0.383  Sum_probs=57.7

Q ss_pred             ccccCccCceeEEEEEEcCC---cEEEEEEccccc-cccHHHHHHHHHHHhcCC-CCCc--ceeeEEEEeC---CeeEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDG---QEIAVKRLSKAS-GQGQEEFMNEVMVISNLQ-HRNL--VRLLGCCVER---EENMLI  569 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV  569 (662)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|.++|+.+. |++|  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56788999999999887653   356677653322 123457889999999995 6665  8888888765   457899


Q ss_pred             EEccCCCCH
Q 006090          570 YEYMPNKSL  578 (662)
Q Consensus       570 ~Ey~~~gsL  578 (662)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987653

>PRK10593 hypothetical protein; Provisional

Probab=97.87  E-value=0.00021  Score=74.56  Aligned_cols=76  Identities=11%  Similarity=0.084  Sum_probs=57.2

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-C--CCcceeeEEEEeC---CeeEEEEEcc
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-H--RNLVRLLGCCVER---EENMLIYEYM  573 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H--~nIv~l~g~~~~~---~~~~lV~Ey~  573 (662)
                      .+.||.|..+.||+....++ .+.+|..+.  ......|..|.+.|+.+. +  ..+.+++++|...   +..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            57899999999999987655 455666432  113358899999999885 2  4688999988653   5689999999


Q ss_pred             CCCCH
Q 006090          574 PNKSL  578 (662)
Q Consensus       574 ~~gsL  578 (662)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.77  E-value=0.00038  Score=67.64  Aligned_cols=128  Identities=19%  Similarity=0.246  Sum_probs=88.1

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccc----------------cccHHHHHHHHHHHhcCC------CCCcceee
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS----------------GQGQEEFMNEVMVISNLQ------HRNLVRLL  557 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~----------------~~~~~~f~~E~~~l~~l~------H~nIv~l~  557 (662)
                      ...||+|+.=.||.  +++.....||+.....                ....+++++|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999988885  3445667788776543                123466777776655554      78899999


Q ss_pred             EEEEeCCeeEEEEEccCC------CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          558 GCCVEREENMLIYEYMPN------KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       558 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                      |+.+.+...-+|+|.+..      -+|.+++.+    ..++. ...+...   +-..||-++.   |+.+||+|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999988899997643      358888832    23444 3333333   3344666655   99999999999996


Q ss_pred             CCC----ceEEEe
Q 006090          632 DDL----NPKISD  640 (662)
Q Consensus       632 ~~~----~~ki~D  640 (662)
                      .+.    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            532    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.70  E-value=0.0003  Score=70.74  Aligned_cols=142  Identities=18%  Similarity=0.182  Sum_probs=78.3

Q ss_pred             cccCccCce-eEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCC---CCcceeeEEEEeCC---eeEEEEEcc
Q 006090          501 NKLGQGGFG-PVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH---RNLVRLLGCCVERE---ENMLIYEYM  573 (662)
Q Consensus       501 ~~lG~G~fG-~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H---~nIv~l~g~~~~~~---~~~lV~Ey~  573 (662)
                      +.|+.|+.. .||+.    +..+++|....  ......+.+|.+.+..+..   --+.++++.....+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567766665 48875    23466676443  2234578899999887752   13455555443322   348899999


Q ss_pred             CCCCHHHH------------------hcCCCCCC-C------------C-CHHHHH--HHH-------HHHHHHH-H-HH
Q 006090          574 PNKSLDSF------------------LFDPQRQS-L------------L-DWPKRF--NII-------KGISRGL-L-YL  610 (662)
Q Consensus       574 ~~gsL~~~------------------l~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~~L-~-yL  610 (662)
                      +|.++.+.                  |+.-.... .            + .|....  .+.       .+....+ . ++
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            98776422                  11110000 0            0 111110  000       0111111 1 11


Q ss_pred             Hh--CCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          611 HR--DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       611 H~--~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +.  ..++.++|+|+.+.|||++.+...-|.||+.|..-.
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gD  196 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGD  196 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcCC
Confidence            11  123448999999999999977667899999886543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.00066  Score=73.09  Aligned_cols=76  Identities=14%  Similarity=0.200  Sum_probs=55.8

Q ss_pred             ccccCccCceeEEEEEEcCC-cEEEEEEcccc------c-cccHHHHHHHHHHHhcCC---CCCcceeeEEEEeCCeeEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDG-QEIAVKRLSKA------S-GQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENML  568 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~-~~vAvK~l~~~------~-~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l  568 (662)
                      .+.||.|.+..||++...+| +.+.||.-.+.      . +.....+..|.+.|..+.   -..+++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46899999999999998876 58999974321      1 224567788888887762   2467888887  4466789


Q ss_pred             EEEccCCCC
Q 006090          569 IYEYMPNKS  577 (662)
Q Consensus       569 V~Ey~~~gs  577 (662)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.66  E-value=0.00045  Score=66.70  Aligned_cols=125  Identities=25%  Similarity=0.399  Sum_probs=90.1

Q ss_pred             cccccccccCccCc-eeEEEEEEcCCcEEEEEEccc---c--------cc----------ccHHHHHHHHHHHhcCC---
Q 006090          495 NNFQLANKLGQGGF-GPVYKGKLQDGQEIAVKRLSK---A--------SG----------QGQEEFMNEVMVISNLQ---  549 (662)
Q Consensus       495 ~~f~~~~~lG~G~f-G~Vykg~~~~~~~vAvK~l~~---~--------~~----------~~~~~f~~E~~~l~~l~---  549 (662)
                      .+++..+.||.|.. |.|||+++. |+.+|+|..+.   .        ..          ....-|..|.+..++|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 999999996 78999998321   0        00          11235889999988885   


Q ss_pred             CCCc--ceeeEEEEeCC------------------eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 006090          550 HRNL--VRLLGCCVERE------------------ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY  609 (662)
Q Consensus       550 H~nI--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  609 (662)
                      +.++  |+.+||..-..                  ..-||.||++...            .+.    ..=+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4466  89999874321                  1247777775433            112    2235678888889


Q ss_pred             HHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       610 LH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      +|..+   |+-+|++++|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99887   999999999976     4588999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.56  E-value=0.00044  Score=70.47  Aligned_cols=141  Identities=15%  Similarity=0.072  Sum_probs=80.4

Q ss_pred             ccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc-ceeeEEEEeCCeeEEEEEccCCCCHHH
Q 006090          502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEYMPNKSLDS  580 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~  580 (662)
                      .+..|-...+|+... +++.+++|..............+|.++++.+....+ .++++...    ..+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            345677788998874 466788887644222211235678888888854333 44555432    368999999876542


Q ss_pred             H-----------------hcCCC-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCceEecCCCCCc
Q 006090          581 F-----------------LFDPQ-RQSLLDWPKR-FNIIKG---------ISRGLLYLHRD-----SRLRIIHRDLKASN  627 (662)
Q Consensus       581 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~iiHrDlkp~N  627 (662)
                      .                 ||+.. ....++.... .....+         +.+-+..+-..     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 12111 1111222211 111111         11112222211     12358999999999


Q ss_pred             EEEcCCCceEEEeeCcccccc
Q 006090          628 ILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       628 ILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||+++++ ++|.||..|..-.
T Consensus       158 il~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             EEEeCCC-CEEEeccccCcCC
Confidence            9999877 7899999887543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.56  E-value=0.00072  Score=67.81  Aligned_cols=144  Identities=19%  Similarity=0.235  Sum_probs=83.1

Q ss_pred             cccCccCceeEEEEEEcC--CcEEEEEEccccccccHHHHHHHHHHHhcCCCC-CcceeeEEEEeCCeeEEEEEccCCCC
Q 006090          501 NKLGQGGFGPVYKGKLQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR-NLVRLLGCCVEREENMLIYEYMPNKS  577 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~--~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey~~~gs  577 (662)
                      +.|..|-...+|+....+  ++.+++|....... ....-.+|+.++..+... -.+++++...    ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567778888999998764  57888887654222 112234688888877433 3455555432    248999999877


Q ss_pred             HHHH-----------------hcCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 006090          578 LDSF-----------------LFDPQRQ--------SLL-DWPKRFNIIK----------------------GISRGLLY  609 (662)
Q Consensus       578 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~L~y  609 (662)
                      +...                 |++....        ... -+.....+..                      .+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321                 1111111        011 1222111110                      11111112


Q ss_pred             H----HhC-CCCceEecCCCCCcEEEcC-CCceEEEeeCccccccC
Q 006090          610 L----HRD-SRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       610 L----H~~-~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~  649 (662)
                      |    ... .+..++|+|+.+.|||++. ++.+.|.||..|..-..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~  204 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYR  204 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCch
Confidence            2    111 2346999999999999998 57899999998875543

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.36  E-value=0.0014  Score=68.22  Aligned_cols=143  Identities=18%  Similarity=0.186  Sum_probs=87.1

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCC--CcceeeEE------EEeCCeeEEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR--NLVRLLGC------CVEREENMLIYE  571 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~--nIv~l~g~------~~~~~~~~lV~E  571 (662)
                      .+.|..|....+|+....+ ..+++|+...   ........|++++..+.+.  .+.+++..      ....+..++|+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778778899987654 4678887754   2334566778777777432  35555442      123455689999


Q ss_pred             ccCCCCHHH----H----------hcCC----C----CCCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 006090          572 YMPNKSLDS----F----------LFDP----Q----RQSLLDWPKRF----------NIIKGISRGLLYLHR----DSR  615 (662)
Q Consensus       572 y~~~gsL~~----~----------l~~~----~----~~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~  615 (662)
                      |++|..+..    .          |+..    .    ......|....          .....+..++.++..    .-+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    0          1110    0    01112333221          111223445555553    122


Q ss_pred             CceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          616 LRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       616 ~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ..++|+|+.|.|||++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999988889999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.23  E-value=0.0032  Score=59.13  Aligned_cols=128  Identities=21%  Similarity=0.282  Sum_probs=86.9

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcc-eeeEEEEeCCeeEEEEEccCCCCH
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV-RLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      .+.|++|.+|.||++.+. +.++|+|+-..  ......+..|+++|..++-.++. +++.|.    ...+.|||+.|..|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence            578999999999999987 56889887654  34457888999999998766654 455543    33455999999888


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CCcEEEcCCCceEEEeeCccccc
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK-ASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk-p~NILl~~~~~~ki~DFGla~~~  647 (662)
                      .+.-..      .+-.+..    .+++.---|-..+   |-|..|. |...+|-.+..+.|+||.-|..-
T Consensus       100 ~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         100 GKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            776421      1222332    3444433333333   7787774 55555555559999999999844

>PRK05231 homoserine kinase; Provisional

Probab=97.02  E-value=0.013  Score=61.72  Aligned_cols=141  Identities=16%  Similarity=0.168  Sum_probs=76.6

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC--CCCcceeeE------EEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ--HRNLVRLLG------CCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g------~~~~~~~~~lV~Ey  572 (662)
                      +.|..|....+|+.+..++ .+++|+....   .......|+.++..|.  .-.+.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566677778999887655 6778876521   2233334555555542  122344442      12235567899999


Q ss_pred             cCCCCHHH-----------Hh---cCCC--------CCCCCCH-HHHHH------------HH-HHHHHHHHHHHhC---
Q 006090          573 MPNKSLDS-----------FL---FDPQ--------RQSLLDW-PKRFN------------II-KGISRGLLYLHRD---  613 (662)
Q Consensus       573 ~~~gsL~~-----------~l---~~~~--------~~~~l~~-~~~~~------------i~-~~ia~~L~yLH~~---  613 (662)
                      ++|..+..           .|   +...        ....+.| .....            .. ..+...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99875321           11   1100        0011212 11111            11 1111222333211   


Q ss_pred             -CCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          614 -SRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       614 -~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                       -+..++|+|+.|.|||++.+...-|.||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             23459999999999999977666899999885

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.90  E-value=0.018  Score=60.26  Aligned_cols=143  Identities=18%  Similarity=0.203  Sum_probs=82.9

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCC--CCcceeeEEE------EeCCeeEEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH--RNLVRLLGCC------VEREENMLIYE  571 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~------~~~~~~~lV~E  571 (662)
                      .+.++.|....+|+.+..++ ..++|......  ...+...|++++..|..  -.+.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45667777788999876545 56678764421  23445566777766632  2345554421      22455789999


Q ss_pred             ccCCCCHHH-----------H---hcCCCC-------C--CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 006090          572 YMPNKSLDS-----------F---LFDPQR-------Q--SLLDWPKRF------------NIIKGISRGLLYLHR----  612 (662)
Q Consensus       572 y~~~gsL~~-----------~---l~~~~~-------~--~~l~~~~~~------------~i~~~ia~~L~yLH~----  612 (662)
                      |++|..+..           .   ++....       .  ..-.|....            .....+.+.+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998855321           1   111000       0  011222111            011223445555543    


Q ss_pred             CCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       613 ~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      ..+..++|+|+.+.||+++.++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999998877899999984

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.87  E-value=0.0078  Score=62.16  Aligned_cols=74  Identities=18%  Similarity=0.274  Sum_probs=49.3

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC---CCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      ..+.++-|....+|+.. .+++.+-||.-.   ......|..|.+-|+.|.   -..+.+++++...++..+||+||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            35678888889999987 557888899765   334467888998888773   44688999998888888999999987


Q ss_pred             C
Q 006090          576 K  576 (662)
Q Consensus       576 g  576 (662)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.84  E-value=0.00095  Score=53.78  Aligned_cols=35  Identities=17%  Similarity=0.631  Sum_probs=28.8

Q ss_pred             cccchhHHHHhhccCCCeeeEeecCCc-eeEEeecc
Q 006090          357 SSANEDKCKDQCSNNCSCKAYAYEIGV-GCMIWTHN  391 (662)
Q Consensus       357 ~~~~~~~C~~~Cl~nCsC~a~~y~~~~-~C~~~~~~  391 (662)
                      ...+.++|++.|+.+|+|.||.|..+. .|+++...
T Consensus        23 ~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~   58 (73)
T cd01100          23 FASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE   58 (73)
T ss_pred             ecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence            346889999999999999999998544 49986654

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.80  E-value=0.013  Score=61.26  Aligned_cols=144  Identities=24%  Similarity=0.281  Sum_probs=85.0

Q ss_pred             cccCccCceeEEEEEEcC-------CcEEEEEEccccccccHHHHHHHHHHHhcCCCCC-cceeeEEEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQD-------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN-LVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~-------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey  572 (662)
                      +.+..|-...+|+.+..+       ++.+++|...... .......+|.+++..+.... ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            445556667889888664       4788888865432 23344567888777774322 3456666532    368999


Q ss_pred             cCCCCHHHH-----------------hcCCCCCC------CC--CHHHHHH--------------------------HHH
Q 006090          573 MPNKSLDSF-----------------LFDPQRQS------LL--DWPKRFN--------------------------IIK  601 (662)
Q Consensus       573 ~~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~  601 (662)
                      ++|..+...                 ||+.....      ..  -|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431                 11111100      00  1111100                          112


Q ss_pred             HHHHHHHHHHh------CCCCceEecCCCCCcEEEcCC----CceEEEeeCccccccC
Q 006090          602 GISRGLLYLHR------DSRLRIIHRDLKASNILLDDD----LNPKISDFGLARIFGG  649 (662)
Q Consensus       602 ~ia~~L~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~ki~DFGla~~~~~  649 (662)
                      .+.+-+.+|..      ..+..++|+|+.|.|||++++    +.++++||..|..-.+
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p  216 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR  216 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc
Confidence            22333444432      234569999999999999985    8899999999886543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=96.80  E-value=0.0086  Score=63.80  Aligned_cols=143  Identities=19%  Similarity=0.264  Sum_probs=81.6

Q ss_pred             cccCccCceeEEEEEEcC-----CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc-ceeeEEEEeCCeeEEEEEccC
Q 006090          501 NKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~-----~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ..+-.|-.-.+|+....+     ++.+++|.......... .-.+|..++..+...++ .++++.+..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345446677889887542     35788887765432222 22578888887754333 3556665322    5899998


Q ss_pred             CCCHHHH-----------------hcCCCC---CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 006090          575 NKSLDSF-----------------LFDPQR---QSLLDWPKRFNIIKG-----------------ISRGLLYL----HR-  612 (662)
Q Consensus       575 ~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~-----------------ia~~L~yL----H~-  612 (662)
                      +.+|...                 +|+...   .....|.+..+...+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7776421                 122110   111122222222211                 11122222    21 


Q ss_pred             CCCCceEecCCCCCcEEEcC-CCceEEEeeCcccccc
Q 006090          613 DSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFG  648 (662)
Q Consensus       613 ~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~  648 (662)
                      ..+..++|+|+++.|||+++ ++.++|+||..|..-.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP  233 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence            22345899999999999986 4789999999987554

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.65  E-value=0.018  Score=60.89  Aligned_cols=79  Identities=15%  Similarity=0.135  Sum_probs=52.2

Q ss_pred             ccCccCceeEEEEEEcCC-cEEEEEEccc-------cccccHHHHHHHHHHHhcCC--CC-CcceeeEEEEeCCeeEEEE
Q 006090          502 KLGQGGFGPVYKGKLQDG-QEIAVKRLSK-------ASGQGQEEFMNEVMVISNLQ--HR-NLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       502 ~lG~G~fG~Vykg~~~~~-~~vAvK~l~~-------~~~~~~~~f~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~  570 (662)
                      .||.|...-||++..+++ +.|+||.-.+       .-+....+...|.+.|....  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999998754 5899996432       11233455567777776653  23 45666554  566678999


Q ss_pred             EccCCC-CHHHHh
Q 006090          571 EYMPNK-SLDSFL  582 (662)
Q Consensus       571 Ey~~~g-sL~~~l  582 (662)
                      |+++.. .|.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            999643 355554

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.63  E-value=0.014  Score=60.03  Aligned_cols=33  Identities=27%  Similarity=0.489  Sum_probs=27.3

Q ss_pred             CceEecCCCCCcEEEcCCCc-eEEEeeCcccccc
Q 006090          616 LRIIHRDLKASNILLDDDLN-PKISDFGLARIFG  648 (662)
Q Consensus       616 ~~iiHrDlkp~NILl~~~~~-~ki~DFGla~~~~  648 (662)
                      ..++|+|++|.|||+++++. .-|.||+.+.+-.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            45899999999999997554 5699999987654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.60  E-value=0.02  Score=59.65  Aligned_cols=138  Identities=17%  Similarity=0.257  Sum_probs=79.5

Q ss_pred             eEEEEEEcCCcEEEEEEccc--cccccHHHHHHHHHHHhcCC--CCCcceeeEEEEeCC--eeEEEEEccCCCCHHHHhc
Q 006090          510 PVYKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVERE--ENMLIYEYMPNKSLDSFLF  583 (662)
Q Consensus       510 ~Vykg~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~  583 (662)
                      .+|..... ++..++. .-.  ..........+|..+|+.+.  -.-+.+.++.|.++.  ..+.||||++|..+.+.+.
T Consensus        40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            34444333 5666666 211  12233445567777777763  234566788888776  6799999998743322211


Q ss_pred             ---------------------CC--------------CCCCCCCHHHHHHHH--------HHHHHHHHHHHhC-----CC
Q 006090          584 ---------------------DP--------------QRQSLLDWPKRFNII--------KGISRGLLYLHRD-----SR  615 (662)
Q Consensus       584 ---------------------~~--------------~~~~~l~~~~~~~i~--------~~ia~~L~yLH~~-----~~  615 (662)
                                           +-              ..+..-.|...+..+        -....-..+|+++     ++
T Consensus       118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~  197 (321)
T COG3173         118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP  197 (321)
T ss_pred             cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence                                 00              000111122211100        1122234455443     23


Q ss_pred             CceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       616 ~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +.++|+|+.+.|++++.+..+-|.||+++.+-.+
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            5699999999999999999999999999986554

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.28  E-value=0.06  Score=58.04  Aligned_cols=80  Identities=13%  Similarity=0.099  Sum_probs=53.3

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEcccc----cc---ccHHHHHHHHHHHhcCC---CCCcceeeEEEEeCCeeEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA----SG---QGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~----~~---~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .+.||.|..-.||+.... ++.++||+-...    ..   .....-..|.+.|+.+.   ...+.++++++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            578899999999998864 567888865411    11   12333445566666553   357888999886  456889


Q ss_pred             EEccCC--CCHHHHh
Q 006090          570 YEYMPN--KSLDSFL  582 (662)
Q Consensus       570 ~Ey~~~--gsL~~~l  582 (662)
                      |||+++  ..+.+.|
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999976  3455544

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.18  E-value=0.0063  Score=62.36  Aligned_cols=131  Identities=18%  Similarity=0.268  Sum_probs=89.7

Q ss_pred             cccccccCccCceeEEEEEEcCCcEEEEEEcccc--------------------ccc--cHHHHHHHHHHHhcCC-C-CC
Q 006090          497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--------------------SGQ--GQEEFMNEVMVISNLQ-H-RN  552 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--------------------~~~--~~~~f~~E~~~l~~l~-H-~n  552 (662)
                      ++..++||-|.-+.||.+-..+|++.++|.-.-.                    +..  ..-...+|...|+.+. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            5678999999999999999998999888732110                    000  0123456888888774 2 23


Q ss_pred             cceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 006090          553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD  632 (662)
Q Consensus       553 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~  632 (662)
                      |.+.+++    +..++|||++.+-.|...-      ...+..++..-+.++   +--|..++   +||+|..--||++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~~---Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMGL---IVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHHHHH---HHHHHHcC---ceecccchheeEEec
Confidence            5555544    4568999999888776432      123334444333332   33455556   999999999999999


Q ss_pred             CCceEEEeeCc
Q 006090          633 DLNPKISDFGL  643 (662)
Q Consensus       633 ~~~~ki~DFGl  643 (662)
                      +..++++||--
T Consensus       238 d~~i~vIDFPQ  248 (465)
T KOG2268|consen  238 DDKIVVIDFPQ  248 (465)
T ss_pred             CCCEEEeechH
Confidence            99999999963

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.17  E-value=0.00065  Score=78.59  Aligned_cols=148  Identities=20%  Similarity=0.208  Sum_probs=100.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      -+.+.+.+.+-.|.++.++.++-. .+...++|.....   ..+..+..+.+-.++-..+||-+++..--+.-....+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            356777788889999999887633 2333344433221   112222333333333334456666555555556778999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++|..+++|...|+...   ..+..-.......+..++.|||...   +.|||++|.|.|+..++..+++|||+.+..
T Consensus       883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999886532   2343444455666888999999875   899999999999999999999999965544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.05  E-value=0.0012  Score=72.71  Aligned_cols=141  Identities=16%  Similarity=0.114  Sum_probs=96.6

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCC-cceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN-LVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +-+...+.++++++++++|.+--..+....+.+...     .+..-++++|.+++||| .++-++-+..++...++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            334445778899999999987443344445554321     45567889999999999 777777777777788999999


Q ss_pred             CCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          574 PNK-SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       574 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ..+ +.....  ......+..-+...+.+.-+++++|||+..   -+|||    |||..+ +..|..||+.+..+.+.
T Consensus       317 s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  317 STGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             cCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            877 221111  011112333344456667788999999864   58998    777766 68899999999888664

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.04  E-value=0.028  Score=58.75  Aligned_cols=141  Identities=19%  Similarity=0.245  Sum_probs=93.7

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEccccc-----c----ccH-------------H----HHHHHHHHHhcCCCCC
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS-----G----QGQ-------------E----EFMNEVMVISNLQHRN  552 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~-----~----~~~-------------~----~f~~E~~~l~~l~H~n  552 (662)
                      +.--|..|.-+.||.+.-.+|..+|||+++...     .    .+.             +    -...|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345677899999999998899999999875310     0    010             1    1234666677765444


Q ss_pred             cceeeEEEEeCCeeEEEEEccCCCCH-HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          553 LVRLLGCCVEREENMLIYEYMPNKSL-DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       553 Iv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                      |.-.--...  ....|||+|+..-.. .-.|    +...++...+..+-.|++.-|.-|-+.+  ++||.||.--|+|+-
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            331111111  123699999953221 1112    2234677788889999999999998887  599999999999984


Q ss_pred             CCCceEEEeeCcccccc
Q 006090          632 DDLNPKISDFGLARIFG  648 (662)
Q Consensus       632 ~~~~~ki~DFGla~~~~  648 (662)
                       +|.+.|+|.+-+--..
T Consensus       300 -dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             -CCEEEEEEccccccCC
Confidence             5689999988776443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.79  E-value=0.17  Score=52.80  Aligned_cols=29  Identities=31%  Similarity=0.398  Sum_probs=25.5

Q ss_pred             CceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          616 LRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       616 ~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      ..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46899999999999988 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.60  E-value=0.11  Score=54.80  Aligned_cols=136  Identities=24%  Similarity=0.342  Sum_probs=81.6

Q ss_pred             CceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCC------cceeeEEE----EeCCeeEEEEEccCCC
Q 006090          507 GFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN------LVRLLGCC----VEREENMLIYEYMPNK  576 (662)
Q Consensus       507 ~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n------Iv~l~g~~----~~~~~~~lV~Ey~~~g  576 (662)
                      .--.+|+....+++. ++|.....  ....+...|+..|..+.-..      |..+=|-.    ......+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            445689888877766 77877653  34555666777776662111      22222221    1123678899999998


Q ss_pred             CHHH-H-----------h---c---------CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhCC----C
Q 006090          577 SLDS-F-----------L---F---------DPQRQSLLDWPK-------------RFNIIKGISRGLLYLHRDS----R  615 (662)
Q Consensus       577 sL~~-~-----------l---~---------~~~~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~~----~  615 (662)
                      .+.. -           |   +         .+.......|..             ......++...+..+++.-    +
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8772 1           0   1         111112344541             0123344555555555431    1


Q ss_pred             ---CceEecCCCCCcEEEcCCCc-eEEEeeCccc
Q 006090          616 ---LRIIHRDLKASNILLDDDLN-PKISDFGLAR  645 (662)
Q Consensus       616 ---~~iiHrDlkp~NILl~~~~~-~ki~DFGla~  645 (662)
                         ..+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               22999999999999999885 9999999876

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.47  E-value=0.061  Score=57.67  Aligned_cols=81  Identities=14%  Similarity=0.144  Sum_probs=54.3

Q ss_pred             ccccCccCceeEEEEEEcC-CcEEEEEEccc------cccccHHHHHHHHHHHhcCC--CC-CcceeeEEEEeCCeeEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK------ASGQGQEEFMNEVMVISNLQ--HR-NLVRLLGCCVEREENMLI  569 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~------~~~~~~~~f~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lV  569 (662)
                      .+.||-|.-.-||++...+ ++.|+||.-.+      .-+....+...|.+.|+...  -| .+++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5689999999999999753 56899985432      11234566677888877653  23 46667665  55666899


Q ss_pred             EEccCC-CCHHHHh
Q 006090          570 YEYMPN-KSLDSFL  582 (662)
Q Consensus       570 ~Ey~~~-gsL~~~l  582 (662)
                      ||+++. ..|.+.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            999854 2344444

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.27  E-value=0.091  Score=55.66  Aligned_cols=144  Identities=15%  Similarity=0.251  Sum_probs=79.7

Q ss_pred             cccCccCceeEEEEEEcC----CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc-ceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      +.|..|=.-.+|+....+    +..+.+|....... ..-.-.+|..+++.+...++ .++++++. .+   +|.||+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            444446666788887543    23788887754332 22233578888887755444 45666653 22   58999987


Q ss_pred             CCHHHH-----------------hcCCC-C--CCCCCHHHHHHHHHH----------------------HHHHHHHHH--
Q 006090          576 KSLDSF-----------------LFDPQ-R--QSLLDWPKRFNIIKG----------------------ISRGLLYLH--  611 (662)
Q Consensus       576 gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~----------------------ia~~L~yLH--  611 (662)
                      ..|..-                 ||+.. .  ..+--|....++..+                      +.+-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            665321                 11111 0  111123322222211                      111122211  


Q ss_pred             --h-CCCCceEecCCCCCcEEEcC-CCceEEEeeCccccccC
Q 006090          612 --R-DSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       612 --~-~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~  649 (662)
                        . ..+.-..|.|+-+.|||+++ ++.++++||..|..-.+
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~  216 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYR  216 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCcc
Confidence              1 12234789999999999975 57899999999875543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.11  E-value=0.21  Score=49.15  Aligned_cols=59  Identities=20%  Similarity=0.307  Sum_probs=45.6

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhcC---CCCCcceeeEEEEeCCeeEEEEEccCCCCHH
Q 006090          518 DGQEIAVKRLSKASGQGQEEFMNEVMVISNL---QHRNLVRLLGCCVEREENMLIYEYMPNKSLD  579 (662)
Q Consensus       518 ~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  579 (662)
                      +..++-||+-   ..+....|..|+.-|..+   +-.++.+++..-.+..+.|+|+||++-|.++
T Consensus        38 g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          38 GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3567888864   234557889998776666   3466888999999999999999999987766

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.84  E-value=0.042  Score=54.07  Aligned_cols=31  Identities=35%  Similarity=0.472  Sum_probs=22.0

Q ss_pred             ceEecCCCCCcEEE-cCCCceEEEeeCccccc
Q 006090          617 RIIHRDLKASNILL-DDDLNPKISDFGLARIF  647 (662)
Q Consensus       617 ~iiHrDlkp~NILl-~~~~~~ki~DFGla~~~  647 (662)
                      .+.|+||.|.|||+ +.++.++++||..|..-
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n  175 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYN  175 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EEE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhhc
Confidence            47899999999999 88999999999988743

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	662
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-38
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-29
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-26
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-17
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-17
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3soa_A	444	Full-Length Human Camkii Length = 444		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  155 bits (392), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 86/184 (46%), Positives = 114/184 (61%), Gaps = 2/184 (1%)
Query: 466 YANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK 525
           + +   E+     L  L  F+  EL  A++NF   N LG+GGFG VYKG+L DG  +AVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 526 RLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD 584
           RL +   QG E +F  EV +IS   HRNL+RL G C+   E +L+Y YM N S+ S L +
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 585 -PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
            P+ Q  LDWPKR  I  G +RGL YLH     +IIHRD+KA+NILLD++    + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 644 ARIF 647
           A++ 
Sbjct: 181 AKLM 184

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  155 bits (391), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 86/184 (46%), Positives = 114/184 (61%), Gaps = 2/184 (1%)
Query: 466 YANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK 525
           + +   E+     L  L  F+  EL  A++NF   N LG+GGFG VYKG+L DG  +AVK
Sbjct: 9   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 68
Query: 526 RLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD 584
           RL +   QG E +F  EV +IS   HRNL+RL G C+   E +L+Y YM N S+ S L +
Sbjct: 69  RLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 128
Query: 585 -PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
            P+ Q  LDWPKR  I  G +RGL YLH     +IIHRD+KA+NILLD++    + DFGL
Sbjct: 129 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 188
Query: 644 ARIF 647
           A++ 
Sbjct: 189 AKLM 192

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/173 (43%), Positives = 107/173 (61%), Gaps = 5/173 (2%)
Query: 489 ELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
           +L  ATNNF     +G G FG VYKG L+DG ++A+KR +  S QG EEF  E+  +S  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGL 607
           +H +LV L+G C ER E +LIY+YM N +L   L+     ++ + W +R  I  G +RGL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
            YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++  G   DQ     +V
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVV 201

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  126 bits (317), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 72/158 (45%), Positives = 102/158 (64%), Gaps = 4/158 (2%)
Query: 489 ELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
           +L  ATNNF     +G G FG VYKG L+DG ++A+KR +  S QG EEF  E+  +S  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGL 607
           +H +LV L+G C ER E +LIY+YM N +L   L+     ++ + W +R  I  G +RGL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/188 (39%), Positives = 105/188 (55%), Gaps = 14/188 (7%)
Query: 485 FNFEELANATNNFQL------ANKLGQGGFGPVYKGKLQDGQEIAVKRLSK----ASGQG 534
           F+F EL N TNNF         NK+G+GGFG VYKG + +   +AVK+L+      + + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 535 QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWP 594
           +++F  E+ V++  QH NLV LLG   + ++  L+Y YMPN SL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            R  I +G + G+ +LH +     IHRD+K++NILLD+    KISDFGLAR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 655 ATKRLVGT 662
              R+VGT
Sbjct: 191 MXSRIVGT 198

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/188 (39%), Positives = 105/188 (55%), Gaps = 14/188 (7%)
Query: 485 FNFEELANATNNFQL------ANKLGQGGFGPVYKGKLQDGQEIAVKRLSK----ASGQG 534
           F+F EL N TNNF         NK+G+GGFG VYKG + +   +AVK+L+      + + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 535 QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWP 594
           +++F  E+ V++  QH NLV LLG   + ++  L+Y YMPN SL   L        L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            R  I +G + G+ +LH +     IHRD+K++NILLD+    KISDFGLAR         
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 655 ATKRLVGT 662
              R+VGT
Sbjct: 185 MXXRIVGT 192

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/188 (39%), Positives = 105/188 (55%), Gaps = 14/188 (7%)
Query: 485 FNFEELANATNNFQL------ANKLGQGGFGPVYKGKLQDGQEIAVKRLSK----ASGQG 534
           F+F EL N TNNF         NK+G+GGFG VYKG + +   +AVK+L+      + + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 535 QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWP 594
           +++F  E+ V++  QH NLV LLG   + ++  L+Y YMPN SL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            R  I +G + G+ +LH +     IHRD+K++NILLD+    KISDFGLAR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 655 ATKRLVGT 662
              R+VGT
Sbjct: 191 MXXRIVGT 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 102/188 (54%), Gaps = 14/188 (7%)
Query: 485 FNFEELANATNNFQL------ANKLGQGGFGPVYKGKLQDGQEIAVKRLSK----ASGQG 534
           F+F EL N TNNF         NK G+GGFG VYKG + +   +AVK+L+      + + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 535 QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWP 594
           +++F  E+ V +  QH NLV LLG   + ++  L+Y Y PN SL   L        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            R  I +G + G+ +LH +     IHRD+K++NILLD+    KISDFGLAR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 655 ATKRLVGT 662
              R+VGT
Sbjct: 182 XXSRIVGT 189

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGLAR+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGFVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 84/160 (52%), Gaps = 5/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  +LG G FG V+ G   +  ++AVK L K      + F+ E  ++  LQH  LV
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL       E   +I EYM   SL  FL   +   +L  PK  +    I+ G+ Y+ R +
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKN 130
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+N+L+ + L  KI+DFGLAR+   N+  A
Sbjct: 131 ---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 167

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 85/160 (53%), Gaps = 5/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLG G FG V+ G   +  ++AVK L K      + F+ E  ++  LQH  LV
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL     + E   +I E+M   SL  FL   +   +L  PK  +    I+ G+ Y+ R +
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKN 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+N+L+ + L  KI+DFGLAR+   N+  A
Sbjct: 130 ---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 166

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 458 QRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGPVYK 513
           +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG V  
Sbjct: 3   KRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCS 61
Query: 514 GKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENML 568
           G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + +  M+
Sbjct: 62  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 121
Query: 569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628
           + EYM N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A NI
Sbjct: 122 VTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNI 176
Query: 629 LLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           L++ +L  K+SDFGL+R+   + + A T R
Sbjct: 177 LINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 97/180 (53%), Gaps = 11/180 (6%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSKASGQGQE-EF 538
           V  F +  +ATN   +   +G G FG V  G+L+   +    +A+K L     + Q  +F
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 539 MNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
           + E  ++    H N++RL G   + +  M++ EYM N SLDSFL     Q  +   +   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVG 122
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           +++GI+ G+ YL   S +  +HRDL A NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 97/180 (53%), Gaps = 11/180 (6%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSKASGQGQE-EF 538
           V  F +  +ATN   +   +G G FG V  G+L+   +    +A+K L     + Q  +F
Sbjct: 23  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 539 MNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
           + E  ++    H N++RL G   + +  M++ EYM N SLDSFL     Q  +   +   
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVG 139
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           +++GI+ G+ YL   S +  +HRDL A NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 140 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ E M N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGAVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 455 SKVQRLDLGEAYANFSTEK--VNPARLQD--LLVFNFEELANATNNFQLANKLGQGGFGP 510
           S  +RL  G  +      +  V+P   +D    V  F +  +ATN   +   +G G FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 511 VYKGKLQDGQE----IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREE 565
           V  G+L+   +    +A+K L     + Q  +F+ E  ++    H N++RL G   + + 
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKA 625
            M++ E M N SLDSFL     Q  +   +   +++GI+ G+ YL   S +  +HRDL A
Sbjct: 121 VMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 626 SNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 176 RNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 72
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 73  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 130
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 131 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 167

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 73
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 74  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 131
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 132 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 168

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 79
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 80  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 137
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 138 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 174

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 80
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 81  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 138
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 139 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 175

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 77
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 78  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 135
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 172

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 77  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 134
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 135 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 171

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 66
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 67  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 124
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 125 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 161

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 77
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 78  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 135
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 172

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 11/180 (6%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKG--KLQDGQEI--AVKRLSKASGQGQE-EF 538
           V  F +  +ATN   +   +G G FG V  G  KL   +EI  A+K L     + Q  +F
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 539 MNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
           + E  ++    H N++RL G   + +  M++ E M N SLDSFL     Q  +   +   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVG 122
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           +++GI+ G+ YL   S +  +HRDL A NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 243 QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 298
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 299 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 243 QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 298
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 299 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 67  QLYAV-VSEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 122
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 123 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 161

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 81
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 82  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 139
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 140 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 176

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 95/161 (59%), Gaps = 20/161 (12%)
Query: 503 LGQGGFGPVYKGK-LQDGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG VYKG  + +G+     +A+K L++ +G +   EFM+E ++++++ H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
           LG C+      L+ + MP+  L  ++ + +     Q LL+W         I++G++YL  
Sbjct: 106 LGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 158
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
               R++HRDL A N+L+    + KI+DFGLAR+  G++ +
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 326 QLY-AVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 381
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 382 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 171

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 243 QLYAV-VSEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 298
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 299 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 70  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 125
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 126 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 164

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 66  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 121
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 122 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 160

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 96/161 (59%), Gaps = 20/161 (12%)
Query: 503 LGQGGFGPVYKGK-LQDGQ----EIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG VYKG  + +G+     +A+K L++ +G +   EFM+E ++++++ H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
           LG C+      L+ + MP+  L  ++ + +     Q LL+W  +      I++G++YL  
Sbjct: 83  LGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
               R++HRDL A N+L+    + KI+DFGLAR+  G++ +
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 68  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 123
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 124 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 162

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 89/161 (55%), Gaps = 13/161 (8%)
Query: 503 LGQGGFGPVYKGKLQDGQ-----EIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRL 556
           +G G FG VYKG L+         +A+K L     + Q  +F+ E  ++    H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGLLYLHRDSR 615
            G   + +  M+I EYM N +LD FL +   + S+L   +   +++GI+ G+ YL   + 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGIAAGMKYL---AN 165
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           +  +HRDL A NIL++ +L  K+SDFGL+R+   + +   T
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 67
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 68  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 125
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
               IHR+L+A+NIL+ D L+ KI+DFGLAR+   N+  A
Sbjct: 126 ---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTA 162

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 244 QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 299
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGL R+   N+  A
Sbjct: 300 -MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTA 338

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  ++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/157 (35%), Positives = 84/157 (53%), Gaps = 6/157 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 74  QLYAV-VSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVER-- 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+
Sbjct: 130 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 165

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 84/160 (52%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + QL  +LG G FG V+ G      ++A+K L K      E F+ E  ++  L+H  LV
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLV 67
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL D + ++L   P   ++   ++ G+ Y+ R  
Sbjct: 68  QLYAV-VSEEPIYIVTEYMNKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIER-- 123
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  IHRDL+++NIL+ + L  KI+DFGLAR+   N+  A
Sbjct: 124 -MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTA 162

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 74  QLYAV-VSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVER-- 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 130 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 168

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 19/167 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
           +N  L  +LG+G FG V+  +       QD   +AVK L  AS   +++F  E  +++NL
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL----------FDPQRQSLLDWPKRFN 598
           QH ++V+  G CVE +  ++++EYM +  L+ FL           +    + L   +  +
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           I + I+ G++YL   +    +HRDL   N L+ ++L  KI DFG++R
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM    L  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 6/160 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L    V  E   ++ EYM    L  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER-- 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 10/168 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQE-EFMNEVMVISNL 548
            +   +   +G G  G V  G+L+  GQ    +A+K L     + Q  +F++E  ++   
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H N++RL G        M++ EYM N SLD+FL     Q  +   +   +++G+  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGMR 165
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           YL   S L  +HRDL A N+L+D +L  K+SDFGL+R+   + D A T
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 86/168 (51%), Gaps = 23/168 (13%)
Query: 498 QLANKLGQGGFGPVYKGKL------QDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQH 550
           +   +LG+  FG VYKG L      +  Q +A+K L  KA G  +EEF +E M+ + LQH
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF-------------DPQRQSLLDWPKRF 597
            N+V LLG   + +   +I+ Y  +  L  FL              D   +S L+ P   
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +++  I+ G+ YL   S   ++H+DL   N+L+ D LN KISD GL R
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 86/168 (51%), Gaps = 23/168 (13%)
Query: 498 QLANKLGQGGFGPVYKGKL------QDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQH 550
           +   +LG+  FG VYKG L      +  Q +A+K L  KA G  +EEF +E M+ + LQH
Sbjct: 29  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 88
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF-------------DPQRQSLLDWPKRF 597
            N+V LLG   + +   +I+ Y  +  L  FL              D   +S L+ P   
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +++  I+ G+ YL   S   ++H+DL   N+L+ D LN KISD GL R
Sbjct: 149 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 89/161 (55%), Gaps = 10/161 (6%)
Query: 503 LGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
           +G G FG V  G+L+  G+    +A+K L     + Q  +F+ E  ++    H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           G   + +  M++ EYM N SLD+FL     Q  +   +   +++GIS G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI--QLVGMLRGISAGMKYL---SDMG 144
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
            +HRDL A NIL++ +L  K+SDFGL+R+   + + A T R
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 10/168 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQE-EFMNEVMVISNL 548
            +   +   +G G  G V  G+L+  GQ    +A+K L     + Q  +F++E  ++   
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H N++RL G        M++ EYM N SLD+FL     Q  +   +   +++G+  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGMR 165
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           YL   S L  +HRDL A N+L+D +L  K+SDFGL+R+   + D A T
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/164 (35%), Positives = 86/164 (52%), Gaps = 9/164 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G  G V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL    V +E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++   +
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
               IHRDL+A+NIL+ D L+ KI+DFGLAR+    +D   T R
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDAEXTAR 167

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE--EFMNEVMVISNLQHRNL 553
           +  +  K+G G FG V++ +   G ++AVK L +     +   EF+ EV ++  L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V  +G   +     ++ EY+   SL   L     +  LD  +R ++   +++G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
               I+HRDLK+ N+L+D     K+ DFGL+R+
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 97/188 (51%), Gaps = 19/188 (10%)
Query: 485 FNFEELANATNNF---------QLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKA- 530
           F FE+   A   F         ++   +G G FG V  G+L+  G+    +A+K L    
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
           + + + +F++E  ++    H N++ L G   + +  M+I EYM N SLD+FL   +    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGR 127
Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
               +   +++GI  G+ YL   S +  +HRDL A NIL++ +L  K+SDFG++R+   +
Sbjct: 128 FTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 651 QDQAATKR 658
            + A T R
Sbjct: 185 PEAAYTTR 192

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE--EFMNEVMVISNLQHRNL 553
           +  +  K+G G FG V++ +   G ++AVK L +     +   EF+ EV ++  L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V  +G   +     ++ EY+   SL   L     +  LD  +R ++   +++G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
               I+HR+LK+ N+L+D     K+ DFGL+R+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLG G FG V+        ++AVK + K      E F+ E  V+  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 73
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHR 612
           +L    V +E   +I E+M   SL  FL   +  +Q L   PK  +    I+ G+ ++ +
Sbjct: 74  KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQ 129
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +    IHRDL+A+NIL+   L  KI+DFGLAR+   N+  A
Sbjct: 130 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 168

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 91/167 (54%), Gaps = 10/167 (5%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKA-SGQGQEEFMNEVMVISNLQHR 551
            ++   +G G FG V  G+L+  G+    +A+K L    + + + +F++E  ++    H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N++ L G   + +  M+I EYM N SLD+FL   +        +   +++GI  G+ YL 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYL- 126
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
             S +  +HRDL A NIL++ +L  K+SDFG++R+   + + A T R
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLG G FG V+        ++AVK + K      E F+ E  V+  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHR 612
           +L    V +E   +I E+M   SL  FL   +  +Q L   PK  +    I+ G+ ++ +
Sbjct: 247 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQ 302
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +    IHRDL+A+NIL+   L  KI+DFGLAR+   N+  A
Sbjct: 303 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 94/172 (54%), Gaps = 15/172 (8%)
Query: 498 QLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQE-EFMNEVMVISNLQHRN 552
           ++   +G G FG V +G+L+  G++   +A+K L     + Q  EF++E  ++   +H N
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLF--DPQRQSLLDWPKRFNIIKGISRGLLYL 610
           ++RL G        M++ E+M N +LDSFL   D Q   +    +   +++GI+ G+ YL
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI----QLVGMLRGIASGMRYL 134
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN-QDQAATKRLVG 661
              + +  +HRDL A NIL++ +L  K+SDFGL+R    N  D   T  L G
Sbjct: 135 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 91/167 (54%), Gaps = 10/167 (5%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKA-SGQGQEEFMNEVMVISNLQHR 551
            ++   +G G FG V  G+L+  G+    +A+K L    + + + +F++E  ++    H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N++ L G   + +  M+I EYM N SLD+FL   +        +   +++GI  G+ YL 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYL- 132
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
             S +  +HRDL A NIL++ +L  K+SDFG++R+   + + A T R
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 93/170 (54%), Gaps = 11/170 (6%)
Query: 498 QLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQE-EFMNEVMVISNLQHRN 552
           ++   +G G FG V +G+L+  G++   +A+K L     + Q  EF++E  ++   +H N
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           ++RL G        M++ E+M N +LDSFL     Q  +   +   +++GI+ G+ YL  
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYL-- 132
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN-QDQAATKRLVG 661
            + +  +HRDL A NIL++ +L  K+SDFGL+R    N  D   T  L G
Sbjct: 133 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 16  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 75
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 133
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 134 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 179

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 159
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 205

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 76
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 134
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 135 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 180

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 73
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 131
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 18  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 77
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 135
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 136 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 181

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 68
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 126
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 127 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 172

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 69
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 127
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 128 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 173

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 88
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 146
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 74
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 132
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 133 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 178

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 88
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 146
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 6/161 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +  + +KLG G +G VY G  +     +AVK L K      EEF+ E  V+  ++H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V+LLG C       ++ EYMP  +L  +L +  R+ +      + +   IS  + YL + 
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLY-MATQISSAMEYLEKK 149
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           +    IHRDL A N L+ ++   K++DFGL+R+  G+   A
Sbjct: 150 N---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTA 187

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 89/177 (50%), Gaps = 19/177 (10%)
Query: 485 FNFEELANATNNF---------QLANKLGQGGFGPVYKG--KLQDGQEI--AVKRLSKAS 531
           F FE+   A   F         ++   +G G FG V  G  KL   +EI  A+K L    
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 532 GQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
            + Q  +F++E  ++    H N++ L G   +    M+I E+M N SLDSFL   Q    
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQ 131
Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
               +   +++GI+ G+ YL   + +  +HRDL A NIL++ +L  K+SDFGL+R  
Sbjct: 132 FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 6/170 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+   A
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 173

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 26/189 (13%)
Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLS 528
           NP    D  V + +       +  L  +LG+G FG V+  +       QD   +AVK L 
Sbjct: 26  NPQYFSDACVHHIKR-----RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK 80
Query: 529 KASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQ 586
           +AS   +++F  E  +++ LQH+++VR  G C E    ++++EYM +  L+ FL    P 
Sbjct: 81  EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 140
Query: 587 RQSL----------LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP 636
            + L          L   +   +   ++ G++YL   + L  +HRDL   N L+   L  
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV 197
Query: 637 KISDFGLAR 645
           KI DFG++R
Sbjct: 198 KIGDFGMSR 206

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 6/170 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 63
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 122
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+   A
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 169

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDP----QRQSLLDWPKRFNIIKGISRGLLYL 610
           +L G C ++    +I EYM N  L ++L +     Q Q LL+      + K +   + YL
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYL 136
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
                 + +HRDL A N L++D    K+SDFGL+R    +++ ++ 
Sbjct: 137 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV 179

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 73
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDP----QRQSLLDWPKRFNIIKGISRGLLYL 610
           +L G C ++    +I EYM N  L ++L +     Q Q LL+      + K +   + YL
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYL 127
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 + +HRDL A N L++D    K+SDFGL+R
Sbjct: 128 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 159

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDP----QRQSLLDWPKRFNIIKGISRGLLYL 610
           +L G C ++    +I EYM N  L ++L +     Q Q LL+      + K +   + YL
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYL 136
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 + +HRDL A N L++D    K+SDFGL+R
Sbjct: 137 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 6/170 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 121
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+   A
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 66
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDP----QRQSLLDWPKRFNIIKGISRGLLYL 610
           +L G C ++    +I EYM N  L ++L +     Q Q LL+      + K +   + YL
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 + +HRDL A N L++D    K+SDFGL+R
Sbjct: 121 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDP----QRQSLLDWPKRFNIIKGISRGLLYL 610
           +L G C ++    +I EYM N  L ++L +     Q Q LL+      + K +   + YL
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 + +HRDL A N L++D    K+SDFGL+R
Sbjct: 122 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 22/201 (10%)
Query: 459 RLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVY----KG 514
           RL  G  YA+     VNP       V+  +E   A     ++ +LGQG FG VY    KG
Sbjct: 16  RLGNGVLYAS-----VNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKG 70
Query: 515 KLQDGQE--IAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE 571
            ++D  E  +A+K +++A+   +  EF+NE  V+      ++VRLLG   + +  ++I E
Sbjct: 71  VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 130
Query: 572 YMPNKSLDSFL--FDPQRQS--LLDWP---KRFNIIKGISRGLLYLHRDSRLRIIHRDLK 624
            M    L S+L    P+ ++  +L  P   K   +   I+ G+ YL+ +   + +HRDL 
Sbjct: 131 LMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLA 187
Query: 625 ASNILLDDDLNPKISDFGLAR 645
           A N ++ +D   KI DFG+ R
Sbjct: 188 ARNCMVAEDFTVKIGDFGMTR 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 6/170 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 121
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+   A
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDP----QRQSLLDWPKRFNIIKGISRGLLYL 610
           +L G C ++    +I EYM N  L ++L +     Q Q LL+      + K +   + YL
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 + +HRDL A N L++D    K+SDFGL+R
Sbjct: 122 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 66
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 125
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 126 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 6/161 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +  + +KLG G FG VY+G  +     +AVK L K      EEF+ E  V+  ++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V+LLG C       +I E+M   +L  +L +  RQ  +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 128
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           +    IHRDL A N L+ ++   K++DFGL+R+  G+   A
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDP----QRQSLLDWPKRFNIIKGISRGLLYL 610
           +L G C ++    +I EYM N  L ++L +     Q Q LL+      + K +   + YL
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYL 116
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 + +HRDL A N L++D    K+SDFGL+R
Sbjct: 117 ESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 87/164 (53%), Gaps = 12/164 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           YL      R IHRDL   NIL++++   KI DFGL ++   +++
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 64
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 123
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 64
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 123
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 75
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 134
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 135 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 64
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 123
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  +       +   IS
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 121
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  +       +   IS
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 121
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 63
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 122
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  +       +   IS
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 121
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 62
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  +       +   IS
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 121
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 14  HLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 73
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI E++P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGME 131
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 73
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L        +D  K       I +G+ 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGME 131
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHRDL   NIL++++   KI DFGL ++   +++    K
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  +       +   IS
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 502 KLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +LG+G FG V+  +       QD   +AVK L +AS   +++F  E  +++ LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSL----------LDWPKRFNIIKGI 603
             G C E    ++++EYM +  L+ FL    P  + L          L   +   +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + G++YL   + L  +HRDL   N L+   L  KI DFG++R
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 502 KLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +LG+G FG V+  +       QD   +AVK L +AS   +++F  E  +++ LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSL----------LDWPKRFNIIKGI 603
             G C E    ++++EYM +  L+ FL    P  + L          L   +   +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + G++YL   + L  +HRDL   N L+   L  KI DFG++R
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLG G FG V+        ++AVK + K      E F+ E  V+  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 240
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ--RQSLLDWPKRFNIIKGISRGLLYLHR 612
           +L    V +E   +I E+M   SL  FL   +  +Q L   PK  +    I+ G+ ++ +
Sbjct: 241 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMAFIEQ 296
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
            +    IHRDL+A+NIL+   L  KI+DFGLAR+
Sbjct: 297 RN---YIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 97/186 (52%), Gaps = 17/186 (9%)
Query: 474 VNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRL 527
           VNP       V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +
Sbjct: 4   VNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63
Query: 528 SKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FD 584
           ++A+   +  EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 585 PQRQS--LLDWPKRFNIIK---GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS 639
           P+ ++  +L  P    +I+    I+ G+ YL+ +   + +HRDL A N ++ +D   KI 
Sbjct: 124 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180
Query: 640 DFGLAR 645
           DFG+ R
Sbjct: 181 DFGMTR 186

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 83/161 (51%), Gaps = 6/161 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V+  ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V+LLG C       +I E+M   +L  +L +  RQ  +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 128
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           +    IHRDL A N L+ ++   K++DFGL+R+  G+   A
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 496 NFQLANKLGQGGFGPVYKGK---LQD--GQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           + +   +LG+G FG V   +   LQD  G+ +AVK+L  ++ +   +F  E+ ++ +LQH
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 71
Query: 551 RNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            N+V+  G C    R    LI EY+P  SL  +L   + +  +D  K       I +G+ 
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 129
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           YL      R IHR+L   NIL++++   KI DFGL ++   +++    K
Sbjct: 130 YL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 175

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 6/162 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + +     +E+F+ E  V+  L H  LV
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L++E+M +  L  +L    ++ L        +   +  G+ YL   S
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
              +IHRDL A N L+ ++   K+SDFG+ R    +Q  ++T
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 474 VNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRL 527
           VNP       V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +
Sbjct: 4   VNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63
Query: 528 SKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ 586
           ++A+   +  EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-L 122
Query: 587 RQSLLDWP--------KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
           R ++ + P        K   +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179
Query: 639 SDFGLAR 645
            DFG+ R
Sbjct: 180 GDFGMTR 186

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V+  ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V+LLG C       +I E+M   +L  +L +  RQ  +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 128
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
           +    IHRDL A N L+ ++   K++DFGL+R+  G+
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 90/166 (54%), Gaps = 18/166 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQ-------EEFMNEVMV 544
           A N  +   ++G+GGFG V+KG+L +D   +A+K L     +G+       +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +SNL H N+V+L G         ++ E++P   L   L D  +   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLD--DDLNP---KISDFGLAR 645
            G+ Y+ ++    I+HRDL++ NI L   D+  P   K++DFGL++
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 93/176 (52%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE- 536
           VF  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLD 592
           EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 593 WP---KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            P   K   +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 269
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ +      + +   IS
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQIS 328
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHR+L A N L+ ++   K++DFGL+R+  G+
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRN 552
           +N +L   +G+G +G VYKG L D + +AVK  S A+ Q    F+NE  +  +  ++H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 553 LVRLLG-----CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           + R +          R E +L+ EY PN SL  +L         DW     +   ++RGL
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGL 124
Query: 608 LYLHRD------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
            YLH +       +  I HRDL + N+L+ +D    ISDFGL+    GN+
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAV 308
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  ++      +   IS
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQIS 367
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             + YL + +    IHR+L A N L+ ++   K++DFGL+R+  G+
Sbjct: 368 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 410

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 6/162 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + +     +E+F+ E  V+  L H  LV
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 68
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L++E+M +  L  +L    ++ L        +   +  G+ YL    
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
              +IHRDL A N L+ ++   K+SDFG+ R    +Q  ++T
Sbjct: 127 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 6/162 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + +     +E+F+ E  V+  L H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L++E+M +  L  +L    ++ L        +   +  G+ YL    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
              +IHRDL A N L+ ++   K+SDFG+ R    +Q  ++T
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 6/162 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + +     +E+F+ E  V+  L H  LV
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L++E+M +  L  +L    ++ L        +   +  G+ YL    
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
              +IHRDL A N L+ ++   K+SDFG+ R    +Q  ++T
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE- 536
           V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLD 592
           EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 593 WP---KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            P   K   +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 21/169 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DG--QEIAVKRLSK-ASGQGQEEFMNEVMVISNL-Q 549
           N+ +  + +G+G FG V K +++ DG   + A+KR+ + AS     +F  E+ V+  L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDP------QRQSLLDWPKR 596
           H N++ LLG C  R    L  EY P+ +L  FL        DP         S L   + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    ++RG+ YL   S+ + IHRDL A NIL+ ++   KI+DFGL+R
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE- 536
           V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLD 592
           EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 593 WP---KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            P   K   +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE- 536
           V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLD 592
           EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 593 WP---KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            P   K   +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 21/169 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DG--QEIAVKRLSK-ASGQGQEEFMNEVMVISNL-Q 549
           N+ +  + +G+G FG V K +++ DG   + A+KR+ + AS     +F  E+ V+  L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDP------QRQSLLDWPKR 596
           H N++ LLG C  R    L  EY P+ +L  FL        DP         S L   + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    ++RG+ YL   S+ + IHRDL A NIL+ ++   KI+DFGL+R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE- 536
           V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLD 592
           EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 593 WP---KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            P   K   +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 22/166 (13%)
Query: 499 LANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
           L  +LG+G FG V+  +       +D   +AVK L   +   +++F  E  +++NLQH +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWPKR-----------FNI 599
           +V+  G C + +  ++++EYM +  L+ FL    P    L+D   R            +I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              I+ G++YL   +    +HRDL   N L+  +L  KI DFG++R
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 122 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 6/162 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + + S   +++F+ E  V+  L H  LV
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLV 85
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L++E+M +  L  +L    ++ L        +   +  G+ YL    
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
              +IHRDL A N L+ ++   K+SDFG+ R    +Q  ++T
Sbjct: 144 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 182

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 128 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 129 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 129 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 128 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 498 QLANKLGQGGFGPVYKG--KLQDGQEI--AVKRLSKASGQGQE-EFMNEVMVISNLQHRN 552
           ++   +G G FG V  G  KL   +EI  A+K L     + Q  +F++E  ++    H N
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           ++ L G   +    M+I E+M N SLDSFL   Q        +   +++GI+ G+ YL  
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYL-- 125
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            + +  +HR L A NIL++ +L  K+SDFGL+R  
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFL 159

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 134 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 89/167 (53%), Gaps = 17/167 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE-EFMNEVMVI 545
           A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  EF+NE  V+
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLDWP---KRFN 598
                 ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L  P   K   
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 130 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 131 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 89/166 (53%), Gaps = 18/166 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQ-------EEFMNEVMV 544
           A N  +   ++G+GGFG V+KG+L +D   +A+K L     +G+       +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +SNL H N+V+L G         ++ E++P   L   L D  +   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLD--DDLNP---KISDFGLAR 645
            G+ Y+ ++    I+HRDL++ NI L   D+  P   K++DFG ++
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVK-----RLSKASGQGQEEFMNEVMVISNLQ 549
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG+ E   E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++++L      ++E +++ EY  N+  D  +   QR  + +   R    + I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 127
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            HR    +I+HRDLK  N+LLD+ LN KI+DFGL+ I 
Sbjct: 128 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 135 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVK-----RLSKASGQGQEEFMNEVMVISNLQ 549
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG+ E   E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++++L      ++E +++ EY  N+  D  +   QR  + +   R    + I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 128
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            HR    +I+HRDLK  N+LLD+ LN KI+DFGL+ I 
Sbjct: 129 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 163

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
           L H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 89/167 (53%), Gaps = 17/167 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE-EFMNEVMVI 545
           A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  EF+NE  V+
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLDWP---KRFN 598
                 ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L  P   K   
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 19/177 (10%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE- 536
           V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWP-- 594
           EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    R ++ + P  
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPAMANNPVL 122
Query: 595 ------KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 K   +   I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVK-----RLSKASGQGQEEFMNEVMVISNLQ 549
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG+ E   E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++++L      ++E +++ EY  N+  D  +   QR  + +   R    + I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 122
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            HR    +I+HRDLK  N+LLD+ LN KI+DFGL+ I 
Sbjct: 123 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 157

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 128 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVK-----RLSKASGQGQEEFMNEVMVISNLQ 549
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG+ E   E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++++L      ++E +++ EY  N+  D  +   QR  + +   R    + I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            HR    +I+HRDLK  N+LLD+ LN KI+DFGL+ I 
Sbjct: 119 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 153

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 153 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 198

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 147
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 128 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 88/165 (53%), Gaps = 10/165 (6%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQE---IAVKRLSKASGQGQE-EFMNEVMVISNLQHR 551
            ++   +G G FG V  G+L+  G+    +A+K L     + Q  +F+ E  ++    H 
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V L G     +  M++ E+M N +LD+FL     Q  +   +   +++GI+ G+ YL 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI--QLVGMLRGIAAGMRYL- 161
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
             + +  +HRDL A NIL++ +L  K+SDFGL+R+   + +   T
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYT 204

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 131 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 148
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 138 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNL 548
           N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS L
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGIS 604
            H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
            G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 89/166 (53%), Gaps = 18/166 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQ-------EEFMNEVMV 544
           A N  +   ++G+GGFG V+KG+L +D   +A+K L     +G+       +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +SNL H N+V+L G         ++ E++P   L   L D  +   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLD--DDLNP---KISDFGLAR 645
            G+ Y+ ++    I+HRDL++ NI L   D+  P   K++DF L++
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 148
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 141
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 146
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 167
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 452 KENSKVQ-RLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGP 510
           K+  K Q R  + E+Y   S   ++P +L     +N E+     NN Q    LG G FG 
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLP----YN-EKWEFPRNNLQFGKTLGAGAFGK 61
Query: 511 VYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE 562
           V +      GK     ++AVK L S A    +E  M+E+ ++S+L QH N+V LLG C  
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121
Query: 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL------ 616
               ++I EY     L +FL    R  +L+    F I    +     LH  S++      
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSR--VLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 617 ----RIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 IHRD+ A N+LL +    KI DFGLAR
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 6/162 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + +     +E+F+ E  V+  L H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L+ E+M +  L  +L    ++ L        +   +  G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
              +IHRDL A N L+ ++   K+SDFG+ R    +Q  ++T
Sbjct: 125 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 144
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 168
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 16  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  +RG+ YLH  S   I
Sbjct: 76  YST-KPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +D   KI DFGLA +
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATV 157

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 8/156 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLS-KASGQG-QEEFMNEVMVISNLQHRN 552
             +Q   K+G+G +G VYK K   G+ +A+KR+   A  +G     + E+ ++  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V L+          L++E+M  K L   L D  +  L D   +  + + + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               RI+HRDLK  N+L++ D   K++DFGLAR FG
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 8/156 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLS-KASGQG-QEEFMNEVMVISNLQHRN 552
             +Q   K+G+G +G VYK K   G+ +A+KR+   A  +G     + E+ ++  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V L+          L++E+M  K L   L D  +  L D   +  + + + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               RI+HRDLK  N+L++ D   K++DFGLAR FG
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 92/176 (52%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVY----KGKLQDGQE--IAVKRLSKASGQGQE- 536
           V+  +E   A     ++ +LGQG FG VY    KG ++D  E  +A+K +++A+   +  
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQS--LLD 592
           EF+NE  V+      ++VRLLG   + +  ++I E M    L S+L    P+ ++  +L 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 593 WP---KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            P   K   +   I+ G+ YL+ +   + +HRDL A N  + +D   KI DFG+ R
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 40/205 (19%)
Query: 460 LDLGEAYANFSTEKVNPARLQDL---------LVFNFEELANATNNFQLANKLGQGGFGP 510
           L +G    +     +NP  +Q +         L+ +F E+            +G+G FG 
Sbjct: 3   LHMGSNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV------------IGRGHFGC 50
Query: 511 VYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCCVERE- 564
           VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LLG C+  E 
Sbjct: 51  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 110
Query: 565 ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
             +++  YM +  L +F+     +P  + L+ +  +      +++G+ +L   +  + +H
Sbjct: 111 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL---ASKKFVH 161
Query: 621 RDLKASNILLDDDLNPKISDFGLAR 645
           RDL A N +LD+    K++DFGLAR
Sbjct: 162 RDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
            G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 125 EGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +DL  KI DFGLA +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 24/183 (13%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKL--QDGQ--EIAVK--RLSKASGQGQEEFM 539
             E++    N   L   LG+G FG V +G L  +DG   ++AVK  +L  +S +  EEF+
Sbjct: 25  KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 540 NEVMVISNLQHRNLVRLLGCCVEREEN-----MLIYEYMPNKSLDSFLFDPQRQSLLDWP 594
           +E   + +  H N++RLLG C+E         M+I  +M    L ++L   + ++    P
Sbjct: 85  SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GP 141
Query: 595 KRFNI------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA-RIF 647
           K   +      +  I+ G+ YL   S    +HRDL A N +L DD+   ++DFGL+ +I+
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 648 GGN 650
            G+
Sbjct: 199 SGD 201

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 14  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 74  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +DL  KI DFGLA +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATV 155

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +DL  KI DFGLA +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 452 KENSKVQ-RLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGP 510
           K+  K Q R  + E+Y   S   ++P +L     +N E+     NN Q    LG G FG 
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLP----YN-EKWEFPRNNLQFGKTLGAGAFGK 61
Query: 511 VYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE 562
           V +      GK     ++AVK L S A    +E  M+E+ ++S+L QH N+V LLG C  
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121
Query: 563 REENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
               ++I EY     L +FL        D +    L+     +    +++G+ +L   + 
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN- 180
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              IHRD+ A N+LL +    KI DFGLAR
Sbjct: 181 --CIHRDVAARNVLLTNGHVAKIGDFGLAR 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 21/169 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DG--QEIAVKRLSK-ASGQGQEEFMNEVMVISNL-Q 549
           N+ +  + +G+G FG V K +++ DG   + A+KR+ + AS     +F  E+ V+  L  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDP------QRQSLLDWPKR 596
           H N++ LLG C  R    L  EY P+ +L  FL        DP         S L   + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    ++RG+ YL   S+ + IHR+L A NIL+ ++   KI+DFGL+R
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +DL  KI DFGLA +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 6/157 (3%)
Query: 503 LGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
           LG+G FG   K    + G+ + +K L +   + Q  F+ EV V+  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR 621
           + +    I EY+   +L   +      S   W +R +  K I+ G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 622 DLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           DL + N L+ ++ N  ++DFGLAR+    + Q    R
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 77/146 (52%), Gaps = 6/146 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  +RG+ YLH  S   I
Sbjct: 88  YST-KPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK++NI L +D   KI DFGLA
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 208
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 88/159 (55%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L +F+ D    + +  P   + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 88/153 (57%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E   +++  YM +  L +F+     +P  + L+ +  +      +++G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 147
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 89/153 (58%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 558 GCCVEREEN-MLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E + +++  YM +  L +F+     +P  + L+ +  +      +++G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 89/153 (58%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKL--QDGQEI--AVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G L   DG++I  AVK L++ +  G+  +F+ E +++ +  H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 558 GCCVEREEN-MLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           G C+  E + +++  YM +  L +F+     +P  + L+ +  +      +++G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +DL  KI DFGLA +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATV 181

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNL 548
           N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGIS 604
            H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
            G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 39  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 99  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +DL  KI DFGLA +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATV 180

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNL 548
           N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGIS 604
            H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
            G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 23/202 (11%)
Query: 459 RLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYK----- 513
           R  + E+Y   S   ++P +L     +N E+     NN Q    LG G FG V +     
Sbjct: 7   RWKIIESYEGNSYTFIDPTQLP----YN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFG 61
Query: 514 -GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIY 570
            GK     ++AVK L S A    +E  M+E+ ++S+L QH N+V LLG C      ++I 
Sbjct: 62  LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 121
Query: 571 EYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL 623
           EY     L +FL        D +    L+     +    +++G+ +L   +    IHRD+
Sbjct: 122 EYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDV 178
Query: 624 KASNILLDDDLNPKISDFGLAR 645
            A N+LL +    KI DFGLAR
Sbjct: 179 AARNVLLTNGHVAKIGDFGLAR 200

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 78/146 (53%), Gaps = 6/146 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK++NI L +DL  KI DFGLA
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    L  G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 135 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 78/146 (53%), Gaps = 6/146 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 32  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 92  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK++NI L +DL  KI DFGLA
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 452 KENSKVQ-RLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGP 510
           K+  K Q R  + E+Y   S   ++P +L     +N E+     NN Q    LG G FG 
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLP----YN-EKWEFPRNNLQFGKTLGAGAFGK 61
Query: 511 VYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE 562
           V +      GK     ++AVK L S A    +E  M+E+ ++S+L QH N+V LLG C  
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121
Query: 563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL------ 616
               ++I EY     L +FL    R  +L+    F I          LH  S++      
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSR--VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAF 179
Query: 617 ----RIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 IHRD+ A N+LL +    KI DFGLAR
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 156

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 78/146 (53%), Gaps = 6/146 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
               + +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK++NI L +DL  KI DFGLA
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                 +  ++ ++    SL   L   + +   +  K  +I +  ++G+ YLH  S   I
Sbjct: 72  YSTA-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRDLK++NI L +DL  KI DFGLA +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    L  G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 128 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 85/163 (52%), Gaps = 13/163 (7%)
Query: 503 LGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRL 556
           LG+G FG V   +        G+++AVK L   SG     +   E+ ++ NL H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 557 LGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            G C E   N   LI E++P+ SL  +L  P+ ++ ++  ++      I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           R + +HRDL A N+L++ +   KI DFGL +    +++    K
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 186

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 85/163 (52%), Gaps = 13/163 (7%)
Query: 503 LGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRL 556
           LG+G FG V   +        G+++AVK L   SG     +   E+ ++ NL H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 557 LGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            G C E   N   LI E++P+ SL  +L  P+ ++ ++  ++      I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           R + +HRDL A N+L++ +   KI DFGL +    +++    K
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 174

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++  +G
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                 +  ++ ++    SL   L   + +   +  K  +I +  +RG+ YLH  S   I
Sbjct: 88  YSTA-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK++NI L +D   KI DFGLA
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           L  +LG G FG V  GK +   ++AVK + + S   ++EF  E   +  L H  LV+  G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
            C +     ++ EY+ N  L ++L    +   L+  +   +   +  G+ +L      + 
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
           IHRDL A N L+D DL  K+SDFG+ R    +Q
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    L  G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 135 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L +F+ D    + +  P   + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFG A++ G  + +
Sbjct: 132 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 154

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+AR
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFG A++ G  + +
Sbjct: 130 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFG A++ G  + +
Sbjct: 130 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 92/169 (54%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+  L +A S +  +E ++E  V++++
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W         I+
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 161
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFGLA++ G  + +
Sbjct: 162 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFG A++ G  + +
Sbjct: 135 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFG A++ G  + +
Sbjct: 128 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 20/169 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEI----AVKRLSKA-SGQGQEEFMNEVMVISNL 548
             F+    LG G FG VYKG  + +G+++    A+K L +A S +  +E ++E  V++++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +     Q LL+W  +      I+
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           +G+ YL  D RL  +HRDL A N+L+    + KI+DFG A++ G  + +
Sbjct: 130 KGMNYLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ +  L  F+ D    + +  P   + +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ +  L  F+ D    + +  P   + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 157

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQE 536
           VF  +E   +     L  +LGQG FG VY+G  +D         +AVK +++ AS + + 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP 594
           EF+NE  V+      ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 595 -----KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +   +   I+ G+ YL+     + +HRDL A N ++  D   KI DFG+ R
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ +  L  F+ D    + +  P   + +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQE 536
           VF  +E   +     L  +LGQG FG VY+G  +D         +AVK +++ AS + + 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP 594
           EF+NE  V+      ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 595 -----KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +   +   I+ G+ YL+     + +HRDL A N ++  D   KI DFG+ R
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQE 536
           VF  +E   +     L  +LGQG FG VY+G  +D         +AVK +++ AS + + 
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP 594
           EF+NE  V+      ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 595 -----KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +   +   I+ G+ YL+     + +HRDL A N ++  D   KI DFG+ R
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQE 536
           VF  +E   +     L  +LGQG FG VY+G  +D         +AVK +++ AS + + 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP 594
           EF+NE  V+      ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 595 -----KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +   +   I+ G+ YL+     + +HRDL A N ++  D   KI DFG+ R
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQ 549
           +  NFQ   K+G+G +G VYK + +  G+ +A+K  RL   +       + E+ ++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++ +  L  F+ D    + +  P   + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL +    P + S L      ++ + I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL  +     IHRD+ A N LL         KI DFG+A+
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/178 (33%), Positives = 88/178 (49%), Gaps = 28/178 (15%)
Query: 482 LLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEE 537
           LL  +F EL        L   +G GGFG VY+     G E+AVK           Q  E 
Sbjct: 1   LLEIDFAELT-------LEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIEN 52
Query: 538 FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS--LLDWPK 595
              E  + + L+H N++ L G C++     L+ E+     L+  L   +     L++W  
Sbjct: 53  VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAV 112
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL-----DDDLN---PKISDFGLAR 645
           +      I+RG+ YLH ++ + IIHRDLK+SNIL+     + DL+    KI+DFGLAR
Sbjct: 113 Q------IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 12/161 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNL 553
              +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V++ L+H NL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 248
Query: 554 VRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLLYLH 611
           V+LLG  VE +  + ++ EYM   SL  +L    R  L  D   +F++   +   + YL 
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLE 306
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            ++    +HRDL A N+L+ +D   K+SDFGL +     QD
Sbjct: 307 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 452 KENSKVQ-RLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGP 510
           K+  K Q R  + E+Y   S   ++P +L     +N E+     NN Q    LG G FG 
Sbjct: 7   KQKPKYQVRWKIIESYEGNSYTFIDPTQLP----YN-EKWEFPRNNLQFGKTLGAGAFGK 61
Query: 511 VYK------GKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE 562
           V +      GK     ++AVK L S A    +E  M+E+ ++S+L QH N+V LLG C  
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121
Query: 563 REENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDWPKR--FNIIKGISRGLLY 609
               ++I EY     L +FL           ++P          R   +    +++G+ +
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAF 181
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L   +    IHRD+ A N+LL +    KI DFGLAR
Sbjct: 182 L---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 81/149 (54%), Gaps = 11/149 (7%)
Query: 503 LGQGGFGPVYKG----KLQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLL 557
           +G+G FG VY G    + Q+  + A+K LS+ +   Q E F+ E +++  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 558 GCCVERE-ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           G  +  E    ++  YM +  L  F+  PQR   +     F +   ++RG+ YL   +  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYL---AEQ 143
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLAR 645
           + +HRDL A N +LD+    K++DFGLAR
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+   RL   +       + E+ ++  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            NFQ   K+G+G +G VYK + +  G+ +A+   RL   +       + E+ ++  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+LL       +  L++E++ ++ L  F+ D    + +  P   + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
                R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 12/161 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNL 553
              +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V++ L+H NL
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 76
Query: 554 VRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLLYLH 611
           V+LLG  VE +  + ++ EYM   SL  +L    R  L  D   +F++   +   + YL 
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLE 134
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            ++    +HRDL A N+L+ +D   K+SDFGL +     QD
Sbjct: 135 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQE 536
           V+  +E   +     L  +LGQG FG VY+G  +D         +AVK +++ AS + + 
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP 594
           EF+NE  V+      ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 595 -----KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +   +   I+ G+ YL+     + +HRDL A N ++  D   KI DFG+ R
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+A+K + K   +    ++   EV ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   LI EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCHQ 132
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQD 652
               RI+HRDLKA N+LLD D+N KI+DFG +  F  GG  D
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+A+K + K   +    ++   EV ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   LI EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCHQ 129
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQD 652
               RI+HRDLKA N+LLD D+N KI+DFG +  F  GG  D
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 168

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 12/161 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNL 553
              +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V++ L+H NL
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 61
Query: 554 VRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLLYLH 611
           V+LLG  VE +  + ++ EYM   SL  +L    R  L  D   +F++   +   + YL 
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLE 119
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            ++    +HRDL A N+L+ +D   K+SDFGL +     QD
Sbjct: 120 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 12/161 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRNL 553
              +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V++ L+H NL
Sbjct: 12  KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 67
Query: 554 VRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRGLLYLH 611
           V+LLG  VE +  + ++ EYM   SL  +L    R  L  D   +F++   +   + YL 
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLE 125
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            ++    +HRDL A N+L+ +D   K+SDFGL +     QD
Sbjct: 126 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 163

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 83/149 (55%), Gaps = 6/149 (4%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +++  +LG G FG VYK K ++ G   A K +   S +  E+++ E+ +++   H  +V+
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           LLG      +  ++ E+ P  ++D+ + +  R   L  P+   + + +   L +LH    
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK-- 128
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLA 644
            RIIHRDLKA N+L+  + + +++DFG++
Sbjct: 129 -RIIHRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 17/161 (10%)
Query: 499 LANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHR 551
           L  +LGQG FG VY+G  +D         +AVK +++ AS + + EF+NE  V+      
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP-----KRFNIIKGIS 604
           ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P     +   +   I+
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            G+ YL+     + +HRDL A N ++  D   KI DFG+ R
Sbjct: 140 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 17/178 (9%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQGQEEFMNE 541
           FEE      + +  ++LG+G FG V   +        G  +AVK+L  +    Q +F  E
Sbjct: 4   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 58
Query: 542 VMVISNLQHRNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           + ++  L    +V+  G      R E  L+ EY+P+  L  FL   + ++ LD  +    
Sbjct: 59  IQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 116
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
              I +G+ YL   SR R +HRDL A NIL++ + + KI+DFGLA++   ++D    +
Sbjct: 117 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVR 171

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 83/149 (55%), Gaps = 6/149 (4%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +++  +LG G FG VYK K ++ G   A K +   S +  E+++ E+ +++   H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           LLG      +  ++ E+ P  ++D+ + +  R   L  P+   + + +   L +LH    
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLA 644
            RIIHRDLKA N+L+  + + +++DFG++
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 31/179 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKGK------LQDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           NN +    +G+G FG V++ +       +    +AVK L  +AS   Q +F  E  +++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL----------------- 590
             + N+V+LLG C   +   L++EYM    L+ FL      ++                 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 591 ----LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               L   ++  I + ++ G+ YL   S  + +HRDL   N L+ +++  KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 6/148 (4%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           L+ ++G G FG VYKGK      + + ++   + +  + F NEV V+   +H N++  +G
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
             + ++   ++ ++    SL   L    +++     +  +I +  ++G+ YLH  +   I
Sbjct: 100 -YMTKDNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKN---I 153
Query: 619 IHRDLKASNILLDDDLNPKISDFGLARI 646
           IHRD+K++NI L + L  KI DFGLA +
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATV 181

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 95/170 (55%), Gaps = 17/170 (10%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGK-LQDGQE-IAVKRLSKASGQGQEEF--MNEVMVI 545
           L  A   ++   ++G+G +G V+K + L++G   +A+KR+   +G+       + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 546 SNLQ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
            +L+   H N+VRL   C     +RE  + L++E++ ++ L ++L D   +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFGLARI+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 95/171 (55%), Gaps = 17/171 (9%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGK-LQDGQE-IAVKRLSKASGQGQEEF--MNEVMVI 545
           L  A   ++   ++G+G +G V+K + L++G   +A+KR+   +G+       + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 546 SNLQ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
            +L+   H N+VRL   C     +RE  + L++E++ ++ L ++L D   +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFGLARI+ 
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQGQEEFMNE 541
           FEE      + +  ++LG+G FG V   +        G  +AVK+L  +    Q +F  E
Sbjct: 20  FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 74
Query: 542 VMVISNLQHRNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           + ++  L    +V+  G      R+   L+ EY+P+  L  FL   + ++ LD  +    
Sbjct: 75  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 132
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
              I +G+ YL   SR R +HRDL A NIL++ + + KI+DFGLA++   ++D
Sbjct: 133 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 95/171 (55%), Gaps = 17/171 (9%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGK-LQDGQE-IAVKRLSKASGQGQEEF--MNEVMVI 545
           L  A   ++   ++G+G +G V+K + L++G   +A+KR+   +G+       + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 546 SNLQ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
            +L+   H N+VRL   C     +RE  + L++E++ ++ L ++L D   +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFGLARI+ 
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQE 536
           V+  +E   +     L  +LGQG FG VY+G  +D         +AVK +++ AS + + 
Sbjct: 7   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 66
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP 594
           EF+NE  V+      ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P
Sbjct: 67  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 595 -----KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +   +   I+ G+ YL+     + +HR+L A N ++  D   KI DFG+ R
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQGQEEFMNE 541
           FEE      + +  ++LG+G FG V   +        G  +AVK+L  +    Q +F  E
Sbjct: 7   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 61
Query: 542 VMVISNLQHRNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           + ++  L    +V+  G      R+   L+ EY+P+  L  FL   + ++ LD  +    
Sbjct: 62  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 119
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
              I +G+ YL   SR R +HRDL A NIL++ + + KI+DFGLA++   ++D
Sbjct: 120 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 169

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKASGQGQEEFMNE 541
           FEE      + +  ++LG+G FG V   +        G  +AVK+L  +    Q +F  E
Sbjct: 8   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 62
Query: 542 VMVISNLQHRNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           + ++  L    +V+  G      R+   L+ EY+P+  L  FL   + ++ LD  +    
Sbjct: 63  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 120
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
              I +G+ YL   SR R +HRDL A NIL++ + + KI+DFGLA++   ++D
Sbjct: 121 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 170

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSK-ASGQGQE 536
           V+  +E   +     L  +LGQG FG VY+G  +D         +AVK +++ AS + + 
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL--FDPQRQSLLDWP 594
           EF+NE  V+      ++VRLLG   + +  +++ E M +  L S+L    P+ ++    P
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 595 -----KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +   +   I+ G+ YL+     + +HR+L A N ++  D   KI DFG+ R
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+          +AVK L     +  +  ++F+ EV  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +     M + E  P  SL   L   Q   LL    R+ +   ++ G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            YL      R IHRDL A N+LL      KI DFGL R    N D    +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQ 171

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEF-MNEVMVISNLQ 549
           ++++ F+   KLG G +  VYKG     G  +A+K +   S +G     + E+ ++  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPN---KSLDSFLFDPQRQSLLDWPKRFNIIK----G 602
           H N+VRL        +  L++E+M N   K +DS       + L       N++K     
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-----ELNLVKYFQWQ 116
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           + +GL + H +   +I+HRDLK  N+L++     K+ DFGLAR FG
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 152

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK--LQDGQ--EIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+     G+   +AVK L     +  +  ++F+ EV  + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +     M + E  P  SL   L   Q   LL    R+ +   ++ G+
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            YL      R IHRDL A N+LL      KI DFGL R    N D    +
Sbjct: 135 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQ 181

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 170

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/166 (34%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGK--LQDGQ--EIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+     G+   +AVK L     +  +  ++F+ EV  + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +     M + E  P  SL   L   Q   LL    R+ +   ++ G+
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
            YL      R IHRDL A N+LL      KI DFGL R    N D 
Sbjct: 135 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+          +AVK L     +  +  ++F+ EV  + +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +     M + E  P  SL   L   Q   LL    R+ +   ++ G+
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
            YL      R IHRDL A N+LL      KI DFGL R    N D 
Sbjct: 129 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+          +AVK L     +  +  ++F+ EV  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +     M + E  P  SL   L   Q   LL    R+ +   ++ G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
            YL      R IHRDL A N+LL      KI DFGL R    N D 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 464 EAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYK------GKLQ 517
           E+Y   S   ++P +L     +N E+     NN Q    LG G FG V +      GK  
Sbjct: 5   ESYEGNSYTFIDPTQLP----YN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED 59
Query: 518 DGQEIAVKRL-SKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPN 575
              ++AVK L S A    +E  M+E+ ++S+L QH N+V LLG C      ++I EY   
Sbjct: 60  AVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 119
Query: 576 KSLDSFL--------------------FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
             L +FL                     D +    L+     +    +++G+ +L   + 
Sbjct: 120 GDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN- 178
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              IHRD+ A N+LL +    KI DFGLAR
Sbjct: 179 --CIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+          +AVK L     +  +  ++F+ EV  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +     M + E  P  SL   L   Q   LL    R+ +   ++ G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
            YL      R IHRDL A N+LL      KI DFGL R    N D 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+          +AVK L     +  +  ++F+ EV  + +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +     M + E  P  SL   L   Q   LL    R+ +   ++ G+
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
            YL      R IHRDL A N+LL      KI DFGL R    N D 
Sbjct: 129 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 89/172 (51%), Gaps = 12/172 (6%)
Query: 495 NNFQLAN-KLGQGGFGPVYKG--KLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQ 549
           +N  +A+ +LG G FG V +G  +++  Q ++A+K L + + +   EE M E  ++  L 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           +  +VRL+G C + E  ML+ E      L  FL   + +  +       ++  +S G+ Y
Sbjct: 69  NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKY 125
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           L   +    +HRDL A N+LL +    KISDFGL++  G + D   T R  G
Sbjct: 126 LEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAG 173

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 91/160 (56%), Gaps = 20/160 (12%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQ-HR 551
           ++L  KLG+G +G V+K    + G+ +AVK++  A   S   Q  F  E+M+++ L  H 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 552 NLVRLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           N+V LL   V R +N     L+++YM     ++ L    R ++L+   +  ++  + + +
Sbjct: 70  NIVNLLN--VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            YLH      ++HRD+K SNILL+ + + K++DFGL+R F
Sbjct: 123 KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 503 LGQGGFG--------PVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNL 553
           LG+G FG        P   G    G+ +AVK L +  G Q +  +  E+ ++  L H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 554 VRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           V+  GCC ++ E    L+ EY+P  SL  +L     +  +   +     + I  G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  IHR L A N+LLD+D   KI DFGLA+
Sbjct: 130 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AVK + K   +    ++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQ 131
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                I+HRDLKA N+LLD D+N KI+DFG +  F
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQHR 551
           +F++ N LG+G F  VY+ + +  G E+A+K + K +       +   NEV +   L+H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           +++ L     +     L+ E   N  ++ +L +  +    +  + F  +  I  G+LYLH
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH 129
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
                 I+HRDL  SN+LL  ++N KI+DFGLA
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 503 LGQGGFG--------PVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNL 553
           LG+G FG        P   G    G+ +AVK L +  G Q +  +  E+ ++  L H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 554 VRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           V+  GCC ++ E    L+ EY+P  SL  +L     +  +   +     + I  G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  IHR L A N+LLD+D   KI DFGLA+
Sbjct: 129 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AVK + K   +    ++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQ 131
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                I+HRDLKA N+LLD D+N KI+DFG +  F
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   +   L   Q+ S  D  +    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AVK + K   +    ++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQ 131
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                I+HRDLKA N+LLD D+N KI+DFG +  F
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + ++ + I A+K L KA  +    + +   EV + S+L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   +   L   Q+ S  D  +    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AVK + K   +    ++   EV ++  L H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQ 132
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                I+HRDLKA N+LLD D+N KI+DFG +  F
Sbjct: 133 KY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF 164

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 15/172 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEE--FMNEVMVISNLQHRNL 553
           + +   LG+G FG V K K +   QE AVK ++KAS + ++    + EV ++  L H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           ++L     +     ++ E      L   +   +R S  D  +   IIK +  G+ Y+H+ 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKH 140
Query: 614 SRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +   I+HRDLK  NILL+    D + KI DFGL+  F   Q     K  +GT
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGT 186

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 15/172 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEE--FMNEVMVISNLQHRNL 553
           + +   LG+G FG V K K +   QE AVK ++KAS + ++    + EV ++  L H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           ++L     +     ++ E      L   +   +R S  D  +   IIK +  G+ Y+H+ 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKH 140
Query: 614 SRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +   I+HRDLK  NILL+    D + KI DFGL+  F   Q     K  +GT
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGT 186

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAV-KRLSKASGQGQEEFMNEVMVISNLQH 550
           N  + +++  +LG G FG VYK + ++   +A  K +   S +  E++M E+ ++++  H
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V+LL          ++ E+    ++D+ + + +R   L   +   + K     L YL
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 151
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H +   +IIHRDLKA NIL   D + K++DFG++
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAV-KRLSKASGQGQEEFMNEVMVISNLQH 550
           N  + +++  +LG G FG VYK + ++   +A  K +   S +  E++M E+ ++++  H
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V+LL          ++ E+    ++D+ + + +R   L   +   + K     L YL
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 151
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H +   +IIHRDLKA NIL   D + K++DFG++
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAV-KRLSKASGQGQEEFMNEVMVISNLQH 550
           N  + +++  +LG G FG VYK + ++   +A  K +   S +  E++M E+ ++++  H
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V+LL          ++ E+    ++D+ + + +R   L   +   + K     L YL
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 151
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H +   +IIHRDLKA NIL   D + K++DFG++
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 86/179 (48%), Gaps = 31/179 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKG-----KLQDG-QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
            N  L   LG+G FG V K      K + G   +AVK L + AS     + ++E  V+  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWP 594
           + H ++++L G C +    +LI EY    SL  FL + ++              S LD P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 595 KRFNIIKG--------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               +  G        IS+G+ YL   + ++++HRDL A NIL+ +    KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 77/154 (50%), Gaps = 21/154 (13%)
Query: 503 LGQGGFG--------PVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNL 553
           LG+G FG        P   G    G+ +AVK L    G Q +  +  E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 554 VRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++  GCC ++ E    L+ EY+P  SL  +L    R S+    +     + I  G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLH 134
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  IHR+L A N+LLD+D   KI DFGLA+
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 86/179 (48%), Gaps = 31/179 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKG-----KLQDG-QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
            N  L   LG+G FG V K      K + G   +AVK L + AS     + ++E  V+  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWP 594
           + H ++++L G C +    +LI EY    SL  FL + ++              S LD P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 595 KRFNIIKG--------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               +  G        IS+G+ YL   + ++++HRDL A NIL+ +    KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 77/154 (50%), Gaps = 21/154 (13%)
Query: 503 LGQGGFG--------PVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNL 553
           LG+G FG        P   G    G+ +AVK L    G Q +  +  E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 554 VRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++  GCC ++ E    L+ EY+P  SL  +L    R S+    +     + I  G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLH 134
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  IHR+L A N+LLD+D   KI DFGLA+
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 16/170 (9%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQHRN 552
           F    ++G G FG VY  + +++ + +A+K++S +  Q  E   + + EV  +  L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
            ++  GC +      L+ EY    + D  L +  ++ L +  +   +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEV-EIAAVTHGALQGLAYLHS 172
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            +   +IHRD+KA NILL +    K+ DFG A I       A     VGT
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGT 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 87/162 (53%), Gaps = 10/162 (6%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           RD+K+ NILL  D + K++DFG        Q + +T  +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI++FG
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG 155

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 11/163 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AV+ + K   +    ++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQ 131
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLAR--IFGGNQDQ 653
                I+HRDLKA N+LLD D+N KI+DFG +    FG   D+
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE 171

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQHRN 552
           F    ++G G FG VY  + +++ + +A+K++S +  Q  E   + + EV  +  L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
            ++  GC +      L+ EY    + D  L +  ++ L +  +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEV-EIAAVTHGALQGLAYLHS 133
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            +   +IHRD+KA NILL +    K+ DFG A I  
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AV+ + K   +    ++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQ 131
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                I+HRDLKA N+LLD D+N KI+DFG +  F
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNL 548
           A  +F++   LG+G FG VY  + +  + I A+K L KA  +    + +   EV + S+L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     R+IHRD+K  N+LL      KI++FG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG 156

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 83/155 (53%), Gaps = 20/155 (12%)
Query: 503 LGQGGFGPVYKGK-LQDGQ----EIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG VYKG  + DG+     +A+K L +  S +  +E ++E  V++ +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHR 612
           LG C+      L+ + MP   L   + + +     Q LL+W  +      I++G+ YL  
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
              +R++HRDL A N+L+    + KI+DFGLAR+ 
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 169

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 469 FSTEKVNPARLQDLLVFNFEELANATNNFQLAN-KLGQGGFGPVYKG--KLQDGQ-EIAV 524
           F +   +P  L+D  +F         +N  +A+ +LG G FG V +G  +++  Q ++A+
Sbjct: 315 FESPFSDPEELKDKKLFL------KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 525 KRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF 583
           K L + + +   EE M E  ++  L +  +VRL+G C + E  ML+ E      L  FL 
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV 427
Query: 584 DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
             + +  +       ++  +S G+ YL   +    +HR+L A N+LL +    KISDFGL
Sbjct: 428 GKREE--IPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 644 ARIFGGNQDQAATKRLVG 661
           ++  G + D   T R  G
Sbjct: 483 SKALGAD-DSYYTARSAG 499

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 503 LGQGGFG--------PVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNL 553
           LG+G FG        P   G    G+ +AVK L   +G Q +  +  E+ ++  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 554 VRLLGCCVER--EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++  GCC +       L+ EY+P  SL  +L    R S+    +     + I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLH 151
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  IHRDL A N+LLD+D   KI DFGLA+
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 92/168 (54%), Gaps = 17/168 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR-LSKASGQG-QEEFMNEVMVISNL 548
           +  + ++   K+GQG FG V+K +  + GQ++A+K+ L +   +G     + E+ ++  L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 549 QHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           +H N+V L+  C  +            L++++  +  L   L +   +  L   KR  ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 131
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           + +  GL Y+HR+   +I+HRD+KA+N+L+  D   K++DFGLAR F 
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEE--FMNEVMVISNLQHRNLVRLLGC 559
           LG+G FG V K K +   QE AVK ++KAS + ++    + EV ++  L H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
             +     ++ E      L   +   +R S  D  +   IIK +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 620 HRDLKASNILLDD---DLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           HRDLK  NILL+    D + KI DFGL+  F   Q     K  +GT
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGT 186

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 92/168 (54%), Gaps = 17/168 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR-LSKASGQG-QEEFMNEVMVISNL 548
           +  + ++   K+GQG FG V+K +  + GQ++A+K+ L +   +G     + E+ ++  L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 549 QHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           +H N+V L+  C  +            L++++  +  L   L +   +  L   KR  ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 131
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           + +  GL Y+HR+   +I+HRD+KA+N+L+  D   K++DFGLAR F 
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 92/168 (54%), Gaps = 17/168 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR-LSKASGQG-QEEFMNEVMVISNL 548
           +  + ++   K+GQG FG V+K +  + GQ++A+K+ L +   +G     + E+ ++  L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 549 QHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           +H N+V L+  C  +            L++++  +  L   L +   +  L   KR  ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 131
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           + +  GL Y+HR+   +I+HRD+KA+N+L+  D   K++DFGLAR F 
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 21/179 (11%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLVR 555
            QL     +G FG V+K +L + + +AVK       Q  Q E+  EV  +  ++H N+++
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQ 82
Query: 556 LLGCCVEREENM-----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            +G   +R  ++     LI  +    SL  FL    + +++ W +  +I + ++RGL YL
Sbjct: 83  FIGA-EKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYL 137
Query: 611 HRD-------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H D        +  I HRD+K+ N+LL ++L   I+DFGLA  F   +    T   VGT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 92/168 (54%), Gaps = 17/168 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKR-LSKASGQG-QEEFMNEVMVISNL 548
           +  + ++   K+GQG FG V+K +  + GQ++A+K+ L +   +G     + E+ ++  L
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 549 QHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           +H N+V L+  C  +            L++++  +  L   L +   +  L   KR  ++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VM 130
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           + +  GL Y+HR+   +I+HRD+KA+N+L+  D   K++DFGLAR F 
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 23/163 (14%)
Query: 502 KLGQGGFGPVYKGKLQDGQ-EIAVKRLSKAS-------------GQGQEEFMNEVMVISN 547
           KLG G +G V   K ++G  E A+K + K+               +  EE  NE+ ++ +
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L H N+++L     +++   L+ E+     L   + +  +    D     NI+K I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGI 159
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIF 647
            YLH+ +   I+HRD+K  NILL++    LN KI DFGL+  F
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 85/179 (47%), Gaps = 31/179 (17%)
Query: 495 NNFQLANKLGQGGFGPVYKG-----KLQDG-QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
            N  L   LG+G FG V K      K + G   +AVK L + AS     + ++E  V+  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWP 594
           + H ++++L G C +    +LI EY    SL  FL + ++              S LD P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 595 KRFNIIKG--------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               +  G        IS+G+ YL   + + ++HRDL A NIL+ +    KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 82/149 (55%), Gaps = 8/149 (5%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           K+G+G +G VYK +   G+  A+K  RL K         + E+ ++  L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
              ++  +L++E++ ++ L   L D     L     +  +++ ++ G+ Y H     R++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLN-GIAYCHDR---RVL 122
Query: 620 HRDLKASNILLDDDLNPKISDFGLARIFG 648
           HRDLK  N+L++ +   KI+DFGLAR FG
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 89/163 (54%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ NILL  D + K++DFG  A+I     +Q+    +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSEMVGT 179

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 82/149 (55%), Gaps = 8/149 (5%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           K+G+G +G VYK +   G+  A+K  RL K         + E+ ++  L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
              ++  +L++E++ ++ L   L D     L     +  +++ ++ G+ Y H     R++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLN-GIAYCHDR---RVL 122
Query: 620 HRDLKASNILLDDDLNPKISDFGLARIFG 648
           HRDLK  N+L++ +   KI+DFGLAR FG
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 90/166 (54%), Gaps = 16/166 (9%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF--MNEVMVISNLQ 549
           AT+ ++   ++G G +G VYK +    G  +A+K +   +G+       + EV ++  L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 550 ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
              H N+VRL+  C     +RE  + L++E++ ++ L ++L D      L      ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
              RGL +LH +    I+HRDLK  NIL+      K++DFGLARI+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 90/166 (54%), Gaps = 16/166 (9%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF--MNEVMVISNLQ 549
           AT+ ++   ++G G +G VYK +    G  +A+K +   +G+       + EV ++  L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 550 ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
              H N+VRL+  C     +RE  + L++E++ ++ L ++L D      L      ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
              RGL +LH +    I+HRDLK  NIL+      K++DFGLARI+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 82/149 (55%), Gaps = 8/149 (5%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           K+G+G +G VYK +   G+  A+K  RL K         + E+ ++  L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRII 619
              ++  +L++E++ ++ L   L D     L     +  +++ ++ G+ Y H     R++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLN-GIAYCHDR---RVL 122
Query: 620 HRDLKASNILLDDDLNPKISDFGLARIFG 648
           HRDLK  N+L++ +   KI+DFGLAR FG
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 81/148 (54%), Gaps = 10/148 (6%)
Query: 501 NKLGQGGFGPVYKGK--LQDGQEIAVKRLSKASGQGQE-EFMNEVMVISNLQHRNLVRLL 557
           +KLG+G +  VYKGK  L D   +A+K +     +G     + EV ++ +L+H N+V L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
                 +   L++EY+ +K L  +L D      +   K F  +  + RGL Y HR    +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ---K 120
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++HRDLK  N+L+++    K++DFGLAR
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 90/166 (54%), Gaps = 16/166 (9%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF--MNEVMVISNLQ 549
           AT+ ++   ++G G +G VYK +    G  +A+K +   +G+       + EV ++  L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 550 ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
              H N+VRL+  C     +RE  + L++E++ ++ L ++L D      L      ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
              RGL +LH +    I+HRDLK  NIL+      K++DFGLARI+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 89/163 (54%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ NILL  D + K++DFG  A+I     +Q+    +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGT 179

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNLQH 550
            +F +   LG+G FG VY  + +  + I A+K L K   +    + +   EV + S+L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           H     R+IHRD+K  N+LL  +   KI+DFG
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AVK + K   +    ++   EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L    R    +   +F   + I   + Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQYCHQ 131
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                I+HRDLKA N+LLD D N KI+DFG +  F
Sbjct: 132 KF---IVHRDLKAENLLLDADXNIKIADFGFSNEF 163

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 89/163 (54%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ NILL  D + K++DFG  A+I     +Q+    +VGT
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGT 180

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQG---QEEFMNEVMVISNLQH 550
            +F +   LG+G FG VY  + +  + I A+K L K   +    + +   EV + S+L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N++RL G   +     LI EY P   L +   + Q+ S  D  +    I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           H     R+IHRD+K  N+LL  +   KI+DFG
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFM--NEVMVIS 546
           + +   ++++   +G G +G   K + + DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 547 NLQHRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGI 603
            L+H N+VR     ++R    L  + EY     L S +    + +  LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 604 SRGLLYLHR--DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           +  L   HR  D    ++HRDLK +N+ LD   N K+ DFGLARI   N D+   K  VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVG 178
Query: 662 T 662
           T
Sbjct: 179 T 179

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 87/162 (53%), Gaps = 10/162 (6%)
Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           R++K+ NILL  D + K++DFG        Q + +T  +VGT
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 180

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFM--NEVMVIS 546
           + +   ++++   +G G +G   K + + DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 547 NLQHRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGI 603
            L+H N+VR     ++R    L  + EY     L S +    + +  LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 604 SRGLLYLHR--DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           +  L   HR  D    ++HRDLK +N+ LD   N K+ DFGLARI   N D +  K  VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178
Query: 662 T 662
           T
Sbjct: 179 T 179

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFM--NEVMVIS 546
           + +   ++++   +G G +G   K + + DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 547 NLQHRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGI 603
            L+H N+VR     ++R    L  + EY     L S +    + +  LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 604 SRGLLYLHR--DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           +  L   HR  D    ++HRDLK +N+ LD   N K+ DFGLARI   N D +  K  VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVG 178
Query: 662 T 662
           T
Sbjct: 179 T 179

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 20/177 (11%)
Query: 475 NPARLQ------DLLVFNFEELANATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRL 527
           NP R Q      D L    EE+      F +  KLG+G +G VYK    + GQ +A+K++
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEV------FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 528 SKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR 587
              S    +E + E+ ++      ++V+  G   +  +  ++ EY    S+   +    R
Sbjct: 63  PVESDL--QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LR 118
Query: 588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
              L   +   I++   +GL YLH    +R IHRD+KA NILL+ + + K++DFG+A
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 90/177 (50%), Gaps = 13/177 (7%)
Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG 534
           +PAR  D +  +   L +    F+L   +G G +G VYKG+     ++A  ++   +G  
Sbjct: 6   SPARSLDEI--DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 535 QEEFMNEV-MVISNLQHRNLVRLLGCCVER------EENMLIYEYMPNKSLDSFLFDPQR 587
           +EE   E+ M+     HRN+    G  +++      ++  L+ E+    S+   + + + 
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            +L +    + I + I RGL +LH+    ++IHRD+K  N+LL ++   K+ DFG++
Sbjct: 124 NTLKEEWIAY-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 14/168 (8%)
Query: 480 QDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEE 537
           +D  V N E+L        L  ++G+G FG V+ G+L+ D   +AVK   +      + +
Sbjct: 106 KDKWVLNHEDLV-------LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK 158
Query: 538 FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           F+ E  ++    H N+VRL+G C +++   ++ E +      +FL      + L      
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLL 216
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            ++   + G+ YL        IHRDL A N L+ +    KISDFG++R
Sbjct: 217 QMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 14/168 (8%)
Query: 480 QDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEE 537
           +D  V N E+L        L  ++G+G FG V+ G+L+ D   +AVK   +      + +
Sbjct: 106 KDKWVLNHEDLV-------LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK 158
Query: 538 FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           F+ E  ++    H N+VRL+G C +++   ++ E +      +FL      + L      
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLL 216
Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            ++   + G+ YL        IHRDL A N L+ +    KISDFG++R
Sbjct: 217 QMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 503 LGQGGFGPVY--KGKLQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           LG+G FG V   K K+  GQE AVK +SK        +E  + EV ++  L H N+++L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
               ++    L+ E      L   +   +R S +D  +   II+ +  G+ Y+H++   +
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 146
Query: 618 IIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQ 651
           I+HRDLK  N+LL+    D N +I DFGL+  F  ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
            ++F+    LGQG FG V K +   D +  A+K++ + + +     ++EVM++++L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 553 LVRLLGCCVER------------EENMLI-YEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           +VR     +ER            +  + I  EY  N++L   +         D  + + +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD--EYWRL 121
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            + I   L Y+H      IIHRDLK  NI +D+  N KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 503 LGQGGFGPVY--KGKLQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           LG+G FG V   K K+  GQE AVK +SK        +E  + EV ++  L H N+++L 
Sbjct: 40  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
               ++    L+ E      L   +   +R S +D  +   II+ +  G+ Y+H++   +
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 152
Query: 618 IIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQ 651
           I+HRDLK  N+LL+    D N +I DFGL+  F  ++
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 189

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 503 LGQGGFGPVY--KGKLQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           LG+G FG V   K K+  GQE AVK +SK        +E  + EV ++  L H N+++L 
Sbjct: 57  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
               ++    L+ E      L   +   +R S +D  +   II+ +  G+ Y+H++   +
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 169
Query: 618 IIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQ 651
           I+HRDLK  N+LL+    D N +I DFGL+  F  ++
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 206

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 503 LGQGGFGPVY--KGKLQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           LG+G FG V   K K+  GQE AVK +SK        +E  + EV ++  L H N+++L 
Sbjct: 58  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
               ++    L+ E      L   +   +R S +D  +   II+ +  G+ Y+H++   +
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 170
Query: 618 IIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQ 651
           I+HRDLK  N+LL+    D N +I DFGL+  F  ++
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 207

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 86/163 (52%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V   + +  G+++AVK +     Q +E   NEV+++ + QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  EE  ++ E++   +L   +     Q  L+  +   + + + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A+I   ++D    K LVGT
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGT 204

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+AVK + K   +    ++   EV ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L       +   L+ EY     +  +L         +   +F   + I   + Y H+
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF---RQIVSAVQYCHQ 124
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                I+HRDLKA N+LLD D+N KI+DFG +  F
Sbjct: 125 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 156

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 80/172 (46%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L  C  + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 153
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 154 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK-ASGQGQEEFMNEVMVISN 547
           A  +  L   LG+G FG VY+G   + +     +AVK   K  +   +E+FM+E +++ N
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII---KGIS 604
           L H ++V+L+G  +E E   +I E  P   L  +L +  + SL    K   ++     I 
Sbjct: 66  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQIC 119
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRL 659
           + + YL     +  +HRD+   NIL+      K+ DFGL+R I   +  +A+  RL
Sbjct: 120 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 172

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK-ASGQGQEEFMNEVMVISN 547
           A  +  L   LG+G FG VY+G   + +     +AVK   K  +   +E+FM+E +++ N
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII---KGIS 604
           L H ++V+L+G  +E E   +I E  P   L  +L +  + SL    K   ++     I 
Sbjct: 70  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQIC 123
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRL 659
           + + YL     +  +HRD+   NIL+      K+ DFGL+R I   +  +A+  RL
Sbjct: 124 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 497 FQLANKLGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMN---EVMVISNLQHRN 552
           + +   LG+G FG V      +  Q++A+K +S+   +  +  M    E+  +  L+H +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +++L        + +++ EY   +  D ++ + +R +  D  +RF   + I   + Y HR
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFD-YIVEKKRMTE-DEGRRF--FQQIICAIEYCHR 126
Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
               +I+HRDLK  N+LLDD+LN KI+DFGL+ I 
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSK-ASGQGQEEFMNEVMVISN 547
           A  +  L   LG+G FG VY+G   + +     +AVK   K  +   +E+FM+E +++ N
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII---KGIS 604
           L H ++V+L+G  +E E   +I E  P   L  +L +  + SL    K   ++     I 
Sbjct: 82  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQIC 135
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRL 659
           + + YL     +  +HRD+   NIL+      K+ DFGL+R I   +  +A+  RL
Sbjct: 136 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEE-----FMNEVMV 544
           A + + ++   KLG+G +G VYK       + +A+KR+     + +EE      + EV +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL---EHEEEGVPGTAIREVSL 86
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  LQHRN++ L           LI+EY  N        +P     +     + +I G++
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILL---DDDLNP--KISDFGLARIFG 648
               + H  SR R +HRDLK  N+LL   D    P  KI DFGLAR FG
Sbjct: 147 ----FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 21/166 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           +G+G +G V K + +D G+ +A+K+   S      ++  M E+ ++  L+H NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW----PKRFNIIKGISRGLLYLHRDSR 615
           C +++   L++E++ +  LD     P     LD+       F II GI  G  + H    
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGI--GFCHSH---- 143
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN----QDQAATK 657
             IIHRD+K  NIL+      K+ DFG AR          D+ AT+
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR 188

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 31/194 (15%)
Query: 479 LQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKL--QDGQ--EIAVKRLSK--ASG 532
           + D L    E++      F L   LG+G FG V + +L  +DG   ++AVK L     + 
Sbjct: 7   ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 533 QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN------MLIYEYMPNKSLDSFL---- 582
              EEF+ E   +    H ++ +L+G  +           M+I  +M +  L +FL    
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 583 -----FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637
                F+   Q+L+    RF +   I+ G+ YL   S    IHRDL A N +L +D+   
Sbjct: 127 IGENPFNLPLQTLV----RFMV--DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVC 177
Query: 638 ISDFGLAR-IFGGN 650
           ++DFGL+R I+ G+
Sbjct: 178 VADFGLSRKIYSGD 191

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              ++   +G+G FG VY G+      I +  + + +    + F  EVM     +H N+V
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
             +G C+      +I      ++L S + D   + +LD  K   I + I +G+ YLH   
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
              I+H+DLK+ N+  D+     I+DFGL  I G
Sbjct: 151 ---ILHKDLKSKNVFYDNG-KVVITDFGLFSISG 180

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 503 LGQGGFGPVY--KGKLQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           LG+G FG V   K K+  GQE AVK +SK        +E  + EV ++  L H N+ +L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
               ++    L+ E      L   +   +R S +D  +   II+ +  G+ Y H++   +
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYXHKN---K 146
Query: 618 IIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQ 651
           I+HRDLK  N+LL+    D N +I DFGL+  F  ++
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 14/153 (9%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRL-----SKASGQGQEEFMNEVMVISNLQHRNLVRL 556
           LG+G F  VYK + ++  Q +A+K++     S+A        + E+ ++  L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS-RGLLYLHRDSR 615
           L     +    L++++M    L+  + D    SL+  P        ++ +GL YLH+   
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
             I+HRDLK +N+LLD++   K++DFGLA+ FG
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
            ++F+    LGQG FG V K +   D +  A+K++ + + +     ++EVM++++L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 553 LVRLLGCCVER------------EENMLI-YEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           +VR     +ER            +  + I  EY  N +L   +         D  + + +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD--EYWRL 121
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            + I   L Y+H      IIHRDLK  NI +D+  N KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 12/172 (6%)
Query: 481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM 539
           DLL +++E   N          LG+G +G VY G+ L +   IA+K + +   +  +   
Sbjct: 13  DLLEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH 67
Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
            E+ +  +L+H+N+V+ LG   E     +  E +P  SL S L   +   L D  +    
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGF 126
Query: 600 -IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGG 649
             K I  GL YLH +   +I+HRD+K  N+L++      KISDFG ++   G
Sbjct: 127 YTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQ-GQEEFMNEVMVISNLQHRN 552
           ++++L   +G G    V        +E +A+KR++    Q   +E + E+  +S   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-----PQRQSLLDWPKRFNIIKGISRGL 607
           +V      V ++E  L+ + +   S+   +         +  +LD      I++ +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD---QAATKRLVGT 662
            YLH++ +   IHRD+KA NILL +D + +I+DFG++       D       K  VGT
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 19/169 (11%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM-----NEVMVIS 546
           AT+ ++   ++G G +G VYK +    G  +A+K +   +G G    +      EV ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 547 NLQ---HRNLVRLLGCCV----EREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
            L+   H N+VRL+  C     +RE  + L++E++ ++ L ++L D      L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           +++   RGL +LH +    I+HRDLK  NIL+      K++DFGLARI+
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 493 ATNNFQLANK---LGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
           A N+F   +K   LG G FG V+K  +   G ++A K +     + +EE  NE+ V++ L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSL-DSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
            H NL++L      + + +L+ EY+    L D  + +    + LD       +K I  G+
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGI 200
Query: 608 LYLHRDSRLRIIHRDLKASNILL--DDDLNPKISDFGLARIF 647
            ++H   ++ I+H DLK  NIL    D    KI DFGLAR +
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 84/157 (53%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V     ++ G +IAVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 112
Query: 554 VRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 113 IGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 168
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 169 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQ-GQEEFMNEVMVISNLQHRN 552
           ++++L   +G G    V        +E +A+KR++    Q   +E + E+  +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-----PQRQSLLDWPKRFNIIKGISRGL 607
           +V      V ++E  L+ + +   S+   +         +  +LD      I++ +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD---QAATKRLVGT 662
            YLH++ +   IHRD+KA NILL +D + +I+DFG++       D       K  VGT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ + + L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQHR 551
           ++ L + LG G FG V  GK +  G ++AVK L++   +  +   +   E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++++L        +  ++ EY+    L  ++    R   LD  +   + + I  G+ Y H
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH 133
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
           R     ++HRDLK  N+LLD  +N KI+DFGL+ +    +
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   ++    D +E+   ++   S       +E+   E+ +  +L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                E+N  ++  +      S L   +R+  L  P+    ++ I  G  YLHR+   R+
Sbjct: 83  FF---EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   ++    D +E+   ++   S       +E+   E+ +  +L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
              + +   ++ E    +SL       +R+  L  P+    ++ I  G  YLHR+   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   ++    D +E+   ++   S       +E+   E+ +  +L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
              + +   ++ E    +SL       +R+  L  P+    ++ I  G  YLHR+   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNL 548
           A    ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L
Sbjct: 1   APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGL 607
            H N+V+  G   E     L  EY     L    FD     + +  P        +  G+
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +YLH    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 117 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   ++    D +E+   ++   S       +E+   E+ +  +L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
              + +   ++ E    +SL       +R+  L  P+    ++ I  G  YLHR+   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLV 554
           + QL     +G FG V+K +L +   +AVK       Q  Q E   E+     ++H NL+
Sbjct: 16  SLQLLEIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLL 72
Query: 555 RLLGCCVEREENM-----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           + +    +R  N+     LI  +    SL  +L    + +++ W +  ++ + +SRGL Y
Sbjct: 73  QFIAA-EKRGSNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSY 127
Query: 610 LHRD--------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           LH D         +  I HRD K+ N+LL  DL   ++DFGLA  F   +    T   VG
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVG 187
Query: 662 T 662
           T
Sbjct: 188 T 188

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   ++    D +E+   ++   S       +E+   E+ +  +L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
              + +   ++ E    +SL       +R+  L  P+    ++ I  G  YLHR+   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   ++    D +E+   ++   S       +E+   E+ +  +L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
              + +   ++ E    +SL       +R+  L  P+    ++ I  G  YLHR+   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 23/164 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKR--LSKASGQGQEEFMNEVMVISNLQHR 551
             ++   K+G+G +G V+K K ++  EI A+KR  L           + E+ ++  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQ-RQSLLDWPKRFNIIKGIS 604
           N+VRL       ++  L++E+  ++ L  +        DP+  +S L     F ++KG+ 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFL-----FQLLKGLG 115
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
               + H  SR  ++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 116 ----FCH--SR-NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 123
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 123
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 7/150 (4%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
           LG+G +G VY G+ L +   IA+K + +   +  +    E+ +  +L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-IKGISRGLLYLHRDSRLRIIH 620
           E     +  E +P  SL S L   +   L D  +      K I  GL YLH +   +I+H
Sbjct: 76  ENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 131
Query: 621 RDLKASNILLDDDLNP-KISDFGLARIFGG 649
           RD+K  N+L++      KISDFG ++   G
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAG 161

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 25/173 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P +++  D  K F  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 149 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD---GQEIAVKRLSKASGQGQE---EFMNEVMVISNLQH 550
           +++ +KLG GG   VY    +D     ++A+K +     + +E    F  EV   S L H
Sbjct: 13  YKIVDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           +N+V ++    E +   L+ EY+   +L  ++   +    L      N    I  G+ + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHA 127
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    +RI+HRD+K  NIL+D +   KI DFG+A+          T  ++GT
Sbjct: 128 HD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGT 175

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 81/151 (53%), Gaps = 11/151 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEFMNEVMVISNLQHRNLV 554
           F   +++G+G FG VYKG     +E+ A+K +  + +    E+   E+ V+S      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           R  G  ++  +  +I EY+   S LD     P  ++ +       I++ I +GL YLH +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 135
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
              R IHRD+KA+N+LL +  + K++DFG+A
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVA 163

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           F+P    +  L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 470 STEKV--NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKR 526
           S +KV  N +   D+L  +F       ++F++   LG+G FG VY  + +    I A+K 
Sbjct: 1   SMQKVMENSSGTPDILTRHF-----TIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKV 55
Query: 527 L--SKASGQGQE-EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLF 583
           L  S+   +G E +   E+ + ++L H N++RL     +R    LI EY P   L   L 
Sbjct: 56  LFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL- 114
Query: 584 DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
             Q+    D  +   I++ ++  L+Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 115 --QKSCTFDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
            ++F+    LGQG FG V K +   D +  A+K++ + + +     ++EV ++++L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQY 63
Query: 553 LVRLLGCCVER------------EENMLI-YEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           +VR     +ER            +  + I  EY  N++L   +         D  + + +
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD--EYWRL 121
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            + I   L Y+H      IIHR+LK  NI +D+  N KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 23/172 (13%)
Query: 501 NKLGQGGFG-PVYKGKLQDGQEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
            K+G+G FG  +     +DG++  +K +  S+ S + +EE   EV V++N++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 558 GCCVEREENMLIYEYMPNKSL-------DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
               E     ++ +Y     L          LF  Q   +LDW         I   L ++
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF--QEDQILDW------FVQICLALKHV 141
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H     +I+HRD+K+ NI L  D   ++ DFG+AR+     + A  +  +GT
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGT 188

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 499 LAN--KLGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           LAN  K+G+G  G V    +   G+++AVK++     Q +E   NEV+++ +  H N+V 
Sbjct: 47  LANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           +    +  +E  ++ E++   +L   +      + ++  +   +   + R L YLH    
Sbjct: 107 MYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQG- 161
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGT 662
             +IHRD+K+ +ILL  D   K+SDFG    F     +   KR  LVGT
Sbjct: 162 --VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGT 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              ++   +G+G FG V K K +  +++A+K++   S +  + F+ E+  +S + H N+V
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 65
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+      L+ EY    SL + L   +           +     S+G+ YLH   
Sbjct: 66  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 615 RLRIIHRDLKASNILL-DDDLNPKISDFGLA 644
              +IHRDLK  N+LL       KI DFG A
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMV 544
           N  + +    +LG G F  V K +     LQ   +   KR +K+S +G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL   +++SL +  +    +K I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTE-EEATEFLKQIL 124
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA-RIFGGNQ 651
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA +I  GN+
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQS 589
             + +H+N++ LLG C +     +I EY    +L  +L                +P+ Q 
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ- 146
Query: 590 LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            L      +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 147 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 28/165 (16%)
Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG V+KG  + +G+ I     +K +   SG Q  +   + ++ I +L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS--------LLDWPKRFNIIKGISRGLL 608
           LG C       L+ +Y+P  SL     D  RQ         LL+W  +      I++G+ 
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           YL       ++HR+L A N+LL      +++DFG+A +   +  Q
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS---KASGQGQEEFMNEVMVISN 547
           N   NF++  K+G+G F  VY+   L DG  +A+K++        + + + + E+ ++  
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR--FNIIKGISR 605
           L H N+++     +E  E  ++ E      L   +   ++Q  L  P+R  +     +  
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCS 147
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            L ++H  SR R++HRD+K +N+ +      K+ D GL R F       A   LVGT
Sbjct: 148 ALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGT 199

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 457 VQRLDLGEAYANFSTEKVNPARLQ-----DLLVFNFEELANATNNFQLANKLGQGGFGPV 511
           V+R + GE    + +  ++P  L      + L ++  +     +  +L   LG+G FG V
Sbjct: 21  VKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQV 80
Query: 512 YKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNL-QHRNLVRLLGCCVER 563
            +       K    + +AVK L + +   +    M+E+ ++ ++  H N+V LLG C + 
Sbjct: 81  IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140
Query: 564 E-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNIIKG-------ISRGLLY 609
               M+I E+    +L ++L      F P + +  D  K F  ++        +++G+ +
Sbjct: 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 201 L---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 30/172 (17%)
Query: 499 LANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL- 548
           L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++  + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQSLLDW 593
           +H+N++ LLG C +     +I EY    +L  +L                +P+ Q  L  
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ--LSS 190
Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 191 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              ++   +G+G FG V K K +  +++A+K++   S +  + F+ E+  +S + H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+      L+ EY    SL + L   +           +     S+G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 615 RLRIIHRDLKASNILL-DDDLNPKISDFGLA 644
              +IHRDLK  N+LL       KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQS 589
             + +H+N++ LLG C +     +I EY    +L  +L                +P+ Q 
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ- 135
Query: 590 LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            L      +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 136 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQS 589
             + +H+N++ LLG C +     +I EY    +L  +L                +P+ Q 
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ- 138
Query: 590 LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            L      +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 139 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQS 589
             + +H+N++ LLG C +     +I EY    +L  +L                +P+ Q 
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ- 139
Query: 590 LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            L      +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 140 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 28/165 (16%)
Query: 503 LGQGGFGPVYKGK-LQDGQEI----AVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRL 556
           LG G FG V+KG  + +G+ I     +K +   SG Q  +   + ++ I +L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS--------LLDWPKRFNIIKGISRGLL 608
           LG C       L+ +Y+P  SL     D  RQ         LL+W  +      I++G+ 
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           YL       ++HR+L A N+LL      +++DFG+A +   +  Q
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQS 589
             + +H+N++ LLG C +     +I EY    +L  +L                +P+ Q 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ- 131
Query: 590 LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            L      +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 132 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 145
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 146 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P + +  D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 130
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 131 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQS 589
             + +H+N++ LLG C +     +I EY    +L  +L                +P+ Q 
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ- 146
Query: 590 LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            L      +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 147 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 146
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 496 NFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL 548
           N +    LG G FG V         K     ++AVK L  KA    +E  M+E+ +++ L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 549 -QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDWPKR 596
             H N+V LLG C       LI+EY     L ++L            + + Q  L+  + 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 597 FNIIK---------GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            N++           +++G+ +L   S    +HRDL A N+L+      KI DFGLAR
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 145
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 146 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K     ++AVK L S A+ +   + ++E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQS 589
             + +H+N++ LLG C +     +I EY    +L  +L                +P+ Q 
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ- 146
Query: 590 LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            L      +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 147 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 148
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 148
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/173 (32%), Positives = 90/173 (52%), Gaps = 20/173 (11%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK-----RLSKAS-GQGQEEFMNEVMV 544
           +  +++++  +LG G F  V K + +  G+E A K     RLS +  G  +EE   EV +
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGI 603
           +  ++H N++ L      + + +LI E +    L  FL   +++SL  D   +F  +K I
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQF--LKQI 124
Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDD--LNPKIS--DFGLA-RIFGGNQ 651
             G+ YLH     RI H DLK  NI+L D    NP+I   DFG+A +I  GN+
Sbjct: 125 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 174

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 148
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 146
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 148
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 146
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 149
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 150 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 149
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 150 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P + +  D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 123
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 124 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P + +  D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 151
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 152 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 148
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 125
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 126 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 135
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 136 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 124
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P + +  D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 135
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 136 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 148
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F  V   + L   +E A+K L K     + +      E  V+S L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 126
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 127 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P + +  D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLS-KASGQGQEEFMNEVMVISNLQHR 551
             ++ L   LG+G  G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYL 610
           N+V+  G   E     L  EY     L    FD     + +  P        +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P + +  D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 87/162 (53%), Gaps = 23/162 (14%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKR--LSKASGQGQEEFMNEVMVISNLQHRNL 553
           ++   K+G+G +G V+K K ++  EI A+KR  L           + E+ ++  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFL------FDPQ-RQSLLDWPKRFNIIKGISRG 606
           VRL       ++  L++E+  ++ L  +        DP+  +S L     F ++KG+   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFL-----FQLLKGLG-- 115
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
             + H  SR  ++HRDLK  N+L++ +   K+++FGLAR FG
Sbjct: 116 --FCH--SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P + +  D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 17/170 (10%)
Query: 494 TNNFQLANKLGQGGFGPVY--KGKLQDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL 548
           ++ +Q   KLG G +G V   K KL  G E A+K + K+S          ++EV V+  L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H N+++L     ++    L+ E      L   +   Q+ S +D      I+K +  G  
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTT 135
Query: 609 YLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARIF--GGNQDQ 653
           YLH+ +   I+HRDLK  N+LL+    D   KI DFGL+  F  GG   +
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 182

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 89/170 (52%), Gaps = 20/170 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVK-----RLSKAS-GQGQEEFMNEVMVISN 547
           +++++  +LG G F  V K + +  G+E A K     RLS +  G  +EE   EV ++  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRG 606
           ++H N++ L      + + +LI E +    L  FL   +++SL  D   +F  +K I  G
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQF--LKQILDG 120
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDD--LNPKIS--DFGLA-RIFGGNQ 651
           + YLH     RI H DLK  NI+L D    NP+I   DFG+A +I  GN+
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 103 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 158
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 159 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 145
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQHR 551
           ++ L + LG G FG V  G+ Q  G ++AVK L++   +  +   +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++++L        +  ++ EY+    L  ++    R   ++  + F   + I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           R     ++HRDLK  N+LLD  +N KI+DFGL+ + 
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 494 TNNFQLANKLGQGGFGPVY--KGKLQDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL 548
           ++ +Q   KLG G +G V   K KL  G E A+K + K+S          ++EV V+  L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H N+++L     ++    L+ E      L   +   Q+ S +D      I+K +  G  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTT 118
Query: 609 YLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARIF 647
           YLH+ +   I+HRDLK  N+LL+    D   KI DFGL+  F
Sbjct: 119 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 157

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 495 NNFQLANKLGQGGFGP-VYKGKLQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
            +F+    LG+G F   V   +L   +E A+K L K     + +      E  V+S L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              V+L     + E+      Y  N  L  ++   +  S  +   RF   + +S  L YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS-ALEYL 146
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 12/161 (7%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQHRNL 553
           +QL  +LG+G F  V +  K+  GQE A K ++  K S +  ++   E  +   L+H N+
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           VRL     E   + LI++ +    L   +   +  S  D     + I+ I   +L+ H  
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHCH-- 138
Query: 614 SRLRIIHRDLKASNILLDDDLN---PKISDFGLARIFGGNQ 651
            ++ ++HRDLK  N+LL   L     K++DFGLA    G Q
Sbjct: 139 -QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 178

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 104 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 159
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 160 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQHR 551
           ++ L + LG G FG V  G+ Q  G ++AVK L++   +  +   +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++++L        +  ++ EY+    L  ++    R   ++  + F   + I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           R     ++HRDLK  N+LLD  +N KI+DFGL+ + 
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LSK   S    +    E+ ++ +++H N+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 151
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 152 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 104 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 159
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 160 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +F+    +G GGFG V+K K + DG+   +KR+        E+   EV  ++ L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIV 67
Query: 555 RLLGC-------------CVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
              GC                R +   ++   E+    +L+ ++ + +R   LD      
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           + + I++G+ Y+H     ++I+RDLK SNI L D    KI DFGL 
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLV 169

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   +I+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 144
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 145 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 81
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 82  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 137
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 138 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q    +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 93
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 94  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 149
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 150 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L           +D  R  +  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 136
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 137 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 21/158 (13%)
Query: 503 LGQGGFGPVYKGKLQD----GQ----EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           LGQG F  ++KG  ++    GQ    E+ +K L KA     E F     ++S L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
              G CV  +EN+L+ E++   SLD++L   +    + W  +  + K ++  + +L  ++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 615 RLRIIHRDLKASNILL--DDDL---NP---KISDFGLA 644
              +IH ++ A NILL  ++D    NP   K+SD G++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 135
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 136 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 15/172 (8%)
Query: 497 FQLANKLGQGGFGPVY--KGKLQDGQE-IAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           +Q   KLG G +G V   + K+   +  I + R +  S     + + EV V+  L H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           ++L     ++    L+ E      L   +    + + +D      IIK +  G+ YLH+ 
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLHKH 155
Query: 614 SRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +   I+HRDLK  N+LL+    D   KI DFGL+ +F   ++Q   K  +GT
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 87/170 (51%), Gaps = 20/170 (11%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS------GQGQEEFMNEVMVISN 547
           +++++  +LG G F  V K + +  G+E A K + K        G  +EE   EV ++  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL-DWPKRFNIIKGISRG 606
           ++H N++ L      + + +LI E +    L  FL   +++SL  D   +F  +K I  G
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQF--LKQILDG 141
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDD--LNPKIS--DFGLA-RIFGGNQ 651
           + YLH     RI H DLK  NI+L D    NP+I   DFG+A +I  GN+
Sbjct: 142 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 144
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 145 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 136
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 137 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 144
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 145 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 162
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 163 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 146
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +   L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P +    D+    ++
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 600 IK---GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           I     +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 141
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 25/170 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ-----------------EE 537
           N++++   L QG F  +   + +D +  A+K+  K+  + +                 ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 538 FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSL---DSFLFDPQRQSLLDWP 594
           F NE+ +I+++++   +   G     +E  +IYEYM N S+   D + F   +      P
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 595 KRF--NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
            +    IIK +     Y+H +    I HRD+K SNIL+D +   K+SDFG
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 141
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 150
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 151 YIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 146
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 144
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 145 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 82
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 83  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 138
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 139 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNL 548
           +  +FQ+   LG G FG V+  +   +G+  A+K L K      +  E   +E +++S +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H  ++R+ G   + ++  +I +Y+    L S L   QR      P        +   L 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALE 120
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           YLH      II+RDLK  NILLD + + KI+DFG A+
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 145
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   Y+    D +E+   ++   S       +E+   E+ +  +L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                E++  +Y  +      S L   +R+  +  P+    ++   +G+ YLH +   R+
Sbjct: 110 FF---EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L+DD++ KI DFGLA
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 146
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 9/157 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEFMNEVMVISN 547
           +A+    F    ++G+G FG V+KG     Q++ A+K +  + +    E+   E+ V+S 
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
                + +  G  ++  +  +I EY+   S      D  R    D  +   ++K I +GL
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGL 133
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            YLH + +   IHRD+KA+N+LL +  + K++DFG+A
Sbjct: 134 DYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA 167

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 141
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           N       LG G FG V +       K      +AVK L  ++   + E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG---- 602
           L  H N+V LLG C      ++I EY     L +FL   +R S +       I++     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 141
Query: 603 ------------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                       +++G+ +L   +    IHRDL A NILL      KI DFGLAR
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 193

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 151
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 152 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ 549
           + +  +LG G F  V K +     L+   +   KR S+AS +G  +EE   EV ++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++ L      R + +LI E +    L  FL   Q++SL +  +  + IK I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSE-EEATSFIKQILDGVNY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA 644
           LH     +I H DLK  NI+L D   P    K+ DFGLA
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 151
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 152 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 145
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   Y+    D +E+   ++   S       +E+   E+ +  +L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                E++  +Y  +      S L   +R+  +  P+    ++   +G+ YLH +   R+
Sbjct: 110 FF---EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L+DD++ KI DFGLA
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 103 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 158
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 159 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ---EEFMNEVMVISNL 548
             ++F +   LG+G FG VY  + +  + I A+K L K+  + +    +   E+ + S+L
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++R+     +R+   L+ E+ P   L   L   Q+    D  +    ++ ++  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALH 129
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     ++IHRD+K  N+L+      KI+DFG
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQ---EEFMNEVMVISNL 548
             ++F +   LG+G FG VY  + +  + I A+K L K+  + +    +   E+ + S+L
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N++R+     +R+   L+ E+ P   L   L   Q+    D  +    ++ ++  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALH 128
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
           Y H     ++IHRD+K  N+L+      KI+DFG
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 36/178 (20%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +F+    +G GGFG V+K K + DG+   ++R+        E+   EV  ++ L H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVK----YNNEKAEREVKALAKLDHVNIV 68
Query: 555 RLLGC-------CVEREENMLIYEYMPNKSLDS--------FL-------------FDPQ 586
              GC           ++++   +Y P  S +S        F+              + +
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           R   LD      + + I++G+ Y+H     ++IHRDLK SNI L D    KI DFGL 
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLV 183

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 104 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 159
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 160 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   Y+    D +E+   ++   S       +E+   E+ +  +L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                E++  +Y  +      S L   +R+  +  P+    ++   +G+ YLH +   R+
Sbjct: 110 FF---EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L+DD++ KI DFGLA
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 146
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ 549
           + +  +LG G F  V K +     L+   +   KR S+AS +G  +EE   EV ++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++ L      R + +LI E +    L  FL   Q++SL +  +  + IK I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSE-EEATSFIKQILDGVNY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLAR 645
           LH     +I H DLK  NI+L D   P    K+ DFGLA 
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ 549
           + +  +LG G F  V K +     L+   +   KR S+AS +G  +EE   EV ++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++ L      R + +LI E +    L  FL   Q++SL +  +  + IK I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSE-EEATSFIKQILDGVNY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA 644
           LH     +I H DLK  NI+L D   P    K+ DFGLA
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 150
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 151 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGF   Y+    D +E+   ++   S       +E+   E+ +  +L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRI 618
                E++  +Y  +      S L   +R+  +  P+    ++   +G+ YLH +   R+
Sbjct: 94  FF---EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 619 IHRDLKASNILLDDDLNPKISDFGLA 644
           IHRDLK  N+ L+DD++ KI DFGLA
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ 549
           + +  +LG G F  V K +     L+   +   KR S+AS +G  +EE   EV ++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++ L      R + +LI E +    L  FL   Q++SL +  +  + IK I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSE-EEATSFIKQILDGVNY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA 644
           LH     +I H DLK  NI+L D   P    K+ DFGLA
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ 549
           + +  +LG G F  V K +     L+   +   KR S+AS +G  +EE   EV ++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++ L      R + +LI E +    L  FL   Q++SL +  +  + IK I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSE-EEATSFIKQILDGVNY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA 644
           LH     +I H DLK  NI+L D   P    K+ DFGLA
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 162
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 163 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 19/173 (10%)
Query: 485 FNFEELANAT----NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEE 537
           F  +ELA         +Q  + +G G +G V      + G  +AVK+LS+   S    + 
Sbjct: 4   FYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 538 FMNEVMVISNLQHRNLVRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLD 592
              E+ ++ +++H N++ LL        +E   ++ +  ++    L++ +   +   L D
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCAKLTD 120
Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              +F +I  I RGL Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 121 DHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           N       LG G FG V +       K      +AVK L  ++   + E  M+E+ V+S 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEY--------MPNKSLDSFLFDPQRQSLLDWPKRFN 598
           L  H N+V LLG C      ++I EY           +  DSF+      ++++  +   
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 599 IIKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            ++        +++G+ +L   +    IHRDL A NILL      KI DFGLAR
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 209

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           N       LG G FG V +       K      +AVK L  ++   + E  M+E+ V+S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG---- 602
           L  H N+V LLG C      ++I EY     L +FL   +R S +       I++     
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 164
Query: 603 ------------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                       +++G+ +L   +    IHRDL A NILL      KI DFGLAR
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           N       LG G FG V +       K      +AVK L  ++   + E  M+E+ V+S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG---- 602
           L  H N+V LLG C      ++I EY     L +FL   +R S +       I++     
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 164
Query: 603 ------------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                       +++G+ +L   +    IHRDL A NILL      KI DFGLAR
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +   L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P +    D+    ++
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 600 IK---GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           I     +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 147 ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQH 550
           T  +QL  +LG+G F  V +  K+  GQE A   ++  K S +  ++   E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+VRL     E   + LI++ +    L   +   +  S  D     + I+ I   +L+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHC 126
Query: 611 HRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLARIFGGNQ 651
           H   ++ ++HR+LK  N+LL   L     K++DFGLA    G Q
Sbjct: 127 H---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 141
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 142 YIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHR 551
             ++   K+G+G +G V+K + +D GQ +A+K+  ++      ++  + E+ ++  L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS----RGL 607
           NLV LL     +    L++EY  +  L     D  ++ + +     +++K I+    + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPE-----HLVKSITWQTLQAV 115
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            + H+ +    IHRD+K  NIL+      K+ DFG AR+  G  D
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 145
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 146 YIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           N       LG G FG V +       K      +AVK L  ++   + E  M+E+ V+S 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG---- 602
           L  H N+V LLG C      ++I EY     L +FL   +R S +       I++     
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 159
Query: 603 ------------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                       +++G+ +L   +    IHRDL A NILL      KI DFGLAR
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 211

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 497 FQLANKLGQGGFGPVYKGK-----LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQ 549
           + +  +LG G F  V K +     L+   +   KR S+AS +G  +EE   EV ++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++ L      R + +LI E +    L  FL   Q++SL +  +  + IK I  G+ Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSE-EEATSFIKQILDGVNY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLA 644
           LH     +I H DLK  NI+L D   P    K+ DFGLA
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 11/157 (7%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEFMNEVMVISNL 548
           A+    F    K+G+G FG V+KG     Q++ A+K +  + +    E+   E+ V+S  
Sbjct: 18  ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
               + +  G  ++  +  +I EY+   S LD  L +P     LD  +   I++ I +GL
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGL 132
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            YLH + +   IHRD+KA+N+LL +    K++DFG+A
Sbjct: 133 DYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 166

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I  Y    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 12/166 (7%)
Query: 492 NATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNL 548
           + T+ +QL   +G+G F  V +  KL  G E A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N+VRL     E   + L+++ +    L   +   +  S  D     + I+ I   +L
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVL 117
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLARIFGGNQ 651
           + H+   + ++HRDLK  N+LL         K++DFGLA    G+Q
Sbjct: 118 HCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ 160

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 82/161 (50%), Gaps = 19/161 (11%)
Query: 495 NNFQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ 549
              Q    +G G +G V   Y  +L+  Q++AVK+LS+   S         E+ ++ +L+
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 550 HRNLVRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           H N++ LL        +E    + +   +    L++ +   + Q+L D   +F ++  + 
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KSQALSDEHVQF-LVYQLL 141
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           RGL Y+H      IIHRDLK SN+ +++D   +I DFGLAR
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 145
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 13/169 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEFMNEVMVISNLQHRNLV 554
           F    K+G+G FG V+KG     Q++ A+K +  + +    E+   E+ V+S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +  G  ++  +  +I EY+   S LD  L +P     LD  +   I++ I +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 123
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            +   IHRD+KA+N+LL +    K++DFG+A      Q +  T   VGT
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 167

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 11/151 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEFMNEVMVISNLQHRNLV 554
           F    K+G+G FG V+KG     Q++ A+K +  + +    E+   E+ V+S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +  G  ++  +  +I EY+   S LD  L +P     LD  +   I++ I +GL YLH +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 143
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            +   IHRD+KA+N+LL +    K++DFG+A
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVA 171

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 125
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI D+GLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 11/151 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLS-KASGQGQEEFMNEVMVISNLQHRNLV 554
           F    K+G+G FG V+KG     Q++ A+K +  + +    E+   E+ V+S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 555 RLLGCCVEREENMLIYEYMPNKS-LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +  G  ++  +  +I EY+   S LD  L +P     LD  +   I++ I +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 123
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            +   IHRD+KA+N+LL +    K++DFG+A
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 82/161 (50%), Gaps = 19/161 (11%)
Query: 495 NNFQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ 549
              Q    +G G +G V   Y  +L+  Q++AVK+LS+   S         E+ ++ +L+
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 77
Query: 550 HRNLVRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           H N++ LL        +E    + +   +    L++ +   + Q+L D   +F ++  + 
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQF-LVYQLL 133
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           RGL Y+H      IIHRDLK SN+ +++D   +I DFGLAR
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 26/174 (14%)
Query: 495 NNFQLANKLGQGGFGPVY--------KGKLQDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V         K K ++   +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQR--QSLL 591
             + +H+N++ LLG C +     +I  Y    +L  +L           +D  R  +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KSQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DFGL R
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 24/161 (14%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL----- 556
           LG GG G V+     D  + +A+K++     Q  +  + E+ +I  L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 557 ---------LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
                    +G   E     ++ EYM    L + L   ++  LL+   R  + + + RGL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLLEEHARLFMYQ-LLRGL 133
Query: 608 LYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIF 647
            Y+H  +   ++HRDLK +N+ ++ +DL  KI DFGLARI 
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +  +L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P +    D  K F  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE--DLYKDFLT 146
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR    + D
Sbjct: 147 LEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 490
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 502 KLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----QEEFMNEVMVISNLQHRNLVRL 556
           +LG G FG V KG  Q  + +    +     +      ++E + E  V+  L +  +VR+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
           +G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ YL   +  
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 489
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
             +HRDL A N+LL      KISDFGL++    +++
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 70  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 126
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    ++  G+ +AVK++     Q +E   NEV+++ + QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L   +      + ++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 179

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    ++  G+ +AVK++     Q +E   NEV+++ + QH N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L   +      + ++  +   +   + + L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 183

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI DF LAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 82/161 (50%), Gaps = 19/161 (11%)
Query: 495 NNFQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ 549
              Q    +G G +G V   Y  +L+  Q++AVK+LS+   S         E+ ++ +L+
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 550 HRNLVRLL-----GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           H N++ LL        +E    + +   +    L++ +   + Q+L D   +F ++  + 
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQF-LVYQLL 141
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           RGL Y+H      IIHRDLK SN+ +++D   +I DFGLAR
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    ++  G+ +AVK++     Q +E   NEV+++ + QH N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L   +      + ++  +   +   + + L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 190

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQHR 551
            +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    H 
Sbjct: 40  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++V+L+G   E     +I E      L SFL    R+  LD          +S  L YL 
Sbjct: 100 HIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
                R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 157 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 199

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 70  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 126
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 75  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 70  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 126
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 73  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 129
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 174

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    ++  G+ +AVK++     Q +E   NEV+++ + QH N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L   +      + ++  +   +   + + L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 188

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 72  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 128
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 123
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 26/180 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQGQEE-FMNEVMVISN 547
           +   L   LG+G FG V +       K    + +AVK L + +   +    M+E+ ++ +
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 548 L-QHRNLVRLLGCCVERE-ENMLIYEYMPNKSLDSFL------FDPQRQSLLDWPKRFNI 599
           +  H N+V LLG C +     M+I E+    +L ++L      F P +    D  K F  
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE-DLYKDFLT 146
Query: 600 IKG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           ++        +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 21/158 (13%)
Query: 503 LGQGGFGPVYKGKLQD----GQ----EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           LGQG F  ++KG  ++    GQ    E+ +K L KA     E F     ++S L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
              G C   +EN+L+ E++   SLD++L   +    + W  +  + K ++  + +L  ++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 615 RLRIIHRDLKASNILL--DDDL---NP---KISDFGLA 644
              +IH ++ A NILL  ++D    NP   K+SD G++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRN 552
            +F+    LG+GGFG V++ K + D    A+KR+   + +  +E+ M EV  ++ L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW-------PKR-----FNII 600
           +VR     +E+     +    P   L   +   ++++L DW        +R      +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
             I+  + +LH      ++HRDLK SNI    D   K+ DFGL      ++++   
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    ++  G+ +AVK++     Q +E   NEV+++ + QH N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L   +      + ++  +   +   + + L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI  FGLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           +NF+    LG+G FG V   ++++ G   AVK L K         E  M E  ++S  ++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 551 RNLVRLLGCCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
              +  L CC +  + +  + E++    L   +F  Q+    D  + RF   + IS  L+
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIIS-ALM 138
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +LH      II+RDLK  N+LLD + + K++DFG+ +
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 502 KLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
           K+G+G  G V    ++  G+ +AVK++     Q +E   NEV+++ + QH N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
           +  +E  ++ E++   +L   +      + ++  +   +   + + L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 621 RDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKRLVGT 662
           RD+K+ +ILL  D   K+SDFG  A++   +++    K LVGT
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGT 310

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 10/166 (6%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEV 542
           +F+   +  + +++   +G G +G V   + +  GQ++A+K++  A       +  + E+
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 543 MVISNLQHRNLVRL---LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
            ++ + +H N++ +   L   V   E   +Y  +     D        Q L     R+ +
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 165
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            + + RGL Y+H     ++IHRDLK SN+L++++   KI DFG+AR
Sbjct: 166 YQ-LLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQH 550
           T+ +QL  +LG+G F  V +  K+  GQE A K ++  K S +  ++   E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+VRL     E   + L+++ +    L   +   +  S  D     + I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVNHC 119
Query: 611 HRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIFGGNQ 651
           H +    I+HRDLK  N+LL         K++DFGLA    G+Q
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI D GLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 12/166 (7%)
Query: 492 NATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNL 548
           + T+ +QL  +LG+G F  V +  K+  GQE A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N+VRL     E   + L+++ +    L   +   +  S  D     + I+ I   + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVN 117
Query: 609 YLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIFGGNQ 651
           + H +    I+HRDLK  N+LL         K++DFGLA    G+Q
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 10/166 (6%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEV 542
           +F+   +  + +++   +G G +G V   + +  GQ++A+K++  A       +  + E+
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 543 MVISNLQHRNLVRL---LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
            ++ + +H N++ +   L   V   E   +Y  +     D        Q L     R+ +
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 164
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            + + RGL Y+H     ++IHRDLK SN+L++++   KI DFG+AR
Sbjct: 165 YQ-LLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI D GLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQHR 551
            +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++V+L+G   E     +I E      L SFL    R+  LD          +S  L YL 
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
                R +HRD+ A N+L+  +   K+ DFGL+R    +    A+K
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFM-NEVMVISNLQHRNLV 554
           F+    LG G F  V   + +  G+  AVK + K + +G+E  + NE+ V+  ++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            L           L+ + +    L   + +    +  D      +I+ +   + YLHR  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQVLDAVYYLHR-- 138
Query: 615 RLRIIHRDLKASNILL---DDDLNPKISDFGLARIFG 648
            + I+HRDLK  N+L    D++    ISDFGL+++ G
Sbjct: 139 -MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG 174

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 11/168 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G           +A+K     +    +E+F+ E + +    
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SFL    R+  LD          +S  L Y
Sbjct: 70  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 126
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
           L      R +HRD+ A N+L+      K+ DFGL+R    +    A+K
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H N+
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 554 VRLLGC-----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           + LL        +E   ++ +  ++    L++ +   + Q L D   +F +I  I RGL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLK 139
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           Y+H      IIHRDLK SN+ +++D   KI D GLAR
Sbjct: 140 YIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNL 548
              +   L   +G+G +G V++G  Q G+ +AVK  S    +    + E  N VM    L
Sbjct: 5   TVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 59
Query: 549 QHRNLVRLLGC-CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           +H N++  +      R  +  ++       + S L+D  + + LD      I+  I+ GL
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGS-LYDYLQLTTLDTVSCLRIVLSIASGL 118
Query: 608 LYLHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG--------GNQDQA 654
            +LH +      +  I HRDLK+ NIL+  +    I+D GLA +          GN  + 
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 655 ATKRLVG 661
            TKR + 
Sbjct: 179 GTKRYMA 185

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLV 554
           +++  +LG GGFG V +   QD G+++A+K+  +  S + +E +  E+ ++  L H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 555 RL------LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
                   L      +  +L  EY     L  +L   +    L       ++  IS  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 609 YLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           YLH +   RIIHRDLK  NI+L      L  KI D G A+
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLV 554
           +++  +LG GGFG V +   QD G+++A+K+  +  S + +E +  E+ ++  L H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 555 RL------LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
                   L      +  +L  EY     L  +L   +    L       ++  IS  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 609 YLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           YLH +   RIIHRDLK  NI+L      L  KI D G A+
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 173

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFM 539
           D L   FE++   T+       LG+G +  V     LQ+G+E AVK + K +G  +    
Sbjct: 4   DSLPGKFEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVF 58
Query: 540 NEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
            EV  +   Q ++N++ L+    +     L++E +   S+ + +   Q+Q   +  +   
Sbjct: 59  REVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASR 115
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLD--DDLNP-KISDFGL 643
           +++ ++  L +LH      I HRDLK  NIL +  + ++P KI DF L
Sbjct: 116 VVRDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDL 160

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNL 548
               +  L   +G+G +G V++G  Q G+ +AVK  S    +    + E  N VM    L
Sbjct: 5   TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 59
Query: 549 QHRNLVRLLGC-CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           +H N++  +      R  +  ++       + S L+D  + + LD      I+  I+ GL
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGS-LYDYLQLTTLDTVSCLRIVLSIASGL 118
Query: 608 LYLHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG--------GNQDQA 654
            +LH +      +  I HRDLK+ NIL+  +    I+D GLA +          GN  + 
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 655 ATKRLVG 661
            TKR + 
Sbjct: 179 GTKRYMA 185

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 23/187 (12%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNL 548
                  L   +G+G +G V++G  Q G+ +AVK  S    +    + E  N VM    L
Sbjct: 34  TVARQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 88
Query: 549 QHRNLVRLLGC-CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           +H N++  +      R  +  ++       + S L+D  + + LD      I+  I+ GL
Sbjct: 89  RHENILGFIASDMTSRHSSTQLWLITHYHEMGS-LYDYLQLTTLDTVSCLRIVLSIASGL 147
Query: 608 LYLHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG--------GNQDQA 654
            +LH +      +  I HRDLK+ NIL+  +    I+D GLA +          GN  + 
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 207
Query: 655 ATKRLVG 661
            TKR + 
Sbjct: 208 GTKRYMA 214

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 487 FEELANATNNFQLANK-LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQE---EFMNE 541
           F+ + N  N + L +K LG+G F  V +      GQE A K L K   +GQ+   E ++E
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHE 78
Query: 542 VMVISNLQH-RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           + V+   +    ++ L        E +LI EY     + S    P+   ++       +I
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLI 137
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLARIFG 648
           K I  G+ YLH+++   I+H DLK  NILL   + P    KI DFG++R  G
Sbjct: 138 KQILEGVYYLHQNN---IVHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIG 185

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKASGQG-QEEFMNEVMVISNLQHR 551
            +L   +G+G FG V++G     +     +A+K     +    +E+F+ E + +    H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++V+L+G   E     +I E      L SFL    R+  LD          +S  L YL 
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
                R +HRD+ A N+L+      K+ DFGL+R    +    A+K
Sbjct: 509 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 551

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 497 FQLANKLGQGGFGPVY-KGKLQDGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLV 554
           F    KLG G FG V+   +   G E  +K ++K   Q   E+   E+ V+ +L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRD 613
           ++     +     ++ E      L   +   Q R   L       ++K +   L Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 614 SRLRIIHRDLKASNILLDDDLNP----KISDFGLARIFGGNQ 651
               ++H+DLK  NIL  D  +P    KI DFGLA +F  ++
Sbjct: 144 ---HVVHKDLKPENILFQDT-SPHSPIKIIDFGLAELFKSDE 181

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 9/154 (5%)
Query: 495 NNFQLANKLGQGGFGPV-YKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            ++    KLG+GGF  V     L DG   A+KR+     Q +EE   E  +     H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 554 VRLLGCCVE----REENMLIYEYMPNKSL-DSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +RL+  C+     + E  L+  +    +L +       + + L   +   ++ GI RGL 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
            +H        HRDLK +NILL D+  P + D G
Sbjct: 149 AIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHR 551
           +F+L   LG+G FG V+  + +   Q  A+K L K         E  M E  V+S     
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 78
Query: 552 NLVRLLGCCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +  + C  + +EN+  + EY+    L   ++  Q     D  +       I  GL +L
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR----------IFGGNQDQAATKRLV 660
           H      I++RDLK  NILLD D + KI+DFG+ +           F G  D  A + L+
Sbjct: 136 HSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 661 G 661
           G
Sbjct: 193 G 193

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 8/165 (4%)
Query: 495 NNFQLANKLGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           +++ +  +LG G FG V++  +   G   A K +       +E    E+  +S L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V L     +  E ++IYE+M    L   + D   +   D  +    ++ + +GL ++H +
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 274
Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAAT 656
           +    +H DLK  NI+     +   K+ DFGL       Q    T
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 69/132 (52%), Gaps = 17/132 (12%)
Query: 536 EEFMNEVMVISNLQHRNLVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQSLLDW 593
           E+   E+ ++  L H N+V+L+    +  E+ L  ++E +    +      P  + L + 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSED 137
Query: 594 PKRF---NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
             RF   ++IKGI     YLH     +IIHRD+K SN+L+ +D + KI+DFG++  F G+
Sbjct: 138 QARFYFQDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 651 QDQAATKRLVGT 662
              A     VGT
Sbjct: 191 --DALLSNTVGT 200

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 8/165 (4%)
Query: 495 NNFQLANKLGQGGFGPVYK-GKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           +++ +  +LG G FG V++  +   G   A K +       +E    E+  +S L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V L     +  E ++IYE+M    L   + D   +   D  +    ++ + +GL ++H +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAAT 656
           +    +H DLK  NI+     +   K+ DFGL       Q    T
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N F+    LG+G FG V   K +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H  S   +++RDLK  N++LD D + KI+DFGL +   G +D A  K   GT
Sbjct: 125 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 172

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLS--KASGQGQEEFMNEVMVISNLQH 550
           T+++QL  +LG+G F  V +  K    QE A K ++  K S +  ++   E  +   L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+VRL     E   + L+++ +    L   +   +  S  D     + I  I   + ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIHQILESVNHI 146
Query: 611 HRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLARIFGGNQ 651
           H+     I+HRDLK  N+LL         K++DFGLA    G Q
Sbjct: 147 HQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ 187

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N F+    LG+G FG V   K +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H  S   +++RDLK  N++LD D + KI+DFGL +   G +D A  K   GT
Sbjct: 126 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 173

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N F+    LG+G FG V   K +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H  S   +++RDLK  N++LD D + KI+DFGL +   G +D A  K   GT
Sbjct: 127 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 174

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 21/181 (11%)
Query: 496 NFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHR 551
           +F L   LG+G FG V+  + +   Q  A+K L K         E  M E  V+S     
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 552 NLVRLLGCCVEREENML-IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +  + C  + +EN+  + EY+    L   ++  Q     D  +       I  GL +L
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR----------IFGGNQDQAATKRLV 660
           H      I++RDLK  NILLD D + KI+DFG+ +           F G  D  A + L+
Sbjct: 135 HSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 661 G 661
           G
Sbjct: 192 G 192

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N F+    LG+G FG V   K +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H  S   +++RDLK  N++LD D + KI+DFGL +   G +D A  K   GT
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 312

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N F+    LG+G FG V   K +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H  S   +++RDLK  N++LD D + KI+DFGL +   G +D A  K   GT
Sbjct: 268 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 315

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 30/158 (18%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           +G G +G V      + G+++A+K+LS+   S    +    E++++ ++QH N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 560 CVEREENMLIYEYMPNKSL----DSFLFDPQRQSLLD--------WPKRFNIIKGISRGL 607
                       + P  SL    D +L  P  Q+ L           K   ++  + +GL
Sbjct: 92  ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            Y+H      ++HRDLK  N+ +++D   KI DFGLAR
Sbjct: 140 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCC 560
           L +GGF  VY+ + +  G+E A+KRL     +     + EV  +  L  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 561 -VEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
            + +EE+       L+   +    L  FL   + +  L       I     R + ++HR 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            +  IIHRDLK  N+LL +    K+ DFG A
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 30/158 (18%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           +G G +G V      + G+++A+K+LS+   S    +    E++++ ++QH N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 560 CVEREENMLIYEYMPNKSL----DSFLFDPQRQSLLD--------WPKRFNIIKGISRGL 607
                       + P  SL    D +L  P  Q+ L           K   ++  + +GL
Sbjct: 110 ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGL 157
Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            Y+H      ++HRDLK  N+ +++D   KI DFGLAR
Sbjct: 158 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQ 549
           N +++FQL + LG+G +G V     +  G+ +A+K++            + E+ ++ + +
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 550 HRNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           H N++ +         E    + I + +    L   +     Q L D   ++ I + + R
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-R 123
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            +  LH  +   +IHRDLK SN+L++ + + K+ DFGLARI 
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQ 549
           N +++FQL + LG+G +G V     +  G+ +A+K++            + E+ ++ + +
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 550 HRNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           H N++ +         E    + I + +    L   +     Q L D   ++ I + + R
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-R 123
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            +  LH  +   +IHRDLK SN+L++ + + K+ DFGLARI 
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 15/170 (8%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           F++ ++LG+G    VY+ K +  Q+  A+K L K   +  +    E+ V+  L H N+++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           L        E  L+ E +    L   + +    S  D     + +K I   + YLH +  
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---DAVKQILEAVAYLHENG- 168
Query: 616 LRIIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             I+HRDLK  N+L      D   KI+DFGL++I    + Q   K + GT
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGT 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQ 549
           N +++FQL + LG+G +G V     +  G+ +A+K++            + E+ ++ + +
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 550 HRNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           H N++ +         E    + I + +    L   +     Q L D   ++ I + + R
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-R 123
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            +  LH  +   +IHRDLK SN+L++ + + K+ DFGLARI 
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI----AVKRLSKAS----GQGQEEFMNEVMVIS 546
            NF+L   LG G +G V+  +   G +     A+K L KA+     +  E    E  V+ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 547 NLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +++    +  L    + E  + LI +Y+    L + L   QR+   +   +  + + I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGE-IVL 170
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
            L +LH+   L II+RD+K  NILLD + +  ++DFGL++ F  ++ + A
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 84  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 499 LANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEF-MNEVMVISNLQHRNLVRL 556
           L++ LGQG    V++G+ +  G   A+K  +  S     +  M E  V+  L H+N+V+L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 557 LGCCVERE----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
               +E E      +LI E+ P  SL + L +P     L   +   +++ +  G+ +L  
Sbjct: 73  F--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 613 DSRLRIIHRDLKASNILL----DDDLNPKISDFGLAR 645
           +    I+HR++K  NI+     D     K++DFG AR
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEI----AVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGFG V+  +++   ++     + +      +G +  M E  +++ +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSRLR 617
               + +  L+   M    +   +++    +     P+       I  GL +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           II+RDLK  N+LLDDD N +ISD GLA      Q +  TK   GT
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEI----AVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGFG V+  +++   ++     + +      +G +  M E  +++ +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSRLR 617
               + +  L+   M    +   +++    +     P+       I  GL +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           II+RDLK  N+LLDDD N +ISD GLA      Q +  TK   GT
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEI----AVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGFG V+  +++   ++     + +      +G +  M E  +++ +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSRLR 617
               + +  L+   M    +   +++    +     P+       I  GL +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           II+RDLK  N+LLDDD N +ISD GLA      Q +  TK   GT
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 503 LGQGGFGPVYKGKLQDGQEI----AVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           LG+GGFG V+  +++   ++     + +      +G +  M E  +++ +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRDSRLR 617
               + +  L+   M    +   +++    +     P+       I  GL +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           II+RDLK  N+LLDDD N +ISD GLA      Q +  TK   GT
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 29/183 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVR 555
           L   +G+G +G V++G L  G+ +AVK  S    Q    + E  N V+    L+H N++ 
Sbjct: 12  LVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVL----LRHDNILG 66
Query: 556 LLGCCVEREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
            +   +    +     LI  Y  + SL  FL   QRQ+L +      +    + GL +LH
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFL---QRQTL-EPHLALRLAVSAACGLAHLH 122
Query: 612 RD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG--------GNQDQAATKR 658
            +      +  I HRD K+ N+L+  +L   I+D GLA +          GN  +  TKR
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 659 LVG 661
            + 
Sbjct: 183 YMA 185

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 499 LANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEF-MNEVMVISNLQHRNLVRL 556
           L++ LGQG    V++G+ +  G   A+K  +  S     +  M E  V+  L H+N+V+L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 557 LGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
                E      +LI E+ P  SL + L +P     L   +   +++ +  G+ +L  + 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 615 RLRIIHRDLKASNILL----DDDLNPKISDFGLAR 645
              I+HR++K  NI+     D     K++DFG AR
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGKLQDG-QEIAVKRLSKASGQ--GQEEFMNEVMVISN 547
               +N+++ + +G+G +G VY    ++  + +A+K++++        +  + E+ +++ 
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 548 LQHRNLVRLLGCCVEREENMLIYE--YMPNKSLDSFLFDPQRQSLLDWPKRF-NIIKGIS 604
           L+   ++RL    +   E++L ++  Y+  +  DS L    +  +    +    I+  + 
Sbjct: 84  LKSDYIIRLHDLIIP--EDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLL 141
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            G  ++H      IIHRDLK +N LL+ D + KI DFGLAR    ++D
Sbjct: 142 LGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 78  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 125
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 85  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 132
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 89  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 136
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 137 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 182

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 495 NNFQLANKLGQGGFGPVY----KGKLQDGQEIAVKRLSKASGQGQEEFMNEVM--VISNL 548
           ++F+L   LGQG FG V+      +   G   A+K L KA+ + ++    ++   +++++
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H  +V+L        +  LI +++  +  D F    +     +   +F + + ++ GL 
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLD 144
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +LH    L II+RDLK  NILLD++ + K++DFGL++
Sbjct: 145 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 34/181 (18%)
Query: 489 ELANAT----NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNE 541
           E+A++T      +Q    +G G  G V        G  +AVK+LS+   +    +    E
Sbjct: 14  EVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRE 73
Query: 542 VMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQRQSL--- 590
           ++++  + H+N++ LL              + P K+L+ F        L D     +   
Sbjct: 74  LVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHM 121
Query: 591 -LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
            LD  +   ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 178
Query: 650 N 650
           N
Sbjct: 179 N 179

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL---SKASGQGQEEFMNEVMVISNLQHR 551
              Q+  ++G+G +G V+ GK + G+++AVK      +AS   + E    V+    ++H 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL----MRHE 91
Query: 552 NLVRLLGCCVERE----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           N++  +   ++      +  LI +Y  N SL    +D  + + LD      +      GL
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGL 147
Query: 608 LYLHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +LH +      +  I HRDLK+ NIL+  +    I+D GLA  F  + ++ 
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 84  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 122 NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 170 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 32/118 (27%)
Query: 537 EFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR 596
           E M +V ++ +L   +L +LL C           +++ N  +  FL+             
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKC-----------QHLSNDHICYFLYQ------------ 136
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
                 I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 137 ------ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI--AVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           + L N +G+G +G V K  +Q G  I  A K++ K   +  + F  E+ ++ +L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL       E+N  IY  M   +          + +        I+K +   + Y H   
Sbjct: 70  RLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 615 RLRIIHRDLKASNILL--DDDLNP-KISDFGLARIF 647
           +L + HRDLK  N L   D   +P K+ DFGLA  F
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 86  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 133
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 134 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 179

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 84  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQEI--AVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           + L N +G+G +G V K  +Q G  I  A K++ K   +  + F  E+ ++ +L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL       E+N  IY  M   +          + +        I+K +   + Y H   
Sbjct: 87  RLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 615 RLRIIHRDLKASNILL--DDDLNP-KISDFGLARIF 647
           +L + HRDLK  N L   D   +P K+ DFGLA  F
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 176

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P KSL+ F        L D       Q  LD  +   +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 84  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQGQEEFM-NEVMVISNLQHRNLV 554
           +   + LG G F  V   + +  Q+ +A+K ++K + +G+E  M NE+ V+  ++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            L           LI + +    L   + +    +  D  +   +I  +   + YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 615 RLRIIHRDLKASNIL---LDDDLNPKISDFGLARI 646
            L I+HRDLK  N+L   LD+D    ISDFGL+++
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 13/173 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
            +F     LG+G FG V     +  +E+ A+K L K         E  M E  V++ L  
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
              +  L  C +  + +  + EY+    L   ++  Q+      P+       IS GL +
Sbjct: 79  PPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFF 135
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH+     II+RDLK  N++LD + + KI+DFG+ +      D   T+   GT
Sbjct: 136 LHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGT 183

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL---LG 558
           +G G FG VY+ KL D G+ +A+K++     QG+     E+ ++  L H N+VRL     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 559 CCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRD 613
              E+++ +   L+ +Y+P      +  +   +Q+L + + K +  +  + R L Y+H  
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS- 140
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 77  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 124
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 125 LYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 170

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQGQEEFM-NEVMVISNLQHRNLV 554
           +   + LG G F  V   + +  Q+ +A+K ++K + +G+E  M NE+ V+  ++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            L           LI + +    L   + +    +  D  +   +I  +   + YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 615 RLRIIHRDLKASNIL---LDDDLNPKISDFGLARI 646
            L I+HRDLK  N+L   LD+D    ISDFGL+++
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL---LG 558
           +G G FG VY+ KL D G+ +A+K++     QG+     E+ ++  L H N+VRL     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 559 CCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
              E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS-- 140
Query: 615 RLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
              I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV----RL 556
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++     +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
               +E+ +++    Y+    +++ L+   +   L        +  I RGL Y+H  +  
Sbjct: 91  RAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV----RL 556
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++     +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
               +E+ +++    Y+    +++ L+   +   L        +  I RGL Y+H  +  
Sbjct: 91  RAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 122 NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 170 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 174
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 175 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRNLV----RL 556
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++     +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
               +E+ +++    Y+    +++ L+   +   L        +  I RGL Y+H  +  
Sbjct: 95  RAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 168
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 169 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 199

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL---LG 558
           +G G FG VY+ KL D G+ +A+K++     QG+     E+ ++  L H N+VRL     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 559 CCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHRD 613
              E+++ +   L+ +Y+P      +  +   +Q+L + + K +  +  + R L Y+H  
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIH-- 139
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQGQEEFM-NEVMVISNLQHRNLV 554
           +   + LG G F  V   + +  Q+ +A+K ++K + +G+E  M NE+ V+  ++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            L           LI + +    L   + +    +  D  +   +I  +   + YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 615 RLRIIHRDLKASNIL---LDDDLNPKISDFGLARI 646
            L I+HRDLK  N+L   LD+D    ISDFGL+++
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 178
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 179 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 209

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 189

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V           +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+L++   + KI DFGLARI     D  
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHT 201

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV----RL 556
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++     +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
               +E+ +++    Y+    +++ L+   +   L        +  I RGL Y+H  +  
Sbjct: 91  RAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHT 181

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 187

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 178

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV----RL 556
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++     +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
               +E+ +++    Y+    +++ L+   +   L        +  I RGL Y+H  +  
Sbjct: 91  RAPTIEQMKDV----YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 497 FQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQGQEEFM-NEVMVISNLQHRNLV 554
           +   + LG G F  V   + +  Q+ +A+K ++K + +G+E  M NE+ V+  ++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            L           LI + +    L   + +    +  D  +   +I  +   + YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 615 RLRIIHRDLKASNIL---LDDDLNPKISDFGLARI 646
            L I+HRDLK  N+L   LD+D    ISDFGL+++
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 176
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 177 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 219
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 220 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 250

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 201

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N+F     LG+G FG V   + +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 611 H-RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H RD    +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 122 HSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 174
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 175 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVM---VISNLQH 550
           N+F     LG+G FG V   + +  G+  A+K L K     ++E  + V    V+ N +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 611 H-RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H RD    +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 125 HSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 171

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVM---VISNLQH 550
           N+F     LG+G FG V   + +  G+  A+K L K     ++E  + V    V+ N +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 611 H-RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H RD    +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 122 HSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 77  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 145
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 146 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 176

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 78  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 84  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 84  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ- 535
           A ++DL+     EL    + + +   +  G +G V  G   +G  +A+KR+      G+ 
Sbjct: 8   AAMRDLIA----ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63
Query: 536 ----------EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDP 585
                     +  + E+ ++++  H N++ L    V  EE  +   Y+  + + + L   
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 586 -QRQSLLDWPKRFN-IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
              Q ++  P+     +  I  GL  LH      ++HRDL   NILL D+ +  I DF L
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL 180
Query: 644 AR 645
           AR
Sbjct: 181 AR 182

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N+F     LG+G FG V   + +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 611 H-RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H RD    +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 122 HSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 489 ELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISN 547
           +  N    F     LG G F  V+  K +  G+  A+K + K+         NE+ V+  
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK 62
Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMP-----NKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
           ++H N+V L           L+ + +      ++ L+  ++  +  SL        +I+ 
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--------VIQQ 114
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNIL-LDDDLNPK--ISDFGLARI 646
           +   + YLH +    I+HRDLK  N+L L  + N K  I+DFGL+++
Sbjct: 115 VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 85  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 78  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 85  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 535 QEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW 593
           +E  + EV ++  +  H N+++L           L+++ M    L  +L   ++ +L + 
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEK 124
Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
             R  I++ +   +  LH+   L I+HRDLK  NILLDDD+N K++DFG +
Sbjct: 125 ETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 497 FQLANKLGQGGFGPV---YKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
           +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++  + H+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQR----QSLLDWPKRFNI 599
           N++ LL              + P K+L+ F        L D       Q  LD  +   +
Sbjct: 83  NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 130
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G
Sbjct: 131 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 176

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N+F     LG+G FG V   + +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 611 H-RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H RD    +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 122 HSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQ- 535
           A ++DL+     EL    + + +   +  G +G V  G   +G  +A+KR+      G+ 
Sbjct: 8   AAMRDLIA----ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63
Query: 536 ----------EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDP 585
                     +  + E+ ++++  H N++ L    V  EE  +   Y+  + + + L   
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 586 -QRQSLLDWPKRFN-IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL 643
              Q ++  P+     +  I  GL  LH      ++HRDL   NILL D+ +  I DF L
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL 180
Query: 644 AR 645
           AR
Sbjct: 181 AR 182

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 535 QEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW 593
           +E  + EV ++  +  H N+++L           L+++ M    L  +L   ++ +L + 
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEK 124
Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
             R  I++ +   +  LH+   L I+HRDLK  NILLDDD+N K++DFG +
Sbjct: 125 ETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N+F     LG+G FG V   + +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 611 H-RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H RD    +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 122 HSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNL 553
           +Q    +G G  G V        G  +AVK+LS+   +    +    E++++  + H+N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSF--------LFDPQRQSL----LDWPKRFNIIK 601
           + LL              + P K+L+ F        L D     +    LD  +   ++ 
Sbjct: 84  ISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY 131
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
            +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR    N
Sbjct: 132 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN 177

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N+F     LG+G FG V   + +  G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L    F   R+ +    +       I   L YL
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 611 H-RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H RD    +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 127 HSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 173

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLS--KASGQGQEEFMNEVMVISNLQH 550
           ++N+ +  +LG+G F  V +   +  G E A K ++  K S +  ++   E  +   LQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+VRL     E   + L+++ +    L   +   +  S  D     + I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYC 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLA 644
           H +    I+HR+LK  N+LL         K++DFGLA
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLS--KASGQGQEEFMNEVMVISNLQH 550
           ++N+ +  +LG+G F  V +   +  G E A K ++  K S +  ++   E  +   LQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+VRL     E   + L+++ +    L   +   +  S  D     + I+ I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYC 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLA 644
           H +    I+HR+LK  N+LL         K++DFGLA
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 154

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLS--KASGQGQEEFMNEVMVISNLQH 550
           ++N+ +  +LG+G F  V +   +  G E A K ++  K S +  ++   E  +   LQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+VRL     E   + L+++ +    L   +   +  S  D     + I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYC 121
Query: 611 HRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLA 644
           H +    I+HR+LK  N+LL         K++DFGLA
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 535 QEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW 593
           +E  + EV ++  +  H N+++L           L+++ M    L  +L   ++ +L + 
Sbjct: 54  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEK 111
Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
             R  I++ +   +  LH+   L I+HRDLK  NILLDDD+N K++DFG +
Sbjct: 112 ETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV----RL 556
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++     +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
               +E+ +++ +  ++    L   L    +   L        +  I RGL Y+H  +  
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 165 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 201

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    +G G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EYMP   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 153
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 154 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 184

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQDGQ-EIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHT 183

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 152
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 153 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    +G G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EYMP   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 152
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 153 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 148
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 149 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 179

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 21/154 (13%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHR 612
               E+++ +   L+ +Y+P      +  +   +Q+L + + K +  +  + R L Y+H 
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS 159
Query: 613 DSRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
                I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 160 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 190

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 72/154 (46%), Gaps = 5/154 (3%)
Query: 503 LGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCC 560
           +G+G +G V       +   +A++++S    Q   +  + E+ ++   +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
                  +   Y+    +++ L+   +   L        +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
           RDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 21/154 (13%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHR 612
               E+++ +   L+ +Y+P      +  +   +Q+L + + K +  +  + R L Y+H 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS 140
Query: 613 DSRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
                I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 144
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 145 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 175

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V K + +    I  ++L     +   + + + E+ V+       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L + +R      P+     +   + RGL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-----IPEEILGKVSIAVLRGLAYL 130
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   A +RL GT
Sbjct: 131 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGT 188

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 21/154 (13%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHR 612
               E+++ +   L+ +Y+P      +  +   +Q+L + + K +  +  + R L Y+H 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS 140
Query: 613 DSRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
                I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 21/154 (13%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHR 612
               E+++ +   L+ +Y+P      +  +   +Q+L + + K +  +  + R L Y+H 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS 140
Query: 613 DSRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
                I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 21/154 (13%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSL-LDWPKRFNIIKGISRGLLYLHR 612
               E+++ +   L+ +Y+P      +  +   +Q+L + + K +  +  + R L Y+H 
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIHS 141
Query: 613 DSRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
                I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 142 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 172

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLS--KASGQGQEEFMNEVMVISNLQH 550
           ++N+ +  +LG+G F  V +   +  G E A K ++  K S +  ++   E  +   LQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+VRL     E   + L+++ +    L   +   +  S  D     + I+ I   + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 144
Query: 611 HRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLA 644
           H +    I+HR+LK  N+LL         K++DFGLA
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI--AVKRLSKAS---GQGQEEFMNEV-MVISNL 548
           ++F     +G+G FG V   +    +E+  AVK L K +    + ++  M+E  +++ N+
Sbjct: 38  SDFHFLKVIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H  LV L       ++   + +Y+    L    +  QR+     P+       I+  L 
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALG 153
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           YLH    L I++RDLK  NILLD   +  ++DFGL +
Sbjct: 154 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +E    +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     K++DFGLA+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG 193

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ---GQEEFMNEV 542
            E      N F+    LG+GGFG V   +++  G+  A K+L K   +   G+   +NE 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
            ++  +  R +V L      ++   L+   M    L   ++   +    +    F   + 
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE- 294
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           I  GL  LHR+   RI++RDLK  NILLDD  + +ISD GLA
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 8/154 (5%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ---GQEEFMNEVMVISNLQH 550
           N F+    LG+GGFG V   +++  G+  A K+L K   +   G+   +NE  ++  +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           R +V L      ++   L+   M    L   ++   +    +    F   + I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDL 302
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           HR+   RI++RDLK  NILLDD  + +ISD GLA
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 8/142 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNL-Q 549
           T  F    K+G G FG V+K  K  DG   A+KR  K  A    ++  + EV   + L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLL 608
           H ++VR      E +  ++  EY    SL   + +  R  S     +  +++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 609 YLHRDSRLRIIHRDLKASNILL 630
           Y+H    + ++H D+K SNI +
Sbjct: 128 YIH---SMSLVHMDIKPSNIFI 146

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSKASGQGQEEFMNEVM--VISNL 548
           + F+L   LGQG FG V+  K   G    Q  A+K L KA+ + ++    ++   ++  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H  +V+L        +  LI +++  +  D F    +     +   +F + + ++  L 
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALD 140
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +LH    L II+RDLK  NILLD++ + K++DFGL++
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 8/142 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNL-Q 549
           T  F    K+G G FG V+K  K  DG   A+KR  K  A    ++  + EV   + L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLL 608
           H ++VR      E +  ++  EY    SL   + +  R  S     +  +++  + RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 609 YLHRDSRLRIIHRDLKASNILL 630
           Y+H    + ++H D+K SNI +
Sbjct: 130 YIH---SMSLVHMDIKPSNIFI 148

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--------SGQGQEEFMNEVMV 544
           +  +   + LG G FG V+     +  +E+ VK + K               +   E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNK---SLDSFLFDPQRQSLLDWPKRFNIIK 601
           +S ++H N++++L       EN   ++ +  K    LD F F   R   LD P    I +
Sbjct: 83  LSRVEHANIIKVLDIF----ENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFR 137
Query: 602 GISRGLLYLHRDSRLR-IIHRDLKASNILLDDDLNPKISDFGLA 644
            +   + YL    RL+ IIHRD+K  NI++ +D   K+ DFG A
Sbjct: 138 QLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 503 LGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRL---L 557
           +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 558 GCCVEREENM---LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
               E+++ +   L+ +Y+P      +  +   +Q+L     +  + + + R L Y+H  
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHS- 140
Query: 614 SRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
               I HRD+K  N+LLD D    K+ DFG A+
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 497 FQLANKLGQGGFGPVYKGK----LQDGQEIAVKRLSKA----SGQGQEEFMNEVMVISNL 548
           F+L   LG+GG+G V++ +       G+  A+K L KA    + +       E  ++  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H  +V L+       +  LI EY+    L       +R+ +         +  IS  L 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +LH+     II+RDLK  NI+L+   + K++DFGL +
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 8/142 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNL-Q 549
           T  F    K+G G FG V+K  K  DG   A+KR  K  A    ++  + EV   + L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLL 608
           H ++VR      E +  ++  EY    SL   + +  R  S     +  +++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 609 YLHRDSRLRIIHRDLKASNILL 630
           Y+H    + ++H D+K SNI +
Sbjct: 128 YIH---SMSLVHMDIKPSNIFI 146

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 497 FQLANKLGQGGFGPVYKGK----LQDGQEIAVKRLSKA----SGQGQEEFMNEVMVISNL 548
           F+L   LG+GG+G V++ +       G+  A+K L KA    + +       E  ++  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H  +V L+       +  LI EY+    L       +R+ +         +  IS  L 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +LH+     II+RDLK  NI+L+   + K++DFGL +
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 8/142 (5%)
Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNL-Q 549
           T  F    K+G G FG V+K  K  DG   A+KR  K  A    ++  + EV   + L Q
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLL 608
           H ++VR      E +  ++  EY    SL   + +  R  S     +  +++  + RGL 
Sbjct: 66  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 125
Query: 609 YLHRDSRLRIIHRDLKASNILL 630
           Y+H    + ++H D+K SNI +
Sbjct: 126 YIH---SMSLVHMDIKPSNIFI 144

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    +G G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSKASGQGQEEFMNEVM--VISNL 548
           + F+L   LGQG FG V+  K   G    Q  A+K L KA+ + ++    ++   ++  +
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H  +V+L        +  LI +++  +  D F    +     +   +F + + ++  L 
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALD 141
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +LH    L II+RDLK  NILLD++ + K++DFGL++
Sbjct: 142 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSKASGQGQEEFMNEVM--VISNL 548
           + F+L   LGQG FG V+  K   G    Q  A+K L KA+ + ++    ++   ++  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H  +V+L        +  LI +++  +  D F    +     +   +F + + ++  L 
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALD 140
Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +LH    L II+RDLK  NILLD++ + K++DFGL++
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----Q 549
            +F L   +G+G +  V   +L+    I   R+ K      +E ++ V    ++      
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H  LV L  C         + EY+    L   +F  QRQ  L           IS  L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           LH      II+RDLK  N+LLD + + K++D+G+ +
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 143
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 179

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 491 ANATNNFQLANKLGQGGFGPVYKGKLQDGQE-IAVKRLSKASGQ--GQEEFMNEVMVISN 547
            +  +N+ + + +G+G +G VY    ++ ++ +A+K++++        +  + E+ +++ 
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 548 LQHRNLVRLLGCCVEREENMLIYE--YMPNKSLDSFLFDPQRQSLLDWPKRFN--IIKGI 603
           L+   ++RL    +   +++L ++  Y+  +  DS L     + L   P       IK I
Sbjct: 82  LKSDYIIRLYDLIIP--DDLLKFDELYIVLEIADSDL-----KKLFKTPIFLTEEHIKTI 134
Query: 604 SRGLL----YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
              LL    ++H      IIHRDLK +N LL+ D + K+ DFGLAR     +D
Sbjct: 135 LYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 502 KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEE--FMNEVMVISNLQHRNLVRLLG 558
           ++G+G +G V K   +  GQ +AVKR+     + +++   M+  +V+ +     +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 559 CCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL--HRDSRL 616
                 +  +  E M + S D F       S+LD      I+  I+   +    H    L
Sbjct: 89  ALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 617 RIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           +IIHRD+K SNILLD   N K+ DFG++   G   D  A  R  G
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAG 187

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 193

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +E    +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     +++DFGLA+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG 193

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 46/170 (27%)
Query: 502 KLGQGGFGPVYKGKLQDGQ------EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           ++G+G F  VYKG   +        E+  ++L+K+  Q    F  E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 556 LLGC---------CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK----- 601
                        C+     +L+ E   + +L ++L            KRF + K     
Sbjct: 90  FYDSWESTVKGKKCI-----VLVTELXTSGTLKTYL------------KRFKVXKIKVLR 132
Query: 602 ----GISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARI 646
                I +GL +LH  +   IIHRDLK  NI +     + KI D GLA +
Sbjct: 133 SWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNE 541
           NFE  A+   + +   +LG+G +G V K + +  GQ +AVKR+ +A+   QE+    M+ 
Sbjct: 45  NFEVKAD---DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDL 100
Query: 542 VMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF---LFDPQRQSLLDWPKRFN 598
            + +  +     V   G    RE ++ I   + + SLD F   + D  +    D   +  
Sbjct: 101 DISMRTVDCPFTVTFYGALF-REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 159
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           +   I + L +LH  S+L +IHRD+K SN+L++     K+ DFG++
Sbjct: 160 V--SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL-SKASGQGQEEFMNEVM 543
           NFE  A+   + +   +LG+G +G V K + +  GQ  AVKR+ +  + Q Q+  + ++ 
Sbjct: 28  NFEVKAD---DLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLD 84
Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF---LFDPQRQSLLDWPKRFNII 600
           +                + RE ++ I   + + SLD F   + D  +    D   +  + 
Sbjct: 85  ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAV- 143
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
             I + L +LH  S+L +IHRD+K SN+L++     K  DFG++
Sbjct: 144 -SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 31/159 (19%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGC 559
           +G G +G V      + G ++A+K+L +   S    +    E+ ++ +++H N++ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 560 CVEREENMLIYEYMPNKSLDSF----LFDP---------QRQSLLDWPKRFNIIKGISRG 606
                       + P+++LD F    L  P          +   L   +   ++  + +G
Sbjct: 93  ------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           L Y+H      IIHRDLK  N+ +++D   KI DFGLAR
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 193

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 84/165 (50%), Gaps = 27/165 (16%)
Query: 495 NNFQLANKLGQGGFGPVYKG--KLQDGQEIAVKRLSKASGQ--GQEEFMNEVMVISNLQH 550
           + +++ + +G G +G V +   KL+  + +A+K++ +        +  + E+ +++ L H
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLE-KRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDS----------FLFDPQRQSLLDWPKRFNII 600
            ++V++L   + ++       Y+  +  DS          +L +   ++LL     +N++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL-----YNLL 166
Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            G+     Y+H      I+HRDLK +N L++ D + K+ DFGLAR
Sbjct: 167 VGVK----YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RN 552
           +++QL  KLG+G +  V++   + + +++ VK L       + +   E+ ++ NL+   N
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KNKIKREIKILENLRGGPN 93
Query: 553 LVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           ++ L     +       L++E++ N       F    Q+L D+  RF + + I + L Y 
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTD-----FKQLYQTLTDYDIRFYMYE-ILKALDYC 147
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIFGGNQD 652
           H    + I+HRD+K  N+++D +    ++ D+GLA  +   Q+
Sbjct: 148 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVR 555
           L   +G+G FG V++GK + G+E+AVK  S    +    + E    VM    L+H N++ 
Sbjct: 13  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 67
Query: 556 LLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            +    + ++N       L+ +Y  + SL    FD   +  +       +    + GL +
Sbjct: 68  FIAA--DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 121
Query: 610 LHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           LH +      +  I HRDLK+ NIL+  +    I+D GLA
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVR 555
           L   +G+G FG V++GK + G+E+AVK  S    +    + E    VM    L+H N++ 
Sbjct: 8   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 62
Query: 556 LLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            +    + ++N       L+ +Y  + SL    FD   +  +       +    + GL +
Sbjct: 63  FIAA--DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 116
Query: 610 LHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           LH +      +  I HRDLK+ NIL+  +    I+D GLA
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVR 555
           L   +G+G FG V++GK + G+E+AVK  S    +    + E    VM    L+H N++ 
Sbjct: 10  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 64
Query: 556 LLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            +    + ++N       L+ +Y  + SL    FD   +  +       +    + GL +
Sbjct: 65  FIAA--DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 118
Query: 610 LHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           LH +      +  I HRDLK+ NIL+  +    I+D GLA
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 16/155 (10%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           + +  +LG G FG V++  +   G+    K ++      +    NE+ +++ L H  L+ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW----PKRFNIIKGISRGLLYLH 611
           L     ++ E +LI E++        LFD  R +  D+     +  N ++    GL ++H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGE----LFD--RIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 612 RDSRLRIIHRDLKASNILLDDDL--NPKISDFGLA 644
             S   I+H D+K  NI+ +     + KI DFGLA
Sbjct: 167 EHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 198

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 150
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 186

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 23/168 (13%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVY--KGKLQDGQE--IAVKRLSKASGQGQEEFMNEV 542
           +E +   +N F++ +K+G+G F  VY    +LQ G E  IA+K L   S   +     + 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS----LDSFLFDPQRQSLLDWPKRFN 598
           + ++  Q  N++ +  C  + +  ++   Y+ ++S    L+S  F   R+ +L      N
Sbjct: 73  LTVAGGQD-NVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYML------N 125
Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLAR 645
           + K + R    +H+     I+HRD+K SN L +  L    + DFGLA+
Sbjct: 126 LFKALKR----IHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVR 555
           L   +G+G FG V++GK + G+E+AVK  S    +    + E    VM    L+H N++ 
Sbjct: 33  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 87
Query: 556 LLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            +    + ++N       L+ +Y  + SL    FD   +  +       +    + GL +
Sbjct: 88  FIAA--DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 141
Query: 610 LHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           LH +      +  I HRDLK+ NIL+  +    I+D GLA
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVR 555
           L   +G+G FG V++GK + G+E+AVK  S    +    + E    VM    L+H N++ 
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 61
Query: 556 LLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            +    + ++N       L+ +Y  + SL    FD   +  +       +    + GL +
Sbjct: 62  FIAA--DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 115
Query: 610 LHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           LH +      +  I HRDLK+ NIL+  +    I+D GLA
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQ 549
            ++ +   +LG+G +G V K + +  GQ +AVKR+ +A+   QE+    M+  + +  + 
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVD 64
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSF---LFDPQRQSLLDWPKRFNIIKGISRG 606
               V   G    RE ++ I   + + SLD F   + D  +    D   +  +   I + 
Sbjct: 65  CPFTVTFYGALF-REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKA 121
Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           L +LH  S+L +IHRD+K SN+L++     K+ DFG++
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----Q 549
            +F L   +G+G +  V   +L+    I   ++ K      +E ++ V    ++      
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H  LV L  C         + EY+    L   +F  QRQ  L           IS  L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           LH      II+RDLK  N+LLD + + K++D+G+ +
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----Q 549
            +F L   +G+G +  V   +L+    I   ++ K      +E ++ V    ++      
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H  LV L  C         + EY+    L   +F  QRQ  L           IS  L Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           LH      II+RDLK  N+LLD + + K++D+G+ +
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 150
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 186

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEFMN---EVMVISNLQH 550
           ++F++   +G+G FG V   +  D +++ A+K ++K     + E  N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV L     + E+  ++ + +    L   L   Q+            I  +   L YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYL 131
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
                 RIIHRD+K  NILLD+  +  I+DF +A + 
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG---QEEFMNEVMVISNLQHRNLVR 555
           L   +G+G FG V++GK + G+E+AVK  S    +    + E    VM    L+H N++ 
Sbjct: 46  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 100
Query: 556 LLGCCVEREEN------MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            +    + ++N       L+ +Y  + SL    FD   +  +       +    + GL +
Sbjct: 101 FIAA--DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 154
Query: 610 LHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           LH +      +  I HRDLK+ NIL+  +    I+D GLA
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+P   + S L   +R      P        I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 214

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----Q 549
            +F L   +G+G +  V   +L+    I   ++ K      +E ++ V    ++      
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H  LV L  C         + EY+    L   +F  QRQ  L           IS  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           LH      II+RDLK  N+LLD + + K++D+G+ +
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 120
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG 193

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 8/158 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
           + + ++ ++L   +G G FG     + +   E+   +  +   +  E    E++   +L+
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+VR     +      ++ EY     L   + +  R S  +   RF   + IS G+ Y
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-GVSY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLAR 645
            H    +++ HRDLK  N LLD    P  KI+DFG ++
Sbjct: 131 AH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK 165

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 29/170 (17%)
Query: 497 FQLANKLGQGGFGPVYKG-KLQDGQEIAVK-----RLSKASGQGQEEFMNEVMVISNLQH 550
           ++L   +G+G F  V +    + GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSL---------DSFLFDPQRQSLLDWPKRFNIIK 601
            ++V LL          +++E+M    L           F++     S        + ++
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS--------HYMR 137
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP---KISDFGLARIFG 648
            I   L Y H ++   IIHRD+K  N+LL    N    K+ DFG+A   G
Sbjct: 138 QILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 182
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 240

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L +L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 123
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGT 181

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L +L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
             + +A  LG+G FG V++      ++  + +  K  G  Q     E+ +++  +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR--FNIIKGISRGLLYLHR 612
            L       EE ++I+E++    LD  +F+    S  +  +R   + +  +   L +LH 
Sbjct: 65  HLHESFESMEELVMIFEFISG--LD--IFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 613 DSRLRIIHRDLKASNILLDDDLNP--KISDFGLAR 645
            +   I H D++  NI+     +   KI +FG AR
Sbjct: 121 HN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 438 TFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNF 497
           T  A  W A+    +E S     + G       TEK+ P   +       EE+  AT+  
Sbjct: 49  TSLAKTWAARGSRSREPSPKTEDNEG----VLLTEKLKPVDYE-----YREEVHWATHQL 99
Query: 498 QLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF-MNEVMVISNLQHRNLVR 555
               +LG+G FG V++ +  Q G + AVK++        E F   E+M  + L    +V 
Sbjct: 100 ----RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 149
Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           L G   E     +  E +   SL   +   + Q  L   +    +     GL YLH  SR
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR 204
Query: 616 LRIIHRDLKASNILLDDD-LNPKISDFGLA 644
            RI+H D+KA N+LL  D  +  + DFG A
Sbjct: 205 -RILHGDVKADNVLLSSDGSHAALCDFGHA 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 438 TFFAWRWFAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNF 497
           T  A  W A+    +E S     + G       TEK+ P   +       EE+  AT+  
Sbjct: 30  TSLAKTWAARGSRSREPSPKTEDNEG----VLLTEKLKPVDYE-----YREEVHWATHQL 80
Query: 498 QLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRL 556
               +LG+G FG V++ +  Q G + AVK++     + +E     +M  + L    +V L
Sbjct: 81  ----RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE-----LMACAGLTSPRIVPL 131
Query: 557 LGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRL 616
            G   E     +  E +   SL   +   + Q  L   +    +     GL YLH  SR 
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR- 185
Query: 617 RIIHRDLKASNILLDDD-LNPKISDFGLA 644
           RI+H D+KA N+LL  D  +  + DFG A
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHA 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 8/158 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
           + + ++ ++L   +G G FG     + +   E+   +  +   +  E    E++   +L+
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+VR     +      ++ EY     L   + +  R S  +   RF   + IS G+ Y
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-GVSY 129
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLAR 645
            H    +++ HRDLK  N LLD    P  KI DFG ++
Sbjct: 130 CH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 164

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 456 KVQRLDLGEA----YANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPV 511
           K++ L+L E        F T+K     L+D             ++F+  ++LG G  G V
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKD-------------DDFEKISELGAGNGGVV 49
Query: 512 YKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI 569
           +K   +    +  ++L     +   + + + E+ V+       +V   G      E  + 
Sbjct: 50  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109
Query: 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYLHRDSRLRIIHRDLKASN 627
            E+M   SLD  L    R      P++    +   + +GL YL    + +I+HRD+K SN
Sbjct: 110 MEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSN 162
Query: 628 ILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
           IL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 205

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHRN 552
           ++F+  ++LG G  G V+K   +    +  ++L     +   + + + E+ V+       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKGISRGLLYL 610
           +V   G      E  +  E+M   SLD  L    R      P++    +   + +GL YL
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYL 139
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFG--------LARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG        +A  F G +   + +RL GT
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 197

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 15/135 (11%)
Query: 519 GQEIAVKRLSKASGQGQEEFMNEVMVISNLQ---------HRNLVRLLGCCVEREENMLI 569
           G E AVK +   + +   E + EV   +  +         H +++ L+          L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL 629
           ++ M    L  +L +   +  L   +  +I++ +   + +LH ++   I+HRDLK  NIL
Sbjct: 179 FDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232
Query: 630 LDDDLNPKISDFGLA 644
           LDD++  ++SDFG +
Sbjct: 233 LDDNMQIRLSDFGFS 247

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L +L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+++D     K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEE--FMNEVMVISNLQHR 551
           N+ +   ++G G  G V+K + +  G  IAVK++ ++  + + +   M+  +V+ +    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 552 NLVRLLGCCVEREENMLIYEYMPN--KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            +V+  G  +   +  +  E M    + L   +  P  + +L       +   I + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYY 139
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           L    +  +IHRD+K SNILLD+    K+ DFG++
Sbjct: 140 LK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  +   +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY P   + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 194

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ----- 549
            ++L   LG+GGFG V+ G +L D  ++A+K + +    G     + V     +      
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 550 -----HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF---NIIK 601
                H  ++RLL     +E  ML+ E  P  + D F +  ++  L + P R     ++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN-PKISDFG 642
            I       H  SR  ++HRD+K  NIL+D      K+ DFG
Sbjct: 151 AIQ------HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFG 185

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCC 560
           LG+G    V     L   QE AVK + K  G  +     EV ++   Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
            E +   L++E M   S+ S +   +  + L+      +++ ++  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG---IAH 134
Query: 621 RDLKASNILLD--DDLNP-KISDFGL 643
           RDLK  NIL +  + ++P KI DFGL
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGL 160

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 41/187 (21%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQH 550
           N+F +   +G+GGFG VY  +  D G+  A+K L K      QG+   +NE +++S    
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---- 244
Query: 551 RNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFD-----------PQRQSLLDWPK 595
             LV    C    C      M    + P+K   SF+ D            Q     +   
Sbjct: 245 --LVSTGDCPFIVC------MSYAFHTPDKL--SFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
           RF   + I  GL ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+
Sbjct: 295 RFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 656 TKRLVGT 662
               VGT
Sbjct: 351 ----VGT 353

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 41/187 (21%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQH 550
           N+F +   +G+GGFG VY  +  D G+  A+K L K      QG+   +NE +++S    
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---- 244
Query: 551 RNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFD-----------PQRQSLLDWPK 595
             LV    C    C      M    + P+K   SF+ D            Q     +   
Sbjct: 245 --LVSTGDCPFIVC------MSYAFHTPDKL--SFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
           RF   + I  GL ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+
Sbjct: 295 RFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 656 TKRLVGT 662
               VGT
Sbjct: 351 ----VGT 353

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 41/187 (21%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQH 550
           N+F +   +G+GGFG VY  +  D G+  A+K L K      QG+   +NE +++S    
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---- 244
Query: 551 RNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFD-----------PQRQSLLDWPK 595
             LV    C    C      M    + P+K   SF+ D            Q     +   
Sbjct: 245 --LVSTGDCPFIVC------MSYAFHTPDKL--SFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
           RF   + I  GL ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+
Sbjct: 295 RFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 656 TKRLVGT 662
               VGT
Sbjct: 351 ----VGT 353

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 41/187 (21%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQH 550
           N+F +   +G+GGFG VY  +  D G+  A+K L K      QG+   +NE +++S    
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---- 243
Query: 551 RNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFD-----------PQRQSLLDWPK 595
             LV    C    C      M    + P+K   SF+ D            Q     +   
Sbjct: 244 --LVSTGDCPFIVC------MSYAFHTPDKL--SFILDLMNGGDLHYHLSQHGVFSEADM 293
Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
           RF   + I  GL ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+
Sbjct: 294 RFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 349
Query: 656 TKRLVGT 662
               VGT
Sbjct: 350 ----VGT 352

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 18/154 (11%)
Query: 503 LGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHRNLVRLLGCCV 561
           +G G FG V++ KL +  E+A+K++ +      + F N E+ ++  ++H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 562 ----EREENM--LIYEYMPNKSLD-SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
               +++E    L+ EY+P      S  +   +Q++     +  + + + R L Y+H   
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAYIH--- 158
Query: 615 RLRIIHRDLKASNILLDDDLNP-KISDFGLARIF 647
            + I HRD+K  N+LLD      K+ DFG A+I 
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQ 549
           ++ ++L   LG GG   V+  + L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 550 HRNLVRLLGCC-VEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKR-FNIIKGIS 604
           H  +V +      E     L Y   EY+   +L   +      +    PKR   +I    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT----PKRAIEVIADAC 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA-TKRLVGT 662
           + L + H++    IIHRD+K +NIL+      K+ DFG+AR    + +    T  ++GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIA----VKRLSKASGQGQEEFMNEVMVI 545
           + + ++ ++L   +G G FG     + +   E+     ++R  K +   + E +N     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH---- 69
Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
            +L+H N+VR     +      ++ EY     L   + +  R S  +   RF   + IS 
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS- 126
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLAR 645
           G+ Y H    +++ HRDLK  N LLD    P  KI DFG ++
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 165

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F+    LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 13/173 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----Q 549
            +F     LG+G FG V   + +   E+   ++ K     Q++ +   MV   +     +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
              L +L  C    +    + EY+    L   ++  Q+      P        I+ GL +
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           L       II+RDLK  N++LD + + KI+DFG+ +      D   TK   GT
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGT 184

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQ 549
           ++ ++L   LG GG   V+  + L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 550 HRNLVRLLGCC-VEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKR-FNIIKGIS 604
           H  +V +      E     L Y   EY+   +L   +      +    PKR   +I    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT----PKRAIEVIADAC 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA-TKRLVGT 662
           + L + H++    IIHRD+K +NI++      K+ DFG+AR    + +    T  ++GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 521 EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN-KSLD 579
           E AVK + K+     EE     +++   QH N++ L     + +   L+ E M   + LD
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL-LDDDLNP-- 636
             L    RQ      +   ++  I + + YLH      ++HRDLK SNIL +D+  NP  
Sbjct: 111 KIL----RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPEC 163
Query: 637 -KISDFGLAR 645
            +I DFG A+
Sbjct: 164 LRICDFGFAK 173

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQ 549
           ++ ++L   LG GG   V+  + L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 550 HRNLVRLLGCC-VEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKR-FNIIKGIS 604
           H  +V +      E     L Y   EY+   +L   +      +    PKR   +I    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT----PKRAIEVIADAC 126
Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA-TKRLVGT 662
           + L + H++    IIHRD+K +NI++      K+ DFG+AR    + +    T  ++GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 8/158 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
           + + ++ +     +G G FG     + +  +E+   +  +      E    E++   +L+
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR 74
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+VR     +      +I EY     L   + +  R S  +   RF   + +S G+ Y
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS--EDEARFFFQQLLS-GVSY 131
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLAR 645
            H    ++I HRDLK  N LLD    P  KI DFG ++
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 13/173 (7%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-----Q 549
            +F     LG+G FG V   + +   E+   ++ K     Q++ +   MV   +     +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
              L +L  C    +    + EY+    L   ++  Q+      P        I+ GL +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           L       II+RDLK  N++LD + + KI+DFG+ +      D   TK   GT
Sbjct: 458 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGT 505

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 64  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 121
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 122 AVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D+    +++DFG A+   G
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG 180

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEEFMNEVMVIS 546
           L     ++ +   +G+G FG V   + +  Q++ A+K LSK     +    F  E   I 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 547 NLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD---PQRQSLLDWPKRFNIIKG 602
              +   V  L C  + ++ + ++ EYMP   L + + +   P++     W K +     
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT---- 180
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
            +  +L L     + +IHRD+K  N+LLD   + K++DFG
Sbjct: 181 -AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 521 EIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN-KSLD 579
           E AVK + K+     EE     +++   QH N++ L     + +   L+ E M   + LD
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 580 SFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL-LDDDLNP-- 636
             L    RQ      +   ++  I + + YLH      ++HRDLK SNIL +D+  NP  
Sbjct: 111 KIL----RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPEC 163
Query: 637 -KISDFGLAR 645
            +I DFG A+
Sbjct: 164 LRICDFGFAK 173

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 494 TNNFQLANKLGQGGFGPVYKGKLQDG--QEIAVKRLSKASGQGQEEFMNEVMVISNLQHR 551
           T+ +++   +G G +  V K  +      E AVK + K+     EE     +++   QH 
Sbjct: 21  TDGYEVKEDIGVGSYS-VCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHP 76
Query: 552 NLVRLLGCCVEREENMLIYEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           N++ L     + +   ++ E M   + LD  L    RQ      +   ++  I++ + YL
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYL 132
Query: 611 HRDSRLRIIHRDLKASNIL-LDDDLNP---KISDFGLAR 645
           H      ++HRDLK SNIL +D+  NP   +I DFG A+
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 84  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 141
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 142 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN---- 540
           + +E     + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N    
Sbjct: 22  HMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 81
Query: 541 --EVMVISNLQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR 596
             EV+++  +      ++RLL    ER ++ ++    P    D F F  +R +L +   R
Sbjct: 82  PMEVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 140
Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            +    +   + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 141 -SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 183

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 72/172 (41%), Gaps = 15/172 (8%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    L +I+RDLK  N+L+D     +++DFG A+   G     AT  L GT
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGT 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 62/218 (28%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRN 552
            +F+    +G+GGFG V++ K + D    A+KR+   + +  +E+ M EV  ++ L+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 553 LVRLLGCCVE------REENMLIY-------------EYMPNKSLDSFLFDP-------- 585
           +VR     +E      +EE   I+               M   S+     DP        
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 586 ------------------QRQSLLDWPKR------------FNIIKGISRGLLYLHRDSR 615
                             ++++L DW  R             +I   I+  + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
             ++HRDLK SNI    D   K+ DFGL      ++++
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 64  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 121
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 83  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 140
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 141 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 67  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 124
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 125 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 159

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 64  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 121
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 83  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 140
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 141 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 86/180 (47%), Gaps = 12/180 (6%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMV 544
           F+ ++     + +  ++G GG   V++   +  Q  A+K   L +A  Q  + + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 545 ISNLQHRN--LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
           ++ LQ  +  ++RL    +  +   ++ E   N  L+S+L   +++S+  W +R +  K 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL--KKKKSIDPW-ERKSYWKN 135
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +   +  +H+     I+H DLK +N L+ D +  K+ DFG+A     +         VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 191

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 84  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 141
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 142 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 84  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 141
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 142 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 69  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 126
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 127 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 69  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 126
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 127 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 8/158 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
           + + ++ ++L   +G G FG     + +   E+   +  +   +  E    E++   +L+
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+VR     +      ++ EY     L   + +  R S  +   RF   + IS G+ Y
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-GVSY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLAR 645
            H    +++ HRDLK  N LLD    P  KI  FG ++
Sbjct: 131 CH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 97  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 155 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 8/158 (5%)
Query: 490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
           + + ++ ++L   +G G FG     + +   E+   +  +   +  E    E++   +L+
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+VR     +      ++ EY     L   + +  R S  +   RF   + IS G+ Y
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARFFFQQLIS-GVSY 130
Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLAR 645
            H    +++ HRDLK  N LLD    P  KI  FG ++
Sbjct: 131 CH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 97  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 155 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 69  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 126
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 127 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 96  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 154 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 68  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 125
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 126 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 97  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 155 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 103 VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 160
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 161 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 195

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 96  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 154 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 96  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 154 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 97  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 155 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 86/180 (47%), Gaps = 12/180 (6%)
Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMV 544
           F+ ++     + +  ++G GG   V++   +  Q  A+K   L +A  Q  + + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 545 ISNLQHRN--LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
           ++ LQ  +  ++RL    +  +   ++ E   N  L+S+L   +++S+  W +R +  K 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL--KKKKSIDPW-ERKSYWKN 135
Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +   +  +H+     I+H DLK +N L+ D +  K+ DFG+A     +         VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGT 191

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 96  VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 154 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 111 VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 168
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 169 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 25/177 (14%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEF--MNEVMVISNLQHR 551
           + FQ+    GQG FG V  GK +  G  +A+K++ +       E   M ++ V   L H 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAV---LHHP 79
Query: 552 NLVRL------LGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-----RFNI 599
           N+V+L      LG    R+  + ++ EY+P+ +L     +  R+ +   P       F +
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGNQDQAA 655
           I+ I  G L+L     + + HRD+K  N+L+++ D   K+ DFG A+    ++   A
Sbjct: 139 IRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 111 VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 168
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 169 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 495 NNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMN------EVMVISN 547
           + +Q+   LG GGFG VY G ++ D   +A+K + K       E  N      EV+++  
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 548 LQH--RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL    ER ++ ++    P    D F F  +R +L +   R +    +  
Sbjct: 116 VSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLE 173
Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFG 642
            + + H      ++HRD+K  NIL+D +    K+ DFG
Sbjct: 174 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 208

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K ++ G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L   +R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG 649
           H    L +I+RDLK  N+L+D     +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 11/146 (7%)
Query: 503 LGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCC 560
           LG+G    V     L   QE AVK + K  G  +     EV ++   Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
            E +   L++E M   S+ S +   +  + L+      +++ ++  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG---IAH 134
Query: 621 RDLKASNILLD--DDLNP-KISDFGL 643
           RDLK  NIL +  + ++P KI DF L
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDL 160

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	662
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-99
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-86
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-67
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-43
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-25
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-14
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	9e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-13
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	7e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-11
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	2e-11
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-11
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	8e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	4e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	2e-09
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	2e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-07
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	4e-07
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	4e-06
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-07
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	9e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	3e-05
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	5e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  306 bits (786), Expect = 1e-99
 Identities = 76/192 (39%), Positives = 106/192 (55%), Gaps = 14/192 (7%)

Query: 481 DLLVFNFEELANATNNF------QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSK----A 530
               F+F EL N TNNF         NK+G+GGFG VYKG + +   +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
           + + +++F  E+ V++  QH NLV LLG   + ++  L+Y YMPN SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
           L W  R  I +G + G+ +LH +     IHRD+K++NILLD+    KISDFGLAR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 651 QDQAATKRLVGT 662
                T R+VGT
Sbjct: 187 AQTVMTSRIVGT 198

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  303 bits (779), Expect = 2e-98
 Identities = 86/181 (47%), Positives = 112/181 (61%), Gaps = 3/181 (1%)

Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE-EFMNEV 542
            F+  EL  A++NF   N LG+GGFG VYKG+L DG  +AVKRL +   QG E +F  EV
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIK 601
            +IS   HRNL+RL G C+   E +L+Y YM N S+ S L + P+ Q  LDWPKR  I  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           G +RGL YLH     +IIHRD+KA+NILLD++    + DFGLA++         T  + G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197

Query: 662 T 662
           T
Sbjct: 198 T 198

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  272 bits (697), Expect = 3e-86
 Identities = 74/179 (41%), Positives = 106/179 (59%), Gaps = 4/179 (2%)

Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMV 544
               +L  ATNNF     +G G FG VYKG L+DG ++A+KR +  S QG EEF  E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-LDWPKRFNIIKGI 603
           +S  +H +LV L+G C ER E +LIY+YM N +L   L+     ++ + W +R  I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +RGL YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++          +  + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  222 bits (567), Expect = 3e-67
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 17/189 (8%)

Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMV 544
              E L   +   QL     +G FG V+K +L   + +AVK       Q   +   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 545 ISNLQHRNLVRLLGCCVE----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           +  ++H N+++ +G          +  LI  +    SL  FL    + +++ W +  +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 601 KGISRGLLYLHRD-------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           + ++RGL YLH D        +  I HRD+K+ N+LL ++L   I+DFGLA  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 654 AATKRLVGT 662
             T   VGT
Sbjct: 188 GDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  202 bits (516), Expect = 9e-60
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 27/197 (13%)

Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--V 542
               E +   +N +L   +G+G +G VYKG L D + +AVK  S A+ Q    F+NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 543 MVISNLQHRNLVRLLGCCVEREEN-----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
             +  ++H N+ R +        +     +L+ EY PN SL  +L         DW    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 598 NIIKGISRGLLYLHRD------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN- 650
            +   ++RGL YLH +       +  I HRDL + N+L+ +D    ISDFGL+    GN 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 651 -----QDQAATKRLVGT 662
                ++  A    VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  172 bits (438), Expect = 6e-49
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 13/179 (7%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL--SKASGQGQEEFMNEVM 543
            + +L        +  K+G G FG V++ +   G ++AVK L       +   EF+ EV 
Sbjct: 35  PWCDL-------NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVA 86

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
           ++  L+H N+V  +G   +     ++ EY+   SL   L     +  LD  +R ++   +
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           ++G+ YLH      I+HR+LK+ N+L+D     K+ DFGL+R+        ++K   GT
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGT 202

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  171 bits (435), Expect = 2e-48
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 13/175 (7%)

Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVM 543
           F   +L            LG+G FG   K    + G+ + +K L +   + Q  F+ EV 
Sbjct: 7   FRPSDL-------IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
           V+  L+H N+++ +G   + +    I EY+   +L   +     Q    W +R +  K I
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDI 117

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           + G+ YLH    + IIHRDL + N L+ ++ N  ++DFGLAR+    + Q    R
Sbjct: 118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  163 bits (416), Expect = 3e-46
 Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 14/166 (8%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL--SKASGQGQEEFMNEVM 543
           +F++L           KL +   G ++KG+ Q G +I VK L     S +   +F  E  
Sbjct: 8   DFKQL-------NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECP 59

Query: 544 VISNLQHRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
            +    H N++ +LG C         LI  +MP  SL + L +     ++D  +      
Sbjct: 60  RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFAL 118

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            ++RG+ +LH    L I    L + ++++D+D+  +IS   +   F
Sbjct: 119 DMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  164 bits (418), Expect = 4e-46
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 6/153 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              ++   +G+G FG V K K +  +++A+K++   S   ++ F+ E+  +S + H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+      L+ EY    SL + L   +           +     S+G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 615 RLRIIHRDLKASNILLDDDLN-PKISDFGLARI 646
              +IHRDLK  N+LL       KI DFG A  
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  160 bits (406), Expect = 8e-45
 Identities = 56/189 (29%), Positives = 83/189 (43%), Gaps = 28/189 (14%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL----SKASGQGQEEFMNE 541
           +F EL        L   +G GGFG VY+     G E+AVK       +   Q  E    E
Sbjct: 5   DFAEL-------TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQE 56

Query: 542 VMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIK 601
             + + L+H N++ L G C++     L+ E+     L+  L   +    +      N   
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAV 112

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP--------KISDFGLARIFGGNQDQ 653
            I+RG+ YLH ++ + IIHRDLK+SNIL+   +          KI+DFGLAR       +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHR 168

Query: 654 AATKRLVGT 662
                  G 
Sbjct: 169 TTKMSAAGA 177

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  160 bits (407), Expect = 9e-45
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 30/201 (14%)

Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ 533
           +      L      E+       +   ++G+GGFG V+KG+L  D   +A+K L     +
Sbjct: 6   SEFPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE 58

Query: 534 GQ-------EEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQ 586
           G+       +EF  EV ++SNL H N+V+L G         ++ E++P   L   L D  
Sbjct: 59  GETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA 116

Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-----DDLNPKISDF 641
               + W  +  ++  I+ G+ Y+  +    I+HRDL++ NI L        +  K++DF
Sbjct: 117 HP--IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 642 GLARIFGGNQDQAATKRLVGT 662
           GL++         +   L+G 
Sbjct: 174 GLSQQ-----SVHSVSGLLGN 189

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  157 bits (400), Expect = 9e-44
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 19/180 (10%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVM 543
              ++        +  ++G G FG VYKGK     ++AVK L+    + Q  + F NEV 
Sbjct: 22  PDGQI-------TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVG 72

Query: 544 VISNLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
           V+   +H N++  +G        + ++ ++    SL   L   + +   +  K  +I + 
Sbjct: 73  VLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQ 128

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            +RG+ YLH      IIHRDLK++NI L +D   KI DFGLA            ++L G+
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  155 bits (395), Expect = 7e-43
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 21/178 (11%)

Query: 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRNLVR 555
            L   +G+G +G V++G  Q G+ +AVK  S    + ++ +  E  +     L+H N++ 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILG 66

Query: 556 LLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
            +   +    +     LI  Y    SL  +L    + + LD      I+  I+ GL +LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLH 122

Query: 612 RDSRLR-----IIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQDQAATKRLVGT 662
            +         I HRDLK+ NIL+  +    I+D GLA +     NQ        VGT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  156 bits (395), Expect = 1e-42
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 21/178 (11%)

Query: 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRNLVR 555
           Q+  ++G+G +G V+ GK + G+++AVK         +  +  E  +     ++H N++ 
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILG 95

Query: 556 LLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
            +   ++   +     LI +Y  N SL  +L    + + LD      +      GL +LH
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLH 151

Query: 612 RDSRLR-----IIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQDQAATKRLVGT 662
            +         I HRDLK+ NIL+  +    I+D GLA  F    N+        VGT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  152 bits (386), Expect = 2e-41
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 18/204 (8%)

Query: 460 LDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDG 519
           L L  A +           LQ+  +  FE+L       ++   +G+G FG VY G+    
Sbjct: 6   LSLLSARSFPRKASQTSIFLQEWDI-PFEQL-------EIGELIGKGRFGQVYHGRWH-- 55

Query: 520 QEIAVKRL--SKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577
            E+A++ +   + +    + F  EVM     +H N+V  +G C+      +I      ++
Sbjct: 56  GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115

Query: 578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK 637
           L S + D +    LD  K   I + I +G+ YLH      I+H+DLK+ N+  D+     
Sbjct: 116 LYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVV 169

Query: 638 ISDFGLARIFGGNQDQAATKRLVG 661
           I+DFGL  I G  Q      +L  
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRI 193

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  150 bits (381), Expect = 1e-40
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 21/178 (11%)

Query: 498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRNLVR 555
            L   +G+G FG V++GK + G+E+AVK  S    + +  +  E  +     L+H N++ 
Sbjct: 45  VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILG 100

Query: 556 LLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
            +    +         L+ +Y  + SL  +L     +  +       +    + GL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLH 156

Query: 612 RD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIF--GGNQDQAATKRLVGT 662
            +      +  I HRDLK+ NIL+  +    I+D GLA       +    A    VGT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  149 bits (378), Expect = 9e-40
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 7/154 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRL-SKASGQGQEEFMNEVMVISNLQHRN 552
            +  L  ++G+G FG V+ G+L+ D   +AVK          + +F+ E  ++    H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +VRL+G C +++   ++ E +      +FL      + L       ++   + G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE- 230

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
                 IHRDL A N L+ +    KISDFG++R 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  145 bits (367), Expect = 2e-39
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 6/157 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + +     +E+F+ E  V+  L H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L+ E+M +  L  +L    ++ L        +   +  G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
              +IHRDL A N L+ ++   K+SDFG+ R    +Q
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  146 bits (371), Expect = 2e-39
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 12/165 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
            + +   +LG+G FG V   +        G+ +AVK+L  ++ +   +F  E+ ++ +LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           H N+V+  G C         LI EY+P  SL  +L   + +  +D  K       I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            YL      R IHRDL   NIL++++   KI DFGL ++   +++
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  145 bits (368), Expect = 3e-39
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 12/165 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
            + +   +LG+G FG V   +        G+ +AVK+L  ++ +   +F  E+ ++ +LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           H N+V+  G C         LI EY+P  SL  +L   + +  +D  K       I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            YL      R IHRDL   NIL++++   KI DFGL ++   +++
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  145 bits (368), Expect = 4e-39
 Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 22/170 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL 548
            +  L  +LG+G FG V+  +       +D   +AVK L   +   +++F  E  +++NL
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLLDWPK 595
           QH ++V+  G C + +  ++++EYM +  L+ FL                Q +  L   +
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +I   I+ G++YL   +    +HRDL   N L+  +L  KI DFG++R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  144 bits (365), Expect = 4e-39
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 6/157 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
               L  +LG G FG V  GK +   ++AVK + K     ++EF  E   +  L H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +  G C +     ++ EY+ N  L ++L        L+  +   +   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
             + IHRDL A N L+D DL  K+SDFG+ R    +Q
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  144 bits (366), Expect = 5e-39
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 6/157 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + K     ++EF+ E  V+ NL H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C ++    +I EYM N  L ++L + + +      +   + K +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYL---E 137

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
             + +HRDL A N L++D    K+SDFGL+R    ++
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  144 bits (366), Expect = 5e-39
 Identities = 53/164 (32%), Positives = 82/164 (50%), Gaps = 6/164 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG-QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V+  ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V+LLG C       +I E+M   +L  +L +  RQ  +       +   IS  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL--- 127

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            +   IHRDL A N L+ ++   K++DFGL+R+  G+   A   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  145 bits (368), Expect = 7e-39
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 21/169 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRLSKASGQGQEEFMNEVMVISNL 548
            +  L  +LG+G FG V+  +  +         +AVK L +AS   +++F  E  +++ L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL------------FDPQRQSLLDWPKR 596
           QH+++VR  G C E    ++++EYM +  L+ FL             +      L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +   ++ G++YL   + L  +HRDL   N L+   L  KI DFG++R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  144 bits (366), Expect = 8e-39
 Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 15/166 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL---QDGQEI--AVKRL-SKASGQGQEEFMNEVMVISNL 548
              +    LG+G FG V         DG     AVK L + A  Q +  +  E+ ++  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 549 QHRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
            H ++++  GCC +       L+ EY+P  SL  +L     +  +   +     + I  G
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           + YLH       IHRDL A N+LLD+D   KI DFGLA+      +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  144 bits (366), Expect = 1e-38
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 12/165 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
            + +  ++LG+G FG V   +        G  +AVK+L  +    Q +F  E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 550 HRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
              +V+  G           L+ EY+P+  L  FL   + ++ LD  +       I +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            YL      R +HRDL A NIL++ + + KI+DFGLA++   ++D
Sbjct: 141 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  144 bits (366), Expect = 1e-38
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 20/168 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
             F+    LG G FG VYKG      E     +A+K L +A+     +E ++E  V++++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ----SLLDWPKRFNIIKGIS 604
            + ++ RLLG C+      LI + MP   L  ++ + +       LL+W         I+
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           +G+ YL      R++HRDL A N+L+    + KI+DFGLA++ G  + 
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  143 bits (363), Expect = 1e-38
 Identities = 57/171 (33%), Positives = 85/171 (49%), Gaps = 23/171 (13%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
           +  +   +LG+  FG VYKG L         Q +A+K L   A G  +EEF +E M+ + 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLLDWP 594
           LQH N+V LLG   + +   +I+ Y  +  L  FL              D   +S L+ P
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
              +++  I+ G+ YL   S   ++H+DL   N+L+ D LN KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  143 bits (364), Expect = 1e-38
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 13/166 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRL-SKASGQGQEEFMNEVMVISNL 548
              +    LG+G FG V   +        G+++AVK L  ++ G    +   E+ ++ NL
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 549 QHRNLVRLLGCCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
            H N+V+  G C E   N   LI E++P+ SL  +L  P+ ++ ++  ++      I +G
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           + YL      + +HRDL A N+L++ +   KI DFGL +    +++
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  144 bits (365), Expect = 2e-38
 Identities = 52/169 (30%), Positives = 89/169 (52%), Gaps = 10/169 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRL-SKASGQGQEEFMNEVMVISNLQ 549
           +   +   +G G  G V  G+L+    +++  A+K L +  + + + +F++E  ++    
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++RL G        M++ EYM N SLD+FL     Q      +   +++G+  G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           L   S L  +HRDL A N+L+D +L  K+SDFGL+R+   + D A T  
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  142 bits (360), Expect = 2e-38
 Identities = 57/157 (36%), Positives = 82/157 (52%), Gaps = 6/157 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L K      + F+ E  ++  LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL     + E   +I EYM N SL  FL  P    L    K  ++   I+ G+ ++    
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---E 126

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  147 bits (372), Expect = 4e-38
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 6/164 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +  + +KLG G +G VY+G  +     +AVK L K      EEF+ E  V+  ++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V+LLG C       +I E+M   +L  +L +  RQ  +       +   IS  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL--- 334

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            +   IHR+L A N L+ ++   K++DFGL+R+  G+   A   
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (358), Expect = 4e-38
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 8/152 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V++ L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 77

Query: 555 RLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +LLG  VE +    ++ EYM   SL  +L    R  L            +   + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 133

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +HRDL A N+L+ +D   K+SDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  141 bits (358), Expect = 6e-38
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 21/167 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASGQGQEEFMNEVMVIS 546
            +      LGQG F  ++KG  ++          E+ +K L KA     E F     ++S
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 547 NLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
            L H++LV   G CV  +EN+L+ E++   SLD++L   +    ++   +  + K ++  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLAAA 125

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNP--------KISDFGLAR 645
           + +L       +IH ++ A NILL  + +         K+SD G++ 
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  145 bits (368), Expect = 8e-38
 Identities = 54/162 (33%), Positives = 79/162 (48%), Gaps = 6/162 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLG G FG V+        ++AVK + K      E F+ E  V+  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L     + E   +I E+M   SL  FL   +       PK  +    I+ G+ ++    
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---E 301

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           +   IHRDL+A+NIL+   L  KI+DFGLAR+   N+  A  
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  143 bits (362), Expect = 9e-38
 Identities = 57/169 (33%), Positives = 91/169 (53%), Gaps = 10/169 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQ 549
            N  +   +G G FG V  G+L+    +EI  A+K L    + + + +F+ E  ++    
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++RL G   + +  M++ EYM N SLDSFL     Q      +   +++GI+ G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKY 162

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           L   S +  +HRDL A NIL++ +L  K+SDFGL R+   + + A T R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  142 bits (360), Expect = 1e-37
 Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 11/170 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSK-ASGQGQEEFMNEVMVISNL 548
           +       +G G FG VYKG L+         +A+K L    + + + +F+ E  ++   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H N++RL G   + +  M+I EYM N +LD FL +   +      +   +++GI+ G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 161

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR 658
           YL   + +  +HRDL A NIL++ +L  K+SDFGL+R+   + +   T  
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  144 bits (366), Expect = 1e-37
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 8/152 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V++ L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 555 RLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +LLG  VE +    ++ EYM   SL  +L    R  L            +   + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 305

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                +HRDL A N+L+ +D   K+SDFGL +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (354), Expect = 5e-37
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 20/172 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
              +    LG G FG V+KG      E     + +K +   SG+   +   + ++ I +L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ----SLLDWPKRFNIIKGIS 604
            H ++VRLLG C       L+ +Y+P  SL   +   +       LL+W         I+
Sbjct: 73  DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIA 125

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           +G+ YL       ++HR+L A N+LL      +++DFG+A +   +  Q   
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (351), Expect = 5e-37
 Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 21/170 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKG--KLQDGQEI--AVKRL---SKASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G      G+ +  AVK L     +  +  ++F+ EV  + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ----SLLDWPKRFNIIKGI 603
           L HRNL+RL G  +      ++ E  P  SL   L   Q      +L  +         +
Sbjct: 78  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQV 130

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           + G+ YL      R IHRDL A N+LL      KI DFGL R    N D 
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  139 bits (353), Expect = 6e-37
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 12/168 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
             F+    LG G FG VYKG      E     +A+K L +A+     +E ++E  V++++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            + ++ RLLG C+      LI + MP   L  ++ + +    +      N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           YL      R++HRDL A N+L+    + KI+DFGLA++ G  + +   
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (351), Expect = 7e-37
 Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 11/154 (7%)

Query: 498 QLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
                +G+G FG VY G+  D  +     A+K LS+    Q  E F+ E +++  L H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 553 LVRLLGCCVEREE-NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++ L+G  +  E    ++  YM +  L  F+  PQR          +    ++RG+ YL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL- 140

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  139 bits (352), Expect = 7e-37
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 17/165 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRLSK-ASGQGQEEFMNEVMVISN 547
               ++ +LGQG FG VY+G  +   +      +A+K +++ AS + + EF+NE  V+  
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNII 600
               ++VRLLG   + +  ++I E M    L S+L        +    +     K   + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             I+ G+ YL   +  + +HRDL A N ++ +D   KI DFG+ R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (359), Expect = 1e-36
 Identities = 56/166 (33%), Positives = 85/166 (51%), Gaps = 6/166 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L     E E   ++ EYM   SL  FL     + L   P+  ++   I+ G+ Y+    
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYV---E 297

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
           R+  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A      
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  138 bits (351), Expect = 1e-36
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 21/169 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE---IAVKRL-SKASGQGQEEFMNEVMVISNL-Q 549
           N+ +  + +G+G FG V K +++        A+KR+   AS     +F  E+ V+  L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------FDPQRQSLLDWPKRFNIIK- 601
           H N++ LLG C  R    L  EY P+ +L  FL        DP            +  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 602 -----GISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 ++RG+ YL   S+ + IHRDL A NIL+ ++   KI+DFGL+R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (362), Expect = 1e-36
 Identities = 56/166 (33%), Positives = 85/166 (51%), Gaps = 6/166 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+  L+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L     E E   ++ EYM   SL  FL     + L   P+  ++   I+ G+ Y+    
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYV---E 380

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
           R+  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A      
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (349), Expect = 1e-36
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 11/154 (7%)

Query: 498 QLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
                +G+G FG VY G L D        AVK L++        +F+ E +++ +  H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 553 LVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++ LLG C+  E + +++  YM +  L +F+ +                  +++G+ YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL- 144

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (349), Expect = 2e-36
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 17/165 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE----IAVKRLSK--ASGQGQEEFMNEVMVISNL 548
           N   L   LG+G FG V +G L+        +AVK +    +S +  EEF++E   + + 
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 549 QHRNLVRLLGCCVERE-----ENMLIYEYMPNKSLDSFL---FDPQRQSLLDWPKRFNII 600
            H N++RLLG C+E       + M+I  +M    L ++L           +        +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             I+ G+ YL   S    +HRDL A N +L DD+   ++DFGL++
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (349), Expect = 3e-36
 Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 17/165 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL      P + S L      ++ + I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL        IHRD+ A N LL         KI DFG+AR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  136 bits (345), Expect = 3e-36
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 10/155 (6%)

Query: 502 KLGQGGFGPVYKGKLQDGQE---IAVKRLSK-ASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           +LG G FG V +G  +  ++   +A+K L +       EE M E  ++  L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           G C + E  ML+ E      L  FL   + +  +       ++  +S G+ YL       
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            +HRDL A N+LL +    KISDFGL++  G +  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (344), Expect = 4e-36
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 11/162 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQ 549
            +  L   LG+G FG VY+G      G++I  AVK   K  +   +E+FM+E +++ NL 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E E   +I E  P   L  +L   +    L           I + + Y
Sbjct: 72  HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAY 128

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
           L     +  +HRD+   NIL+      K+ DFGL+R      
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (343), Expect = 6e-36
 Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 11/157 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEI--AVKRLSK-ASGQGQEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +   +  A+K      S   +E+F+ E + +    
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G         +I E      L SFL   +    LD          +S  L Y
Sbjct: 75  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 131

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
           L      R +HRD+ A N+L+  +   K+ DFGL+R 
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  137 bits (347), Expect = 6e-36
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 31/179 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           NN +    +G+G FG V++ +            +AVK L  +AS   Q +F  E  +++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------------FDPQ 586
             + N+V+LLG C   +   L++EYM    L+ FL                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
               L   ++  I + ++ G+ YL   S  + +HRDL   N L+ +++  KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (348), Expect = 7e-36
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 11/154 (7%)

Query: 498 QLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSK-ASGQGQEEFMNEVMVISNLQHRN 552
                +G+G FG VY G L D        AVK L++        +F+ E +++ +  H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 553 LVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           ++ LLG C+  E + +++  YM +  L +F+ +                  +++G+ +L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL- 208

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  137 bits (347), Expect = 1e-35
 Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 17/165 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
            N  L   LG G FG VY+G++          ++AVK L +  S Q + +F+ E ++IS 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL----FDPQRQSLLDWPKRFNIIKGI 603
             H+N+VR +G  ++     ++ E M    L SFL      P + S L      ++ + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLAR 645
           + G  YL        IHRD+ A N LL         KI DFG+AR
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (343), Expect = 1e-35
 Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 18/166 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG----QEIAVKRLSK--ASGQGQEEFMNEVMVISNL 548
             F L   LG+G FG V + +L+       ++AVK L     +    EEF+ E   +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 549 QHRNLVRLLGCCVEREEN------MLIYEYMPNKSLDSFLFD---PQRQSLLDWPKRFNI 599
            H ++ +L+G  +           M+I  +M +  L +FL      +    L        
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +  I+ G+ YL   S    IHRDL A N +L +D+   ++DFGL+R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  134 bits (340), Expect = 2e-35
 Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 13/164 (7%)

Query: 495 NNFQLANK-LGQGGFGPVYKGKLQDG---QEIAVKRLSKA--SGQGQEEFMNEVMVISNL 548
               L +K LG G FG V KG  Q     + +AVK L         ++E + E  V+  L
Sbjct: 16  KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            +  +VR++G C E E  ML+ E      L+ +L   Q+   +       ++  +S G+ 
Sbjct: 76  DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMK 131

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           YL        +HRDL A N+LL      KISDFGL++    +++
Sbjct: 132 YL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  135 bits (342), Expect = 3e-35
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 22/170 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRL-SKASGQGQEEFMNEVMVISN 547
           NN Q    LG G FG V +       +      +AVK L S A    +E  M+E+ ++S+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDWPK 595
           L QH N+V LLG C      ++I EY     L +FL                 S      
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             +    +++G+ +L   +    IHRD+ A N+LL +    KI DFGLAR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (338), Expect = 6e-35
 Identities = 52/179 (29%), Positives = 76/179 (42%), Gaps = 31/179 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG------QEIAVKRL-SKASGQGQEEFMNEVMVISN 547
            N  L   LG+G FG V K              +AVK L   AS     + ++E  V+  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG--- 602
           + H ++++L G C +    +LI EY    SL  FL +        L      N       
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 603 ----------------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                           IS+G+ YL   + ++++HRDL A NIL+ +    KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  134 bits (339), Expect = 7e-35
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 26/174 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V   +              +AVK L   A+ +   + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  134 bits (340), Expect = 8e-35
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 26/174 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V   +              +AVK L   A+ +   + ++E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L              +   +  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +    +    ++RG+ YL   +  + IHRDL A N+L+ ++   KI+DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  133 bits (336), Expect = 1e-34
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 25/173 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           +  +L   LG+G FG V +            + +AVK L   A+       M+E+ ++ +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 548 L-QHRNLVRLLGCCVEREE-NMLIYEYMPNKSLDSFL-------------FDPQRQSLLD 592
           +  H N+V LLG C +     M+I E+    +L ++L              +   +  L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                     +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  132 bits (335), Expect = 2e-34
 Identities = 53/174 (30%), Positives = 72/174 (41%), Gaps = 26/174 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRL-SKASGQGQEEFMNEVMVISN 547
           N       LG G FG V +       +      +AVK L   A    +E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL---------------FDPQRQSLL 591
           L  H N+V LLG C      ++I EY     L +FL                    +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           D     +    +++G+ +L   +    IHRDL A NILL      KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (344), Expect = 5e-34
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 10/155 (6%)

Query: 502 KLGQGGFGPVYKGKLQDGQE---IAVKRL-SKASGQGQEEFMNEVMVISNLQHRNLVRLL 557
           +LG G FG V +G  +  ++   +A+K L         EE M E  ++  L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 558 GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR 617
           G C + E  ML+ E      L  FL   + +  +       ++  +S G+ YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
            +HR+L A N+LL +    KISDFGL++  G +  
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  131 bits (331), Expect = 2e-33
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 26/174 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRL-SKASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V   +             ++AVK L S A+ +   + ++E+ ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLL 591
             + +H+N++ LLG C +     +I EY    +L  +L                  +  L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                 +    ++RG+ YL   +  + IHRDL A N+L+ +D   KI+DFGLAR
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (328), Expect = 3e-33
 Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 31/179 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE------IAVKRL-SKASGQGQEEFMNEVMVISN 547
            N +    LG G FG V         +      +AVK L  KA    +E  M+E+ +++ 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----------FDPQRQSLLDWPK 595
           L  H N+V LLG C       LI+EY     L ++L            + + Q  L+  +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 596 RFNIIKG---------ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
             N++           +++G+ +L        +HRDL A N+L+      KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  134 bits (339), Expect = 3e-33
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 14/172 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKG--KLQDGQEI--AVKRL-SKASGQGQEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G     +   +  A+K   +  S   +E+F+ E + +    
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G         +I E      L SFL    R+  LD          +S  L Y
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
           L      R +HRD+ A N+L+  +   K+ DFGL+R     +D    K   G
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKG 552

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  129 bits (327), Expect = 3e-33
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 9/171 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
             +    K+G+G FG     K  +DG++  +K   +S+ S + +EE   EV V++N++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V+      E     ++ +Y     L   + + Q+  L    +  +    I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
                +I+HRD+K+ NI L  D   ++ DFG+AR+     + A     +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  127 bits (321), Expect = 9e-33
 Identities = 41/173 (23%), Positives = 80/173 (46%), Gaps = 10/173 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL---SKASGQGQEEFMNEVMVISNLQH 550
            NF++  K+G+G F  VY+   L DG  +A+K++        + + + + E+ ++  L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-FDPQRQSLLDWPKRFNIIKGISRGLLY 609
            N+++     +E  E  ++ E      L   +    +++ L+     +     +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +H     R++HRD+K +N+ +      K+ D GL R F      A +  LVGT
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  126 bits (318), Expect = 1e-32
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 28/185 (15%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +F+    +G GGFG V+K K   DG+   +KR+   +    E+   EV  ++ L H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 554 VRLLGCCVEREENM----------------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           V   GC    + +                 +  E+    +L+ ++ + +R   LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            + + I++G+ Y+H     ++I+RDLK SNI L D    KI DFGL      N  +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR- 180

Query: 658 RLVGT 662
              GT
Sbjct: 181 -SKGT 184

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  126 bits (318), Expect = 2e-32
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 24/180 (13%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
            ++F+    LGQG FG V K +   D +  A+K++     +     ++EVM++++L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 553 LVRLLGCCVEREENML----------IY---EYMPNKSLDSFLFD--PQRQSLLDWPKRF 597
           +VR     +ER   +           ++   EY  N +L    +D            + +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK 657
            + + I   L Y+H      IIHRDLK  NI +D+  N KI DFGLA+    + D     
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  126 bits (319), Expect = 2e-32
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 9/171 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           ++    KLG+GGF  V   + L DG   A+KR+     Q +EE   E  +     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 555 RLLGCCVEREENM----LIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLY 609
           RL+  C+          L+  +    +L + +     + + L   +   ++ GI RGL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
           +H        HRDLK +NILL D+  P + D G       + + +     +
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  125 bits (316), Expect = 3e-32
 Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 17/176 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRN 552
            +F+    LG+GGFG V++ K   D    A+KR+        +E+ M EV  ++ L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 553 LVRLLGCCVEREE---------NMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
           +VR     +E+            + +Y   +    ++L  ++         +     +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
             I+  + +LH      ++HRDLK SNI    D   K+ DFGL      ++++   
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (315), Expect = 4e-32
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 7/162 (4%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV 561
           LG+G +G VY G+ L +   IA+K + +   +  +    E+ +  +L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR 621
           E     +  E +P  SL + L         +        K I  GL YLH +   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 622 DLKASNILLDDDL-NPKISDFGLARIFGGNQDQAATKRLVGT 662
           D+K  N+L++      KISDFG ++   G      T    GT
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (311), Expect = 1e-31
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 10/176 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHR 551
            ++++   +G G +G   K +   DG+ +  K       +   ++  ++EV ++  L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 552 NLVRLLGCCVEREENML--IYEYMPNKSLDSFL-FDPQRQSLLDWPKRFNIIKGISRGLL 608
           N+VR     ++R    L  + EY     L S +    + +  LD      ++  ++  L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 609 YLH--RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             H   D    ++HRDLK +N+ LD   N K+ DFGLARI   +   A T   VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  122 bits (308), Expect = 4e-31
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 16/174 (9%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRNL 553
            +   ++G+G F  VYKG   +   E+A    +  K +   ++ F  E  ++  LQH N+
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 554 VRLLGCCV---EREENMLIY-EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           VR         + ++ +++  E M + +L ++L   +R  ++      +  + I +GL +
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQF 144

Query: 610 LHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH      IIHRDLK  NI +     + KI D GLA +   +      K ++GT
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 193

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  121 bits (306), Expect = 1e-30
 Identities = 42/180 (23%), Positives = 83/180 (46%), Gaps = 12/180 (6%)

Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMV 544
           F+ ++     + +  ++G GG   V++   +  Q  A+K   L +A  Q  + + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 545 ISNLQHRNL--VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
           ++ LQ  +   +RL    +  +   ++ E   N  L+S+L   +++  +D  +R +  K 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 135

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +   +  +H   +  I+H DLK +N L+ D    K+ DFG+A     +         VGT
Sbjct: 136 MLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (306), Expect = 1e-30
 Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 16/180 (8%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQ 549
            + + + L++ LGQG    V++G+  + G   A+K  +  S     +  M E  V+  L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 550 HRNLVRLLGCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           H+N+V+L     E           E+ P  SL + L +P     L   +   +++ +  G
Sbjct: 66  HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 607 LLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           + +L       I+HR++K  NI+     D     K++DFG AR    ++ Q  +  L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (301), Expect = 5e-30
 Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 14/169 (8%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
                K+G+G  G V   +    G+++AVK +     Q +E   NEV+++ + QH N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           +    +  EE  ++ E++   +L     D   Q  L+  +   + + + + L YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGT 662
             +IHRD+K+ +ILL  D   K+SDFG    F     +   KR  LVGT
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGT 204

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  120 bits (303), Expect = 5e-30
 Identities = 40/172 (23%), Positives = 79/172 (45%), Gaps = 12/172 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRN 552
             + +  ++G GG   V++   +  Q  A+K ++   A  Q  + + NE+  ++ LQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 553 L--VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              +RL    +  +   ++ E   N  L+S+L   +++  +D  +R +  K +   +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H   +  I+H DLK +N L+ D    K+ DFG+A     +         VGT
Sbjct: 125 H---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  121 bits (305), Expect = 7e-30
 Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 16/180 (8%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQ 549
            + + + L++ LGQG    V++G+  + G   A+K  +  S     +  M E  V+  L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 550 HRNLVRLLGCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           H+N+V+L     E           E+ P  SL + L +P     L   +   +++ +  G
Sbjct: 66  HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 607 LLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           + +L       I+HR++K  NI+     D     K++DFG AR    ++ Q  +  L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (301), Expect = 7e-30
 Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 20/181 (11%)

Query: 489 ELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEFMNEVMVI 545
           E     +      ++G+G FG V++ K  Q G + AVK  RL           + E++  
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVAC 104

Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           + L    +V L G   E     +  E +   SL   +   ++   L   +    +     
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALE 161

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLA-RIFGGNQDQAATKR--LVG 661
           GL YLH     RI+H D+KA N+LL  D +   + DFG A  +      ++      + G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 662 T 662
           T
Sbjct: 219 T 219

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (298), Expect = 8e-30
 Identities = 48/169 (28%), Positives = 88/169 (52%), Gaps = 14/169 (8%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +    K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
            L   +  +E  ++ EY+   SL     D   ++ +D  +   + +   + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGT 662
            ++IHRD+K+ NILL  D + K++DFG    F        +KR  +VGT
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (296), Expect = 2e-29
 Identities = 45/175 (25%), Positives = 86/175 (49%), Gaps = 24/175 (13%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR 555
           +++  +LG G FG VYK K  + G   A K +   S +  E+++ E+ +++   H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLY 609
           LLG      +  ++ E+ P  ++D+ +        L+  +         + + +   L +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIM--------LELDRGLTEPQIQVVCRQMLEALNF 132

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGT 662
           LH     RIIHRDLKA N+L+  + + +++DFG++        +   KR   +GT
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGT 180

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (299), Expect = 3e-29
 Identities = 40/172 (23%), Positives = 78/172 (45%), Gaps = 12/172 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNLQHRN 552
             + +  ++G GG   V++   +  Q  A+K   L +A  Q  + + NE+  ++ LQ  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 553 L--VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
              +RL    +  +   ++ E   N  L+S+L   +++  +D  +R +  K +   +  +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H   +  I+H DLK +N L+ D    K+ DFG+A     +         VG 
Sbjct: 172 H---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  113 bits (285), Expect = 5e-28
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 15/182 (8%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQ 549
              ++++L   +G G    V         +++A+KR++    Q   +E + E+  +S   
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGI 603
           H N+V      V ++E  L+ + +   S+   +               +      I++ +
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL-ARIFGGNQDQAATKR--LV 660
             GL YLH++     IHRD+KA NILL +D + +I+DFG+ A +  G        R   V
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 661 GT 662
           GT
Sbjct: 188 GT 189

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  113 bits (286), Expect = 7e-28
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 16/156 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEE-FMNEVMVISNLQHR 551
            +     LG+GGF   ++       +  A K + K+      Q E    E+ +  +L H+
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
           ++V   G   E  + + ++ E    +SL     +   +R++L +   R+  ++ I  G  
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQ 155

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           YLHR    R+IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 156 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  112 bits (283), Expect = 8e-28
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 16/156 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEE-FMNEVMVISNLQHR 551
            +     LG+GGF   ++       +  A K + K+      Q E    E+ +  +L H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 552 NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
           ++V   G   E  + + ++ E    +SL     +   +R++L +   R+  ++ I  G  
Sbjct: 76  HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQ 129

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           YLHR    R+IHRDLK  N+ L++DL  KI DFGLA
Sbjct: 130 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  112 bits (283), Expect = 1e-27
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 19/167 (11%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVI 545
           ++++ F+   KLG G +  VYKG     G  +A+K +        EE        E+ ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIREISLM 57

Query: 546 SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS- 604
             L+H N+VRL        +  L++E+M    L  ++ D +           N++K    
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLVKYFQW 115

Query: 605 ---RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
              +GL + H +   +I+HRDLK  N+L++     K+ DFGLAR FG
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  116 bits (291), Expect = 3e-27
 Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 19/179 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNL 553
            +++  +LG GGFG V +      G+++A+K+  +       E +  E+ ++  L H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 554 VRLLGCCVEREENM-------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           V       +  + +       L  EY     L  +L   +    L       ++  IS  
Sbjct: 75  VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 607 LLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           L YLH     RIIHRDLK  NI+L      L  KI D G A+     +        VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGT 186

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 4e-27
 Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 10/176 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNL 553
             ++   L +GGF  VY+ + +  G+E A+KRL     +     + EV  +  L  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 554 VRLLGCCVEREENM-------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
           V+        +E         L+   +    L  FL   + +  L       I     R 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           + ++HR  +  IIHRDLK  N+LL +    K+ DFG A       D + + +    
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (278), Expect = 5e-27
 Identities = 49/168 (29%), Positives = 83/168 (49%), Gaps = 11/168 (6%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQHRNLV 554
           F    K+G+G FG V+KG   +  + +A+K +     + + E+   E+ V+S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +  G  ++  +  +I EY+   S    L        LD  +   I++ I +GL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE- 138

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             + IHRD+KA+N+LL +    K++DFG+A      Q +  T   VGT
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 7e-27
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 15/196 (7%)

Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQ 533
           + +  + L   +   L +    F+L   +G G +G VYKG+ ++ GQ  A+K +   +G 
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62

Query: 534 GQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENM------LIYEYMPNKSLDSFLFDPQ 586
            +EE   E+ ++     HRN+    G  +++          L+ E+    S+   L    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNT 121

Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
           + + L       I + I RGL +LH+    ++IHRD+K  N+LL ++   K+ DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 647 FGGNQDQAATKRLVGT 662
                 +  T   +GT
Sbjct: 179 LDRTVGRRNT--FIGT 192

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (279), Expect = 8e-27
 Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 12/160 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVISNL 548
             ++  + LG+G F  VYK +     Q +A+K++        ++ +N     E+ ++  L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H N++ LL     +    L++++M    L+  + D          K +  +    +GL 
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLE 126

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           YLH+     I+HRDLK +N+LLD++   K++DFGLA+ FG
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (274), Expect = 9e-27
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 23/161 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEE-FMNEVMVISNLQH 550
            +F++ N LG+G F  VY+ + +  G E+A+K + K +    G  +   NEV +   L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGI 603
            +++ L     E    + L+ E   N  +           L +  K F+       +  I
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEM----NR----YLKNRVKPFSENEARHFMHQI 121

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
             G+LYLH      I+HRDL  SN+LL  ++N KI+DFGLA
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  110 bits (277), Expect = 1e-26
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 22/158 (13%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF---MNEVMVISNLQHRN 552
           F    ++G G FG VY  + +++ + +A+K++S +  Q  E++   + EV  +  L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRG 606
            ++  GC +      L+ EY    + D          L    K         +  G  +G
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDL---------LEVHKKPLQEVEIAAVTHGALQG 166

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           L YLH      +IHRD+KA NILL +    K+ DFG A
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (273), Expect = 2e-26
 Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEE-FMNEVMVISNLQH 550
            +F++   LG+G FG VY  +  Q    +A+K L KA     G E     EV + S+L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N++RL G   +     LI EY P  ++   L   Q+ S  D  +    I  ++  L Y 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 125

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H     R+IHRD+K  N+LL      KI+DFG +
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFGWS 156

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  109 bits (274), Expect = 2e-26
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 14/172 (8%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
              F +  KLG+G +G VYK    + GQ +A+K++        +E + E+ ++      +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+  G   +  +  ++ EY    S+   +    R   L   +   I++   +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVGT 662
               R IHRD+KA NILL+ + + K++DFG+A    G       KR  ++GT
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGT 188

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  107 bits (271), Expect = 3e-26
 Identities = 44/158 (27%), Positives = 80/158 (50%), Gaps = 12/158 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQH 550
             +    K+G+G +G VYK +   G+  A+K++     +  E      + E+ ++  L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V+L      ++  +L++E++  + L   L   +        K F  +  +  G+ Y 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYC 116

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           H     R++HRDLK  N+L++ +   KI+DFGLAR FG
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  108 bits (272), Expect = 4e-26
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 12/158 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQH 550
             +Q   K+G+G +G VYK K   G+ +A+KR+        E      + E+ ++  L H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHH 78

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V L+          L++E+M  K L   L + +        K +  +  + RG+ + 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHC 135

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           H+    RI+HRDLK  N+L++ D   K++DFGLAR FG
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  108 bits (271), Expect = 4e-26
 Identities = 43/171 (25%), Positives = 65/171 (38%), Gaps = 13/171 (7%)

Query: 496 NFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNL-QHR 551
           +FQ  ++LG G +G V+K    +DG+  AVKR        + +   + EV     + QH 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
             VRL     E     L  E     SL          + L   + +  ++     L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
                 ++H D+K +NI L      K+ DFGL     G           G 
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGD 219

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  107 bits (271), Expect = 4e-26
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 12/159 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQ 549
            NFQ   K+G+G +G VYK +    G+ +A+K++        E      + E+ ++  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELN 60

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N+V+LL       +  L++E++  + L  F+ D    + +  P   + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H     R++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  110 bits (276), Expect = 6e-26
 Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 20/176 (11%)

Query: 496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLV 554
           +F   + LG G  G +    + D +++AVKR+             EV ++    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 555 RLLGCCVEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           R    C E++     +  E     +L  ++   Q+       +   +++  + GL +LH 
Sbjct: 82  RYF--CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH- 135

Query: 613 DSRLRIIHRDLKASNILL-----DDDLNPKISDFGLARIFGGNQD-QAATKRLVGT 662
              L I+HRDLK  NIL+        +   ISDFGL +     +   +    + GT
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (272), Expect = 7e-26
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 25/178 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM--------------- 539
           N++++   L QG F  +   + +D +  A+K+  K+  + + +F                
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 540 --NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-----FDPQRQSLLD 592
             NE+ +I+++++   +   G     +E  +IYEYM N S+  F       D      + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
                 IIK +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  106 bits (268), Expect = 8e-26
 Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 13/159 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQ 549
             ++   K+G+G +G V+K K  +  + +A+KR+        E      + E+ ++  L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H+N+VRL       ++  L++E+   + L  +          +  K F  +  + +GL +
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGF 116

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            H      ++HRDLK  N+L++ +   K+++FGLAR FG
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (264), Expect = 2e-25
 Identities = 50/183 (27%), Positives = 73/183 (39%), Gaps = 29/183 (15%)

Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKR--LSKASGQGQEEFMNEVMVISNL-Q 549
           T  F    K+G G FG V+K  K  DG   A+KR     A    ++  + EV   + L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 550 HRNLVRLLGCCVEREENMLIY-EYMPNKSLDSFLFDPQRQ-SLLDWPKRFNIIKGISRGL 607
           H ++VR      E + +MLI  EY    SL   + +  R  S     +  +++  + RGL
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNP-------------------KISDFGLARIFG 648
            Y+H      ++H D+K SNI +     P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 649 GNQ 651
             Q
Sbjct: 186 SPQ 188

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  106 bits (266), Expect = 3e-25
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 16/160 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN-----EVMVISNL 548
             +   +KLG+G +  VYKGK       +A+K +        EE        EV ++ +L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDL 57

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           +H N+V L       +   L++EY+ +K L  +L D      +   K F  +  + RGL 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLA 114

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           Y HR    +++HRDLK  N+L+++    K++DFGLAR   
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (267), Expect = 5e-25
 Identities = 35/195 (17%), Positives = 67/195 (34%), Gaps = 14/195 (7%)

Query: 478 RLQDLLVFNFEELANATNNFQLANKLGQG--GFGPVYKGK-LQDGQEIAVKR--LSKASG 532
            +++L              ++L   +G+G      V   +    G+ + V+R  L   S 
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 533 QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLD 592
           +       E+ V     H N+V      +   E  ++  +M   S    L        ++
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN 126

Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
                 I++G+ + L Y+H       +HR +KAS+IL+  D    +S          +  
Sbjct: 127 ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 653 QAAT-----KRLVGT 662
           +        K  V  
Sbjct: 184 RQRVVHDFPKYSVKV 198

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  105 bits (264), Expect = 5e-25
 Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 15/160 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN--EVMVISNLQHR 551
             ++   K+G+G +G V+K +    GQ +A+K+  ++      + +   E+ ++  L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 552 NLVRLLGCCVEREENMLIYEYMPN---KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           NLV LL     +    L++EY  +     LD        Q  +      +I     + + 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR------YQRGVPEHLVKSITWQTLQAVN 116

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           + H+      IHRD+K  NIL+      K+ DFG AR+  
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  104 bits (261), Expect = 7e-25
 Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 24/189 (12%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVM 543
           N        + F    KLG G FG V+  +    G E  +K ++K   Q   E    E+ 
Sbjct: 13  NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQR-QSLLDWPKRFN---- 598
           V+ +L H N++++     +     ++ E      L     +  R  S     K  +    
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYV 126

Query: 599 --IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQ 653
             ++K +   L Y H      ++H+DLK  NIL          KI DFGLA +F  ++  
Sbjct: 127 AELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 654 AATKRLVGT 662
                  GT
Sbjct: 184 ---TNAAGT 189

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  105 bits (264), Expect = 9e-25
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 25/169 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEF----MNEVMVISN 547
           + ++   K+GQG FG V+K +  + GQ++A+K   +       +E F    + E+ ++  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE----KEGFPITALREIKILQL 72

Query: 548 LQHRNLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI 599
           L+H N+V L+  C  +            L++++     L   L +   +  L   KR   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRV-- 129

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           ++ +  GL Y+HR+   +I+HRD+KA+N+L+  D   K++DFGLAR F 
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (264), Expect = 1e-24
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)

Query: 502 KLGQGGFGPVYKGKLQD---GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLG 558
           K+G+G +G VYK K +D    ++ A+K++ + +G        E+ ++  L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSA-CREIALLRELKHPNVISLQK 85

Query: 559 CCVEREEN--MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN--IIKGIS----RGLLYL 610
             +   +    L+++Y     L   +   +       P +    ++K +      G+ YL
Sbjct: 86  VFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLARIFG 648
           H +    ++HRDLK +NIL+  +       KI+D G AR+F 
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (259), Expect = 2e-24
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 19/170 (11%)

Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEF----MNEVMVIS 546
           AT+ ++   ++G G +G VYK +    G  +A+K +     G G        + EV ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 547 NLQ---HRNLVRLLGCCVEREEN-----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
            L+   H N+VRL+  C     +      L++E++ ++ L ++L D      L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +++   RGL +LH +    I+HRDLK  NIL+      K++DFGLARI+ 
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  103 bits (260), Expect = 2e-24
 Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 31/170 (18%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEF----MNEVMVISNLQ 549
           + ++   KLG+G +G VYK       + +A+KR+       +E      + EV ++  LQ
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN--IIKGIS--- 604
           HRN++ L           LI+EY      ++ L     +  +D     +  +IK      
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYA-----ENDL-----KKYMDKNPDVSMRVIKSFLYQL 141

Query: 605 -RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIFG 648
             G+ + H     R +HRDLK  N+LL           KI DFGLAR FG
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  102 bits (257), Expect = 2e-24
 Identities = 58/192 (30%), Positives = 84/192 (43%), Gaps = 31/192 (16%)

Query: 485 FNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNE 541
            N          + +   LG+G FG V K K     QE AVK ++KA    +     + E
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71

Query: 542 VMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN- 598
           V ++  L H N+++L     +     ++ E          LFD   +R       KRF+ 
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKR-------KRFSE 120

Query: 599 -----IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGN 650
                IIK +  G+ Y+H   +  I+HRDLK  NILL   + D + KI DFGL+  F  N
Sbjct: 121 HDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 651 QDQAATKRLVGT 662
                 K  +GT
Sbjct: 178 T---KMKDRIGT 186

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  101 bits (255), Expect = 4e-24
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 10/154 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEE-FMNEVMVISNLQH 550
           ++F +   LG+G FG VY  +  Q+   +A+K L K+    +G E     E+ + S+L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N++R+     +R+   L+ E+ P   L   L   Q+    D  +    ++ ++  L Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 130

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
           H     ++IHRD+K  N+L+      KI+DFG +
Sbjct: 131 HE---RKVIHRDIKPENLLMGYKGELKIADFGWS 161

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  102 bits (257), Expect = 5e-24
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 23/164 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK--RLSKASGQGQEEF----MNEVMVISN 547
             ++    +G+G +G V K +    G+ +A+K    S       +      M E+ ++  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD----DKMVKKIAMREIKLLKQ 80

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPN---KSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           L+H NLV LL  C +++   L++E++ +     L+         + LD+      +  I 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL------FPNGLDYQVVQKYLFQII 134

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
            G+ + H      IIHRD+K  NIL+      K+ DFG AR   
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (261), Expect = 5e-24
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 33/207 (15%)

Query: 477 ARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQE 536
           +R+ ++   NFE+  +  N       LG G  G V       G+ +AVKR+        +
Sbjct: 1   SRIANIP--NFEQ--SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CD 53

Query: 537 EFMNEVMV-ISNLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFL----FDPQRQSL 590
             + E+ +   +  H N++R   C    +  + +  E   N +L   +       +   L
Sbjct: 54  IALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKL 111

Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------DDLNPK 637
                  ++++ I+ G+ +LH    L+IIHRDLK  NIL+              ++L   
Sbjct: 112 QKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168

Query: 638 ISDFGLARIFGGNQD--QAATKRLVGT 662
           ISDFGL +     Q   +       GT
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGT 195

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (257), Expect = 8e-24
 Identities = 40/177 (22%), Positives = 73/177 (41%), Gaps = 15/177 (8%)

Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
            +  + + +  +LG G FG V++      G+    K ++      +    NE+ +++ L 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGL 607
           H  L+ L     ++ E +LI E++        LFD        +   +  N ++    GL
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGL 162

Query: 608 LYLHRDSRLRIIHRDLKASNILL--DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            ++H      I+H D+K  NI+       + KI DFGLA     ++     K    T
Sbjct: 163 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (251), Expect = 1e-23
 Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 29/184 (15%)

Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ 549
            +    + L N +G+G +G V            A K++ K   +  + F  E+ ++ +L 
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIK 601
           H N++RL     +  +  L+ E          LF+    +       + F       I+K
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHK-------RVFRESDAARIMK 113

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKR 658
            +   + Y H   +L + HRDLK  N L      D   K+ DFGLA  F   +     + 
Sbjct: 114 DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRT 167

Query: 659 LVGT 662
            VGT
Sbjct: 168 KVGT 171

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  103 bits (258), Expect = 2e-23
 Identities = 58/191 (30%), Positives = 84/191 (43%), Gaps = 31/191 (16%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEV 542
           N          + +   LG+G FG V K K     QE AVK ++KA    +     + EV
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72

Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN-- 598
            ++  L H N+++L     +     ++ E          LFD   +R       KRF+  
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKR-------KRFSEH 121

Query: 599 ----IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQ 651
               IIK +  G+ Y+H   +  I+HRDLK  NILL   + D + KI DFGL+  F  N 
Sbjct: 122 DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178

Query: 652 DQAATKRLVGT 662
                K  +GT
Sbjct: 179 KM---KDRIGT 186

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  101 bits (252), Expect = 3e-23
 Identities = 24/233 (10%), Positives = 52/233 (22%), Gaps = 36/233 (15%)

Query: 449 KAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGF 508
           K  +E     R +  +  A            Q+        L+      +L   L  G  
Sbjct: 16  KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75

Query: 509 GPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQHRNLVRLLGCC---- 560
             V+  + ++  ++ A+K  +     S    E         + L   +            
Sbjct: 76  SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135

Query: 561 ---VEREENM-------------------LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
                  ++                    L+             +  F    +       
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
              +   + R    L       ++H      N+ +  D    + D       G
Sbjct: 196 LHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (257), Expect = 3e-23
 Identities = 55/193 (28%), Positives = 84/193 (43%), Gaps = 31/193 (16%)

Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMN 540
           +F   +  + +  +Q   KLG G +G V   +      E A+K + K   S     + + 
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85

Query: 541 EVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN 598
           EV V+  L H N+++L     ++    L+ E          LFD    R        +FN
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHR-------MKFN 134

Query: 599 ------IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGG 649
                 IIK +  G+ YLH   +  I+HRDLK  N+LL   + D   KI DFGL+ +F  
Sbjct: 135 EVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191

Query: 650 NQDQAATKRLVGT 662
            +     K  +GT
Sbjct: 192 QK---KMKERLGT 201

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  100 bits (252), Expect = 4e-23
 Identities = 46/188 (24%), Positives = 83/188 (44%), Gaps = 30/188 (15%)

Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG 534
           +P ++  +L  + +        +     +G G FG V++ KL +  E+A+K++ +     
Sbjct: 20  DPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ----- 74

Query: 535 QEEFMN-EVMVISNLQHRNLVRLLGCCVEREENM------LIYEYMP---NKSLDSFLFD 584
            + F N E+ ++  ++H N+V L        +        L+ EY+P    ++   +   
Sbjct: 75  DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL 134

Query: 585 PQRQSLLDWPKRFNIIKGIS----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KIS 639
            Q   +L       +IK       R L Y+H    + I HRD+K  N+LLD      K+ 
Sbjct: 135 KQTMPML-------LIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI 184

Query: 640 DFGLARIF 647
           DFG A+I 
Sbjct: 185 DFGSAKIL 192

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 19/177 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL-SKASGQGQEEFMNEVMVI-SNLQHR 551
            + +   ++G+G +G V K      GQ +AVKR+ S    + Q++ + ++ V+  +    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISR 605
            +V+  G      +  +  E M + S D F     +                 I     +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            L +L     L+IIHRD+K SNILLD   N K+ DFG++   G   D  A  R  G 
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGC 188

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 20/177 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL-SKASGQGQEEFMNEVMVI-SNLQHR 551
           ++ +   +LG+G +G V K + +  GQ +AVKR+ +  + Q Q+  + ++ +    +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISR 605
             V   G      +  +  E M + SLD F      + ++D  +         I   I +
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            L +LH  S+L +IHRD+K SN+L++     K+ DFG++   G   D  A     G 
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGC 172

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 99.6 bits (248), Expect = 6e-23
 Identities = 49/237 (20%), Positives = 80/237 (33%), Gaps = 72/237 (30%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS-KASGQGQEEFMNEVMVISNLQHRN 552
            +F+    +G+GGFG V++ K   D    A+KR+        +E+ M EV  ++ L+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 553 LVRLLGCCVEREENMLIYEYMP------------------------NKSLDSFLFDP--- 585
           +VR     +E        E                            + +D F       
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 586 ------------------QRQSLLDWPKRFN------------IIKGISRGLLYLHRDSR 615
                             ++++L DW  R              I   I+  + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATK----------RLVGT 662
             ++HRDLK SNI    D   K+ DFGL      ++++                VGT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (250), Expect = 7e-23
 Identities = 51/172 (29%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
                  LG G FG V+K +    G ++A K +     + +EE  NE+ V++ L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +L      + + +L+ EY+        LFD        L        +K I  G+ ++H 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH- 204

Query: 613 DSRLRIIHRDLKASNILL--DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             ++ I+H DLK  NIL    D    KI DFGLAR +   +     K   GT
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGT 251

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 24/182 (13%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG---------QEEFMNEVM 543
             N++    LG+G    V +       +E AVK +    G           +E  + EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 544 VISNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNII 600
           ++  +  H N+++L           L+++ M    L    FD   ++ +L +   R  I+
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETR-KIM 130

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
           + +   +  LH+   L I+HRDLK  NILLDDD+N K++DFG +      +     + + 
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVC 184

Query: 661 GT 662
           GT
Sbjct: 185 GT 186

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.0 bits (245), Expect = 8e-23
 Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 19/177 (10%)

Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQH 550
           ++N+ +  +LG+G F  V +      G E A K ++    S +  ++   E  +   LQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
            N+VRL     E   + L+++ +    L    F+    R+   +     + I+ I   + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119

Query: 609 YLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           Y H      I+HR+LK  N+LL         K++DFGLA     ++   A     GT
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGT 170

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (254), Expect = 1e-22
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 15/174 (8%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
            +++ +  +LG G FG V++      G   A K +       +E    E+  +S L+H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYL 610
           LV L     +  E ++IYE+M        LF+      + +   +    ++ + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGT 662
           H       +H DLK  NI+     +   K+ DFGL       Q   + K   GT
Sbjct: 272 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (252), Expect = 1e-22
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 32/194 (16%)

Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFM 539
           +F     A  ++ ++    LG+G FG V   K    GQE AVK +SK        +E  +
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74

Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF 597
            EV ++  L H N+++L     ++    L+ E      L    FD    R       KRF
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISR-------KRF 123

Query: 598 N------IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFG 648
           +      II+ +  G+ Y+H+    +I+HRDLK  N+LL     D N +I DFGL+  F 
Sbjct: 124 SEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 649 GNQDQAATKRLVGT 662
            ++     K  +GT
Sbjct: 181 ASKKM---KDKIGT 191

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 98.4 bits (246), Expect = 1e-22
 Identities = 48/170 (28%), Positives = 88/170 (51%), Gaps = 25/170 (14%)

Query: 495 NNFQLANKLGQGGFGPVYKGK--LQDGQEIAVK--RLSKASGQGQEEF----MNEVMVIS 546
             ++   ++G+G +G V+K +     G+ +A+K  R+      G+E      + EV V+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLR 66

Query: 547 NLQ---HRNLVRLLGCCVEREEN-----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
           +L+   H N+VRL   C     +      L++E++ ++ L ++L D   +  +      +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKD 124

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           ++  + RGL +LH     R++HRDLK  NIL+      K++DFGLARI+ 
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 99.1 bits (247), Expect = 1e-22
 Identities = 46/202 (22%), Positives = 84/202 (41%), Gaps = 11/202 (5%)

Query: 463 GEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKL-QDGQE 521
           G+       ++    RL+  L    +      ++F+  ++LG G  G V+K      G  
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 522 IAVKRLS-KASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDS 580
           +A K +  +     + + + E+ V+       +V   G      E  +  E+M   SLD 
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 581 FLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
            L   ++   +       +   + +GL YL    + +I+HRD+K SNIL++     K+ D
Sbjct: 121 VL---KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 641 FGLARIFGGNQDQAATKRLVGT 662
           FG++    G    +     VGT
Sbjct: 176 FGVS----GQLIDSMANSFVGT 193

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 30/181 (16%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
              F     LG G F  V+  K    G+  A+K + K+         NE+ V+  ++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKGIS 604
           +V L           L+ + +    L    FD   +R         +       +I+ + 
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGV-------YTEKDASLVIQQVL 116

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
             + YLH      I+HRDLK  N+L    +++    I+DFGL+++              G
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACG 169

Query: 662 T 662
           T
Sbjct: 170 T 170

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 39/197 (19%), Positives = 77/197 (39%), Gaps = 35/197 (17%)

Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG-------- 534
           + ++         +   + +G+G    V +      G E AVK +   + +         
Sbjct: 83  LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV 142

Query: 535 QEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLL 591
           +E    E  ++  +  H +++ L+          L+++ M    L    FD   ++    
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEK---- 194

Query: 592 DWPKRF------NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                       +I++ +   + +LH      I+HRDLK  NILLDD++  ++SDFG + 
Sbjct: 195 ---VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSC 248

Query: 646 IFGGNQDQAATKRLVGT 662
                +     + L GT
Sbjct: 249 HLEPGE---KLRELCGT 262

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 29/183 (15%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK-----RLSKASGQGQEEFMNEVMVISNLQH 550
           ++L   +G+G F  V +    + GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKG 602
            ++V LL          +++E+M        L     +R         +      + ++ 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADA---GFVYSEAVASHYMRQ 138

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
           I   L Y H      IIHRD+K   +LL   ++    K+  FG+A   G +   A  +  
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-- 193

Query: 660 VGT 662
           VGT
Sbjct: 194 VGT 196

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 97.6 bits (243), Expect = 3e-22
 Identities = 43/230 (18%), Positives = 71/230 (30%), Gaps = 50/230 (21%)

Query: 480 QDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK-----RLSKASGQ 533
           ++ L F    L      + L   +GQG +G V      Q     A+K     ++ + + +
Sbjct: 11  RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70

Query: 534 GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM-------------------- 573
             E    EV ++  L H N+ RL     + +   L+ E                      
Sbjct: 71  DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130

Query: 574 -----------PNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLYLHRDSRL 616
                        +  +  +                      I++ I   L YLH     
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---Q 187

Query: 617 RIIHRDLKASNILL--DDDLNPKISDFGLARIFGGNQ--DQAATKRLVGT 662
            I HRD+K  N L   +     K+ DFGL++ F      +        GT
Sbjct: 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 36/176 (20%), Positives = 69/176 (39%), Gaps = 16/176 (9%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
                + +A  LG+G FG V++       +    K +    G  Q     E+ +++  +H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLL 608
           RN++ L       EE ++I+E++        +F+        L+  +  + +  +   L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKRLVGT 662
           +LH      I H D++  NI+     +   KI +FG AR           + L   
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.7 bits (239), Expect = 5e-22
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 24/185 (12%)

Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------SGQGQEEFMNEVM 543
           +   +++++  +LG G F  V K +    G+E A K + K        G  +EE   EV 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIK 601
           ++  ++H N++ L      + + +LI E +    L    FD   +++SL +  +    +K
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTE-DEATQFLK 115

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATK 657
            I  G+ YLH     RI H DLK  NI+L      +   K+ DFG+A            K
Sbjct: 116 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFK 169

Query: 658 RLVGT 662
            + GT
Sbjct: 170 NIFGT 174

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.9 bits (244), Expect = 5e-22
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 31/170 (18%)

Query: 494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQHR 551
             ++     +G G FG VY+ KL D G+ +A+K++ +      + F N E+ ++  L H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107

Query: 552 NLVRLLGCCVEREENM------LIYEYMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
           N+VRL        E        L+ +Y+P    +    +    Q   ++        +K 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-------YVKL 160

Query: 603 IS----RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP-KISDFGLARIF 647
                 R L Y+H      I HRD+K  N+LLD D    K+ DFG A+  
Sbjct: 161 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 26/183 (14%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE--------FMNEVMV 544
            + + ++  LG G  G V      +  +++A+K +SK                   E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
           +  L H  ++++     + E+  ++ E M    L    FD     + L +   +      
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
           +   + YLH      IIHRDLK  N+LL   ++D   KI+DFG ++I G   + +  + L
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 176

Query: 660 VGT 662
            GT
Sbjct: 177 CGT 179

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.0 bits (241), Expect = 6e-22
 Identities = 26/218 (11%), Positives = 65/218 (29%), Gaps = 27/218 (12%)

Query: 464 EAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK------LQ 517
            +Y N    +     ++        E    +    + + LG+G F  VY+         +
Sbjct: 39  SSYPNTFEWQCKLPAIK-----PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93

Query: 518 DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKS 577
           + Q+  +K    A+          +  +        ++     + +  ++L+ E     +
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 578 LDSFL--FDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN 635
           L + +  +    + ++      +    +   +  +H      IIH D+K  N +L +   
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFL 210

Query: 636 P-----------KISDFGLARIFGGNQDQAATKRLVGT 662
                        + D G +                 T
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 96.6 bits (241), Expect = 9e-22
 Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 31/183 (16%)

Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQH 550
           ++N+ +  +LG+G F  V +      G E A K ++    S +  ++   E  +   LQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKG 602
            N+VRL     E   + L+++ +        LF+    R+        +      + I+ 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTG----GELFEDIVAREF-------YSEADASHCIQQ 136

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
           I   + Y H      I+HR+LK  N+LL         K++DFGLA     ++   A    
Sbjct: 137 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGF 190

Query: 660 VGT 662
            GT
Sbjct: 191 AGT 193

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 24/185 (12%)

Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS------GQGQEEFMNEVM 543
               + + +  +LG G F  V K +    G E A K + K        G  +EE   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIK 601
           ++  + H N++ L      R + +LI E +        LFD   Q++SL +  +  + IK
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSE-EEATSFIK 122

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATK 657
            I  G+ YLH     +I H DLK  NI+L        + K+ DFGLA            K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFK 176

Query: 658 RLVGT 662
            + GT
Sbjct: 177 NIFGT 181

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 24/185 (12%)

Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------SGQGQEEFMNEVM 543
               + + +  +LG G F  V K +    G E A K + K        G  +EE   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 544 VISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIK 601
           ++  + H N++ L      R + +LI E +        LFD   Q++SL +  +  + IK
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSE-EEATSFIK 122

Query: 602 GISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATK 657
            I  G+ YLH     +I H DLK  NI+L        + K+ DFGLA            K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFK 176

Query: 658 RLVGT 662
            + GT
Sbjct: 177 NIFGT 181

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 42/183 (22%), Positives = 78/183 (42%), Gaps = 26/183 (14%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE--------FMNEVMV 544
            + + ++  LG G  G V      +  +++A++ +SK                   E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
           +  L H  ++++     + E+  ++ E M    L    FD     + L +   +      
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRL 659
           +   + YLH      IIHRDLK  N+LL   ++D   KI+DFG ++I G   + +  + L
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 301

Query: 660 VGT 662
            GT
Sbjct: 302 CGT 304

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 47/176 (26%), Positives = 71/176 (40%), Gaps = 28/176 (15%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCC 560
           LG+G    V     L   QE AVK + K  G  +     EV ++   Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN------IIKGISRGLLYLHRDS 614
            E +   L++E M   S+         +      + FN      +++ ++  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHKR-----RHFNELEASVVVQDVASALDFLHN-- 129

Query: 615 RLRIIHRDLKASNILL---DDDLNPKISDFGLARIF--GGNQDQAATKRL---VGT 662
              I HRDLK  NIL    +     KI DF L       G+    +T  L    G+
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 52/184 (28%), Positives = 79/184 (42%), Gaps = 24/184 (13%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------SGQGQEEFMNEVMV 544
           N  + +    +LG G F  V K +    G + A K + K        G  +E+   EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
           +  +QH N++ L      + + +LI E +    L    FD   +++SL +  +    +K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTE-EEATEFLKQ 122

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLARIFGGNQDQAATKR 658
           I  G+ YLH    L+I H DLK  NI+L          KI DFGLA            K 
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176

Query: 659 LVGT 662
           + GT
Sbjct: 177 IFGT 180

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 95.3 bits (237), Expect = 6e-21
 Identities = 39/184 (21%), Positives = 85/184 (46%), Gaps = 39/184 (21%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
            + +++ + +G G +G V +     + + +A+K++ +        F +         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIA 104

Query: 544 VISNLQHRNLVRLLG-CCVEREENM----LIYEYMP---NKSLDS--FLFDPQRQSLLDW 593
           +++ L H ++V++L     +  E      ++ E       K   +  +L +   ++LL  
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL-- 162

Query: 594 PKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
              +N++     G+ Y+H  S   I+HRDLK +N L++ D + K+ DFGLAR     ++ 
Sbjct: 163 ---YNLL----VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 654 AATK 657
            +  
Sbjct: 213 NSQL 216

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.5 bits (238), Expect = 6e-21
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 38/202 (18%)

Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA------------ 530
           ++  ++      ++    KLG G +G V   K      E A+K + K+            
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 531 -SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQS 589
              +  EE  NE+ ++ +L H N+++L     +++   L+ E+     L    F+     
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FE----- 135

Query: 590 LLDWPKRFN------IIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISD 640
            +    +F+      I+K I  G+ YLH+     I+HRD+K  NILL   +  LN KI D
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVD 192

Query: 641 FGLARIFGGNQDQAATKRLVGT 662
           FGL+  F  +      +  +GT
Sbjct: 193 FGLSSFFSKDYKL---RDRLGT 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 41/197 (20%), Positives = 76/197 (38%), Gaps = 23/197 (11%)

Query: 475 NPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRL-SKASG 532
           +  +    L    +      N+ +   ++G G  G V+K +  + G  IAVK++    + 
Sbjct: 5   SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64

Query: 533 QGQEEFMNEVMVI-SNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLL 591
           +  +  + ++ V+  +     +V+  G  +   +  +  E M     +            
Sbjct: 65  EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--------K 115

Query: 592 DWPKRFN------IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                        +   I + L YL    +  +IHRD+K SNILLD+    K+ DFG++ 
Sbjct: 116 RMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS- 172

Query: 646 IFGGNQDQAATKRLVGT 662
             G   D  A  R  G 
Sbjct: 173 --GRLVDDKAKDRSAGC 187

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 40/181 (22%), Positives = 79/181 (43%), Gaps = 21/181 (11%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
             E      + FQ+    GQG FG V  GK +  G  +A+K++ +       E    +  
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQD 72

Query: 545 ISNLQHRNLVRLLGC-CVEREENM------LIYEYMP---NKSLDSFLFDPQRQSLLDWP 594
           ++ L H N+V+L        E +       ++ EY+P   ++   ++    ++ +     
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY--YRRQVAPPPIL 130

Query: 595 KRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFGGNQ 651
            +   +  + R +  LH  S + + HRD+K  N+L+++    L  K+ DFG A+    ++
Sbjct: 131 IKV-FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSE 186

Query: 652 D 652
            
Sbjct: 187 P 187

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 93.2 bits (231), Expect = 2e-20
 Identities = 26/194 (13%), Positives = 50/194 (25%), Gaps = 38/194 (19%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH-------- 550
           LGQ       +    + G+   V              ++   EV+ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 551 --------RNLVRLLGCCV--------EREENMLIYEYMPNKSLDSFLF------DPQRQ 588
                    +LV+                   +  +   P    +   F           
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 589 SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
             L    R  +   + R L  LH      ++H  L+  +I+LD      ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 649 GNQDQAATKRLVGT 662
            +   +   R    
Sbjct: 263 ASA-VSPIGRGFAP 275

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 32/174 (18%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQH 550
            + + + LG+G +G V +    +     AVK L K        G+     E+ ++  L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 551 RNLVRLLGCCVEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN---------- 598
           +N+++L+      E+    ++ EY      +  + D   +      KRF           
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE------KRFPVCQAHGYFCQ 117

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
           +I G+     YLH      I+H+D+K  N+LL      KIS  G+A        
Sbjct: 118 LIDGLE----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 27/185 (14%)

Query: 492 NATNNFQLANK-LGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISN 547
           N  N + L +K LG+G F  V +      GQE A K L K       + E ++E+ V+  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 548 LQHR-NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF------NII 600
            +    ++ L        E +LI EY     +    F      L +  +         +I
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS---LCLPELAEMVSENDVIRLI 137

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATK 657
           K I  G+ YLH+     I+H DLK  NILL       + KI DFG++R  G        +
Sbjct: 138 KQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELR 191

Query: 658 RLVGT 662
            ++GT
Sbjct: 192 EIMGT 196

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 13/171 (7%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM----NEVMVISNLQHR 551
           +++ +KLG GG   VY  +      ++A+K +     + +EE +     EV   S L H+
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+V ++    E +   L+ EY+   +L  ++   +    L      N    I  G+ + H
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH 128

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
               +RI+HRD+K  NIL+D +   KI DFG+A+          T  ++GT
Sbjct: 129 D---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGT 175

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 46/196 (23%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN------------- 540
           N + L +++G+G +G V       D    A+K LSK     Q  F               
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 541 -------------EVMVISNLQHRNLVRLLGCCVEREENMLIY---EYMPNKSLDSFLFD 584
                        E+ ++  L H N+V+L+   ++      +Y   E +    +     +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME 127

Query: 585 -PQRQSLLDWPKRF---NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD 640
            P  + L +   RF   ++IKGI     YLH     +IIHRD+K SN+L+ +D + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 641 FGLARIFGGNQDQAAT 656
           FG++  F G+    + 
Sbjct: 181 FGVSNEFKGSDALLSN 196

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.0 bits (228), Expect = 4e-20
 Identities = 23/181 (12%), Positives = 46/181 (25%), Gaps = 39/181 (21%)

Query: 503 LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE------------------------ 537
           LGQ       +    + G+   V                                     
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 538 ----FMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSF-----LFD-PQR 587
               F+    ++ + Q + ++R+          +  +   P    +       L      
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 588 QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
              L    R  +   + R L  LH      ++H  L+  +I+LD      ++ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 648 G 648
           G
Sbjct: 257 G 257

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 92.7 bits (231), Expect = 4e-20
 Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 30/186 (16%)

Query: 491 ANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE--FMNEVMVISN 547
              T  +QL  +LG+G F  V +   +  GQE A   ++      ++      E  +   
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NI 599
           L+H N+VRL     E   + LI++ +        LF+    R+        +      + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTG----GELFEDIVAREY-------YSEADASHC 115

Query: 600 IKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAAT 656
           I+ I   +L+ H+   + ++HR+LK  N+LL         K++DFGLA    G Q     
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172

Query: 657 KRLVGT 662
               GT
Sbjct: 173 --FAGT 176

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 93.0 bits (231), Expect = 7e-20
 Identities = 36/175 (20%), Positives = 70/175 (40%), Gaps = 25/175 (14%)

Query: 497 FQLANKLGQGGFGPVYKGK---LQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQHRN 552
           +++   +  GG G +Y      + +G+ + +K L  +     Q   M E   ++ + H +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140

Query: 553 LVRLL--GCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           +V++       +R  + + Y   EY+  +SL            L   +    +  I   L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPAL 195

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            YLH    + +++ DLK  NI+L ++   K+ D G            +   L GT
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGT 240

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 41/182 (22%), Positives = 72/182 (39%), Gaps = 32/182 (17%)

Query: 494 TNNFQLANKLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN 552
           T+ +++   +G G +    +        E AVK + K+     EE   E++ +   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEIL-LRYGQHPN 77

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIKGIS 604
           ++ L     + +   ++ E M    L     D   ++       K F+      ++  I+
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-------KFFSEREASAVLFTIT 126

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILL---DDDLNP-KISDFGLARIFGGNQDQAATKRLV 660
           + + YLH      ++HRDLK SNIL      +    +I DFG A+          T    
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PC 181

Query: 661 GT 662
            T
Sbjct: 182 YT 183

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 49/178 (27%), Positives = 74/178 (41%), Gaps = 22/178 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEEF-MNEVMVISNLQH 550
            +F+    LG+G F  V   +        A+K L K     + +  +   E  V+S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG------IS 604
              V+L     + E+      Y  N  L  ++   ++         F+          I 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKI------GSFDETCTRFYTAEIV 140

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             L YLH      IIHRDLK  NILL++D++ +I+DFG A++      QA     VGT
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 10/170 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNL 553
           ++ L   LG+G +G V         + +AVK +         E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYLHR 612
           V+  G   E     L  EY     L   +         D  + F+ ++ G+     YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
              + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 31/205 (15%)

Query: 470 STEKVNPARLQDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLS 528
           ++     A L      +       ++ F++ ++LG+G    VY+ K     +  A+K L 
Sbjct: 28  ASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK 87

Query: 529 KASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQ 586
           K     ++    E+ V+  L H N+++L        E  L+ E +    L    FD   +
Sbjct: 88  KT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVE 141

Query: 587 RQSLLDWPKRF------NIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPK 637
           +         +      + +K I   + YLH      I+HRDLK  N+L      D   K
Sbjct: 142 K-------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLK 191

Query: 638 ISDFGLARIFGGNQDQAATKRLVGT 662
           I+DFGL++I          K + GT
Sbjct: 192 IADFGLSKIVEHQV---LMKTVCGT 213

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 17/176 (9%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFM----NEVMVISNLQHR 551
           ++L   LG GG   V+  + L+D +++AVK L +A       F      E    + L H 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72

Query: 552 NLVRLLGCCVEREENMLIY----EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
            +V +            +     EY+   +L   +     +  +   +   +I    + L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL 129

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR-IFGGNQDQAATKRLVGT 662
            + H+     IIHRD+K +NI++      K+ DFG+AR I         T  ++GT
Sbjct: 130 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 18/174 (10%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMVISNLQHRNL 553
           ++ L   LG+G +G V         + +AVK +         E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF---NIIKGISRGLL 608
           V+  G   E     L  EY     L    FD       + +   +     ++ G+     
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           YLH    + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 87.7 bits (218), Expect = 8e-19
 Identities = 41/188 (21%), Positives = 71/188 (37%), Gaps = 34/188 (18%)

Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEE--FMN---- 540
             EL    + + +   +  G +G V  G   +G  +A+KR+      G+      +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 541 -----EVMVISNLQHRNLVRLLGC-CVEREENM----LIYEYMPN------KSLDSFLFD 584
                E+ ++++  H N++ L        E  M    L+ E M              +  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133

Query: 585 PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
              Q  +     ++I+     GL  LH      ++HRDL   NILL D+ +  I DF LA
Sbjct: 134 QHIQYFM-----YHIL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA 181

Query: 645 RIFGGNQD 652
           R    + +
Sbjct: 182 REDTADAN 189

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 32/173 (18%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
              +     +G G +G V      + G+++A+K+LS+        F +         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 544 VISNLQHRNLVRLLGCCV--EREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           ++ ++QH N++ LL          N     L+  +M      + L         +   ++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
            ++  + +GL Y+H      ++HRDLK  N+ +++D   KI DFGLAR     
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 32/174 (18%)

Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGC 559
            LG+G F    K    +  Q  AVK +SK     +     E+  +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 560 CVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIKGISRGLLYLH 611
             ++    L+ E +    L    F+   ++       K F+      I++ +   + ++H
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKK-------KHFSETEASYIMRKLVSAVSHMH 123

Query: 612 RDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
               + ++HRDLK  N+L    +D+L  KI DFG AR+   +     T     T
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP--CFT 172

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRN 552
           N++L   +G+G F  V   + +  G+E+A+K + K   +    ++   EV ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 553 LVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYL 610
           +V+L    +E E+ + LI EY     +  +L    R    +   +F  I+  +     Y 
Sbjct: 76  IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           H+    RI+HRDLKA N+LLD D+N KI+DFG +  F
Sbjct: 131 HQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 16/162 (9%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--------SGQGQEEFMNEVMVIS 546
            +   + LG G FG V+     +  +E+ VK + K               +   E+ ++S
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 547 NLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISR 605
            ++H N++++L    E +        M        LF    R   LD P    I + +  
Sbjct: 85  RVEHANIIKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            + YL       IIHRD+K  NI++ +D   K+ DFG A   
Sbjct: 142 AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 86.9 bits (215), Expect = 6e-18
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 21/177 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMV---ISN 547
           N+F +   +G+GGFG VY  +  D  ++ A+K L K      QG+   +NE ++   +S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 548 LQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISR 605
                +V +        + +  I + M    L   L    +  +      RF   + I  
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE-IIL 303

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           GL ++H      +++RDLK +NILLD+  + +ISD GLA  F   +        VGT
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.1 bits (213), Expect = 6e-18
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 32/174 (18%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
              +Q    +G G  G V         + +A+K+LS+        F N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 544 VISNLQHRNLVRLLG--CCVEREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           ++  + H+N++ LL      +  E      L+ E M     D+ L    +  L      +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
            + + +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G + 
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 84.3 bits (209), Expect = 7e-18
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 21/165 (12%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN------EVMVISNL 548
            +Q+   LG GGFG VY G  + D   +A+K + K       E  N      EV+++  +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 549 QHR--NLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGI 603
                 ++RLL    ER ++  LI E  P    D  LFD   +R +L +   R +    +
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQV 158

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIF 647
              + + H      ++HRD+K  NIL+D +    K+ DFG   + 
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.9 bits (208), Expect = 9e-18
 Identities = 41/167 (24%), Positives = 83/167 (49%), Gaps = 19/167 (11%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ- 549
              +++QL  KLG+G +  V++   + + +++ VK L       +++   E+ ++ NL+ 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89

Query: 550 HRNLVRLLGCCVEREENM---LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG 606
             N++ L    V+   +    L++E++ N            Q+L D+  RF  +  I + 
Sbjct: 90  GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKA 142

Query: 607 LLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQD 652
           L Y H  S   I+HRD+K  N+++D +    ++ D+GLA  +   Q+
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 85.2 bits (211), Expect = 9e-18
 Identities = 38/183 (20%), Positives = 76/183 (41%), Gaps = 35/183 (19%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
            +N+ + + +G+G +G VY        + +A+K++++        F +         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77

Query: 544 VISNLQHRNLVRLLGCCV-EREENM----LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
           +++ L+   ++RL    + +         ++ E       K   +         L +   
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEEHI 131

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
           +  I+  +  G  ++H      IIHRDLK +N LL+ D + K+ DFGLAR     +D   
Sbjct: 132 KT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 656 TKR 658
              
Sbjct: 188 VND 190

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
           ++ L + LG G FG V  G+    G ++AVK L++    S     +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYL 610
           ++++L        +  ++ EY+    L  ++    R   ++  + F  I+  +     Y 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YC 127

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           HR     ++HRDLK  N+LLD  +N KI+DFGL+ + 
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 85.2 bits (211), Expect = 2e-17
 Identities = 53/182 (29%), Positives = 82/182 (45%), Gaps = 28/182 (15%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQH 550
           + F     LG+GGFG V+  +++   ++ A K+L+K      +G +  M E  +++ +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 551 RNLVRLLGCCVEREENM-LIYEYMP---------NKSLDSFLFDPQRQSLLDWPKRFNII 600
           R +V L     E + ++ L+   M          N   D+  F   R         F   
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
           + I  GL +LH+     II+RDLK  N+LLDDD N +ISD GLA      Q +       
Sbjct: 297 Q-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YA 350

Query: 661 GT 662
           GT
Sbjct: 351 GT 352

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 21/175 (12%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQG-QEEFMNEVMVISNLQHRN 552
           ++L   +G+GG G VY+ +     + +A+K +S+  +S    +     E      LQ  +
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 553 LVRL--LGCCVEREENMLIY---EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           +V +   G     E +  +Y     +    L + L   +RQ  L  P+   I++ I   L
Sbjct: 96  VVPIHDFG-----EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSAL 147

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
              H        HRD+K  NIL+  D    + DFG+A      +        VGT
Sbjct: 148 DAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGT 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 21/166 (12%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN------EV----MV 544
            ++L   LG+GGFG V+ G  L D  ++A+K + +    G     +      EV     V
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKG 602
            +   H  ++RLL     +E  ML+ E  P  + D  LFD   ++  L + P R      
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSR-CFFGQ 147

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIF 647
           +   + + H      ++HRD+K  NIL+D      K+ DFG   + 
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 32/174 (18%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
              +Q    +G G  G V         + +A+K+LS+        F N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 544 VISNLQHRNLVRLL------GCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           ++  + H+N++ LL          E ++  ++ E M     D+ L    +  L      +
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
            ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G + 
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.1 bits (208), Expect = 4e-17
 Identities = 54/179 (30%), Positives = 77/179 (43%), Gaps = 25/179 (13%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQH 550
           N F+    LG+GGFG V   +++   ++ A K+L K      +G+   +NE  ++  +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSL-------DSFLFDPQRQSLLDWPKRFNIIKGI 603
           R +V L      ++   L+   M    L           F   R         F   + I
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAE-I 295

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             GL  LHR    RI++RDLK  NILLDD  + +ISD GLA      Q     K  VGT
Sbjct: 296 CCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 348

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 39/170 (22%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
            + +   LG+G FG V      +  Q++A+K +S+              E+  +  L+H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSF---------LFD--PQRQSLLDWPKR--FN 598
           ++++L             Y+ +   + D           LFD   +++ + +   R  F 
Sbjct: 70  HIIKL-------------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ 115

Query: 599 -IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
            II  I     Y HR    +I+HRDLK  N+LLDD+LN KI+DFGL+ I 
Sbjct: 116 QIICAIE----YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 39/166 (23%), Positives = 61/166 (36%), Gaps = 32/166 (19%)

Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
            LG G  G V +    + GQ+ A+K L  +    QE    +          ++V +L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHH-WQASGGPHIVCILDVY 91

Query: 561 VEREENM----LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRFN------IIKGISRGLL 608
                      +I E M        LF    +R       + F       I++ I   + 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGE----LFSRIQERGD-----QAFTEREAAEIMRDIGTAIQ 142

Query: 609 YLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQ 651
           +LH      I HRD+K  N+L    + D   K++DFG A+    N 
Sbjct: 143 FLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 37/179 (20%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
              +   + +G+G +G V       +   +A+K++S         F +         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 544 VISNLQHRNLVRLLGCCV-EREENM----LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
           ++   +H N++ +         E M    ++ + M     K L +       Q L +   
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-------QHLSNDHI 130

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
            +  +  I RGL Y+H  S   ++HRDLK SN+LL+   + KI DFGLAR+   + D  
Sbjct: 131 CY-FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 12/157 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
           ++ L + LG G FG V  GK    G ++AVK L++    S     +   E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYL 610
           ++++L        +  ++ EY+    L  ++    R    +  + F  I+ G+     Y 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YC 132

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF 647
           HR     ++HRDLK  N+LLD  +N KI+DFGL+ + 
Sbjct: 133 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 41/173 (23%), Positives = 78/173 (45%), Gaps = 31/173 (17%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
              ++    +G G +G V      + G ++A+K+L +        F +         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 544 VISNLQHRNLVRLLGCCV--EREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           ++ +++H N++ LL      E  ++     L+  +M    L   +   + + L +   +F
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF 132

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
            ++  + +GL Y+H      IIHRDLK  N+ +++D   KI DFGLAR     
Sbjct: 133 -LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 38/183 (20%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
              ++L  KLG+G +G V+K    + G+ +AVK++  A       F N         E+M
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 544 VISNLQ-HRNLVRLLGCCVEREENM----LIYEYMP---NKSLDSFLFDPQRQSLLDWPK 595
           +++ L  H N+V LL   V R +N     L+++YM    +  + +         L    K
Sbjct: 61  ILTELSGHENIVNLLN--VLRADNDRDVYLVFDYMETDLHAVIRA-------NILEPVHK 111

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA 655
           ++ ++  + + + YLH  S   ++HRD+K SNILL+ + + K++DFGL+R F   +    
Sbjct: 112 QY-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 656 TKR 658
              
Sbjct: 168 NIP 170

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 35/167 (20%), Positives = 62/167 (37%), Gaps = 34/167 (20%)

Query: 502 KLGQGGFGPVYKG-KLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGC 559
            LG G  G V +    +  ++ A+K L         +   EV +        ++VR++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123

Query: 560 C---VEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKGISRGL 607
                   + + ++ E +    L    F     R       + F       I+K I   +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKSIGEAI 174

Query: 608 LYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQ 651
            YLH    + I HRD+K  N+L      +   K++DFG A+    + 
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 48/189 (25%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
            + +     LG GG G V+        + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 544 VISNLQHRNLVRLL----------GCCVEREENM----LIYEYMP---NKSLDSFLFDPQ 586
           +I  L H N+V++              V     +    ++ EYM       L+       
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ------ 114

Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLAR 645
              LL+   R   +  + RGL Y+H  +   ++HRDLK +N+ ++ +DL  KI DFGLAR
Sbjct: 115 -GPLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 646 IFGGNQDQA 654
           I   +    
Sbjct: 170 IMDPHYSHK 178

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 31/168 (18%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
              +Q  + +G G +G V      + G  +AVK+LS+        F +         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 544 VISNLQHRNLVRLLGCCV--EREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRF 597
           ++ +++H N++ LL         E      L+   M    L++ +   + Q L D   +F
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV---KCQKLTDDHVQF 136

Query: 598 NIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
            +I  I RGL Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 42/207 (20%), Positives = 80/207 (38%), Gaps = 59/207 (28%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMN-EVMVISNLQ 549
            ++  + L   LG G FG V +    + G+  A+K++ +        + N E+ ++  L 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLD 58

Query: 550 HRNLVRLLGCCVEREENM--------------------------------------LIYE 571
           H N+++L+       +                                        +I E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 572 YMP---NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI 628
           Y+P   +K L SF+     +S+         I  + R + ++H    L I HRD+K  N+
Sbjct: 119 YVPDTLHKVLKSFI--RSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIKPQNL 172

Query: 629 LLD---DDLNPKISDFGLARIFGGNQD 652
           L++   + L  K+ DFG A+    ++ 
Sbjct: 173 LVNSKDNTL--KLCDFGSAKKLIPSEP 197

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.4 bits (194), Expect = 8e-16
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 31/178 (17%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMN---------EVM 543
           +++FQL + LG+G +G V        G+ +A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 544 VISNLQHRNLVRLLGC-CVEREENM----LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN 598
           ++ + +H N++ +      +  EN     +I E M    L   +     Q L D   ++ 
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQY- 116

Query: 599 IIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            I    R +  LH      +IHRDLK SN+L++ + + K+ DFGLARI   +    + 
Sbjct: 117 FIYQTLRAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 52/223 (23%), Positives = 85/223 (38%), Gaps = 35/223 (15%)

Query: 445 FAKRKAMKENSKVQRLDLGEAYANFSTEKVNPARLQDLLVFNFEELANATNNFQLANKLG 504
            ++++++KE     + D  + +   S                        + F     LG
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQL------------------DQFDRIKTLG 50

Query: 505 QGGFGPVYKGKLQDGQEI-AVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCC 560
            G FG V   K ++     A+K L K      +  E  +NE  ++  +    LV+L    
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110

Query: 561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLYLHRDSRLRII 619
            +     ++ EY+    + S L   +R      P  RF     I     YLH    L +I
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLI 163

Query: 620 HRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +RDLK  N+L+D     +++DFG A+   G      T  L GT
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGT 201

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 17/174 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           ++F++   +G+G FG V   +  D +++ A+K ++K     + E      E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
             LV L     + EE+M ++ + +    L   L   Q+         +  I + +   L 
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICE-LVMALD 129

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           YL      RIIHRD+K  NILLD+  +  I+DF +A +      +     + GT
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGT 177

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 36/160 (22%), Positives = 61/160 (38%), Gaps = 34/160 (21%)

Query: 502 KLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGC 559
            LG G  G V +    +  ++ A+K L         +   EV +     Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79

Query: 560 C---VEREENM-LIYEYMPNKSLDSFLFD--PQRQSLLDWPKRF------NIIKGISRGL 607
                   + + ++ E +    L    F     R       + F       I+K I   +
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD-----QAFTEREASEIMKSIGEAI 130

Query: 608 LYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLA 644
            YLH    + I HRD+K  N+L      +   K++DFG A
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 12/156 (7%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +G G FG     +     + +AVK + + +    E    E++   +L+H N+V
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIV 79

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN-IIKGISRGLLYLHRD 613
           R     +      +I EY     L   + +  R S  +    F  ++ G+S    Y H  
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCHS- 134

Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIF 647
             ++I HRDLK  N LLD    P  KI DFG ++  
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.9 bits (183), Expect = 1e-14
 Identities = 35/208 (16%), Positives = 64/208 (30%), Gaps = 47/208 (22%)

Query: 484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRL--------SKASGQGQ 535
              F      T   Q   K+G+G FG V++    D   +A+K +        + +  +  
Sbjct: 10  PVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 536 EEFMNEVMVISNLQ---------HRNLVRLLGCCVER----EENMLIYEYM--------- 573
           EE + E+++   L              + L      +       +  +++          
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 574 -PNKSLDSFLF------------DPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH 620
            P+   D  LF            +  R  L       +I+  ++  L        LR  H
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEH 185

Query: 621 RDLKASNILLDDDLNPKISDFGLARIFG 648
           RDL   N+LL      K+      +   
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSST 213

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 27/178 (15%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKAS--GQGQEE-FMNEVMVISNLQH 550
            +FQ+   LG G FG V+  + +      A+K L K       Q E   +E +++S + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG------IS 604
             ++R+ G   + ++  +I +Y+    L S L   ++       +RF           + 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKS------QRFPNPVAKFYAAEVC 116

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             L YLH      II+RDLK  NILLD + + KI+DFG A+          T  L GT
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGT 166

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 16/155 (10%), Positives = 48/155 (30%), Gaps = 16/155 (10%)

Query: 497 FQLANKLGQGGFGPVYKGKLQD---GQEIAVKRL---SKASGQGQEEFMNEVMVISNLQH 550
           ++L    G       ++    D    +++A+  +           +E ++  + +S +  
Sbjct: 33  YRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             + R+L     R   +++ E++   SL                     ++ ++      
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAA 145

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           HR     +       S + +  D +  ++      
Sbjct: 146 HRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 39/172 (22%), Positives = 74/172 (43%), Gaps = 12/172 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
            ++++   +G+G FG V   + +  +++ A+K LSK     + +   F  E  +++    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +V+L     +     ++ EYMP   L + +       + +   RF   + +   L  +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVL-ALDAI 184

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H    +  IHRD+K  N+LLD   + K++DFG                 VGT
Sbjct: 185 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGT 232

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 12/173 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
            +F++   +G+G FG V   KL++  ++ A+K L+K     + E   F  E  V+ N   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           + +  L     + + N+ L+ +Y     L + L   + +   +   RF + + +   +  
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVI-AIDS 190

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +H+   L  +HRD+K  NIL+D + + +++DFG       +     +   VGT
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGT 239

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 19/168 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRL-SKASGQGQEEFMNEVMVISN 547
           +  +L   LG+G FG V +            + +AVK L   A+       M+E+ ++ +
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 548 L-QHRNLVRLLGCCVER-EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +  H N+V LLG C +     M+I E+    +L ++L            KR   +   ++
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
           G  +      +  I  DLK     +    +   S F   +     +++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
           +++G+ +L   +  + IHRDL A NILL +    KI DFGLAR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 12/173 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEE---FMNEVMVISNLQH 550
           ++F++   +G+G F  V   K++   ++ A+K ++K     + E   F  E  V+ N   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           R + +L     + E  + L+ EY     L + L     +   +   RF + + +   +  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAEIVM-AIDS 177

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           +HR   L  +HRD+K  NILLD   + +++DFG       +     +   VGT
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGT 226

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 66.8 bits (163), Expect = 9e-14
 Identities = 25/126 (19%), Positives = 48/126 (38%), Gaps = 21/126 (16%)

Query: 25  DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
           + +T+ + +   +S+      F +     D N       + Y+       T VW +N   
Sbjct: 2   NLLTNGEGLYAGQSLDVEPYHFIMQE---DCNL------VLYDHS-----TSVWASNTGI 47

Query: 85  PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
                     +  DGN VV + + +  W+S+      N N    L + GN+V++ +    
Sbjct: 48  LGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVR--GNGNYVLVLQEDGNVVIYGS---- 100

Query: 145 SIWDSF 150
            IW + 
Sbjct: 101 DIWSTG 106

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 13/173 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N F+    LG+G FG V   K +      A+K L K     ++E    + E  V+ N +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLLY 609
             L  L       +    + EY     L    F   R+ +    + RF   + +S  L Y
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVS-ALDY 263

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH  S   +++RDLK  N++LD D + KI+DFGL +   G +D A  K   GT
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 312

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 64.4 bits (157), Expect = 7e-13
 Identities = 22/125 (17%), Positives = 45/125 (36%), Gaps = 21/125 (16%)

Query: 25  DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
           ++++S   +    S+   G  ++L     D NF      + Y+ G       VW +N   
Sbjct: 2   NSLSSPNSLFTGHSL-EVGPSYRLIMQG-DCNF------VLYDSG-----KPVWASNTGG 48

Query: 85  PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
                        +GNLV+ +   +V W +  +      +    L    N+V++      
Sbjct: 49  LGSGCRLTLH--NNGNLVIYDQSNRVIWQTKTNG--KEDHYVLVLQQDRNVVIYGP---- 100

Query: 145 SIWDS 149
            +W +
Sbjct: 101 VVWAT 105

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 14/168 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVISNLQH 550
           N+F     LG+G FG V   + +      A+K L K     ++E    + E  V+ N +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 551 RNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
             L  L     +  + +  + EY     L    F   R+ +    + RF   + I   L 
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALE 119

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           YLH      +++RD+K  N++LD D + KI+DFGL +    +     T
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 27/165 (16%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RN 552
           N ++L  K+G G FG +Y G  +  G+E+A+K     +   Q     E  +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
           +  +  C  E + N+++ E +   SL+  LF+          ++F++        + ISR
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFC-------SRKFSLKTVLLLADQMISR 117

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK---ISDFGLARIF 647
            + Y+H  +    IHRD+K  N L+          I DFGLA+ +
Sbjct: 118 -IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 29/167 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RN 552
            NF++  K+G G FG +  GK L   + +A+K     S   Q     E      L     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDG 66

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
           + ++       + N ++ E +   SL+  LFD          + F++       I+ ISR
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLC-------DRTFSLKTVLMIAIQLISR 117

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK-----ISDFGLARIF 647
            + Y+H  +   +I+RD+K  N L+    N       I DF LA+ +
Sbjct: 118 -MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 65.6 bits (161), Expect = 1e-11
 Identities = 47/170 (27%), Positives = 88/170 (51%), Gaps = 16/170 (9%)

Query: 495 NNFQLANKLGQGGFGPVY---KGKLQDGQEI-AVKRLSKAS--GQGQEEFMNEVMVISNL 548
           + F+L   LGQG FG V+   K    D +++ A+K L KA+   + +     E  ++  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 549 QHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRG 606
            H  +V+L     + E  + LI +++    L  F     ++ +      +F + + ++  
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--F-TRLSKEVMFTEEDVKFYLAE-LALA 138

Query: 607 LLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           L +LH    L II+RDLK  NILLD++ + K++DFGL++    ++ +A +
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 66.6 bits (162), Expect = 2e-11
 Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNE--VMVISNL 548
            +F     LG+G FG V   + +   E+ AVK L K      ++    M E  V+ +   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 399

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
           +   L +L  C    +    + EY+    L   ++  Q+      P   F     I+ GL
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF-YAAEIAIGL 455

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            +L       II+RDLK  N++LD + + KI+DFG+ +    +     T
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 60.7 bits (147), Expect = 2e-11
 Identities = 19/135 (14%), Positives = 44/135 (32%), Gaps = 24/135 (17%)

Query: 15  YSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANK 74
           +S          + +++ +     I+     ++      D N       + Y+       
Sbjct: 5   FSKQPDDNHPQILHATESL----EILFGTHVYRF-IMQTDCNL------VLYDNN----- 48

Query: 75  TVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGN 134
             +W  N       +     +  DG LVV+  +    W S V+      +    L    N
Sbjct: 49  NPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAG--KAGHYVLVLQPDRN 104

Query: 135 LVLHDNISQVSIWDS 149
           +V++ +    ++W +
Sbjct: 105 VVIYGD----ALWAT 115

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 60.3 bits (146), Expect = 2e-11
 Identities = 22/125 (17%), Positives = 39/125 (31%), Gaps = 22/125 (17%)

Query: 25  DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
           + + S Q +    S+ +              N       + Y  G       +W +N ++
Sbjct: 3   NVLLSGQTLHADHSLQAGAYTLT---IQNKCNL------VKYQNG-----RQIWASNTDR 48

Query: 85  PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
               S    T+  DGNLV+ +      W S      +N      L   G  V++      
Sbjct: 49  R--GSGCRLTLLSDGNLVIYDHNNNDVWGSACWG--DNGKYALVLQKDGRFVIYGP---- 100

Query: 145 SIWDS 149
            +W  
Sbjct: 101 VLWSL 105

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 32/167 (19%), Positives = 73/167 (43%), Gaps = 29/167 (17%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RN 552
            ++++  ++G+G FG +++G  L + Q++A+K   + S   Q     E      L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTG 67

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
           +  +     E   N+L+ + +   SL+  L D          ++F++        + ++R
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLC-------GRKFSVKTVAMAAKQMLAR 118

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK-----ISDFGLARIF 647
            +  +H  S   +++RD+K  N L+    +       + DFG+ + +
Sbjct: 119 -VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 64.1 bits (157), Expect = 3e-11
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 18/172 (10%)

Query: 495 NNFQLANKLGQGGFGPVY---KGKLQDGQEI-AVKRLSKAS----GQGQEEFMNEVMVIS 546
             F+L   LG+GG+G V+   K    +  +I A+K L KA      +       E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 547 NLQHRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGIS 604
            ++H  +V L+    +    + LI EY+    L       +R+ +       F + + IS
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAE-IS 131

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
             L +LH+     II+RDLK  NI+L+   + K++DFGL +    +     T
Sbjct: 132 MALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 42/189 (22%), Positives = 74/189 (39%), Gaps = 65/189 (34%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ------ 549
           + L  KLG G F  V+  K + +   +A+K + +      E   +E+ ++  +       
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 550 -----HRNLVRLLGCCVEREENMLIYEYMPNKSLDSF------------LFDPQRQSLLD 592
                  ++++LL                     D F            +F+   ++LL 
Sbjct: 80  EDSMGANHILKLL---------------------DHFNHKGPNGVHVVMVFEVLGENLLA 118

Query: 593 WPKRFN-------IIKGISR----GLLYLHRDSRLRIIHRDLKASNILLDDDLNP----- 636
             K++         +K IS+    GL Y+HR  R  IIH D+K  N+L++   +P     
Sbjct: 119 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 176

Query: 637 -KISDFGLA 644
            KI+D G A
Sbjct: 177 IKIADLGNA 185

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 27/165 (16%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           N F+L  K+G G FG +Y G  +Q  +E+A+K  +  +   Q  +  E  +   LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64

Query: 554 V-RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI-------IKGISR 605
           +  +    VE + N+L+ + +   SL+  LF+          ++ ++        + I+R
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFC-------SRKLSLKTVLMLADQMINR 115

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPK---ISDFGLARIF 647
            + ++H  S    +HRD+K  N L+          I DFGLA+ +
Sbjct: 116 -VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVIS-NLQ 549
           +NF+    LG+G FG V   ++++  ++ AVK L K      ++    M E  ++S    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
           H  L +L  C    +    + E++    L   +F  Q+    D  + RF     I   L+
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-YAAEIISALM 138

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           +LH      II+RDLK  N+LLD + + K++DFG+ +    N    AT
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.4 bits (155), Expect = 5e-11
 Identities = 50/169 (29%), Positives = 75/169 (44%), Gaps = 15/169 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMV-ISNLQ 549
            +F L   +G+G +  V   +L+    I A+K + K      E+      E  V      
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 550 HRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
           H  LV L   C + E  +  + EY+    L   +F  QRQ  L     RF   + IS  L
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 123

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            YLH      II+RDLK  N+LLD + + K++D+G+ +      D  +T
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 54/168 (32%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-- 550
              + +  KLG G F  V+    +Q  + +A+K + K++    E  ++E+ ++ ++++  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 551 -----RNLVRLLGCCVEREENMLIYEYMPNKSLDSF------------LFDPQRQSLLDW 593
                R +V  L                    LD F            +F+     LL W
Sbjct: 95  PNDPNREMVVQL--------------------LDDFKISGVNGTHICMVFEVLGHHLLKW 134

Query: 594 PKRFN-------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILL 630
             + N        +K I + +L    YLH  ++ RIIH D+K  NILL
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILL 180

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 58.7 bits (142), Expect = 8e-11
 Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 22/125 (17%)

Query: 25  DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
           + + S + +   E + +   ++       D N       + Y+         +W  N   
Sbjct: 2   NILYSGETLSPGEFLNNG--RYVFIMQE-DCNL------VLYDVD-----KPIWATNTGG 47

Query: 85  PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
              D     ++  DGNLVV + +    W+SN      N N    L    N+V++      
Sbjct: 48  L--DRRCHLSMQSDGNLVVYSPRNNPIWASNTGG--ENGNYVCVLQKDRNVVIYGT---- 99

Query: 145 SIWDS 149
           + W +
Sbjct: 100 ARWAT 104

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 63.0 bits (154), Expect = 9e-11
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 13/168 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVIS-NLQ 549
            +F L   LG+G FG V+  + +   +  A+K L K      ++    M E  V+S   +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
           H  L  +      +E    + EY+    L   ++  Q     D  +  F     I  GL 
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATF-YAAEIILGLQ 132

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           +LH      I++RDLK  NILLD D + KI+DFG+ +       +  T
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.0 bits (154), Expect = 9e-11
 Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNE--VMVISNL 548
            +F     LG+G FG V   + +   E+ AVK L K      ++    M E  V+ +   
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 78

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
           +   L +L  C    +    + EY+    L   ++  Q+      P   F     I+ GL
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF-YAAEIAIGL 134

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            +L       II+RDLK  N++LD + + KI+DFG+ +    +     T
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMV-ISNLQ 549
           ++F     +G+G FG V   + +  +   AVK L K +   ++E    M+E  V + N++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 550 HRNLVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGL 607
           H  LV L     +  + +  + +Y+    L    +  QR+     P+ RF   + I+  L
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAE-IASAL 152

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
            YLH    L I++RDLK  NILLD   +  ++DFGL 
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 13/168 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI-AVKRLSKASGQGQEEF---MNEVMVIS-NLQ 549
            +F L   +G+G +  V   +L+    I A++ + K      E+      E  V      
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGISRGLL 608
           H  LV L  C         + EY+    L   +F  QRQ  L     RF   + IS  L 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 167

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           YLH      II+RDLK  N+LLD + + K++D+G+ +      D  +T
Sbjct: 168 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 56.9 bits (137), Expect = 4e-10
 Identities = 29/126 (23%), Positives = 51/126 (40%), Gaps = 20/126 (15%)

Query: 24  TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRN 83
           +D + S   +    S+      +     + D N       + Y+         VW +  N
Sbjct: 1   SDRLNSGHQLDTGGSLAEG--GYLFIIQN-DCNL------VLYDNN-----RAVWASGTN 46

Query: 84  KPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQ 143
                S  +  +  DGNLV+ +G + + W+SN +    N N    L    N+V++DN S 
Sbjct: 47  GK--ASGCVLKMQNDGNLVIYSGSRAI-WASNTNR--QNGNYYLILQRDRNVVIYDN-SN 100

Query: 144 VSIWDS 149
            +IW +
Sbjct: 101 NAIWAT 106

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 19/161 (11%)

Query: 495 NNFQLANKLGQGGFGPVY---KGKLQDGQEI-AVKRLSKAS----GQGQEEFMNEVMVIS 546
            NF+L   LG G +G V+   K    D  ++ A+K L KA+     +  E    E  V+ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 547 NLQHRN-LVRLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPK-RFNIIKGI 603
           +++    LV L     + E  + LI +Y+    L + L    ++      + +  + + I
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGE-I 168

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA 644
              L +LH+   L II+RD+K  NILLD + +  ++DFGL+
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 37/204 (18%), Positives = 75/204 (36%), Gaps = 50/204 (24%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEI------AVKRLSKASGQ-----------GQEE 537
             +++   +GQGGFG +Y   +   + +       VK     +G             + E
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 538 FMNEVMVISNLQHRNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW 593
            + + +    L++  + +  G        +    +I +           F    Q + + 
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD----------RFGSDLQKIYEA 144

Query: 594 -PKRFNI-------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI--SDFGL 643
             KRF+        ++ +   L Y+H       +H D+KASN+LL+     ++   D+GL
Sbjct: 145 NAKRFSRKTVLQLSLRILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200

Query: 644 ARIF---GGNQD--QAATKRLVGT 662
           A  +   G ++       +   GT
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGT 224

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 34/181 (18%), Positives = 67/181 (37%), Gaps = 42/181 (23%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIA---VKRLSKASGQ-----------GQEEFM 539
           N + L  K+G GGFG +Y        ++ A   VK   + +G             +++ +
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 540 NEVMVISNLQHRNLVRLLGC----CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPK 595
            + +    L +  +    G        R    ++ E +    L         Q +     
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDL---------QKISGQNG 146

Query: 596 RFNI-------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI--SDFGLARI 646
            F         I+ +   L Y+H +     +H D+KA+N+LL      ++  +D+GL+  
Sbjct: 147 TFKKSTVLQLGIRMLDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

Query: 647 F 647
           +
Sbjct: 203 Y 203

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 54.5 bits (131), Expect = 2e-09
 Identities = 19/130 (14%), Positives = 41/130 (31%), Gaps = 23/130 (17%)

Query: 20  TATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWV 79
                + + S Q +     + +   +  +     D N       + Y           W 
Sbjct: 2   IPFTNNLLFSGQVLYGDGRLTAKNHQLVMQG---DCNL------VLYGG------KYGWQ 46

Query: 80  ANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHD 139
           +N +           ++  G L++ +   +  WSS  SS          L D G  V++ 
Sbjct: 47  SNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSRSSS--KQGEYVLILQDDGFGVIYG 102

Query: 140 NISQVSIWDS 149
                +I+++
Sbjct: 103 P----AIFET 108

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 52.6 bits (126), Expect = 1e-08
 Identities = 23/127 (18%), Positives = 40/127 (31%), Gaps = 25/127 (19%)

Query: 23  ATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANR 82
            T+ + S Q +     + +      +     D N    Y G W +   +  +        
Sbjct: 2   GTNYLLSGQTLDTEGHLKNGDFDLVMQ---DDCNLV-LYNGNWQSNTANNGRDCK----- 52

Query: 83  NKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNIS 142
                      T+++ G LV+ NG     W S   S     N  A +   G LV+     
Sbjct: 53  ----------LTLTDYGELVIKNGDGSTVWKSGAQS--VKGNYAAVVHPDGRLVVFGP-- 98

Query: 143 QVSIWDS 149
             S++  
Sbjct: 99  --SVFKI 103

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 26/183 (14%), Positives = 58/183 (31%), Gaps = 43/183 (23%)

Query: 495 NNFQLANKLGQGGFGPVYKGK---------LQDGQEIAVKRLSKASGQGQEEFMNEVMVI 545
             ++L +   +   G +Y+               Q+ ++K L    G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 546 SNLQHRNLVRLLGC------------CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW 593
             LQ     +L                 + +   L+   +  +SL S L    +      
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK------ 153

Query: 594 PKRFNI-------IKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI--SDFGLA 644
               +         + +   L +LH +     +H ++ A NI +D +   ++  + +G A
Sbjct: 154 -HVLSERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

Query: 645 RIF 647
             +
Sbjct: 209 FRY 211

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 52.1 bits (125), Expect = 2e-08
 Identities = 16/127 (12%), Positives = 37/127 (29%), Gaps = 20/127 (15%)

Query: 23  ATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANR 82
             + + SSQ + D   + +            D N       +           +VW +  
Sbjct: 5   VRNVLFSSQVMYDNAQLATRDYSLV---MRDDCNL------VLTKGS---KTNIVWESGT 52

Query: 83  NKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNIS 142
           +           +   G L + + +    + SN        +    L  +G  V++    
Sbjct: 53  SGR--GQHCFMRLGHSGELDITDDRLNTVFVSNTVG--QEGDYVLILQINGQAVVYGP-- 106

Query: 143 QVSIWDS 149
             ++W +
Sbjct: 107 --AVWST 111

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 37/170 (21%), Positives = 69/170 (40%), Gaps = 33/170 (19%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK------RLSKASGQGQEEFMNEVMVIS 546
            + +++ + +G+G FG V K     + + +A+K           +         EV ++ 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLE 105

Query: 547 NLQHR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNII 600
            +          +V L    + R    L++E + + +L   L +   + +       N+ 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGV-----SLNLT 159

Query: 601 KGISR----GLLYLHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLA 644
           +  ++     LL+L     L IIH DLK  NILL +      KI DFG +
Sbjct: 160 RKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 37/169 (21%), Positives = 72/169 (42%), Gaps = 39/169 (23%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVK------RLSKASGQGQEEFMNEVMVISNLQ 549
           +++   +G+G FG V K    +  Q +A+K      R  + +         E+ ++ +L+
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLR 151

Query: 550 HR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNI--IK 601
            +      N++ +L     R    + +E      L   L++  +++     + F++  ++
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKF---QGFSLPLVR 203

Query: 602 GISR----GLLYLHRDSRLRIIHRDLKASNILLDDDLNP--KISDFGLA 644
             +      L  LH+    RIIH DLK  NILL        K+ DFG +
Sbjct: 204 KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 51.2 bits (121), Expect = 4e-07
 Identities = 37/257 (14%), Positives = 73/257 (28%), Gaps = 36/257 (14%)

Query: 20  TATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFT--NRYIGIWYNKGGSANKTVV 77
               T  + + Q +   + ++S   +FKL     DGN    +    +W            
Sbjct: 10  NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQ-GDGNLVIQDNGATVWVA--NEQQPFSS 66

Query: 78  WVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS---NTRAQLLDSGN 134
            +  RNK                  + +  ++  W ++ S+  +N     T   L D GN
Sbjct: 67  TIPLRNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGN 121

Query: 135 LVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSL-SNPSIGSFSAGL 193
           +VL D+++  +   +         S +             L     L      G+ ++ L
Sbjct: 122 IVLVDSLALWNGTPAIPLVPGAIDSLL-------------LAPGSELVQGVVYGAGASKL 168

Query: 194 DSFTIPEVFIWINGTRPYWRSGPW--NGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTF 251
                  +  +       W +G         +   D N V     N          + + 
Sbjct: 169 VFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGN-------AVLWHSH 221

Query: 252 AFADNDVFFALTPQGNL 268
                     L   G++
Sbjct: 222 TGGHASAVLRLQANGSI 238

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 47.7 bits (112), Expect = 4e-06
 Identities = 22/115 (19%), Positives = 38/115 (33%), Gaps = 9/115 (7%)

Query: 36  PESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTI 95
              +++ GS+   G     G     + G         N    W A         +     
Sbjct: 145 DSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGK---GAVRAVF 201

Query: 96  SEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSF 150
             DGNLVV      V W S+      +++   +L  +G++ + D      +W  F
Sbjct: 202 QGDGNLVVYGAGNAVLWHSHTG---GHASAVLRLQANGSIAILDE---KPVWARF 250

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 42.7 bits (99), Expect = 2e-04
 Identities = 23/150 (15%), Positives = 38/150 (25%), Gaps = 15/150 (10%)

Query: 11  SSCFYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFF-SPDGNFTNRYIGIWYN-- 67
           +   +     A   D      ++ D  +  S+    +       DGN         +N  
Sbjct: 75  APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGT 134

Query: 68  --------KGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSL 119
                      S          +       +       DGNLV         W++     
Sbjct: 135 PAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQ-- 192

Query: 120 ANNSNTRAQLLDSGNLVLHDNISQVSIWDS 149
                 RA     GNLV++       +W S
Sbjct: 193 -GKGAVRAVFQGDGNLVVYGA-GNAVLWHS 220

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 41/196 (20%), Positives = 65/196 (33%), Gaps = 62/196 (31%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVK------RLSKASGQGQEEFMNEVMVIS 546
            N F +  K+G G FG V   + + + +  AVK      + ++++         E  ++ 
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILK 86

Query: 547 NLQHR-----NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLLDW 593
            +Q+      N+V+                         F+        F+P   SL + 
Sbjct: 87  KIQNDDINNNNIVKYH---------------------GKFMYYDHMCLIFEPLGPSLYEI 125

Query: 594 PKRFN-------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG 642
             R N        IK     +L    YL +   + + H DLK  NILLDD    K     
Sbjct: 126 ITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182

Query: 643 LARIFGGNQDQAATKR 658
                G       TK 
Sbjct: 183 RRVTDGKKIQIYRTKS 198

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 46.5 bits (109), Expect = 9e-06
 Identities = 13/77 (16%), Positives = 24/77 (31%), Gaps = 8/77 (10%)

Query: 73  NKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDS 132
               VW  N          +     +G + VL  +    W+S  S   +       L   
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSR--SAGRYVFVLQPD 222

Query: 133 GNLVLHDNISQVSIWDS 149
            NL ++      ++W +
Sbjct: 223 RNLAIYGG----ALWTT 235

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 44.9 bits (105), Expect = 3e-05
 Identities = 34/172 (19%), Positives = 57/172 (33%), Gaps = 7/172 (4%)

Query: 64  IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
           I +  G S   +     +  + L  SS  FT+  D NLV+ +      W+SN +     +
Sbjct: 3   ILF--GLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV-RVWASNTA---GAT 56

Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSN 183
             RA L   G LV+    + +  W S  + +   Y  +       T     L    + + 
Sbjct: 57  GCRAVLQSDGLLVILTAQNTI-RWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNK 115

Query: 184 PSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDG 235
            S+   + G       +       T    +S   +        D N V  D 
Sbjct: 116 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR 167

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111

 Score = 42.1 bits (99), Expect = 5e-05
 Identities = 16/125 (12%), Positives = 36/125 (28%), Gaps = 22/125 (17%)

Query: 26  TITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKP 85
            + +   I     +    + F +     D N       + YN+         + +N +  
Sbjct: 4   VLLTGDVIHTDNQLSYESAAFVMQG---DCNL------VLYNEA------GGFQSNTHGR 48

Query: 86  LIDSSGIFTISEDGNLVVLNGK-KQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
                    ++  G L + +       W    S      N  A L    ++ ++      
Sbjct: 49  --GVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP---- 102

Query: 145 SIWDS 149
           +IW +
Sbjct: 103 AIWST 107

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 5e-05
 Identities = 38/249 (15%), Positives = 74/249 (29%), Gaps = 76/249 (30%)

Query: 452 KENSKVQRLDLGEA--------YANFSTEKVNPARLQDLLVFNFEELANATNNF------ 497
           K+   VQ+  + E          +   TE+  P+ +  + +   + L N    F      
Sbjct: 74  KQEEMVQKF-VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132

Query: 498 ------QLANKL------------GQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM 539
                 +L   L            G  G G   K  +      A+      S + Q +  
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCL--SYKVQCKMD 181

Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDW----PK 595
            ++  ++          L  C   E  + + + +       +  DP   S  D       
Sbjct: 182 FKIFWLN----------LKNCNSPETVLEMLQKL------LYQIDPNWTSRSDHSSNIKL 225

Query: 596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD-FGL-ARIFGGNQDQ 653
           R + I+             RL +  +  +   ++L +  N K  + F L  +I    + +
Sbjct: 226 RIHSIQ---------AELRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFK 275

Query: 654 AATKRLVGT 662
             T  L   
Sbjct: 276 QVTDFLSAA 284

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.2 bits (105), Expect = 8e-05
 Identities = 32/177 (18%), Positives = 64/177 (36%), Gaps = 48/177 (27%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK--LQDGQEIAVK------RLSKASGQGQEEFMNEVMVI 545
           +  +++ + LG+G FG V +       G+ +AVK      R  +A+        +E+ V+
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVL 65

Query: 546 SNLQHR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFN- 598
            +L           V++L          +++E +               S  D+ K    
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-------------GLSTYDFIKENGF 112

Query: 599 ------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR 645
                  I+ ++  +     +LH     ++ H DLK  NIL       +  +  + R
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 9e-05
 Identities = 30/201 (14%), Positives = 64/201 (31%), Gaps = 83/201 (41%)

Query: 494 TNNFQLANKLGQGGFGPVYKG--KLQDGQEIAVK------RLSKASGQGQEEFMNEVMVI 545
              +++   LG+G FG V +     +   ++A+K      +  +A+         E+ V+
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVL 70

Query: 546 SNLQHR------NLVRLLGCCVEREENMLIYEYMPNKSLDSFL--------FDPQRQSLL 591
             ++ +        V +                      D F         F+   ++  
Sbjct: 71  KKIKEKDKENKFLCVLMS---------------------DWFNFHGHMCIAFELLGKNTF 109

Query: 592 DWPKRFN-------IIKGISRGLL----YLHRDSRLRIIHRDLKASNILLDDDLNP---- 636
           ++ K  N        ++ ++  L     +LH     ++ H DLK  NIL  +        
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN 166

Query: 637 ---------------KISDFG 642
                          +++DFG
Sbjct: 167 EHKSCEEKSVKNTSIRVADFG 187

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	662
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.98
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.98
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.98
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.98
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.95
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.95
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.94
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.94
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.93
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.93
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.93
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.93
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.93
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.93
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.93
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.93
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.92
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.92
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.92
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.92
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.92
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.92
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.92
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.92
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.92
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.92
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.92
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.92
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.92
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.92
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.92
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.92
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.92
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.92
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.92
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.92
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.92
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.92
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.91
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.91
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.91
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.91
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.91
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.91
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.91
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.91
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.91
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.91
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.91
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.91
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.91
3bhy_A	283	Death-associated protein kinase 3; death associate	99.91
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.91
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.91
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.91
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.91
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.91
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.91
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.91
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.91
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.91
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.91
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.91
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.91
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.91
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.91
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.91
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.9
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.9
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.9
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.9
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.9
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.9
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.9
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.9
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.9
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.9
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.9
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.9
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.9
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.9
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.9
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.9
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.9
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.9
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.9
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.9
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
3uqc_A	286	Probable conserved transmembrane protein; structur	99.9
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.9
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.9
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.9
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.9
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.9
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.89
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.89
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.89
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.89
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.89
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.89
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.89
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.89
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.89
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.89
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.89
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.88
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.88
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.88
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.88
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.88
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.88
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.88
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.88
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.87
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.87
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.87
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.87
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.87
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.87
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.87
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.86
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.86
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.86
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.84
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.84
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.82
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.81
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.77
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.72
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.72
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.68
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.68
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.64
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.61
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.58
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.57
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.34
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.33
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.16
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.16
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.12
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.07
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.93
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.8
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.6
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.47
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.43
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.24
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.93
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.92
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.8
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.52
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.12
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.96
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.93
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.88
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.64
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.48
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.71
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.24
2ll3_A	82	Micronemal protein 4; cell adhesion; NMR {Toxoplas	86.97
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.94
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.19

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=6.5e-43  Score=355.84  Aligned_cols=225  Identities=16%  Similarity=0.178  Sum_probs=173.5

Q ss_pred             cccccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCC----CceEEE
Q 006090           20 TATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDS----SGIFTI   95 (662)
Q Consensus        20 ~~~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~----~~~l~~   95 (662)
                      ++++.|+|++|++|++|++|+|++|.|+||||+++    ++||   |+    +.+ |||+|||+.|+.++    +++|+|
T Consensus        10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~----~~~l---y~----~~~-vvW~Anr~~p~~~~~~~~~~~l~l   77 (276)
T 3m7h_A           10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG----NLVI---QD----NGA-TVWVANEQQPFSSTIPLRNKKAPL   77 (276)
T ss_dssp             CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS----CEEE---EE----TTE-EEEECSTTSTTEEEEECCCTTCCS
T ss_pred             ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC----CeEE---EC----CCC-eEEECCCCCCcCCcccccceEEEE
Confidence            35678999999999999999999999999999543    5676   65    456 99999999999874    689999


Q ss_pred             ecCccEEE--EcCCCCEEEeeccccCc---CCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           96 SEDGNLVV--LNGKKQVHWSSNVSSLA---NNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        96 ~~~G~l~l--~~~~~~~~w~~~~~~~~---~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      +.||+|+|  .|++|.+||+|++....   ..+++.|+|+|+|||||+|   +.+||||  ||||||||||++|.++++|
T Consensus        78 ~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g  152 (276)
T 3m7h_A           78 AFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPG  152 (276)
T ss_dssp             EEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred             eCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccC
Confidence            99999999  78889999999975311   0246799999999999997   5689999  9999999999999999998


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCCCCcceecccCCcceeeeeeEeeecCCCCeEEEE
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLT  250 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (662)
                      ++  |   ++.+||++|.|+++||+++.  ++++.++..+||++|+|++.....    .......+.+...+ ....+.+
T Consensus       153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l----~l~~dGnLvl~d~~-~~~vWsS  220 (276)
T 3m7h_A          153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRA----VFQGDGNLVVYGAG-NAVLWHS  220 (276)
T ss_dssp             EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEE----EECTTSCEEEECTT-SCEEEEC
T ss_pred             cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEE----EEcCCCeEEEEeCC-CcEEEEe
Confidence            65  6   57899999999999999985  445534568999999997643111    11111122222221 2234433


Q ss_pred             EEEeCCcEEEEEccCCcEEEEEe
Q 006090          251 FAFADNDVFFALTPQGNLEERAW  273 (662)
Q Consensus       251 ~~~~~~~~~~~l~~~G~l~~~~~  273 (662)
                      ++......+++|+.||+|++|.|
T Consensus       221 ~t~~~~~~rl~Ld~dGnLvly~~  243 (276)
T 3m7h_A          221 HTGGHASAVLRLQANGSIAILDE  243 (276)
T ss_dssp             SCTTCTTCEEEECTTSCEEEEEE
T ss_pred             cCCCCCCEEEEEcCCccEEEEcC
Confidence            33323344599999999999987

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=2.7e-36  Score=302.01  Aligned_cols=216  Identities=14%  Similarity=0.202  Sum_probs=163.5

Q ss_pred             cccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccE
Q 006090           22 TATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNL  101 (662)
Q Consensus        22 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l  101 (662)
                      ++.|+|.+|++|.+|++|  ++|.|+|||+.++ +     +. +|..     +++||+|||+.|   ..++|+|+.||||
T Consensus         6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~g-n-----l~-ly~~-----~~~vW~an~~~~---~~~~l~l~~dGnL   68 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDC-N-----LV-LFDS-----DVRVWASNTAGA---TGCRAVLQSDGLL   68 (236)
T ss_dssp             CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTS-C-----EE-EEES-----SSEEECCCCCSC---SCCBCCBCSSSCB
T ss_pred             eccceeCCCCEECCCCEE--EcCCEEEEECCCC-c-----EE-EEEC-----CEEEEECCCCCC---CCeEEEEcCCCcE
Confidence            567999999999999999  5999999999776 4     22 3432     499999999988   4578999999999


Q ss_pred             EEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCcccc-ccCCcccccc-cCCc-----eeE
Q 006090          102 VVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTF-YSEMKVSTDL-RTGK-----KVQ  174 (662)
Q Consensus       102 ~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTl-Lpg~~l~~~~-~tg~-----~~~  174 (662)
                      ||+|++|.+||+|++..  ..+...|+|+|+|||||++.    ++||||||||||+ ||+|  |.+. .+|+     +++
T Consensus        69 vl~d~~~~~vW~s~~~~--~~~~~~~~l~d~Gnlvl~~~----~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~  140 (236)
T 1dlp_A           69 VILTAQNTIRWSSGTKG--SIGNYVLVLQPDRTVTIYGP----GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQT  140 (236)
T ss_dssp             CCBCTTTCCSCCCCCCC--CSSCCEEEECSSSCEEEECS----EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCE
T ss_pred             EEEcCCCcEEEeCCccc--cCCcEEEEEeCCCCEEEecC----CEEECCCCCCcccccCCc--cceEEecCCcCCCccce
Confidence            99999999999999763  23456899999999999952    7999999999887 6765  5554 6665     567


Q ss_pred             EEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCCCCcceecccCCcceeeeeeEeeecCCCCeEEEEEEEe
Q 006090          175 LTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGRYFIGIPDMNSVYLDGFNLGEDHQKGTRYLTFAFA  254 (662)
Q Consensus       175 L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (662)
                      |+   +.+||++|.|+|+|+++|  +++++ ++..+||++++|++. +...+++..... .+.+..+  ..+.+.++...
T Consensus       141 L~---s~~d~s~G~~~l~l~~dG--~LvL~-~~~~~~W~s~~~~~~-~~~~~~L~~~Gn-l~ly~~~--~~~vw~s~~~~  210 (236)
T 1dlp_A          141 LH---ATQSLQLSPYRLSMETDC--NLVLF-DRDDRVWSTNTAGKG-TGCRAVLQPNGR-MDVLTNQ--NIAVWTSGNSR  210 (236)
T ss_dssp             EC---SSCCCBCSSCEEEEETTT--EEEEE-BTTBCCSCCCCCSSC-SSCEEEEETTTE-EEEEETT--TEEEEECCCCC
T ss_pred             EE---cCcEeecCcEEEEECCCC--cEEEE-cCCEeEEeCCCcCCC-CceEEEECCCCc-EEEEeCC--CcEEEEeCCCC
Confidence            87   478999999999999998  56666 777899999999653 445555532211 1112112  34455544433


Q ss_pred             CC-cEEEEEccCCcEEEEE
Q 006090          255 DN-DVFFALTPQGNLEERA  272 (662)
Q Consensus       255 ~~-~~~~~l~~~G~l~~~~  272 (662)
                      +. ...++||+||++++|.
T Consensus       211 ~~~~~rl~Ld~dG~l~ly~  229 (236)
T 1dlp_A          211 SAGRYVFVLQPDRNLAIYG  229 (236)
T ss_dssp             SSSCCEEEECSSSCEEEEC
T ss_pred             CCCCEEEEEcCCCcEEEeC
Confidence            33 2349999999999984

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-35  Score=306.01  Aligned_cols=166  Identities=31%  Similarity=0.542  Sum_probs=142.2

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      .++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            357888999999999999999864      46789999998766667789999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceE
Q 006090          568 LIYEYMPNKSLDSFLFDP----------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK  637 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  637 (662)
                      ||||||++|+|.++|++.          .....++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            999999999999999642          23456999999999999999999999987   99999999999999999999


Q ss_pred             EEeeCccccccCCcccccccccccC
Q 006090          638 ISDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       638 i~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      |+|||+|+.+.............||
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt  193 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLP  193 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred             ECCcccceecCCCCceeecCceecC
Confidence            9999999988665443333334454

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=307.39  Aligned_cols=165  Identities=29%  Similarity=0.505  Sum_probs=134.6

Q ss_pred             cccccccccCccCceeEEEEEEc------CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|.+.++||+|+||+||+|+++      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56788899999999999999864      467899999987766777899999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          569 IYEYMPNKSLDSFLFDPQ------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      |||||++|+|.++|++..            ...+++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999996532            1246999999999999999999999987   9999999999999999999


Q ss_pred             EEEeeCccccccCCcccccccccccC
Q 006090          637 KISDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       637 ki~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      ||+|||+|+.+..........+.+||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt  223 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLP  223 (329)
T ss_dssp             EECCCC----------------CCCC
T ss_pred             EEcccccceeccCCCcceecCccccc
Confidence            99999999988655443334445554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-34  Score=301.19  Aligned_cols=165  Identities=33%  Similarity=0.513  Sum_probs=140.2

Q ss_pred             cccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      .++++.++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566899999999999999873      46789999997543 344678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006090          568 LIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL  634 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~  634 (662)
                      ||||||++|+|.++|.....             ...++|.++++|+.|||+||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999964321             246999999999999999999999987   99999999999999999


Q ss_pred             ceEEEeeCccccccCCcccccccccccC
Q 006090          635 NPKISDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       635 ~~ki~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      .+||+|||+|+.+........+...+||
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt  210 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLP  210 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred             CEEECCcccceeccCCCceeEecccccC
Confidence            9999999999988655444344445565

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6e-34  Score=294.72  Aligned_cols=162  Identities=31%  Similarity=0.427  Sum_probs=145.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+++.. +++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999975 6899999999653   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.++|.+   ...+++.++..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+..+
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999953   345899999999999999999999998   999999999999999999999999999999766


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      .....+.+++||
T Consensus       186 ~~~~~~~~~~GT  197 (311)
T 4aw0_A          186 SKQARANSFVGT  197 (311)
T ss_dssp             TTCCCBCCCCSC
T ss_pred             CCcccccCcccC
Confidence            555556668887

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-33  Score=296.41  Aligned_cols=159  Identities=27%  Similarity=0.447  Sum_probs=142.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +.|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999975 68999999997655556677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ  653 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~  653 (662)
                      ++|+|.+++.+    ..+++.++..++.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+......
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999943    35899999999999999999999998   999999999999999999999999999988665432


Q ss_pred             ccccccccC
Q 006090          654 AATKRLVGT  662 (662)
Q Consensus       654 ~~~~~~~Gt  662 (662)
                        ..+++||
T Consensus       227 --~~~~~GT  233 (346)
T 4fih_A          227 --RKSLVGT  233 (346)
T ss_dssp             --BCCCCSC
T ss_pred             --ccccccC
Confidence              3346777

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=293.13  Aligned_cols=161  Identities=30%  Similarity=0.529  Sum_probs=132.4

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+++.+.++||+|+||+||+|+++  ..||||+++..  ..+..++|.+|++++++++|||||+++|+|.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            456788899999999999999975  36999998643  33456789999999999999999999999864 56899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ||++|+|.++|+..  ...++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+||+|||+|+.+....
T Consensus       112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999643  345999999999999999999999987   9999999999999999999999999999886554


Q ss_pred             ccccccccccC
Q 006090          652 DQAATKRLVGT  662 (662)
Q Consensus       652 ~~~~~~~~~Gt  662 (662)
                      ....+...+||
T Consensus       187 ~~~~~~~~~GT  197 (307)
T 3omv_A          187 GSQQVEQPTGS  197 (307)
T ss_dssp             -------CCCC
T ss_pred             cceeecccccC
Confidence            44444556776

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-33  Score=296.49  Aligned_cols=162  Identities=26%  Similarity=0.440  Sum_probs=135.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||++...  .....+.|.+|+++|++++|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999975 6899999998653  23346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ||++|+|.++|... ....+++.++..|+.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999542 3345799999999999999999999998   9999999999999999999999999999886532


Q ss_pred             ccccccccccC
Q 006090          652 DQAATKRLVGT  662 (662)
Q Consensus       652 ~~~~~~~~~Gt  662 (662)
                      .  ....++||
T Consensus       180 ~--~~~~~~GT  188 (350)
T 4b9d_A          180 E--LARACIGT  188 (350)
T ss_dssp             H--HHHHHHSC
T ss_pred             c--cccccCCC
Confidence            2  23335676

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.5e-33  Score=297.88  Aligned_cols=160  Identities=27%  Similarity=0.444  Sum_probs=143.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            356999999999999999999975 6899999999765556667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      |++|+|.+++..    ..+++.++..|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.+.....
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999999943    34899999999999999999999998   99999999999999999999999999998866543


Q ss_pred             cccccccccC
Q 006090          653 QAATKRLVGT  662 (662)
Q Consensus       653 ~~~~~~~~Gt  662 (662)
                      .  ...++||
T Consensus       303 ~--~~~~~GT  310 (423)
T 4fie_A          303 R--RKSLVGT  310 (423)
T ss_dssp             C--BCCCEEC
T ss_pred             c--ccccccC
Confidence            2  3346777

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.98  E-value=9.5e-33  Score=292.26  Aligned_cols=176  Identities=27%  Similarity=0.419  Sum_probs=148.0

Q ss_pred             ccCHHHHHhhccccccccccCccCceeEEEEEEcC------CcEEEEEEcccccc-ccHHHHHHHHHHHhcCCC-CCcce
Q 006090          484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKASG-QGQEEFMNEVMVISNLQH-RNLVR  555 (662)
Q Consensus       484 ~~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H-~nIv~  555 (662)
                      .++..+++...++|++.++||+|+||+||+|++..      ++.||||+++.... ...++|.+|+++|.+++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            35666777778899999999999999999998653      35799999976433 346789999999999965 99999


Q ss_pred             eeEEEEeC-CeeEEEEEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 006090          556 LLGCCVER-EENMLIYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR  621 (662)
Q Consensus       556 l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHr  621 (662)
                      ++|+|.+. +..+||||||++|+|.++|++..             ....++|.+++.|+.|||+||.|||+++   ||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence            99999775 56899999999999999996422             1345899999999999999999999988   9999


Q ss_pred             CCCCCcEEEcCCCceEEEeeCccccccCCcccccccccccC
Q 006090          622 DLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       622 Dlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      ||||+||||++++.+||+|||+|+.+..+.....+...+||
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt  250 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  250 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence            99999999999999999999999988766554444445665

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.98  E-value=1.5e-32  Score=285.88  Aligned_cols=160  Identities=29%  Similarity=0.450  Sum_probs=130.0

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHH--HHHHHHhcCCCCCcceeeEEEEeCC----eeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFM--NEVMVISNLQHRNLVRLLGCCVERE----ENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~--~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l  568 (662)
                      ++|.+.++||+|+||+||+|++. |+.||||+++..   ..+++.  .|+..+.+++|||||+++|+|.+++    ..+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            45778899999999999999985 899999999653   233343  4555567889999999999998764    5799


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      |||||++|+|.++|++    ..++|..+.+|+.|+|+||+|||++     ..++||||||||+||||++++++||+|||+
T Consensus        79 V~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            9999999999999953    3589999999999999999999987     234699999999999999999999999999


Q ss_pred             cccccCCcccc--cccccccC
Q 006090          644 ARIFGGNQDQA--ATKRLVGT  662 (662)
Q Consensus       644 a~~~~~~~~~~--~~~~~~Gt  662 (662)
                      |+.........  .+...+||
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT  175 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGT  175 (303)
T ss_dssp             CEEEETTTTEESCC-----CC
T ss_pred             CccccCCCCceeeeccccccc
Confidence            99886654332  23335666

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.98  E-value=2.2e-32  Score=281.45  Aligned_cols=157  Identities=29%  Similarity=0.456  Sum_probs=133.3

Q ss_pred             ccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe----CCeeEEEE
Q 006090          498 QLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----REENMLIY  570 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  570 (662)
                      .+.++||+|+||+||+|... +++.||||++...  .....+.|.+|++++++++|||||++++++.+    +...+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999975 5889999998643  23345689999999999999999999999875    34578999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~  649 (662)
                      |||++|+|.++|.+   ...+++..+..++.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999953   346899999999999999999999975 46999999999999984 78999999999987544


Q ss_pred             CcccccccccccC
Q 006090          650 NQDQAATKRLVGT  662 (662)
Q Consensus       650 ~~~~~~~~~~~Gt  662 (662)
                      ..    ..+++||
T Consensus       185 ~~----~~~~~GT  193 (290)
T 3fpq_A          185 SF----AKAVIGT  193 (290)
T ss_dssp             TS----BEESCSS
T ss_pred             Cc----cCCcccC
Confidence            32    3346776

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.98  E-value=2.4e-32  Score=283.15  Aligned_cols=154  Identities=27%  Similarity=0.468  Sum_probs=128.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe-------
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-------  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-------  565 (662)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999975 689999999865332 345679999999999999999999999976543       


Q ss_pred             -----eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEe
Q 006090          566 -----NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD  640 (662)
Q Consensus       566 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~D  640 (662)
                           .|+|||||++|+|.+++.+.......++..++.|+.||++||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999976554455677888999999999999999998   99999999999999999999999


Q ss_pred             eCccccccCCc
Q 006090          641 FGLARIFGGNQ  651 (662)
Q Consensus       641 FGla~~~~~~~  651 (662)
                      ||+|+.+..+.
T Consensus       162 FGla~~~~~~~  172 (299)
T 4g31_A          162 FGLVTAMDQDE  172 (299)
T ss_dssp             CCCC-------
T ss_pred             CccceecCCCc
Confidence            99999987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=3.4e-32  Score=284.92  Aligned_cols=158  Identities=25%  Similarity=0.336  Sum_probs=133.0

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .+.|.+.++||+|+||+||+|+.. +++.||||+++....     +.+|+.++++++|||||++++++.+++..||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356888899999999999999975 689999999965321     24699999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccccCCc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGGNQ  651 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~~~~~  651 (662)
                      |++|+|.++|.+   ...+++.++..|+.||+.||+|||+++   ||||||||+||||+.++ ++||+|||+|+.+..+.
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999953   345999999999999999999999988   99999999999999987 69999999999986543


Q ss_pred             cc---ccccccccC
Q 006090          652 DQ---AATKRLVGT  662 (662)
Q Consensus       652 ~~---~~~~~~~Gt  662 (662)
                      ..   .....++||
T Consensus       206 ~~~~~~~~~~~~GT  219 (336)
T 4g3f_A          206 LGKSLLTGDYIPGT  219 (336)
T ss_dssp             --------CCCCCC
T ss_pred             cccceecCCccccC
Confidence            22   122335676

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=1.3e-32  Score=284.66  Aligned_cols=160  Identities=28%  Similarity=0.343  Sum_probs=131.4

Q ss_pred             cccccccccCccCceeEEEEEEc----CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|++.+.||+|+||+||+|+..    .++.||||++++..  ......+.+|+++|++++|||||++++++.+++..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    46789999986532  2334578899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |||||++|+|.++|.+   ...+++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999953   346899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCcccccccccccC
Q 006090          649 GNQDQAATKRLVGT  662 (662)
Q Consensus       649 ~~~~~~~~~~~~Gt  662 (662)
                      .....  ..+++||
T Consensus       178 ~~~~~--~~~~~GT  189 (304)
T 3ubd_A          178 DHEKK--AYSFCGT  189 (304)
T ss_dssp             ---CC--CCSCCCC
T ss_pred             CCCcc--ccccccC
Confidence            54332  3346776

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=6.1e-32  Score=275.75  Aligned_cols=158  Identities=30%  Similarity=0.523  Sum_probs=125.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            67999999999999999999965 68999999986532   234567999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+ +|+|.++|.+   ...+++.++..++.||+.||+|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6899999853   345999999999999999999999998   999999999999999999999999999987553


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      .   ...+.+||
T Consensus       166 ~---~~~~~~GT  174 (275)
T 3hyh_A          166 N---FLKTSCGS  174 (275)
T ss_dssp             ------------
T ss_pred             C---ccCCeeEC
Confidence            3   12335666

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=272.40  Aligned_cols=161  Identities=24%  Similarity=0.473  Sum_probs=135.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------Ce
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------EE  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~  565 (662)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|+++|++++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999975 68999999996532  23456789999999999999999999998643      56


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .|||||||+ |+|.++|.+   ...+++.++..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            799999996 789999943   456999999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCc--ccccccccccC
Q 006090          646 IFGGNQ--DQAATKRLVGT  662 (662)
Q Consensus       646 ~~~~~~--~~~~~~~~~Gt  662 (662)
                      .+....  .......++||
T Consensus       207 ~~~~~~~~~~~~~~~~~GT  225 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVAT  225 (398)
T ss_dssp             CC-------CCCCCSSCCC
T ss_pred             ecccCccccccccccceeC
Confidence            885432  12234446776

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=6.5e-29  Score=264.31  Aligned_cols=149  Identities=23%  Similarity=0.385  Sum_probs=132.7

Q ss_pred             HhhccccccccccCccCceeEEEEEEc----CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCe
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE  565 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~  565 (662)
                      ....++|++.++||+|+||+||+|+.+    .++.||||++...  .....+.+|+++|+.+ +|||||++++++.+++.
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            345678999999999999999999853    4678999998653  3456788999999998 69999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCcc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLA  644 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGla  644 (662)
                      .+|||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+||||+.+ +.+||+|||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            999999999999999982      3899999999999999999999998   9999999999999987 79999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.+.+.
T Consensus       166 ~~~~~~  171 (361)
T 4f9c_A          166 QGTHDT  171 (361)
T ss_dssp             EECTTC
T ss_pred             cccCCc
Confidence            977543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=5.2e-29  Score=279.99  Aligned_cols=158  Identities=28%  Similarity=0.373  Sum_probs=135.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHH---HHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFM---NEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|++.++||+|+||+||+++.. +++.||||++.+..   ......+.   .++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999976 68999999986421   22233333   4466777889999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ||||||+||+|.++|.+   ...+++..+..++.||+.||.|||+++   ||||||||+||||+++|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999953   346899999999999999999999988   999999999999999999999999999988


Q ss_pred             cCCcccccccccccC
Q 006090          648 GGNQDQAATKRLVGT  662 (662)
Q Consensus       648 ~~~~~~~~~~~~~Gt  662 (662)
                      ....    +.+++||
T Consensus       343 ~~~~----~~t~~GT  353 (689)
T 3v5w_A          343 SKKK----PHASVGT  353 (689)
T ss_dssp             SSCC----CCSCCSC
T ss_pred             CCCC----CCCccCC
Confidence            6543    3346787

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.96  E-value=1.5e-28  Score=277.03  Aligned_cols=160  Identities=26%  Similarity=0.446  Sum_probs=141.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|++.+.||+|+||.||+++.. +|+.||+|.+........+.+.+|+++|++++|||||+|++++.+++..+||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999975 68999999997655556778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD--LNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~ki~DFGla~~~~~~~  651 (662)
                      ++|+|.++|.+  ....+++.++..++.||+.||.|||+++   |+||||||+||||+.+  +.+||+|||+|+.+....
T Consensus       237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999999954  2345899999999999999999999998   9999999999999864  899999999999986654


Q ss_pred             ccccccccccC
Q 006090          652 DQAATKRLVGT  662 (662)
Q Consensus       652 ~~~~~~~~~Gt  662 (662)
                      .   ....+||
T Consensus       312 ~---~~~~~GT  319 (573)
T 3uto_A          312 S---VKVTTGT  319 (573)
T ss_dssp             E---EEEECSS
T ss_pred             c---eeeeEEC
Confidence            2   2234565

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.95  E-value=1.2e-27  Score=261.12  Aligned_cols=171  Identities=22%  Similarity=0.271  Sum_probs=145.1

Q ss_pred             CHHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEE
Q 006090          486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCV  561 (662)
Q Consensus       486 ~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~  561 (662)
                      .+.++....++|++.++||+|+||+||+++.. +++.||+|++.+..   ......+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            44556667789999999999999999999986 47889999986521   222345889999999999999999999999


Q ss_pred             eCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       562 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      +++..+|||||+++|+|.++|.+.  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999999642  345899999999999999999999988   999999999999999999999999


Q ss_pred             CccccccCCcccccccccccC
Q 006090          642 GLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       642 Gla~~~~~~~~~~~~~~~~Gt  662 (662)
                      |+|+.+....... ....+||
T Consensus       220 Gla~~~~~~~~~~-~~~~~GT  239 (437)
T 4aw2_A          220 GSCLKLMEDGTVQ-SSVAVGT  239 (437)
T ss_dssp             TTCEECCTTSCEE-CCSCCSC
T ss_pred             hhhhhcccCCCcc-cccccCC
Confidence            9998876544322 2224555

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.95  E-value=1.2e-27  Score=250.73  Aligned_cols=163  Identities=44%  Similarity=0.746  Sum_probs=145.7

Q ss_pred             cCHHHHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC
Q 006090          485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE  564 (662)
Q Consensus       485 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~  564 (662)
                      +.+.++...+++|++.+.||+|+||.||+|+.++++.||||++........+.+.+|++++++++||||+++++++.+++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34445566778999999999999999999998889999999988766667788999999999999999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ..++||||+++|+|.+++.... ....+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999996533 2336899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ++.....
T Consensus       186 ~~~~~~~  192 (321)
T 2qkw_B          186 SKKGTEL  192 (321)
T ss_dssp             CEECSSS
T ss_pred             ccccccc
Confidence            9876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.94  E-value=3.6e-27  Score=247.57  Aligned_cols=172  Identities=47%  Similarity=0.781  Sum_probs=150.4

Q ss_pred             ccccccCHHHHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeE
Q 006090          480 QDLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLG  558 (662)
Q Consensus       480 ~~~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g  558 (662)
                      .....+++.++....++|.+.+.||+|+||.||+|+..+++.||||++..... .....|.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34567889999999999999999999999999999988899999999875432 23447899999999999999999999


Q ss_pred             EEEeCCeeEEEEEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceE
Q 006090          559 CCVEREENMLIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK  637 (662)
Q Consensus       559 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  637 (662)
                      ++.+.+..++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+....+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999996543 344699999999999999999999998333499999999999999999999


Q ss_pred             EEeeCccccccCCc
Q 006090          638 ISDFGLARIFGGNQ  651 (662)
Q Consensus       638 i~DFGla~~~~~~~  651 (662)
                      |+|||+++.+....
T Consensus       175 l~Dfg~~~~~~~~~  188 (326)
T 3uim_A          175 VGDFGLAKLMDYKD  188 (326)
T ss_dssp             ECCCSSCEECCSSS
T ss_pred             eccCccccccCccc
Confidence            99999999886543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.94  E-value=1.9e-26  Score=241.92  Aligned_cols=160  Identities=28%  Similarity=0.439  Sum_probs=143.6

Q ss_pred             ccCHHHHHhhccc----------cccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCC
Q 006090          484 VFNFEELANATNN----------FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN  552 (662)
Q Consensus       484 ~~~~~~l~~~~~~----------f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n  552 (662)
                      .++++++..+++.          |+..++||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4677777766543          677789999999999999976 68999999997666666788999999999999999


Q ss_pred             cceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 006090          553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD  632 (662)
Q Consensus       553 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~  632 (662)
                      |+++++++...+..++||||+++++|.+++.+    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            99999999999999999999999999999843    35899999999999999999999987   999999999999999


Q ss_pred             CCceEEEeeCccccccCC
Q 006090          633 DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       633 ~~~~ki~DFGla~~~~~~  650 (662)
                      ++.+||+|||+++.+...
T Consensus       177 ~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             TCCEEECCCTTCEECCSS
T ss_pred             CCcEEEeeeeeeeecccC
Confidence            999999999999988654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=1.5e-26  Score=241.14  Aligned_cols=152  Identities=30%  Similarity=0.547  Sum_probs=138.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.++||+|+||+||+++.. +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367888999999999999999975 5889999998776666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++...  ...+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999542  345899999999999999999999998   999999999999999999999999999987544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.94  E-value=1.6e-26  Score=240.26  Aligned_cols=167  Identities=43%  Similarity=0.687  Sum_probs=148.6

Q ss_pred             cccccCHHHHHhhccccccc------cccCccCceeEEEEEEcCCcEEEEEEcccc----ccccHHHHHHHHHHHhcCCC
Q 006090          481 DLLVFNFEELANATNNFQLA------NKLGQGGFGPVYKGKLQDGQEIAVKRLSKA----SGQGQEEFMNEVMVISNLQH  550 (662)
Q Consensus       481 ~~~~~~~~~l~~~~~~f~~~------~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~~l~~l~H  550 (662)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||||++...    .....+.|.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45678999999999988766      8899999999999987 4889999998642    22345789999999999999


Q ss_pred             CCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006090          551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL  630 (662)
Q Consensus       551 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl  630 (662)
                      |||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||.|||+++   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999975544567999999999999999999999988   9999999999999


Q ss_pred             cCCCceEEEeeCccccccCCc
Q 006090          631 DDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       631 ~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ++++.+||+|||+++......
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCS
T ss_pred             cCCCcEEEeeccccccccccc
Confidence            999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=1.9e-26  Score=239.22  Aligned_cols=152  Identities=28%  Similarity=0.479  Sum_probs=138.3

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            36799999999999999999986 46899999998765556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      +++++|.+++.+    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999943    35899999999999999999999998   99999999999999999999999999998865543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.94  E-value=2.1e-26  Score=241.62  Aligned_cols=153  Identities=26%  Similarity=0.449  Sum_probs=135.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe-------
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-------  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-------  565 (662)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            67899999999999999999986 78999999986433 3356789999999999999999999999876542       


Q ss_pred             --------------------------------------------------eEEEEEccCCCCHHHHhcCCCCCCCCCHHH
Q 006090          566 --------------------------------------------------NMLIYEYMPNKSLDSFLFDPQRQSLLDWPK  595 (662)
Q Consensus       566 --------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~  595 (662)
                                                                        .++||||+++++|.+++.........++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                              789999999999999997765556678888


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          596 RFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       596 ~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            9999999999999999988   999999999999999999999999999988664

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=1.5e-26  Score=243.54  Aligned_cols=151  Identities=30%  Similarity=0.512  Sum_probs=136.3

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++...  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999997 47899999998653  2334567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=8.1e-27  Score=252.64  Aligned_cols=158  Identities=22%  Similarity=0.294  Sum_probs=139.1

Q ss_pred             HHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe
Q 006090          487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE  562 (662)
Q Consensus       487 ~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~  562 (662)
                      ..++....++|.+.++||+|+||+||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556789999999999999999999976 5889999998652   12234568899999999999999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      ++..++||||+++|+|.+++.+    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999999943    34899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCc
Q 006090          643 LARIFGGNQ  651 (662)
Q Consensus       643 la~~~~~~~  651 (662)
                      +|+.+....
T Consensus       214 ~a~~~~~~~  222 (410)
T 3v8s_A          214 TCMKMNKEG  222 (410)
T ss_dssp             TCEECCTTS
T ss_pred             eeEeeccCC
Confidence            999876543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.94  E-value=2.5e-26  Score=246.00  Aligned_cols=154  Identities=28%  Similarity=0.511  Sum_probs=135.5

Q ss_pred             ccccccccccCccCceeEEEEEEc--------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER  563 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~--------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~  563 (662)
                      .++|.+.+.||+|+||.||+|+..        ++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468999999999999999999863        34579999997543 23456899999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL  630 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl  630 (662)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||++||.|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999964321             235899999999999999999999988   9999999999999


Q ss_pred             cCCCceEEEeeCccccccCC
Q 006090          631 DDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       631 ~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++++.+||+|||+|+.+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCC
T ss_pred             CCCCCEEEccccCCcccCcc
Confidence            99999999999999977654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.94  E-value=2.5e-26  Score=242.61  Aligned_cols=149  Identities=28%  Similarity=0.338  Sum_probs=134.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+++.. +++.||+|++++.   .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            67899999999999999999976 6899999998653   2345677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+....
T Consensus        85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999843   345899999999999999999999988   99999999999999999999999999997543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.94  E-value=2.3e-26  Score=241.59  Aligned_cols=162  Identities=30%  Similarity=0.450  Sum_probs=137.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            68999999999999999999976 68899999986432 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      +++++|.+++..   ...+++.++..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            999999999843   345899999999999999999999988   99999999999999999999999999998754433


Q ss_pred             cccccccccC
Q 006090          653 QAATKRLVGT  662 (662)
Q Consensus       653 ~~~~~~~~Gt  662 (662)
                      .......+||
T Consensus       161 ~~~~~~~~gt  170 (323)
T 3tki_A          161 ERLLNKMCGT  170 (323)
T ss_dssp             ECCBCSCCSC
T ss_pred             ccccCCCccC
Confidence            3223334443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=1.5e-26  Score=250.67  Aligned_cols=162  Identities=23%  Similarity=0.280  Sum_probs=141.6

Q ss_pred             cCHHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEE
Q 006090          485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCC  560 (662)
Q Consensus       485 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~  560 (662)
                      +.+.++....++|++.+.||+|+||+||+++.. +++.||||++.+..   ....+.+.+|..++.+++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            344555566789999999999999999999975 68999999986522   22344688999999999999999999999


Q ss_pred             EeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEe
Q 006090          561 VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD  640 (662)
Q Consensus       561 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~D  640 (662)
                      .+.+..+|||||+++|+|.++|.+.  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence            9999999999999999999999532  235899999999999999999999988   99999999999999999999999


Q ss_pred             eCccccccCCc
Q 006090          641 FGLARIFGGNQ  651 (662)
Q Consensus       641 FGla~~~~~~~  651 (662)
                      ||+|+.+....
T Consensus       206 FGla~~~~~~~  216 (412)
T 2vd5_A          206 FGSCLKLRADG  216 (412)
T ss_dssp             CTTCEECCTTS
T ss_pred             chhheeccCCC
Confidence            99999886543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.93  E-value=2.1e-26  Score=241.69  Aligned_cols=154  Identities=31%  Similarity=0.516  Sum_probs=132.5

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC----eeEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----ENML  568 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l  568 (662)
                      ..++|++.++||+|+||.||+|+.. ++.||||++... ......+..|+.++++++||||+++++++.+..    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3478999999999999999999876 799999999653 333455667899999999999999999998854    3699


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-------SRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      ||||+++|+|.+++..    ..+++..+..++.||++||+|||+.       ...+|+||||||+|||++.++.+||+||
T Consensus       100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999943    3489999999999999999999987       0113999999999999999999999999


Q ss_pred             CccccccCCcc
Q 006090          642 GLARIFGGNQD  652 (662)
Q Consensus       642 Gla~~~~~~~~  652 (662)
                      |+|+.+.....
T Consensus       176 g~a~~~~~~~~  186 (322)
T 3soc_A          176 GLALKFEAGKS  186 (322)
T ss_dssp             TTCEEECTTSC
T ss_pred             CcccccccccC
Confidence            99998866543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=3.3e-26  Score=243.35  Aligned_cols=150  Identities=29%  Similarity=0.418  Sum_probs=133.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|++.+.||+|+||+||+++.. +++.||||++++.   .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            368999999999999999999976 5889999998753   233456788999999988 69999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999953   345899999999999999999999998   9999999999999999999999999999754


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       176 ~  176 (353)
T 3txo_A          176 C  176 (353)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.93  E-value=1.9e-26  Score=240.62  Aligned_cols=159  Identities=29%  Similarity=0.562  Sum_probs=133.2

Q ss_pred             HHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      +....++|++.+.||+|+||.||+|+. .++.||||++....  ....++|.+|++++++++||||+++++++.+.+..+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            334457899999999999999999987 48899999986543  234568999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++|+|.+++........+++..++.++.||++||+|||+++ .+|+||||||+|||++.++.+||+|||+++..
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999999999965433334899999999999999999999875 45999999999999999999999999999876


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       190 ~~~  192 (309)
T 3p86_A          190 AST  192 (309)
T ss_dssp             ---
T ss_pred             ccc
Confidence            543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.93  E-value=6.9e-26  Score=238.10  Aligned_cols=152  Identities=30%  Similarity=0.586  Sum_probs=134.9

Q ss_pred             ccccccccccCccCceeEEEEEEc----CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|.+.+.||+|+||.||+|+..    .+..||||+++.. .....+.|.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            367899999999999999999974    3456999999754 33445789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++++|.+++...  ...+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999543  345899999999999999999999988   9999999999999999999999999999886


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       203 ~~  204 (325)
T 3kul_A          203 DD  204 (325)
T ss_dssp             --
T ss_pred             cC
Confidence            54

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.93  E-value=2.5e-26  Score=244.29  Aligned_cols=165  Identities=28%  Similarity=0.466  Sum_probs=141.2

Q ss_pred             ccCHHHHHhhccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcce
Q 006090          484 VFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVR  555 (662)
Q Consensus       484 ~~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~  555 (662)
                      .+...++....++|.+.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3556666677889999999999999999999842      35789999997643 33456799999999999 7999999


Q ss_pred             eeEEEEeCCe-eEEEEEccCCCCHHHHhcCCCC-----------------------------------------------
Q 006090          556 LLGCCVEREE-NMLIYEYMPNKSLDSFLFDPQR-----------------------------------------------  587 (662)
Q Consensus       556 l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~-----------------------------------------------  587 (662)
                      +++++.+.+. .++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999988655 8999999999999999965332                                               


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          588 ----------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       588 ----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                                      ...+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            122899999999999999999999998   9999999999999999999999999999875543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.93  E-value=1.6e-25  Score=238.69  Aligned_cols=151  Identities=32%  Similarity=0.447  Sum_probs=135.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .+.|.+.+.||+|+||.||+++.. +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999976 588999999865322      1357899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEeeC
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFG  642 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~ki~DFG  642 (662)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999943   346899999999999999999999988   99999999999998877    79999999


Q ss_pred             ccccccCC
Q 006090          643 LARIFGGN  650 (662)
Q Consensus       643 la~~~~~~  650 (662)
                      +++.+...
T Consensus       165 ~a~~~~~~  172 (361)
T 2yab_A          165 LAHEIEDG  172 (361)
T ss_dssp             SCEECCTT
T ss_pred             CceEcCCC
Confidence            99988654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=4.8e-26  Score=245.32  Aligned_cols=150  Identities=26%  Similarity=0.337  Sum_probs=132.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|++.++||+|+||+||+++.. +++.||+|++++..   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            367999999999999999999976 57889999987532   22345688999999887 89999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|..++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999853   345899999999999999999999998   9999999999999999999999999999743


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       205 ~  205 (396)
T 4dc2_A          205 R  205 (396)
T ss_dssp             C
T ss_pred             c
Confidence            3

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=6.2e-26  Score=234.93  Aligned_cols=151  Identities=28%  Similarity=0.464  Sum_probs=134.0

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+....   ....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367999999999999999999965 68899999885432   23356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999943   345899999999999999999999988   99999999999999999999999999998754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       164 ~  164 (294)
T 4eqm_A          164 T  164 (294)
T ss_dssp             -
T ss_pred             c
Confidence            4

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=8e-26  Score=242.72  Aligned_cols=150  Identities=25%  Similarity=0.389  Sum_probs=135.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||++... +++.||+|.+...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67899999999999999999976 5789999998643   2344678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999954   345899999999999999999999998   999999999999999999999999999987544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=7.2e-26  Score=230.90  Aligned_cols=151  Identities=28%  Similarity=0.566  Sum_probs=137.2

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|++.+.||+|+||.||++...+++.||+|++... ....+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            3678889999999999999999988899999999753 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++++|.+++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence            999999999542  345899999999999999999999998   999999999999999999999999999977543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.93  E-value=3.9e-26  Score=244.69  Aligned_cols=153  Identities=33%  Similarity=0.617  Sum_probs=128.4

Q ss_pred             ccccccccccCccCceeEEEEEEc----CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|.+.+.||+|+||.||+|+..    ++..||||+++.. .....++|.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357899999999999999999875    4678999999754 23445689999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++.+.  ...+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999642  345899999999999999999999988   9999999999999999999999999999886


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       199 ~~~  201 (373)
T 2qol_A          199 DDP  201 (373)
T ss_dssp             ---
T ss_pred             cCC
Confidence            543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=9.4e-26  Score=236.37  Aligned_cols=149  Identities=31%  Similarity=0.443  Sum_probs=134.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+++.. +++.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            67899999999999999999976 68999999986532   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999953   345899999999999999999999988   99999999999999999999999999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.93  E-value=4.8e-26  Score=243.12  Aligned_cols=152  Identities=16%  Similarity=0.213  Sum_probs=132.8

Q ss_pred             hhccccccccccCccCceeEEEEE------EcCCcEEEEEEccccccccHHHHHHHHHHHhcCC---CCCcceeeEEEEe
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGK------LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVE  562 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~------~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~  562 (662)
                      ...++|.+.++||+|+||.||+|.      ..+++.||||+++..   ...++..|++++.+++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345789999999999999999994      446889999999653   4567888888888886   9999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--------
Q 006090          563 REENMLIYEYMPNKSLDSFLFDP--QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--------  632 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--------  632 (662)
                      ++..++||||+++|+|.+++...  .....+++..+..|+.||++||+|||+++   |+||||||+||||+.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence            99999999999999999999531  12456999999999999999999999987   999999999999998        


Q ss_pred             ---CCceEEEeeCccccccC
Q 006090          633 ---DLNPKISDFGLARIFGG  649 (662)
Q Consensus       633 ---~~~~ki~DFGla~~~~~  649 (662)
                         ++.+||+|||+|+.+..
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~  235 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKL  235 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGG
T ss_pred             ccccCCEEEeeCchhhhhhc
Confidence               89999999999987653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=7.5e-26  Score=239.75  Aligned_cols=151  Identities=30%  Similarity=0.408  Sum_probs=134.3

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  567 (662)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999976 58899999997532   33456788999999876 8999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+..
T Consensus        95 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999953   245899999999999999999999998   999999999999999999999999999976


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ..
T Consensus       169 ~~  170 (345)
T 1xjd_A          169 ML  170 (345)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=9.6e-26  Score=239.02  Aligned_cols=149  Identities=27%  Similarity=0.344  Sum_probs=133.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+..   ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57889999999999999999976 58899999997532   23356688999999988 899999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999853   245899999999999999999999998   99999999999999999999999999997543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.93  E-value=1.8e-25  Score=233.94  Aligned_cols=155  Identities=28%  Similarity=0.464  Sum_probs=137.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC--eeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE--ENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV  569 (662)
                      .++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367999999999999999999976 48899999987533 344678899999999999999999999998765  67999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEeeCccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLAR  645 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~ki~DFGla~  645 (662)
                      |||+++++|.+++........+++.++..++.||++||+|||+.+   |+||||||+|||+    +.++.+||+|||+|+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999998   9999999999999    788889999999999


Q ss_pred             cccCCc
Q 006090          646 IFGGNQ  651 (662)
Q Consensus       646 ~~~~~~  651 (662)
                      .+....
T Consensus       165 ~~~~~~  170 (319)
T 4euu_A          165 ELEDDE  170 (319)
T ss_dssp             ECCTTC
T ss_pred             ecCCCC
Confidence            886543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.93  E-value=3.7e-26  Score=245.30  Aligned_cols=152  Identities=28%  Similarity=0.525  Sum_probs=135.6

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ..++|.+.+.||+|+||.||+|+.. +++.||||.++.... ...++|.+|++++++++||||++++|++.+++..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467889999999999999999986 688999999875422 33457899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++...  ...+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus       192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999532  234899999999999999999999998   99999999999999999999999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2.5e-25  Score=233.41  Aligned_cols=151  Identities=23%  Similarity=0.344  Sum_probs=135.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.+.||+|+||.||+++.. +++.+|+|.+... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 5789999998753 34556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++..  ....+++.++..++.||++||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999943  2345899999999999999999999998   999999999999987  789999999999988654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.93  E-value=1.3e-25  Score=232.56  Aligned_cols=150  Identities=28%  Similarity=0.464  Sum_probs=128.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--------------------------ccHHHHHHHHHHHh
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--------------------------QGQEEFMNEVMVIS  546 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--------------------------~~~~~f~~E~~~l~  546 (662)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999875 588999999864321                          12356899999999


Q ss_pred             cCCCCCcceeeEEEEe--CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006090          547 NLQHRNLVRLLGCCVE--REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK  624 (662)
Q Consensus       547 ~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk  624 (662)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++.++..++.||++||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999998865    2346899999999999999999999998   9999999


Q ss_pred             CCcEEEcCCCceEEEeeCccccccCC
Q 006090          625 ASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       625 p~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+|||++.++.+||+|||+++.+...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~  190 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGS  190 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccc
Confidence            99999999999999999999987654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.93  E-value=5.7e-26  Score=239.88  Aligned_cols=158  Identities=29%  Similarity=0.547  Sum_probs=138.3

Q ss_pred             HHhhccccccccccCccCceeEEEEEEcC------CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEe
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE  562 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~  562 (662)
                      +....++|.+.+.||+|+||.||+|+..+      ++.||||.++... ....+.|.+|++++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            33456889999999999999999999753      4789999997543 3345689999999999999999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQR---------------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHR  621 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHr  621 (662)
                      ++..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9999999999999999999964221                     156899999999999999999999998   9999


Q ss_pred             CCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          622 DLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       622 Dlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||||+|||+++++.+||+|||+++.+...
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  227 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSA  227 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccC
Confidence            99999999999999999999999877543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=1.6e-25  Score=228.09  Aligned_cols=152  Identities=31%  Similarity=0.534  Sum_probs=137.6

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|++.+.||+|+||.||+++..++..||+|++... ....+++.+|++++.+++||||+++++++.++...++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            4678999999999999999999988889999999753 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ++++|.+++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            999999999542  234899999999999999999999988   9999999999999999999999999999876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.93  E-value=9.3e-26  Score=237.31  Aligned_cols=150  Identities=29%  Similarity=0.384  Sum_probs=125.5

Q ss_pred             ccccccccccCccCceeEEEEEE----cCCcEEEEEEccccc----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~----~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++++..    ......+.+|++++++++||||+++++++.+++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36799999999999999999987    468999999987532    2334568899999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||||+++++|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999943   345889999999999999999999998   9999999999999999999999999998


Q ss_pred             cccC
Q 006090          646 IFGG  649 (662)
Q Consensus       646 ~~~~  649 (662)
                      ....
T Consensus       170 ~~~~  173 (327)
T 3a62_A          170 ESIH  173 (327)
T ss_dssp             ----
T ss_pred             cccc
Confidence            7643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=3.5e-25  Score=232.84  Aligned_cols=150  Identities=31%  Similarity=0.436  Sum_probs=134.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|.+.+.||+|+||.||++... +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            57889999999999999999976 588999999865322      23678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEeeCc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFGL  643 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~ki~DFGl  643 (662)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999943   346899999999999999999999988   99999999999999887    899999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ++.+...
T Consensus       165 a~~~~~~  171 (326)
T 2y0a_A          165 AHKIDFG  171 (326)
T ss_dssp             CEECCTT
T ss_pred             CeECCCC
Confidence            9988543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.93  E-value=1.6e-25  Score=229.99  Aligned_cols=151  Identities=31%  Similarity=0.553  Sum_probs=134.5

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..++|++.+.||+|+||.||++...++..||||++... ....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            34689999999999999999999988889999999753 34467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++...  ...+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999642  335899999999999999999999988   99999999999999999999999999997754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.93  E-value=6.2e-26  Score=234.60  Aligned_cols=152  Identities=32%  Similarity=0.593  Sum_probs=132.2

Q ss_pred             ccccccccccCccCceeEEEEEE-----cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--Cee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-----~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  566 (662)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.|.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36789999999999999999985     25789999999876666678899999999999999999999998654  457


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++++|.+++...  ...+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999543  234899999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCC
Q 006090          647 FGGN  650 (662)
Q Consensus       647 ~~~~  650 (662)
                      +...
T Consensus       164 ~~~~  167 (295)
T 3ugc_A          164 LPQD  167 (295)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            7654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=1.7e-25  Score=237.54  Aligned_cols=150  Identities=27%  Similarity=0.367  Sum_probs=135.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67999999999999999999976 68999999986532   234678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999953   245899999999999999999999988   999999999999999999999999999987543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.93  E-value=1.2e-25  Score=249.93  Aligned_cols=153  Identities=31%  Similarity=0.558  Sum_probs=138.1

Q ss_pred             hccccccccccCccCceeEEEEEEcC-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ..++|.+.++||+|+||.||+|.+.. +..||||.++.. ....++|.+|+++|++++||||++++++|.+....++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45678999999999999999999874 789999999763 3457889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++|+|.++|... ....+++..++.|+.||++||+|||+++   |+||||||+||||++++.+||+|||+++.+...
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999999643 2345899999999999999999999998   999999999999999999999999999987543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.93  E-value=1e-25  Score=234.69  Aligned_cols=156  Identities=31%  Similarity=0.504  Sum_probs=136.6

Q ss_pred             hccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      ..++|.+.+.||+|+||.||+++..      +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            4578999999999999999999862      34789999997533 3445789999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQR---------------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK  624 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk  624 (662)
                      .++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999964322                     134899999999999999999999988   9999999


Q ss_pred             CCcEEEcCCCceEEEeeCccccccCCc
Q 006090          625 ASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       625 p~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      |+|||+++++.+||+|||+++.+....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~  204 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEED  204 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred             hheEEEcCCCCEEEccccccccccccc
Confidence            999999999999999999999876543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=2.6e-25  Score=232.18  Aligned_cols=151  Identities=31%  Similarity=0.497  Sum_probs=133.0

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|++.++||+|+||+||+++..+++.||+|++.....  .....+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            478999999999999999999998899999999865322  234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |++ ++|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       100 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            998 5888887542  345899999999999999999999988   999999999999999999999999999987543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=1.6e-25  Score=238.04  Aligned_cols=150  Identities=27%  Similarity=0.362  Sum_probs=134.1

Q ss_pred             ccccccccccCccCceeEEEEEEcC-CcEEEEEEcccc---ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|.+.+.||+|+||+||+++... ++.||||++++.   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4689999999999999999999864 788999998753   224456788999999988 79999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus        99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999953   235899999999999999999999998   9999999999999999999999999999754


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       173 ~  173 (353)
T 2i0e_A          173 W  173 (353)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.93  E-value=5.7e-26  Score=249.95  Aligned_cols=154  Identities=34%  Similarity=0.546  Sum_probs=137.3

Q ss_pred             HHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +....++|.+.++||+|+||.||+|.++++..||||+++.. ....+.|.+|+++|++++||||+++++++. .+..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            34456789999999999999999999988899999999763 345788999999999999999999999986 6678999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++|+|.++|.... ...+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus       261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999995421 235789999999999999999999988   99999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.92  E-value=2.3e-25  Score=239.55  Aligned_cols=155  Identities=29%  Similarity=0.486  Sum_probs=136.1

Q ss_pred             hccccccccccCccCceeEEEEEEc--------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE  562 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~--------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~  562 (662)
                      ..++|.+.++||+|+||.||+|+..        .+..||||+++... ....+.+.+|+++++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4578999999999999999999863        23579999997543 33457899999999999 89999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL  629 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL  629 (662)
                      ++..++||||+++|+|.+++.....             ...+++.+++.|+.||++||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999964321             245899999999999999999999988   999999999999


Q ss_pred             EcCCCceEEEeeCccccccCC
Q 006090          630 LDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~~~  650 (662)
                      |++++.+||+|||+|+.+...
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~  244 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHI  244 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCC
T ss_pred             EcCCCcEEEcccCcccccccc
Confidence            999999999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.6e-25  Score=236.73  Aligned_cols=157  Identities=30%  Similarity=0.500  Sum_probs=134.8

Q ss_pred             hhccccccccccCccCceeEEEEEEc------CCcEEEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeC
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVER  563 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~  563 (662)
                      ...++|.+.+.||+|+||.||+|+..      +++.||||.+... .....+.+.+|+.++.++ +||||+++++++.+.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            34578999999999999999999962      3568999998753 234467899999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQ--------------------SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDL  623 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl  623 (662)
                      +..++||||+++|+|.+++......                    ..+++..++.++.||++||.|||+++   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            9999999999999999999653321                    34899999999999999999999988   999999


Q ss_pred             CCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          624 KASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       624 kp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ||+|||++.++.+||+|||+++.+....
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~  226 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDS  226 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCc
Confidence            9999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.92  E-value=4e-25  Score=228.29  Aligned_cols=150  Identities=27%  Similarity=0.486  Sum_probs=131.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47889999999999999999976 58899999986432  2334778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++ +|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9975 55555532  2345899999999999999999999998   999999999999999999999999999987543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.92  E-value=4.2e-25  Score=235.66  Aligned_cols=151  Identities=26%  Similarity=0.438  Sum_probs=134.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|.+.+.||+|+||.||++... +++.||+|.+...  .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999975 5889999998653  2234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~DFGla~~~  647 (662)
                      ||+++|+|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++   .+||+|||+++.+
T Consensus       108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999843   345899999999999999999999998   99999999999998654   5999999999987


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       182 ~~~  184 (362)
T 2bdw_A          182 NDS  184 (362)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            644

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.92  E-value=2.3e-25  Score=236.77  Aligned_cols=154  Identities=26%  Similarity=0.400  Sum_probs=134.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      .+.|++.+.||+|+||.||++... +++.||||++....     ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999875 68999999985321     224678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEeeCc
Q 006090          568 LIYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN---PKISDFGL  643 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~ki~DFGl  643 (662)
                      +||||+++++|.+++.+.. ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988875322 2345899999999999999999999998   999999999999987654   99999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ++.+...
T Consensus       180 a~~~~~~  186 (351)
T 3c0i_A          180 AIQLGES  186 (351)
T ss_dssp             CEECCTT
T ss_pred             eeEecCC
Confidence            9988654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.92  E-value=9.1e-26  Score=241.33  Aligned_cols=153  Identities=34%  Similarity=0.565  Sum_probs=133.1

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .++|.+.+.||+|+||.||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367899999999999999999853      4568999999653 334556799999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEE
Q 006090          567 MLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKIS  639 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~  639 (662)
                      ++||||+++|+|.+++....    ....+++.+++.++.||++||+|||+++   |+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996422    2245899999999999999999999998   99999999999999555   59999


Q ss_pred             eeCccccccC
Q 006090          640 DFGLARIFGG  649 (662)
Q Consensus       640 DFGla~~~~~  649 (662)
                      |||+|+.+..
T Consensus       227 DFG~a~~~~~  236 (367)
T 3l9p_A          227 DFGMARDIYR  236 (367)
T ss_dssp             CCHHHHHHHH
T ss_pred             CCcccccccc
Confidence            9999987643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.92  E-value=5.5e-25  Score=236.73  Aligned_cols=152  Identities=24%  Similarity=0.397  Sum_probs=136.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|++++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            367999999999999999999976 6889999998765555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~ki~DFGla~~~~~~  650 (662)
                      +++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+|+.+...
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999999542  335899999999999999999999988   999999999999974  468999999999988654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=5.2e-25  Score=225.38  Aligned_cols=151  Identities=25%  Similarity=0.408  Sum_probs=137.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.++...++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            467999999999999999999976 4678999999776666778999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998843   345899999999999999999999998   9999999999999   7889999999999998765


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       162 ~  162 (277)
T 3f3z_A          162 G  162 (277)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.92  E-value=9.3e-26  Score=236.42  Aligned_cols=157  Identities=29%  Similarity=0.524  Sum_probs=123.0

Q ss_pred             HhhccccccccccCccCceeEEEEEEcCCc----EEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQDGQ----EIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE  564 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~----~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~  564 (662)
                      ....++|.+.+.||+|+||.||+|+.....    .||||.++..  .....+.|.+|++++++++||||+++++++.+..
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            345578999999999999999999865432    7999998753  3345678999999999999999999999998876


Q ss_pred             ee------EEEEEccCCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006090          565 EN------MLIYEYMPNKSLDSFLFDPQ---RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN  635 (662)
Q Consensus       565 ~~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~  635 (662)
                      ..      ++||||+++|+|.+++....   ....+++.++..++.||++||.|||+++   |+||||||+|||+++++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            65      99999999999999985321   2235899999999999999999999998   999999999999999999


Q ss_pred             eEEEeeCccccccCC
Q 006090          636 PKISDFGLARIFGGN  650 (662)
Q Consensus       636 ~ki~DFGla~~~~~~  650 (662)
                      +||+|||+|+.+...
T Consensus       176 ~kl~Dfg~a~~~~~~  190 (323)
T 3qup_A          176 VCVADFGLSRKIYSG  190 (323)
T ss_dssp             EEECCCCC-------
T ss_pred             EEEeecccccccccc
Confidence            999999999887543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.92  E-value=4.5e-25  Score=243.32  Aligned_cols=150  Identities=29%  Similarity=0.525  Sum_probs=135.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            67899999999999999999976 68999999986532   233567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999943   345899999999999999999999988   999999999999999999999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=1e-25  Score=247.43  Aligned_cols=151  Identities=28%  Similarity=0.335  Sum_probs=125.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|++.+.||+|+||.||+++.. +++.||||++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999965 6889999998753   233456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |||+++|+|.+++..   ...+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.+||+|||+|+...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999843   3458999999999999999999998 77   9999999999999999999999999998754


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       301 ~~  302 (446)
T 4ejn_A          301 KD  302 (446)
T ss_dssp             C-
T ss_pred             CC
Confidence            43

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.92  E-value=3.8e-25  Score=236.96  Aligned_cols=149  Identities=32%  Similarity=0.447  Sum_probs=127.8

Q ss_pred             ccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          498 QLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      ...+.||+|+||.||+|+.. +++.||+|+++.......++|.+|++++++++||||+++++++.+.+..+|||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            34678999999999999975 68999999998755566778999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCCceEEEeeCccccccCCc
Q 006090          577 SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL--DDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       577 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~~~ki~DFGla~~~~~~~  651 (662)
                      +|.+++.+.  ...+++..+..++.||++||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.+....
T Consensus       172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            999988532  235899999999999999999999988   9999999999999  567899999999999886543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.92  E-value=3.3e-25  Score=228.48  Aligned_cols=149  Identities=28%  Similarity=0.494  Sum_probs=133.4

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|.+.+.||+|+||.||+|+..+++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688899999999999999999889999999986432  23357889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      +++ +|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            975 999988543  245899999999999999999999988   99999999999999999999999999987754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=5e-25  Score=246.75  Aligned_cols=154  Identities=31%  Similarity=0.432  Sum_probs=137.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|.+.+.||+|+||.||+++.. +++.||||++...   .......+.+|+++|++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 6899999998653   233456789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++|+|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999996532 335899999999999999999999998   99999999999999999999999999998865


Q ss_pred             Cc
Q 006090          650 NQ  651 (662)
Q Consensus       650 ~~  651 (662)
                      ..
T Consensus       339 ~~  340 (576)
T 2acx_A          339 GQ  340 (576)
T ss_dssp             TC
T ss_pred             Cc
Confidence            43

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.92  E-value=1.1e-25  Score=235.77  Aligned_cols=160  Identities=30%  Similarity=0.525  Sum_probs=138.5

Q ss_pred             HHHHhhccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEE
Q 006090          488 EELANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCC  560 (662)
Q Consensus       488 ~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~  560 (662)
                      +++....++|.+.+.||+|+||.||+|+..      .++.||||.+.... ......|.+|++++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344456688999999999999999999864      36789999997533 23456799999999999999999999999


Q ss_pred             EeCCeeEEEEEccCCCCHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 006090          561 VEREENMLIYEYMPNKSLDSFLFDPQ-------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD  633 (662)
Q Consensus       561 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~  633 (662)
                      .+++..++||||+++|+|.+++....       ....+++..++.++.||++||.|||+++   |+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence            99999999999999999999985321       1245789999999999999999999998   9999999999999999


Q ss_pred             CceEEEeeCccccccCC
Q 006090          634 LNPKISDFGLARIFGGN  650 (662)
Q Consensus       634 ~~~ki~DFGla~~~~~~  650 (662)
                      +.+||+|||+++.+...
T Consensus       175 ~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             CCEEECCTTCCCGGGGG
T ss_pred             CeEEECcCccccccccc
Confidence            99999999999877543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.92  E-value=2.9e-25  Score=234.34  Aligned_cols=149  Identities=28%  Similarity=0.492  Sum_probs=133.3

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6799999999999999999997 46889999998642   1233467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+ +|+|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 7899988843   345899999999999999999999998   999999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.92  E-value=3.2e-25  Score=230.93  Aligned_cols=157  Identities=33%  Similarity=0.519  Sum_probs=137.4

Q ss_pred             hccccccccccCccCceeEEEEEE------cCCcEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~------~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~  564 (662)
                      ..++|.+.+.||+|+||.||+|+.      .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            447899999999999999999985      2467899999975432 3457899999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQR---------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL  629 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL  629 (662)
                      ..++||||+++|+|.+++.....               ...+++..++.++.||++||.|||+++   |+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999964321               225899999999999999999999988   999999999999


Q ss_pred             EcCCCceEEEeeCccccccCCcc
Q 006090          630 LDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      ++.++.+||+|||+++.+.....
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~  200 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSN  200 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTT
T ss_pred             EcCCCCEEEcccccccccccccc
Confidence            99999999999999998866543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=4.1e-25  Score=242.74  Aligned_cols=150  Identities=32%  Similarity=0.553  Sum_probs=133.8

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-eeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-ENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E  571 (662)
                      ..++|.+.+.||+|+||.||+|+.. ++.||||+++..  ...+.|.+|+++|++++||||+++++++.+.. ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467899999999999999999986 789999999753  35678999999999999999999999988765 6899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            99999999999643 2334799999999999999999999998   99999999999999999999999999986644

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.92  E-value=6.5e-25  Score=231.35  Aligned_cols=155  Identities=28%  Similarity=0.513  Sum_probs=135.2

Q ss_pred             hccccccccccCccCceeEEEEEEc--------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ--------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE  562 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~--------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~  562 (662)
                      ..++|.+.+.||+|+||.||+|+..        +++.||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3478999999999999999999863        46789999997543 33456799999999999 89999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL  629 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL  629 (662)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999965332             234899999999999999999999998   999999999999


Q ss_pred             EcCCCceEEEeeCccccccCC
Q 006090          630 LDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++.++.+||+|||+++.+...
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~  210 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNI  210 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTT
T ss_pred             EcCCCCEEEcccccccccccc
Confidence            999999999999999987654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.92  E-value=7.4e-25  Score=226.80  Aligned_cols=147  Identities=29%  Similarity=0.497  Sum_probs=127.7

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhc--CCCCCcceeeEEEEeC----CeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISN--LQHRNLVRLLGCCVER----EENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~----~~~~  567 (662)
                      .++|++.+.||+|+||+||+|+. +++.||||++..   .....+..|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 589999999864   344566777777766  7899999999997653    4578


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH--------RDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                      +||||+++|+|.+++.    ...+++..++.++.||++||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    235899999999999999999999        655   9999999999999999999999


Q ss_pred             eeCccccccCCc
Q 006090          640 DFGLARIFGGNQ  651 (662)
Q Consensus       640 DFGla~~~~~~~  651 (662)
                      |||+|+.+....
T Consensus       156 Dfg~a~~~~~~~  167 (301)
T 3q4u_A          156 DLGLAVMHSQST  167 (301)
T ss_dssp             CCTTCEEEETTT
T ss_pred             eCCCeeeccccc
Confidence            999998876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=2.4e-25  Score=238.29  Aligned_cols=150  Identities=28%  Similarity=0.364  Sum_probs=124.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHH-HhcCCCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMV-ISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|++.+.||+|+||+||+++.. +++.||||++.+...   .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367999999999999999999976 578899999975432   234556777776 567899999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999953   345889999999999999999999988   9999999999999999999999999999754


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       191 ~  191 (373)
T 2r5t_A          191 E  191 (373)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.92  E-value=3.4e-25  Score=232.92  Aligned_cols=152  Identities=32%  Similarity=0.600  Sum_probs=128.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCc----EEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|++.++||+|+||+||+|+.. +++    .||+|.+... .....++|.+|+.++++++||||++++++|.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            67899999999999999999964 344    3688887543 3345678999999999999999999999998765 789


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+||+++|+|.+++...  ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999643  345899999999999999999999988   9999999999999999999999999999886


Q ss_pred             CCcc
Q 006090          649 GNQD  652 (662)
Q Consensus       649 ~~~~  652 (662)
                      ....
T Consensus       169 ~~~~  172 (327)
T 3poz_A          169 AEEK  172 (327)
T ss_dssp             TTCC
T ss_pred             CCcc
Confidence            5543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=1.2e-25  Score=234.64  Aligned_cols=151  Identities=24%  Similarity=0.410  Sum_probs=129.1

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe----
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE----  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~----  565 (662)
                      .++|++.+.||+|+||.||+++. .+++.||||++.....   .....|.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36799999999999999999996 4688999999975422   334578999999999999999999999887654    


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||||+++++|.+++..   ...+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3999999999999999953   345899999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       165 ~~~~~  169 (311)
T 3ork_A          165 AIADS  169 (311)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.92  E-value=7.7e-25  Score=223.72  Aligned_cols=151  Identities=30%  Similarity=0.451  Sum_probs=135.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            367999999999999999999976 68899999986432 3345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999843   345899999999999999999999988   999999999999999999999999999877543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.92  E-value=3.1e-26  Score=241.69  Aligned_cols=148  Identities=21%  Similarity=0.313  Sum_probs=126.0

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccc--------cccHHHHHHHHHHHhcCC---------CCCccee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--------GQGQEEFMNEVMVISNLQ---------HRNLVRL  556 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~nIv~l  556 (662)
                      .++|++.++||+|+||+||+|+. +++.||||++....        ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788899999999999999998 68999999987532        223478899999988885         8888888


Q ss_pred             eEEEE------------------------------eCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 006090          557 LGCCV------------------------------EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRG  606 (662)
Q Consensus       557 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  606 (662)
                      .+.+.                              +.+..+|||||+++|++.+.+.+    ..+++..+..|+.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            87754                              26788999999999977666632    458999999999999999


Q ss_pred             HHHHH-hCCCCceEecCCCCCcEEEcCCC--------------------ceEEEeeCccccccC
Q 006090          607 LLYLH-RDSRLRIIHRDLKASNILLDDDL--------------------NPKISDFGLARIFGG  649 (662)
Q Consensus       607 L~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~ki~DFGla~~~~~  649 (662)
                      |.||| +.+   |+||||||+||||+.++                    .+||+|||+|+.+..
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            99999 887   99999999999999887                    899999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.92  E-value=2.2e-25  Score=245.10  Aligned_cols=153  Identities=35%  Similarity=0.600  Sum_probs=133.0

Q ss_pred             hhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ...++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            3457789999999999999999999888889999997643 446789999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++|+|.++|... ....+++.+++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999999532 2245899999999999999999999988   999999999999999999999999999987543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.92  E-value=4.7e-25  Score=235.25  Aligned_cols=148  Identities=24%  Similarity=0.365  Sum_probs=130.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999976 6889999999753 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--eEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN--PKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~ki~DFGla~~~~  648 (662)
                      +++|+|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.  +||+|||+|+...
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999999843   335899999999999999999999988   999999999999988765  9999999998543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.92  E-value=6.7e-25  Score=237.02  Aligned_cols=155  Identities=28%  Similarity=0.464  Sum_probs=136.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC--eeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE--ENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV  569 (662)
                      .++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367999999999999999999976 48999999997533 344677889999999999999999999998765  67999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEeeCccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKISDFGLAR  645 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~ki~DFGla~  645 (662)
                      |||+++|+|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+|+
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999966544445999999999999999999999998   9999999999999    778889999999999


Q ss_pred             cccCCc
Q 006090          646 IFGGNQ  651 (662)
Q Consensus       646 ~~~~~~  651 (662)
                      .+....
T Consensus       165 ~~~~~~  170 (396)
T 4eut_A          165 ELEDDE  170 (396)
T ss_dssp             ECCCGG
T ss_pred             EccCCC
Confidence            876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=1e-24  Score=243.50  Aligned_cols=154  Identities=31%  Similarity=0.449  Sum_probs=137.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||+||+++.. +++.||+|++.+..   ......+.+|++++++++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999985 68999999986532   234578899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++.... ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986533 2346899999999999999999999988   99999999999999999999999999998865


Q ss_pred             Cc
Q 006090          650 NQ  651 (662)
Q Consensus       650 ~~  651 (662)
                      ..
T Consensus       342 ~~  343 (543)
T 3c4z_A          342 GQ  343 (543)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=7.1e-25  Score=239.96  Aligned_cols=152  Identities=28%  Similarity=0.414  Sum_probs=133.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|++.+.||+|+||.||++... +++.+|+|.+....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            467999999999999999999865 68899999986532  234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~ki~DFGla~~~  647 (662)
                      ||+++|+|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++   .++.+||+|||+|+.+
T Consensus        90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999853   345899999999999999999999998   99999999999998   4678999999999888


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       164 ~~~~  167 (444)
T 3soa_A          164 EGEQ  167 (444)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            6543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=5e-25  Score=226.87  Aligned_cols=151  Identities=29%  Similarity=0.504  Sum_probs=135.2

Q ss_pred             ccccccccccCccCceeEEEEEEcC-C-------cEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD-G-------QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~-~-------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      .++|.+.+.||+|+||.||+|+... +       ..||+|.+........+.|.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678899999999999999998653 3       4799999977666677889999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--------eE
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN--------PK  637 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~k  637 (662)
                      .++||||+++++|.+++.+.  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999542  234899999999999999999999998   999999999999999887        99


Q ss_pred             EEeeCccccccC
Q 006090          638 ISDFGLARIFGG  649 (662)
Q Consensus       638 i~DFGla~~~~~  649 (662)
                      |+|||+++....
T Consensus       162 l~Dfg~~~~~~~  173 (289)
T 4fvq_A          162 LSDPGISITVLP  173 (289)
T ss_dssp             ECCCCSCTTTSC
T ss_pred             eccCcccccccC
Confidence            999999987644

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=6.1e-25  Score=229.29  Aligned_cols=150  Identities=28%  Similarity=0.331  Sum_probs=128.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||++....  ......+..|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999986 68999999886432  23344556666666555 8999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+ +++|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 67999988543  345899999999999999999999988   999999999999999999999999999887544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=1.4e-24  Score=227.19  Aligned_cols=153  Identities=29%  Similarity=0.500  Sum_probs=120.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467888999999999999999865 58899999986533 2345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDP---QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |++ ++|.+++...   .....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 6999988532   12245899999999999999999999988   9999999999999999999999999999875


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       160 ~~  161 (317)
T 2pmi_A          160 IP  161 (317)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.92  E-value=5.7e-25  Score=225.32  Aligned_cols=152  Identities=37%  Similarity=0.621  Sum_probs=134.9

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..++|.+.+.||+|+||.||+|...+++.||||.+... ....+.|.+|++++++++||||+++++++. .+..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            44789999999999999999999888889999998753 345678999999999999999999999986 4568999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++... ....+++.++..++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999999432 1225899999999999999999999998   999999999999999999999999999987654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.5e-25  Score=236.78  Aligned_cols=150  Identities=30%  Similarity=0.389  Sum_probs=133.9

Q ss_pred             cccccccccCccCceeEEEEEE----cCCcEEEEEEccccc----cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCe
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREE  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~----~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~  565 (662)
                      ++|.+.+.||+|+||.||+++.    .+++.||||+++...    ....+.+.+|++++.++ +||||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6899999999999999999997    368999999987532    23345678899999999 69999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999953   235899999999999999999999988   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       208 ~~~~~  212 (355)
T 1vzo_A          208 EFVAD  212 (355)
T ss_dssp             ECCGG
T ss_pred             ecccC
Confidence            87543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.92  E-value=7.4e-25  Score=232.61  Aligned_cols=150  Identities=28%  Similarity=0.434  Sum_probs=122.1

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ..++|.+.+.||+|+||.||+|+.. +++.||||+++..  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3467999999999999999999986 5789999998753  245678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFGla~~~~  648 (662)
                      |+++++|.+++..   ...+++.++..++.||++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999953   345899999999999999999999988   999999999999975   8899999999999875


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       203 ~~  204 (349)
T 2w4o_A          203 HQ  204 (349)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=1.1e-24  Score=225.76  Aligned_cols=152  Identities=30%  Similarity=0.556  Sum_probs=132.1

Q ss_pred             cccccccccCccCceeEEEEEE-----cCCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--Cee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-----~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  566 (662)
                      +.|++.+.||+|+||.||++++     .+++.||||++... .....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4688899999999999999984     35789999998753 334567899999999999999999999999877  567


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999999432  245899999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       176 ~~~~~  180 (302)
T 4e5w_A          176 IETDK  180 (302)
T ss_dssp             CCTTC
T ss_pred             ccCCC
Confidence            86543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.92  E-value=4.4e-25  Score=243.08  Aligned_cols=150  Identities=22%  Similarity=0.456  Sum_probs=123.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-----Ce
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-----EE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  565 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+++|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999865 6889999998653  233457899999999999999999999999544     46


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||||+ +++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+|+
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5799999853   345899999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       205 ~~~~~  209 (458)
T 3rp9_A          205 TVDYP  209 (458)
T ss_dssp             CTTSC
T ss_pred             hccCc
Confidence            88643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=4.2e-25  Score=233.53  Aligned_cols=157  Identities=27%  Similarity=0.344  Sum_probs=133.6

Q ss_pred             HHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-----ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-----SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER  563 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~  563 (662)
                      +....++|.+.+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3445678999999999999999999975 5789999988643     234567899999999999999999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQ-------------------------------------RQSLLDWPKRFNIIKGISRG  606 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~  606 (662)
                      +..++||||+++|+|.+++....                                     ....+++..+..++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999984100                                     01124567788999999999


Q ss_pred             HHHHHhCCCCceEecCCCCCcEEEcCCC--ceEEEeeCccccccC
Q 006090          607 LLYLHRDSRLRIIHRDLKASNILLDDDL--NPKISDFGLARIFGG  649 (662)
Q Consensus       607 L~yLH~~~~~~iiHrDlkp~NILl~~~~--~~ki~DFGla~~~~~  649 (662)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||+++.+..
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            99999998   99999999999998776  899999999997744

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=3.4e-25  Score=232.70  Aligned_cols=152  Identities=28%  Similarity=0.500  Sum_probs=130.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcE----EEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQE----IAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~----vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|.+.+.||+|+||.||+|+.. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57888999999999999999965 3443    7888775432 334467889999999999999999999986 566889


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999643  345888999999999999999999998   9999999999999999999999999999886


Q ss_pred             CCcc
Q 006090          649 GNQD  652 (662)
Q Consensus       649 ~~~~  652 (662)
                      ....
T Consensus       167 ~~~~  170 (325)
T 3kex_A          167 PDDK  170 (325)
T ss_dssp             CCTT
T ss_pred             cccc
Confidence            5543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.92  E-value=1.9e-25  Score=235.07  Aligned_cols=158  Identities=33%  Similarity=0.520  Sum_probs=136.3

Q ss_pred             HhhccccccccccCccCceeEEEEEEcC-C-----cEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeEEEEe
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQD-G-----QEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE  562 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~~-~-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~  562 (662)
                      ....++|.+.+.||+|+||.||+|.... +     ..||+|.+.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999999642 2     479999987543 23456799999999999 89999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQ-----------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                      .+..++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+++   |+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence            999999999999999999985321           1345899999999999999999999988   99999999999999


Q ss_pred             CCCceEEEeeCccccccCCc
Q 006090          632 DDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       632 ~~~~~ki~DFGla~~~~~~~  651 (662)
                      .++.+||+|||+++.+....
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~  218 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDS  218 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCT
T ss_pred             CCCeEEECcccccccccccc
Confidence            99999999999999775543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.92  E-value=6.6e-25  Score=232.34  Aligned_cols=161  Identities=24%  Similarity=0.369  Sum_probs=132.2

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCC--CCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQH--RNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|++.+.||+|+||.||++...+++.||||++...  ..+..+.+.+|++++.+++|  |||+++++++.++...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999888999999998643  23345789999999999976  9999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      || +.+++|.+++..   ...+++.++..++.||++||.|||+++   |+||||||+|||++ ++.+||+|||+|+.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999954   345899999999999999999999998   99999999999997 57899999999998865


Q ss_pred             CcccccccccccC
Q 006090          650 NQDQAATKRLVGT  662 (662)
Q Consensus       650 ~~~~~~~~~~~Gt  662 (662)
                      ..........+||
T Consensus       160 ~~~~~~~~~~~gt  172 (343)
T 3dbq_A          160 DTTSVVKDSQVGT  172 (343)
T ss_dssp             ----------CCC
T ss_pred             ccccccCCCCcCC
Confidence            5433222233443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.92  E-value=3.2e-25  Score=228.18  Aligned_cols=155  Identities=32%  Similarity=0.553  Sum_probs=138.9

Q ss_pred             hhccccccccccCccCceeEEEEEEcC-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ...++|.+.+.||+|+||.||+|.... ++.||+|.+.. .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            345789999999999999999999864 78899999875 3445678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999999542 2345899999999999999999999998   999999999999999999999999999988654


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      .
T Consensus       165 ~  165 (288)
T 3kfa_A          165 T  165 (288)
T ss_dssp             S
T ss_pred             c
Confidence            3

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=7.2e-25  Score=222.84  Aligned_cols=150  Identities=29%  Similarity=0.550  Sum_probs=136.3

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|.+.+.||+|+||.||++...+++.||+|.+... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3678889999999999999999988889999999763 334578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++++|.+++...  ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999542  345899999999999999999999998   99999999999999999999999999997754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.92  E-value=8.2e-25  Score=230.19  Aligned_cols=150  Identities=22%  Similarity=0.285  Sum_probs=132.5

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|.+.+.||+|+||.||+|+. .+++.||||.+....  ....+.+|+++++++ +||||+++++++.+++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36799999999999999999996 468999999986432  234688999999999 89999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----eEEEeeCcccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN-----PKISDFGLARI  646 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~ki~DFGla~~  646 (662)
                      |+ +++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.     +||+|||+|+.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999999543  346899999999999999999999998   999999999999999887     99999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       160 ~~~~~  164 (330)
T 2izr_A          160 YIDPE  164 (330)
T ss_dssp             SBCTT
T ss_pred             eecCC
Confidence            76543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=6.3e-25  Score=231.79  Aligned_cols=152  Identities=26%  Similarity=0.406  Sum_probs=134.4

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--------QGQEEFMNEVMVISNLQHRNLVRLLGCCVERE  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~  564 (662)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++.....        .....+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            468999999999999999999864 688999999865321        13346788999999999999999999999999


Q ss_pred             eeEEEEEccCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          565 ENMLIYEYMPNK-SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       565 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      ..++||||+..| +|.+++..   ...+++..+..|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            999999999777 99999954   335899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCc
Q 006090          644 ARIFGGNQ  651 (662)
Q Consensus       644 a~~~~~~~  651 (662)
                      ++.+....
T Consensus       177 a~~~~~~~  184 (335)
T 3dls_A          177 AAYLERGK  184 (335)
T ss_dssp             CEECCTTC
T ss_pred             ceECCCCC
Confidence            99886543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.92  E-value=1.3e-24  Score=234.03  Aligned_cols=151  Identities=19%  Similarity=0.274  Sum_probs=135.3

Q ss_pred             ccccccccccCcc--CceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQG--GFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G--~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|++.++||+|  +||.||+++.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999976 68999999986532  2345678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++... ....+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||++..+.
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998543 2245899999999999999999999998   9999999999999999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.92  E-value=8.4e-25  Score=239.03  Aligned_cols=150  Identities=25%  Similarity=0.464  Sum_probs=131.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-----Ce
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-----EE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  565 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999975 5789999999753  223456899999999999999999999999876     56


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||||++ ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999996 699999953   345899999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       178 ~~~~~  182 (432)
T 3n9x_A          178 TINSE  182 (432)
T ss_dssp             EC---
T ss_pred             ccccc
Confidence            88654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.92  E-value=6.5e-25  Score=228.91  Aligned_cols=164  Identities=28%  Similarity=0.479  Sum_probs=139.8

Q ss_pred             cCHHHHHhhccccccccccCccCceeEEEEEE------cCCcEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCCccee
Q 006090          485 FNFEELANATNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRL  556 (662)
Q Consensus       485 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~------~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l  556 (662)
                      +...++....++|.+.+.||+|+||.||+|+.      .+++.||||.+..... ...+.+.+|++++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            45556666678999999999999999999985      2467899999975432 3456799999999999 79999999


Q ss_pred             eEEEEeCC-eeEEEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 006090          557 LGCCVERE-ENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRD  622 (662)
Q Consensus       557 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD  622 (662)
                      ++++.+.+ ..++||||+++++|.+++.....             ...+++..+..++.||++||.|||+++   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99998765 48999999999999999965332             123889999999999999999999988   99999


Q ss_pred             CCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          623 LKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       623 lkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      |||+|||++.++.+||+|||+++.+....
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  202 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDP  202 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             CccceEEECCCCCEEECCCccccccccCc
Confidence            99999999999999999999999876543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.92  E-value=1.6e-24  Score=225.65  Aligned_cols=150  Identities=27%  Similarity=0.434  Sum_probs=133.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.++||+|+||.||+++.. +++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999976 589999998865322  235678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999998843   345899999999999999999999998   999999999999999999999999999987643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=1.9e-24  Score=221.32  Aligned_cols=151  Identities=30%  Similarity=0.506  Sum_probs=135.0

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.+....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            367999999999999999999974 68999999986432   22357899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999999542  345899999999999999999999998   99999999999999999999999999998754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.91  E-value=3.9e-25  Score=248.10  Aligned_cols=152  Identities=35%  Similarity=0.596  Sum_probs=135.6

Q ss_pred             hhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ...++|.+.++||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..+||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3457789999999999999999999888889999997643 446789999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++|+|.++|... ....+++.+++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+++.+..
T Consensus       342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999532 2245899999999999999999999988   99999999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=2e-24  Score=226.28  Aligned_cols=151  Identities=32%  Similarity=0.453  Sum_probs=135.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .++|.+.+.||+|+||.||+++.. +++.||||.+.....      ...+++.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            367899999999999999999976 588999999865322      1367899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEeeC
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFG  642 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~ki~DFG  642 (662)
                      ++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954   345899999999999999999999988   99999999999999988    79999999


Q ss_pred             ccccccCC
Q 006090          643 LARIFGGN  650 (662)
Q Consensus       643 la~~~~~~  650 (662)
                      +++.+...
T Consensus       165 ~~~~~~~~  172 (321)
T 2a2a_A          165 LAHEIEDG  172 (321)
T ss_dssp             TCEECCTT
T ss_pred             cceecCcc
Confidence            99987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=1.6e-24  Score=220.97  Aligned_cols=152  Identities=34%  Similarity=0.520  Sum_probs=125.8

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccc----cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|++.+.||+|+||.||+|... ++.||||++....    ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357889999999999999999975 8899999986532    23357899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--------CCceEEEee
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--------DLNPKISDF  641 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--------~~~~ki~DF  641 (662)
                      |||+++++|.+++.    ...+++..+..++.|+++||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999993    345899999999999999999999987666999999999999986        778999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |+++.+...
T Consensus       161 g~~~~~~~~  169 (271)
T 3dtc_A          161 GLAREWHRT  169 (271)
T ss_dssp             CC-------
T ss_pred             Ccccccccc
Confidence            999877554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.91  E-value=1.8e-24  Score=225.82  Aligned_cols=148  Identities=28%  Similarity=0.403  Sum_probs=130.6

Q ss_pred             cccccc-cccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLA-NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~-~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +.|.+. +.||+|+||.||+++.. +++.||||++..........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567764 78999999999999854 6899999999766556678899999999985 79999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~ki~DFGla~~~~  648 (662)
                      |+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||+|||+++.+.
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999954   245899999999999999999999998   999999999999998776   9999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.91  E-value=1.6e-24  Score=222.27  Aligned_cols=155  Identities=30%  Similarity=0.456  Sum_probs=134.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|.+.+.||+|+||.||++... +++.||||++...  ......++.+|+..+.++ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467999999999999999999976 6899999998753  234467888999999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---------------
Q 006090          570 YEYMPNKSLDSFLFDPQR-QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---------------  633 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---------------  633 (662)
                      |||+++++|.+++..... ...+++..+..++.||++||.|||+++   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999954211 256899999999999999999999998   9999999999999844               


Q ss_pred             ----CceEEEeeCccccccCCc
Q 006090          634 ----LNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       634 ----~~~ki~DFGla~~~~~~~  651 (662)
                          ..+||+|||+++......
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~  188 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ  188 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC
T ss_pred             cCCceEEEEcccccccccCCcc
Confidence                479999999999886543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.91  E-value=2.5e-24  Score=222.42  Aligned_cols=150  Identities=28%  Similarity=0.420  Sum_probs=134.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367899999999999999999976 47889999886532   23456789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++..   ...+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998843   345899999999999999999999998   99999999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=1.4e-24  Score=227.96  Aligned_cols=152  Identities=30%  Similarity=0.536  Sum_probs=135.6

Q ss_pred             cccccccccCccCceeEEEEEE-----cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-----~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~  567 (662)
                      ++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6789999999999999999984     3578999999987666667789999999999999999999999874  55688


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999532  234899999999999999999999988   999999999999999999999999999988


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       178 ~~~~  181 (327)
T 3lxl_A          178 PLDK  181 (327)
T ss_dssp             CTTC
T ss_pred             ccCC
Confidence            6543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.91  E-value=1.3e-24  Score=236.67  Aligned_cols=151  Identities=24%  Similarity=0.377  Sum_probs=127.9

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--------cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER  563 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~  563 (662)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3578999999999999999999875 57899999986421        112235889999999999999999999975 5


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEe
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISD  640 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~D  640 (662)
                      +..++||||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++   .+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            567999999999999999843   345899999999999999999999988   99999999999997544   599999


Q ss_pred             eCccccccCC
Q 006090          641 FGLARIFGGN  650 (662)
Q Consensus       641 FGla~~~~~~  650 (662)
                      ||+|+.+...
T Consensus       286 FG~a~~~~~~  295 (419)
T 3i6u_A          286 FGHSKILGET  295 (419)
T ss_dssp             SSTTTSCC--
T ss_pred             cccceecCCC
Confidence            9999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.91  E-value=1.8e-24  Score=227.26  Aligned_cols=142  Identities=25%  Similarity=0.372  Sum_probs=125.9

Q ss_pred             ccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEccCCCC
Q 006090          500 ANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKS  577 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  577 (662)
                      .++||+|+||.||++... +++.||||++..   .....+.+|+.+++++. ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999976 588999999864   34567889999999997 9999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEeeCccccccCC
Q 006090          578 LDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NPKISDFGLARIFGGN  650 (662)
Q Consensus       578 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ki~DFGla~~~~~~  650 (662)
                      |.+++..   ...+++.++..++.||++||.|||+++   |+||||||+|||++.++   .+||+|||+++.....
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999954   345899999999999999999999988   99999999999998766   8999999999977544

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.91  E-value=2.3e-24  Score=227.42  Aligned_cols=151  Identities=28%  Similarity=0.422  Sum_probs=135.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999976 47889999986532   23456789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++..   ...+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999999843   345899999999999999999999998   99999999999999999999999999998754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       194 ~  194 (335)
T 2owb_A          194 D  194 (335)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.91  E-value=1.5e-24  Score=223.24  Aligned_cols=153  Identities=27%  Similarity=0.437  Sum_probs=132.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|.+.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            67899999999999999999975 58899999986543 33567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEeeCcccccc
Q 006090          573 MPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFG  648 (662)
Q Consensus       573 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~ki~DFGla~~~~  648 (662)
                      +++++|.+++.... ....+++..+..++.||++||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999885321 2356899999999999999999999988   9999999999999   456789999999998875


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       179 ~~  180 (285)
T 3is5_A          179 SD  180 (285)
T ss_dssp             --
T ss_pred             Cc
Confidence            54

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.91  E-value=9.3e-25  Score=227.77  Aligned_cols=161  Identities=30%  Similarity=0.564  Sum_probs=128.6

Q ss_pred             HHHHHhhccccccccccCccCceeEEEEEEc----CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEE
Q 006090          487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCC  560 (662)
Q Consensus       487 ~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~  560 (662)
                      ..++....++|.+.+.||+|+||.||+|+..    .++.||+|.+...  .....+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3444445678999999999999999999865    2457999998753  233456799999999999999999999999


Q ss_pred             EeCCe-----eEEEEEccCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 006090          561 VEREE-----NMLIYEYMPNKSLDSFLFDP---QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD  632 (662)
Q Consensus       561 ~~~~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~  632 (662)
                      .+.+.     .++||||+++++|.+++...   .....+++..++.++.||++||.|||+++   |+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence            87654     49999999999999998422   23356899999999999999999999987   999999999999999


Q ss_pred             CCceEEEeeCccccccCC
Q 006090          633 DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       633 ~~~~ki~DFGla~~~~~~  650 (662)
                      ++.+||+|||+++.+...
T Consensus       183 ~~~~kl~Dfg~~~~~~~~  200 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSG  200 (313)
T ss_dssp             TSCEEECSCSCC------
T ss_pred             CCcEEEeecCcceecccc
Confidence            999999999999877543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.91  E-value=3.1e-24  Score=221.47  Aligned_cols=150  Identities=29%  Similarity=0.420  Sum_probs=132.0

Q ss_pred             cccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      |.....||+|+||.||+|+.. +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            444568999999999999964 6789999999766556678899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEeeCccccccC
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGG  649 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ki~DFGla~~~~~  649 (662)
                      ++|.+++........+++..+..++.||++||.|||+.+   |+||||||+|||++. ++.+||+|||+++.+..
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999965444445788999999999999999999988   999999999999998 89999999999988754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.91  E-value=1.4e-24  Score=222.93  Aligned_cols=152  Identities=26%  Similarity=0.454  Sum_probs=124.4

Q ss_pred             hccccccccccCccCceeEEEEEEcC----CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ..++|++.+.||+|+||.||+|....    +..||+|.+.... ....+.|.+|+.++++++||||+++++++ .++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            34689999999999999999998743    4569999987532 33456799999999999999999999997 456789


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++++|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999999532  335899999999999999999999988   999999999999999999999999999987


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       167 ~~~  169 (281)
T 1mp8_A          167 EDS  169 (281)
T ss_dssp             ---
T ss_pred             Ccc
Confidence            543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.91  E-value=1.7e-24  Score=248.93  Aligned_cols=161  Identities=28%  Similarity=0.368  Sum_probs=138.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|++.+.||+|+||+||+++.. +++.||||++++.   .....+.+..|..++..+ +||||+++++++.+.+..+|
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467999999999999999999976 5788999998753   234456788999999988 79999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.++|..   ...+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+...
T Consensus       420 V~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999999953   245899999999999999999999998   9999999999999999999999999999754


Q ss_pred             CCcccccccccccC
Q 006090          649 GNQDQAATKRLVGT  662 (662)
Q Consensus       649 ~~~~~~~~~~~~Gt  662 (662)
                      .....  +..++||
T Consensus       494 ~~~~~--~~~~~GT  505 (674)
T 3pfq_A          494 WDGVT--TKTFCGT  505 (674)
T ss_dssp             CTTCC--BCCCCSC
T ss_pred             cCCcc--cccccCC
Confidence            33322  3335565

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.91  E-value=1.5e-24  Score=233.75  Aligned_cols=160  Identities=24%  Similarity=0.362  Sum_probs=132.1

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCC--CCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .+|.+.+.||+|+||.||++...+++.||||++...  .....+.+.+|++++++++  ||||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            569999999999999999999888999999998643  2345678999999999996  599999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      | +.+++|.+++.+.   ..+++.++..++.||++||.|||+.+   |+||||||+||||+ ++.+||+|||+|+.+...
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 5689999999542   35889999999999999999999987   99999999999995 579999999999988655


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      .........+||
T Consensus       208 ~~~~~~~~~~gt  219 (390)
T 2zmd_A          208 TTSVVKDSQVGA  219 (390)
T ss_dssp             ------CCSCCC
T ss_pred             CccccCCCCCcC
Confidence            433323334454

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=6.3e-24  Score=220.38  Aligned_cols=150  Identities=29%  Similarity=0.471  Sum_probs=135.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+.|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888999999999999999865 68899999986533 3456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999942    45899999999999999999999998   999999999999999999999999999887654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.91  E-value=2e-24  Score=229.13  Aligned_cols=150  Identities=30%  Similarity=0.504  Sum_probs=132.3

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +.|...+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            5688899999999999999996 468999999986432   223467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||++ |+|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 6888877432  345899999999999999999999998   999999999999999999999999999887543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=2.1e-24  Score=229.76  Aligned_cols=164  Identities=26%  Similarity=0.322  Sum_probs=141.1

Q ss_pred             cccccCHHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-----CCCcc
Q 006090          481 DLLVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-----HRNLV  554 (662)
Q Consensus       481 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----H~nIv  554 (662)
                      +...+++.+.....++|.+.++||+|+||.||+|+.. +++.||||++.. .....+.+..|++++++++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3444555565666789999999999999999999974 688999999874 3345567888999999986     99999


Q ss_pred             eeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--
Q 006090          555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--  632 (662)
Q Consensus       555 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--  632 (662)
                      ++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            9999999999999999999 99999999543 2235899999999999999999999988   999999999999976  


Q ss_pred             -----------------------CCceEEEeeCccccccCC
Q 006090          633 -----------------------DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       633 -----------------------~~~~ki~DFGla~~~~~~  650 (662)
                                             ++.+||+|||+|+.....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~  215 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY  215 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC
Confidence                                   789999999999976543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=2.1e-24  Score=232.43  Aligned_cols=148  Identities=30%  Similarity=0.598  Sum_probs=123.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCC--eeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVERE--ENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~  567 (662)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  ..+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            468999999999999999999865 6899999998643  2344567889999999997 999999999998654  679


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||++ ++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9999997 689999843    35899999999999999999999998   999999999999999999999999999987


Q ss_pred             cC
Q 006090          648 GG  649 (662)
Q Consensus       648 ~~  649 (662)
                      ..
T Consensus       160 ~~  161 (388)
T 3oz6_A          160 VN  161 (388)
T ss_dssp             SS
T ss_pred             cc
Confidence            43

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.91  E-value=1.9e-24  Score=221.52  Aligned_cols=151  Identities=31%  Similarity=0.458  Sum_probs=132.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|++.+.||+|+||.||+++.. +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999876 56789999985422   23356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999843   245899999999999999999999987   99999999999999999999999999976654


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       162 ~  162 (279)
T 3fdn_A          162 S  162 (279)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.91  E-value=2.9e-24  Score=225.60  Aligned_cols=153  Identities=31%  Similarity=0.590  Sum_probs=135.1

Q ss_pred             ccccccccccCccCceeEEEEEE-----cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC--ee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-----QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE--EN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-----~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~  566 (662)
                      .++|++.+.||+|+||.||++++     .+++.||||++........+.|.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35788999999999999999984     358899999998766666778999999999999999999999987654  67


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++++|.+++...  ...+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999543  235899999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       195 ~~~~~  199 (326)
T 2w1i_A          195 LPQDK  199 (326)
T ss_dssp             CCSSC
T ss_pred             ccccc
Confidence            86543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.91  E-value=3.8e-24  Score=228.56  Aligned_cols=155  Identities=23%  Similarity=0.411  Sum_probs=136.9

Q ss_pred             HHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--------ccHHHHHHHHHHHhcC-CCCCcceeeEE
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--------QGQEEFMNEVMVISNL-QHRNLVRLLGC  559 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l-~H~nIv~l~g~  559 (662)
                      .....++|.+.+.||+|+||.||+|+.. +|+.||||++.....        ...+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3444578999999999999999999986 689999998865321        1145688999999999 79999999999


Q ss_pred             EEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       560 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                      +......++||||+++++|.+++.+   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999953   345899999999999999999999988   9999999999999999999999


Q ss_pred             eeCccccccCC
Q 006090          640 DFGLARIFGGN  650 (662)
Q Consensus       640 DFGla~~~~~~  650 (662)
                      |||+++.+...
T Consensus       243 DfG~~~~~~~~  253 (365)
T 2y7j_A          243 DFGFSCHLEPG  253 (365)
T ss_dssp             CCTTCEECCTT
T ss_pred             ecCcccccCCC
Confidence            99999988654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.91  E-value=4.4e-24  Score=219.09  Aligned_cols=150  Identities=30%  Similarity=0.464  Sum_probs=133.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.++....      ...+.+.+|++++++++||||+++++++.++...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57899999999999999999986 689999998865321      23678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEeeCc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFGL  643 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~ki~DFGl  643 (662)
                      +||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999943   345899999999999999999999988   99999999999999877    899999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ++.+...
T Consensus       159 ~~~~~~~  165 (283)
T 3bhy_A          159 AHKIEAG  165 (283)
T ss_dssp             CEECC--
T ss_pred             ceeccCC
Confidence            9987543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.91  E-value=7.7e-24  Score=221.63  Aligned_cols=148  Identities=32%  Similarity=0.554  Sum_probs=131.4

Q ss_pred             cccccccCccCceeEEEEEEc-----CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEE
Q 006090          497 FQLANKLGQGGFGPVYKGKLQ-----DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENML  568 (662)
Q Consensus       497 f~~~~~lG~G~fG~Vykg~~~-----~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  568 (662)
                      |++.++||+|+||.||++.+.     +++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999998753     57889999997543 24467799999999999999999999999984  56799


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++++|.+++.+    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999943    24899999999999999999999998   9999999999999999999999999999886


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       186 ~~~  188 (318)
T 3lxp_A          186 EGH  188 (318)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.91  E-value=2.7e-24  Score=244.98  Aligned_cols=150  Identities=32%  Similarity=0.588  Sum_probs=130.0

Q ss_pred             ccccccc-ccCccCceeEEEEEEc---CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLAN-KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~-~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      +++.+.+ +||+|+||.||+|.+.   ++..||||+++... ....++|.+|+++|++++|||||++++++.+ +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999875   45679999997643 3456889999999999999999999999976 568999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++|+|.++|...  ...+++..+..|+.||++||+|||+++   |+||||||+||||++++.+||+|||+|+.+..
T Consensus       414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9999999999999542  345899999999999999999999988   99999999999999999999999999998765


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       489 ~  489 (613)
T 2ozo_A          489 D  489 (613)
T ss_dssp             -
T ss_pred             C
Confidence            4

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=3e-24  Score=224.22  Aligned_cols=152  Identities=29%  Similarity=0.433  Sum_probs=132.9

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe----CCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----REENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~l  568 (662)
                      .++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999997 4689999999876555667789999999999999999999999973    346789


Q ss_pred             EEEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          569 IYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ||||+++++|.+++... .....+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998542 12456899999999999999999999998   999999999999999999999999998865


Q ss_pred             c
Q 006090          648 G  648 (662)
Q Consensus       648 ~  648 (662)
                      .
T Consensus       185 ~  185 (317)
T 2buj_A          185 C  185 (317)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=5.5e-24  Score=218.49  Aligned_cols=152  Identities=26%  Similarity=0.441  Sum_probs=134.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999975 5889999998643  2334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN---PKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~ki~DFGla~~~  647 (662)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999988843   345899999999999999999999998   999999999999987655   999999999887


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       159 ~~~~  162 (284)
T 3kk8_A          159 NDSE  162 (284)
T ss_dssp             CSSC
T ss_pred             ccCc
Confidence            6543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.91  E-value=3.3e-24  Score=223.52  Aligned_cols=151  Identities=23%  Similarity=0.309  Sum_probs=130.6

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      -++|.+.+.||+|+||.||+++.. +++.||+|.+.....   ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            378999999999999999999975 688999999875422   2346789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999953   245899999999999999999999998   99999999999999999999999999987754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       187 ~  187 (309)
T 2h34_A          187 E  187 (309)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=4e-24  Score=225.02  Aligned_cols=151  Identities=28%  Similarity=0.474  Sum_probs=127.9

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcC--CCCCcceeeEEEEeC----Cee
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL--QHRNLVRLLGCCVER----EEN  566 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l--~H~nIv~l~g~~~~~----~~~  566 (662)
                      ..++|++.++||+|+||.||+|+.. ++.||||++..   .....+..|.+++..+  +||||+++++++.+.    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec---cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3478999999999999999999986 89999999854   2334556666666654  899999999999987    678


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEEcCCCceEEEee
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS-----RLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      ++||||+++|+|.+++..    ..+++..++.++.|++.||.|||++.     +.+|+||||||+|||++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            999999999999999943    35899999999999999999999871     123999999999999999999999999


Q ss_pred             CccccccCCc
Q 006090          642 GLARIFGGNQ  651 (662)
Q Consensus       642 Gla~~~~~~~  651 (662)
                      |+|+.+....
T Consensus       187 g~a~~~~~~~  196 (337)
T 3mdy_A          187 GLAVKFISDT  196 (337)
T ss_dssp             TTCEECC---
T ss_pred             CCceeecccc
Confidence            9998875543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.91  E-value=2.3e-24  Score=237.47  Aligned_cols=148  Identities=29%  Similarity=0.438  Sum_probs=125.0

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------C
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------E  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~  564 (662)
                      .++|++.++||+|+||+||+|... +++.||||++...  .....+.+.+|+.++++++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999865 5889999999753  233456789999999999999999999999765      3


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||++++ |.+.+..     .+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999754 6666622     3889999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.....
T Consensus       212 ~~~~~~  217 (464)
T 3ttj_A          212 RTAGTS  217 (464)
T ss_dssp             -----C
T ss_pred             eecCCC
Confidence            987653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=7e-24  Score=218.34  Aligned_cols=151  Identities=32%  Similarity=0.602  Sum_probs=132.2

Q ss_pred             cccccccc-ccCccCceeEEEEEEc---CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLAN-KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~-~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|.+.+ .||+|+||.||+|+..   +++.||||.++... ....+.+.+|++++++++||||+++++++ +.+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35666666 9999999999999864   57789999997643 34567899999999999999999999999 5667899


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999953  2345899999999999999999999998   9999999999999999999999999999886


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       162 ~~  163 (287)
T 1u59_A          162 AD  163 (287)
T ss_dssp             TC
T ss_pred             cC
Confidence            54

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.91  E-value=4.1e-24  Score=237.65  Aligned_cols=151  Identities=30%  Similarity=0.479  Sum_probs=130.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|.+.++||+|+||+||+++.. +++.||+|++....  ......+.+|+.++++++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999976 68899999986532  334678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~ki~DFGla~~~  647 (662)
                      ||+++|+|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.+   +.+||+|||+|+.+
T Consensus       116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999998843   345899999999999999999999988   9999999999999764   45999999999988


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       190 ~~~  192 (494)
T 3lij_A          190 ENQ  192 (494)
T ss_dssp             BTT
T ss_pred             CCC
Confidence            654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.91  E-value=3.5e-24  Score=226.71  Aligned_cols=152  Identities=29%  Similarity=0.459  Sum_probs=135.2

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEcccccccc-----------------HHHHHHHHHHHhcCCCCCccee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQG-----------------QEEFMNEVMVISNLQHRNLVRL  556 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~-----------------~~~f~~E~~~l~~l~H~nIv~l  556 (662)
                      .++|.+.+.||+|+||.||+++. +++.||||.+.......                 .+.|.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999999 89999999986432111                 1789999999999999999999


Q ss_pred             eEEEEeCCeeEEEEEccCCCCHHHH------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEE
Q 006090          557 LGCCVEREENMLIYEYMPNKSLDSF------LFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNIL  629 (662)
Q Consensus       557 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NIL  629 (662)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||+.||.|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      532 224679999999999999999999999 77   999999999999


Q ss_pred             EcCCCceEEEeeCccccccCC
Q 006090          630 LDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++.++.+||+|||+++.+...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~  205 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK  205 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT
T ss_pred             EcCCCcEEEeccccccccccc
Confidence            999999999999999987543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.91  E-value=3.7e-24  Score=221.32  Aligned_cols=150  Identities=31%  Similarity=0.531  Sum_probs=132.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe----------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----------  562 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----------  562 (662)
                      .++|++.+.||+|+||.||+|+.. +++.||||.+.. .....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467999999999999999999975 689999999864 33456789999999999999999999999876          


Q ss_pred             ---CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          563 ---REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       563 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                         ....++||||+++++|.+++...  ...+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               35678999999999999999542  234788999999999999999999998   9999999999999999999999


Q ss_pred             eeCccccccC
Q 006090          640 DFGLARIFGG  649 (662)
Q Consensus       640 DFGla~~~~~  649 (662)
                      |||+++.+..
T Consensus       159 dfg~~~~~~~  168 (303)
T 1zy4_A          159 DFGLAKNVHR  168 (303)
T ss_dssp             CCCCCSCTTC
T ss_pred             eCcchhhccc
Confidence            9999988753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.91  E-value=8.1e-24  Score=220.19  Aligned_cols=153  Identities=31%  Similarity=0.550  Sum_probs=128.1

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-----cccHHHHHHHHHHHhcC---CCCCcceeeEEEEeC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-----GQGQEEFMNEVMVISNL---QHRNLVRLLGCCVER  563 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~  563 (662)
                      ..++|++.++||+|+||+||+|+.. +++.||||++....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3578999999999999999999964 68899999986422     12245677888877766   499999999999876


Q ss_pred             C-----eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          564 E-----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       564 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      .     ..++||||++ ++|.+++.... ...+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 69999996532 234899999999999999999999998   999999999999999999999


Q ss_pred             EeeCccccccCC
Q 006090          639 SDFGLARIFGGN  650 (662)
Q Consensus       639 ~DFGla~~~~~~  650 (662)
                      +|||+|+.+...
T Consensus       162 ~Dfg~a~~~~~~  173 (308)
T 3g33_A          162 ADFGLARIYSYQ  173 (308)
T ss_dssp             CSCSCTTTSTTC
T ss_pred             eeCccccccCCC
Confidence            999999987543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.91  E-value=3.5e-24  Score=228.68  Aligned_cols=152  Identities=21%  Similarity=0.337  Sum_probs=126.8

Q ss_pred             hccccccccccCccCceeEEEEEEcC------CcEEEEEEcccccccc-----------HHHHHHHHHHHhcCCCCCcce
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKASGQG-----------QEEFMNEVMVISNLQHRNLVR  555 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~------~~~vAvK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~nIv~  555 (662)
                      ..++|.+.++||+|+||.||+|....      ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998764      4789999986533211           123445666778889999999


Q ss_pred             eeEEEEeC----CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          556 LLGCCVER----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       556 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                      +++++.+.    ...+|||||+ +++|.+++...  ...+++.+++.|+.||+.||.|||+++   |+||||||+||||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99999875    4479999999 99999999542  345999999999999999999999997   99999999999999


Q ss_pred             --CCCceEEEeeCccccccCC
Q 006090          632 --DDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       632 --~~~~~ki~DFGla~~~~~~  650 (662)
                        .++.+||+|||+|+.+...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGG
T ss_pred             cCCCCeEEEEECCcceecccC
Confidence              8899999999999987654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.91  E-value=4.9e-24  Score=224.33  Aligned_cols=149  Identities=28%  Similarity=0.510  Sum_probs=130.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.+.||+|+||.||+++.. +++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            67999999999999999999976 488999998854322  234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999988743   335899999999999999999999998   99999999999999999999999999987754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.91  E-value=6.6e-24  Score=236.58  Aligned_cols=151  Identities=32%  Similarity=0.517  Sum_probs=132.0

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-------------ccHHHHHHHHHHHhcCCCCCcceeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-------------QGQEEFMNEVMVISNLQHRNLVRLLGC  559 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~nIv~l~g~  559 (662)
                      .++|.+.++||+|+||+||+++.. +++.||||++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            478999999999999999999976 578999999865321             335679999999999999999999999


Q ss_pred             EEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ce
Q 006090          560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL---NP  636 (662)
Q Consensus       560 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~  636 (662)
                      +.++...++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999843   345899999999999999999999998   99999999999998876   69


Q ss_pred             EEEeeCccccccCC
Q 006090          637 KISDFGLARIFGGN  650 (662)
Q Consensus       637 ki~DFGla~~~~~~  650 (662)
                      ||+|||+|+.+...
T Consensus       189 kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD  202 (504)
T ss_dssp             EECCCTTCEECCTT
T ss_pred             EEEECCCCEEcCCC
Confidence            99999999988654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.91  E-value=4.3e-24  Score=218.31  Aligned_cols=151  Identities=26%  Similarity=0.491  Sum_probs=135.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.+....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999976 68999999986432   23456889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++++|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999953   235899999999999999999999998   99999999999999999999999999998754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       164 ~  164 (276)
T 2h6d_A          164 G  164 (276)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.91  E-value=5.2e-24  Score=225.42  Aligned_cols=148  Identities=24%  Similarity=0.411  Sum_probs=128.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|++.+.||+|+||.||++... +++.||||.+.....    .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467999999999999999999976 588999999975432    235688888887 79999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CceEEEeeCccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD----LNPKISDFGLARIF  647 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~ki~DFGla~~~  647 (662)
                      |+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||+++.+
T Consensus        97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999999854   345899999999999999999999998   9999999999998543    35999999999987


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       171 ~~~~  174 (342)
T 2qr7_A          171 RAEN  174 (342)
T ss_dssp             BCTT
T ss_pred             cCCC
Confidence            6543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.91  E-value=2.5e-24  Score=224.24  Aligned_cols=150  Identities=29%  Similarity=0.485  Sum_probs=126.8

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|++.+.||+|+||.||+++.. ++.||||.+..  ....+.|.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            57888999999999999999986 78999999864  345678999999999999999999999876  45799999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-eEEEeeCccccccC
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN-PKISDFGLARIFGG  649 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-~ki~DFGla~~~~~  649 (662)
                      +++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.+..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999976554456889999999999999999999943234999999999999998886 79999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=3.9e-24  Score=227.86  Aligned_cols=160  Identities=26%  Similarity=0.388  Sum_probs=133.6

Q ss_pred             cCHHHHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccc-----------cHHHHHHHHHHHhcCCCCCc
Q 006090          485 FNFEELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQ-----------GQEEFMNEVMVISNLQHRNL  553 (662)
Q Consensus       485 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~nI  553 (662)
                      ....++....++|.+.+.||+|+||.||+|...+++.||||++......           ..+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456777888999999999999999999999888999999998643221           13789999999999999999


Q ss_pred             ceeeEEEEeCC-----eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 006090          554 VRLLGCCVERE-----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI  628 (662)
Q Consensus       554 v~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI  628 (662)
                      +++++++...+     ..++||||++ |+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            99999996533     5799999997 688888854  2346899999999999999999999998   99999999999


Q ss_pred             EEcCCCceEEEeeCccccccCC
Q 006090          629 LLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       629 Ll~~~~~~ki~DFGla~~~~~~  650 (662)
                      |++.++.+||+|||+++.....
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~  187 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD  187 (362)
T ss_dssp             EECTTCCEEECCTTC-------
T ss_pred             EEcCCCCEEEEecCcccccccc
Confidence            9999999999999999866443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.2e-24  Score=226.17  Aligned_cols=152  Identities=33%  Similarity=0.590  Sum_probs=128.9

Q ss_pred             ccccccccccCccCceeEEEEEEcC-----CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD-----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~-----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      .++|.+.+.||+|+||.||+|....     +..||||.+.... ......|.+|++++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3578888999999999999998753     2359999987543 234567999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++++|.+++...  ...+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999999542  345899999999999999999999998   999999999999999999999999999987


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       198 ~~~  200 (333)
T 1mqb_A          198 EDD  200 (333)
T ss_dssp             ---
T ss_pred             ccc
Confidence            654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=6.8e-24  Score=219.34  Aligned_cols=152  Identities=27%  Similarity=0.402  Sum_probs=135.0

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---------cccHHHHHHHHHHHhcCC-CCCcceeeEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---------GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCV  561 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~  561 (662)
                      ..++|.+.+.||+|+||.||++... +++.||||.+....         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3478999999999999999999976 58899999986432         122457889999999995 999999999999


Q ss_pred             eCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          562 EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       562 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                      ++...++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999953   345899999999999999999999988   999999999999999999999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |+++.+...
T Consensus       169 g~~~~~~~~  177 (298)
T 1phk_A          169 GFSCQLDPG  177 (298)
T ss_dssp             TTCEECCTT
T ss_pred             cchhhcCCC
Confidence            999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.91  E-value=2.3e-24  Score=226.80  Aligned_cols=151  Identities=29%  Similarity=0.480  Sum_probs=127.9

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc--ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG--QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ..++|.+.++||+|+||+||++... +++.||||++.....  ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4478999999999999999999865 688999999965332  2345788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-----CCCceEEEeeCcc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-----DDLNPKISDFGLA  644 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-----~~~~~ki~DFGla  644 (662)
                      |||++ |+|.+++..   ...+++..+..|+.||++||.|||+++   |+||||||+|||++     +++.+||+|||+|
T Consensus       112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99997 599999843   335899999999999999999999998   99999999999994     5556999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.+...
T Consensus       185 ~~~~~~  190 (329)
T 3gbz_A          185 RAFGIP  190 (329)
T ss_dssp             HHHC--
T ss_pred             cccCCc
Confidence            987543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=2.2e-24  Score=230.97  Aligned_cols=150  Identities=29%  Similarity=0.532  Sum_probs=123.7

Q ss_pred             cccccccccCccCceeEEEEEEcC--C--cEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD--G--QEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~--~--~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~l  568 (662)
                      ..|.+.+.||+|+||.||+|+..+  +  ..||||.++... ....++|.+|+.++++++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            457778999999999999998642  2  368999986532 3456789999999999999999999999865 457799


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999999543  345889999999999999999999998   9999999999999999999999999999775


Q ss_pred             C
Q 006090          649 G  649 (662)
Q Consensus       649 ~  649 (662)
                      .
T Consensus       244 ~  244 (373)
T 3c1x_A          244 D  244 (373)
T ss_dssp             -
T ss_pred             c
Confidence            4

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=3.5e-24  Score=222.02  Aligned_cols=150  Identities=27%  Similarity=0.511  Sum_probs=132.7

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467999999999999999999986 588999999977666677899999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      |+++++|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999998532  345899999999999999999999988   999999999999999999999999998644

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.91  E-value=3.6e-24  Score=219.56  Aligned_cols=149  Identities=32%  Similarity=0.544  Sum_probs=131.5

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe----------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----------  562 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----------  562 (662)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+....    ..+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            367899999999999999999986 68999999986532    356789999999999999999999865          


Q ss_pred             ------CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          563 ------REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       563 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                            ....++||||+++++|.+++... ....+++..+..++.||++||.|||+++   |+||||||+|||+++++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                  34578999999999999999542 2346899999999999999999999988   9999999999999999999


Q ss_pred             EEEeeCccccccCC
Q 006090          637 KISDFGLARIFGGN  650 (662)
Q Consensus       637 ki~DFGla~~~~~~  650 (662)
                      ||+|||+++.+...
T Consensus       162 kl~Dfg~~~~~~~~  175 (284)
T 2a19_B          162 KIGDFGLVTSLKND  175 (284)
T ss_dssp             EECCCTTCEESSCC
T ss_pred             EECcchhheecccc
Confidence            99999999987654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=5.3e-24  Score=220.07  Aligned_cols=149  Identities=32%  Similarity=0.505  Sum_probs=129.9

Q ss_pred             ccccccccCccCceeEEEEEEcC-C---cEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee-EEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQD-G---QEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN-MLI  569 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~-~---~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lV  569 (662)
                      .|...++||+|+||.||+|+..+ +   ..+|+|.+..... ...+.|.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667999999999999998642 2   3699999875333 3457899999999999999999999999877665 999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+.+++|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999652  345899999999999999999999998   99999999999999999999999999987654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.3e-24  Score=227.21  Aligned_cols=152  Identities=29%  Similarity=0.504  Sum_probs=127.4

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccc-----cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-----GQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++......     ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578999999999999999999975 5899999998643221     134688999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++ +|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999985 898888542  345888999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCC
Q 006090          647 FGGN  650 (662)
Q Consensus       647 ~~~~  650 (662)
                      +...
T Consensus       162 ~~~~  165 (346)
T 1ua2_A          162 FGSP  165 (346)
T ss_dssp             TTSC
T ss_pred             ccCC
Confidence            7543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=4.4e-24  Score=224.54  Aligned_cols=152  Identities=32%  Similarity=0.602  Sum_probs=126.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcE----EEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQE----IAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~----vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      .++|++.++||+|+||.||+|... +++.    ||+|.+... .....+++.+|+.++++++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999964 3443    577777543 3445778999999999999999999999998765 78


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +|+||+++|+|.+++...  ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999999543  345899999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       168 ~~~~  171 (327)
T 3lzb_A          168 GAEE  171 (327)
T ss_dssp             ----
T ss_pred             cCcc
Confidence            6543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.91  E-value=5e-24  Score=220.49  Aligned_cols=152  Identities=28%  Similarity=0.519  Sum_probs=130.9

Q ss_pred             ccccccccccCccCceeEEEEEEcC----CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEe-CCeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE-REENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~  567 (662)
                      ..+|.+.+.||+|+||.||+|+..+    ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568889999999999999998642    2358999987533 3345789999999999999999999999755 45679


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++++|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            999999999999999642  345899999999999999999999998   999999999999999999999999999977


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       179 ~~~  181 (298)
T 3f66_A          179 YDK  181 (298)
T ss_dssp             SCG
T ss_pred             ccc
Confidence            543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.91  E-value=1.4e-23  Score=222.70  Aligned_cols=149  Identities=30%  Similarity=0.558  Sum_probs=130.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--------
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--------  563 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--------  563 (662)
                      ++|.+.++||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+.        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            67999999999999999999974 68999999886432  23356788999999999999999999999874        


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      +..++||||+++ +|.+.+...  ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            467999999975 777777443  235899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccC
Q 006090          644 ARIFGG  649 (662)
Q Consensus       644 a~~~~~  649 (662)
                      |+.+..
T Consensus       171 a~~~~~  176 (351)
T 3mi9_A          171 ARAFSL  176 (351)
T ss_dssp             CEECCC
T ss_pred             cccccc
Confidence            998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.90  E-value=1e-23  Score=216.99  Aligned_cols=151  Identities=32%  Similarity=0.604  Sum_probs=129.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccccc-------HHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQG-------QEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~-------~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++.......       .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367899999999999999999975 68899999986432221       267999999999999999999999986554 


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----eEEEe
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN-----PKISD  640 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~ki~D  640 (662)
                       ++||||+++++|.+++.+.  ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999999988543  346899999999999999999999875 45999999999999988776     99999


Q ss_pred             eCccccccC
Q 006090          641 FGLARIFGG  649 (662)
Q Consensus       641 FGla~~~~~  649 (662)
                      ||+++....
T Consensus       173 fg~~~~~~~  181 (287)
T 4f0f_A          173 FGLSQQSVH  181 (287)
T ss_dssp             CTTCBCCSS
T ss_pred             CCccccccc
Confidence            999986654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.90  E-value=2.3e-24  Score=229.55  Aligned_cols=149  Identities=26%  Similarity=0.356  Sum_probs=134.0

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367999999999999999999976 6889999998754 23345679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+. +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999953   23589999999999999999999985 6   9999999999999999999999999998664

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.90  E-value=3.6e-24  Score=224.94  Aligned_cols=153  Identities=34%  Similarity=0.571  Sum_probs=130.4

Q ss_pred             ccccccccccCccCceeEEEEEEc------CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .++|.+.+.||+|+||.||+|+..      +++.||||.+... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            468999999999999999999842      4678999999643 334566899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEE
Q 006090          567 MLIYEYMPNKSLDSFLFDPQ----RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKIS  639 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~  639 (662)
                      ++||||+++++|.+++....    ....+++..++.++.||++||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999996432    1245899999999999999999999988   999999999999994   4469999


Q ss_pred             eeCccccccC
Q 006090          640 DFGLARIFGG  649 (662)
Q Consensus       640 DFGla~~~~~  649 (662)
                      |||+++.+..
T Consensus       186 Dfg~~~~~~~  195 (327)
T 2yfx_A          186 DFGMARDIYR  195 (327)
T ss_dssp             CCHHHHHHHC
T ss_pred             cccccccccc
Confidence            9999987644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=2.3e-24  Score=226.07  Aligned_cols=159  Identities=28%  Similarity=0.522  Sum_probs=135.7

Q ss_pred             CHHHHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEe-
Q 006090          486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE-  562 (662)
Q Consensus       486 ~~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~-  562 (662)
                      ++.++....++|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.+++++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33444556788999999999999999999974 6889999998653 34567899999999999 79999999999987 


Q ss_pred             -----CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceE
Q 006090          563 -----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPK  637 (662)
Q Consensus       563 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  637 (662)
                           .+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                 46789999999999999999543 2346899999999999999999999998   99999999999999999999


Q ss_pred             EEeeCccccccC
Q 006090          638 ISDFGLARIFGG  649 (662)
Q Consensus       638 i~DFGla~~~~~  649 (662)
                      |+|||+++.+..
T Consensus       170 l~Dfg~~~~~~~  181 (326)
T 2x7f_A          170 LVDFGVSAQLDR  181 (326)
T ss_dssp             ECCCTTTC----
T ss_pred             EeeCcCceecCc
Confidence            999999988754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.90  E-value=7.2e-24  Score=217.81  Aligned_cols=149  Identities=27%  Similarity=0.456  Sum_probs=133.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            67999999999999999999976 57789999986432   233567999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999853   235899999999999999999999987   99999999999999999999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.90  E-value=8.8e-24  Score=220.43  Aligned_cols=148  Identities=30%  Similarity=0.476  Sum_probs=125.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEE-----------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCV-----------  561 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~-----------  561 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367999999999999999999986 48899999987665666788999999999999999999999874           


Q ss_pred             ---eCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceE
Q 006090          562 ---EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPK  637 (662)
Q Consensus       562 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k  637 (662)
                         +....++||||++ |+|.+++.+    ..+++..+..++.||++||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999997 699999942    45899999999999999999999998   99999999999997 567999


Q ss_pred             EEeeCccccccC
Q 006090          638 ISDFGLARIFGG  649 (662)
Q Consensus       638 i~DFGla~~~~~  649 (662)
                      |+|||+++.+..
T Consensus       162 l~Dfg~~~~~~~  173 (320)
T 2i6l_A          162 IGDFGLARIMDP  173 (320)
T ss_dssp             ECCCTTCBCC--
T ss_pred             EccCccccccCC
Confidence            999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.90  E-value=4.6e-24  Score=236.67  Aligned_cols=152  Identities=31%  Similarity=0.500  Sum_probs=135.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .++|.+.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999976 68999999986432   34567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEeeCcccc
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARI  646 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~ki~DFGla~~  646 (662)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+|+.
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999999854   345899999999999999999999998   9999999999999   5678999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       179 ~~~~~  183 (484)
T 3nyv_A          179 FEASK  183 (484)
T ss_dssp             BCCCC
T ss_pred             ccccc
Confidence            76543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.90  E-value=7.3e-24  Score=219.90  Aligned_cols=151  Identities=25%  Similarity=0.397  Sum_probs=129.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc----cccHHHHHHHHHHHhcCCCCCcceeeEEEE--eCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQHRNLVRLLGCCV--EREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~--~~~~~  566 (662)
                      .++|.+.+.||+|+||.||++... +++.||+|.+....    ....+.+.+|++++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999975 57899999986532    234678999999999999999999999985  44578


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||++++ |.+++... ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999877 77776432 2346899999999999999999999998   99999999999999999999999999998


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      +..
T Consensus       159 ~~~  161 (305)
T 2wtk_C          159 LHP  161 (305)
T ss_dssp             CCT
T ss_pred             cCc
Confidence            754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.90  E-value=4.4e-24  Score=220.18  Aligned_cols=148  Identities=34%  Similarity=0.571  Sum_probs=123.4

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|.+.++||+|+||.||+|+..  ..||||+++...  ....+.|.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999865  469999986532  34457899999999999999999999965 5566899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+++++|.+++...  ...+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999543  345899999999999999999999988   99999999999999999999999999987754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.90  E-value=8.2e-24  Score=220.27  Aligned_cols=153  Identities=22%  Similarity=0.466  Sum_probs=127.1

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+|... +++.||||++...   .......+.+|+.++++++||||+++++++.+++..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            57999999999999999999964 6899999998742   2334567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++... .....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999998531 12346899999999999999999999998   99999999999999999999999999987754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       189 ~  189 (310)
T 2wqm_A          189 K  189 (310)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.90  E-value=5e-24  Score=219.89  Aligned_cols=152  Identities=32%  Similarity=0.528  Sum_probs=131.3

Q ss_pred             hcccccccc-ccCccCceeEEEEEEc---CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          493 ATNNFQLAN-KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       493 ~~~~f~~~~-~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      ..++|.+.+ .||+|+||.||+|...   .++.||||++....  ....+++.+|++++++++||||+++++++ +.+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788777 9999999999999653   36789999987542  22357899999999999999999999999 66778


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            999999999999999954   345899999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       167 ~~~~~  171 (291)
T 1xbb_A          167 LRADE  171 (291)
T ss_dssp             CCTTC
T ss_pred             eccCC
Confidence            86543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.90  E-value=1.2e-23  Score=222.07  Aligned_cols=149  Identities=28%  Similarity=0.462  Sum_probs=132.0

Q ss_pred             hhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhc--CCCCCcceeeEEEEeCC----e
Q 006090          492 NATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISN--LQHRNLVRLLGCCVERE----E  565 (662)
Q Consensus       492 ~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~~----~  565 (662)
                      ...++|.+.+.||+|+||.||+|+.. ++.||||.+..   .....+.+|++++..  ++||||+++++++.+..    .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            34578999999999999999999984 89999999864   345678889998887  78999999999999876    7


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcCCCceE
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH--------RDSRLRIIHRDLKASNILLDDDLNPK  637 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~k  637 (662)
                      .++||||+++|+|.+++.+    ..+++.+++.++.||+.||.|||        +.+   |+||||||+|||+++++.+|
T Consensus       115 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred             eEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence            8999999999999999943    35899999999999999999999        555   99999999999999999999


Q ss_pred             EEeeCccccccCCc
Q 006090          638 ISDFGLARIFGGNQ  651 (662)
Q Consensus       638 i~DFGla~~~~~~~  651 (662)
                      |+|||+++.+....
T Consensus       188 L~Dfg~~~~~~~~~  201 (342)
T 1b6c_B          188 IADLGLAVRHDSAT  201 (342)
T ss_dssp             ECCCTTCEEEETTT
T ss_pred             EEECCCceeccccc
Confidence            99999998886543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=5.4e-24  Score=221.12  Aligned_cols=150  Identities=25%  Similarity=0.442  Sum_probs=131.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            367899999999999999999975 6899999999765444556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~ki~DFGla~~~~~  649 (662)
                      +++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999999843   345899999999999999999999988   9999999999999   7889999999999987644

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.90  E-value=5e-24  Score=236.49  Aligned_cols=151  Identities=32%  Similarity=0.510  Sum_probs=134.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|.+.++||+|+||+||+++.. +++.||||++...  .......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            367999999999999999999976 6899999998642  2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~ki~DFGla~~~  647 (662)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+|+.+
T Consensus       101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999998843   245899999999999999999999998   99999999999995   4567999999999987


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       175 ~~~  177 (486)
T 3mwu_A          175 QQN  177 (486)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            554

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.90  E-value=8.7e-24  Score=221.99  Aligned_cols=151  Identities=35%  Similarity=0.627  Sum_probs=130.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcE--EEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQE--IAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~--vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|.+.+.||+|+||.||+++.. ++..  +|+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999965 4554  499988643 233456799999999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          570 YEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      |||+++++|.+++....             ....+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996532             2346899999999999999999999988   9999999999999999999


Q ss_pred             EEEeeCcccccc
Q 006090          637 KISDFGLARIFG  648 (662)
Q Consensus       637 ki~DFGla~~~~  648 (662)
                      ||+|||+++...
T Consensus       182 kL~Dfg~~~~~~  193 (327)
T 1fvr_A          182 KIADFGLSRGQE  193 (327)
T ss_dssp             EECCTTCEESSC
T ss_pred             EEcccCcCcccc
Confidence            999999998543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.90  E-value=2.6e-24  Score=225.87  Aligned_cols=149  Identities=30%  Similarity=0.518  Sum_probs=128.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccc-cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|.+.++||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            47889999999999999999976 6889999998643222 222456799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++ ++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            97 5899888543  345899999999999999999999998   99999999999999999999999999987653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.90  E-value=1.2e-23  Score=217.48  Aligned_cols=150  Identities=18%  Similarity=0.306  Sum_probs=132.4

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++...  .....+.+|+.++.++ +|+|++++++++.++...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            36799999999999999999996 46899999988643  2344688999999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----eEEEeeCcccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN-----PKISDFGLARI  646 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~ki~DFGla~~  646 (662)
                      |+ +++|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.     +||+|||+|+.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999542  235899999999999999999999987   999999999999988776     99999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       161 ~~~~~  165 (298)
T 1csn_A          161 YRDPV  165 (298)
T ss_dssp             SBCTT
T ss_pred             ccccc
Confidence            86543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.90  E-value=2.7e-24  Score=222.62  Aligned_cols=154  Identities=26%  Similarity=0.474  Sum_probs=121.0

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ..++|.+.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999864 68899999986432 334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          571 EYMPNKSLDSFLFD-----PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       571 Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      ||+++++|.+++..     ......+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999852     123456899999999999999999999988   9999999999999999999999999998


Q ss_pred             cccC
Q 006090          646 IFGG  649 (662)
Q Consensus       646 ~~~~  649 (662)
                      .+..
T Consensus       170 ~~~~  173 (303)
T 2vwi_A          170 FLAT  173 (303)
T ss_dssp             HCC-
T ss_pred             eecc
Confidence            7754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.90  E-value=7.7e-24  Score=229.01  Aligned_cols=146  Identities=25%  Similarity=0.331  Sum_probs=124.1

Q ss_pred             cccccc-cccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHh-cCCCCCcceeeEEEEe----CCeeE
Q 006090          495 NNFQLA-NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVIS-NLQHRNLVRLLGCCVE----REENM  567 (662)
Q Consensus       495 ~~f~~~-~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~----~~~~~  567 (662)
                      ++|.+. +.||+|+||+||++... +++.||||++..     ...+.+|++++. ..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456655 68999999999999975 588999999853     245778888874 4589999999999876    56689


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeCcc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLA  644 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFGla  644 (662)
                      |||||+++|+|.++|... ....+++.++..|+.||++||.|||+.+   |+||||||+||||+.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999653 2345899999999999999999999988   999999999999998   789999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       212 ~~~~~  216 (400)
T 1nxk_A          212 KETTS  216 (400)
T ss_dssp             EECC-
T ss_pred             cccCC
Confidence            97754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=1.5e-23  Score=218.62  Aligned_cols=151  Identities=28%  Similarity=0.497  Sum_probs=130.6

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ..++|++.+.||+|+||.||+|... +++.||||.+...  ...+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3467999999999999999999976 5899999998653  345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+...
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999842  2345899999999999999999999988   999999999999999999999999999887654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=8.4e-24  Score=222.69  Aligned_cols=149  Identities=38%  Similarity=0.637  Sum_probs=123.0

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHH--hcCCCCCcceeeEEEEe-----CCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVI--SNLQHRNLVRLLGCCVE-----REEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l--~~l~H~nIv~l~g~~~~-----~~~~  566 (662)
                      .++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++  ..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36789999999999999999987 5899999998642   334555555554  45899999999987653     2256


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecCCCCCcEEEcCCCceEEEe
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS------RLRIIHRDLKASNILLDDDLNPKISD  640 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiHrDlkp~NILl~~~~~~ki~D  640 (662)
                      ++||||+++|+|.+++..    ...++..+..++.||++||.|||+..      +.+|+||||||+||||+.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            899999999999999943    23589999999999999999999981      11399999999999999999999999


Q ss_pred             eCccccccCC
Q 006090          641 FGLARIFGGN  650 (662)
Q Consensus       641 FGla~~~~~~  650 (662)
                      ||+|+.+...
T Consensus       164 FG~a~~~~~~  173 (336)
T 3g2f_A          164 FGLSMRLTGN  173 (336)
T ss_dssp             CTTCEECSSS
T ss_pred             ccceeecccc
Confidence            9999987543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=2e-23  Score=219.15  Aligned_cols=145  Identities=24%  Similarity=0.434  Sum_probs=130.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEe--CCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVE--REENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~  570 (662)
                      ++|++.+.||+|+||.||+|... +++.||||+++.   ...+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67999999999999999999864 688999999864   34578999999999997 9999999999998  56789999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~~~  649 (662)
                      ||+++++|.+++.      .+++.++..++.||++||+|||+.+   |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999983      2789999999999999999999998   99999999999999777 899999999998765


Q ss_pred             Cc
Q 006090          650 NQ  651 (662)
Q Consensus       650 ~~  651 (662)
                      ..
T Consensus       184 ~~  185 (330)
T 3nsz_A          184 GQ  185 (330)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=6.9e-24  Score=226.72  Aligned_cols=149  Identities=27%  Similarity=0.457  Sum_probs=125.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------  564 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|++++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999974 6899999998643  2233567899999999999999999999998763      


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999843    35899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.....
T Consensus       176 ~~~~~~  181 (367)
T 1cm8_A          176 RQADSE  181 (367)
T ss_dssp             EECCSS
T ss_pred             cccccc
Confidence            987543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.90  E-value=9.6e-25  Score=234.21  Aligned_cols=153  Identities=16%  Similarity=0.200  Sum_probs=126.1

Q ss_pred             hccccccccccCccCceeEEEEEE-cCCcEEEEEEcccc---ccccHHHHHHHH---HHHhcCCCCCcceee-------E
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEV---MVISNLQHRNLVRLL-------G  558 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~---~~~~~~~f~~E~---~~l~~l~H~nIv~l~-------g  558 (662)
                      ..++|.+.+.||+|+||+||+|+. .+++.||||++...   .....+.|.+|+   +++++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999996 46899999998642   334567899999   455566899999998       6


Q ss_pred             EEEeCCe-----------------eEEEEEccCCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006090          559 CCVEREE-----------------NMLIYEYMPNKSLDSFLFDPQR----QSLLDWPKRFNIIKGISRGLLYLHRDSRLR  617 (662)
Q Consensus       559 ~~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  617 (662)
                      ++.+.+.                 .+|||||+ +|+|.+++.....    ...+++..++.|+.||++||+|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            6665532                 78999999 6899999953211    123446888999999999999999998   


Q ss_pred             eEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          618 IIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       618 iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+||||||+||||+.++.+||+|||+|+..+.
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~  258 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  258 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence            99999999999999999999999999997543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=1.2e-23  Score=220.39  Aligned_cols=150  Identities=24%  Similarity=0.386  Sum_probs=128.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--------cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~  564 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||.+....        ......+.+|++++++++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            367999999999999999999975 57899999986432        122345889999999999999999999987655


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEee
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN---PKISDF  641 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~ki~DF  641 (662)
                       .++||||+++++|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             8999999999999999843   346899999999999999999999988   999999999999987664   999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |+++.+...
T Consensus       162 g~~~~~~~~  170 (322)
T 2ycf_A          162 GHSKILGET  170 (322)
T ss_dssp             TTCEECCCC
T ss_pred             ccceecccc
Confidence            999987543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.90  E-value=6.2e-24  Score=216.10  Aligned_cols=151  Identities=25%  Similarity=0.433  Sum_probs=133.0

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC--CeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER--EENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+|+.. ++.||||+++...  ....+.|.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888999999999999999986 8899999987532  34456899999999999999999999999887  7789999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||+++|+|.+++... ....+++.++..++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||++....
T Consensus        89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999653 2336899999999999999999999875 459999999999999999999999999876543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=7.6e-24  Score=217.30  Aligned_cols=152  Identities=31%  Similarity=0.489  Sum_probs=130.4

Q ss_pred             hccccccccccCccCceeEEEEEEcC----CcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ..++|.+.+.||+|+||.||+|+...    +..||+|.+... .....+.|.+|++++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34689999999999999999998653    235999998764 23456789999999999999999999999764 4568


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++++|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            999999999999999542  345899999999999999999999988   999999999999999999999999999987


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       164 ~~~  166 (281)
T 3cc6_A          164 EDE  166 (281)
T ss_dssp             ---
T ss_pred             ccc
Confidence            553

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.90  E-value=4.5e-24  Score=243.82  Aligned_cols=144  Identities=32%  Similarity=0.535  Sum_probs=126.2

Q ss_pred             cccCccCceeEEEEEEc---CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....++|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999764   45789999997543  2346789999999999999999999999964 557899999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      |+|.++|..   ...+++..+..|+.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            999999943   345899999999999999999999998   9999999999999999999999999999886543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.90  E-value=7.2e-24  Score=224.53  Aligned_cols=150  Identities=21%  Similarity=0.338  Sum_probs=124.2

Q ss_pred             ccccccccccCccCceeEEEEEEc----CCcEEEEEEccccccc-----------cHHHHHHHHHHHhcCCCCCcceeeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKASGQ-----------GQEEFMNEVMVISNLQHRNLVRLLG  558 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~nIv~l~g  558 (662)
                      .++|.+.+.||+|+||.||+|...    .+..+|||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999975    4678999988653221           1234678889999999999999999


Q ss_pred             EEEe----CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006090          559 CCVE----REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL  634 (662)
Q Consensus       559 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~  634 (662)
                      ++.+    ....++||||+ +++|.+++...   ..+++.+++.++.||+.||+|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67889999999 99999999542   26899999999999999999999988   99999999999999887


Q ss_pred             --ceEEEeeCccccccCC
Q 006090          635 --NPKISDFGLARIFGGN  650 (662)
Q Consensus       635 --~~ki~DFGla~~~~~~  650 (662)
                        .+||+|||+|+.+...
T Consensus       189 ~~~~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPN  206 (345)
T ss_dssp             TTSEEECCCTTCEESSGG
T ss_pred             CCcEEEEeCCCceecccc
Confidence              9999999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.90  E-value=1.4e-23  Score=220.70  Aligned_cols=157  Identities=31%  Similarity=0.448  Sum_probs=134.5

Q ss_pred             HHhhccccccc-cccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCC
Q 006090          490 LANATNNFQLA-NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVERE  564 (662)
Q Consensus       490 l~~~~~~f~~~-~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~  564 (662)
                      .....+.|.+. ++||+|+||.||++... +++.||+|++....  .....++.+|+.++.+++ ||||+++++++.+.+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            33445677776 88999999999999976 58999999987532  334678999999999994 799999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEee
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDF  641 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DF  641 (662)
                      ..++||||+++|+|.+++... ....+++.++..++.||+.||+|||+++   |+||||||+|||++.   ++.+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence            999999999999999998542 3356899999999999999999999998   999999999999998   789999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |+++.+...
T Consensus       179 g~a~~~~~~  187 (327)
T 3lm5_A          179 GMSRKIGHA  187 (327)
T ss_dssp             GGCEEC---
T ss_pred             ccccccCCc
Confidence            999987654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.90  E-value=4.1e-24  Score=224.66  Aligned_cols=156  Identities=28%  Similarity=0.420  Sum_probs=134.9

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEe--------
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVE--------  562 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~--------  562 (662)
                      ...+|.+.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..        
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3468999999999999999999975 68899999987655566778999999999996 9999999999953        


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                      ....++||||++ |+|.+++........+++.+++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            334789999995 799998864334456999999999999999999999875 459999999999999999999999999


Q ss_pred             ccccccCC
Q 006090          643 LARIFGGN  650 (662)
Q Consensus       643 la~~~~~~  650 (662)
                      +++.+...
T Consensus       184 ~~~~~~~~  191 (337)
T 3ll6_A          184 SATTISHY  191 (337)
T ss_dssp             TCBCCSSC
T ss_pred             cceecccc
Confidence            99987653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.90  E-value=1.7e-23  Score=215.68  Aligned_cols=152  Identities=28%  Similarity=0.435  Sum_probs=131.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe----CCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----REENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~  567 (662)
                      ..|.+.+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    +...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45788889999999999999875 5788999988643  23446779999999999999999999999876    35579


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEeeCcccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARI  646 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~ki~DFGla~~  646 (662)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999943   245899999999999999999999875 4599999999999998 789999999999987


Q ss_pred             ccCC
Q 006090          647 FGGN  650 (662)
Q Consensus       647 ~~~~  650 (662)
                      ....
T Consensus       182 ~~~~  185 (290)
T 1t4h_A          182 KRAS  185 (290)
T ss_dssp             CCTT
T ss_pred             cccc
Confidence            6544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.90  E-value=2e-23  Score=215.25  Aligned_cols=143  Identities=11%  Similarity=0.077  Sum_probs=127.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|.+.+.||+|+||.||+|+.. +++.||||.+.....   ...+.|.+|+.++++++||||+++++++.+++..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67999999999999999999976 489999999975432   23478999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      ||+++++|.+++.+    . ....++..|+.||++||.|||+++   |+||||||+||||+.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence            99999999999932    2 355678899999999999999998   9999999999999999999999887654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.90  E-value=1.5e-23  Score=223.76  Aligned_cols=150  Identities=25%  Similarity=0.417  Sum_probs=131.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC-----ee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE-----EN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~  566 (662)
                      .++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++....     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999865 67889999987533 233477899999999999999999999997653     57


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||++ ++|.+++..    ..+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 599998843    35899999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      .....
T Consensus       178 ~~~~~  182 (364)
T 3qyz_A          178 ADPDH  182 (364)
T ss_dssp             CCGGG
T ss_pred             cCCCC
Confidence            86543

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.90  E-value=1.7e-23  Score=216.56  Aligned_cols=150  Identities=29%  Similarity=0.556  Sum_probs=130.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57889999999999999999976 68999999986532  2334778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |++ ++|.+++... ....+++..+..++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  155 (299)
T 2r3i_A           83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  155 (299)
T ss_dssp             CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence            997 6999998543 2245889999999999999999999998   99999999999999999999999999988754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.90  E-value=4.4e-24  Score=240.52  Aligned_cols=142  Identities=18%  Similarity=0.236  Sum_probs=111.7

Q ss_pred             cccCccCceeEEEEE-EcCCcEEEEEEccccc----------cccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEE
Q 006090          501 NKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS----------GQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~-~~~~~~vAvK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ...+.|++|.+..++ .--|+.++||.+....          ....++|.+|+++|+++ .|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            456677777666654 2348899999986421          22346799999999999 69999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||++|++|.++|.+   ..+++..   +|+.||+.||+|||+++   ||||||||+||||++++++||+|||+|+.+.
T Consensus       320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999999954   3446654   48899999999999998   9999999999999999999999999999886


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      .+.
T Consensus       391 ~~~  393 (569)
T 4azs_A          391 QDC  393 (569)
T ss_dssp             ---
T ss_pred             CCC
Confidence            543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.90  E-value=1e-23  Score=225.35  Aligned_cols=148  Identities=31%  Similarity=0.459  Sum_probs=115.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------C
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------E  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~  564 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999864 6889999998653  223456788999999999999999999999764      4


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++|+||+ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999999 7899988843    45899999999999999999999988   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       180 ~~~~~  184 (367)
T 2fst_X          180 RHTAD  184 (367)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            97654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.90  E-value=1.3e-23  Score=226.80  Aligned_cols=151  Identities=25%  Similarity=0.379  Sum_probs=125.2

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe------eE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE------NM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~  567 (662)
                      ..+|.+.+.||+|+||.||+|+...+..+|+|++.....    ...+|+++++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357999999999999999999988777799998854322    22369999999999999999999976543      68


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEeeCcccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARI  646 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~ki~DFGla~~  646 (662)
                      +||||++++.+............+++..+..++.||++||+|||+.+   |+||||||+||||+ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987654443322223456899999999999999999999988   99999999999999 799999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       192 ~~~~~  196 (394)
T 4e7w_A          192 LIAGE  196 (394)
T ss_dssp             CCTTC
T ss_pred             ccCCC
Confidence            75543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.89  E-value=2.2e-23  Score=224.01  Aligned_cols=153  Identities=24%  Similarity=0.364  Sum_probs=125.6

Q ss_pred             HhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------  563 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------  563 (662)
                      ....++|.+.+.||+|+||.||+|... +++.||||++.....    ...+|+++++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999864 689999999864322    234799999999999999999998543      


Q ss_pred             --------------------------------CeeEEEEEccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 006090          564 --------------------------------EENMLIYEYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYL  610 (662)
Q Consensus       564 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL  610 (662)
                                                      ...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            33789999998 5877776421 2235689999999999999999999


Q ss_pred             HhCCCCceEecCCCCCcEEEc-CCCceEEEeeCccccccCCc
Q 006090          611 HRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       611 H~~~~~~iiHrDlkp~NILl~-~~~~~ki~DFGla~~~~~~~  651 (662)
                      |+.+   |+||||||+|||++ +++.+||+|||+|+.+....
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            9987   99999999999998 68899999999999875543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.89  E-value=1.2e-23  Score=215.46  Aligned_cols=157  Identities=27%  Similarity=0.476  Sum_probs=131.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l  568 (662)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+  +...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999976 68899999986432  3345679999999999999999999998865  567899


Q ss_pred             EEEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          569 IYEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDS--RLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999985422 2345899999999999999999999975  1349999999999999999999999999998


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       165 ~~~~~  169 (279)
T 2w5a_A          165 ILNHD  169 (279)
T ss_dssp             HC---
T ss_pred             eeccc
Confidence            87543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.89  E-value=1.1e-23  Score=216.71  Aligned_cols=153  Identities=26%  Similarity=0.369  Sum_probs=121.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-cc-HHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QG-QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|++.+.||+|+||.||++... +++.||||++..... .. .+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999999974 688999999875322 22 233445555688889999999999999999999999


Q ss_pred             EccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          571 EYMPNKSLDSFLFDP-QRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||++ |+|.+++... .....+++..+..++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5888877431 1235689999999999999999999997 7   9999999999999999999999999998875


Q ss_pred             CC
Q 006090          649 GN  650 (662)
Q Consensus       649 ~~  650 (662)
                      ..
T Consensus       162 ~~  163 (290)
T 3fme_A          162 DD  163 (290)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.89  E-value=1.6e-23  Score=215.68  Aligned_cols=152  Identities=34%  Similarity=0.501  Sum_probs=124.9

Q ss_pred             ccccccccccCccCceeEEEEEEc--CCc--EEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ--DGQ--EIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~--~~~--~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~  566 (662)
                      .++|++.+.||+|+||.||+|++.  +++  .||||.++..   .....+.+.+|++++++++||||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999864  233  6899988653   2344678999999999999999999999998765 8


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++|+||+++++|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999999542  235889999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       171 ~~~~~  175 (291)
T 1u46_A          171 LPQND  175 (291)
T ss_dssp             CCC-C
T ss_pred             ccccc
Confidence            86543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.89  E-value=6.4e-24  Score=217.50  Aligned_cols=150  Identities=32%  Similarity=0.550  Sum_probs=125.7

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-CeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-EENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey  572 (662)
                      .++|++.+.||+|+||.||+++.. ++.||||.++..  ...+.|.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467999999999999999999875 889999998753  3567899999999999999999999997655 468999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +++++|.+++... ....+++..+..++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++.....
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            9999999999532 1223788999999999999999999988   999999999999999999999999999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.89  E-value=2.3e-23  Score=222.98  Aligned_cols=148  Identities=28%  Similarity=0.434  Sum_probs=124.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------  564 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999865 6889999998653  2234567889999999999999999999998765      


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||++ ++|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            6799999997 57888883     23889999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.....
T Consensus       175 ~~~~~~  180 (371)
T 2xrw_A          175 RTAGTS  180 (371)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            987543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.89  E-value=2.6e-23  Score=220.41  Aligned_cols=148  Identities=28%  Similarity=0.471  Sum_probs=130.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-----Cee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-----EEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  566 (662)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999976 68899999996432 23456788999999999999999999998764     567


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||||++ ++|.+++..    ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 689998843    35899999999999999999999988   99999999999999999999999999998


Q ss_pred             ccC
Q 006090          647 FGG  649 (662)
Q Consensus       647 ~~~  649 (662)
                      +..
T Consensus       162 ~~~  164 (353)
T 2b9h_A          162 IDE  164 (353)
T ss_dssp             CC-
T ss_pred             ccc
Confidence            764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.89  E-value=1.9e-23  Score=241.24  Aligned_cols=147  Identities=21%  Similarity=0.378  Sum_probs=128.3

Q ss_pred             cccccccccCccCceeEEEEEEc--CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe-----e
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ--DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-----N  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~--~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~  566 (662)
                      ++|.+.+.||+|+||.||++...  +++.||||++... .......|.+|++++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999975  5899999998643 23445678999999999999999999999988665     6


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      +|||||+++++|.+++..     .+++.+++.|+.||++||.|||+++   |+||||||+||||+.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999987732     5899999999999999999999998   9999999999999986 999999999998


Q ss_pred             ccCC
Q 006090          647 FGGN  650 (662)
Q Consensus       647 ~~~~  650 (662)
                      +...
T Consensus       231 ~~~~  234 (681)
T 2pzi_A          231 INSF  234 (681)
T ss_dssp             TTCC
T ss_pred             cccC
Confidence            7653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=5.6e-23  Score=213.05  Aligned_cols=147  Identities=25%  Similarity=0.352  Sum_probs=127.5

Q ss_pred             cccccc-cccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHH-hcCCCCCcceeeEEEEe----CCeeE
Q 006090          495 NNFQLA-NKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVI-SNLQHRNLVRLLGCCVE----REENM  567 (662)
Q Consensus       495 ~~f~~~-~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~  567 (662)
                      ++|.+. +.||+|+||.||++... +++.||+|++..     ...+.+|++++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            556666 77999999999999974 688999999853     24677888887 55689999999999987    66789


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeCcc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLA  644 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFGla  644 (662)
                      +||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999642 2346899999999999999999999988   999999999999998   789999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.+...
T Consensus       168 ~~~~~~  173 (299)
T 3m2w_A          168 KETTGE  173 (299)
T ss_dssp             EECTTC
T ss_pred             cccccc
Confidence            887653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.89  E-value=5.7e-23  Score=211.51  Aligned_cols=151  Identities=32%  Similarity=0.505  Sum_probs=134.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|.+.+.||+|+||.||+++.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999976 68899999986432  345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD---LNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~ki~DFGla~~~  647 (662)
                      ||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.+   +.+||+|||+++.+
T Consensus       101 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999998843   235899999999999999999999988   9999999999999764   47999999999987


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       175 ~~~  177 (287)
T 2wei_A          175 QQN  177 (287)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            554

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.89  E-value=3e-23  Score=220.62  Aligned_cols=158  Identities=25%  Similarity=0.360  Sum_probs=119.9

Q ss_pred             HHHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe--
Q 006090          489 ELANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE--  565 (662)
Q Consensus       489 ~l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~--  565 (662)
                      +.....++|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|++.++.++||||+++++++.....  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            34455688999999999999999999975 6889999988653 3334566788888999999999999999976443  


Q ss_pred             -----eEEEEEccCCCCHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCcEEEcC-CCce
Q 006090          566 -----NMLIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLYLH--RDSRLRIIHRDLKASNILLDD-DLNP  636 (662)
Q Consensus       566 -----~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiHrDlkp~NILl~~-~~~~  636 (662)
                           .++||||++++ |...+.. ......+++..+..++.||+.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 78999999864 4433321 123456899999999999999999999  776   999999999999997 8999


Q ss_pred             EEEeeCccccccCCc
Q 006090          637 KISDFGLARIFGGNQ  651 (662)
Q Consensus       637 ki~DFGla~~~~~~~  651 (662)
                      ||+|||+|+.+....
T Consensus       172 kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE  186 (360)
T ss_dssp             EECCCTTCBCCCTTS
T ss_pred             EEeeCCCceecCCCC
Confidence            999999999886543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.89  E-value=1.1e-23  Score=223.73  Aligned_cols=147  Identities=18%  Similarity=0.270  Sum_probs=128.4

Q ss_pred             ccccccccccCccCceeEEEEEEcC---------CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcce---------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD---------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVR---------  555 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~---------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~---------  555 (662)
                      .++|.+.+.||+|+||.||+|+...         ++.||||.+...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999763         789999998643     36889999999999999987         


Q ss_pred             ------eeEEEEe-CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 006090          556 ------LLGCCVE-REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNI  628 (662)
Q Consensus       556 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI  628 (662)
                            +++++.. +...++||||+ +++|.+++... ....+++.+++.|+.||++||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6788877 67889999999 99999999542 2356899999999999999999999998   99999999999


Q ss_pred             EEcCCC--ceEEEeeCccccccCC
Q 006090          629 LLDDDL--NPKISDFGLARIFGGN  650 (662)
Q Consensus       629 Ll~~~~--~~ki~DFGla~~~~~~  650 (662)
                      |++.++  .+||+|||+++.+...
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGG
T ss_pred             EEcCCCCceEEEecCcceeeccCC
Confidence            999998  9999999999987654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.89  E-value=2.8e-23  Score=226.11  Aligned_cols=148  Identities=28%  Similarity=0.410  Sum_probs=122.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC----C--eeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER----E--ENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~----~--~~~  567 (662)
                      .+|.+.+.||+|+||.||+|+.. +++.||||++....    +.+.+|++++++++||||+++++++...    +  ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999986 58999999986432    2234799999999999999999998652    2  256


Q ss_pred             EEEEccCCCCHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCccc
Q 006090          568 LIYEYMPNKSLDSFLFD-PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLAR  645 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGla~  645 (662)
                      +||||+++ +|.+.+.. ......+++..+..++.||++||.|||+++   |+||||||+||||+.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999985 56555532 122456899999999999999999999987   9999999999999965 578999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       206 ~~~~~  210 (420)
T 1j1b_A          206 QLVRG  210 (420)
T ss_dssp             ECCTT
T ss_pred             hcccC
Confidence            87544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.89  E-value=2.9e-23  Score=216.48  Aligned_cols=153  Identities=24%  Similarity=0.356  Sum_probs=131.3

Q ss_pred             HhhccccccccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCC--CCCcceeeEEEEeCCee
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVEREEN  566 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~~  566 (662)
                      ....++|.+.+.||+|+||.||++...+++.||||.+...  .....+.+.+|++++.+++  ||||+++++++.+++..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3445789999999999999999999888999999998643  2344678999999999996  59999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ++||| +.+++|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||+++ +.+||+|||+++.
T Consensus       104 ~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence            99999 668999999954   345899999999999999999999998   999999999999975 8999999999998


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +....
T Consensus       176 ~~~~~  180 (313)
T 3cek_A          176 MQPDT  180 (313)
T ss_dssp             -----
T ss_pred             ccCcc
Confidence            76543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.89  E-value=4.2e-23  Score=236.72  Aligned_cols=155  Identities=26%  Similarity=0.438  Sum_probs=133.5

Q ss_pred             HHhhccccccccccCccCceeEEEEEEcC----CcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE  564 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~  564 (662)
                      .....++|.+.+.||+|+||.||+|....    +..||||++.... ....+.|.+|+.++++++||||+++++++. ++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            33445789999999999999999998742    4579999987533 334578999999999999999999999984 56


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||+++|+|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            689999999999999999532  335899999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.+...
T Consensus       539 ~~~~~~  544 (656)
T 2j0j_A          539 RYMEDS  544 (656)
T ss_dssp             CSCCC-
T ss_pred             eecCCC
Confidence            987554

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.89  E-value=5.3e-23  Score=222.75  Aligned_cols=149  Identities=28%  Similarity=0.479  Sum_probs=116.5

Q ss_pred             ccccc-ccccCccCceeEEEEEEc---CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCeeEE
Q 006090          495 NNFQL-ANKLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENML  568 (662)
Q Consensus       495 ~~f~~-~~~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l  568 (662)
                      +.|.+ .++||+|+||.||+|+..   +++.||||++...  .....+.+|++++++++||||+++++++..  +...++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34554 468999999999999975   4788999999753  234578899999999999999999999965  667899


Q ss_pred             EEEccCCCCHHHHhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEE
Q 006090          569 IYEYMPNKSLDSFLFD------PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL----DDDLNPKI  638 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~ki  638 (662)
                      ||||++ ++|.+++..      ......+++..+..|+.||+.||.|||+.+   |+||||||+||||    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 578877742      112235899999999999999999999998   9999999999999    77889999


Q ss_pred             EeeCccccccC
Q 006090          639 SDFGLARIFGG  649 (662)
Q Consensus       639 ~DFGla~~~~~  649 (662)
                      +|||+|+.+..
T Consensus       174 ~Dfg~a~~~~~  184 (405)
T 3rgf_A          174 ADMGFARLFNS  184 (405)
T ss_dssp             CCTTCCC----
T ss_pred             EECCCceecCC
Confidence            99999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.89  E-value=3e-23  Score=217.37  Aligned_cols=152  Identities=30%  Similarity=0.545  Sum_probs=128.3

Q ss_pred             hccccccccccCccCceeEEEEEE--cCCcEEEEEEcccccc--ccHHHHHHHHHHHhcC---CCCCcceeeEEEE----
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKL--QDGQEIAVKRLSKASG--QGQEEFMNEVMVISNL---QHRNLVRLLGCCV----  561 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~--~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~----  561 (662)
                      ..++|.+.+.||+|+||.||+++.  .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  3578999998864322  2234566777777665   8999999999997    


Q ss_pred             -eCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEe
Q 006090          562 -EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISD  640 (662)
Q Consensus       562 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~D  640 (662)
                       .....++||||++ |+|.+++.... ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4566799999998 69999985432 234899999999999999999999998   99999999999999999999999


Q ss_pred             eCccccccC
Q 006090          641 FGLARIFGG  649 (662)
Q Consensus       641 FGla~~~~~  649 (662)
                      ||+++.+..
T Consensus       164 fg~~~~~~~  172 (326)
T 1blx_A          164 FGLARIYSF  172 (326)
T ss_dssp             CCSCCCCCG
T ss_pred             CcccccccC
Confidence            999988754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.88  E-value=8.6e-23  Score=210.58  Aligned_cols=151  Identities=24%  Similarity=0.409  Sum_probs=125.6

Q ss_pred             hccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEE-EeCCeeEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC-VEREENMLIY  570 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~  570 (662)
                      ..++|.+.+.||+|+||.||+|+. .+++.||||++...  .....+.+|++++++++|++++..++.+ .+++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            347899999999999999999996 46889999986542  2234588999999999988777666665 6677889999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~ki~DFGla~~~  647 (662)
                      ||+ +++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||+   ++++.+||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998532  235899999999999999999999998   9999999999999   78999999999999988


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       159 ~~~~  162 (296)
T 4hgt_A          159 RDAR  162 (296)
T ss_dssp             BCTT
T ss_pred             cCcc
Confidence            6543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.88  E-value=1.8e-23  Score=217.87  Aligned_cols=154  Identities=25%  Similarity=0.413  Sum_probs=124.9

Q ss_pred             HhhccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc------ccHHHHHHHHHHHhcC----CCCCcceeeEE
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG------QGQEEFMNEVMVISNL----QHRNLVRLLGC  559 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l----~H~nIv~l~g~  559 (662)
                      ....++|.+.+.||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            334578999999999999999999864 688999999865322      1233466789988888    89999999999


Q ss_pred             EEeCCeeEEEEEc-cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceE
Q 006090          560 CVEREENMLIYEY-MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPK  637 (662)
Q Consensus       560 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k  637 (662)
                      +.+.+..++|+|| +++++|.+++.+   ...+++..+..++.||++||.|||+.+   |+||||||+|||++ +++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 789999999954   335899999999999999999999998   99999999999999 889999


Q ss_pred             EEeeCccccccCC
Q 006090          638 ISDFGLARIFGGN  650 (662)
Q Consensus       638 i~DFGla~~~~~~  650 (662)
                      |+|||+++.+...
T Consensus       181 l~dfg~~~~~~~~  193 (312)
T 2iwi_A          181 LIDFGSGALLHDE  193 (312)
T ss_dssp             ECCCSSCEECCSS
T ss_pred             EEEcchhhhcccC
Confidence            9999999988654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.88  E-value=7.2e-23  Score=219.10  Aligned_cols=148  Identities=26%  Similarity=0.465  Sum_probs=126.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCee----
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREEN----  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~----  566 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999865 68899999997532  23356789999999999999999999999887665    


Q ss_pred             --EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          567 --MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       567 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                        ++||||++ ++|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 68988872     23899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCC
Q 006090          645 RIFGGN  650 (662)
Q Consensus       645 ~~~~~~  650 (662)
                      +.....
T Consensus       192 ~~~~~~  197 (371)
T 4exu_A          192 RHADAE  197 (371)
T ss_dssp             ------
T ss_pred             cccccC
Confidence            877543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.88  E-value=1.3e-22  Score=221.41  Aligned_cols=150  Identities=23%  Similarity=0.333  Sum_probs=129.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcC------CCCCcceeeEEEEeCCee
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNL------QHRNLVRLLGCCVEREEN  566 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l------~H~nIv~l~g~~~~~~~~  566 (662)
                      ..+|++.++||+|+||+||+|... +++.||||++.. .....+.+.+|++++..+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            357999999999999999999875 588999999975 233456778888888776      577999999999999999


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--eEEEeeCcc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN--PKISDFGLA  644 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~ki~DFGla  644 (662)
                      ++||||++ ++|.+++... ....+++..+..|+.||++||+|||+++   |+||||||+||||+.++.  +||+|||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6899988543 2335899999999999999999999988   999999999999999987  999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       250 ~~~~~  254 (429)
T 3kvw_A          250 CYEHQ  254 (429)
T ss_dssp             EETTC
T ss_pred             eecCC
Confidence            87654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.88  E-value=1.6e-22  Score=208.67  Aligned_cols=150  Identities=24%  Similarity=0.415  Sum_probs=128.6

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEE-EeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCC-VEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E  571 (662)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++....  ...++.+|+.++++++|++++..++.+ .++...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999996 478999999886432  334688999999999988766666555 56777899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~ki~DFGla~~~~  648 (662)
                      |+ +++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||+   ++++.+||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999532  345899999999999999999999998   9999999999999   588899999999999886


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       160 ~~~  162 (296)
T 3uzp_A          160 DAR  162 (296)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.88  E-value=3.8e-23  Score=221.15  Aligned_cols=151  Identities=12%  Similarity=0.143  Sum_probs=113.7

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcC--CCCCcceee-------EEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNL--QHRNLVRLL-------GCC  560 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l--~H~nIv~l~-------g~~  560 (662)
                      ...|.+.+.||+|+||.||+|+.. +++.||||++.....   ...+.+++|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456889999999999999999975 689999999976432   3355678885544444  799977754       555


Q ss_pred             EeC-----------------CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCc
Q 006090          561 VER-----------------EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKR------FNIIKGISRGLLYLHRDSRLR  617 (662)
Q Consensus       561 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~  617 (662)
                      ...                 ...++||||++ |+|.+++....  ..+++..+      +.++.||++||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            443                 33799999999 89999995421  22455556      788899999999999998   


Q ss_pred             eEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          618 IIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       618 iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |+||||||+||||+.++.+||+|||+|+.....
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~  247 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR  247 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence            999999999999999999999999999987543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.88  E-value=9.3e-23  Score=216.54  Aligned_cols=147  Identities=26%  Similarity=0.466  Sum_probs=127.4

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe-----
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE-----  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-----  565 (662)
                      .++|.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999975 68999999986532  2335678999999999999999999999987654     


Q ss_pred             -eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          566 -NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       566 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                       .++||||++ ++|.+++.     ..+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 68888772     23899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccC
Q 006090          645 RIFGG  649 (662)
Q Consensus       645 ~~~~~  649 (662)
                      +....
T Consensus       174 ~~~~~  178 (353)
T 3coi_A          174 RHADA  178 (353)
T ss_dssp             TC---
T ss_pred             cCCCC
Confidence            87654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.88  E-value=2.7e-22  Score=221.47  Aligned_cols=150  Identities=25%  Similarity=0.416  Sum_probs=129.6

Q ss_pred             ccccccccccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcCCC-CCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .++|.+.++||+|+||.||+|+. .+++.||||++....  ...++..|+++++.++| ++|..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36799999999999999999996 468999999876432  23458899999999976 667777777888889999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~ki~DFGla~~~~  648 (662)
                      |+ +++|.+++...  ...+++.+++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+|+.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999532  335899999999999999999999998   9999999999999   688999999999999886


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       158 ~~~  160 (483)
T 3sv0_A          158 DTS  160 (483)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=6.4e-23  Score=214.88  Aligned_cols=154  Identities=25%  Similarity=0.388  Sum_probs=133.2

Q ss_pred             HhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccc------cHHHHHHHHHHHhcCC--CCCcceeeEEEE
Q 006090          491 ANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ------GQEEFMNEVMVISNLQ--HRNLVRLLGCCV  561 (662)
Q Consensus       491 ~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~--H~nIv~l~g~~~  561 (662)
                      ....++|.+.+.||+|+||.||+|+.. +++.||||.+......      ..+.+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            334578999999999999999999864 6889999998653221      2345778999999996  599999999999


Q ss_pred             eCCeeEEEEEccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEE
Q 006090          562 EREENMLIYEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKIS  639 (662)
Q Consensus       562 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~ki~  639 (662)
                      +.+..++|+||+.+ ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999986 899999853   345899999999999999999999988   99999999999999 78899999


Q ss_pred             eeCccccccCC
Q 006090          640 DFGLARIFGGN  650 (662)
Q Consensus       640 DFGla~~~~~~  650 (662)
                      |||+++.+...
T Consensus       193 Dfg~~~~~~~~  203 (320)
T 3a99_A          193 DFGSGALLKDT  203 (320)
T ss_dssp             CCTTCEECCSS
T ss_pred             eCccccccccc
Confidence            99999987654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.88  E-value=1.8e-22  Score=212.10  Aligned_cols=151  Identities=23%  Similarity=0.362  Sum_probs=130.7

Q ss_pred             ccccccccccCccCceeEEEEEE-c-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCC------CcceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKL-Q-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR------NLVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~-~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~------nIv~l~g~~~~~~~  565 (662)
                      .++|++.+.||+|+||.||++.. . +++.||||+++.. ....+.+.+|++++++++|+      +++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            36799999999999999999986 3 5789999998753 34456788999999888655      49999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------------
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-------------  632 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------------  632 (662)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 89999998543 2245899999999999999999999998   999999999999988             


Q ss_pred             ------CCceEEEeeCccccccCC
Q 006090          633 ------DLNPKISDFGLARIFGGN  650 (662)
Q Consensus       633 ------~~~~ki~DFGla~~~~~~  650 (662)
                            ++.+||+|||+++.....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~  190 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH  190 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC
T ss_pred             ccccccCCCceEeeCcccccCccc
Confidence                  668999999999976543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=1.4e-22  Score=212.78  Aligned_cols=153  Identities=26%  Similarity=0.390  Sum_probs=126.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHH-HHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVM-VISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|.+.+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888999999999999999975 68899999987532 233456666666 677789999999999999999999999


Q ss_pred             EccCCCCHHHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          571 EYMPNKSLDSFLFD--PQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       571 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ||+++ +|.+++..  ......+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 88877742  11245689999999999999999999997 7   999999999999999999999999999887


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       177 ~~~  179 (327)
T 3aln_A          177 VDS  179 (327)
T ss_dssp             ---
T ss_pred             ccc
Confidence            543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.88  E-value=1.3e-22  Score=218.19  Aligned_cols=135  Identities=24%  Similarity=0.381  Sum_probs=113.9

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC--------CCCcceeeEEEE---
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ--------HRNLVRLLGCCV---  561 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--------H~nIv~l~g~~~---  561 (662)
                      .++|.+.++||+|+||+||+|+.. +++.||||++.. .....+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            368999999999999999999864 588999999975 3345677899999999885        788999999998   


Q ss_pred             -eCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC
Q 006090          562 -EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDL  634 (662)
Q Consensus       562 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~  634 (662)
                       +....++||||+ +++|.+++... ....+++..+..|+.||++||.|||++ +   |+||||||+||||+.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence             456789999999 56666665432 224589999999999999999999998 7   99999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.87  E-value=1.7e-22  Score=220.84  Aligned_cols=150  Identities=27%  Similarity=0.330  Sum_probs=121.0

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +.|...+.||+|+||+||.+...+++.||||++...   ..+.+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345556889999999998776667999999998642   345678999999876 8999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-------------Cce
Q 006090          574 PNKSLDSFLFDPQRQS----LLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-------------LNP  636 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~  636 (662)
                      + |+|.+++.......    ..++..++.++.||+.||+|||+++   |+||||||+||||+.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999996532211    1233456789999999999999988   9999999999999754             489


Q ss_pred             EEEeeCccccccCCc
Q 006090          637 KISDFGLARIFGGNQ  651 (662)
Q Consensus       637 ki~DFGla~~~~~~~  651 (662)
                      ||+|||+|+.+....
T Consensus       168 kL~DFG~a~~~~~~~  182 (434)
T 2rio_A          168 LISDFGLCKKLDSGQ  182 (434)
T ss_dssp             EECCCTTCEECCC--
T ss_pred             EEcccccceecCCCC
Confidence            999999999886643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.87  E-value=6.4e-23  Score=232.18  Aligned_cols=153  Identities=29%  Similarity=0.449  Sum_probs=132.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe------CCee
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE------REEN  566 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~------~~~~  566 (662)
                      ++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999874 6889999998753 33446779999999999999999999999765      6677


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEeeCc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLN---PKISDFGL  643 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~ki~DFGl  643 (662)
                      ++||||+++|+|.+++........+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976555556899999999999999999999988   999999999999997764   99999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ++.+...
T Consensus       171 a~~~~~~  177 (676)
T 3qa8_A          171 AKELDQG  177 (676)
T ss_dssp             CCBTTSC
T ss_pred             ccccccc
Confidence            9987654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.87  E-value=6.1e-22  Score=208.93  Aligned_cols=148  Identities=27%  Similarity=0.358  Sum_probs=120.7

Q ss_pred             cccccccc-ccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHH-HHHhcCCCCCcceeeEEEEe----CCee
Q 006090          494 TNNFQLAN-KLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEV-MVISNLQHRNLVRLLGCCVE----REEN  566 (662)
Q Consensus       494 ~~~f~~~~-~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~-~~l~~l~H~nIv~l~g~~~~----~~~~  566 (662)
                      .++|.+.+ .||+|+||.||++... +++.||||++... .    ...+|+ ..+..++||||+++++++..    +...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            46788754 6999999999999976 6899999998642 1    222333 34567799999999999976    4457


Q ss_pred             EEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeCc
Q 006090          567 MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGL  643 (662)
Q Consensus       567 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFGl  643 (662)
                      ++||||+++|+|.+++... ....+++.++..++.||++||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999653 2346899999999999999999999998   999999999999986   45599999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      ++.....
T Consensus       178 ~~~~~~~  184 (336)
T 3fhr_A          178 AKETTQN  184 (336)
T ss_dssp             CEEC---
T ss_pred             ceecccc
Confidence            9877543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.87  E-value=2.6e-22  Score=219.03  Aligned_cols=148  Identities=25%  Similarity=0.356  Sum_probs=121.4

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..+|...+.||+|+||+|+.....+++.||||++.....   ..+.+|+++++++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            457888999999999996655556789999999865332   2356899999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCceEEEeeCccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-----DLNPKISDFGLARIF  647 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~ki~DFGla~~~  647 (662)
                      ++ |+|.+++....  ..+.+..+..++.||++||.|||+.+   |+||||||+||||+.     ...+||+|||+|+.+
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 69999996533  22444566789999999999999998   999999999999953     236889999999988


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       174 ~~~  176 (432)
T 3p23_A          174 AVG  176 (432)
T ss_dssp             ---
T ss_pred             cCC
Confidence            654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.87  E-value=5.4e-23  Score=214.74  Aligned_cols=151  Identities=30%  Similarity=0.538  Sum_probs=128.5

Q ss_pred             HHhhccccccccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      .....++|++.+.||+|+||.||+|+...  .+|+|.+...  .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            33445789999999999999999998763  5999988643  2233456889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++++|.+++.+.  ...+++..+..++.||++||+|||+++   |+||||||+|||++ ++.+||+|||+++..
T Consensus       106 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999999999999999542  345889999999999999999999998   99999999999998 679999999998876


Q ss_pred             c
Q 006090          648 G  648 (662)
Q Consensus       648 ~  648 (662)
                      .
T Consensus       180 ~  180 (319)
T 2y4i_B          180 G  180 (319)
T ss_dssp             -
T ss_pred             c
Confidence            4

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.87  E-value=5.2e-22  Score=207.02  Aligned_cols=151  Identities=25%  Similarity=0.413  Sum_probs=116.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc-cc-HHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-QG-QEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .++|++.+.||+|+||.||+++.. +++.||||++..... .. .+.+.++..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            367888999999999999999986 689999999865322 22 233445555688889999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+ ++.+..++..  ....+++..+..++.||++||.|||++ +   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 4555555432  134589999999999999999999985 7   99999999999999999999999999987754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       178 ~  178 (318)
T 2dyl_A          178 D  178 (318)
T ss_dssp             -
T ss_pred             C
Confidence            3

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.87  E-value=1.9e-21  Score=167.92  Aligned_cols=105  Identities=19%  Similarity=0.344  Sum_probs=90.0

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      .++|.+||.|.+|++|.|  |.|.|.|+.++ +     |.++..      .++||+|||+.|.. ..++|+|+.||||||
T Consensus         1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~Dg-N-----Lvly~~------~~~vW~ant~~~~~-~~~~L~l~~dGnLvL   65 (105)
T 4h3o_A            1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDC-N-----LVLYDH------STSTWASNTEIGGK-SGCSAVLQSDGNFVV   65 (105)
T ss_dssp             CCEECTTEEECTTCEEEE--TTEEEEECTTS-C-----EEEEET------TEEEEECCCCCTTC-CSCEEEECTTSCEEE
T ss_pred             CCCcCCCCEEcCCCEEEE--CCEEEEECCCC-e-----EEEEEC------CEEEEEecCCCCCC-ccEEEEEeCCccEEE
Confidence            378999999999999998  78999999988 4     555432      38999999999965 457999999999999


Q ss_pred             EcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       104 ~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      +|+++.+||+|++..  ..+...|+|+|+|||||++.    +||||
T Consensus        66 ~d~~~~~vWss~t~~--~~~~~~l~L~ddGNlVly~~----~~W~S  105 (105)
T 4h3o_A           66 YDSSGRSLWASHSTR--GSGNYILILQDDGNVIIYGS----DIWST  105 (105)
T ss_dssp             ECTTCCEEEECCCCC--CSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred             ECCCcEEEEEecCCC--CCCCEEEEEeCCCeEEEECC----cEecC
Confidence            999999999999864  33567899999999999963    59998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.86  E-value=1e-21  Score=207.78  Aligned_cols=151  Identities=22%  Similarity=0.367  Sum_probs=128.4

Q ss_pred             ccccccccccCccCceeEEEEEEc-CC-cEEEEEEccccccccHHHHHHHHHHHhcCCCCC------cceeeEEEEeCCe
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DG-QEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN------LVRLLGCCVEREE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n------Iv~l~g~~~~~~~  565 (662)
                      .++|.+.+.||+|+||.||++... ++ +.||||+++. .....+.+.+|+.++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999999975 34 6899999975 2345667889999999887665      9999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---------------
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILL---------------  630 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---------------  630 (662)
                      .++||||+ +++|.+++... ....+++.++..++.||++||.|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66777776432 2245899999999999999999999987   9999999999999               


Q ss_pred             ----cCCCceEEEeeCccccccCC
Q 006090          631 ----DDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       631 ----~~~~~~ki~DFGla~~~~~~  650 (662)
                          +.++.+||+|||+++.....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~  195 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH  195 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC
T ss_pred             cccccCCCcEEEeecCcccccccc
Confidence                67889999999999876543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.86  E-value=3e-22  Score=224.35  Aligned_cols=136  Identities=19%  Similarity=0.284  Sum_probs=110.4

Q ss_pred             cccccCccCceeEEEEEEcCCcEEEEEEcccccc--------ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          499 LANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG--------QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       499 ~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ..++||+|+||.||+++.. ++.+++|+......        ...+.|.+|++++++++||||+++..++...+..+|||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            3578999999999999654 78888887643211        11346899999999999999998877877888899999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++++|.+++.+           +..++.||++||.|||+++   |+||||||+|||+++  .+||+|||+|+.+...
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999999943           5689999999999999988   999999999999999  9999999999998765


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      +
T Consensus       483 ~  483 (540)
T 3en9_A          483 E  483 (540)
T ss_dssp             H
T ss_pred             c
Confidence            4

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.86  E-value=6e-22  Score=211.49  Aligned_cols=150  Identities=23%  Similarity=0.384  Sum_probs=128.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-----------CCCcceeeEEEEe
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-----------HRNLVRLLGCCVE  562 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~g~~~~  562 (662)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++.. .......+.+|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            67999999999999999999964 688999999874 3344567889999998876           8999999999987


Q ss_pred             CC----eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEc------
Q 006090          563 RE----ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLD------  631 (662)
Q Consensus       563 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~------  631 (662)
                      .+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +   |+||||||+||||+      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            54    679999999 899999985432 33589999999999999999999997 7   99999999999994      


Q ss_pred             CCCceEEEeeCccccccCC
Q 006090          632 DDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       632 ~~~~~ki~DFGla~~~~~~  650 (662)
                      ..+.+||+|||+|+.+...
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~  191 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH  191 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC
T ss_pred             CcceEEEcccccccccCCC
Confidence            4448999999999987653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.86  E-value=1.4e-21  Score=209.93  Aligned_cols=154  Identities=25%  Similarity=0.340  Sum_probs=129.5

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-CC-----CcceeeEEEEeCCe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HR-----NLVRLLGCCVEREE  565 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----nIv~l~g~~~~~~~  565 (662)
                      ..++|.+.+.||+|+||+||+|... +++.||||+++. ......++..|+.++..++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999976 578999999974 2344567888999888874 55     49999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCceEEEeeCc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD--DDLNPKISDFGL  643 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~ki~DFGl  643 (662)
                      .++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 59999986432 235899999999999999999999531 3499999999999995  477899999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      |+.+...
T Consensus       208 a~~~~~~  214 (382)
T 2vx3_A          208 SCQLGQR  214 (382)
T ss_dssp             CEETTCC
T ss_pred             ceecccc
Confidence            9987543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=7.4e-22  Score=202.95  Aligned_cols=145  Identities=19%  Similarity=0.182  Sum_probs=117.1

Q ss_pred             HHHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEcccccc------------------ccHHHHHHHHHHHhcCC
Q 006090          488 EELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG------------------QGQEEFMNEVMVISNLQ  549 (662)
Q Consensus       488 ~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~~l~  549 (662)
                      ..+......|.+.+.||+|+||.||+|...+++.||||.++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344444566778899999999999999997799999999864221                  12456899999999998


Q ss_pred             CCCcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006090          550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL  629 (662)
Q Consensus       550 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL  629 (662)
                        | +++.+++. .+..++||||+++++|.+ +..         .....++.||++||.|||+.+   |+||||||+|||
T Consensus       163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence              4 66666543 356699999999999988 521         123479999999999999988   999999999999


Q ss_pred             EcCCCceEEEeeCccccccCC
Q 006090          630 LDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++ ++.+||+|||+|+.....
T Consensus       226 l~-~~~vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVEVGEE  245 (282)
T ss_dssp             EE-TTEEEECCCTTCEETTST
T ss_pred             EE-CCcEEEEECCCCeECCCC
Confidence            99 999999999999977543

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.84  E-value=1.1e-20  Score=164.95  Aligned_cols=110  Identities=20%  Similarity=0.389  Sum_probs=94.2

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      +|+|.+|+.|.+|+.|+ ++|.|+|+|+.++ +     | |+|+.     .++||.+|++.|.  ..++++|+.||||||
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dG-n-----l-vl~~~-----~~~vW~sn~~~~~--~~~~l~l~~dGNLVl   65 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDC-N-----F-VLYDS-----GKPVWASNTGGLG--SGCRLTLHNNGNLVI   65 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTS-C-----E-EEEET-----TEEEEECCCTTSC--SSCEEEECTTSCEEE
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCC-c-----E-EEEEC-----CEEEEECCCCCCC--CcEEEEEeCCCCEEE
Confidence            47899999999999999 9999999999887 4     2 66652     4899999998773  457899999999999


Q ss_pred             EcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCc
Q 006090          104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPT  154 (662)
Q Consensus       104 ~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~Pt  154 (662)
                      +|.++.++|+|++..  ..+...++|+|+|||||++.    ++||||+||.
T Consensus        66 ~~~~~~~~W~S~t~~--~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~  110 (110)
T 3a0c_A           66 YDQSNRVIWQTKTNG--KEDHYVLVLQQDRNVVIYGP----VVWATGSGPA  110 (110)
T ss_dssp             ECTTCCEEEECCCCC--SSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred             ECCCCcEEEecCCCC--CCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence            999999999999864  33566899999999999963    7999999984

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.84  E-value=2.1e-20  Score=165.33  Aligned_cols=108  Identities=18%  Similarity=0.332  Sum_probs=93.6

Q ss_pred             cccccccCCCcccCCCeEE--ecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCc
Q 006090           22 TATDTITSSQFIRDPESII--SSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDG   99 (662)
Q Consensus        22 ~~~~~l~~g~~l~~~~~l~--S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G   99 (662)
                      ++.++|.+|++|.+|+.|+  |++|.|+|+|+.++ +     | +||+.     .++||+|||+.|  +.++.|+|+.||
T Consensus         6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dg-n-----l-vly~~-----~~~vW~sn~~~~--~~~~~l~l~~dG   71 (119)
T 1b2p_A            6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDC-N-----L-VLYDN-----NNPIWATNTGGL--GNGCRAVLQPDG   71 (119)
T ss_dssp             CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTS-C-----E-EEEET-----TEEEEECCCTTS--CSSCEEEECTTS
T ss_pred             ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCC-C-----E-EEEEC-----CEEEEeCCCccC--CCceEEEEccCC
Confidence            5678999999999999999  99999999999987 4     2 57763     599999999877  345799999999


Q ss_pred             cEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          100 NLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       100 ~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      ||||+|.++.++|+|++..  ..+...++|+|+|||||++    .++|||
T Consensus        72 NLVl~d~~~~~lW~S~~~~--~~g~~~l~l~~~Gnlvl~~----~~~W~S  115 (119)
T 1b2p_A           72 VLVVITNENVTVWQSPVAG--KAGHYVLVLQPDRNVVIYG----DALWAT  115 (119)
T ss_dssp             CEEEECTTCCEEEECSCCC--CSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred             EEEEEeCCCcEEEcCCCCC--CCCCEEEEEECCCcEEEEC----ccEeCC
Confidence            9999999999999999764  3356789999999999997    279998

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.82  E-value=8e-20  Score=160.98  Aligned_cols=110  Identities=21%  Similarity=0.366  Sum_probs=92.5

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      .|+|.+||+|.+|++|+  +|.|+|+|+.++ +     | ++|+     ..++||+||++.|.  .+++|+|+.||||||
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dg-n-----l-vly~-----~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl   65 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKC-N-----L-VKYQ-----NGRQIWASNTDRRG--SGCRLTLLSDGNLVI   65 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTS-C-----E-EEEE-----TTEEEEECSCTTSC--SSCEEEECTTSCEEE
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCC-c-----E-EEEe-----CCEEEEeCCCCCCC--CceEEEECCCCcEEE
Confidence            48999999999999998  799999998877 3     2 2354     25899999999883  457899999999999


Q ss_pred             EcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCcc
Q 006090          104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTD  155 (662)
Q Consensus       104 ~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtD  155 (662)
                      +|.++.++|+|++..  ..+...++|+|+|||||++.    ++||||.++..
T Consensus        66 ~d~~~~~vW~S~~~~--~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~  111 (115)
T 2dpf_A           66 YDHNNNDVWGSACWG--DNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR  111 (115)
T ss_dssp             ECTTCCEEEECCCCC--SSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred             ECCCceEEEEcCCCC--CCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence            999999999999763  23467899999999999952    79999998765

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.81  E-value=2.5e-20  Score=202.29  Aligned_cols=153  Identities=18%  Similarity=0.184  Sum_probs=116.2

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHHHHHHhcCCC-CCcc---------eee-
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQH-RNLV---------RLL-  557 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H-~nIv---------~l~-  557 (662)
                      ....|...+.||+|+||.||+|+.. +++.||||++....   ....+.|.+|+.+++.++| +|..         ... 
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456788899999999999999954 68999999987322   2336789999999999987 3211         111 


Q ss_pred             -----------EEEEe-----CCeeEEEEEccCCCCHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006090          558 -----------GCCVE-----REENMLIYEYMPNKSLDSFLFD----PQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLR  617 (662)
Q Consensus       558 -----------g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  617 (662)
                                 .+...     ....+++|+++ +++|.+++..    ......+++..++.|+.||++||+|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                       11111     12346667765 6899998831    122345788899999999999999999988   


Q ss_pred             eEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          618 IIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       618 iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |+||||||+||||+.++.+||+|||+|+..+.
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~  263 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  263 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCC
Confidence            99999999999999999999999999987654

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.80  E-value=3.2e-19  Score=156.41  Aligned_cols=110  Identities=25%  Similarity=0.457  Sum_probs=91.9

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      +|+|.+||.|.+|++|  ++|.|+|+|+.++ +     | ++|+.     .++||++|++.+  +.+++|+|+.||||||
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dg-n-----l-vl~~~-----~~~vW~sn~~~~--~~~~~l~l~~~GNLvl   64 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDC-N-----L-VLYDN-----NRAVWASGTNGK--ASGCVLKMQNDGNLVI   64 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTS-C-----E-EEEET-----TEEEEECCCTTS--CSSEEEEECTTSCEEE
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCC-c-----E-EEEEC-----CEEEEeCCCcCC--CCCEEEEEeCCCCEEE
Confidence            4899999999999999  5799999999988 4     2 35643     489999999864  3457899999999999


Q ss_pred             EcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCC
Q 006090          104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEP  153 (662)
Q Consensus       104 ~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~P  153 (662)
                      +| ++.++|+|.+..  ..+...++|+++|||||++. .+.++||||++.
T Consensus        65 ~d-~~~~~W~S~~~~--~~g~~~l~l~~dGnlvl~~~-~~~~~W~S~~~~  110 (112)
T 1xd5_A           65 YS-GSRAIWASNTNR--QNGNYYLILQRDRNVVIYDN-SNNAIWATHTNV  110 (112)
T ss_dssp             EE-TTEEEEECCCCC--SCCCCEEEECTTSCEEEECT-TSCEEEECCCCC
T ss_pred             Ec-CCEEEEECCccC--CCCCEEEEEeCCCcEEEECC-CCceEEECCCcc
Confidence            99 888999998763  33567899999999999974 356899999985

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=1.9e-19  Score=182.53  Aligned_cols=141  Identities=17%  Similarity=0.163  Sum_probs=109.8

Q ss_pred             cccccccccCccCceeEEEEEE-cCCcE--EEEEEccccccc------------------------cHHHHHHHHHHHhc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKL-QDGQE--IAVKRLSKASGQ------------------------GQEEFMNEVMVISN  547 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~-~~~~~--vAvK~l~~~~~~------------------------~~~~f~~E~~~l~~  547 (662)
                      .-|.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+..|.+
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467789999999999999998 67888  999987542111                        11368899999999


Q ss_pred             CCCCCc--ceeeEEEEeCCeeEEEEEccCC-C----CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceE
Q 006090          548 LQHRNL--VRLLGCCVEREENMLIYEYMPN-K----SLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH-RDSRLRII  619 (662)
Q Consensus       548 l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ii  619 (662)
                      ++|+++  +.+++.    ...+|||||+.+ |    +|.+++..      .++.....++.||+.||.||| +.+   |+
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            988764  444442    356899999942 4    67766521      224467789999999999999 877   99


Q ss_pred             ecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          620 HRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       620 HrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||||||+|||+++  .++|+|||+|......
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            9999999999998  9999999999987543

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.77  E-value=1.8e-18  Score=150.71  Aligned_cols=103  Identities=21%  Similarity=0.405  Sum_probs=86.6

Q ss_pred             ccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEE
Q 006090           25 DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVL  104 (662)
Q Consensus        25 ~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~  104 (662)
                      ++|.+||.|.+|+.|+  +|.|+|.|+.++ +     | +.|..     .++||.+|++.+  +..+.|+|+.||||||+
T Consensus         2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dG-n-----L-vly~~-----~~~vW~snt~~~--~~~~~l~l~~dGNLvl~   65 (109)
T 3dzw_A            2 NILYSGETLSPGEFLN--NGRYVFIMQEDC-N-----L-VLYDV-----DKPIWATNTGGL--DRRCHLSMQSDGNLVVY   65 (109)
T ss_dssp             CEEETTEEECTTCEEE--ETTEEEEECTTS-C-----E-EEEET-----TEEEEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred             CCcCCCCEeCCCCEEE--CCCEEEEEcCCC-c-----E-EEEeC-----CEEEEECCcccC--CCCEEEEEeCCCCEEEE
Confidence            6899999999999996  699999999887 4     2 22543     489999999876  34578999999999999


Q ss_pred             cCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          105 NGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       105 ~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      |.++.++|++++..  ......|+|+|+|||||++.    ++|||
T Consensus        66 ~~~~~~~W~S~t~~--~~~~~~~~L~ddGNlvly~~----~~W~s  104 (109)
T 3dzw_A           66 SPRNNPIWASNTGG--ENGNYVCVLQKDRNVVIYGT----ARWAT  104 (109)
T ss_dssp             CTTSCEEEECCCCC--SSSCEEEEECTTSCEEEEES----CCCCC
T ss_pred             CCCCCEEEECCCCC--CCCCEEEEEeCCCEEEEECC----CEEeC
Confidence            99999999999863  22456899999999999973    69998

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.72  E-value=2.2e-17  Score=143.85  Aligned_cols=105  Identities=18%  Similarity=0.295  Sum_probs=86.4

Q ss_pred             cccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccE
Q 006090           22 TATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNL  101 (662)
Q Consensus        22 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l  101 (662)
                      +++|+|.+||.|.+|+.|+|  |.|.|.|..++ +     |.+ |..      .+||.+|++..  +..+.|+|+.||||
T Consensus         4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dG-n-----Lvl-~~~------~~vW~snt~~~--~~~~~l~l~~dGNL   66 (110)
T 3r0e_B            4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDC-N-----LVL-YGG------KYGWQSNTHGN--GEHCFLRLNHKGEL   66 (110)
T ss_dssp             CBTTEEETTCEEETTEEEEC--SSCEEEECTTS-C-----EEE-ECS------SSCEECCCTTS--SSSCEEEECTTSCE
T ss_pred             cccCEECCCCEecCCCEEEe--CCEEEEEcCCC-e-----EEE-ECC------eEEEECCCcCC--CcCEEEEEeCCCcE
Confidence            67899999999999999998  45899887776 4     434 532      48999999863  34578999999999


Q ss_pred             EEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          102 VVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       102 ~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      ||+|.++.++|++++..  ..+...|+|+|+|||||++    .++|+|
T Consensus        67 vl~d~~~~~iW~S~t~~--~~~~~~~~L~~dGNlvly~----~~~W~t  108 (110)
T 3r0e_B           67 IIKDDDFKTIWSSRSSS--KQGEYVLILQDDGFGVIYG----PAIFET  108 (110)
T ss_dssp             EEECTTCCEEEECCCCC--SSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred             EEEeCCCCEEEEcCCcC--CCCCEEEEEcCCccEEEec----CCEecC
Confidence            99999999999999853  2345789999999999996    379997

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.72  E-value=6e-17  Score=141.82  Aligned_cols=108  Identities=15%  Similarity=0.281  Sum_probs=89.4

Q ss_pred             cccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccE
Q 006090           22 TATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNL  101 (662)
Q Consensus        22 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l  101 (662)
                      .+.++|.+||.|.+|+.|.+  |.|.|.|+.++ +     |.++..    ...++||.+|+..+  +..+.|.|+.||||
T Consensus         4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dG-N-----LvL~~~----~~~~~vWssnt~~~--~~~~~l~l~~dGNL   69 (113)
T 3mez_B            4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDC-N-----LVLTKG----SKTNIVWESGTSGR--GQHCFMRLGHSGEL   69 (113)
T ss_dssp             CCSSEEETTCEEETTCEEEE--TTEEEEECTTS-C-----EEEEET----TTTEEEEECCCTTS--CSSCEEEECTTSCE
T ss_pred             ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCC-E-----EEEEEC----CCCEEEEECCcccC--CcCEEEEEeCCCcE
Confidence            45799999999999999975  88999998887 4     545432    13589999999876  34578999999999


Q ss_pred             EEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          102 VVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       102 ~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      ||+|.++.++|++++..  ..+...|+|+|+|||||++    .++|+|
T Consensus        70 Vl~d~~~~~iW~S~t~~--~~~~~~~~L~~dGnlvly~----~~~W~s  111 (113)
T 3mez_B           70 DITDDRLNTVFVSNTVG--QEGDYVLILQINGQAVVYG----PAVWST  111 (113)
T ss_dssp             EEECTTSCEEEECSCCC--SSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred             EEECCCCCEEEECCCcC--CCCCEEEEEcCCceEEEec----CCEecC
Confidence            99999999999999864  2245789999999999995    479997

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.68  E-value=1.3e-16  Score=139.61  Aligned_cols=96  Identities=26%  Similarity=0.434  Sum_probs=77.7

Q ss_pred             CCCCCceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccc
Q 006090           86 LIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVST  165 (662)
Q Consensus        86 ~~~~~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~  165 (662)
                      +.+...+|.|+.||+|+|++. +.++|++++..  ......|+|+|+|||||++  .+.++||||+              
T Consensus        16 L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~--~~~~~~l~l~~~GNLvl~d--~~~~~W~S~~--------------   76 (112)
T 1xd5_A           16 LAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNG--KASGCVLKMQNDGNLVIYS--GSRAIWASNT--------------   76 (112)
T ss_dssp             EEETTEEEEECTTSCEEEEET-TEEEEECCCTT--SCSSEEEEECTTSCEEEEE--TTEEEEECCC--------------
T ss_pred             EeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcC--CCCCEEEEEeCCCCEEEEc--CCEEEEECCc--------------
Confidence            334457899999999999988 78999999863  2245789999999999998  4678999994              


Q ss_pred             cccCCceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCCCC
Q 006090          166 DLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNG  219 (662)
Q Consensus       166 ~~~tg~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~~~  219 (662)
                                       +|++|.|++.|+++|.  ++++.....+||++++|+|
T Consensus        77 -----------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 -----------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             -----------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             -----------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence                             3456889999999998  4555345779999999976

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.68  E-value=1.9e-16  Score=137.61  Aligned_cols=103  Identities=24%  Similarity=0.393  Sum_probs=85.3

Q ss_pred             cccccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccE
Q 006090           22 TATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNL  101 (662)
Q Consensus        22 ~~~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l  101 (662)
                      ++.|+|.+||.|.+|+.|  .+|.|.|.|+.++ +     | +.|..        +|.+|+..+  +..++|+|+.||||
T Consensus         1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dG-N-----L-vl~~~--------~Wssnt~~~--~~~~~l~l~~dGnL   61 (109)
T 3r0e_A            1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDC-N-----L-VLYNG--------NWQSNTANN--GRDCKLTLTDYGEL   61 (109)
T ss_dssp             CCCSEEETTCEECTTCEE--EETTEEEEECTTS-C-----E-EEETT--------TEECCCTTS--CSSCEEEECTTSCE
T ss_pred             CccCCcCCCCCcCCCCEe--ECCCEEEEEecCC-e-----E-EEEeC--------eEEcCCCCC--CCcEEEEEcCCCeE
Confidence            367999999999999999  4699999998887 4     2 23431        699998865  34579999999999


Q ss_pred             EEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          102 VVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       102 ~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      ||+|.++.++|++++..  ..+...|+|+|+|||||++    .++|+|
T Consensus        62 vl~d~~~~~vWss~t~~--~~~~~~~~L~~dGNlvly~----~~~W~s  103 (109)
T 3r0e_A           62 VIKNGDGSTVWKSGAQS--VKGNYAAVVHPDGRLVVFG----PSVFKI  103 (109)
T ss_dssp             EEECTTSCEEEECCCCC--SSSCCEEEEETTTEEEEEC----SEEEEE
T ss_pred             EEEeCCCCEEEcCCCcC--CCcCEEEEEcCCCeEEEEe----cCEECC
Confidence            99999999999999863  3345789999999999995    479997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=5.8e-17  Score=171.46  Aligned_cols=140  Identities=13%  Similarity=0.189  Sum_probs=101.3

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEcccccc--------------ccHHH--------HHHHHHHHhcCCCC
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG--------------QGQEE--------FMNEVMVISNLQHR  551 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~--------------~~~~~--------f~~E~~~l~~l~H~  551 (662)
                      ..-|.+...||+|+||.||+|...+|+.||||+++....              .....        ...|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            345899999999999999999998999999998753210              00111        23456666666544


Q ss_pred             CcceeeEEEEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006090          552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD  631 (662)
Q Consensus       552 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~  631 (662)
                      ++.-..-+..  ...+|||||+++++|..+...         .....++.||+.+|.|||+.+   ||||||||.||||+
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence            4322211211  234799999999988765411         123567899999999999988   99999999999998


Q ss_pred             CCC----------ceEEEeeCccccc
Q 006090          632 DDL----------NPKISDFGLARIF  647 (662)
Q Consensus       632 ~~~----------~~ki~DFGla~~~  647 (662)
                      +++          .+.|+||+-+--.
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCCcccccccccceEEEEeCCcccC
Confidence            877          3899999977644

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.64  E-value=9e-16  Score=133.71  Aligned_cols=89  Identities=27%  Similarity=0.403  Sum_probs=72.7

Q ss_pred             CCceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCccccccc
Q 006090           89 SSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLR  168 (662)
Q Consensus        89 ~~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~  168 (662)
                      ...+|.|+.||||||++ .+.+||++++..  ......|+|+|+|||||++. .+.++||||                  
T Consensus        20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~--~~~~~~l~l~~dGNLVl~~~-~~~~~W~S~------------------   77 (110)
T 3a0c_A           20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGG--LGSGCRLTLHNNGNLVIYDQ-SNRVIWQTK------------------   77 (110)
T ss_dssp             TTEEEEECTTSCEEEEE-TTEEEEECCCTT--SCSSCEEEECTTSCEEEECT-TCCEEEECC------------------
T ss_pred             CCEEEEEcCCCcEEEEE-CCEEEEECCCCC--CCCcEEEEEeCCCCEEEECC-CCcEEEecC------------------
Confidence            34789999999999999 588999999864  22456899999999999986 467899999                  


Q ss_pred             CCceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCC
Q 006090          169 TGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPW  217 (662)
Q Consensus       169 tg~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~  217 (662)
                                   +++++|.|+++|+++|.  ++++ ++  +||+++++
T Consensus        78 -------------t~~~~g~~~l~l~~dGn--lvl~-~~--~~W~S~~~  108 (110)
T 3a0c_A           78 -------------TNGKEDHYVLVLQQDRN--VVIY-GP--VVWATGSG  108 (110)
T ss_dssp             -------------CCCSSSCCEEEECTTSC--EEEE-CS--EEEECSCC
T ss_pred             -------------CCCCCCCEEEEEeCCcc--EEEE-CC--CEecCCCc
Confidence                         24567899999999998  4455 54  79999875

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.61  E-value=2.5e-15  Score=130.99  Aligned_cols=105  Identities=13%  Similarity=0.217  Sum_probs=84.2

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      +++|.+||.|.+|+.|.  +|.|.|.|+.++ +     | +.|..    . . ||.+|+..+  +..+.|+|+.||||||
T Consensus         2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dG-n-----L-vl~~~----~-~-vW~snt~~~--~~~~~l~l~~dGNLVl   64 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDC-N-----L-VLYNE----A-G-GFQSNTHGR--GVDCTLRLNNRGQLEI   64 (111)
T ss_dssp             TTEEETTCEECTTCEEE--ETTEEEEECTTS-C-----E-EEECS----S-C-CEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred             cCEeCCCCEeCCCCEEe--cCCEEEEEccCC-e-----E-EEECC----C-C-EEECCcccC--CcCEEEEEcCCCcEEE
Confidence            57999999999999994  689999998887 4     3 33543    2 3 999999876  3457999999999999


Q ss_pred             EcCCCC-EEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          104 LNGKKQ-VHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       104 ~~~~~~-~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      +|.++. ++|+|++......+...|+|+|+|||||++    .++|+|
T Consensus        65 ~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s  107 (111)
T 3mez_A           65 HSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST  107 (111)
T ss_dssp             ECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred             EeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence            999876 599999642123346789999999999995    479997

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.58  E-value=8.1e-15  Score=129.34  Aligned_cols=86  Identities=26%  Similarity=0.427  Sum_probs=71.1

Q ss_pred             ceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           91 GIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        91 ~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      .+|.|+.||+|+|++. +.+||++++..  ......|+|+|+|||||+|. .+.++||||                    
T Consensus        32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~--~~~~~~l~l~~dGNLVl~d~-~~~~lW~S~--------------------   87 (119)
T 1b2p_A           32 YRFIMQTDCNLVLYDN-NNPIWATNTGG--LGNGCRAVLQPDGVLVVITN-ENVTVWQSP--------------------   87 (119)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTT--SCSSCEEEECTTSCEEEECT-TCCEEEECS--------------------
T ss_pred             EEEEEecCCCEEEEEC-CEEEEeCCCcc--CCCceEEEEccCCEEEEEeC-CCcEEEcCC--------------------
Confidence            5799999999999987 89999999863  22357899999999999985 467899999                    


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                 ++|++|.|+++|+++|.  ++++ +  .+||++|+
T Consensus        88 -----------~~~~~g~~~l~l~~~Gn--lvl~-~--~~~W~Sg~  117 (119)
T 1b2p_A           88 -----------VAGKAGHYVLVLQPDRN--VVIY-G--DALWATQT  117 (119)
T ss_dssp             -----------CCCCSSCEEEEECTTSC--EEEE-E--SEEEECCC
T ss_pred             -----------CCCCCCCEEEEEECCCc--EEEE-C--ccEeCCCC
Confidence                       34567899999999998  4455 4  38999986

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.57  E-value=1.2e-14  Score=127.67  Aligned_cols=91  Identities=29%  Similarity=0.428  Sum_probs=74.2

Q ss_pred             CceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccC
Q 006090           90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRT  169 (662)
Q Consensus        90 ~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~t  169 (662)
                      ...|.|+.||+|+|++ .+.++|++++..  ......++|+++|||||+|. .+.++||||++                 
T Consensus        21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~--~~~~~~l~l~~~GnLvl~d~-~~~~vW~S~~~-----------------   79 (115)
T 2dpf_A           21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDR--RGSGCRLTLLSDGNLVIYDH-NNNDVWGSACW-----------------   79 (115)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECSCTT--SCSSCEEEECTTSCEEEECT-TCCEEEECCCC-----------------
T ss_pred             CEEEEEcCCCcEEEEe-CCEEEEeCCCCC--CCCceEEEECCCCcEEEECC-CceEEEEcCCC-----------------
Confidence            3679999999999998 588999999864  22356899999999999985 45689999998                 


Q ss_pred             CceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCCCCc
Q 006090          170 GKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNGR  220 (662)
Q Consensus       170 g~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~~~~  220 (662)
                                    +++|.|++.++++|.  ++++ +.  +||++++|...
T Consensus        80 --------------~~~g~~~l~l~~dGn--lvl~-~~--~~W~S~~~~~~  111 (115)
T 2dpf_A           80 --------------GDNGKYALVLQKDGR--FVIY-GP--VLWSLGPNGCR  111 (115)
T ss_dssp             --------------CSSSCCEEEECTTSC--EEEE-CS--EEECSSTTCBC
T ss_pred             --------------CCCCCEEEEEeCCCe--EEEE-CC--CEEECCCCCCc
Confidence                          356789999999997  4455 54  89999999654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=3.2e-12  Score=129.23  Aligned_cols=145  Identities=15%  Similarity=0.064  Sum_probs=115.2

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      -..|.+...++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..++||||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            356777788888889999999865 6889999986432233446889999999884 77889999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD---------------------------------------  613 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------  613 (662)
                      ++|.+|.+.+.        +......++.+++++|+.||+.                                       
T Consensus        92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999987641        1122347889999999999981                                       


Q ss_pred             -----------------CCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          614 -----------------SRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       614 -----------------~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                                       .+..++|+|++|.|||++++..+.|+||+.+..-
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                             1144999999999999987766789999988644

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.34  E-value=3.6e-12  Score=110.93  Aligned_cols=90  Identities=22%  Similarity=0.381  Sum_probs=69.3

Q ss_pred             CCceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCccccccc
Q 006090           89 SSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLR  168 (662)
Q Consensus        89 ~~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~  168 (662)
                      ...+|.|+.||||||++.++  +|++++..  ......|+|+|+|||||++.+...++|||..+                
T Consensus        20 g~~~L~~q~dGnLvl~~~~~--vW~snt~~--~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~----------------   79 (111)
T 3mez_A           20 ESAAFVMQGDCNLVLYNEAG--GFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS----------------   79 (111)
T ss_dssp             TTEEEEECTTSCEEEECSSC--CEECCCTT--SCSSCEEEECTTSCEEEECSSCSSCSEEESSS----------------
T ss_pred             CCEEEEEccCCeEEEECCCC--EEECCccc--CCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc----------------
Confidence            44689999999999999877  99999864  22347899999999999986444569998621                


Q ss_pred             CCceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          169 TGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       169 tg~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                   .....|.|.+.++++|...++   .  .++|.+++
T Consensus        80 -------------~~~~~~~~~l~Lq~dGNlvly---~--~~~W~s~t  109 (111)
T 3mez_A           80 -------------VNTVRGNYAATLGPDQHVTIY---G--PAIWSTPA  109 (111)
T ss_dssp             -------------CCCCSSCCEEEECTTSCEEEE---C--SEEEECCC
T ss_pred             -------------cCCCCcCEEEEECCCCeEEEe---c--cCEEccCC
Confidence                         011347899999999986654   4  57999875

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.33  E-value=4.4e-12  Score=110.74  Aligned_cols=96  Identities=22%  Similarity=0.314  Sum_probs=72.0

Q ss_pred             CCCCCCCCCceEEEecCccEEEEcC-CCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccC
Q 006090           82 RNKPLIDSSGIFTISEDGNLVVLNG-KKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSE  160 (662)
Q Consensus        82 r~~p~~~~~~~l~~~~~G~l~l~~~-~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg  160 (662)
                      .+.|+.+...+|.|+.||||||++. .+.++|++++..  ......|+|+|+|||||++.+ +.++|||=.+        
T Consensus        17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~--~~~~~~l~l~~dGNLVl~d~~-~~~iW~S~t~--------   85 (113)
T 3mez_B           17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSG--RGQHCFMRLGHSGELDITDDR-LNTVFVSNTV--------   85 (113)
T ss_dssp             TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTT--SCSSCEEEECTTSCEEEECTT-SCEEEECSCC--------
T ss_pred             CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCccc--CCcCEEEEEeCCCcEEEECCC-CCEEEECCCc--------
Confidence            3445555557899999999999998 589999999863  223568999999999999863 5679997211        


Q ss_pred             CcccccccCCceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          161 MKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       161 ~~l~~~~~tg~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                             ...|.|.+.++++|...++   +  .+.|.+|+
T Consensus        86 -----------------------~~~~~~~~~L~~dGnlvly---~--~~~W~s~~  113 (113)
T 3mez_B           86 -----------------------GQEGDYVLILQINGQAVVY---G--PAVWSTAA  113 (113)
T ss_dssp             -----------------------CSSSCCEEEECTTSCEEEE---C--SEEEESCC
T ss_pred             -----------------------CCCCCEEEEEcCCceEEEe---c--CCEecCCC
Confidence                                   0124588999999986654   4  57898875

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.33  E-value=5.4e-12  Score=127.98  Aligned_cols=110  Identities=20%  Similarity=0.358  Sum_probs=84.3

Q ss_pred             ccccccCCCc----ccCCCeEEec----CCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEE
Q 006090           23 ATDTITSSQF----IRDPESIISS----GSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFT   94 (662)
Q Consensus        23 ~~~~l~~g~~----l~~~~~l~S~----~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~   94 (662)
                      .+||+.||+.    |..|+.|.|+    .|.|.|.|...+    ..+  + |.+    ..+++|.+++..+  +. ..|.
T Consensus       135 ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dG----nlv--L-y~~----~~~~yW~Sgt~~~--~~-~~l~  200 (276)
T 3m7h_A          135 PAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDG----NLV--A-YGP----NGAATWNAGTQGK--GA-VRAV  200 (276)
T ss_dssp             TTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTS----CEE--E-ECT----TSSEEEECCCTTT--TC-CEEE
T ss_pred             cccccccccccccccccCcccccCCCCCCceEEEeecCCc----eEE--E-EeC----CCeEEEECCCCCC--cc-EEEE
Confidence            4689999999    8888888553    345555554333    233  3 332    2489999999876  23 7899


Q ss_pred             EecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccC
Q 006090           95 ISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE  152 (662)
Q Consensus        95 ~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~  152 (662)
                      ++.+|+|+++|.++.++|++++..  . ....|+|+++|||||++.   .++||||||
T Consensus       201 l~~dGnLvl~d~~~~~vWsS~t~~--~-~~~rl~Ld~dGnLvly~~---~~~Wqsf~~  252 (276)
T 3m7h_A          201 FQGDGNLVVYGAGNAVLWHSHTGG--H-ASAVLRLQANGSIAILDE---KPVWARFGF  252 (276)
T ss_dssp             ECTTSCEEEECTTSCEEEECSCTT--C-TTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred             EcCCCeEEEEeCCCcEEEEecCCC--C-CCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence            999999999999889999999763  2 357999999999999964   579999997

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.16  E-value=3.6e-11  Score=120.77  Aligned_cols=139  Identities=17%  Similarity=0.168  Sum_probs=103.7

Q ss_pred             ccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCC--cceeeEEEEeCCeeEEEEEcc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN--LVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .+.+....+.|..+.||+....+|+.+++|.....   ....+..|+.+++.+.+.+  +.+++++..+++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44433333456669999998777788999987543   2345778999998885434  667999988888889999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS---------------------------------------  614 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  614 (662)
                      +|.+|.  ...      .+   ...++.++++.|+.||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998884  311      11   2367788888888888743                                       


Q ss_pred             ----------------CCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          615 ----------------RLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       615 ----------------~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                                      +..++|+|++|.|||++.+..++|+||+.|....
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~  216 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD  216 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence                            1239999999999999887777899999987654

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.16  E-value=1.5e-10  Score=100.44  Aligned_cols=87  Identities=22%  Similarity=0.401  Sum_probs=66.5

Q ss_pred             CceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccC
Q 006090           90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRT  169 (662)
Q Consensus        90 ~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~t  169 (662)
                      ..+|.|+.||+|||++. +.++|++++..  ......++|+|+|||||+|. .+.++|||....                
T Consensus        20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~--~~~~~~l~l~~dGNLvl~~~-~~~~~W~S~t~~----------------   79 (109)
T 3dzw_A           20 RYVFIMQEDCNLVLYDV-DKPIWATNTGG--LDRRCHLSMQSDGNLVVYSP-RNNPIWASNTGG----------------   79 (109)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTT--SSSSCEEEECTTSCEEEECT-TSCEEEECCCCC----------------
T ss_pred             CEEEEEcCCCcEEEEeC-CEEEEECCccc--CCCCEEEEEeCCCCEEEECC-CCCEEEECCCCC----------------
Confidence            36899999999999988 78999999864  22356899999999999985 356899984211                


Q ss_pred             CceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          170 GKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       170 g~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                     ..+.|.+.++++|...++   +.  +.|.+++
T Consensus        80 ---------------~~~~~~~~L~ddGNlvly---~~--~~W~s~t  106 (109)
T 3dzw_A           80 ---------------ENGNYVCVLQKDRNVVIY---GT--ARWATGT  106 (109)
T ss_dssp             ---------------SSSCEEEEECTTSCEEEE---ES--CCCCCCC
T ss_pred             ---------------CCCCEEEEEeCCCEEEEE---CC--CEEeCCC
Confidence                           124678899999986654   32  6888775

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.12  E-value=1.7e-10  Score=100.09  Aligned_cols=86  Identities=21%  Similarity=0.400  Sum_probs=65.0

Q ss_pred             CceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccC
Q 006090           90 SGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRT  169 (662)
Q Consensus        90 ~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~t  169 (662)
                      ..+|.++.||||||++.  .++|++++..  ......++|+|+|||||+|. .+.++|||-.+-                
T Consensus        25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~--~~~~~~l~l~~dGNLvl~d~-~~~~iW~S~t~~----------------   83 (110)
T 3r0e_B           25 NHQLVMQGDCNLVLYGG--KYGWQSNTHG--NGEHCFLRLNHKGELIIKDD-DFKTIWSSRSSS----------------   83 (110)
T ss_dssp             SCEEEECTTSCEEEECS--SSCEECCCTT--SSSSCEEEECTTSCEEEECT-TCCEEEECCCCC----------------
T ss_pred             CEEEEEcCCCeEEEECC--eEEEECCCcC--CCcCEEEEEeCCCcEEEEeC-CCCEEEEcCCcC----------------
Confidence            36899999999999987  5899999863  22346899999999999986 356899983210                


Q ss_pred             CceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          170 GKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       170 g~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                     ..|.|.+.++++|...++   +  .+.|.+|+
T Consensus        84 ---------------~~~~~~~~L~~dGNlvly---~--~~~W~t~~  110 (110)
T 3r0e_B           84 ---------------KQGEYVLILQDDGFGVIY---G--PAIFETSS  110 (110)
T ss_dssp             ---------------SSSCCEEEECTTSCEEEE---C--SEEEESCC
T ss_pred             ---------------CCCCEEEEEcCCccEEEe---c--CCEecCCC
Confidence                           124588899999986654   4  37888763

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.07  E-value=3.6e-10  Score=97.88  Aligned_cols=91  Identities=26%  Similarity=0.502  Sum_probs=67.5

Q ss_pred             CCCCCCCceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcc
Q 006090           84 KPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKV  163 (662)
Q Consensus        84 ~p~~~~~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l  163 (662)
                      .|+.+....|.++.||||||+++    +|++++..  ......++|+++|||||+|. .+.++|+|-     |       
T Consensus        16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~--~~~~~~l~l~~dGnLvl~d~-~~~~vWss~-----t-------   76 (109)
T 3r0e_A           16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTAN--NGRDCKLTLTDYGELVIKNG-DGSTVWKSG-----A-------   76 (109)
T ss_dssp             CEEEETTEEEEECTTSCEEEETT----TEECCCTT--SCSSCEEEECTTSCEEEECT-TSCEEEECC-----C-------
T ss_pred             CEeECCCEEEEEecCCeEEEEeC----eEEcCCCC--CCCcEEEEEcCCCeEEEEeC-CCCEEEcCC-----C-------
Confidence            33333456899999999999985    79999864  22357899999999999986 356799761     1       


Q ss_pred             cccccCCceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCC
Q 006090          164 STDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPW  217 (662)
Q Consensus       164 ~~~~~tg~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~  217 (662)
                                         ....+.|.+.++++|...++   .  .+.|.+++|
T Consensus        77 -------------------~~~~~~~~~~L~~dGNlvly---~--~~~W~s~t~  106 (109)
T 3r0e_A           77 -------------------QSVKGNYAAVVHPDGRLVVF---G--PSVFKIDPW  106 (109)
T ss_dssp             -------------------CCSSSCCEEEEETTTEEEEE---C--SEEEEECTT
T ss_pred             -------------------cCCCcCEEEEEcCCCeEEEE---e--cCEECCCCc
Confidence                               00235688999999986654   4  578999987

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=5.6e-10  Score=118.20  Aligned_cols=142  Identities=15%  Similarity=0.231  Sum_probs=107.8

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEcc--ccc-cccHHHHHHHHHHHhcCC--CCCcceeeEEEEeC---CeeEEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLS--KAS-GQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVER---EENMLIYE  571 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~--~~~-~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~E  571 (662)
                      .+.|+.|.+..||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..++++++++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            5788999999999998764 678888765  321 122356788999999886  56688999998876   34799999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS-------------------------------------  614 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------  614 (662)
                      |+++..+.+..     ...++..++..++.++++.|+.||+..                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99998874322     123678888999999999999999831                                     


Q ss_pred             ------------------CCceEecCCCCCcEEEcCCCc--eEEEeeCccccc
Q 006090          615 ------------------RLRIIHRDLKASNILLDDDLN--PKISDFGLARIF  647 (662)
Q Consensus       615 ------------------~~~iiHrDlkp~NILl~~~~~--~ki~DFGla~~~  647 (662)
                                        +..++|+|++|.|||++.++.  +.|.||+++..-
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              256999999999999997753  689999998743

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.93  E-value=5.1e-09  Score=89.84  Aligned_cols=78  Identities=27%  Similarity=0.408  Sum_probs=59.5

Q ss_pred             ceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           91 GIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        91 ~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      -+|.++.||||||++. +.+||++++.. ....+..++|+++|||||+|. .+.++|+|-     |              
T Consensus        21 y~l~~q~DgNLvly~~-~~~vW~ant~~-~~~~~~~L~l~~dGnLvL~d~-~~~~vWss~-----t--------------   78 (105)
T 4h3o_A           21 YHFIMQDDCNLVLYDH-STSTWASNTEI-GGKSGCSAVLQSDGNFVVYDS-SGRSLWASH-----S--------------   78 (105)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCCC-TTCCSCEEEECTTSCEEEECT-TCCEEEECC-----C--------------
T ss_pred             EEEEECCCCeEEEEEC-CEEEEEecCCC-CCCccEEEEEeCCccEEEECC-CcEEEEEec-----C--------------
Confidence            4799999999999985 57999999864 222456899999999999986 356799861     1              


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEE
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVF  202 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~  202 (662)
                                  ....+.|.+.|+++|...++
T Consensus        79 ------------~~~~~~~~l~L~ddGNlVly   98 (105)
T 4h3o_A           79 ------------TRGSGNYILILQDDGNVIIY   98 (105)
T ss_dssp             ------------CCCSSCEEEEECTTSCEEEE
T ss_pred             ------------CCCCCCEEEEEeCCCeEEEE
Confidence                        11345688999999986543

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.80  E-value=1.2e-08  Score=101.29  Aligned_cols=88  Identities=28%  Similarity=0.424  Sum_probs=68.6

Q ss_pred             ceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           91 GIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        91 ~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      -.|.|+.||+|+|+++ +++||.+|+..  . ....++|+++|||||+|. .+.++|+|+++.                 
T Consensus        28 f~l~f~~~gnl~ly~~-~~~vW~an~~~--~-~~~~l~l~~dGnLvl~d~-~~~~vW~s~~~~-----------------   85 (236)
T 1dlp_A           28 FRFTMQSDCNLVLFDS-DVRVWASNTAG--A-TGCRAVLQSDGLLVILTA-QNTIRWSSGTKG-----------------   85 (236)
T ss_dssp             EEEEECTTSCEEEEES-SSEEECCCCCS--C-SCCBCCBCSSSCBCCBCT-TTCCSCCCCCCC-----------------
T ss_pred             EEEEECCCCcEEEEEC-CEEEEECCCCC--C-CCeEEEEcCCCcEEEEcC-CCcEEEeCCccc-----------------
Confidence            5788899999999986 78999999864  2 566899999999999985 456899998651                 


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCCCC
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPWNG  219 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~~~  219 (662)
                                    ..|.|.+.|+++|...++   ..  .||.+..+..
T Consensus        86 --------------~~~~~~~~l~d~Gnlvl~---~~--~~W~S~~~p~  115 (236)
T 1dlp_A           86 --------------SIGNYVLVLQPDRTVTIY---GP--GLWDSGTSNK  115 (236)
T ss_dssp             --------------CSSCCEEEECSSSCEEEE---CS--EEEECSCCCS
T ss_pred             --------------cCCcEEEEEeCCCCEEEe---cC--CEEECCCCCC
Confidence                          235678889888885543   32  7999887643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.53  E-value=1.2e-07  Score=97.63  Aligned_cols=138  Identities=21%  Similarity=0.248  Sum_probs=102.0

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCC--cceeeEEEEeCC---eeEEEEEcc
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRN--LVRLLGCCVERE---ENMLIYEYM  573 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~n--Iv~l~g~~~~~~---~~~lV~Ey~  573 (662)
                      .+.++.|....||+..    ..+++|....  ......+.+|.++++.+ .+..  +.++++.....+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568899999999863    5688887543  23456788999999887 3433  455655544333   348999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD----------------------------------------  613 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------  613 (662)
                      +|.+|.+...     ..++..++..++.++++.|+.||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988875431     2367788889999999999999962                                        


Q ss_pred             ---------------CCCceEecCCCCCcEEEcC--CCceEEEeeCcccccc
Q 006090          614 ---------------SRLRIIHRDLKASNILLDD--DLNPKISDFGLARIFG  648 (662)
Q Consensus       614 ---------------~~~~iiHrDlkp~NILl~~--~~~~ki~DFGla~~~~  648 (662)
                                     .++.++|+|++|.|||+++  +..+.|+||+.+..-.
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~  225 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD  225 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence                           1245899999999999998  5568999999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.43  E-value=1.3e-06  Score=90.00  Aligned_cols=139  Identities=19%  Similarity=0.146  Sum_probs=99.4

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCC---CcceeeEEEE-eCCeeEEEEEccCC
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHR---NLVRLLGCCV-EREENMLIYEYMPN  575 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~  575 (662)
                      .+.++.|....||+.    ++.+++|+-.  .......+.+|.++|..+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899988    5677788743  223456789999999998642   3677777775 34557899999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS-----------------------------------------  614 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------------  614 (662)
                      .+|.+....     .++..++..++.++++.|+.||+..                                         
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888764311     2455666666777777777766532                                         


Q ss_pred             ----------------CCceEecCCCCCcEEEcC---CCc-eEEEeeCccccccC
Q 006090          615 ----------------RLRIIHRDLKASNILLDD---DLN-PKISDFGLARIFGG  649 (662)
Q Consensus       615 ----------------~~~iiHrDlkp~NILl~~---~~~-~ki~DFGla~~~~~  649 (662)
                                      ++.++|+|++|.|||++.   ++. +.|+||+.+..-.+
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence                            234799999999999987   355 58999998876543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=1.3e-06  Score=88.00  Aligned_cols=137  Identities=18%  Similarity=0.173  Sum_probs=99.6

Q ss_pred             ccCccCce-eEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          502 KLGQGGFG-PVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       502 ~lG~G~fG-~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      .+..|..+ .||+.... ++..+.+|+-..   ....++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44445555 58988765 456788887543   23457888999988874 44578899999999999999999999888


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS--------------------------------------------  614 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------------  614 (662)
                      .+....       .......++.++++.|+-||...                                            
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            776421       11233456667777777777531                                            


Q ss_pred             -----------CCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          615 -----------RLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       615 -----------~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                                 ++.++|+|+.+.|||++.++.+-|.||+.+..-.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd  225 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD  225 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence                       1237999999999999988778899999987543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=1.5e-06  Score=91.37  Aligned_cols=81  Identities=9%  Similarity=-0.013  Sum_probs=56.8

Q ss_pred             cccc-CccCceeEEEEEEc-------CCcEEEEEEccccc---cccHHHHHHHHHHHhcCC-C--CCcceeeEEEEeC--
Q 006090          500 ANKL-GQGGFGPVYKGKLQ-------DGQEIAVKRLSKAS---GQGQEEFMNEVMVISNLQ-H--RNLVRLLGCCVER--  563 (662)
Q Consensus       500 ~~~l-G~G~fG~Vykg~~~-------~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~-H--~nIv~l~g~~~~~--  563 (662)
                      .+.| +.|....+|+....       +++.+++|......   ......+.+|+.+++.+. +  ..+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999998764       25678888764322   111245778888888774 3  4578888887665  


Q ss_pred             -CeeEEEEEccCCCCHHH
Q 006090          564 -EENMLIYEYMPNKSLDS  580 (662)
Q Consensus       564 -~~~~lV~Ey~~~gsL~~  580 (662)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             34689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.93  E-value=2.6e-05  Score=83.30  Aligned_cols=75  Identities=13%  Similarity=0.160  Sum_probs=50.5

Q ss_pred             ccccCccCceeEEEEEEc-CCcEEEEEEcccccc-------ccHHHHHHHHHHHhcCC-C-C-CcceeeEEEEeCCeeEE
Q 006090          500 ANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG-------QGQEEFMNEVMVISNLQ-H-R-NLVRLLGCCVEREENML  568 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~-------~~~~~f~~E~~~l~~l~-H-~-nIv~l~g~~~~~~~~~l  568 (662)
                      .+.||.|..+.||++... +++.++||.......       .....+..|.++++.+. + + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999764 467899997643211       12345678988888773 2 3 34466654  4556789


Q ss_pred             EEEccCCC
Q 006090          569 IYEYMPNK  576 (662)
Q Consensus       569 V~Ey~~~g  576 (662)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.92  E-value=2.8e-05  Score=80.81  Aligned_cols=142  Identities=15%  Similarity=0.264  Sum_probs=81.6

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC--CCCcceeeE------EEEeCCeeEEEEEc
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ--HRNLVRLLG------CCVEREENMLIYEY  572 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g------~~~~~~~~~lV~Ey  572 (662)
                      +.|+.|....||+....++ .+++|+....    ..++..|..++..+.  .-.+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999987654 5888887641    233344555554442  123344443      12346778999999


Q ss_pred             cCCCCHH-----------H---HhcC----CC-C------CCCCCHHHHH------------------------------
Q 006090          573 MPNKSLD-----------S---FLFD----PQ-R------QSLLDWPKRF------------------------------  597 (662)
Q Consensus       573 ~~~gsL~-----------~---~l~~----~~-~------~~~l~~~~~~------------------------------  597 (662)
                      ++|..+.           .   .|+.    .. .      ...-.|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           0   1111    00 0      0112343211                              


Q ss_pred             -HHHHHHHHHHHHHHh----------CCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          598 -NIIKGISRGLLYLHR----------DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       598 -~i~~~ia~~L~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                       .+..++.+++.+|++          ..+..++|+|+++.|||++.++.+.|+||+.+..-
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence             111224456677763          12356999999999999988889999999988643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.80  E-value=0.00012  Score=74.30  Aligned_cols=79  Identities=18%  Similarity=0.233  Sum_probs=58.4

Q ss_pred             ccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-C--CCcceeeEEEEeCCeeEEEEEc
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-H--RNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .+...+.+|.|..+.||+.++.+|+.+.+|+...........|..|...|+.|. .  .-+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            344567899999999999999999999999875544444557889999888774 2  2355566542    34789999


Q ss_pred             cCCCCH
Q 006090          573 MPNKSL  578 (662)
Q Consensus       573 ~~~gsL  578 (662)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.76  E-value=0.00014  Score=74.94  Aligned_cols=138  Identities=20%  Similarity=0.157  Sum_probs=93.3

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC---CCCcceeeEEEEeCCeeEEEEEccCCC
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ---HRNLVRLLGCCVEREENMLIYEYMPNK  576 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~g  576 (662)
                      .+.|+.|....+|+.... ++.+++|+...   .....|..|.+.|+.|.   ...++++++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467899999999999864 67788887643   23567889999888873   367889999998888899999999987


Q ss_pred             CHHH--------H---hcCCCC---C----------------CCCCHHHHH---HHHH----------------HHHHHH
Q 006090          577 SLDS--------F---LFDPQR---Q----------------SLLDWPKRF---NIIK----------------GISRGL  607 (662)
Q Consensus       577 sL~~--------~---l~~~~~---~----------------~~l~~~~~~---~i~~----------------~ia~~L  607 (662)
                      .+..        .   |+....   .                -.-+|...+   ++..                .+...+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6421        1   222111   0                012565432   1111                112122


Q ss_pred             -HHHHh-CCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          608 -LYLHR-DSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       608 -~yLH~-~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                       ..|.. ..++.++|+|+.+.|+|++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             23321 2356799999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.52  E-value=0.00033  Score=75.33  Aligned_cols=73  Identities=15%  Similarity=0.214  Sum_probs=45.8

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEcccc------c-c--ccHHHHHHHHHHHh-cCCCCCcceeeEEEEeCCeeEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA------S-G--QGQEEFMNEVMVIS-NLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~------~-~--~~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      .+.||.|....||+... +++.++||.....      . .  .....+..|+..+. ...+..+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            46789999999999965 4678999943211      1 1  12233434443322 22234577777765  5677999


Q ss_pred             EEcc-CC
Q 006090          570 YEYM-PN  575 (662)
Q Consensus       570 ~Ey~-~~  575 (662)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.30  E-value=0.0011  Score=68.13  Aligned_cols=144  Identities=13%  Similarity=0.115  Sum_probs=80.9

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-C-CCcceeeEE------EEeCCeeEEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-H-RNLVRLLGC------CVEREENMLIYE  571 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H-~nIv~l~g~------~~~~~~~~lV~E  571 (662)
                      .+.|+.|....+|+....++ .+++|.....  .....+..|+.++..+. | -.+.+++..      ....+..++++|
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            35567788889999987655 6778887642  12234556777766653 1 123333321      123456789999


Q ss_pred             ccCCCCHHH-----------H---hcCC----CCC-----CCCCHHHHHH------------HHHHHHHHHHHHHhC---
Q 006090          572 YMPNKSLDS-----------F---LFDP----QRQ-----SLLDWPKRFN------------IIKGISRGLLYLHRD---  613 (662)
Q Consensus       572 y~~~gsL~~-----------~---l~~~----~~~-----~~l~~~~~~~------------i~~~ia~~L~yLH~~---  613 (662)
                      |++|..+..           .   ++..    ...     ....|...+.            +...+.+.+.++++.   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            999865321           0   1110    000     0112333111            011244556666542   


Q ss_pred             -CCCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          614 -SRLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       614 -~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                       .+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             234599999999999999876678999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.12  E-value=0.002  Score=66.69  Aligned_cols=143  Identities=16%  Similarity=0.148  Sum_probs=73.5

Q ss_pred             cccCccCcee-EEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC--CCCcceeeEEEEeCCeeEEEEEccCCCC
Q 006090          501 NKLGQGGFGP-VYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVEREENMLIYEYMPNKS  577 (662)
Q Consensus       501 ~~lG~G~fG~-Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  577 (662)
                      +.|+.|.... +|+....+++.+++|.......   ..+..|+.++..+.  .-.+.+++.+..+.  -+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            4555554443 6677654466777775433211   23345666666553  23466777764333  378999997766


Q ss_pred             HHHHhc---------------------CCCC--CCCCCHHHHH--------------------HHHHHHHHHHHHHH---
Q 006090          578 LDSFLF---------------------DPQR--QSLLDWPKRF--------------------NIIKGISRGLLYLH---  611 (662)
Q Consensus       578 L~~~l~---------------------~~~~--~~~l~~~~~~--------------------~i~~~ia~~L~yLH---  611 (662)
                      +.+.+.                     ....  ....+.....                    .....+.+.+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654331                     1100  0111111100                    00011122222221   


Q ss_pred             hCCCCceEecCCCCCcEEEcCC----CceEEEeeCcccccc
Q 006090          612 RDSRLRIIHRDLKASNILLDDD----LNPKISDFGLARIFG  648 (662)
Q Consensus       612 ~~~~~~iiHrDlkp~NILl~~~----~~~ki~DFGla~~~~  648 (662)
                      ...+..++|+|+.+.|||++.+    ..+.|.||+.+..-.
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            1223569999999999999875    689999999887543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.11  E-value=0.0005  Score=74.09  Aligned_cols=73  Identities=15%  Similarity=0.312  Sum_probs=49.6

Q ss_pred             ccccCccCceeEEEEEEcC--------CcEEEEEEccccccccHHHHHHHHHHHhcCCCCC-cceeeEEEEeCCeeEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN-LVRLLGCCVEREENMLIY  570 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~--------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~  570 (662)
                      .+.|+.|-...+|+....+        ++.+.+|+....  .....+.+|..++..+...+ ..++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4577888889999998753        467888887431  11245668998888874333 367777653  2  3899


Q ss_pred             EccCCCCH
Q 006090          571 EYMPNKSL  578 (662)
Q Consensus       571 Ey~~~gsL  578 (662)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.04  E-value=0.0038  Score=64.28  Aligned_cols=143  Identities=15%  Similarity=0.169  Sum_probs=82.5

Q ss_pred             cccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC--CCCcceeeEE-----EEeCCeeEEEEEcc
Q 006090          501 NKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ--HRNLVRLLGC-----CVEREENMLIYEYM  573 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~-----~~~~~~~~lV~Ey~  573 (662)
                      ..++ |....||+....+|+.+++|...... .....+..|..++..+.  .-.+++++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 77788999887777789999886321 23456667888777663  2234455443     22345668899999


Q ss_pred             CCCCHH-----H------H---hcC---CC---CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 006090          574 PNKSLD-----S------F---LFD---PQ---RQSLLDWPKR----FNI---------------IKGISRGLLYLHRD-  613 (662)
Q Consensus       574 ~~gsL~-----~------~---l~~---~~---~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~-  613 (662)
                      +|..+.     .      .   ++.   ..   .....++...    ..+               ...+.+.+..+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     1      0   110   00   1112232211    001               11111223333321 


Q ss_pred             ---CCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          614 ---SRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       614 ---~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                         .+..++|+|+++.|||++ + .+.|.||+.+..-
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence               234589999999999999 4 8999999887644

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.96  E-value=0.0015  Score=66.54  Aligned_cols=139  Identities=14%  Similarity=0.135  Sum_probs=75.3

Q ss_pred             ccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc-ceeeEEEEeCCeeEEEEEcc-CCCC
Q 006090          500 ANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEYM-PNKS  577 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gs  577 (662)
                      .+.|+.|....+|+.     +.+++|+....... .....+|+.+++.+...++ .+++++  +.+..++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            467888999999998     55778876542211 1123467777766632222 466654  344568999999 6544


Q ss_pred             HHHH------------------hcCCCCC--CCCCH-HHHHHHHH--------------HHHHHHH----HHHh-CCCCc
Q 006090          578 LDSF------------------LFDPQRQ--SLLDW-PKRFNIIK--------------GISRGLL----YLHR-DSRLR  617 (662)
Q Consensus       578 L~~~------------------l~~~~~~--~~l~~-~~~~~i~~--------------~ia~~L~----yLH~-~~~~~  617 (662)
                      |...                  ||.....  ...+. .....+..              .+.+.+.    .+.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4310                  1111100  00111 11111100              0111111    1111 22345


Q ss_pred             eEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          618 IIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       618 iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ++|+|+.+.||| ..++.+.|+||..|..-
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            899999999999 66678899999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.93  E-value=0.006  Score=66.12  Aligned_cols=74  Identities=14%  Similarity=0.068  Sum_probs=47.6

Q ss_pred             ccccCccCceeEEEEEEcC-CcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc-ceeeEEEEeCCeeEEEEEccCCCC
Q 006090          500 ANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEYMPNKS  577 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gs  577 (662)
                      .+.|+.|-...+|+....+ +..+++|+....... ...-.+|..++..+...++ .++++.+  .+  .+||||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence            4678888889999998864 477888876432211 1112478888888864444 5777776  22  25999998755


Q ss_pred             H
Q 006090          578 L  578 (662)
Q Consensus       578 L  578 (662)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.88  E-value=0.0024  Score=67.48  Aligned_cols=142  Identities=18%  Similarity=0.234  Sum_probs=82.9

Q ss_pred             cccCccCceeEEEEEEcC--------CcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEEE
Q 006090          501 NKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~--------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      +.|..|-...+|+....+        ++.+.+|+... .......+.+|.++++.+. +.-..++++++.+  .  +|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEE
Confidence            566667778899988642        46788887633 2234556678998888774 3223677776643  2  9999


Q ss_pred             ccCCCCHHHH-----------------hcCCC-C-CCCCC--HHHHHHHHHHHH-------------------HHHHHH-
Q 006090          572 YMPNKSLDSF-----------------LFDPQ-R-QSLLD--WPKRFNIIKGIS-------------------RGLLYL-  610 (662)
Q Consensus       572 y~~~gsL~~~-----------------l~~~~-~-~~~l~--~~~~~~i~~~ia-------------------~~L~yL-  610 (662)
                      |++|..|..-                 |+... . .....  |.+..++..++.                   +.+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655321                 11111 0 11122  344444443332                   123333 


Q ss_pred             ---HhC-CCCceEecCCCCCcEEEcCC----CceEEEeeCccccc
Q 006090          611 ---HRD-SRLRIIHRDLKASNILLDDD----LNPKISDFGLARIF  647 (662)
Q Consensus       611 ---H~~-~~~~iiHrDlkp~NILl~~~----~~~ki~DFGla~~~  647 (662)
                         ... .+..++|+|+.+.|||++.+    +.+.|+||..|..-
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence               222 23458999999999999876    78999999988743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.64  E-value=0.0018  Score=68.16  Aligned_cols=74  Identities=14%  Similarity=0.164  Sum_probs=44.0

Q ss_pred             ccccCccCceeEEEEEEcC---------CcEEEEEEccccccccHHHHHHHHHHHhcCCCCC-cceeeEEEEeCCeeEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQD---------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRN-LVRLLGCCVEREENMLI  569 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~---------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV  569 (662)
                      .+.|+.|..-.+|+....+         ++.+++|+...... .......|.+++..+...+ +.++++..  .  .++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567778888899998753         26788887654221 1112356777777774223 45676654  2  3789


Q ss_pred             EEccCCCCH
Q 006090          570 YEYMPNKSL  578 (662)
Q Consensus       570 ~Ey~~~gsL  578 (662)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.48  E-value=0.0098  Score=61.74  Aligned_cols=34  Identities=21%  Similarity=0.349  Sum_probs=29.1

Q ss_pred             CCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       615 ~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      +..++|+|+.+.|||++.++.+.|.||+.+..-.
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            3569999999999999988889999998876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.24  E-value=0.24  Score=52.83  Aligned_cols=142  Identities=15%  Similarity=0.153  Sum_probs=82.6

Q ss_pred             ccccCccCceeEEEEEEcC--------CcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~--------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .+.+..|-...+|+....+        ++.+++|+..... .....-.+|..+++.+. +.=..++++.+  .  .++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3566667788899998763        5778888764322 11122346777777764 22245666543  2  37899


Q ss_pred             EccCCCCHHHH-----------------hcC--------CC--CCCCCCHHHHHHHHHH-------------------HH
Q 006090          571 EYMPNKSLDSF-----------------LFD--------PQ--RQSLLDWPKRFNIIKG-------------------IS  604 (662)
Q Consensus       571 Ey~~~gsL~~~-----------------l~~--------~~--~~~~l~~~~~~~i~~~-------------------ia  604 (662)
                      ||++|..|..-                 ||+        ..  ...+.-|.+..+...+                   +.
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998654210                 111        00  1111124433333222                   12


Q ss_pred             HHHHHHHh---------------------CCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          605 RGLLYLHR---------------------DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       605 ~~L~yLH~---------------------~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      ..+..|.+                     ..+..++|+|+.+.||| +.++.+.|+||..|..-
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            23333321                     12345899999999999 88889999999998743

>2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M*

Probab=86.97  E-value=0.6  Score=37.03  Aligned_cols=34  Identities=18%  Similarity=0.532  Sum_probs=28.2

Q ss_pred             cccchhHHHHhhccCCCeeeEeecC-CceeEEeec
Q 006090          357 SSANEDKCKDQCSNNCSCKAYAYEI-GVGCMIWTH  390 (662)
Q Consensus       357 ~~~~~~~C~~~Cl~nCsC~a~~y~~-~~~C~~~~~  390 (662)
                      ...++++|+..|+.+=.|.+|.|+. ...|++..+
T Consensus        28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~   62 (82)
T 2ll3_A           28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG   62 (82)
T ss_dssp             ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred             cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence            3468999999999999999999984 445998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.94  E-value=0.25  Score=52.24  Aligned_cols=30  Identities=27%  Similarity=0.393  Sum_probs=25.4

Q ss_pred             eEecCCCCCcEEE------cCCCceEEEeeCccccc
Q 006090          618 IIHRDLKASNILL------DDDLNPKISDFGLARIF  647 (662)
Q Consensus       618 iiHrDlkp~NILl------~~~~~~ki~DFGla~~~  647 (662)
                      ++|+|+.+.|||+      +++..++++||-+|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            5799999999999      45678999999988743

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.19  E-value=0.17  Score=54.63  Aligned_cols=60  Identities=8%  Similarity=0.096  Sum_probs=18.5

Q ss_pred             ccccCccCceeEEEEEEcC-CcEEEE------EEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe
Q 006090          500 ANKLGQGGFGPVYKGKLQD-GQEIAV------KRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE  562 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~-~~~vAv------K~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~  562 (662)
                      .++||   ||.||+|.+.. ..+|||      |..+..  ..+....|.+|..++...+|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            46676   99999999864 367888      766542  22344578899999999999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	662
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-45
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-42
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-41
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-38
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-38
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-34
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-19
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-18
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	4e-14
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	2e-13
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	6e-13
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	1e-12
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	9e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 6e-51
 Identities = 49/168 (29%), Positives = 83/168 (49%), Gaps = 6/168 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
               +  ++G G FG VYKGK      + +  ++  + Q  + F NEV V+   +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
             +G      +  ++ ++    SL   L     ++  +  K  +I +  ++G+ YLH  S
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
              IIHRDLK++NI L +DL  KI DFGLA +          ++L G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-48
 Identities = 58/162 (35%), Positives = 85/162 (52%), Gaps = 6/162 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++  LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           RL     + E   +I EYM N SL  FL  P     L   K  ++   I+ G+ ++   +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
               IHRDL+A+NIL+ D L+ KI+DFGLAR+   N+  A  
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 5e-48
 Identities = 41/172 (23%), Positives = 73/172 (42%), Gaps = 11/172 (6%)

Query: 493 ATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQH 550
             ++F+  ++LG G  G V+K      G  +A K +        + + + E+ V+     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +V   G      E  +  E+M   SLD  L   ++   +       +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
               + +I+HRD+K SNIL++     K+ DFG++     +         VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 4e-47
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 6/166 (3%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           N  + +++  +LG G FG VYK +  +     A K +   S +  E++M E+ ++++  H
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V+LL          ++ E+    ++D+ + + +R   L   +   + K     L YL
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           H     +IIHRDLKA NIL   D + K++DFG++        +  +
Sbjct: 127 H---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-46
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 7/168 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            +     +LG G FG V  GK +   ++A+K + + S   ++EF+ E  V+ NL H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C ++    +I EYM N  L ++L + + +      +   + K +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             + +HRDL A N L++D    K+SDFGL+R    + +  ++      
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFP 164

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (416), Expect = 2e-46
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 19/191 (9%)

Query: 485 FNFEELANATNNF---------QLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKA- 530
           F FE+   A   F         ++   +G G FG V  G L    +    +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 531 SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL 590
           + + + +F++E  ++    H N++ L G   +    M+I E+M N SLDSFL     Q  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 591 LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
               +   +++GI+ G+ YL     +  +HRDL A NIL++ +L  K+SDFGL+R    +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 651 QDQAATKRLVG 661
                    +G
Sbjct: 182 TSDPTYTSALG 192

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  163 bits (414), Expect = 2e-46
 Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 6/172 (3%)

Query: 486 NFEELANATNNFQLANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKASGQGQEEFMNEVMV 544
           N+++      +  + +KLG G +G VY+G  +     +AVK L + + +  EEF+ E  V
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H NLV+LLG C       +I E+M   +L  +L +  RQ  +       +   IS
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 125

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
             + YL    +   IHRDL A N L+ ++   K++DFGL+R+  G+   A  
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-46
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 8/169 (4%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRN 552
           ++++   +G G +G   K +   DG+ +  K L   S     ++  ++EV ++  L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 553 LVRLLGCCVEREENML--IYEYMPNKSLDSFLFDPQRQS-LLDWPKRFNIIKGISRGLLY 609
           +VR     ++R    L  + EY     L S +    ++   LD      ++  ++  L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 610 LHR--DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            HR  D    ++HRDLK +N+ LD   N K+ DFGLARI   +   A  
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (413), Expect = 7e-46
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 10/164 (6%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQE---EFMNEVMVISNLQHRN 552
           F    ++G G FG VY  + +++ + +A+K++S +  Q  E   + + EV  +  L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
            ++  GC +      L+ EY    + D        +  L   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH- 132

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
                +IHRD+KA NILL +    K+ DFG A I         T
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 2e-45
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 31/204 (15%)

Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFM 539
              L    NN +    +G+G FG V++ +       +    +AVK L + AS   Q +F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 540 NEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL--------- 590
            E  +++   + N+V+LLG C   +   L++EYM    L+ FL      ++         
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 591 ------------LDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI 638
                       L   ++  I + ++ G+ YL      + +HRDL   N L+ +++  KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181

Query: 639 SDFGLARIFGGNQDQAATKRLVGT 662
           +DFGL+R         A       
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIP 205

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-45
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 7/168 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           +      ++G G FG V+ G   +  ++A+K + +     +E+F+ E  V+  L H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L G C+E+    L++E+M +  L  +L    ++ L        +   +  G+ YL    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLE--- 118

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
              +IHRDL A N L+ ++   K+SDFG+ R    +Q   ++      
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-44
 Identities = 54/162 (33%), Positives = 84/162 (51%), Gaps = 6/162 (3%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +L  KLGQG FG V+ G       +A+K L   +    E F+ E  V+  L+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
           +L       E   ++ EYM   SL  FL   +    L  P+  ++   I+ G+ Y+ R  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            +  +HRDL+A+NIL+ ++L  K++DFGLAR+   N+  A  
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-44
 Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 8/170 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRN 552
            ++ L   LG+G +G V         + +AVK +         E    E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+  G   E     L  EY     L   +   +    +  P        +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
              + I HRD+K  N+LLD+  N KISDFGLA +F  N  +    ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 8/161 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
              +L   +G+G FG V  G    G ++AVK +        + F+ E  V++ L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63

Query: 555 RLLGCCVEREENM-LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +LLG  VE +  + ++ EYM   SL  +L   + +S+L           +   + YL  +
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 614 SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA 654
                +HRDL A N+L+ +D   K+SDFGL +     QD  
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 5e-44
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 12/181 (6%)

Query: 488 EELANATNNFQLAN-KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKASGQGQ-EEFMNEV 542
           ++L    +N  +A+ +LG G FG V +G  +      ++A+K L + + +   EE M E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 543 MVISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKG 602
            ++  L +  +VRL+G C + E  ML+ E      L  FL   + +  +       ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ-AATKRLVG 661
           +S G+ YL        +HRDL A N+LL +    KISDFGL++  G +     A      
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 662 T 662
            
Sbjct: 175 P 175

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-43
 Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 17/179 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
               L   +G+G FG V++GK   G+E+AVK  S    +       E+     L+H N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENIL 60

Query: 555 RLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             +    +         L+ +Y  + SL  +L     +  +       +    + GL +L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116

Query: 611 HRD-----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD--QAATKRLVGT 662
           H +      +  I HRDLK+ NIL+  +    I+D GLA       D    A    VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 7e-43
 Identities = 52/191 (27%), Positives = 74/191 (38%), Gaps = 26/191 (13%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSKASGQGQ-EEFMNEVMVISN 547
           N       LG G FG V +              +AVK L  ++   + E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL---------------L 591
           L  H N+V LLG C      ++I EY     L +FL   +   +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
           D     +    +++G+ +L        IHRDL A NILL      KI DFGLAR    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 652 DQAATKRLVGT 662
           +          
Sbjct: 200 NYVVKGNARLP 210

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-42
 Identities = 46/196 (23%), Positives = 76/196 (38%), Gaps = 31/196 (15%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQD------GQEIAVKRLSKASGQGQ-EEFMNEVMVISN 547
            N +    LG G FG V               ++AVK L + +   + E  M+E+ +++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 548 L-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQ------------------ 588
           L  H N+V LLG C       LI+EY     L ++L   + +                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 589 --SLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
             ++L +         +++G+ +L        +HRDL A N+L+      KI DFGLAR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 647 FGGNQDQAATKRLVGT 662
              + +          
Sbjct: 214 IMSDSNYVVRGNARLP 229

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-42
 Identities = 53/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQH 550
            +F++   LG+G FG VY  +  Q    +A+K L KA       + +   EV + S+L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N++RL G   +     LI EY P  ++   L   Q+ S  D  +    I  ++  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H     R+IHRD+K  N+LL      KI+DFG +     ++       L GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 7e-42
 Identities = 45/172 (26%), Positives = 85/172 (49%), Gaps = 10/172 (5%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH 550
           +    +    K+GQG  G VY    +  GQE+A+++++      +E  +NE++V+   ++
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            N+V  L   +  +E  ++ EY+   SL   + +       D  +   + +   + L +L
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFL 132

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H     ++IHRD+K+ NILL  D + K++DFG         +Q+    +VGT
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGT 179

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-41
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 13/168 (7%)

Query: 501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKASGQGQ--EEFMNEVMVISNLQHRNLVR 555
            +LG G FG V KG  Q     + +AVK L   +      +E + E  V+  L +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 556 LLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSR 615
           ++G C E E  ML+ E      L+ +L   +    +       ++  +S G+ YL     
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 616 LRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQA-ATKRLVGT 662
              +HRDL A N+LL      KISDFGL++    +++   A       
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 5e-41
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 16/174 (9%)

Query: 497 FQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRNL 553
            +   ++G+G F  VYKG   +   E+A   L     +   ++ F  E  ++  LQH N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 554 VRLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           VR         +     +L+ E M + +L ++L   +R  ++      +  + I +GL +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQF 127

Query: 610 LHRDSRLRIIHRDLKASNILLDD-DLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH  +   IIHRDLK  NI +     + KI D GLA +   +      K ++GT
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 176

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 9e-41
 Identities = 55/175 (31%), Positives = 76/175 (43%), Gaps = 13/175 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSK---ASGQGQEEFMNEVMVISN 547
            + +L  KLG G FG V +G+          +AVK L     +  +  ++F+ EV  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           L HRNL+RL G  +      ++ E  P  SL   L   Q   LL    R      ++ G+
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            YL      R IHRDL A N+LL      KI DFGL R    N D    +     
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-40
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 24/186 (12%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDG---QEIAVKRLSK-ASGQGQEEFMNEVMVISNL-Q 549
           N+ +  + +G+G FG V K +++      + A+KR+ + AS     +F  E+ V+  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFL-------------FDPQRQSLLDWPKR 596
           H N++ LLG C  R    L  EY P+ +L  FL                   S L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 597 FNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
            +    ++RG+ YL +    + IHRDL A NIL+ ++   KI+DFGL+R   G +     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 657 KRLVGT 662
                 
Sbjct: 184 TMGRLP 189

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 8/167 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           +++ +  +LG G FG V++      G   A K +       +E    E+  +S L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           V L     +  E ++IYE+M    L   + D   +  +   +    ++ + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141

Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQDQAATKR 658
                +H DLK  NI+     +   K+ DFGL       Q    T  
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-39
 Identities = 50/170 (29%), Positives = 70/170 (41%), Gaps = 10/170 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHR 551
           +F+    LG+G F  V   + L   +E A+K L K              E  V+S L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
             V+L     + E+      Y  N  L  ++         D          I   L YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
                 IIHRDLK  NILL++D++ +I+DFG A++      QA     VG
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-39
 Identities = 50/172 (29%), Positives = 89/172 (51%), Gaps = 12/172 (6%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQE----IAVKRLSKA-SGQGQEEFMNEVMVISNLQH 550
           F+    LG G FG VYKG  + +G++    +A+K L +A S +  +E ++E  V++++ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
            ++ RLLG C+      LI + MP   L  +    + +  +      N    I++G+ YL
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
                 R++HRDL A N+L+    + KI+DFGLA++ G  + +   +     
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  145 bits (367), Expect = 4e-39
 Identities = 36/160 (22%), Positives = 69/160 (43%), Gaps = 8/160 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           + + +  +LG G FG V++      G+    K ++      +    NE+ +++ L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           + L     ++ E +LI E++    L   +        +   +  N ++    GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 614 SRLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQ 651
               I+H D+K  NI+ +       KI DFGLA     ++
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-38
 Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 5/167 (2%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ-EEFMNEVMVISNLQ 549
           +    +   + +G+G +G V       +   +A+K++S    Q   +  + E+ ++   +
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H N++ +           +   Y+    + + L+   +   L        +  I RGL Y
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           +H      ++HRDLK SN+LL+   + KI DFGLAR+   + D    
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 18/192 (9%)

Query: 475 NPARLQDL--LVFNFEELANATNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLS 528
           NP  +Q +  +V     L     +F     +G+G FG VY G L D        AVK L+
Sbjct: 10  NPELVQAVQHVVIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64

Query: 529 KASGQGQ-EEFMNEVMVISNLQHRNLVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQ 586
           + +  G+  +F+ E +++ +  H N++ LLG C+  E + +++  YM +  L +F+ +  
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124

Query: 587 RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARI 646
               +     F +          +   +  + +HRDL A N +LD+    K++DFGLAR 
Sbjct: 125 HNPTVKDLIGFGLQVAK-----GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179

Query: 647 FGGNQDQAATKR 658
               +  +   +
Sbjct: 180 MYDKEFDSVHNK 191

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  142 bits (360), Expect = 4e-38
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 13/164 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA---SGQGQEEFMNEVMVIS---N 547
           N+F +   +G+GGFG VY  +    G+  A+K L K      QG+   +NE +++S    
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
                +V +       ++   I + M    L   L    +  +            I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
            ++H      +++RDLK +NILLD+  + +ISD GLA  F   +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 5e-38
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVISN 547
               ++ +LGQG FG VY+G        +    +A+K +++ AS + + EF+NE  V+  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 548 LQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-------LDWPKRFNII 600
               ++VRLLG   + +  ++I E M    L S+L   +               K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 601 KGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
             I+ G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R            + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 661 GT 662
             
Sbjct: 197 LP 198

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 6e-38
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 11/168 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQE-----IAVKRLSKASGQGQ-EEFMNEVMVISNL 548
           +       +G G FG VYKG L+         +A+K L     + Q  +F+ E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 549 QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
            H N++RL G   + +  M+I EYM N +LD FL +   +      +   +++GI+ G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124

Query: 609 YLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
           YL     +  +HRDL A NIL++ +L  K+SDFGL+R+   + +   T
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-38
 Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 25/190 (13%)

Query: 495 NNFQLANKLGQGGFGPVYKG------KLQDGQEIAVKRLSKASGQG-QEEFMNEVMVIS- 546
           +  +L   LG+G FG V +       K    + +AVK L + +        M+E+ ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 547 NLQHRNLVRLLGCCVEREEN-MLIYEYMPNKSLDSFLFDPQRQSL-------------LD 592
              H N+V LLG C +     M+I E+    +L ++L   + + +             L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 593 WPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD 652
                     +++G+ +L      + IHRDL A NILL +    KI DFGLAR    + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 653 QAATKRLVGT 662
                     
Sbjct: 190 YVRKGDARLP 199

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 8e-38
 Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 12/173 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKASGQG-QEEFMNEVMVISNLQ 549
              +L   +G+G FG V++G           +A+K     +    +E+F+ E + +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H ++V+L+G   E     +I E      L SF     R+  LD          +S  L Y
Sbjct: 67  HPHIVKLIGVITENPV-WIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAY 123

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           L      R +HRD+ A N+L+  +   K+ DFGL+R    +    A+ +    
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLP 172

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 20/178 (11%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASG---------QGQEEFMNEVMVI 545
           N++    LG+G    V +       +E AVK +    G         + +E  + EV ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 546 SNLQ-HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
             +  H N+++L           L+++ M    L  +L     +  L   +   I++ + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
             +  LH+   L I+HRDLK  NILLDDD+N K++DFG +      +     + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  133 bits (334), Expect = 2e-35
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 8/164 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQGQEEFMNEVMVISNLQHRN 552
             +    K+G+G +G VYK +   G+  A+K  RL K         + E+ ++  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+L      ++  +L++E++                 L+     + +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH- 117

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
               R++HRDLK  N+L++ +   KI+DFGLAR FG    +   
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-35
 Identities = 35/160 (21%), Positives = 69/160 (43%), Gaps = 9/160 (5%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
            + +A  LG+G FG V++       +    K + K  G  Q     E+ +++  +HRN++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            L       EE ++I+E++    +   +     +  L+  +  + +  +   L +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH--- 119

Query: 615 RLRIIHRDLKASNILLDDDLNP--KISDFGLARIFGGNQD 652
              I H D++  NI+     +   KI +FG AR      +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  132 bits (334), Expect = 5e-35
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 10/161 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
            +FQ+   LG G FG V+  +   +G+  A+K L K      +  E   +E +++S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             ++R+ G   + ++  +I +Y+    L S L   QR            +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
                  II+RDLK  NILLD + + KI+DFG A+      
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-34
 Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 26/191 (13%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL--------QDGQEIAVKRLSK-ASGQGQEEFMNEVMVI 545
           +   L   LG+G FG V   +             ++AVK L   A+ +   + ++E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 546 SNL-QHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSL-------------L 591
             + +H+N++ LLG C +     +I EY    +L  +L   +   L             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 592 DWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
                 +    ++RG+ YL      + IHRDL A N+L+ +D   KI+DFGLAR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 652 DQAATKRLVGT 662
               T      
Sbjct: 190 YYKKTTNGRLP 200

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (331), Expect = 1e-34
 Identities = 42/181 (23%), Positives = 77/181 (42%), Gaps = 14/181 (7%)

Query: 487 FEELANATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-FMNEVMV 544
           +++  +  + +   + LG G F  V   +  +  + +A+K ++K + +G+E    NE+ V
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  ++H N+V L           LI + +    L   +     +          +I  + 
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILL---DDDLNPKISDFGLARIFGGNQDQAATKRLVG 661
             + YLH      I+HRDLK  N+L    D+D    ISDFGL+++              G
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171

Query: 662 T 662
           T
Sbjct: 172 T 172

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-34
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 15/166 (9%)

Query: 496 NFQLANKLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLV 554
           ++     +G G FG VY+ KL   G+ +A+K++ +     +     E+ ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIV 76

Query: 555 RLLGCCVEREENM------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLL 608
           RL        E        L+ +Y+P           + +  L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 609 YLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGLARIFGGNQDQ 653
           Y+H      I HRD+K  N+LLD D    K+ DFG A+     +  
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 39/178 (21%), Positives = 74/178 (41%), Gaps = 15/178 (8%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQ---EEFMNEVMVISNLQ 549
           ++ ++L   LG GG   V+  + L+  +++AVK L     +       F  E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 550 HRNLVRLLGCCVEREEN----MLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           H  +V +               ++ EY+   +L   +        +   +   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAA-TKRLVGT 662
            L + H+     IIHRD+K +NI++      K+ DFG+AR    + +    T  ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 9e-33
 Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 13/173 (7%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNEVMVIS-NLQ 549
            +F L   LG+G FG V+  +  +  Q  A+K L K      ++    M E  V+S   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 550 HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
           H  L  +      +E    + EY+    L   +    +    D  +       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           LH      I++RDLK  NILLD D + KI+DFG+ +       +  T    GT
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-32
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 8/164 (4%)

Query: 496 NFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHRN 552
           NFQ   K+G+G +G VYK +    G+ +A+K++     +       + E+ ++  L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 553 LVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR 612
           +V+LL       +  L++E++          D    + +  P   + +  + +GL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 613 DSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAAT 656
               R++HRDLK  N+L++ +   K++DFGLAR FG        
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 4e-32
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 14/168 (8%)

Query: 501 NKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE-----FMNEVMVISNLQHRNLV 554
           + LG+G F  VYK +     Q +A+K++        ++      + E+ ++  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 555 RLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS 614
            LL     +    L++++M                +L        +    +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 615 RLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
              I+HRDLK +N+LLD++   K++DFGLA+ FG      A    V T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVT 163

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 7e-32
 Identities = 42/181 (23%), Positives = 87/181 (48%), Gaps = 19/181 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNLQHR 551
           + ++   K+GQG FG V+K +  + GQ++A+K++   + +       + E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 552 NLVRLLGCCVEREENM--------LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGI 603
           N+V L+  C  +            L++++  +           +       +   +++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126

Query: 604 SRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKR--LVG 661
              L  L+   R +I+HRD+KA+N+L+  D   K++DFGLAR F   ++    +    V 
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 662 T 662
           T
Sbjct: 184 T 184

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 7e-31
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 16/180 (8%)

Query: 493 ATNNFQLANKLGQGGFGPVYKGK--LQDGQEIAVKRLSKASGQG--QEEFMNEVMVISNL 548
           A   ++   ++G+G +G V+K +     G+ +A+KR+   +G+       + EV V+ +L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 549 ---QHRNLVRLLGCCVEREENMLIYEYMPNKSLDS---FLFDPQRQSLLDWPKRFNIIKG 602
              +H N+VRL   C     +      +  + +D       D   +  +      +++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           + RGL +LH     R++HRDLK  NIL+      K++DFGLARI+           +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 8e-31
 Identities = 49/172 (28%), Positives = 73/172 (42%), Gaps = 12/172 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE---FMNEVMVISNLQH 550
           N+F     LG+G FG V   +    G+  A+K L K     ++E    + E  V+ N +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             L  L       +    + EY     L   L    R+ +    +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           H      +++RD+K  N++LD D + KI+DFGL +   G  D A  K   GT
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 168

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 8e-30
 Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 9/162 (5%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
             ++   K+G+G +G V+K K  +  + +A+KR+             + E+ ++  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 552 NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH 611
           N+VRL       ++  L++E+        F          D     + +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 612 RDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
                 ++HRDLK  N+L++ +   K+++FGLAR FG     
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (295), Expect = 1e-29
 Identities = 43/161 (26%), Positives = 65/161 (40%), Gaps = 10/161 (6%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK---ASGQGQEEFMNEVMVISNLQH 550
           + F     LG G FG V   K  + G   A+K L K      +  E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 551 RNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
             LV+L     +     ++ EY+    + S L    R      P        I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ 651
           H    L +I+RDLK  N+L+D     +++DFG A+   G  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 39/178 (21%), Positives = 66/178 (37%), Gaps = 19/178 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEE------FMNEVMVISN 547
           + +Q+   LG GGFG VY G  + D   +A+K + K       E         EV+++  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 548 LQ--HRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +      ++RLL      +  +LI E                +  L      +    +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
            + + H      ++HRD+K  NIL+D +    K+ DFG   +              GT
Sbjct: 122 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGT 172

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  116 bits (290), Expect = 2e-29
 Identities = 30/179 (16%), Positives = 69/179 (38%), Gaps = 18/179 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
            ++++  ++G+G FG +++G  L + Q++A+K   + S     +  +E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTG 62

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +  +    +   + ++   +   SL+  L    R             K +   +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH-- 118

Query: 614 SRLRIIHRDLKASNILLDDDLNP-----KISDFGLARIF-----GGNQDQAATKRLVGT 662
               +++RD+K  N L+    +       + DFG+ + +       +      K L GT
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 4e-29
 Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 20/182 (10%)

Query: 492 NATNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKAS------GQGQEEFMNEVMV 544
           N  + +    +LG G F  V K +    G + A K + K        G  +E+   EV +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 545 ISNLQHRNLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           +  +QH N++ L      + + +LI E +    L  FL + +    L   +    +K I 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNP----KISDFGLARIFGGNQDQAATKRLV 660
            G+ YLH    L+I H DLK  NI+L D   P    KI DFGLA       +    K + 
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177

Query: 661 GT 662
           GT
Sbjct: 178 GT 179

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 1e-28
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 7/160 (4%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSK--ASGQGQEEFMNEVMVISNLQHR 551
             ++    +G G +G V      + G ++A+K+L +   S    +    E+ ++ +++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 552 NLVRLLGCCVEREENMLIYE-YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           N++ LL      E      + Y+    + + L    +   L   +   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 611 HRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN 650
           H      IIHRDLK  N+ +++D   KI DFGLAR     
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (280), Expect = 6e-28
 Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 16/177 (9%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL 553
           N ++L  K+G G FG +Y G  +  G+E+A+K     +     +   E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVG 64

Query: 554 VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD 613
           +  +  C    +  ++   +   SL+       R+          +   +   + Y+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120

Query: 614 SRLRIIHRDLKASNIL---LDDDLNPKISDFGLARIFGGNQDQA-----ATKRLVGT 662
                IHRD+K  N L           I DFGLA+ +   +          K L GT
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 7e-28
 Identities = 36/169 (21%), Positives = 71/169 (42%), Gaps = 19/169 (11%)

Query: 495 NNFQLANK-LGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHR 551
           +++++ ++ LG G  G V +    +  ++ A+K L         +   EV +     Q  
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65

Query: 552 NLVRLLGCC----VEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGL 607
           ++VR++         R+  +++ E +    L S + D +        +   I+K I   +
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAI 124

Query: 608 LYLHRDSRLRIIHRDLKASNILLDDDLNP---KISDFGLARIFGGNQDQ 653
            YLH    + I HRD+K  N+L          K++DFG A+    +   
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-27
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 15/168 (8%)

Query: 495 NNFQLANKLGQGGFGPVYKGKL----QDGQEIAVKRLSKAS----GQGQEEFMNEVMVIS 546
            NF+L   LG G +G V+  +       G+  A+K L KA+     +  E    E  V+ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 547 NLQHR-NLVRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           +++    LV L        +  LI +Y+    L + L   +R +  +       I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ 653
            +L L    +L II+RD+K  NILLD + +  ++DFGL++ F  ++ +
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  111 bits (278), Expect = 2e-27
 Identities = 39/164 (23%), Positives = 81/164 (49%), Gaps = 17/164 (10%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRN 552
           +++QL  KLG+G +  V++   + + +++ VK L       +++   E+ ++ NL+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 553 LVRLLGCCVEREENM--LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYL 610
           ++ L     +       L++E++ N            Q+L D+  RF  +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDYC 145

Query: 611 HRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGGNQDQ 653
           H    + I+HRD+K  N+++D +    ++ D+GLA  +   Q+ 
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  101 bits (253), Expect = 2e-25
 Identities = 32/176 (18%), Positives = 62/176 (35%), Gaps = 28/176 (15%)

Query: 499 LANKLGQGGFGPVYKGKLQDGQEIAVK--RLSKASGQ--------GQEEFMNEVMVISNL 548
           +   +G+G    V+    +   E  VK  ++   S +        G   F    +  +  
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 549 QHRNLVRLLGCCVER----EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGIS 604
           + R L +L G  V +    E N ++ E +  K L     +   +          ++  I 
Sbjct: 64  EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE----------VLDMIL 113

Query: 605 RGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLV 660
             +   +      I+H DL   N+L+ ++    I DF  +   G    +   +R V
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDV 165

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-25
 Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 21/177 (11%)

Query: 495 NNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHR 551
             +Q    +G G  G V         + +A+K+LS+   +    +    E++++  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 552 NLVRLLGCCV------EREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISR 605
           N++ LL          E ++  L+ E M          +       D  +   ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130

Query: 606 GLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT 662
           G+ +LH      IIHRDLK SNI++  D   KI DFGLAR  G +         V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVT 181

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 8e-25
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 7/159 (4%)

Query: 494 TNNFQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQH 550
              +Q  + +G G +G V      + G  +AVK+LS+   S    +    E+ ++ +++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 551 RNLVRLLGCCVEREENMLI-YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLY 609
            N++ LL               Y+    + + L +  +   L       +I  I RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 610 LHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG 648
           +H      IIHRDLK SN+ +++D   KI DFGLAR   
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.8 bits (216), Expect = 3e-19
 Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 23/182 (12%)

Query: 497 FQLANKLGQGGFGPVYKGK-LQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-- 553
           + L  KLG G F  V+  K + +   +A+K +        E   +E+ ++  +   +   
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73

Query: 554 ---------VRLLGCCVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRF--NIIKG 602
                    ++LL     +  N +    +     ++ L   ++      P  +   I K 
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 603 ISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP------KISDFGLARIFGGNQDQAAT 656
           +  GL Y+HR  R  IIH D+K  N+L++   +P      KI+D G A  +  +   +  
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 657 KR 658
            R
Sbjct: 192 TR 193

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 78.1 bits (192), Expect = 4e-18
 Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 14/115 (12%)

Query: 36  PESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTI 95
               + +G    +  +       +  + ++ +       T VW +N             +
Sbjct: 6   NGEGLYAGQSLDVEPYHF-IMQEDCNLVLYDHS------TSVWASNTGILGKKGCKA-VL 57

Query: 96  SEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSF 150
             DGN VV + + +  W+S+      N N    L + GN+V++ +     IW + 
Sbjct: 58  QSDGNFVVYDAEGRSLWASHSVR--GNGNYVLVLQEDGNVVIYGS----DIWSTG 106

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 67.3 bits (164), Expect = 4e-14
 Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 12/105 (11%)

Query: 54  DGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWS 113
           +GN       I Y+     N       +  + L  S    ++  D NLV+ +   +V WS
Sbjct: 8   NGNS------ILYST--QGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRV-WS 58

Query: 114 SNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFY 158
           +N +     +  RA L  +G + +  N   +++W S    +   Y
Sbjct: 59  TNTAG--KGTGCRAVLQPNGRMDVLTN-QNIAVWTSGNSRSAGRY 100

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 65.0 bits (158), Expect = 2e-13
 Identities = 20/136 (14%), Positives = 45/136 (33%), Gaps = 24/136 (17%)

Query: 14  FYSDFGTATATDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSAN 73
            +S          + +++ +     I+     ++    + D N       + Y+     N
Sbjct: 4   IFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQT-DCNL------VLYD-----N 47

Query: 74  KTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSG 133
              +W  N             +  DG LVV+  +    W S V+      +    L    
Sbjct: 48  NNPIWATNTGGLGNGC--RAVLQPDGVLVVITNENVTVWQSPVAG--KAGHYVLVLQPDR 103

Query: 134 NLVLHDNISQVSIWDS 149
           N+V++ +    ++W +
Sbjct: 104 NVVIYGD----ALWAT 115

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 63.4 bits (154), Expect = 6e-13
 Identities = 24/96 (25%), Positives = 38/96 (39%), Gaps = 7/96 (7%)

Query: 64  IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNS 123
           I +    S   +     +  + L  SS  FT+  D NLV+ +   +V W+SN +     +
Sbjct: 3   ILFGL--SHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRV-WASNTA---GAT 56

Query: 124 NTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYS 159
             RA L   G LV+         W S  + +   Y 
Sbjct: 57  GCRAVLQSDGLLVILTA-QNTIRWSSGTKGSIGNYV 91

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 62.3 bits (151), Expect = 1e-12
 Identities = 24/126 (19%), Positives = 38/126 (30%), Gaps = 22/126 (17%)

Query: 25  DTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNK 84
           + + S + +   E +      F       D N                    +W  N   
Sbjct: 2   NILYSGETLSTGEFLNYG--SFVFIMQE-DCNLVLYD-----------VDKPIWATNTGG 47

Query: 85  PLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQV 144
                S   ++  DGNLVV N   +  W+SN      N N    L    N+V++      
Sbjct: 48  L--SRSCFLSMQTDGNLVVYNPSNKPIWASNTGG--QNGNYVCILQKDRNVVIYGT---- 99

Query: 145 SIWDSF 150
             W + 
Sbjct: 100 DRWATG 105

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 54.4 bits (130), Expect = 9e-10
 Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 20/132 (15%)

Query: 24  TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRN 83
           +D + S   +    S+      +     + D N       + Y+     N   VW +  N
Sbjct: 1   SDRLNSGHQLDTGGSLAEG--GYLFIIQN-DCNL------VLYD-----NNRAVWASGTN 46

Query: 84  KPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQ 143
                   +  +  DGNLV+ +G + +  S+       N N    L    N+V++DN S 
Sbjct: 47  GKASGC--VLKMQNDGNLVIYSGSRAIWASNTNRQ---NGNYYLILQRDRNVVIYDN-SN 100

Query: 144 VSIWDSFQEPTD 155
            +IW +     +
Sbjct: 101 NAIWATHTNVGN 112

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	662
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.98
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.98
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.95
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.95
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.95
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.95
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.95
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.94
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.94
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.93
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.92
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.91
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.85
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.84
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.84
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.83
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.67
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.65
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.59
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.47
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.24
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.03
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.0
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.99
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.82
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.03
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.43
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.61
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.98
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	88.8
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	81.68

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-33  Score=281.96  Aligned_cols=162  Identities=30%  Similarity=0.450  Sum_probs=140.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||++.... ....+.|.+|++++++++|||||++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999975 68999999986532 23456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      +++|+|.++|..   ...+++.++..++.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.+..+..
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999943   346899999999999999999999998   99999999999999999999999999999866544


Q ss_pred             cccccccccC
Q 006090          653 QAATKRLVGT  662 (662)
Q Consensus       653 ~~~~~~~~Gt  662 (662)
                      .......+||
T Consensus       159 ~~~~~~~~GT  168 (271)
T d1nvra_         159 ERLLNKMCGT  168 (271)
T ss_dssp             ECCBCCCCSC
T ss_pred             cccccceeeC
Confidence            4444556776

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-33  Score=287.08  Aligned_cols=158  Identities=31%  Similarity=0.528  Sum_probs=141.1

Q ss_pred             HHhhccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          490 LANATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       490 l~~~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++...++|++.++||+|+||+||+|++. +++.||||+++. .....++|.+|+++|++++|||||+++|+|.+++..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC-ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3344578999999999999999999986 588999999975 34556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.++|.+. ....+++..++.|+.|||+||.|||+++   |+||||||+||||++++.+||+|||+|+.+.
T Consensus        91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999998543 3356899999999999999999999988   9999999999999999999999999999886


Q ss_pred             CCcc
Q 006090          649 GNQD  652 (662)
Q Consensus       649 ~~~~  652 (662)
                      .+..
T Consensus       167 ~~~~  170 (287)
T d1opja_         167 GDTY  170 (287)
T ss_dssp             SSSS
T ss_pred             CCCc
Confidence            6543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.9e-33  Score=281.07  Aligned_cols=153  Identities=37%  Similarity=0.620  Sum_probs=136.2

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ..++|++.++||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|++. ++..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence            34678899999999999999999988899999999753 455678999999999999999999999875 4567999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      +++|+|.+++... ....++|.+++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.+....
T Consensus        89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999988542 2235899999999999999999999987   9999999999999999999999999999986654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.1e-32  Score=278.57  Aligned_cols=151  Identities=29%  Similarity=0.572  Sum_probs=131.7

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|++.++||+|+||+||+|++.+++.||||+++. .....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            56888999999999999999998889999999976 34556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      +|+|.+++...  ...+++..++.|+.|||+||.|||+++   |+||||||+||||++++.+||+|||+|+.+....
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99999998643  346899999999999999999999988   9999999999999999999999999999886543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5e-32  Score=277.53  Aligned_cols=159  Identities=28%  Similarity=0.489  Sum_probs=141.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999964 68999999997655566778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCccc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQDQ  653 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~  653 (662)
                      ++|+|.+++.+    ..+++.++..++.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+.+..+...
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999998843    35899999999999999999999998   999999999999999999999999999988654432


Q ss_pred             ccccccccC
Q 006090          654 AATKRLVGT  662 (662)
Q Consensus       654 ~~~~~~~Gt  662 (662)
                        ....+||
T Consensus       173 --~~~~~gt  179 (293)
T d1yhwa1         173 --RSTMVGT  179 (293)
T ss_dssp             --BCCCCSC
T ss_pred             --ccccccC
Confidence              2234565

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.6e-33  Score=281.16  Aligned_cols=162  Identities=33%  Similarity=0.541  Sum_probs=132.5

Q ss_pred             hccccccccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ..++|.+.++||+|+||+||+|+++  ..||||+++..  .....++|.+|++++++++|||||+++|++. .+..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence            3467888999999999999999875  46999998643  3455678999999999999999999999875 45689999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.++|...  ...+++.+++.|+.|||+||+|||+++   ||||||||+||||++++.+||+|||+|+.....
T Consensus        83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            999999999999643  345899999999999999999999987   999999999999999999999999999988665


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      .......++.||
T Consensus       158 ~~~~~~~~~~gt  169 (276)
T d1uwha_         158 SGSHQFEQLSGS  169 (276)
T ss_dssp             --------CCCC
T ss_pred             CCcccccccccC
Confidence            444344445555

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.2e-32  Score=277.67  Aligned_cols=150  Identities=29%  Similarity=0.462  Sum_probs=137.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      +.|++.++||+|+||+||+|+.. +++.||||++........+.|.+|+++|++++|||||++++++.+++..+|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56888999999999999999975 68899999997766667788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ++|+|.+++.+.  ...+++.++..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999997432  345899999999999999999999998   99999999999999999999999999987754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-31  Score=269.08  Aligned_cols=151  Identities=31%  Similarity=0.562  Sum_probs=137.9

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMP  574 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  574 (662)
                      ++|++.++||+|+||+||+|++++++.||||+++.. ....++|++|+.++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            578889999999999999999988889999999763 4456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          575 NKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       575 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      +|+|.+++...  ...+++..+.+++.|||+||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            99999997543  345899999999999999999999987   9999999999999999999999999999876543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1e-31  Score=276.41  Aligned_cols=152  Identities=32%  Similarity=0.585  Sum_probs=126.5

Q ss_pred             cccccccccCccCceeEEEEEEcC-C---cEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-G---QEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~---~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.++||+|+||+||+|++.. +   ..||||++... .....++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            567788999999999999999752 2   25899988653 334567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||||++|+|.+++...  ...++|.+++.++.|||+||.|||+++   |+||||||+||||++++.+||+|||+|+.+..
T Consensus       106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999988543  345899999999999999999999987   99999999999999999999999999998865


Q ss_pred             Cc
Q 006090          650 NQ  651 (662)
Q Consensus       650 ~~  651 (662)
                      ..
T Consensus       181 ~~  182 (299)
T d1jpaa_         181 DT  182 (299)
T ss_dssp             --
T ss_pred             CC
Confidence            44

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=274.20  Aligned_cols=162  Identities=31%  Similarity=0.427  Sum_probs=137.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 6899999998642   2345578999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999999998765


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      .........+||
T Consensus       162 ~~~~~~~~~~GT  173 (288)
T d1uu3a_         162 SKQARANSFVGT  173 (288)
T ss_dssp             --------CCCC
T ss_pred             CcccccccccCC
Confidence            444444445676

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-31  Score=269.37  Aligned_cols=151  Identities=31%  Similarity=0.464  Sum_probs=136.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+.   .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999975 6889999998642   2334678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.++|.+   ...+++..+..++.||++||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999943   345899999999999999999999988   999999999999999999999999999887654


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      .
T Consensus       160 ~  160 (263)
T d2j4za1         160 R  160 (263)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.2e-32  Score=282.52  Aligned_cols=152  Identities=25%  Similarity=0.347  Sum_probs=136.3

Q ss_pred             hccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ..++|++.++||+|+||+||+|+.. +++.||+|+++... ......+.+|+.+|++++|||||++++++.+++..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999975 68999999986542 334568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRD-SRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++.+   ...+++..+..++.||++||.|||++ +   |+||||||+||||++++.+||+|||+|+.+.+
T Consensus        84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999953   34589999999999999999999974 6   99999999999999999999999999998754


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       158 ~  158 (322)
T d1s9ja_         158 S  158 (322)
T ss_dssp             H
T ss_pred             C
Confidence            3

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=271.92  Aligned_cols=152  Identities=35%  Similarity=0.601  Sum_probs=132.4

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++|++.+.||+|+||+||+|++++++.||||+++. .....+.|.+|+.++++++|||||+++|+|. .+..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            367899999999999999999998888999999975 4456688999999999999999999999985 45689999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ++|+|..++... ....++|.+++.|+.|||+||+|||+++   |+||||||+||||++++.+||+|||+|+.+.+..
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999998542 2345899999999999999999999988   9999999999999999999999999999886544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-30  Score=266.33  Aligned_cols=152  Identities=32%  Similarity=0.587  Sum_probs=131.8

Q ss_pred             cccccccc-ccCccCceeEEEEEEc---CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLAN-KLGQGGFGPVYKGKLQ---DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~-~lG~G~fG~Vykg~~~---~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|.+.+ +||+|+||+||+|.++   ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..+|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            35666677 4999999999999864   34579999997543 3346789999999999999999999999864 56799


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++...  ...+++.++..|+.|||+||+|||+++   |+||||||+||||++++.+||+|||+|+.+.
T Consensus        86 vmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            99999999999998442  345899999999999999999999987   9999999999999999999999999999886


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       161 ~~~  163 (285)
T d1u59a_         161 ADD  163 (285)
T ss_dssp             TCS
T ss_pred             ccc
Confidence            643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.7e-31  Score=273.74  Aligned_cols=167  Identities=28%  Similarity=0.461  Sum_probs=137.9

Q ss_pred             hccccccccccCccCceeEEEEEEcC-C-----cEEEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQD-G-----QEIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~-~-----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~  564 (662)
                      ..++|++.++||+|+||+||+|+... +     ..||||.+... .......|.+|+.+|.++ +|||||+++|++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44789999999999999999998753 2     26999988643 334567899999999998 8999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQR--------------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK  624 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk  624 (662)
                      ..++||||+++|+|.++|.....                    ...+++..++.|+.||++||+|||+++   |||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            99999999999999999965321                    235899999999999999999999988   9999999


Q ss_pred             CCcEEEcCCCceEEEeeCccccccCCcccccccccccC
Q 006090          625 ASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       625 p~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      |+|||++.++.+||+|||+|+............+..||
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  229 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP  229 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence            99999999999999999999988665544333334444

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=1.6e-30  Score=272.97  Aligned_cols=152  Identities=26%  Similarity=0.447  Sum_probs=137.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999975 68999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD--DLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~ki~DFGla~~~~~~~  651 (662)
                      ++|+|.++|.+.  ...+++..+..|+.||+.||.|||+++   ||||||||+||||+.  ++.+||+|||+|+.+....
T Consensus       106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999998542  345899999999999999999999998   999999999999964  6789999999999886554

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-31  Score=269.54  Aligned_cols=157  Identities=27%  Similarity=0.475  Sum_probs=126.6

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEe--CCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVE--REENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV  569 (662)
                      ++|++.+.||+|+||+||+|+.. +++.||||.+....  ....+.|.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999975 68999999986532  3345679999999999999999999999975  3457899


Q ss_pred             EEccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          570 YEYMPNKSLDSFLFDPQ-RQSLLDWPKRFNIIKGISRGLLYLHRDS--RLRIIHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      |||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+++  ..+||||||||+||||++++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999985321 2456999999999999999999999864  23599999999999999999999999999999


Q ss_pred             ccCCc
Q 006090          647 FGGNQ  651 (662)
Q Consensus       647 ~~~~~  651 (662)
                      +..+.
T Consensus       164 ~~~~~  168 (269)
T d2java1         164 LNHDT  168 (269)
T ss_dssp             C----
T ss_pred             cccCC
Confidence            86543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-30  Score=264.78  Aligned_cols=149  Identities=29%  Similarity=0.446  Sum_probs=128.8

Q ss_pred             ccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEe----CCeeEEEE
Q 006090          498 QLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVE----REENMLIY  570 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  570 (662)
                      ++.++||+|+||+||+|+.. +++.||+|++...  .....+.|.+|+++|++++|||||++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999975 5789999998653  23345679999999999999999999999876    34578999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD-DDLNPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~ki~DFGla~~~~~  649 (662)
                      ||+++|+|.+++.+   ...+++.++..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999943   346899999999999999999999875 5699999999999996 578999999999997654


Q ss_pred             C
Q 006090          650 N  650 (662)
Q Consensus       650 ~  650 (662)
                      .
T Consensus       168 ~  168 (270)
T d1t4ha_         168 S  168 (270)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=5.6e-31  Score=271.43  Aligned_cols=170  Identities=28%  Similarity=0.486  Sum_probs=141.7

Q ss_pred             HHHhhccccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEE
Q 006090          489 ELANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCV  561 (662)
Q Consensus       489 ~l~~~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~  561 (662)
                      +++...++|++.++||+|+||+||+|+.+      +++.||||+++.... +..++|.+|++++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            44456688999999999999999999874      346899999975433 34568999999999999999999999999


Q ss_pred             eCCeeEEEEEccCCCCHHHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 006090          562 EREENMLIYEYMPNKSLDSFLFDPQ---------------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIH  620 (662)
Q Consensus       562 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  620 (662)
                      +.+..++||||+++|+|.++|....                     ....+++..++.|+.||+.||+|||+++   |||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999985321                     1235899999999999999999999988   999


Q ss_pred             cCCCCCcEEEcCCCceEEEeeCccccccCCccccccccccc
Q 006090          621 RDLKASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVG  661 (662)
Q Consensus       621 rDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~G  661 (662)
                      |||||+||||+.++.+||+|||+|+.+.+...........|
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~  204 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI  204 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence            99999999999999999999999998865543333333344

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=2.6e-30  Score=271.66  Aligned_cols=152  Identities=24%  Similarity=0.408  Sum_probs=137.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999974 68999999997655556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD--DDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~ki~DFGla~~~~~~~  651 (662)
                      ++|+|.+++..  ....+++.++..|+.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+|+.+..+.
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999988743  2345899999999999999999999988   99999999999998  57899999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-30  Score=271.22  Aligned_cols=160  Identities=28%  Similarity=0.345  Sum_probs=140.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.+.||+|+||+||+|+.. +++.||||++++.   .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999974 6899999998653   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+...
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999999987654


Q ss_pred             cccccccccccC
Q 006090          651 QDQAATKRLVGT  662 (662)
Q Consensus       651 ~~~~~~~~~~Gt  662 (662)
                      ...  ....+||
T Consensus       159 ~~~--~~~~~GT  168 (337)
T d1o6la_         159 GAT--MKTFCGT  168 (337)
T ss_dssp             TCC--BCCCEEC
T ss_pred             Ccc--cccceeC
Confidence            332  3335666

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-30  Score=265.17  Aligned_cols=152  Identities=33%  Similarity=0.591  Sum_probs=128.3

Q ss_pred             cccccccccCccCceeEEEEEEcCC-----cEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDG-----QEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      +.|++.++||+|+||+||+|+++..     ..||||++.... .....+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4578889999999999999997642     369999986533 3345679999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++++|.+++...  ...++|.+++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.+.
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999987532  345899999999999999999999988   9999999999999999999999999999886


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       162 ~~~  164 (283)
T d1mqba_         162 DDP  164 (283)
T ss_dssp             ---
T ss_pred             CCC
Confidence            543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.6e-30  Score=262.90  Aligned_cols=145  Identities=32%  Similarity=0.536  Sum_probs=125.9

Q ss_pred             cccCccCceeEEEEEEcC---CcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEccCC
Q 006090          501 NKLGQGGFGPVYKGKLQD---GQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYMPN  575 (662)
Q Consensus       501 ~~lG~G~fG~Vykg~~~~---~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  575 (662)
                      ++||+|+||+||+|.+++   ++.||||+++...  ....++|.+|+++|++++|||||+++|+|.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998753   4679999986532  2335689999999999999999999999864 557899999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCcc
Q 006090          576 KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQD  652 (662)
Q Consensus       576 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  652 (662)
                      |+|.+++.+   ...+++.+++.|+.|||+||.|||+++   |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            999999953   345899999999999999999999987   99999999999999999999999999998865543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.7e-30  Score=268.19  Aligned_cols=150  Identities=29%  Similarity=0.500  Sum_probs=133.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      +.|+..++||+|+||+||+|+.. +++.||||++.....   ...+.|.+|+++|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999965 688999999865332   33467999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      |||++|+|..++..   ...+++.++..++.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999999877632   346899999999999999999999998   999999999999999999999999999977543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2e-30  Score=267.49  Aligned_cols=152  Identities=24%  Similarity=0.372  Sum_probs=123.3

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      .+.|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++|++++|||||++++++.+++..+||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            366999999999999999999975 68899999986533 2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCceEEEeeCcccccc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLD---DDLNPKISDFGLARIFG  648 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~ki~DFGla~~~~  648 (662)
                      |+++|+|.++|..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999954   346999999999999999999999988   99999999999994   57899999999999876


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       162 ~~~  164 (307)
T d1a06a_         162 PGS  164 (307)
T ss_dssp             ---
T ss_pred             CCC
Confidence            543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.96  E-value=4.5e-30  Score=260.99  Aligned_cols=151  Identities=28%  Similarity=0.435  Sum_probs=135.2

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---------ccHHHHHHHHHHHhcCC-CCCcceeeEEEEeC
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---------QGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER  563 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~  563 (662)
                      ++|++.+.||+|+||+||+|+.. +++.+|||++.....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67999999999999999999974 689999999865321         11346889999999997 99999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          564 EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       564 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      +..+|||||+++|+|.++|..   ...+++.++..++.||++||+|||+++   |+||||||+||||++++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999953   346899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCc
Q 006090          644 ARIFGGNQ  651 (662)
Q Consensus       644 a~~~~~~~  651 (662)
                      |+.+....
T Consensus       157 a~~~~~~~  164 (277)
T d1phka_         157 SCQLDPGE  164 (277)
T ss_dssp             CEECCTTC
T ss_pred             eeEccCCC
Confidence            99886643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=5.8e-30  Score=265.18  Aligned_cols=150  Identities=31%  Similarity=0.439  Sum_probs=135.3

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.++||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57899999999999999999975 6899999998642   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+...
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998843   345788999999999999999999988   999999999999999999999999999988653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=260.68  Aligned_cols=151  Identities=31%  Similarity=0.452  Sum_probs=135.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc------cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS------GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++++..      ....+.|.+|+++|++++|||||++++++.+++..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            67999999999999999999975 68999999986421      123578999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEeeCc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL----NPKISDFGL  643 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~ki~DFGl  643 (662)
                      ||||||++|+|.++|.+   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999953   345999999999999999999999998   99999999999999876    499999999


Q ss_pred             cccccCCc
Q 006090          644 ARIFGGNQ  651 (662)
Q Consensus       644 a~~~~~~~  651 (662)
                      |+.+....
T Consensus       164 a~~~~~~~  171 (293)
T d1jksa_         164 AHKIDFGN  171 (293)
T ss_dssp             CEECTTSC
T ss_pred             hhhcCCCc
Confidence            99886543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.2e-30  Score=264.90  Aligned_cols=167  Identities=28%  Similarity=0.471  Sum_probs=141.1

Q ss_pred             hccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE  565 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~  565 (662)
                      ..++|.+.++||+|+||+||+|++.      +++.||||+++... .+....|.+|++++++++|||||+++|+|..++.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            4478889999999999999999864      25789999997533 3345679999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006090          566 NMLIYEYMPNKSLDSFLFDP-------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKI  638 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki  638 (662)
                      .++||||+++|+|.+++...       .....+++..+.+++.|||+||.|||+++   |+||||||+||||++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence            99999999999999998531       22345799999999999999999999987   999999999999999999999


Q ss_pred             EeeCccccccCCcccccccccccC
Q 006090          639 SDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       639 ~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      +|||+|+.+..........+..||
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t  198 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLP  198 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEEC
T ss_pred             eecccceeccCCcceeeccceecc
Confidence            999999988665443333333443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.3e-29  Score=260.16  Aligned_cols=152  Identities=22%  Similarity=0.343  Sum_probs=135.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      .++|.+.+.||+|+||+||+|... +++.||||.++.. ......+.+|+++|++++|||||++++++.+++..||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367999999999999999999975 6889999999763 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD--LNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~ki~DFGla~~~~~~  650 (662)
                      |++|+|.++|...  ...+++.++..|+.||++||.|||+++   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999432  335899999999999999999999988   9999999999999854  48999999999988654


Q ss_pred             c
Q 006090          651 Q  651 (662)
Q Consensus       651 ~  651 (662)
                      .
T Consensus       158 ~  158 (321)
T d1tkia_         158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=262.98  Aligned_cols=162  Identities=30%  Similarity=0.546  Sum_probs=131.7

Q ss_pred             cccccccccCccCceeEEEEEEc-CCc----EEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQ----EIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      ++|++.++||+|+||+||+|++. +++    .||||+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999865 343    5899988653 345578899999999999999999999999865 5678


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ++||+.+|+|.+++..  ....+++..+++++.|||+||.|||+++   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998854  3446899999999999999999999987   9999999999999999999999999999987


Q ss_pred             CCcccccccccccC
Q 006090          649 GNQDQAATKRLVGT  662 (662)
Q Consensus       649 ~~~~~~~~~~~~Gt  662 (662)
                      .......+....||
T Consensus       163 ~~~~~~~~~~~~gt  176 (317)
T d1xkka_         163 AEEKEYHAEGGKVP  176 (317)
T ss_dssp             TTCC--------CC
T ss_pred             cccccccccccccC
Confidence            65554444334454

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.1e-30  Score=262.09  Aligned_cols=173  Identities=27%  Similarity=0.419  Sum_probs=133.2

Q ss_pred             HHHHHhhccccccccccCccCceeEEEEEEc------CCcEEEEEEccccc-cccHHHHHHHHHHHhcC-CCCCcceeeE
Q 006090          487 FEELANATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNL-QHRNLVRLLG  558 (662)
Q Consensus       487 ~~~l~~~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nIv~l~g  558 (662)
                      ..+++...++|++.++||+|+||.||+|+..      +++.||||+++... ....+++.+|...+.++ +|+||+++++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3444445578999999999999999999864      24689999997533 34456788898888877 6899999999


Q ss_pred             EEEeCC-eeEEEEEccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006090          559 CCVERE-ENMLIYEYMPNKSLDSFLFDPQ-------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLK  624 (662)
Q Consensus       559 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk  624 (662)
                      ++.+.+ ..++|||||++|+|.++|+...             ....+++.+++.++.||++||.|||+++   |||||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence            987654 5799999999999999996422             1345899999999999999999999988   9999999


Q ss_pred             CCcEEEcCCCceEEEeeCccccccCCcccccccccccC
Q 006090          625 ASNILLDDDLNPKISDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       625 p~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      |+||||++++.+||+|||+|+..............+||
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  199 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  199 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence            99999999999999999999988766554444445665

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=3e-29  Score=264.83  Aligned_cols=151  Identities=29%  Similarity=0.394  Sum_probs=131.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc---cccHHHHHHH---HHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS---GQGQEEFMNE---VMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~---~~~~~~f~~E---~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|++.++||+|+||.||+|+.. +++.||||++.+..   ......+.+|   +++++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999975 68999999986421   2233344444   66777889999999999999999999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++|+|.++|.+   ...+++..+..++.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999953   345889999999999999999999998   999999999999999999999999999988


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       158 ~~~~  161 (364)
T d1omwa3         158 SKKK  161 (364)
T ss_dssp             SSSC
T ss_pred             CCCc
Confidence            6653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=3.6e-29  Score=262.79  Aligned_cols=150  Identities=27%  Similarity=0.367  Sum_probs=135.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      ++|++.++||+|+||.||+|+.. +++.||||++.+.   .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 6899999998642   2344577999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ||+.+|+|.+++.+   ...+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999999988643

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.9e-29  Score=255.87  Aligned_cols=153  Identities=34%  Similarity=0.507  Sum_probs=125.6

Q ss_pred             cccccccccCccCceeEEEEEEcC--C--cEEEEEEcccc---ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD--G--QEIAVKRLSKA---SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENM  567 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~--~--~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  567 (662)
                      ++|++.+.||+|+||+||+|++..  +  .+||||++++.   ..+..++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            578999999999999999998642  2  37899998653   23345789999999999999999999999965 4678


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +||||+++|+|.+++..  ....+++..++.++.|||+||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998753  2345899999999999999999999987   999999999999999999999999999998


Q ss_pred             cCCccc
Q 006090          648 GGNQDQ  653 (662)
Q Consensus       648 ~~~~~~  653 (662)
                      ......
T Consensus       162 ~~~~~~  167 (273)
T d1u46a_         162 PQNDDH  167 (273)
T ss_dssp             CC-CCE
T ss_pred             ccCCCc
Confidence            665443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=257.30  Aligned_cols=152  Identities=27%  Similarity=0.467  Sum_probs=124.2

Q ss_pred             ccccccccccCccCceeEEEEEEcC----CcEEEEEEcccccc-ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQD----GQEIAVKRLSKASG-QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENML  568 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~----~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  568 (662)
                      .++|++.+.||+|+||+||+|++..    +..||||.++.... ...+.|.+|++++++++|||||+++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999998753    34689999865433 34567999999999999999999999985 567899


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFG  648 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~  648 (662)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+|+.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998753  2345899999999999999999999988   9999999999999999999999999999876


Q ss_pred             CCc
Q 006090          649 GNQ  651 (662)
Q Consensus       649 ~~~  651 (662)
                      ...
T Consensus       160 ~~~  162 (273)
T d1mp8a_         160 DST  162 (273)
T ss_dssp             ---
T ss_pred             CCc
Confidence            543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-29  Score=258.21  Aligned_cols=153  Identities=34%  Similarity=0.602  Sum_probs=132.4

Q ss_pred             cccccccccCccCceeEEEEEEcC-Cc--EEEEEEcccc-ccccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQD-GQ--EIAVKRLSKA-SGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~-~~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|++.++||+|+||+||+|++.+ +.  .||||++... .....++|.+|+++|.++ +|||||+++|+|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578889999999999999999763 43  5788887543 334566899999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006090          570 YEYMPNKSLDSFLFDP-------------QRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNP  636 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~  636 (662)
                      |||+++|+|.++|+..             .....+++..+++++.|||+||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23457999999999999999999999987   9999999999999999999


Q ss_pred             EEEeeCccccccCC
Q 006090          637 KISDFGLARIFGGN  650 (662)
Q Consensus       637 ki~DFGla~~~~~~  650 (662)
                      ||+|||+|+.....
T Consensus       167 kl~DfG~a~~~~~~  180 (309)
T d1fvra_         167 KIADFGLSRGQEVY  180 (309)
T ss_dssp             EECCTTCEESSCEE
T ss_pred             EEcccccccccccc
Confidence            99999999876543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.1e-29  Score=259.42  Aligned_cols=167  Identities=31%  Similarity=0.463  Sum_probs=141.7

Q ss_pred             hccccccccccCccCceeEEEEEEc------CCcEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCCcceeeEEEEeCC
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQ------DGQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVERE  564 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~  564 (662)
                      ..++|++.++||+|+||.||+|++.      +++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            4478899999999999999999863      356899999975433 3456799999999999 6999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQ---------------RQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL  629 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL  629 (662)
                      ..++||||+++|+|.++|+...               ....+++..+..++.||++||+|||+++   |+||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            9999999999999999986432               2236899999999999999999999998   999999999999


Q ss_pred             EcCCCceEEEeeCccccccCCcccccccccccC
Q 006090          630 LDDDLNPKISDFGLARIFGGNQDQAATKRLVGT  662 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~Gt  662 (662)
                      ++.++.+||+|||+++..............+||
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt  210 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLP  210 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccC
Confidence            999999999999999988765544444334544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-28  Score=254.95  Aligned_cols=147  Identities=29%  Similarity=0.536  Sum_probs=128.7

Q ss_pred             ccccCccCceeEEEEEEcCC----cEEEEEEcccc-ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-CeeEEEEEcc
Q 006090          500 ANKLGQGGFGPVYKGKLQDG----QEIAVKRLSKA-SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-EENMLIYEYM  573 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~  573 (662)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|+++|++++||||++++|+|.+. ...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997532    26899999753 444567899999999999999999999998864 5789999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      ++|+|.+++...  ...+++..+++++.|+|+||.|||+.+   |+||||||+||||++++.+||+|||+++.+....
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999998643  345788999999999999999999987   9999999999999999999999999999886543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.4e-29  Score=257.22  Aligned_cols=160  Identities=31%  Similarity=0.428  Sum_probs=136.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccc---ccccHHHHHHHHHHHh-cCCCCCcceeeEEEEeCCeeEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA---SGQGQEEFMNEVMVIS-NLQHRNLVRLLGCCVEREENMLI  569 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV  569 (662)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++++.   .....+.+..|..++. .++|||||++++++.+++..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999975 6899999999653   2334566777877765 68999999999999999999999


Q ss_pred             EEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccC
Q 006090          570 YEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGG  649 (662)
Q Consensus       570 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~  649 (662)
                      |||+++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+.+..
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999953   345899999999999999999999998   99999999999999999999999999997765


Q ss_pred             CcccccccccccC
Q 006090          650 NQDQAATKRLVGT  662 (662)
Q Consensus       650 ~~~~~~~~~~~Gt  662 (662)
                      ....  .....||
T Consensus       156 ~~~~--~~~~~gt  166 (320)
T d1xjda_         156 GDAK--TNTFCGT  166 (320)
T ss_dssp             TTCC--BCCCCSC
T ss_pred             cccc--ccccCCC
Confidence            4332  2234555

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.5e-29  Score=255.03  Aligned_cols=152  Identities=28%  Similarity=0.523  Sum_probs=130.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999974 68999999986432  2346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      |+.++.+. ++.. .....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 4422 23445999999999999999999999998   9999999999999999999999999999886543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6e-29  Score=256.16  Aligned_cols=150  Identities=28%  Similarity=0.447  Sum_probs=126.3

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHH--HHHHhcCCCCCcceeeEEEEeCC----eeEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNE--VMVISNLQHRNLVRLLGCCVERE----ENML  568 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E--~~~l~~l~H~nIv~l~g~~~~~~----~~~l  568 (662)
                      .+|.+.++||+|+||+||+|+++ |+.||||+++..   ..+++..|  +..+.+++|||||+++|+|.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            45778899999999999999974 899999998642   23344444  44556789999999999998764    5789


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEEcCCCceEEEeeCc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS-----RLRIIHRDLKASNILLDDDLNPKISDFGL  643 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~ki~DFGl  643 (662)
                      |||||++|+|.++|.+    ..++|..+++++.|+|.||+|||+..     ..+|+||||||+||||+.++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            9999999999999953    35899999999999999999999741     24599999999999999999999999999


Q ss_pred             cccccCCcc
Q 006090          644 ARIFGGNQD  652 (662)
Q Consensus       644 a~~~~~~~~  652 (662)
                      ++.+....+
T Consensus       155 ~~~~~~~~~  163 (303)
T d1vjya_         155 AVRHDSATD  163 (303)
T ss_dssp             CEEEETTTT
T ss_pred             cccccCCCc
Confidence            998866443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.9e-29  Score=254.23  Aligned_cols=151  Identities=32%  Similarity=0.552  Sum_probs=126.5

Q ss_pred             ccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-CeeEEEEEc
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-EENMLIYEY  572 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey  572 (662)
                      .++|++.+.||+|+||.||+|+++ ++.||||+++..  ...++|.+|++++++++||||++++|+|.+. +..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            356888999999999999999985 789999999753  4457899999999999999999999999764 567999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      +++|+|.++|... ....++|..+++|+.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence            9999999999542 2235899999999999999999999987   9999999999999999999999999999876543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.95  E-value=9.6e-29  Score=252.70  Aligned_cols=150  Identities=26%  Similarity=0.467  Sum_probs=134.8

Q ss_pred             cccccccccCccCceeEEEEEEcCCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.++||+|+||+||+|+.++++.||||++...  .....+.|.+|+.+|++++|||||++++++.+++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578999999999999999999988999999998653  233467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      +.++.+..+..   ....+++..+..|+.||++||+|||+++   ||||||||+||||+.++.+||+|||+|......
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            98877777663   3456999999999999999999999987   999999999999999999999999999987653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-28  Score=253.30  Aligned_cols=166  Identities=28%  Similarity=0.430  Sum_probs=135.6

Q ss_pred             hccccccccccCccCceeEEEEEEcC--------CcEEEEEEcccccc-ccHHHHHHHHHHHhcC-CCCCcceeeEEEEe
Q 006090          493 ATNNFQLANKLGQGGFGPVYKGKLQD--------GQEIAVKRLSKASG-QGQEEFMNEVMVISNL-QHRNLVRLLGCCVE  562 (662)
Q Consensus       493 ~~~~f~~~~~lG~G~fG~Vykg~~~~--------~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~  562 (662)
                      ..++|.+.++||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +|||||+++|+|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            35788999999999999999998642        24799999976443 3457899999999888 79999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006090          563 REENMLIYEYMPNKSLDSFLFDPQR-------------QSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNIL  629 (662)
Q Consensus       563 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL  629 (662)
                      ++..++||||+++|+|.++|.....             ...+++.+++.++.||+.||+|||+++   ||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence            9999999999999999999964321             245899999999999999999999998   999999999999


Q ss_pred             EcCCCceEEEeeCccccccCCccccccccccc
Q 006090          630 LDDDLNPKISDFGLARIFGGNQDQAATKRLVG  661 (662)
Q Consensus       630 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~G  661 (662)
                      ++.++.+||+|||+++..............+|
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  199 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRL  199 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCC
Confidence            99999999999999998866544333333333

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.9e-29  Score=255.00  Aligned_cols=146  Identities=29%  Similarity=0.457  Sum_probs=125.9

Q ss_pred             ccccCccCceeEEEEEEc-CCcEEEEEEccccccc-----cHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEEcc
Q 006090          500 ANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQ-----GQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYEYM  573 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  573 (662)
                      .++||+|+||+||+|+.. +++.||||+++.....     ..+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999975 6899999998643221     1356899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCCc
Q 006090          574 PNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGNQ  651 (662)
Q Consensus       574 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~  651 (662)
                      +++++..++.   ....+++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9888776652   3345888999999999999999999998   9999999999999999999999999999876543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.95  E-value=2.3e-28  Score=248.72  Aligned_cols=151  Identities=23%  Similarity=0.384  Sum_probs=132.4

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc---ccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCe----
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG---QGQEEFMNEVMVISNLQHRNLVRLLGCCVEREE----  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~----  565 (662)
                      .++|++.+.||+|+||+||+|+.. +++.||||+++....   ...+.|.+|++++++++|||||++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999964 689999999975322   335679999999999999999999999987543    


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .||||||+++++|.+++..   ...+++.++..++.||++||.|||+++   |+||||||+||||+.++..+|+|||+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998843   345899999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .+...
T Consensus       160 ~~~~~  164 (277)
T d1o6ya_         160 AIADS  164 (277)
T ss_dssp             ECC--
T ss_pred             hhccc
Confidence            77543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.4e-28  Score=250.45  Aligned_cols=148  Identities=24%  Similarity=0.335  Sum_probs=126.7

Q ss_pred             ccccccc-ccCccCceeEEEEEE-cCCcEEEEEEccccccccHHHHHHHHHHHhcC-CCCCcceeeEEEEe----CCeeE
Q 006090          495 NNFQLAN-KLGQGGFGPVYKGKL-QDGQEIAVKRLSKASGQGQEEFMNEVMVISNL-QHRNLVRLLGCCVE----REENM  567 (662)
Q Consensus       495 ~~f~~~~-~lG~G~fG~Vykg~~-~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~  567 (662)
                      ++|.+.. .||+|+||+||+|+. .+++.||||+++.     ...+.+|++++.++ +|||||++++++.+    +...|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5787765 599999999999996 4689999999854     34677899987654 89999999999876    45679


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeCcc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLA  644 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFGla  644 (662)
                      +|||||++|+|.++|.+. ....+++.++..|+.||+.||+|||+++   |+||||||+|||+++   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999642 2346999999999999999999999998   999999999999986   457999999999


Q ss_pred             ccccCCc
Q 006090          645 RIFGGNQ  651 (662)
Q Consensus       645 ~~~~~~~  651 (662)
                      +......
T Consensus       162 ~~~~~~~  168 (335)
T d2ozaa1         162 KETTSHN  168 (335)
T ss_dssp             EECCCCC
T ss_pred             eeccCCC
Confidence            9886543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.1e-28  Score=246.16  Aligned_cols=150  Identities=25%  Similarity=0.394  Sum_probs=129.5

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEcccccc------ccHHHHHHHHHHHhcCC--CCCcceeeEEEEeCCe
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASG------QGQEEFMNEVMVISNLQ--HRNLVRLLGCCVEREE  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~  565 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||++.+...      ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999975 689999999864321      12234778999999986  9999999999999999


Q ss_pred             eEEEEEccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEeeCc
Q 006090          566 NMLIYEYMPN-KSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDD-LNPKISDFGL  643 (662)
Q Consensus       566 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~ki~DFGl  643 (662)
                      .++||||+.+ +++.+++..   ...+++.++..++.||++||.|||+++   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 678888743   346899999999999999999999998   9999999999999854 7999999999


Q ss_pred             cccccCC
Q 006090          644 ARIFGGN  650 (662)
Q Consensus       644 a~~~~~~  650 (662)
                      |+.....
T Consensus       158 a~~~~~~  164 (273)
T d1xwsa_         158 GALLKDT  164 (273)
T ss_dssp             CEECCSS
T ss_pred             ceecccc
Confidence            9987543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.8e-27  Score=248.31  Aligned_cols=151  Identities=24%  Similarity=0.400  Sum_probs=127.8

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc-cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC----eeE
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS-GQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE----ENM  567 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~  567 (662)
                      +.+|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+++|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357999999999999999999864 78999999997533 334568899999999999999999999997654    235


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                      +++||+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55667779999999942    35899999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       160 ~~~~  163 (345)
T d1pmea_         160 DPDH  163 (345)
T ss_dssp             CGGG
T ss_pred             cCCC
Confidence            6543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.9e-27  Score=248.66  Aligned_cols=149  Identities=28%  Similarity=0.391  Sum_probs=123.8

Q ss_pred             ccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------eeEE
Q 006090          496 NFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------ENML  568 (662)
Q Consensus       496 ~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~l  568 (662)
                      +|...++||+|+||+||+|+.. +++.||||++.....    .+.+|+++|++++||||+++++++....      ..+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999975 689999999865332    2347999999999999999999986532      3689


Q ss_pred             EEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccc
Q 006090          569 IYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIF  647 (662)
Q Consensus       569 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~  647 (662)
                      ||||++++.+..+.........+++.++..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987654444322233456999999999999999999999988   99999999999999875 8999999999988


Q ss_pred             cCCc
Q 006090          648 GGNQ  651 (662)
Q Consensus       648 ~~~~  651 (662)
                      ....
T Consensus       174 ~~~~  177 (350)
T d1q5ka_         174 VRGE  177 (350)
T ss_dssp             CTTS
T ss_pred             cCCc
Confidence            6543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.94  E-value=7.2e-27  Score=243.46  Aligned_cols=145  Identities=24%  Similarity=0.439  Sum_probs=128.0

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeC--CeeEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVER--EENMLIY  570 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~  570 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||+++.   ...+++.+|+++|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            67999999999999999999974 689999999864   33567899999999995 99999999999854  4578999


Q ss_pred             EccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEeeCccccccC
Q 006090          571 EYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDL-NPKISDFGLARIFGG  649 (662)
Q Consensus       571 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ki~DFGla~~~~~  649 (662)
                      ||+++++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999998764      24899999999999999999999998   99999999999998755 699999999998865


Q ss_pred             Cc
Q 006090          650 NQ  651 (662)
Q Consensus       650 ~~  651 (662)
                      .+
T Consensus       183 ~~  184 (328)
T d3bqca1         183 GQ  184 (328)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7e-27  Score=239.26  Aligned_cols=150  Identities=27%  Similarity=0.455  Sum_probs=134.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeCCeeEEEEE
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVEREENMLIYE  571 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  571 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  ......+.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 68899999986432  2346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccccccCC
Q 006090          572 YMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLARIFGGN  650 (662)
Q Consensus       572 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  650 (662)
                      ++.+++|..++..   ...+++..+..++.|+++||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999999888743   345789999999999999999999988   999999999999999999999999999988654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.5e-26  Score=242.86  Aligned_cols=150  Identities=27%  Similarity=0.453  Sum_probs=125.2

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeCC------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVERE------  564 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------  564 (662)
                      .++|++.++||+|+||+||+|... +++.||||+++..  .....+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999965 6899999999753  2233567899999999999999999999998765      


Q ss_pred             eeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCcc
Q 006090          565 ENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLA  644 (662)
Q Consensus       565 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla  644 (662)
                      ..++||||+ +.+|..++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 567877763    345899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCc
Q 006090          645 RIFGGNQ  651 (662)
Q Consensus       645 ~~~~~~~  651 (662)
                      +......
T Consensus       169 ~~~~~~~  175 (346)
T d1cm8a_         169 RQADSEM  175 (346)
T ss_dssp             EECCSSC
T ss_pred             eccCCcc
Confidence            9886543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.3e-27  Score=243.47  Aligned_cols=152  Identities=29%  Similarity=0.382  Sum_probs=133.3

Q ss_pred             cccccccccCccCceeEEEEEEc----CCcEEEEEEccccc----cccHHHHHHHHHHHhcCCC-CCcceeeEEEEeCCe
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ----DGQEIAVKRLSKAS----GQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREE  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~----~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~  565 (662)
                      ++|++.++||+|+||+||+|+..    +|+.||||.+++..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999852    47899999986432    2345678899999999966 899999999999999


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||||+.+|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999843   334678889999999999999999988   9999999999999999999999999999


Q ss_pred             cccCCcc
Q 006090          646 IFGGNQD  652 (662)
Q Consensus       646 ~~~~~~~  652 (662)
                      .+.....
T Consensus       178 ~~~~~~~  184 (322)
T d1vzoa_         178 EFVADET  184 (322)
T ss_dssp             ECCGGGG
T ss_pred             hhccccc
Confidence            8865443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.2e-26  Score=237.45  Aligned_cols=151  Identities=28%  Similarity=0.508  Sum_probs=128.1

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEcccc--ccccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-------
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKA--SGQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-------  563 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-------  563 (662)
                      .++|++.++||+|+||+||+|+.. +++.||||++...  .....+++.+|+++|++++||||+++++.+...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999974 7899999998543  334467899999999999999999999998653       


Q ss_pred             -CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeC
Q 006090          564 -EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFG  642 (662)
Q Consensus       564 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFG  642 (662)
                       ...++||||++++.+..+..   ....+++..+..++.||++||.|||+++   |+||||||+||||++++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence             45789999998887776552   3345888999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCC
Q 006090          643 LARIFGGN  650 (662)
Q Consensus       643 la~~~~~~  650 (662)
                      +|+.+...
T Consensus       163 ~~~~~~~~  170 (318)
T d3blha1         163 LARAFSLA  170 (318)
T ss_dssp             TCEECCC-
T ss_pred             eeeecccc
Confidence            99877643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.93  E-value=7.1e-26  Score=231.95  Aligned_cols=148  Identities=18%  Similarity=0.312  Sum_probs=128.9

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCC-CCcceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQH-RNLVRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||.+...  .....+++|++.++.++| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            67999999999999999999965 6889999987543  233457789999999965 8999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCceEEEeeCccccc
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD-----DLNPKISDFGLARIF  647 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~ki~DFGla~~~  647 (662)
                      + +++|.+++...  ...+++.++..++.|++.||.|||+++   |+||||||+||||+.     ++.+||+|||+|+.+
T Consensus        83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9 68999988542  335899999999999999999999988   999999999999975     568999999999988


Q ss_pred             cCC
Q 006090          648 GGN  650 (662)
Q Consensus       648 ~~~  650 (662)
                      ...
T Consensus       157 ~~~  159 (293)
T d1csna_         157 RDP  159 (293)
T ss_dssp             BCT
T ss_pred             ccC
Confidence            654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.4e-26  Score=234.92  Aligned_cols=152  Identities=28%  Similarity=0.468  Sum_probs=124.8

Q ss_pred             ccccccccccCccCceeEEEEEEc-C-CcEEEEEEccccc--cccHHHHHHHHHHHhcC---CCCCcceeeEEEEe----
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-D-GQEIAVKRLSKAS--GQGQEEFMNEVMVISNL---QHRNLVRLLGCCVE----  562 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~-~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~----  562 (662)
                      .++|++.++||+|+||+||+|+.. + ++.||||+++...  ......+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 5679999986432  22234566777776655   89999999999864    


Q ss_pred             -CCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEee
Q 006090          563 -REENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDF  641 (662)
Q Consensus       563 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DF  641 (662)
                       ....+++|||++++.+......  ....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             2457899999998877655432  3445899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCC
Q 006090          642 GLARIFGGN  650 (662)
Q Consensus       642 Gla~~~~~~  650 (662)
                      |+++.....
T Consensus       161 g~~~~~~~~  169 (305)
T d1blxa_         161 GLARIYSFQ  169 (305)
T ss_dssp             CSCCCCCGG
T ss_pred             hhhhhhccc
Confidence            999976543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8.5e-26  Score=237.22  Aligned_cols=150  Identities=29%  Similarity=0.419  Sum_probs=126.8

Q ss_pred             ccccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC-----Ce
Q 006090          494 TNNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER-----EE  565 (662)
Q Consensus       494 ~~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  565 (662)
                      .++|++.++||+|+||+||+|+.. +++.||||+++...  ....+.+.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999964 68999999997532  23456789999999999999999999998643     33


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++++||+.+|+|.+++..    ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+|.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            4677888889999999943    35899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .....
T Consensus       170 ~~~~~  174 (348)
T d2gfsa1         170 HTDDE  174 (348)
T ss_dssp             CCTGG
T ss_pred             ccCcc
Confidence            77543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=5e-25  Score=226.29  Aligned_cols=149  Identities=24%  Similarity=0.387  Sum_probs=122.8

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc-ceeeEEEEeCCeeEEEEEc
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL-VRLLGCCVEREENMLIYEY  572 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey  572 (662)
                      ++|++.++||+|+||.||+|+.. +++.||||.+....  ...++..|++++++++|+|+ +.+.++..+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999964 68999999876532  33467899999999987665 4555666778888999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEeeCccccccC
Q 006090          573 MPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDD---DLNPKISDFGLARIFGG  649 (662)
Q Consensus       573 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~ki~DFGla~~~~~  649 (662)
                      + +++|.+.+..  ....+++..+..++.|++.||+|||+++   ||||||||+|||++.   +..+||+|||+|+.+..
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 4566666533  2345899999999999999999999998   999999999999864   55799999999999865


Q ss_pred             Cc
Q 006090          650 NQ  651 (662)
Q Consensus       650 ~~  651 (662)
                      ..
T Consensus       159 ~~  160 (299)
T d1ckia_         159 AR  160 (299)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=7.1e-25  Score=230.70  Aligned_cols=147  Identities=29%  Similarity=0.431  Sum_probs=120.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccc--cccHHHHHHHHHHHhcCCCCCcceeeEEEEeC------Ce
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKAS--GQGQEEFMNEVMVISNLQHRNLVRLLGCCVER------EE  565 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~  565 (662)
                      ++|++.++||+|+||+||+|... +++.||||++....  ......+.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999975 68999999996432  23445789999999999999999999999643      57


Q ss_pred             eEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          566 NMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       566 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .|+||||+.++.+. .+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999765554 442     24789999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 006090          646 IFGGN  650 (662)
Q Consensus       646 ~~~~~  650 (662)
                      .....
T Consensus       168 ~~~~~  172 (355)
T d2b1pa1         168 TAGTS  172 (355)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87654

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.85  E-value=2.3e-21  Score=167.85  Aligned_cols=112  Identities=25%  Similarity=0.444  Sum_probs=93.2

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      +|+|.+||.|.+|+.|+|  |.|.|.|+.++ +     |.++..      .++||.||++.|.  ..+.|.|+.||+|+|
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DG-N-----Lvly~~------~~~vW~s~~~~~~--~~~~l~l~~dGnLvl   64 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDC-N-----LVLYDN------NRAVWASGTNGKA--SGCVLKMQNDGNLVI   64 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTS-C-----EEEEET------TEEEEECCCTTSC--SSEEEEECTTSCEEE
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCC-C-----EEEEcC------CcEEEEccCccCC--CCcEEEEeccccEEE
Confidence            489999999999999985  99999999988 4     555543      3899999999874  457899999999999


Q ss_pred             EcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCcc
Q 006090          104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTD  155 (662)
Q Consensus       104 ~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtD  155 (662)
                      +|. +.++|++++..  ..+...|+|+|+|||||++. .+.++|||+.+|++
T Consensus        65 ~~~-~~~~w~s~t~~--~~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          65 YSG-SRAIWASNTNR--QNGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN  112 (112)
T ss_dssp             EET-TEEEEECCCCC--SCCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred             Eec-CCeEEEEeecc--CCCceEEEEcCCCCEEEECC-CCcEEecCCCccCC
Confidence            997 56777777653  33567899999999999986 46689999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=7.2e-22  Score=188.72  Aligned_cols=135  Identities=19%  Similarity=0.203  Sum_probs=107.6

Q ss_pred             ccccccCccCceeEEEEEEcCCcEEEEEEcccccc------------------ccHHHHHHHHHHHhcCCCCCcceeeEE
Q 006090          498 QLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASG------------------QGQEEFMNEVMVISNLQHRNLVRLLGC  559 (662)
Q Consensus       498 ~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~nIv~l~g~  559 (662)
                      .+.++||+|+||+||+|+..+|++||||+++....                  .....+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988899999998653110                  012345678889999999999998765


Q ss_pred             EEeCCeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006090          560 CVEREENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDSRLRIIHRDLKASNILLDDDLNPKIS  639 (662)
Q Consensus       560 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ki~  639 (662)
                      .    ..+++|||+++..+.++          +......++.|++++|+|||+++   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    24799999988765432          23345678999999999999988   9999999999999965 58999


Q ss_pred             eeCccccccCC
Q 006090          640 DFGLARIFGGN  650 (662)
Q Consensus       640 DFGla~~~~~~  650 (662)
                      |||+|+.....
T Consensus       145 DFG~a~~~~~~  155 (191)
T d1zara2         145 DFPQSVEVGEE  155 (191)
T ss_dssp             CCTTCEETTST
T ss_pred             ECCCcccCCCC
Confidence            99999887644

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.84  E-value=4.8e-21  Score=164.25  Aligned_cols=107  Identities=21%  Similarity=0.327  Sum_probs=91.2

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      +|+|.+|+.|.+|+.|.  +|.|+|.|+.+| +     |.|+..      .++||.||++.|  +..+.|.|+.||+|+|
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DG-N-----Lvly~~------~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl   64 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDC-N-----LVLYDV------DKPIWATNTGGL--SRSCFLSMQTDGNLVV   64 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTS-C-----EEEEET------TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred             CCCccCCCEecCCCEEE--cCCEEEEECCCC-e-----EEEEeC------CceeeEeCCCCC--CCccEEEEeccceEEE
Confidence            47899999999999995  599999999998 4     556543      378999999988  3457899999999999


Q ss_pred             EcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccC
Q 006090          104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE  152 (662)
Q Consensus       104 ~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~  152 (662)
                      +|++|.++|++++..  ..+...|+|+|+|||||++.    ++||||+|
T Consensus        65 ~~~~g~~vWsS~t~~--~~~~~~l~L~ddGNlVly~~----~~W~S~t~  107 (108)
T d1jpca_          65 YNPSNKPIWASNTGG--QNGNYVCILQKDRNVVIYGT----DRWATGTH  107 (108)
T ss_dssp             ECTTCCEEEECCCCC--SCSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred             ECCCccceEEccccC--CCCcEEEEEcCCCCEEEeCC----CcccCCCC
Confidence            999999999999764  33456799999999999963    49999988

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.84  E-value=1.2e-20  Score=161.84  Aligned_cols=108  Identities=20%  Similarity=0.313  Sum_probs=91.1

Q ss_pred             cccccCCCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEE
Q 006090           24 TDTITSSQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVV  103 (662)
Q Consensus        24 ~~~l~~g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l  103 (662)
                      .|+|.+|+.|.+|+.|.+  |.|.|+|+.++ +     |.++. .     .++||+||++.|+. ..++|.|+.||+|||
T Consensus         1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dg-n-----Lvl~~-~-----~~~vW~ant~~~~~-~~~~l~l~~dGnLvl   65 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDC-N-----LVLYD-H-----STSVWASNTGILGK-KGCKAVLQSDGNFVV   65 (109)
T ss_dssp             CCEEETTCEEETTCEEEE--TTEEEEECTTS-C-----EEEEE-T-----TEEEEECCCCCTTC-CCCEEEECTTSCEEE
T ss_pred             CCCccCCCEEeCCCEEEe--CCEEEEecCCC-e-----EEEEe-C-----CEEEEEeCCCCCCc-eeEEEEEcCCceEEE
Confidence            378999999999999975  88999999887 4     44443 2     38899999999975 457899999999999


Q ss_pred             EcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccC
Q 006090          104 LNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQE  152 (662)
Q Consensus       104 ~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~  152 (662)
                      +|++|.++|+|++..  ..+...|+|+|+|||||++.    ++|||+-|
T Consensus        66 ~~~~g~~vW~s~t~~--~~~~~~l~L~ddGNlvly~~----~~W~S~t~  108 (109)
T d1kj1a_          66 YDAEGRSLWASHSVR--GNGNYVLVLQEDGNVVIYGS----DIWSTGTY  108 (109)
T ss_dssp             ECSSSCEEEECCCCC--CSSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred             EeCCCcEEEEEeeEC--CCCCEEEEEeCCCcEEEECC----CEecCCCc
Confidence            999999999999864  34567899999999999953    59999865

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.83  E-value=6e-21  Score=200.81  Aligned_cols=152  Identities=22%  Similarity=0.279  Sum_probs=120.4

Q ss_pred             cccccccccCccCceeEEEEEEc-CCcEEEEEEccccccccHHHHHHHHHHHhcCC-----------CCCcceeeEEEEe
Q 006090          495 NNFQLANKLGQGGFGPVYKGKLQ-DGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-----------HRNLVRLLGCCVE  562 (662)
Q Consensus       495 ~~f~~~~~lG~G~fG~Vykg~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~g~~~~  562 (662)
                      ++|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999974 6899999999753 233567788999888775           5789999998865


Q ss_pred             C--CeeEEEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCC-----
Q 006090          563 R--EENMLIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHR-DSRLRIIHRDLKASNILLDDDL-----  634 (662)
Q Consensus       563 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~-----  634 (662)
                      .  ...+++++++..+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            4  4556777776655433332223344568899999999999999999998 55   99999999999998765     


Q ss_pred             -ceEEEeeCccccccCC
Q 006090          635 -NPKISDFGLARIFGGN  650 (662)
Q Consensus       635 -~~ki~DFGla~~~~~~  650 (662)
                       .+||+|||.|+.....
T Consensus       169 ~~~kl~dfg~s~~~~~~  185 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH  185 (362)
T ss_dssp             EEEEECCCTTCEETTBC
T ss_pred             ceeeEeecccccccccc
Confidence             3999999999876543

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.67  E-value=6.2e-17  Score=140.65  Aligned_cols=102  Identities=22%  Similarity=0.338  Sum_probs=84.2

Q ss_pred             EEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCC
Q 006090           64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQ  143 (662)
Q Consensus        64 iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~  143 (662)
                      |||.++  +.++.+|+++++.|+....-+|.++.||||+|++. +.++|++++..  ......|.|+++|||||++. .+
T Consensus        12 il~~~~--~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~-~~   85 (120)
T d1dlpa2          12 ILYSTQ--GNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTN-QN   85 (120)
T ss_dssp             ECCCC----CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCS--SCSSCEEEEETTTEEEEEET-TT
T ss_pred             EEEcCC--CCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEcccc--CCCcEEEEEeCCeeEEEEcC-CC
Confidence            899887  88899999999999987767999999999999986 67889999864  33457899999999999986 46


Q ss_pred             ceeeeeccCCccccccCCcccccccCCceeEEEEeccCCCCCCcceEeeecCCCCCEEE
Q 006090          144 VSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVF  202 (662)
Q Consensus       144 ~~~WQSFd~PtDTlLpg~~l~~~~~tg~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~  202 (662)
                      .++||||.                               +..+|.|.|.||++|...++
T Consensus        86 ~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          86 IAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             EEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             CEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence            78999973                               23567899999999986654

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.65  E-value=6.9e-16  Score=133.53  Aligned_cols=101  Identities=19%  Similarity=0.366  Sum_probs=80.0

Q ss_pred             CcccCCCeE--EecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEEcCCC
Q 006090           31 QFIRDPESI--ISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKK  108 (662)
Q Consensus        31 ~~l~~~~~l--~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~~~~~  108 (662)
                      +.|.++|.|  .+..|.|.|.|+.+| +     |.+ |..     .++||.+|+..+.  ..+.|.|+.||+|+|+|++|
T Consensus        15 ~~l~~~q~l~~~~~~~~y~l~mQ~DG-N-----LVL-y~~-----~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~g   80 (119)
T d1b2pa_          15 QILHATESLEILFGTHVYRFIMQTDC-N-----LVL-YDN-----NNPIWATNTGGLG--NGCRAVLQPDGVLVVITNEN   80 (119)
T ss_dssp             CEEETTCEEEEEETTEEEEEEECTTS-C-----EEE-EET-----TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTC
T ss_pred             CEEeCCCeEEEecCCceEEEEECCCC-c-----EEE-EEC-----CeEEEEecCCCCC--cceEEEEEeCCCEEEECCCC
Confidence            445555544  567999999999998 5     433 432     3789999998773  45789999999999999999


Q ss_pred             CEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeecc
Q 006090          109 QVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQ  151 (662)
Q Consensus       109 ~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd  151 (662)
                      .++|++++.+  ..+..+|+|+|+|||||++.    ++|||-.
T Consensus        81 ~~vWsS~t~~--~~~~~~l~Lq~DGNlvlYg~----~~W~S~T  117 (119)
T d1b2pa_          81 VTVWQSPVAG--KAGHYVLVLQPDRNVVIYGD----ALWATQT  117 (119)
T ss_dssp             CEEEECSCCC--CSSCEEEEECTTSCEEEEES----EEEECCC
T ss_pred             cEEEECCCcC--CCCceEEEEcCCCCEEEECC----CEeccCC
Confidence            9999999864  33556899999999999953    6999964

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.59  E-value=3.6e-16  Score=134.40  Aligned_cols=110  Identities=25%  Similarity=0.350  Sum_probs=88.9

Q ss_pred             EEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCC
Q 006090           64 IWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQ  143 (662)
Q Consensus        64 iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~  143 (662)
                      |||.-.  .+.+..|+.+.+.++.....+|.|+.||||||++ ++.++|++++.+   ..+..|.|+|+|||||++. .+
T Consensus         3 ~~~~~~--~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~-~~   75 (115)
T d1dlpa1           3 ILFGLS--HEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG---ATGCRAVLQSDGLLVILTA-QN   75 (115)
T ss_dssp             CCBCSS--SSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCT-TT
T ss_pred             EEEecC--CCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCC---CCceEEEEeccCCEEEEcc-CC
Confidence            566543  6667779999999998777799999999999998 478899999863   3578899999999999986 45


Q ss_pred             ceeeeeccCCccccccCCcccccccCCceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          144 VSIWDSFQEPTDTFYSEMKVSTDLRTGKKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       144 ~~~WQSFd~PtDTlLpg~~l~~~~~tg~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                      .+||||+.                               +.++|.|.|.|+++|...+  + .  .+||.+|+
T Consensus        76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvl--Y-~--~~~Wssgt  112 (115)
T d1dlpa1          76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTI--Y-G--PGLWDSGT  112 (115)
T ss_dssp             CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEE--E-C--SEEEECSC
T ss_pred             CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEE--e-C--CCeecCCC
Confidence            68999863                               3467899999999998654  3 3  37999886

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.47  E-value=3.1e-14  Score=122.07  Aligned_cols=97  Identities=23%  Similarity=0.373  Sum_probs=75.7

Q ss_pred             CcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEEcCCCCE
Q 006090           31 QFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQV  110 (662)
Q Consensus        31 ~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~~~~~~~  110 (662)
                      |+|.+++.|  .+|.|.|.|+.+| +     |.++. .     ..+||.+|...+   ..+++.|+.||+|||+|.++.+
T Consensus        15 ~tl~~~~~l--~~g~~~l~~q~DG-N-----LvL~~-~-----~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~   77 (115)
T d1dlpa1          15 QTLHAAQSL--ELSSFRFTMQSDC-N-----LVLFD-S-----DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTI   77 (115)
T ss_dssp             SCCCTTCEE--CSTTEEEEECTTS-C-----EEEEE-S-----SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCC
T ss_pred             ceecCCCcE--EcCCEEEEECCCC-e-----EEEEc-C-----CeeEEEcccCCC---CceEEEEeccCCEEEEccCCCE
Confidence            445555555  3577999999998 4     55543 2     378999997653   3478999999999999999999


Q ss_pred             EEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeec
Q 006090          111 HWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSF  150 (662)
Q Consensus       111 ~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSF  150 (662)
                      ||++.+..  ..+...++|+++|||||++    .++|+|-
T Consensus        78 vWsS~t~~--~~g~y~l~Lq~DGNlvlY~----~~~Wssg  111 (115)
T d1dlpa1          78 RWSSGTKG--SIGNYVLVLQPDRTVTIYG----PGLWDSG  111 (115)
T ss_dssp             SCCCCCCC--CSSCCEEEECSSSCEEEEC----SEEEECS
T ss_pred             EEEcCCCC--CCCCEEEEECCCCcEEEeC----CCeecCC
Confidence            99999874  3456789999999999994    3699984

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.24  E-value=1.2e-11  Score=106.87  Aligned_cols=98  Identities=18%  Similarity=0.306  Sum_probs=73.7

Q ss_pred             CCcccCCCeEEecCCeEEEeeeCCCCCCCceEEEEEecCCCCCCCcEEEEccCCCCCCCCCceEEEecCccEEEEcCCCC
Q 006090           30 SQFIRDPESIISSGSKFKLGFFSPDGNFTNRYIGIWYNKGGSANKTVVWVANRNKPLIDSSGIFTISEDGNLVVLNGKKQ  109 (662)
Q Consensus        30 g~~l~~~~~l~S~~g~f~lgf~~~~~~~~~~~l~iw~~~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~G~l~l~~~~~~  109 (662)
                      .+.|.+++.|.  .|.|.|.|..+| +     |.++..      ..+||.++....  +..+.+.|+.+|||||+|.++.
T Consensus        23 ~~~l~~~q~l~--~g~y~L~~q~DG-N-----LvL~~~------~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~~~~   86 (120)
T d1dlpa2          23 PQTLHATQSLQ--LSPYRLSMETDC-N-----LVLFDR------DDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNI   86 (120)
T ss_dssp             CCEECSSCCCB--CSSCEEEEETTT-E-----EEEEBT------TBCCSCCCCCSS--CSSCEEEEETTTEEEEEETTTE
T ss_pred             ccEEcCCCeeE--cCCEEEEEcCCC-c-----EEEecC------CcEEEEEccccC--CCcEEEEEeCCeeEEEEcCCCC
Confidence            34455555542  466999999888 3     545432      367899986543  4457899999999999999999


Q ss_pred             EEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeee
Q 006090          110 VHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDS  149 (662)
Q Consensus       110 ~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQS  149 (662)
                      ++|++++..  ..+...++|+++||||||+    .++|.|
T Consensus        87 ~lW~S~t~~--~~~~~~l~Lq~DGnlvlY~----~~~W~t  120 (120)
T d1dlpa2          87 AVWTSGNSR--SAGRYVFVLQPDRNLAIYG----GALWTT  120 (120)
T ss_dssp             EEEECCCCC--SSSCCEEEECSSSCEEEEC----CCCCBC
T ss_pred             EEEEeCCCC--CCCcEEEEECCCCcEEEeC----CCcccC
Confidence            999999864  3356789999999999994    258976

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.03  E-value=5.9e-10  Score=95.62  Aligned_cols=85  Identities=24%  Similarity=0.420  Sum_probs=65.5

Q ss_pred             eEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCCc
Q 006090           92 IFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTGK  171 (662)
Q Consensus        92 ~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg~  171 (662)
                      +|.++.||||||+++ +.++|++++.+  ......+.|+++|||||++. .+.++|+|.                     
T Consensus        33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~--~~~~~~l~l~~dGnLvL~d~-~g~~vWsS~---------------------   87 (119)
T d1b2pa_          33 RFIMQTDCNLVLYDN-NNPIWATNTGG--LGNGCRAVLQPDGVLVVITN-ENVTVWQSP---------------------   87 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTT--SCSSCEEEECTTSCEEEECT-TCCEEEECS---------------------
T ss_pred             EEEECCCCcEEEEEC-CeEEEEecCCC--CCcceEEEEEeCCCEEEECC-CCcEEEECC---------------------
Confidence            689999999999976 56899999864  33467899999999999986 456789862                     


Q ss_pred             eeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          172 KVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       172 ~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                +.-+.|.|.+.|+++|...++   .  .+.|.+++
T Consensus        88 ----------t~~~~~~~~l~Lq~DGNlvlY---g--~~~W~S~T  117 (119)
T d1b2pa_          88 ----------VAGKAGHYVLVLQPDRNVVIY---G--DALWATQT  117 (119)
T ss_dssp             ----------CCCCSSCEEEEECTTSCEEEE---E--SEEEECCC
T ss_pred             ----------CcCCCCceEEEEcCCCCEEEE---C--CCEeccCC
Confidence                      112456788999999986654   2  36898875

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.00  E-value=1.2e-09  Score=92.34  Aligned_cols=88  Identities=25%  Similarity=0.444  Sum_probs=66.4

Q ss_pred             ceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           91 GIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        91 ~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      -+|.|+.||||||+. .+.+||++++.. .......+.|+++|||||++. .+.++|+|     +|              
T Consensus        21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~-~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s-----~t--------------   78 (109)
T d1kj1a_          21 YHFIMQEDCNLVLYD-HSTSVWASNTGI-LGKKGCKAVLQSDGNFVVYDA-EGRSLWAS-----HS--------------   78 (109)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCCC-TTCCCCEEEECTTSCEEEECS-SSCEEEEC-----CC--------------
T ss_pred             EEEEecCCCeEEEEe-CCEEEEEeCCCC-CCceeEEEEEcCCceEEEEeC-CCcEEEEE-----ee--------------
Confidence            479999999999987 567899999864 223456799999999999986 46779987     11              


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCCC
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGPW  217 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~~  217 (662)
                                  ....|.|.+.|+++|...++   +  .+.|.|+++
T Consensus        79 ------------~~~~~~~~l~L~ddGNlvly---~--~~~W~S~t~  108 (109)
T d1kj1a_          79 ------------VRGNGNYVLVLQEDGNVVIY---G--SDIWSTGTY  108 (109)
T ss_dssp             ------------CCCSSCCEEEECTTSCEEEE---C--CEEEECCCC
T ss_pred             ------------ECCCCCEEEEEeCCCcEEEE---C--CCEecCCCc
Confidence                        11346788999999986543   3  358988764

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.99  E-value=9.6e-10  Score=92.86  Aligned_cols=86  Identities=23%  Similarity=0.402  Sum_probs=64.9

Q ss_pred             ceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           91 GIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        91 ~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      -+|.++.||||||++. +.+||++++..  ......+.|+++|||||++. .+.++|+|                     
T Consensus        21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~--~~~~~~l~l~~~Gnlvl~~~-~g~~vWsS---------------------   75 (108)
T d1jpca_          21 FVFIMQEDCNLVLYDV-DKPIWATNTGG--LSRSCFLSMQTDGNLVVYNP-SNKPIWAS---------------------   75 (108)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTT--SCSSCEEEECTTSCEEEECT-TCCEEEEC---------------------
T ss_pred             EEEEECCCCeEEEEeC-CceeeEeCCCC--CCCccEEEEeccceEEEECC-CccceEEc---------------------
Confidence            4799999999999974 67899999864  22456899999999999986 46789986                     


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                .+....+.|.+.|+++|...++   ..  +.|.++.
T Consensus        76 ----------~t~~~~~~~~l~L~ddGNlVly---~~--~~W~S~t  106 (108)
T d1jpca_          76 ----------NTGGQNGNYVCILQKDRNVVIY---GT--DRWATGT  106 (108)
T ss_dssp             ----------CCCCSCSCEEEEECTTSCEEEE---EC--CCCCCCC
T ss_pred             ----------cccCCCCcEEEEEcCCCCEEEe---CC--CcccCCC
Confidence                      1112456788999999986654   22  4787764

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.82  E-value=1.4e-08  Score=86.21  Aligned_cols=88  Identities=24%  Similarity=0.426  Sum_probs=65.7

Q ss_pred             ceEEEecCccEEEEcCCCCEEEeeccccCcCCccceEEEccCCCEEEEeCCCCceeeeeccCCccccccCCcccccccCC
Q 006090           91 GIFTISEDGNLVVLNGKKQVHWSSNVSSLANNSNTRAQLLDSGNLVLHDNISQVSIWDSFQEPTDTFYSEMKVSTDLRTG  170 (662)
Q Consensus        91 ~~l~~~~~G~l~l~~~~~~~~w~~~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WQSFd~PtDTlLpg~~l~~~~~tg  170 (662)
                      -.|.|+.||||||++ .+.+||++++..  ....+.+.|+.+|||||++.  +.++|.|                     
T Consensus        21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~--~~~~~~l~l~~dGnLvl~~~--~~~~w~s---------------------   74 (112)
T d1xd5a_          21 YLFIIQNDCNLVLYD-NNRAVWASGTNG--KASGCVLKMQNDGNLVIYSG--SRAIWAS---------------------   74 (112)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCTT--SCSSEEEEECTTSCEEEEET--TEEEEEC---------------------
T ss_pred             EEEEEcCCCCEEEEc-CCcEEEEccCcc--CCCCcEEEEeccccEEEEec--CCeEEEE---------------------
Confidence            479999999999987 467999999764  33567899999999999984  4456654                     


Q ss_pred             ceeEEEEeccCCCCCCcceEeeecCCCCCEEEEEECCCeeeeccCC
Q 006090          171 KKVQLTSWRSLSNPSIGSFSAGLDSFTIPEVFIWINGTRPYWRSGP  216 (662)
Q Consensus       171 ~~~~L~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~yw~~g~  216 (662)
                                .+.-..|.|.+.|+++|...++  .....+.|.|++
T Consensus        75 ----------~t~~~~~~~~l~L~ddGNlvly--~~~~~~~W~S~t  108 (112)
T d1xd5a_          75 ----------NTNRQNGNYYLILQRDRNVVIY--DNSNNAIWATHT  108 (112)
T ss_dssp             ----------CCCCSCCCCEEEECTTSCEEEE--CTTSCEEEECCC
T ss_pred             ----------eeccCCCceEEEEcCCCCEEEE--CCCCcEEecCCC
Confidence                      1122346789999999986544  234567899875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=9.6e-08  Score=93.52  Aligned_cols=150  Identities=16%  Similarity=0.086  Sum_probs=104.8

Q ss_pred             HHHhhccccccccccCccCceeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeE
Q 006090          489 ELANATNNFQLANKLGQGGFGPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENM  567 (662)
Q Consensus       489 ~l~~~~~~f~~~~~lG~G~fG~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~  567 (662)
                      ++...-..|...+..+-++...||+.... ++.+.+|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            44444456655554444445689998754 5667788876544444456778888887763 545788899988899999


Q ss_pred             EEEEccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 006090          568 LIYEYMPNKSLDSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLHRDS---------------------------------  614 (662)
Q Consensus       568 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------  614 (662)
                      +|||++++.++.+.....        .....++.++++.++.||+..                                 
T Consensus        87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998887655211        122345666777777777531                                 


Q ss_pred             -----------------------CCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          615 -----------------------RLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       615 -----------------------~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                                             ...++|+|+.|.|||+++++.+-|.||+.+..-
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                   123789999999999998777789999988754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.03  E-value=8.7e-06  Score=78.63  Aligned_cols=132  Identities=19%  Similarity=0.173  Sum_probs=87.9

Q ss_pred             ccCccCc-eeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCC--CCCcceeeEEEEeCCeeEEEEEccCCCCH
Q 006090          502 KLGQGGF-GPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQ--HRNLVRLLGCCVEREENMLIYEYMPNKSL  578 (662)
Q Consensus       502 ~lG~G~f-G~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  578 (662)
                      .+..|.. ..||+...+++..+.+|.-....   ...+..|...++.+.  ...+.+++++..+++..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455543 67999998878888888765432   234667777777663  34477889988888889999999988665


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 006090          579 DSFLFDPQRQSLLDWPKRFNIIKGISRGLLYLH-----------------------------------------------  611 (662)
Q Consensus       579 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-----------------------------------------------  611 (662)
                      .+..        ...   ..++.++++.|+-||                                               
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        010   111222333333333                                               


Q ss_pred             ----hC----CCCceEecCCCCCcEEEcCCCceEEEeeCccccc
Q 006090          612 ----RD----SRLRIIHRDLKASNILLDDDLNPKISDFGLARIF  647 (662)
Q Consensus       612 ----~~----~~~~iiHrDlkp~NILl~~~~~~ki~DFGla~~~  647 (662)
                          ..    .++.++|+|+.|.|||++.+..+-|+||+.+..-
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g  206 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  206 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence                21    1123899999999999998877889999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.43  E-value=0.00018  Score=74.13  Aligned_cols=76  Identities=13%  Similarity=0.165  Sum_probs=49.2

Q ss_pred             ccccCccCceeEEEEEEcC-CcEEEEEEcccc-------ccccHHHHHHHHHHHhcC-CC--CCcceeeEEEEeCCeeEE
Q 006090          500 ANKLGQGGFGPVYKGKLQD-GQEIAVKRLSKA-------SGQGQEEFMNEVMVISNL-QH--RNLVRLLGCCVEREENML  568 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~-~~~vAvK~l~~~-------~~~~~~~f~~E~~~l~~l-~H--~nIv~l~g~~~~~~~~~l  568 (662)
                      .+.||.|..-.||+....+ ++.++||.-...       ..........|.+.|+.+ .+  ..+++++++  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4678999999999998754 678889864321       111233455688877766 23  345666654  5667789


Q ss_pred             EEEccCCCC
Q 006090          569 IYEYMPNKS  577 (662)
Q Consensus       569 V~Ey~~~gs  577 (662)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.61  E-value=0.0035  Score=62.27  Aligned_cols=135  Identities=16%  Similarity=0.190  Sum_probs=77.5

Q ss_pred             eeEEEEEEcCCcEEEEEEccccccccHHHHHHHHHHHhcCCCCCc--ceeeE-----EEEeCCeeEEEEEccCCCCHHH-
Q 006090          509 GPVYKGKLQDGQEIAVKRLSKASGQGQEEFMNEVMVISNLQHRNL--VRLLG-----CCVEREENMLIYEYMPNKSLDS-  580 (662)
Q Consensus       509 G~Vykg~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nI--v~l~g-----~~~~~~~~~lV~Ey~~~gsL~~-  580 (662)
                      -.||+.+.++|+.+++|..... ....+++..|...+..|...++  +..+.     ....++..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999999999999988653 2345667788888776642221  11111     2244667789999998643221 


Q ss_pred             ----H------h---c----C--CCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCce
Q 006090          581 ----F------L---F----D--PQRQSLLDWP-------------------KRFNIIKGISRGLLYLHR----DSRLRI  618 (662)
Q Consensus       581 ----~------l---~----~--~~~~~~l~~~-------------------~~~~i~~~ia~~L~yLH~----~~~~~i  618 (662)
                          +      |   +    .  ......+++.                   .+-.+...+.+.+..+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0      0   0    0  0011112221                   111122222333333332    223458


Q ss_pred             EecCCCCCcEEEcCCCceEEEeeCcccc
Q 006090          619 IHRDLKASNILLDDDLNPKISDFGLARI  646 (662)
Q Consensus       619 iHrDlkp~NILl~~~~~~ki~DFGla~~  646 (662)
                      ||+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899998874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.88  E-value=0.0068  Score=61.80  Aligned_cols=73  Identities=14%  Similarity=0.264  Sum_probs=47.8

Q ss_pred             ccccCccCceeEEEEEEcCC--------cEEEEEEccccccccHHHHHHHHHHHhcCC-CCCcceeeEEEEeCCeeEEEE
Q 006090          500 ANKLGQGGFGPVYKGKLQDG--------QEIAVKRLSKASGQGQEEFMNEVMVISNLQ-HRNLVRLLGCCVEREENMLIY  570 (662)
Q Consensus       500 ~~~lG~G~fG~Vykg~~~~~--------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  570 (662)
                      .+.|+-|-.=.+|+...+++        +.|.+++...  ........+|..+++.+. |.=..++++++.    -.+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            36777788889999987543        3455555432  223345567888888774 332457888763    26899


Q ss_pred             EccCCCCH
Q 006090          571 EYMPNKSL  578 (662)
Q Consensus       571 Ey~~~gsL  578 (662)
                      ||+++..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.98  E-value=0.083  Score=51.31  Aligned_cols=30  Identities=30%  Similarity=0.358  Sum_probs=27.1

Q ss_pred             CceEecCCCCCcEEEcCCCceEEEeeCccc
Q 006090          616 LRIIHRDLKASNILLDDDLNPKISDFGLAR  645 (662)
Q Consensus       616 ~~iiHrDlkp~NILl~~~~~~ki~DFGla~  645 (662)
                      .++||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            459999999999999998888899999875

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.80  E-value=0.08  Score=32.56  Aligned_cols=32  Identities=38%  Similarity=0.867  Sum_probs=25.7

Q ss_pred             CCCCCCCCCCCCccccCC-CCCcccccCCCccCC
Q 006090          289 NDCDVYGKCGAFGSCNSQ-KIPICSCLLGFEPKN  321 (662)
Q Consensus       289 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gF~~~~  321 (662)
                      |+|.+-..||. |-|+.- ..-.|.|-.||+|..
T Consensus         2 dECsignpCGn-GTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred             CccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence            67999999996 899753 345699999999853

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.68  E-value=0.23  Score=32.45  Aligned_cols=30  Identities=27%  Similarity=0.755  Sum_probs=23.3

Q ss_pred             CCCCC-CCCCCCCccccCC-CCCcccccCCCc
Q 006090          289 NDCDV-YGKCGAFGSCNSQ-KIPICSCLLGFE  318 (662)
Q Consensus       289 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~gF~  318 (662)
                      |+|.. ...|..+|.|... ..-.|.|++||+
T Consensus         4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~   35 (42)
T d2vj3a1           4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT   35 (42)
T ss_dssp             CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred             ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence            56875 5689999999753 345799999996